Citrus Sinensis ID: 028458

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------21
Protein Sequence
MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR
Secondary Structure (PSIPRED)
ccccHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccccccccccccccccccccccccccEEEccccccHHHHccccccccccccHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccEEEEEcccccccccccccccccccEEEEEcccc
Secondary Structure Prediction (SSPRO)
ccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEcccccccEcccccEEccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHHccccccccEEEEcccccccccccHHHHHHHHHHHHEEEcccHcccccHHHEEEEccccccccccccccEEEEEccccccccccccccccccccEEEEEEccc
Coil and Loop (DISEMBL)
MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSnilldkdmnpkisdfgmaricggnelqantsrivgtygymspeyaIQGIFSIKSDVFSFGVLLLEIAWDlwtsnrtleliddpvledeysSKQMLLRYVNIALLCVqesaddrptmnDVVCMLTNeaatllppkqpafsyvrntvtstsstgktedcsiNQVTISLLEAR
Flexible Loop (DISEMBL)
MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAatllppkqpafsYVRNTVtstsstgktedcsinqvtisllear
Low Complexity Region (SEG)
MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR
Disordered region (IsUnstruct)
*LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVR****************************
Disordered Region (DISOPRED)
MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFS**********************VTISLLEAR
Disordered Region (DISEMBL)
MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRN***********EDCSINQVTISLLEAR
Disordered Region (DISPRO)
MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRN*************CSINQVTISLLEA*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	208	2.2.26 [Sep-21-2011]
Q9ZR08	852	G-type lectin S-receptor-	yes	no	0.980	0.239	0.550	2e-61
Q39086	843	Receptor-like serine/thre	no	no	0.985	0.243	0.530	4e-61
Q9S972	847	Receptor-like serine/thre	no	no	0.985	0.242	0.534	4e-59
O81905	850	Receptor-like serine/thre	no	no	0.985	0.241	0.530	2e-58
Q9LW83	850	G-type lectin S-receptor-	no	no	0.995	0.243	0.510	3e-58
O81906	849	G-type lectin S-receptor-	no	no	0.850	0.208	0.567	4e-58
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.985	0.246	0.495	3e-56
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.985	0.243	0.491	6e-56
Q8GWJ7	645	Cysteine-rich receptor-li	no	no	0.990	0.319	0.482	1e-55
Q8GYA4	669	Cysteine-rich receptor-li	no	no	0.942	0.292	0.493	3e-55

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  235 bits (599), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 126/229 (55%), Positives = 160/229 (69%), Gaps = 25/229 (10%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LDW  R  II GIA+GLLYLHQ SR+RIIHRDLK SNILLD++MNPKISDFG+ARI GG+
Sbjct: 626 LDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGS 685

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------------------ 104
           E  ANT+R+VGTYGYMSPEYA++G+FS KSDVFSFGV+++E                   
Sbjct: 686 ETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLSL 745

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
              AWDLW + R +EL+D  +   E    +  L+ +N+ LLCVQE  +DRPTM++VV ML
Sbjct: 746 LGHAWDLWKAERGIELLDQAL--QESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFML 803

Query: 162 -TNEAATLLPPKQPAFSYVR-NTVTSTSSTGKTEDCSINQVTISLLEAR 208
            ++EAATL  PKQPAF   R  + +  SS+ K E CS N++TI+L + R
Sbjct: 804 GSSEAATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTITLEDGR 852

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  234 bits (596), Expect = 4e-61,   Method: Compositional matrix adjust.
 Identities = 123/232 (53%), Positives = 155/232 (66%), Gaps = 27/232 (11%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L+W  R  II GIA+GLLYLHQ SR RIIHRDLK SN+LLDK+M PKISDFGMARI G  
Sbjct: 613 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 672

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------------------ 104
           E +ANT R+VGTYGYMSPEYA+ GIFS+KSDVFSFGVLLLEI                  
Sbjct: 673 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 732

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSK---QMLLRYVNIALLCVQESADDRPTMNDVV 158
               W  W     LE++ DP+  D  SSK     +LR + I LLCVQE A+DRP M+ V+
Sbjct: 733 LGFVWRHWKEGNELEIV-DPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVM 791

Query: 159 CMLTNEAATLLPPKQPAFSYVRNTVT--STSSTGKTEDCSINQVTISLLEAR 208
            ML +E   +  PK+P F   R+ +   S+SST + ++C++NQ+T+S+++AR
Sbjct: 792 VMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  227 bits (578), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 124/232 (53%), Positives = 155/232 (66%), Gaps = 27/232 (11%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L+W  R  II GIA+GLLYLHQ SR RIIHRDLK SN+LLDK+M PKISDFGMARI G  
Sbjct: 617 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 676

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------------------ 104
           E +ANT R+VGTYGYMSPEYA+ GIFS+KSDVFSFGVLLLEI                  
Sbjct: 677 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 736

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSK---QMLLRYVNIALLCVQESADDRPTMNDVV 158
               W  W   + LE++ DP+  D  SS+     +LR + I LLCVQE A+DRP M+ V+
Sbjct: 737 LGFVWRHWKEGKELEIV-DPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVM 795

Query: 159 CMLTNEAATLLPPKQPAFSYVR--NTVTSTSSTGKTEDCSINQVTISLLEAR 208
            ML +E   +  PK+P F   R    V S+SST + ++C++NQVT+S+++AR
Sbjct: 796 VMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  225 bits (573), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 123/232 (53%), Positives = 156/232 (67%), Gaps = 27/232 (11%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L+W  R  II GIA+GLLYLHQ SR RIIHRDLK SNILLDK M PKISDFGMARI G +
Sbjct: 620 LNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRD 679

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------------------ 104
           E +ANT ++VGTYGYMSPEYA+ GIFS+KSDVFSFGVLLLEI                  
Sbjct: 680 ETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNL 739

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSS--KQMLLRYVNIALLCVQESADDRPTMNDVVC 159
               W  W   + LE+I DP++ D  S+  +  +LR + I LLCVQE A+DRPTM+ V+ 
Sbjct: 740 LGCVWRNWKEGKGLEII-DPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVIL 798

Query: 160 MLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTED---CSINQVTISLLEAR 208
           ML +E+ T+  PK P +   R+ + + SS+ K  D    ++NQ+T+S+L+AR
Sbjct: 799 MLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2

 Score =  224 bits (571), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 119/233 (51%), Positives = 153/233 (65%), Gaps = 26/233 (11%)

Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
           ++LDW  R RI+EGI QGLLYLH+YSR+++IHRD+K  NILLD+DMNPKISDFGMARI G
Sbjct: 619 IVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFG 678

Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI---------------- 104
             E +ANT R+ GT+GYMSPEY  +G+FS KSDVFSFGVL+LEI                
Sbjct: 679 AQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGP 738

Query: 105 ------AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
                  W+L+  NR  E+I DP L D       +LR V +ALLCVQ++ADDRP+M DVV
Sbjct: 739 LNLIVHVWNLFKENRVREVI-DPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVV 797

Query: 159 CMLTNEAATLLP-PKQPAF--SYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 208
            M+  +    L  PK+PAF     R++        + E+ S N+VTI+++EAR
Sbjct: 798 SMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850

Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  224 bits (570), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 113/199 (56%), Positives = 143/199 (71%), Gaps = 22/199 (11%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           L+DW  R  IIEGIA+GLLYLH+ SR+RIIHRDLKVSN+LLD +MNPKISDFGMARI GG
Sbjct: 622 LIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGG 681

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI----------------- 104
           N+ +ANT R+VGTYGYMSPEYA++G+FS+KSDV+SFGVLLLEI                 
Sbjct: 682 NQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSL 741

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
              AW L+T  R+ EL+D  +      SK+  LR +++A+LCVQ+SA +RP M  V+ ML
Sbjct: 742 IGYAWYLYTHGRSEELVDPKIRVT--CSKREALRCIHVAMLCVQDSAAERPNMASVLLML 799

Query: 162 TNEAATLLPPKQPAFSYVR 180
            ++ ATL  P+QP F+  R
Sbjct: 800 ESDTATLAAPRQPTFTSTR 818

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  218 bits (554), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 112/226 (49%), Positives = 149/226 (65%), Gaps = 21/226 (9%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LDW  R+ I+ GIA+G+LYLHQ SR+RIIHRDLK SNILLD +M PKISDFGMARI GGN
Sbjct: 609 LDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGN 668

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------------------ 104
           +++  TSR+VGT+GYM+PEYA++G FSIKSDV+SFGVL+LEI                  
Sbjct: 669 QMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHEESSNLVG 728

Query: 105 -AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
             WDLW +    E+ID+ + ++ Y  ++ +++ + I LLCVQE+A DR  M+ VV ML +
Sbjct: 729 HIWDLWENGEATEIIDNLMDQETYDERE-VMKCIQIGLLCVQENASDRVDMSSVVIMLGH 787

Query: 164 EAATLLPPKQPAFSYVRNTVTSTSSTGKTE-DCSINQVTISLLEAR 208
            A  L  PK PAF+  R       +  K +   S+N VT S ++ R
Sbjct: 788 NATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  217 bits (552), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 112/228 (49%), Positives = 147/228 (64%), Gaps = 23/228 (10%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           +LDW TR  I+EGI +GLLYLH+ SR++IIHRDLK SNILLD+++NPKISDFG+ARI   
Sbjct: 617 ILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRA 676

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI----------------- 104
           NE +ANT R+VGTYGYMSPEYA++G FS KSDVFS GV+ LEI                 
Sbjct: 677 NEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLN 736

Query: 105 ----AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM 160
               AW LW       L D  V +  +  ++ + + V+I LLCVQE A+DRP +++V+ M
Sbjct: 737 LLAYAWKLWNDGEAASLADPAVFDKCF--EKEIEKCVHIGLLCVQEVANDRPNVSNVIWM 794

Query: 161 LTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 208
           LT E  +L  PKQPAF   R    + SS   ++  SIN V+++ +  R
Sbjct: 795 LTTENMSLADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2

 Score =  216 bits (549), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 111/230 (48%), Positives = 145/230 (63%), Gaps = 24/230 (10%)

Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
           M LDW  R +II GIA+G+LYLHQ SR+ IIHRDLK  NILLD DMNPKI+DFGMARI G
Sbjct: 418 MKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFG 477

Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI---------------- 104
            ++ +A T R+VGTYGYMSPEYA+ G FS+KSDV+SFGVL+LEI                
Sbjct: 478 MDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESV 537

Query: 105 ------AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
                  W LW++    EL+ DP   D Y + + + R ++IALLCVQE A+DRPTM+ +V
Sbjct: 538 GNLVTYTWRLWSNGSPSELV-DPSFGDNYQTSE-ITRCIHIALLCVQEDAEDRPTMSSIV 595

Query: 159 CMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 208
            MLT     L  P+ P F +      +  S   +  CS+++ +I+ +  R
Sbjct: 596 QMLTTSLIALAEPRPPGFFFRSKQEQAGPSIDSSTHCSVDEASITRVTPR 645

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  214 bits (546), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 112/227 (49%), Positives = 146/227 (64%), Gaps = 31/227 (13%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LDW  R +II G+A+G+LYLHQ SR+ IIHRDLK SNILLD DMNPKI+DFGMARI G +
Sbjct: 442 LDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLD 501

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------------------ 104
           + + NTSRIVGTYGYMSPEYA+ G +S+KSDV+SFGVL+LEI                  
Sbjct: 502 QTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDL 561

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
              AW LW++ R LEL+D  ++E+    +  ++R V+I LLCVQE   +RPT++ +V ML
Sbjct: 562 VSYAWGLWSNGRPLELVDPAIVEN--CQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLML 619

Query: 162 TNEAATLLPPKQPAFSY--------VRNTVTSTSSTGKTEDCSINQV 200
           T+   TL  P+QP   +        +    TS S  G  +D SI  +
Sbjct: 620 TSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDI 666

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	208
302143124	233	unnamed protein product [Vitis vinifera]	0.980	0.875	0.634	2e-73
359493705	830	PREDICTED: receptor-like serine/threonin	0.980	0.245	0.638	3e-73
302143120	674	unnamed protein product [Vitis vinifera]	0.980	0.302	0.638	4e-73
297742753	637	unnamed protein product [Vitis vinifera]	0.980	0.320	0.634	2e-72
302143119	547	unnamed protein product [Vitis vinifera]	0.980	0.372	0.634	2e-72
359484155	865	PREDICTED: receptor-like serine/threonin	0.980	0.235	0.634	2e-72
357516499	750	S-locus receptor kinase [Medicago trunca	0.985	0.273	0.625	2e-72
302143125	585	unnamed protein product [Vitis vinifera]	0.975	0.347	0.638	4e-72
224106535	333	predicted protein [Populus trichocarpa]	0.985	0.615	0.621	6e-72
302143128	692	unnamed protein product [Vitis vinifera]	0.980	0.294	0.619	6e-71

>gi|302143124|emb|CBI20419.3| unnamed protein product [Vitis vinifera]

 Score =  280 bits (717), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 144/227 (63%), Positives = 169/227 (74%), Gaps = 23/227 (10%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           +L+W TRV IIEG+AQGLLYLHQYSR+RIIHRDLK SNILLDKDMNPKISDFGMARI GG
Sbjct: 10  ILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGMARIFGG 69

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI----------------- 104
           NE +A T+ IVGTYGYMSPEYA++G+FS KSDVFSFGVLLLEI                 
Sbjct: 70  NESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNL 128

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
               WDLW  +R  EL+ DP LE+   +  +LLRY+N+ LLCVQESADDRPTM+DVV ML
Sbjct: 129 LGYVWDLWKDSRGQELM-DPGLEETLPT-HILLRYINVGLLCVQESADDRPTMSDVVSML 186

Query: 162 TNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 208
            NE+  L  PKQPAFS +R+ V    S  + E CS+N VT+S++EAR
Sbjct: 187 GNESVRLPSPKQPAFSNLRSGVEPHISQNRPEVCSLNGVTLSVMEAR 233

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493705|ref|XP_003634654.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  280 bits (716), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 145/227 (63%), Positives = 170/227 (74%), Gaps = 23/227 (10%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           +L+W TRV IIEG+AQGLLYLHQYSR+RIIHRDLK SNILLDKDMNPKISDFGMARI GG
Sbjct: 607 ILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGMARIFGG 666

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI----------------- 104
           NE +  T+ IVGTYGYMSPEYA++G+FS KSDVFSFGVLLLEI                 
Sbjct: 667 NESKV-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNL 725

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
              AWDLW  +R LEL+ DP LE+   +  +LLRY+N+ LLCVQESADDRPTM+DVV ML
Sbjct: 726 LGYAWDLWKDSRGLELM-DPGLEETLPT-HILLRYINVGLLCVQESADDRPTMSDVVSML 783

Query: 162 TNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 208
            NE+  L  PKQPAFS +R+ V    S  + E CS+N VT+S++EAR
Sbjct: 784 GNESVRLPSPKQPAFSNLRSGVEPHISQNRPEVCSLNGVTLSVMEAR 830

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143120|emb|CBI20415.3| unnamed protein product [Vitis vinifera]

 Score =  279 bits (714), Expect = 4e-73,   Method: Compositional matrix adjust.
 Identities = 145/227 (63%), Positives = 170/227 (74%), Gaps = 23/227 (10%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           +L+W TRV IIEG+AQGLLYLHQYSR+RIIHRDLK SNILLDKDMNPKISDFGMARI GG
Sbjct: 451 ILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGMARIFGG 510

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI----------------- 104
           NE +  T+ IVGTYGYMSPEYA++G+FS KSDVFSFGVLLLEI                 
Sbjct: 511 NESKV-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNL 569

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
              AWDLW  +R LEL+ DP LE+   +  +LLRY+N+ LLCVQESADDRPTM+DVV ML
Sbjct: 570 LGYAWDLWKDSRGLELM-DPGLEETLPT-HILLRYINVGLLCVQESADDRPTMSDVVSML 627

Query: 162 TNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 208
            NE+  L  PKQPAFS +R+ V    S  + E CS+N VT+S++EAR
Sbjct: 628 GNESVRLPSPKQPAFSNLRSGVEPHISQNRPEVCSLNGVTLSVMEAR 674

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera]

 Score =  277 bits (708), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 144/227 (63%), Positives = 170/227 (74%), Gaps = 23/227 (10%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           +L+W TRV II+G+AQGLLYLHQYSR+RIIHRDLK SNILLDKDMNP+ISDFGMARI GG
Sbjct: 414 ILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARIFGG 473

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI----------------- 104
           NE +A T+ IVGTYGYMSPEYA++G+FS KSDVFSFGVLLLEI                 
Sbjct: 474 NESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNL 532

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
              AWDLW  +R  EL+ DP LE+   +  +LLRY+NI LLCVQESADDRPTM+DVV ML
Sbjct: 533 LGYAWDLWKDSRGQELM-DPGLEETLPT-HILLRYINIGLLCVQESADDRPTMSDVVSML 590

Query: 162 TNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 208
            NE+  L  PKQPAFS +R+ V    S  K + CS+N VT+S++EAR
Sbjct: 591 GNESVRLPSPKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 637

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143119|emb|CBI20414.3| unnamed protein product [Vitis vinifera]

 Score =  277 bits (708), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 144/227 (63%), Positives = 169/227 (74%), Gaps = 23/227 (10%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           +L+W TRV IIEG+AQGLLYLHQYSR+RIIHRDLK SNILLDKD+NPKISDFGMARI G 
Sbjct: 324 ILNWETRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDLNPKISDFGMARIFGS 383

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI----------------- 104
           NE +A T+ IVGTYGYMSPEYA++G+FS KSDVFSFGVLLLEI                 
Sbjct: 384 NESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQSDSLNL 442

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
              AWDLW  +R  EL+ DPVLE E   + +LL+Y+NI LLCVQESADDRPTM+DVV ML
Sbjct: 443 LGYAWDLWKDSRGQELM-DPVLE-EALPRHILLKYINIGLLCVQESADDRPTMSDVVSML 500

Query: 162 TNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 208
            NE+  L  PKQPAFS +R+ V       + E CS+N VT+S++EAR
Sbjct: 501 GNESLHLPSPKQPAFSNLRSGVEPHIFQNRPEMCSLNSVTLSIMEAR 547

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  277 bits (708), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 144/227 (63%), Positives = 170/227 (74%), Gaps = 23/227 (10%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           +L+W TRV II+G+AQGLLYLHQYSR+RIIHRDLK SNILLDKDMNP+ISDFGMARI GG
Sbjct: 642 ILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARIFGG 701

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI----------------- 104
           NE +A T+ IVGTYGYMSPEYA++G+FS KSDVFSFGVLLLEI                 
Sbjct: 702 NESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNL 760

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
              AWDLW  +R  EL+ DP LE+   +  +LLRY+NI LLCVQESADDRPTM+DVV ML
Sbjct: 761 LGYAWDLWKDSRGQELM-DPGLEETLPT-HILLRYINIGLLCVQESADDRPTMSDVVSML 818

Query: 162 TNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 208
            NE+  L  PKQPAFS +R+ V    S  K + CS+N VT+S++EAR
Sbjct: 819 GNESVRLPSPKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 865

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357516499|ref|XP_003628538.1| S-locus receptor kinase [Medicago truncatula] gi|355522560|gb|AET03014.1| S-locus receptor kinase [Medicago truncatula]

 Score =  277 bits (708), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 142/227 (62%), Positives = 168/227 (74%), Gaps = 22/227 (9%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           +LDW TRVRII+GIAQGLLYLHQYSR RIIHRDLK SNILLD +MNPKISDFGMARI G 
Sbjct: 526 MLDWETRVRIIDGIAQGLLYLHQYSRFRIIHRDLKASNILLDANMNPKISDFGMARIFGE 585

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI----------------- 104
           N LQANT+RIVGTYGYMSPEYA++G++SIKSDVFSFGVLLLEI                 
Sbjct: 586 NVLQANTNRIVGTYGYMSPEYAMEGVYSIKSDVFSFGVLLLEIISGKKNTGFYQTNSFNL 645

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
              AWDLWT+N  ++LID  +  D+ S+K ++ +YVNI LLCVQ+S +DRPTM+DVV M+
Sbjct: 646 LGYAWDLWTNNSGMDLIDSKL--DDISNKHLVPKYVNIGLLCVQQSPEDRPTMSDVVTMI 703

Query: 162 TNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 208
            N+  +LL PK PAF  VR    S  S    E+ S+N VT SL+EAR
Sbjct: 704 GNDTTSLLSPKPPAFQNVRGIENSRLSRSIEENVSVNVVTNSLVEAR 750

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143125|emb|CBI20420.3| unnamed protein product [Vitis vinifera]

 Score =  276 bits (706), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 145/227 (63%), Positives = 169/227 (74%), Gaps = 24/227 (10%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           +L+W TRVRIIEG+AQGLLYLHQYSR+R+IHRDLK SNILLDKDMNPKISDFGMARI GG
Sbjct: 363 ILNWETRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGG 422

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI----------------- 104
           NE +A T  IVGTYGYMSPEY ++G+FS KSDVFSFGVLLLEI                 
Sbjct: 423 NESKA-TKHIVGTYGYMSPEYVLRGLFSTKSDVFSFGVLLLEILSGKKITEFYHSDSLNL 481

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
              AWDLW +NR  ELI DPV  +E SS+ +LLRY+N+ALLCVQE+ADDRPTM+DVV ML
Sbjct: 482 LGYAWDLWKNNRGQELI-DPV-PNEISSRHILLRYINVALLCVQENADDRPTMSDVVSML 539

Query: 162 TNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 208
             E   L  P +PAFSY+R  V   +S  + E CS+N VT+S + AR
Sbjct: 540 GRENVLLSSPNEPAFSYLRG-VKPHASQERPEICSLNDVTLSSMGAR 585

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224106535|ref|XP_002333668.1| predicted protein [Populus trichocarpa] gi|222837959|gb|EEE76324.1| predicted protein [Populus trichocarpa]

 Score =  275 bits (704), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 141/227 (62%), Positives = 164/227 (72%), Gaps = 22/227 (9%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           +LDW TR+RIIEGIAQGLLYLH+YSR+RIIHRDLK SNILLD +MNPKISDFGMARI GG
Sbjct: 109 ILDWGTRIRIIEGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARIFGG 168

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI----------------- 104
           NE QANT+RIVGTYGYMSPEYA++G+FSIKSDVFSFGVL+LEI                 
Sbjct: 169 NETQANTNRIVGTYGYMSPEYAMEGLFSIKSDVFSFGVLVLEIVSGKKNTSFYHSGSLNL 228

Query: 105 ---AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
              AW LW SN+ L+L+ DP+L D  S+   LLRY+NI LLCVQES  DRPTM+DV+ M+
Sbjct: 229 LGHAWKLWNSNKALDLM-DPILGDPPSTAT-LLRYINIGLLCVQESPADRPTMSDVISMI 286

Query: 162 TNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 208
            NE   L  PKQPAF   RN     S        S+N VTI+ ++AR
Sbjct: 287 VNEHVALPEPKQPAFVAGRNVAEPRSLMSFAGVPSVNNVTITTIDAR 333

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera]

 Score =  272 bits (696), Expect = 6e-71,   Method: Compositional matrix adjust.
 Identities = 140/226 (61%), Positives = 167/226 (73%), Gaps = 22/226 (9%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LDW  RV IIEGIAQGLLYLH+YSR+RIIHRDLK SNILLD DMNPKISDFGMAR+ GGN
Sbjct: 469 LDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKISDFGMARMFGGN 528

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------------------ 104
           E  ANT+RIVGTYGYMSPEYA++G+FS KSDVFSFGVL+LEI                  
Sbjct: 529 ESYANTNRIVGTYGYMSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNTGFYNSDTLNLI 588

Query: 105 --AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLT 162
             AW+LW S+  + L+ DP+LE + SS+ MLLRY+N+ LLCV+E A DRPT+++VV MLT
Sbjct: 589 GYAWELWKSDMAINLM-DPMLEGQ-SSQYMLLRYINVGLLCVEEIAADRPTLSEVVSMLT 646

Query: 163 NEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 208
           NE A L  PK PAFS VR+     SS  + E  S N ++IS++EAR
Sbjct: 647 NELAVLPSPKHPAFSTVRSMENPRSSMSRPEIYSANGLSISVMEAR 692

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	208
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.557	0.136	0.694	2e-57
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.557	0.137	0.694	4.1e-57
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.490	0.12	0.774	1.4e-55
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.495	0.121	0.776	6.5e-54
TAIR|locus:2093397	850	CES101 "CALLUS EXPRESSION OF R	0.5	0.122	0.711	1.3e-53
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.495	0.121	0.728	1.5e-52
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.490	0.152	0.725	2e-51
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.490	0.130	0.745	1.1e-50
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	0.495	0.124	0.699	2.5e-50
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.490	0.152	0.735	3.9e-50

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 405 (147.6 bits), Expect = 2.0e-57, Sum P(2) = 2.0e-57
 Identities = 84/121 (69%), Positives = 94/121 (77%)

Query:     3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
             L+W  R  II GIA+GLLYLHQ SR RIIHRDLK SN+LLDK+M PKISDFGMARI G  
Sbjct:   617 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 676

Query:    63 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWD-----LWTSNRTLEL 117
             E +ANT R+VGTYGYMSPEYA+ GIFS+KSDVFSFGVLLLEI         + SNR L L
Sbjct:   677 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 736

Query:   118 I 118
             +
Sbjct:   737 L 737

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 405 (147.6 bits), Expect = 4.1e-57, Sum P(2) = 4.1e-57
 Identities = 84/121 (69%), Positives = 94/121 (77%)

Query:     3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
             L+W  R  II GIA+GLLYLHQ SR RIIHRDLK SN+LLDK+M PKISDFGMARI G  
Sbjct:   613 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 672

Query:    63 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWD-----LWTSNRTLEL 117
             E +ANT R+VGTYGYMSPEYA+ GIFS+KSDVFSFGVLLLEI         + SNR L L
Sbjct:   673 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 732

Query:   118 I 118
             +
Sbjct:   733 L 733

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 396 (144.5 bits), Expect = 1.4e-55, Sum P(2) = 1.4e-55
 Identities = 79/102 (77%), Positives = 87/102 (85%)

Query:     3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
             L+W  R  II GIA+GLLYLHQ SR RIIHRDLK SNILLDK M PKISDFGMARI G +
Sbjct:   620 LNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRD 679

Query:    63 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             E +ANT ++VGTYGYMSPEYA+ GIFS+KSDVFSFGVLLLEI
Sbjct:   680 ETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEI 721

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 424 (154.3 bits), Expect = 6.5e-54, Sum P(2) = 6.5e-54
 Identities = 80/103 (77%), Positives = 94/103 (91%)

Query:     2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
             L+DW  R  IIEGIA+GLLYLH+ SR+RIIHRDLKVSN+LLD +MNPKISDFGMARI GG
Sbjct:   622 LIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGG 681

Query:    62 NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             N+ +ANT R+VGTYGYMSPEYA++G+FS+KSDV+SFGVLLLEI
Sbjct:   682 NQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEI 724

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)]

 Score = 401 (146.2 bits), Expect = 1.3e-53, Sum P(2) = 1.3e-53
 Identities = 74/104 (71%), Positives = 89/104 (85%)

Query:     1 MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
             ++LDW  R RI+EGI QGLLYLH+YSR+++IHRD+K  NILLD+DMNPKISDFGMARI G
Sbjct:   619 IVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFG 678

Query:    61 GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
               E +ANT R+ GT+GYMSPEY  +G+FS KSDVFSFGVL+LEI
Sbjct:   679 AQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEI 722

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 402 (146.6 bits), Expect = 1.5e-52, Sum P(2) = 1.5e-52
 Identities = 75/103 (72%), Positives = 91/103 (88%)

Query:     2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
             LLDW  R  IIEGIA+GLLYLH+ SR+R++HRDLK SNILLD DM PKISDFGMAR+ GG
Sbjct:   623 LLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGG 682

Query:    62 NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             ++ Q NT+R+VGT+GYMSPEYA++GIFS+KSDV+ FGVL+LEI
Sbjct:   683 DQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEI 725

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 387 (141.3 bits), Expect = 2.0e-51, Sum P(2) = 2.0e-51
 Identities = 74/102 (72%), Positives = 88/102 (86%)

Query:     3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
             LDW  R +II G+A+G+LYLHQ SR+ IIHRDLK SNILLD DMNPKI+DFGMARI G +
Sbjct:   442 LDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLD 501

Query:    63 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + + NTSRIVGTYGYMSPEYA+ G +S+KSDV+SFGVL+LEI
Sbjct:   502 QTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEI 543

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 404 (147.3 bits), Expect = 1.1e-50, Sum P(2) = 1.1e-50
 Identities = 76/102 (74%), Positives = 89/102 (87%)

Query:     3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
             LDW  RV II+GIA+G+LYLH+ SR+RIIHRDLK SN+LLD DMN KISDFG+AR  GG+
Sbjct:   559 LDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGD 618

Query:    63 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             E +ANT+R+VGTYGYMSPEY I G FS+KSDVFSFGVL+LEI
Sbjct:   619 ETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEI 660

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 380 (138.8 bits), Expect = 2.5e-50, Sum P(2) = 2.5e-50
 Identities = 72/103 (69%), Positives = 89/103 (86%)

Query:     2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
             LLDW TR  II+GI +GL+YLH+ SR++IIHRDLK SNILLD+++NPKISDFG+ARI  G
Sbjct:   605 LLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQG 664

Query:    62 NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             NE + +T R+VGTYGYM+PEYA+ G+FS KSDVFS GV+LLEI
Sbjct:   665 NEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEI 707

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 385 (140.6 bits), Expect = 3.9e-50, Sum P(2) = 3.9e-50
 Identities = 75/102 (73%), Positives = 87/102 (85%)

Query:     3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
             LDW  R  II GIA+G+LYLHQ SR+ IIHRDLK SNILLD DMNPKI+DFGMARI G +
Sbjct:   439 LDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVD 498

Query:    63 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + QANT RI GT+GYMSPEYA++G FS+KSDV+SFGVL+LEI
Sbjct:   499 QSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEI 540

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	208
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-29
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-28
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-27
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-27
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-26
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-21
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-21
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-17
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-16
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-16
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-13
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-13
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-12
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-11
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-10
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-10
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-10
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-08
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-08
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-08
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-08
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	9e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-07
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-05
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.001
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.002
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.003
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.003
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  108 bits (273), Expect = 1e-29
 Identities = 45/106 (42%), Positives = 63/106 (59%), Gaps = 7/106 (6%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGG 61
           L     +RI+  I +GL YLH      IIHRDLK  NILLD D    K++DFG++++   
Sbjct: 89  LSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145

Query: 62  NELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIAW 106
           ++    T  IVGT  YM+PE  +  G +S KSD++S GV+L E+  
Sbjct: 146 DKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPE 189

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  104 bits (263), Expect = 9e-28
 Identities = 55/173 (31%), Positives = 83/173 (47%), Gaps = 25/173 (14%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L     +     IA+G+ YL      + +HRDL   N L+ +D+  KISDFG++R     
Sbjct: 102 LSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR----- 153

Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTS 111
           ++  +      T G     +M+PE    GIF+ KSDV+SFGVLL EI       +   ++
Sbjct: 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213

Query: 112 NRTLELIDDP-VLED-EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLT 162
              LE +     L   EY   ++   Y  + L C Q   +DRPT +++V  L 
Sbjct: 214 EEVLEYLRKGYRLPKPEYCPDEL---Y-ELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  104 bits (262), Expect = 1e-27
 Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 20/169 (11%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L     +     IA+G+ YL        IHRDL   N L+ +++  KISDFG++R    +
Sbjct: 99  LSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 155

Query: 63  ELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIA------WDLWTSNRTL 115
           +        +    +M+PE +++ G F+ KSDV+SFGVLL EI       +   ++   L
Sbjct: 156 DYYRKRGGKL-PIRWMAPE-SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL 213

Query: 116 ELIDDPVLEDEYSSKQMLL---RYVNIALLCVQESADDRPTMNDVVCML 161
           E      L++ Y   Q         ++ L C  E  +DRPT +++V +L
Sbjct: 214 EY-----LKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  103 bits (259), Expect = 3e-27
 Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 20/169 (11%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L     +     IA+G+ YL        IHRDL   N L+ +++  KISDFG++R    +
Sbjct: 100 LSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156

Query: 63  ELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIA------WDLWTSNRTL 115
           +        +    +M+PE +++ G F+ KSDV+SFGVLL EI       +   ++   L
Sbjct: 157 DYYKVKGGKL-PIRWMAPE-SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVL 214

Query: 116 ELIDDPVLEDEYSSKQMLL---RYVNIALLCVQESADDRPTMNDVVCML 161
           E      L+  Y   +          + L C  E  +DRPT +++V +L
Sbjct: 215 EY-----LKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (259), Expect = 5e-27
 Identities = 50/151 (33%), Positives = 73/151 (48%), Gaps = 21/151 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I +GL YLH      IIHRD+K SN+L++     KI+DFG++++      Q NT   VGT
Sbjct: 108 ILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGT 163

Query: 75  YGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIAW-----------DLWTSNRTLELIDDPV 122
             YMSPE  IQG  +S  +D++S G+ LLE A              +   + +     P 
Sbjct: 164 VTYMSPE-RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS 222

Query: 123 LEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
           L  E  S +      +    C+Q+    RP+
Sbjct: 223 LPAEEFSPEF----RDFISACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  101 bits (254), Expect = 2e-26
 Identities = 41/104 (39%), Positives = 57/104 (54%), Gaps = 6/104 (5%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L      +I   I +GL YLH      IIHRDLK  NILLD++   KI+DFG+A+    +
Sbjct: 95  LSEDEAKKIALQILRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKS 151

Query: 63  ELQANTSRIVGTYGYMSPE-YAIQGIFSIKSDVFSFGVLLLEIA 105
              ++ +  VGT  YM+PE       +  K DV+S GV+L E+ 
Sbjct: 152 --SSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELL 193

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 99.9 bits (250), Expect = 9e-26
 Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 25/172 (14%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGG 61
           L     +++   IA+G+ YL        +HRDL   N L+ +++  KISDFG++R I   
Sbjct: 99  LTLKDLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED 155

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTL 115
           +  +      +    +M+PE    G F+ KSDV+SFGVLL EI       +   ++   L
Sbjct: 156 DYYRKRGGGKL-PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL 214

Query: 116 ELIDD------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           EL++D      P    E    ++   Y  + L C     +DRPT +++V  L
Sbjct: 215 ELLEDGYRLPRP----ENCPDEL---Y-ELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 98.0 bits (245), Expect = 3e-25
 Identities = 37/91 (40%), Positives = 51/91 (56%), Gaps = 6/91 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      I+HRDLK  NILLD+D + K++DFG+AR     E     +  VGT
Sbjct: 106 ILSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGT 159

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             YM+PE  +   +    D++S GV+L E+ 
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELL 190

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 89.1 bits (222), Expect = 1e-21
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 13/106 (12%)

Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
            +LDW  +      +   L YLH  SR +I+HRD+K  NI L  +   K+ DFG++++  
Sbjct: 104 QILDWFVQ------LCLALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154

Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
                A T  +VGT  Y+SPE   Q   ++ KSD++S G +L E+ 
Sbjct: 155 STVDLAKT--VVGTPYYLSPE-LCQNKPYNYKSDIWSLGCVLYELC 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 88.8 bits (221), Expect = 1e-21
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 3/91 (3%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I +GL YLH      I+HRD+K +NIL+D D   K++DFG A+  G  E    T  + GT
Sbjct: 110 ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             +M+PE      +   +D++S G  ++E+A
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMA 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 84.6 bits (210), Expect = 4e-20
 Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 19/152 (12%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           + + + +GL YLH      IIHRD+K +NILL  D   K+ DFG++     +    NT  
Sbjct: 103 VCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNT-- 156

Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELI---DDP 121
           +VGT  +M+PE      +  K+D++S G+  +E+A       +L    + L  I     P
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL-PPMKALFKIATNGPP 215

Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
            L    + ++    + +    C+Q++ + RPT
Sbjct: 216 GL---RNPEKWSDEFKDFLKKCLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.8 bits (210), Expect = 6e-20
 Identities = 43/97 (44%), Positives = 59/97 (60%), Gaps = 9/97 (9%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           +I E + +GL YLH     +IIHRD+K SNILL +    K+ DFG++    G  + +   
Sbjct: 109 KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAG 161

Query: 70  RIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
              GT  YM+PE  IQG  +SI SDV+S G+ LLE+A
Sbjct: 162 TFTGTSFYMAPE-RIQGKPYSITSDVWSLGLTLLEVA 197

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 84.1 bits (209), Expect = 7e-20
 Identities = 35/89 (39%), Positives = 49/89 (55%), Gaps = 5/89 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH    + II+RDLK  NILLD D + K++DFG+A+    +E     +   GT
Sbjct: 102 IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKE-LSSEGSRTNT-FCGT 156

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
             Y++PE  +   +    D +S GVLL E
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYE 185

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 80.4 bits (199), Expect = 2e-18
 Identities = 41/93 (44%), Positives = 55/93 (59%), Gaps = 10/93 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR---I 71
           IA+G+ YL        IHRDL   NIL+ +++  KI+DFG+AR+   +E  A       I
Sbjct: 112 IAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI 168

Query: 72  VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             T    +PE A  G F+IKSDV+SFG+LL EI
Sbjct: 169 KWT----APEAANYGRFTIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 80.1 bits (198), Expect = 3e-18
 Identities = 42/100 (42%), Positives = 62/100 (62%), Gaps = 14/100 (14%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL---QA 66
           +I   + +GL YLH   + +IIHRD+K SNIL++     K+ DFG++      +L    A
Sbjct: 104 KIAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG-----QLVNSLA 156

Query: 67  NTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
            T   VGT  YM+PE  IQG  +S+KSD++S G+ L+E+A
Sbjct: 157 KTF--VGTSSYMAPE-RIQGNDYSVKSDIWSLGLSLIELA 193

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 79.4 bits (196), Expect = 4e-18
 Identities = 37/90 (41%), Positives = 57/90 (63%), Gaps = 5/90 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL +      IHRDL   NIL+ +D+  K++DFG+AR+   +   ++  +I   
Sbjct: 113 VAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--P 167

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           Y + +PE A  G FS KSDV+SFG+LL E+
Sbjct: 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 78.8 bits (195), Expect = 6e-18
 Identities = 35/96 (36%), Positives = 59/96 (61%), Gaps = 7/96 (7%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I+    +GL YLH     + IHRD+K  NILL+++   K++DFG++        + NT  
Sbjct: 104 ILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-- 158

Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
           ++GT  +M+PE  IQ I ++ K+D++S G+  +E+A
Sbjct: 159 VIGTPFWMAPE-VIQEIGYNNKADIWSLGITAIEMA 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.3 bits (193), Expect = 2e-17
 Identities = 38/96 (39%), Positives = 59/96 (61%), Gaps = 6/96 (6%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           +I   + +GL YL  Y+  RI+HRD+K SNIL++     K+ DFG++    G  + +   
Sbjct: 107 KIAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIAD 160

Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             VGT  YMSPE    G +++KSDV+S G+ ++E+A
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELA 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 77.5 bits (191), Expect = 2e-17
 Identities = 38/86 (44%), Positives = 52/86 (60%), Gaps = 5/86 (5%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           GL +LH     +I+HRD+K  N+ LD   N KI D G+A++   N   ANT  IVGT  Y
Sbjct: 113 GLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYY 167

Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLE 103
           +SPE      ++ KSDV++ GV+L E
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYE 193

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 77.3 bits (191), Expect = 2e-17
 Identities = 39/100 (39%), Positives = 54/100 (54%), Gaps = 7/100 (7%)

Query: 11  IIEGIAQGLLYLH-----QYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ 65
           I   + Q LL L+           ++HRDLK +NI LD + N K+ DFG+A+I G +   
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166

Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
           A T   VGT  YMSPE      +  KSD++S G L+ E+ 
Sbjct: 167 AKT--YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELC 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 76.8 bits (190), Expect = 5e-17
 Identities = 37/108 (34%), Positives = 51/108 (47%), Gaps = 24/108 (22%)

Query: 15  IAQ---GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL------- 64
            A+    L YLH      IIHRDLK  NILLDKDM+ KI+DFG A++   N         
Sbjct: 108 AAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164

Query: 65  -----------QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                      +   +  VGT  Y+SPE   +      SD+++ G ++
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCII 212

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 75.7 bits (187), Expect = 8e-17
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 9/101 (8%)

Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRI 71
           +  + QGL YLH+     +IHRD+K +NIL  KD   K++DFG+A           +  +
Sbjct: 105 VYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--V 159

Query: 72  VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSN 112
           VGT  +M+PE       S  SD++S G  ++E    L T N
Sbjct: 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIE----LLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 75.6 bits (186), Expect = 1e-16
 Identities = 45/153 (29%), Positives = 66/153 (43%), Gaps = 23/153 (15%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I  GL +LHQ    RI++RDLK  N+LLD   N +ISD G+A        +    R  GT
Sbjct: 104 IICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR-AGT 157

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI--------AWDLWTSNRTLE--LIDDPV-L 123
            GYM+PE     ++    D F+ G  L E+                  L+   ++  V  
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY 217

Query: 124 EDEYSS------KQMLLRYVNIALLCVQESADD 150
            D++S       + +L +     L C   SAD+
Sbjct: 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADE 250

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 74.9 bits (184), Expect = 2e-16
 Identities = 51/149 (34%), Positives = 75/149 (50%), Gaps = 20/149 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++    R   IHRDL+ +NIL+ + +  KI+DFG+AR+   NE  A        
Sbjct: 111 IAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-P 166

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-------TLELIDDPVLEDEY 127
             + +PE    G F+IKSDV+SFG+LL EI     T  R         E+I +  LE  Y
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV----TYGRIPYPGMTNPEVIQN--LERGY 220

Query: 128 SSKQ---MLLRYVNIALLCVQESADDRPT 153
              +          +  LC +E  ++RPT
Sbjct: 221 RMPRPDNCPEELYELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 74.4 bits (183), Expect = 4e-16
 Identities = 34/92 (36%), Positives = 47/92 (51%), Gaps = 6/92 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI--CGGNELQANTSRIV 72
           I +G+ YL      R IHRDL   NIL++ +   KISDFG+A++     +          
Sbjct: 118 ICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + Y +PE      FS  SDV+SFGV L E+
Sbjct: 175 PIFWY-APECLRTSKFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 74.2 bits (183), Expect = 4e-16
 Identities = 35/96 (36%), Positives = 56/96 (58%), Gaps = 5/96 (5%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
            +   + QGL YLH      +IHRD+K  NILL KD + K++DFG A      + + N+ 
Sbjct: 120 YVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS- 175

Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
            +VGT  +M+PE   +  +  K D++S G++ +E+A
Sbjct: 176 -VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.3 bits (183), Expect = 5e-16
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 9/92 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           I  GL +LH+     II+RDLK+ N+LLD + + KI+DFGM +  I GG      TS   
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           GT  Y++PE      +    D ++ GVLL E+
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEM 189

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.4 bits (181), Expect = 7e-16
 Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 9/95 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG------MARICGGNELQANT 68
           I   L YLH      IIHRDLK  NIL+D + + K++DFG      + R    N+ +   
Sbjct: 102 IVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158

Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
            RIVGT  Y++PE  +    S   D +S G +L E
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYE 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 74.4 bits (181), Expect = 8e-16
 Identities = 48/220 (21%), Positives = 82/220 (37%), Gaps = 26/220 (11%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN-PKISDFGMARICGGN----EL 64
            I+  I   L YLH      IIHRD+K  NILLD+D    K+ DFG+A++         +
Sbjct: 105 FILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI 161

Query: 65  QANTSRIVGTYGYMSPEYAIQGIF---SIKSDVFSFGVLLLEIA-----WDLWTSNRTLE 116
            A  S  VGT GYM+PE  +       S  SD++S G+ L E+      ++   ++    
Sbjct: 162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS 221

Query: 117 LIDDPVLEDEYSSKQMLLRY----------VNIALLCVQESADDRPTMNDVVCMLTNEAA 166
                +LE    S    L             ++    + +   +R + +  +        
Sbjct: 222 QTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281

Query: 167 TLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLE 206
            L            ++     S   + +  I+ +    + 
Sbjct: 282 KLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAIS 321

Length = 384

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 72.4 bits (177), Expect = 2e-15
 Identities = 37/91 (40%), Positives = 58/91 (63%), Gaps = 4/91 (4%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 111 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 166

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE A+ G F+IKSDV+SFG+LL E+ 
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELT 197

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.0 bits (176), Expect = 2e-15
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 20/159 (12%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  IHRDL+ +NIL+  ++  KI+DFG+AR+   NE  A        
Sbjct: 111 IADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-P 166

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLE------IAWDLWTSNRTLELIDD----PVLE 124
             + +PE A+ G F+IKSDV+SFG+LL E      + +    +   LE ++     P  +
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQ 226

Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
               S   L++      LC ++  D+RPT   +   L +
Sbjct: 227 GCPESLHELMK------LCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.5 bits (178), Expect = 2e-15
 Identities = 53/154 (34%), Positives = 74/154 (48%), Gaps = 24/154 (15%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I  G  QGL YLH + R   IHRD+K  NILL +    K++DFG A +       AN+  
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS-- 170

Query: 71  IVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIAW---DLWTSNRTLELI-----D 119
            VGT  +M+PE  +   +G +  K DV+S G+  +E+A     L+  N    L      D
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND 230

Query: 120 DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
            P L    SS      + N    C+Q+   DRP+
Sbjct: 231 SPTL----SSNDWSDYFRNFVDSCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 71.7 bits (176), Expect = 3e-15
 Identities = 36/93 (38%), Positives = 54/93 (58%), Gaps = 10/93 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A G+ YL   +    IHRDL   N+L+ ++   K++DFG+AR+   +  +A      G 
Sbjct: 112 VASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GA 164

Query: 75  ---YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
                + +PE A+   FSIKSDV+SFG+LL EI
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 71.6 bits (175), Expect = 3e-15
 Identities = 39/92 (42%), Positives = 59/92 (64%), Gaps = 8/92 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A G+ Y+    R+  IHRDL+ +NIL+   +  KI+DFG+AR+   NE    T+R    
Sbjct: 111 VAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAK 164

Query: 75  Y--GYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +   + +PE A+ G F+IKSDV+SFG+LL E+
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 71.4 bits (176), Expect = 5e-15
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 18/96 (18%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL Y H     RI+HRDLK  NIL+++D   K++DFG+AR   G  L+  T  +V T  
Sbjct: 109 RGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLW 163

Query: 77  YMSPE-------YAIQGIFSIKSDVFSFGVLLLEIA 105
           Y +PE       Y      S   D++S G +  E+ 
Sbjct: 164 YRAPEILLGSKHY------STAVDIWSVGCIFAEMI 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 70.8 bits (174), Expect = 5e-15
 Identities = 38/98 (38%), Positives = 51/98 (52%), Gaps = 7/98 (7%)

Query: 6   VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ 65
             +  I E I   L YLH      IIHRD+K  NILLD+  +  I+DF +A     + L 
Sbjct: 101 QVKFWICE-IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156

Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
            +TS   GT GYM+PE   +  +S+  D +S GV   E
Sbjct: 157 TSTS---GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYE 191

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 70.4 bits (173), Expect = 1e-14
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 3/91 (3%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL      + +HRDL   N ++ +D+  KI DFGM R     +      + +  
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             +M+PE    G+F+ KSDV+SFGV+L E+A
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 70.1 bits (171), Expect = 1e-14
 Identities = 38/90 (42%), Positives = 56/90 (62%), Gaps = 4/90 (4%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ Q +    IHRDL+ +NIL+   +  KI+DFG+AR+   NE  A        
Sbjct: 111 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-P 166

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + +PE    G F+IKSDV+SFG+LL+EI
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEI 196

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.0 bits (174), Expect = 1e-14
 Identities = 40/102 (39%), Positives = 53/102 (51%), Gaps = 26/102 (25%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I  G+ YLH   R  I+HRD+K SN+L++   N KI+DFG++RI        N+S  VGT
Sbjct: 177 ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGT 231

Query: 75  YGYMSPE-------------YAIQGIFSIKSDVFSFGVLLLE 103
             YMSPE             YA         D++S GV +LE
Sbjct: 232 IAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILE 265

Length = 353

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.3 bits (170), Expect = 2e-14
 Identities = 50/157 (31%), Positives = 68/157 (43%), Gaps = 17/157 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE----LQANTSR 70
           IA G+ YL      R IHRDL   NILL  D   KI DFG+ R    NE    ++ +   
Sbjct: 106 IANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH--L 160

Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDDPVLE 124
            V  + + +PE      FS  SDV+ FGV L E+       W   + ++ L+ ID    E
Sbjct: 161 KV-PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE-GE 218

Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                +       N+ L C   +  DRPT   +   L
Sbjct: 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 69.3 bits (170), Expect = 3e-14
 Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 14/162 (8%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICGG 61
           LD      +++ + +GL YLH   +   IHRD+K  NILL +D + KI+DFG+ A +  G
Sbjct: 99  LDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADG 155

Query: 62  NELQANTSR-IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA------WDLWTSNR 113
            +      +  VGT  +M+PE   Q   +  K+D++SFG+  +E+A              
Sbjct: 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215

Query: 114 TLELI--DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
            +  +  D P LE     K+    +  +  LC+Q+    RPT
Sbjct: 216 LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 69.0 bits (169), Expect = 3e-14
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 12/92 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +G+ YL +      +HRDL   N+L+ +D+  K+SDFG+A+       +A+  +  G 
Sbjct: 111 VCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGK 160

Query: 75  Y--GYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
               + +PE   +  FS KSDV+SFG+LL EI
Sbjct: 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.1 bits (169), Expect = 4e-14
 Identities = 39/90 (43%), Positives = 55/90 (61%), Gaps = 5/90 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I  GL +LH+     II+RDLK+ N+LLDKD + KI+DFGM +     E +A+T    GT
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGT 159

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      ++   D +SFGVLL E+
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 68.6 bits (168), Expect = 4e-14
 Identities = 50/157 (31%), Positives = 75/157 (47%), Gaps = 32/157 (20%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           II  +   L Y+H   +V +IHRD+K +NIL+    N K+ DFG+A       L  N+S+
Sbjct: 106 IIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAA-----LLNQNSSK 157

Query: 71  ---IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSN---------RTLEL 117
               VGT  +M+PE   +G  +  K+D++S G+ + E+A    T N         R + L
Sbjct: 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA----TGNPPYSDVDAFRAMML 213

Query: 118 IDD---PVLEDEYSSKQMLLRYVNIALLCVQESADDR 151
           I     P LED   SK +          C+ E   +R
Sbjct: 214 IPKSKPPRLEDNGYSKLLR----EFVAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 68.1 bits (166), Expect = 6e-14
 Identities = 34/90 (37%), Positives = 54/90 (60%), Gaps = 8/90 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL      +++HRDL   NIL+ +D   K+SDFG+AR+     +  + S++   
Sbjct: 109 VAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--P 160

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + +PE      FS KSDV+S+GVLL E+
Sbjct: 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 68.1 bits (167), Expect = 6e-14
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 27/173 (15%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
                 V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R    +
Sbjct: 103 FTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159

Query: 63  ELQANTS--RIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIA-------WDLWTSN 112
           E    T   +I     + +PE AI    F+  SDV+SFG+++ E+        WD  ++ 
Sbjct: 160 EATYTTKGGKI--PIRWTAPE-AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD-MSNQ 215

Query: 113 RTLELIDD----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
             ++ ++D    P   D       L +   + L C Q+  ++RPT + +V  L
Sbjct: 216 DVIKAVEDGYRLPPPMD---CPSALYQ---LMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 68.2 bits (167), Expect = 6e-14
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 27/152 (17%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I  GL YLH   R   +HRD+K +NIL+D +   K++DFGMA+        +      G+
Sbjct: 111 ILLGLEYLH--DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGS 164

Query: 75  YGYMSPEY-AIQGIFSIKSDVFSFGVLLLEIA-----WD-------LWTSNRTLELIDDP 121
             +M+PE  A QG + + +D++S G  +LE+A     W        ++   R+ EL   P
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL---P 221

Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
            + D  S +       +  L C+Q     RPT
Sbjct: 222 PIPDHLSDEAK-----DFILKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 68.3 bits (167), Expect = 7e-14
 Identities = 40/93 (43%), Positives = 51/93 (54%), Gaps = 11/93 (11%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL---QANTSRI 71
           I  GL +LHQ    RII+RDLK  N+LLD D N +ISD G+A      EL   Q+ T   
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAV-----ELKDGQSKTKGY 157

Query: 72  VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            GT G+M+PE      +    D F+ GV L E+
Sbjct: 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEM 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 68.1 bits (166), Expect = 7e-14
 Identities = 38/90 (42%), Positives = 55/90 (61%), Gaps = 4/90 (4%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ Y+    R   IHRDL+ +N+L+ + +  KI+DFG+AR+   NE  A        
Sbjct: 112 IAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-P 167

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + +PE    G F+IKSDV+SFG+LL EI
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 67.6 bits (165), Expect = 8e-14
 Identities = 39/96 (40%), Positives = 55/96 (57%), Gaps = 4/96 (4%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGMARICGGNELQANTS 69
           I+    Q LL LH      I+HRDLK  NILLDK  M  KI DFG+++I      ++   
Sbjct: 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAY 159

Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
            +VGT  Y+SPE      ++ KSD+++ G +L E+A
Sbjct: 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 68.2 bits (167), Expect = 8e-14
 Identities = 36/97 (37%), Positives = 62/97 (63%), Gaps = 8/97 (8%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           +I   + +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMAN 156

Query: 70  RIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
             VGT  YMSPE  +QG  ++++SD++S G+ L+E+A
Sbjct: 157 SFVGTRSYMSPE-RLQGTHYTVQSDIWSLGLSLVEMA 192

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 68.1 bits (166), Expect = 1e-13
 Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 23/155 (14%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I++G+ YL   + ++++HRDL   N+L+ +    KISDFG++R     +     S+    
Sbjct: 136 ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIP 192

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW------------DLWTSNRTLELIDDPV 122
             +M+ E     I++ +SDV+SFGVLL EI               L+   +T   ++ P 
Sbjct: 193 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERP- 251

Query: 123 LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
              E  S++M     N+ L C ++  D RPT  D+
Sbjct: 252 ---ENCSEEMY----NLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 67.5 bits (165), Expect = 1e-13
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 34/163 (20%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   + Y+H+     I+HRD+K  NI L K    K+ DFG+++I G     A T  +VGT
Sbjct: 110 IVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164

Query: 75  YGYMSPEYAIQGI-FSIKSDVFSFGVLL---------------LEIAWDLWTSNRTLELI 118
             YMSPE   QG+ ++ KSD+++ G +L               L +   +   N T  + 
Sbjct: 165 PYYMSPEL-CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV- 222

Query: 119 DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                   YSS+ + L +       +Q+  + RPT ++V+   
Sbjct: 223 ------SVYSSELISLVHS-----LLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.9 bits (166), Expect = 1e-13
 Identities = 37/91 (40%), Positives = 52/91 (57%), Gaps = 7/91 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 73
           IA GL +LH      II+RDLK+ N++LD + + KI+DFGM   C  N     T+R   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM---CKENIFGGKTTRTFCG 163

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T  Y++PE      +    D ++FGVLL E+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 67.6 bits (166), Expect = 1e-13
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 21/99 (21%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL YLH      I+HRD+K SNIL++ D   K++DFG+AR          T+R++ T
Sbjct: 109 LLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164

Query: 75  YGYMSPE---------YAIQGIFSIKSDVFSFGVLLLEI 104
             Y  PE           +        D++S G +L E+
Sbjct: 165 LWYRPPELLLGATRYGPEV--------DMWSVGCILAEL 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 67.4 bits (165), Expect = 1e-13
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 30/151 (19%)

Query: 29  RIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE----YAI 84
           +IIHRD+K SNILLD++ N K+ DFG   I G        +R  G   YM+PE     A 
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPSAR 184

Query: 85  QGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRTLELI------DDPVL----EDEYSS 129
            G + ++SDV+S G+ L E+A     +  W  N   + +      D P+L    E E+S 
Sbjct: 185 DG-YDVRSDVWSLGITLYEVATGKFPYPKW--NSVFDQLTQVVKGDPPILSNSEEREFSP 241

Query: 130 KQMLLRYVNIALLCVQESADDRPTMNDVVCM 160
               + ++N   LC+ +    RP   +++  
Sbjct: 242 S--FVNFIN---LCLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 67.5 bits (165), Expect = 1e-13
 Identities = 37/93 (39%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQANTSRI 71
           +A+G  YL +      IHRD+   N LL         KI+DFGMAR            R 
Sbjct: 125 VAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181

Query: 72  VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +    +M PE  + GIF+ K+DV+SFGVLL EI
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 67.4 bits (164), Expect = 1e-13
 Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 20/157 (12%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I+  I +GL YLH     R IHRD+K +N+LL +  + K++DFG+A      +++ NT  
Sbjct: 106 ILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-- 160

Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELI---DDP 121
            VGT  +M+PE   Q  +  K+D++S G+  +E+A       DL    R L LI     P
Sbjct: 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNSPP 219

Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
            LE +YS       +      C+ +    RPT  +++
Sbjct: 220 TLEGQYSKP-----FKEFVEACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 67.7 bits (165), Expect = 1e-13
 Identities = 40/91 (43%), Positives = 53/91 (58%), Gaps = 7/91 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVG 73
           I  GL +LH      I++RDLK+ NILLD D + KI+DFGM   C  N L  A T    G
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGM---CKENMLGDAKTCTFCG 158

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T  Y++PE  +   ++   D +SFGVLL E+
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 2e-13
 Identities = 39/106 (36%), Positives = 53/106 (50%), Gaps = 16/106 (15%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI--C 59
           L +   +V      A G+ YL        +HRDL   N+LL      KISDFGM+R    
Sbjct: 97  LKELAHQV------AMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147

Query: 60  GGNELQANTSRIVGTY--GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           G +  +A T+   G +   + +PE    G FS KSDV+S+GV L E
Sbjct: 148 GSDYYRATTA---GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWE 190

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 2e-13
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 11/98 (11%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I+  +  GL YLH+      IHRD+K +NILL ++ + K++DFG++      +L +  S+
Sbjct: 103 ILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSK 154

Query: 71  ---IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
               VGT  +M+PE   Q  +  K+D++S G+  +E+A
Sbjct: 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 66.3 bits (162), Expect = 3e-13
 Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 19/153 (12%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +   L ++H     RI+HRD+K +N+ +      K+ D G+ R        A++  +VGT
Sbjct: 115 LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA----------WDLWTSNRTLELIDDPVLE 124
             YMSPE   +  ++ KSD++S G LL E+A           +L++  + +E  D P L 
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP 229

Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
            ++ S++  LR  ++   C+    + RP ++ V
Sbjct: 230 ADHYSEE--LR--DLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 66.0 bits (161), Expect = 3e-13
 Identities = 38/97 (39%), Positives = 60/97 (61%), Gaps = 7/97 (7%)

Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTS 69
           +  I +GL YLH  +R  IIHRD+K +NIL+D     KISDFG+++    N L    N +
Sbjct: 112 VRQILKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168

Query: 70  R--IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           R  + G+  +M+PE   Q  ++ K+D++S G L++E+
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 66.2 bits (161), Expect = 4e-13
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 17/148 (11%)

Query: 23  HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 82
           H +SR R++HRD+K +N+ +      K+ D G+ R        A++  +VGT  YMSPE 
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177

Query: 83  AIQGIFSIKSDVFSFGVLLLEIA----------WDLWTSNRTLELIDDPVLEDEYSSKQM 132
             +  ++ KSD++S G LL E+A           +L++  + +E  D P L  ++ S++ 
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE- 236

Query: 133 LLRYVNIALLCVQESADDRPTMNDVVCM 160
           L + VN   +C+    + RP +  V  +
Sbjct: 237 LRQLVN---MCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 65.4 bits (159), Expect = 6e-13
 Identities = 43/145 (29%), Positives = 73/145 (50%), Gaps = 17/145 (11%)

Query: 23  HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 82
           H +SR R++HRD+K +N+ +      K+ D G+ R        A++  +VGT  YMSPE 
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177

Query: 83  AIQGIFSIKSDVFSFGVLLLEIA----------WDLWTSNRTLELIDDPVLEDEYSSKQM 132
             +  ++ KSD++S G LL E+A           +L++  + +E  D P L  E+ S+  
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE-- 235

Query: 133 LLRYVNIALLCVQESADDRPTMNDV 157
             +   +  +C+    D RP +  V
Sbjct: 236 --KLRELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.8 bits (160), Expect = 6e-13
 Identities = 51/172 (29%), Positives = 88/172 (51%), Gaps = 18/172 (10%)

Query: 14  GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 73
            + +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VG
Sbjct: 111 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVG 164

Query: 74  TYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIAWDLW----TSNRTLELIDDPVLEDEYS 128
           T  YMSPE  +QG  +S++SD++S G+ L+E+A   +       + LEL+    +E + +
Sbjct: 165 TRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPA 223

Query: 129 SKQMLLRYVNIALLCVQESADDRPTMN--DVVCMLTNEAATLLPPKQPAFSY 178
             +   R             D RP M   +++  + NE     PPK P+  +
Sbjct: 224 ESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEP----PPKLPSGVF 271

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.5 bits (160), Expect = 6e-13
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 3/90 (3%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L      + IHRDL   N+L+ +D   KI+DFG+AR     +    T+     
Sbjct: 141 VARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP 197

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVLL EI
Sbjct: 198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 65.5 bits (160), Expect = 7e-13
 Identities = 33/103 (32%), Positives = 59/103 (57%), Gaps = 9/103 (8%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL +    R++HRDL   N+L+    + KI+DFG+A++   
Sbjct: 111 LLNWCVQ------IAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +E + +         +M+ E  +  I++ KSDV+S+GV + E+
Sbjct: 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 65.2 bits (159), Expect = 7e-13
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 11/100 (11%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           ++I   IA G++YL   +    +HRDL   N L+  D+  KI DFGM+R    +    + 
Sbjct: 125 LQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDY 177

Query: 69  SRIVGT----YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            R+ G       +M PE  +   F+ +SDV+SFGV+L EI
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 64.9 bits (158), Expect = 8e-13
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 8/108 (7%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-----DKDMNPKISDFGMA 56
           LL     + I   +A+G +YL Q   +  IHRDL   N L+     D D   KI DFG+A
Sbjct: 102 LLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158

Query: 57  RICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           R    ++        +    +M+PE  + G F+ +SDV+SFGVL+ EI
Sbjct: 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEI 206

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 1e-12
 Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 23/154 (14%)

Query: 16  AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 75
           A G+ YL   +    IHRDL   N L+ ++   KISDFGM+R   G     +        
Sbjct: 103 AAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159

Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD------PVL 123
            + +PE    G ++ +SDV+S+G+LL E        +   ++ +T E I+       P L
Sbjct: 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQL 219

Query: 124 EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
             E   + M        L C     ++RP+ +++
Sbjct: 220 CPEEIYRLM--------LQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 1e-12
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 18/148 (12%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + + + YL        IHRDL   N L+ +D   K+SDFG+AR    ++  ++     GT
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GT 161

Query: 75  ---YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDDPVLED 125
                +  PE      FS KSDV+SFGVL+ E+       ++ ++++  +E +       
Sbjct: 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-- 219

Query: 126 EYSSKQMLLRYVNIALLCVQESADDRPT 153
            Y  K        I   C  E  +DRP 
Sbjct: 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPA 247

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.8 bits (158), Expect = 1e-12
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 3/90 (3%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL   S    +HRDL   N L+ + +  KISDFG++R     +     S+ +  
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M PE  + G F+ +SD++SFGV+L EI
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.8 bits (158), Expect = 1e-12
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 15/103 (14%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           +I   I + L YLH  S++ +IHRD+K SN+L++++   K+ DFG   I G   L  + +
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFG---ISG--YLVDSVA 159

Query: 70  RIV--GTYGYMSPE-----YAIQGIFSIKSDVFSFGVLLLEIA 105
           + +  G   YM+PE        +G + +KSDV+S G+ ++E+A
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELA 201

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 64.7 bits (158), Expect = 1e-12
 Identities = 48/159 (30%), Positives = 72/159 (45%), Gaps = 29/159 (18%)

Query: 15  IAQGLLYL---HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSR 70
           I + L YL   H      +IHRD+K SNILLD   N K+ DFG++ R+    + +A T R
Sbjct: 123 IVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-R 173

Query: 71  IVGTYGYMSPEY----AIQGIFSIKSDVFSFGVLLLEIAWDLW------TSNRTLELI-- 118
             G   YM+PE          + I++DV+S G+ L+E+A   +      T    L  I  
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ 233

Query: 119 -DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND 156
            + P L            +V+   LC+ +    RP   +
Sbjct: 234 EEPPSLPPNEGFSPDFCSFVD---LCLTKDHRKRPKYRE 269

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 1e-12
 Identities = 47/170 (27%), Positives = 72/170 (42%), Gaps = 25/170 (14%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR---- 57
           L + VTR +    I +G+ YLH      I+HRD+K +NIL D   N K+ DFG ++    
Sbjct: 101 LTETVTR-KYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156

Query: 58  ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI--AWDLWTSNRTL 115
           IC           + GT  +MSPE      +  K+DV+S G  ++E+      W     +
Sbjct: 157 ICSS---GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213

Query: 116 ELI-------DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
             I        +P L    S         N       E+A  RP+  +++
Sbjct: 214 AAIFKIATQPTNPQLPSHVSPDA-----RNFLRRTFVENAKKRPSAEELL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 64.5 bits (157), Expect = 1e-12
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 28/165 (16%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           RI   + +GL YL     ++I+HRD+K SN+L++     K+ DFG++       + +   
Sbjct: 99  RIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAK 151

Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWT---------SNRTLELI-- 118
             VGT  YM+PE      + I SDV+S G+  +E+A   +          S   L+L+  
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC 211

Query: 119 ----DDPVLED-EYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
               D PVL   ++S K     +V+    C+++   +RP   +++
Sbjct: 212 IVDEDPPVLPVGQFSEK-----FVHFITQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 63.8 bits (155), Expect = 2e-12
 Identities = 38/95 (40%), Positives = 54/95 (56%), Gaps = 3/95 (3%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           ++ E   Q LL +H   + RI+HRDLK  NI L  ++  KI DFG++R+  G+   A T 
Sbjct: 107 QVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT- 164

Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
              GT  YMSPE      +  KSD++S G +L E+
Sbjct: 165 -FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 63.8 bits (156), Expect = 2e-12
 Identities = 30/84 (35%), Positives = 43/84 (51%), Gaps = 6/84 (7%)

Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH      II+RDLK  N+LLD +   K+ DFG A+     +    T    GT  Y++P
Sbjct: 108 YLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAP 161

Query: 81  EYAIQGIFSIKSDVFSFGVLLLEI 104
           E  +   +    D +S G+LL E+
Sbjct: 162 EIILNKGYDFSVDYWSLGILLYEL 185

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 63.7 bits (155), Expect = 2e-12
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 29/163 (17%)

Query: 13  EGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIV 72
           E + +GL YLH      I+HRDLK  N+L+D D   KISDFG+++             + 
Sbjct: 115 EQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 73  GTYGYMSPE--YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR---TLELID-------- 119
           G+  +M+PE  ++    +S K D++S G ++LE    ++   R     E I         
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLE----MFAGRRPWSDEEAIAAMFKLGNK 227

Query: 120 ---DPVLEDEYSSKQMLLRYVNIALL--CVQESADDRPTMNDV 157
               P+  D      M L  V +  L  C   + D+RPT  ++
Sbjct: 228 RSAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTAREL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 63.7 bits (155), Expect = 2e-12
 Identities = 34/103 (33%), Positives = 57/103 (55%), Gaps = 12/103 (11%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMA-----RICGGN 62
           +   E + +GL YLH+    +IIHRD+K +N+L+D      +I+DFG A     +  G  
Sbjct: 106 INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG 162

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
           E Q    +++GT  +M+PE      +    DV+S G +++E+A
Sbjct: 163 EFQG---QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 63.6 bits (155), Expect = 3e-12
 Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 17/167 (10%)

Query: 6   VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ 65
             +V +   IA G+ +L   S  R +HRDL   N L+      K+S   +++    +E  
Sbjct: 117 KQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173

Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVL 123
              + ++    +++PE   +  FS KSDV+SFGVL+    W+++T        L D+ VL
Sbjct: 174 KLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLM----WEVFTQGELPFYGLSDEEVL 228

Query: 124 EDEYSSKQMLL-------RYVNIALLCVQESADDRPTMNDVVCMLTN 163
               + K  L        R   +   C   +  DRP+ +++V  L  
Sbjct: 229 NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 63.5 bits (154), Expect = 3e-12
 Identities = 34/95 (35%), Positives = 59/95 (62%), Gaps = 5/95 (5%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +++ I +GL YLH   +   IHRD+K +N+LL +  + K++DFG+A      +++ NT  
Sbjct: 106 MLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-- 160

Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
            VGT  +M+PE   Q  +  K+D++S G+  +E+A
Sbjct: 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELA 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 63.0 bits (153), Expect = 4e-12
 Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 26/157 (16%)

Query: 15  IAQGLLYL--HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIV 72
           + +G+ YL   Q+     IHRDL   N L+D     K+SDFG++R    +E  ++    V
Sbjct: 109 VCEGMAYLESKQF-----IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----V 159

Query: 73  GT---YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT-LELIDDPVLEDEYS 128
           G+     +  PE  +   FS KSDV++FGVL+    W++++  +   E  ++    ++ S
Sbjct: 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLM----WEVYSLGKMPYERFNNSETVEKVS 215

Query: 129 SKQMLLR-------YVNIALLCVQESADDRPTMNDVV 158
               L R          I   C  E A++RPT   ++
Sbjct: 216 QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.1 bits (153), Expect = 4e-12
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 13/151 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N ++ +D   KI DFGM R     +      + +  
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELI-DDPVLEDEY 127
             +MSPE    G+F+  SDV+SFGV+L EIA      +   ++ + L  + +  +L+   
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPD 244

Query: 128 SSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
           +   ML   +    +C Q +   RP+  +++
Sbjct: 245 NCPDMLFELMR---MCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 63.4 bits (154), Expect = 4e-12
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL   S +  +HRDL   N L+ K+   KI+DFGM+R     +      R V  
Sbjct: 139 IASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLP 195

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLED--EY---SS 129
             +MS E  + G F+  SDV++FGV L EI   L       +L D+ V+E+  E+     
Sbjct: 196 IRWMSWESILLGKFTTASDVWAFGVTLWEI-LTLCKEQPYSQLSDEQVIENTGEFFRDQG 254

Query: 130 KQMLL--------RYVNIALLCVQESADDRPTMNDVVCMLT 162
           +Q+ L            + L C + +A +RP+  ++   L 
Sbjct: 255 RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 63.5 bits (154), Expect = 4e-12
 Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 24/154 (15%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +  G  QGL YLH ++   +IHRD+K  NILL +    K+ DFG A I       A  + 
Sbjct: 120 VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANX 170

Query: 71  IVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIAW---DLWTSNRTLELI-----D 119
            VGT  +M+PE  +   +G +  K DV+S G+  +E+A     L+  N    L      +
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230

Query: 120 DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
            P L+  + S+     + N    C+Q+   DRPT
Sbjct: 231 SPALQSGHWSEY----FRNFVDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.2 bits (153), Expect = 5e-12
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 18/164 (10%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD      I+  I +GL YLH   +   IHRD+K +N+LL +    K++DFG+A      
Sbjct: 98  LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRTLEL 117
           +++ N    VGT  +M+PE   Q  +  K+D++S G+  +E+A            + L L
Sbjct: 155 QIKRN--TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL 212

Query: 118 I---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
           I   + P LE  YS  + L  +V     C+ +    RPT  +++
Sbjct: 213 IPKNNPPTLEGNYS--KPLKEFVEA---CLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.0 bits (153), Expect = 5e-12
 Identities = 40/92 (43%), Positives = 56/92 (60%), Gaps = 9/92 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I  GL +LH      II+RDLK+ N++LD+D + KI+DFGM   C  N    N  S   G
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGM---CKENVFGDNRASTFCG 158

Query: 74  TYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
           T  Y++PE  +QG+ ++   D +SFGVLL E+
Sbjct: 159 TPDYIAPE-ILQGLKYTFSVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 62.7 bits (152), Expect = 6e-12
 Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 5/91 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA  L YLH+     I+HRDLK  N+ L +    K+ D G+AR+       A+T  ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             YMSPE      ++ KSDV++ G  + E+A
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.9 bits (153), Expect = 6e-12
 Identities = 52/161 (32%), Positives = 88/161 (54%), Gaps = 22/161 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE--LQANTSRIV 72
           +A+G+ +L   SR + IHRDL   NILL ++   KI DFG+AR    +   ++   +R+ 
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPV---LED---- 125
               +M+PE     +++ +SDV+SFGVLL EI + L  S      ID+     L++    
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEI-FSLGASPYPGVQIDEEFCRRLKEGTRM 295

Query: 126 ---EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
              EY++ ++     +I L C   + +DRPT +++V +L +
Sbjct: 296 RAPEYATPEIY----SIMLDCWHNNPEDRPTFSELVEILGD 332

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 63.2 bits (153), Expect = 6e-12
 Identities = 53/160 (33%), Positives = 81/160 (50%), Gaps = 26/160 (16%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I  G  QGL YLH ++   +IHRD+K  NILL +    K++DFG A I       AN+  
Sbjct: 130 ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANS-- 180

Query: 71  IVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIAW---DLWTSNRTLELI-----D 119
            VGT  +M+PE  +   +G +  K DV+S G+  +E+A     L+  N    L      +
Sbjct: 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 240

Query: 120 DPVLE-DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
            P L+ +E+S       + N    C+Q+   DRPT  +++
Sbjct: 241 SPTLQSNEWSD-----YFRNFVDSCLQKIPQDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 62.6 bits (152), Expect = 6e-12
 Identities = 35/104 (33%), Positives = 57/104 (54%), Gaps = 4/104 (3%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
            ++ V  + +   I+  + YL + +    IHRDL   N L+ ++   K++DFG++R+  G
Sbjct: 100 EVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
           +   A+         + +PE      FSIKSDV++FGVLL EIA
Sbjct: 157 DTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 199

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.1 bits (153), Expect = 7e-12
 Identities = 36/93 (38%), Positives = 60/93 (64%), Gaps = 8/93 (8%)

Query: 14  GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 73
            + +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VG
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVG 164

Query: 74  TYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
           T  YMSPE  +QG  +S++SD++S G+ L+E+A
Sbjct: 165 TRSYMSPE-RLQGTHYSVQSDIWSMGLSLVELA 196

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.9 bits (150), Expect = 1e-11
 Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 6/88 (6%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V T  
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLW 174

Query: 77  YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           Y +PE  +Q  ++   D++S G +  E+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 61.8 bits (151), Expect = 1e-11
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 18/96 (18%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +   L YLH      I++RDLK  N+LLD D   KI+DFG A+      ++  T  + GT
Sbjct: 110 VVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGT 161

Query: 75  YGYMSPEYAIQGIFSIK-----SDVFSFGVLLLEIA 105
             Y++PE     I   K      D ++ G+L+ E+ 
Sbjct: 162 PEYLAPE-----IILSKGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 1e-11
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 10/94 (10%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           + L +LH +   ++IHRDLK  NILL  D + K++DFG++     + LQ   +  +GT  
Sbjct: 114 EALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDT-FIGTPY 168

Query: 77  YMSPEYAIQGIFS-----IKSDVFSFGVLLLEIA 105
           +M+PE      F       K+D++S G+ L+E+A
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIELA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 61.7 bits (150), Expect = 1e-11
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 19/154 (12%)

Query: 19  LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 78
           L YLH+  R  I+HRDL  +NI+L +D    I+DFG+A+           + +VGT  Y 
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS 180

Query: 79  SPEYAIQGIFSIKSDVFSFGVLLLEIAW---DLWTSN------RTLELIDDPVLEDEYSS 129
            PE      +  K+DV++FG +L ++       +++N      + +E + +P+ E  YS 
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240

Query: 130 KQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
               +        C+   A+ RP +  V  M+++
Sbjct: 241 DVTDV-----ITSCLTPDAEARPDIIQVSAMISD 269

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 1e-11
 Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 10/100 (10%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I+    +GL YLH+    ++IHRD+K  NILL K+   K+ DFG++        + NT  
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF- 173

Query: 71  IVGTYGYMSPE-----YAIQGIFSIKSDVFSFGVLLLEIA 105
            +GT  +M+PE           +  +SDV+S G+  +E+A
Sbjct: 174 -IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 61.5 bits (149), Expect = 2e-11
 Identities = 44/171 (25%), Positives = 84/171 (49%), Gaps = 34/171 (19%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL     V   HRDL   NIL++ ++  K+SDFG++R+   +   A T
Sbjct: 109 VGMLRGIASGMKYLSDMGYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165

Query: 69  SRIVGTYG------YMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTL 115
           +R     G      + +PE      F+  SDV+S+G+++ E+        W++ ++   +
Sbjct: 166 TR-----GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVI 219

Query: 116 ELIDD-----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           + I++       ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 220 KAIEEGYRLPAPMDCPAALHQLMLD-------CWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 26/160 (16%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I  G  QGL YLH ++   +IHRD+K  NILL +    K++DFG A         AN+  
Sbjct: 126 ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANS-- 176

Query: 71  IVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIAW---DLWTSNRTLELI-----D 119
            VGT  +M+PE  +   +G +  K DV+S G+  +E+A     L+  N    L      D
Sbjct: 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND 236

Query: 120 DPVLE-DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
            P L+ +E++       +V+    C+Q+   +RP   +++
Sbjct: 237 SPTLQSNEWTDS--FRGFVD---YCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 61.5 bits (149), Expect = 2e-11
 Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 13/157 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N ++  D   KI DFGM R     +      + +  
Sbjct: 128 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELI-DDPVLEDEY 127
             +M+PE    G+F+  SD++SFGV+L EI       +   ++ + L+ + D   L+   
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 244

Query: 128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNE 164
           +  +   R  ++  +C Q +   RPT  ++V +L ++
Sbjct: 245 NCPE---RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 61.5 bits (149), Expect = 2e-11
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 9/92 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           I   L++LH      II+RDLK+ N+LLD + + K++DFGM +  I  G      TS   
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFC 157

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           GT  Y++PE   + ++    D ++ GVLL E+
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 61.1 bits (148), Expect = 2e-11
 Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 32/170 (18%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R+     L+ + 
Sbjct: 110 VGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDP 161

Query: 69  SRIVGTYG------YMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTL 115
                T G      + +PE      F+  SDV+SFG+++ E+        WD+ +++  +
Sbjct: 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVM 220

Query: 116 ELIDD----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           + I+D    P   D  S+   L+      L C Q+    RP   D+V +L
Sbjct: 221 KAINDGFRLPAPMDCPSAVYQLM------LQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 60.9 bits (148), Expect = 2e-11
 Identities = 39/96 (40%), Positives = 56/96 (58%), Gaps = 7/96 (7%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           RI   + +GL  LH+    +I+HRDLK +NILL  +   KI D G++++   N   A T 
Sbjct: 107 RIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQ 161

Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             +GT  YM+PE      +S KSD++S G LL E+A
Sbjct: 162 --IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA 195

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.2 bits (148), Expect = 3e-11
 Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 7/91 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 73
           I+ GL +LH   R  II+RDLK+ N++LD + + KI+DFGM   C  + +   T+R   G
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGM---CKEHMVDGVTTRTFCG 163

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T  Y++PE      +    D +++GVLL E+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 194

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 60.7 bits (147), Expect = 3e-11
 Identities = 32/83 (38%), Positives = 55/83 (66%), Gaps = 6/83 (7%)

Query: 23  HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 82
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 166

Query: 83  AIQGI-FSIKSDVFSFGVLLLEI 104
             +G+ +   +D FS G +L ++
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKL 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 60.7 bits (147), Expect = 4e-11
 Identities = 36/90 (40%), Positives = 54/90 (60%), Gaps = 3/90 (3%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   SR R IHRDL   N+L+ +D   KI+DFG+AR     +    TS     
Sbjct: 143 VARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP 199

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFG+L+ EI
Sbjct: 200 VKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 4e-11
 Identities = 33/95 (34%), Positives = 58/95 (61%), Gaps = 14/95 (14%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR---IVG 73
           +GL YLH+  +   IHRD+K +NILL +D + K++DFG++      +L A  ++    +G
Sbjct: 112 KGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIG 163

Query: 74  TYGYMSPEYA---IQGIFSIKSDVFSFGVLLLEIA 105
           T  +M+PE A    +G +  K D+++ G+  +E+A
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.8 bits (147), Expect = 4e-11
 Identities = 36/91 (39%), Positives = 52/91 (57%), Gaps = 7/91 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 73
           IA GL +LH      II+RDLK+ N++LD + + KI+DFGM   C  N     T++   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKENMWDGVTTKTFCG 163

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T  Y++PE      +    D ++FGVLL E+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 60.5 bits (146), Expect = 4e-11
 Identities = 37/110 (33%), Positives = 62/110 (56%), Gaps = 13/110 (11%)

Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
           +LL+W  +      IA+G++YL +    R++HRDL   N+L+    + KI+DFG+AR+  
Sbjct: 110 LLLNWCVQ------IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160

Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWT 110
           G+E + N         +M+ E      F+ +SDV+S+GV +    W+L T
Sbjct: 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTI----WELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 60.0 bits (145), Expect = 5e-11
 Identities = 35/103 (33%), Positives = 57/103 (55%), Gaps = 14/103 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +G+ YL   +   +IHRDL   N L+ ++   K+SDFGM R    ++  ++T    GT
Sbjct: 109 VCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GT 161

Query: 75  ---YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT 114
                + SPE      +S KSDV+SFGVL+    W++++  +T
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLM----WEVFSEGKT 200

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 60.2 bits (146), Expect = 5e-11
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 5/99 (5%)

Query: 8   RVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN 67
            VR+   IA+ +L L    ++ II+RD+K+ NILLD + +  ++DFG+++     E +  
Sbjct: 106 EVRVY--IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163

Query: 68  TSRIVGTYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEI 104
            S   GT  YM+PE    G        D +S GVL  E+
Sbjct: 164 YS-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 60.0 bits (145), Expect = 5e-11
 Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 8/91 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I  G+L+LH    + I++RD+K  N+LLD   N ++SD G+A  +  G       ++  G
Sbjct: 104 ITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAG 156

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T GYM+PE   +  +S   D F+ G  + E+
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEM 187

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.2 bits (146), Expect = 6e-11
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 12/95 (12%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE-----LQANTS 69
           I +G+ YL      R +HRDL   NIL++ +   KI DFG+ ++   ++      +   S
Sbjct: 117 ICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173

Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            I     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 174 PIF----WYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.0 bits (145), Expect = 6e-11
 Identities = 36/91 (39%), Positives = 50/91 (54%), Gaps = 8/91 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I  GL  LHQ    RI++RDLK  NILLD   + +ISD G+A  +  G  ++      VG
Sbjct: 111 ICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VG 163

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T GYM+PE      ++   D ++ G LL E+
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 7e-11
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + QG+ Y H +   R++HRDLK  N+L+D++   K++DFG+AR   G  ++  T  +V T
Sbjct: 108 LLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-T 162

Query: 75  YGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIA 105
             Y +PE  +    +S   D++S G +  E+ 
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 59.8 bits (145), Expect = 7e-11
 Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 15/103 (14%)

Query: 8   RVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR------ICGG 61
           ++ I + +A G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R          
Sbjct: 132 QLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +E  A   R      +M PE      ++ +SDV+++GV+L EI
Sbjct: 189 SENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 59.8 bits (145), Expect = 9e-11
 Identities = 34/90 (37%), Positives = 56/90 (62%), Gaps = 5/90 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A  L +LH    + II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 161

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             YM+PE   +   +  +D +SFGVL+ E+
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEM 191

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.4 bits (144), Expect = 9e-11
 Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 29/169 (17%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI-------CGGNELQAN 67
           IA G+ YLH+     +IH+D+   N ++D+++  KI+D  ++R        C G+    N
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD----N 178

Query: 68  TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDP-----V 122
            +R V    +M+ E  +   +S  SDV+SFGVLL    W+L T  +T  +  DP      
Sbjct: 179 ENRPVK---WMALESLVNKEYSSASDVWSFGVLL----WELMTLGQTPYVEIDPFEMAAY 231

Query: 123 LEDEYSSKQMLL---RYVNIALLCVQESADDRPTMNDVVCMLTNEAATL 168
           L+D Y   Q +        +   C     ++RP+ + +V  LT+  A L
Sbjct: 232 LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 59.5 bits (144), Expect = 1e-10
 Identities = 57/181 (31%), Positives = 77/181 (42%), Gaps = 29/181 (16%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I  GL  LH   R RI++RDLK  NILLD   + +ISD G+A  I  G  ++      VG
Sbjct: 111 ITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VG 163

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI-----AWDLWTSNRTLELIDDPVLED--E 126
           T GYM+PE      ++   D +  G L+ E+      +         E ++  V ED  E
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEE 223

Query: 127 YSSK----------QMLLRYVNIALLCVQESADD---RPTMNDVVCMLTNEAATLLPPKQ 173
           YS K          Q+L +     L C  E A++    P           EA  L PP  
Sbjct: 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN-FKRLEAGMLEPPFC 282

Query: 174 P 174
           P
Sbjct: 283 P 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 59.6 bits (144), Expect = 1e-10
 Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 3/90 (3%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ +D   KI+DFG+AR     +    T+     
Sbjct: 149 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     I++ +SDV+SFGVLL EI
Sbjct: 206 VKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 59.2 bits (143), Expect = 1e-10
 Identities = 42/124 (33%), Positives = 62/124 (50%), Gaps = 15/124 (12%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I  GL  LH+ +    ++RDLK  NILLD   + +ISD G+A +I  G  ++      VG
Sbjct: 111 ILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VG 163

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI-----AWDLWTSNRTLELIDDPVLEDE-- 126
           T GYM+PE      +++  D +  G L+ E+      +         E +D  VLE E  
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV 223

Query: 127 YSSK 130
           YS+K
Sbjct: 224 YSAK 227

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 59.3 bits (144), Expect = 1e-10
 Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 11/94 (11%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL     +  +HRDL   N L+ K+   KI+DFGM+R    N   ++  R+ G 
Sbjct: 139 IASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSDYYRVQGR 191

Query: 75  ----YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
                 +M+ E  + G F+ KSDV++FGV L EI
Sbjct: 192 APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 59.2 bits (143), Expect = 1e-10
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 3/96 (3%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + I   IA G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +     
Sbjct: 125 LAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181

Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            R +    +M PE  +   F+ +SD++SFGV+L EI
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 6/95 (6%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
            ++  + +G+ +LH +   RI+HRDLK  NIL+  D   KI+DFG+ARI       A TS
Sbjct: 111 DLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTS 165

Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +V T  Y +PE  +Q  ++   D++S G +  E+
Sbjct: 166 -VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 1e-10
 Identities = 37/102 (36%), Positives = 57/102 (55%), Gaps = 13/102 (12%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
            DW  +  I E +  G+  LHQ     IIHRD+K  N+L+D+  + K++DFG++R    N
Sbjct: 96  EDWA-KQYIAE-VVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN 150

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIK-SDVFSFGVLLLE 103
           +      + VGT  Y++PE  I G+   K SD +S G ++ E
Sbjct: 151 K------KFVGTPDYLAPE-TILGVGDDKMSDWWSLGCVIFE 185

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 59.0 bits (143), Expect = 1e-10
 Identities = 35/114 (30%), Positives = 58/114 (50%), Gaps = 19/114 (16%)

Query: 2   LLDWVTRVRIIE--------GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D VT  R+ E         + + L +LH      +IHRD+K  +ILL  D   K+SDF
Sbjct: 103 LTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDF 159

Query: 54  GMARICGGNELQANTSR---IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G    C   ++     R   +VGT  +M+PE   +  +  + D++S G++++E+
Sbjct: 160 GF---CA--QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 59.3 bits (143), Expect = 1e-10
 Identities = 34/90 (37%), Positives = 53/90 (58%), Gaps = 3/90 (3%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ +D   KI+DFG+AR     +    T+     
Sbjct: 143 VARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLP 199

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVLL EI
Sbjct: 200 VKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 58.7 bits (142), Expect = 1e-10
 Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 11/103 (10%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           +LDW  +      I   L ++H     +I+HRD+K  NI L KD   K+ DFG+AR+   
Sbjct: 103 ILDWFVQ------ICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
               A T   +GT  Y+SPE      ++ KSD+++ G +L E+
Sbjct: 154 TVELARTC--IGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 22/161 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARIC--GGNELQANTSRIV 72
           +A+G+ +L   SR + IHRDL   NILL ++   KI DFG+AR      + ++  ++R+ 
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPV---LED---- 125
               +M+PE     +++ +SDV+SFGVLL EI + L  S      I++     L+D    
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEI-FSLGASPYPGVQINEEFCQRLKDGTRM 296

Query: 126 ---EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
              E ++ ++      I L C Q    +RPT + +V +L +
Sbjct: 297 RAPENATPEIY----RIMLACWQGDPKERPTFSALVEILGD 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 58.8 bits (143), Expect = 2e-10
 Identities = 25/64 (39%), Positives = 38/64 (59%), Gaps = 4/64 (6%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ Y+H      I+HRDLK +N+L+  D   KI+DFG+AR+    E +  + + V T  Y
Sbjct: 111 GVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWY 166

Query: 78  MSPE 81
            +PE
Sbjct: 167 RAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 58.7 bits (142), Expect = 2e-10
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 7/92 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           +A+G+ +L   +    IHRDL   N+LL      KI DFG+AR  +   N +    +R+ 
Sbjct: 150 VAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL- 205

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
               +M+PE     +++ +SDV+S+G+LL EI
Sbjct: 206 -PVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.5 bits (141), Expect = 2e-10
 Identities = 37/92 (40%), Positives = 57/92 (61%), Gaps = 7/92 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARIC--GGNELQANTSRIV 72
           +A+G+ +L   SR + IHRDL   NILL ++   KI DFG+AR      + ++   +R+ 
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
               +M+PE     +++I+SDV+SFGVLL EI
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.3 bits (141), Expect = 3e-10
 Identities = 31/88 (35%), Positives = 52/88 (59%), Gaps = 9/88 (10%)

Query: 19  LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYG 76
           L++LH++    +I+RDLK+ NILLD + + K++DFGM +  I  G      T+   GT  
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPD 161

Query: 77  YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           Y++PE   +  +    D ++ GVL+ E+
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.1 bits (140), Expect = 3e-10
 Identities = 32/83 (38%), Positives = 54/83 (65%), Gaps = 6/83 (7%)

Query: 23  HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 82
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 166

Query: 83  AIQGI-FSIKSDVFSFGVLLLEI 104
             +G  +   +D FS G +L ++
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKL 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.9 bits (140), Expect = 3e-10
 Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 16/156 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +G+ YL + S    IHRDL   N L+      K+SDFGM R    +E   ++S     
Sbjct: 109 VCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFP 164

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-------TLELIDDPVLEDEY 127
             +  PE      +S KSDV+SFGVL+    W+++T  +         E+++        
Sbjct: 165 VKWSPPEVFNFSKYSSKSDVWSFGVLM----WEVFTEGKMPFEKKSNYEVVEMISRGFRL 220

Query: 128 SSKQMLLRYV-NIALLCVQESADDRPTMNDVVCMLT 162
              ++    V  +   C  E  + RPT  +++  +T
Sbjct: 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.2 bits (140), Expect = 3e-10
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 6/96 (6%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +     +A+G+ YL   S+ + IHRDL   NIL+ ++   KI+DFG++R   G E+    
Sbjct: 115 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 168

Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +       +M+ E     +++  SDV+S+GVLL EI
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 58.1 bits (140), Expect = 3e-10
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 11/100 (11%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V I+  IA G+ +L  +    ++H+DL   N+L+   +N KISD G+ R        A+ 
Sbjct: 127 VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR----EVYAADY 179

Query: 69  SRIVGT----YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +++G       +MSPE  + G FSI SD++S+GV+L E+
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 58.0 bits (140), Expect = 3e-10
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL   S +  +HRDL   N L+ +++  KI+DFGM+R     +      R V  
Sbjct: 147 IASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP 203

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLED--EY---SS 129
             +M+ E  + G F+  SDV++FGV L EI   L       EL D+ V+E+  E+     
Sbjct: 204 IRWMAWECILMGKFTTASDVWAFGVTLWEIL-MLCKEQPYGELTDEQVIENAGEFFRDQG 262

Query: 130 KQMLLR--------YVNIALLCVQESADDRPTMNDVVCMLT 162
           +Q+ L            + L C      +RP+ +D+   LT
Sbjct: 263 RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 57.9 bits (140), Expect = 3e-10
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 10/95 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMA-RICGGNELQANTSRIV 72
           I +GL YLH     +I+HRD+K  N+L++      KISDFG + R+ G N     T    
Sbjct: 117 ILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFT 170

Query: 73  GTYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEIA 105
           GT  YM+PE   +G   +   +D++S G  ++E+A
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMA 205

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.0 bits (140), Expect = 4e-10
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I + I +GL YLH     RIIHRD+K  NI ++      I D G A+      +      
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLG 215

Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           + GT    +PE   +  ++ K+D++S G++L E+
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 57.6 bits (139), Expect = 4e-10
 Identities = 37/94 (39%), Positives = 51/94 (54%), Gaps = 10/94 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNE---LQANTSR 70
           I +G+ YLH       IHRDL   N+LLD D   KI DFG+A+ +  G+E   ++ +   
Sbjct: 116 ICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172

Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            V  Y   + E   +  FS  SDV+SFGV L E+
Sbjct: 173 PVFWY---AVECLKENKFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 57.7 bits (139), Expect = 4e-10
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 6/91 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGGNELQANTSRIVG 73
           I+ GL ++H     +I+HRD+K  NI L K+ M  K+ DFG+AR    +   A T   VG
Sbjct: 110 ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VG 164

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T  Y+SPE      ++ K+D++S G +L E+
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 57.7 bits (139), Expect = 4e-10
 Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 17/156 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL   + +  +HRDL   N L+      KI+DFGM+R     +      R V  
Sbjct: 138 IASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP 194

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLED--EYSSKQM 132
             +M+ E  + G F+  SDV++FGV L E+ + L        L D+ V+E+  E+   Q 
Sbjct: 195 IRWMAWESILLGKFTTASDVWAFGVTLWEM-FTLCKEQPYSLLSDEQVIENTGEFFRNQG 253

Query: 133 LLRYVN-----------IALLCVQESADDRPTMNDV 157
              Y++           + + C      DRPT N +
Sbjct: 254 RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 57.7 bits (139), Expect = 4e-10
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 3/90 (3%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     +    T+     
Sbjct: 146 VARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 203 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 57.7 bits (139), Expect = 4e-10
 Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 6/96 (6%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           ++    +A G+ YL   S  + IHRDL   N+L+ +++  KI+DFG++R   G E+    
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKK 175

Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +       +M+ E     +++ KSDV+SFGVLL EI
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 57.3 bits (138), Expect = 5e-10
 Identities = 36/109 (33%), Positives = 61/109 (55%), Gaps = 13/109 (11%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL +   VR++HRDL   N+L+    + KI+DFG+AR+   
Sbjct: 111 LLNWCVQ------IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWT 110
           +E + +         +M+ E  +   F+ +SDV+S+GV +    W+L T
Sbjct: 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTV----WELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 57.5 bits (140), Expect = 5e-10
 Identities = 23/46 (50%), Positives = 30/46 (65%), Gaps = 3/46 (6%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE 63
           GL YLH      +IHRDLK SNIL++ + + KI DFG+AR    +E
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 57.0 bits (138), Expect = 5e-10
 Identities = 38/110 (34%), Positives = 58/110 (52%), Gaps = 19/110 (17%)

Query: 6   VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ 65
           V RV  ++ + +GL YLH +    I+HRD+K +NI LD +   K+ DFG A       L+
Sbjct: 100 VIRVYTLQ-LLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVK-----LK 150

Query: 66  ANTSRI-------VGTYGYMSPEYAIQGIFSIK---SDVFSFGVLLLEIA 105
            NT+ +        GT  YM+PE    G        +D++S G ++LE+A
Sbjct: 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 57.3 bits (138), Expect = 5e-10
 Identities = 36/111 (32%), Positives = 63/111 (56%), Gaps = 17/111 (15%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL +    R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 111 LLNWCVQ------IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161

Query: 62  NE--LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWT 110
           +E    A   ++     +M+ E  +  I++ +SDV+S+GV +    W+L T
Sbjct: 162 DEKEYHAEGGKV--PIKWMALESILHRIYTHQSDVWSYGVTV----WELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 57.3 bits (138), Expect = 5e-10
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL  +     +H+DL   NIL+ + ++ KISD G++R     +      + +  
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M PE  + G FS  SD++SFGV+L EI
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 6e-10
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + QGL + H +    I+HRDLK  N+L++ +   K++DFG+AR  G        +  V T
Sbjct: 107 LLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVT 161

Query: 75  YGYMSPEYAI-QGIFSIKSDVFSFGVLLLEIA 105
             Y +PE  +    +S   D++S G +  E+ 
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELL 193

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 56.8 bits (138), Expect = 7e-10
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 18/94 (19%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG--GNELQANTSRIVGT 74
           +GL YLH      I+HRDLK +N+L+  D   K++DFG+AR  G    ++   T ++V T
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---THQVV-T 165

Query: 75  YGYMSPEYAIQGIFSIKS-----DVFSFGVLLLE 103
             Y +PE     +F  +      D++S G +  E
Sbjct: 166 RWYRAPEL----LFGARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.0 bits (138), Expect = 8e-10
 Identities = 31/87 (35%), Positives = 50/87 (57%), Gaps = 5/87 (5%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           GL YLH+    +I++RDLK+ N+LLD +   KI+DFG+ +   G      TS   GT  +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEF 167

Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           ++PE   +  ++   D +  GVL+ E+
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.5 bits (137), Expect = 9e-10
 Identities = 33/88 (37%), Positives = 48/88 (54%), Gaps = 6/88 (6%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      I+HRDLK SN+LL+     KI DFG+AR  G   L+  T  +V T  Y
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLVV-TLWY 172

Query: 78  MSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
            +PE  +    +S   D++S G +  E+
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAEL 200

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 56.4 bits (136), Expect = 1e-09
 Identities = 33/101 (32%), Positives = 57/101 (56%), Gaps = 7/101 (6%)

Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNEL- 64
           T ++ +  IA G+ YL   S    IHRDL   N +L +DM   ++DFG+++ I  G+   
Sbjct: 114 TLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR 170

Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
           Q   +++     +++ E     +++ KSDV++FGV + EIA
Sbjct: 171 QGRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 55.9 bits (135), Expect = 1e-09
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 9/98 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ YL      + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 107 VAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWT 110
               +M+ E      F+ KSDV+SFGVLL    W+L T
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLL----WELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 56.5 bits (136), Expect = 1e-09
 Identities = 39/112 (34%), Positives = 60/112 (53%), Gaps = 15/112 (13%)

Query: 2   LLDWVTRVRIIEGIA--------QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D VT   + EG          Q L +LH     ++IHRD+K  NILL  D + K++DF
Sbjct: 103 LTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 159

Query: 54  GM-ARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G  A+I      Q+  S +VGT  +M+PE   +  +  K D++S G++ +E+
Sbjct: 160 GFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 56.8 bits (137), Expect = 1e-09
 Identities = 33/89 (37%), Positives = 51/89 (57%), Gaps = 2/89 (2%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTY 75
           Q LL +H      +IHRD+K +NILL  +   K+ DFG +++     +  +  R   GT 
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY-AATVSDDVGRTFCGTP 209

Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            Y++PE   +  +S K+D+FS GVLL E+
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYEL 238

Length = 496

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.1 bits (135), Expect = 1e-09
 Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 7/101 (6%)

Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNEL- 64
           T VR +  IA G+ YL   S    IHRDL   N +L+++M   ++DFG+++ I  G+   
Sbjct: 114 TLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR 170

Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
           Q   S++     +++ E     +++  SDV++FGV + EI 
Sbjct: 171 QGCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 32/112 (28%), Positives = 51/112 (45%), Gaps = 19/112 (16%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE----- 63
           + I   I   + Y+H  S+  ++HRDLK  NILL       I D+G A      E     
Sbjct: 116 LSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 64  LQANTS-----------RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +  +             +IVGT  YM+PE  +    S  +D+++ GV+L ++
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224

Length = 932

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 34/101 (33%), Positives = 58/101 (57%), Gaps = 7/101 (6%)

Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNEL- 64
             V+ +  IA G+ YL   S    IHRDL   N +L+++MN  ++DFG++ +I  G+   
Sbjct: 113 MLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR 169

Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
           Q   +++     +++ E     +++ KSDV+SFGV + EIA
Sbjct: 170 QGRIAKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIA 208

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 12/80 (15%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI---------CGG 61
            +  + +G+ YLH+     I+HRD+K +NIL+D     KI+DFG+AR           GG
Sbjct: 120 YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 62  NELQANTSRIVGTYGYMSPE 81
                  + +V T  Y  PE
Sbjct: 177 GGGTRKYTNLVVTRWYRPPE 196

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 6/92 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I QG+L+ H     R++HRDLK  N+L+D     K++DFG+AR   G  ++  T  +V T
Sbjct: 110 ILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVV-T 164

Query: 75  YGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
             Y +PE  +    +S   D++S G +  E+A
Sbjct: 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 55.5 bits (133), Expect = 2e-09
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 13/164 (7%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + I + IA G++YL   +    +HRDL   N L+ +++  KI DFGM+R     +     
Sbjct: 123 LHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 179

Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD-P 121
              +    +M PE  +   F+ +SDV+S GV+L EI       W   ++N  +E I    
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239

Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEA 165
           VL+   +  + +     + L C Q     R  + ++  +L N A
Sbjct: 240 VLQRPRTCPKEVYD---LMLGCWQREPHMRLNIKEIHSLLQNLA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 55.4 bits (133), Expect = 2e-09
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 8/90 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + + + YL   +    +HRDL   N+L+ +D   K+SDFG+ +     +   +T ++   
Sbjct: 111 VCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--P 162

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + +PE   +  FS KSDV+SFG+LL EI
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.6 bits (134), Expect = 2e-09
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 14/159 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           +AQG+ +L   +    IHRD+   N+LL      KI DFG+AR  +   N +    +R+ 
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL- 276

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQM 132
               +M+PE     +++++SDV+S+G+LL EI + L  S     L++    +      QM
Sbjct: 277 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEI-FSLGKSPYPGILVNSKFYKMVKRGYQM 334

Query: 133 ------LLRYVNIALLCVQESADDRPTMNDVVCMLTNEA 165
                      +I  +C      +RPT + +  ++  + 
Sbjct: 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 55.2 bits (133), Expect = 2e-09
 Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 30/162 (18%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           RI   + +GL +L +     IIHRD+K +N+L++ +   K+ DFG++    GN L A+ +
Sbjct: 106 RITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GN-LVASLA 158

Query: 70  RI-VGTYGYMSPEY------AIQGIFSIKSDVFSFGVLLLEIAWDLW--------TSNRT 114
           +  +G   YM+PE            ++++SDV+S G+ +LE+A   +             
Sbjct: 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ 218

Query: 115 LELI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
           L  I   D P L   YS       +V     C+ +  + RPT
Sbjct: 219 LSAIVDGDPPTLPSGYSDDAQ--DFVA---KCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 55.5 bits (133), Expect = 2e-09
 Identities = 33/89 (37%), Positives = 53/89 (59%), Gaps = 7/89 (7%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTY 75
           Q L +LH     ++IHRD+K  NILL  D + K++DFG  A+I      Q+  S +VGT 
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTP 180

Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +M+PE   +  +  K D++S G++ +E+
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 55.0 bits (132), Expect = 2e-09
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 11/104 (10%)

Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
            +L W  +      +  G+ ++H+    R++HRD+K  NI L ++   K+ DFG AR+  
Sbjct: 101 TILQWFVQ------MCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151

Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
                A T   VGT  Y+ PE      ++ KSD++S G +L E+
Sbjct: 152 SPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 55.4 bits (133), Expect = 2e-09
 Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 3/96 (3%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + I   IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R     +     
Sbjct: 126 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
              +    +M PE  +   F+ +SDV+SFGV+L EI
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 55.5 bits (134), Expect = 3e-09
 Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 18/165 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I +GL YLH      I+HRD+K  N+L++ +   KI DFG+AR+   +E +  T  +V  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 75  YGYMSPEYAIQGI-FSIKSDVFSFGVLLLE-----IAWDLWTSNRTLELIDD----PVLE 124
           Y Y +PE  +    ++   D++S G +  E     I +   +  + L+LI D    P LE
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227

Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
              S+ +    ++    L         P +  +    T+EA  LL
Sbjct: 228 AMRSACEGARAHI----LRGPHKPPSLPVLYTLSSQATHEAVHLL 268

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.3 bits (133), Expect = 3e-09
 Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 13/95 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +    IHRDL   NILL      KI DFG+AR     +++ +++ +V  
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274

Query: 75  YG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
                  +M+PE     +++ +SDV+S+G+LL EI
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 55.0 bits (132), Expect = 3e-09
 Identities = 32/84 (38%), Positives = 46/84 (54%), Gaps = 5/84 (5%)

Query: 22  LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSP 80
           L    R RI++RDLK  NILLD   + +ISD G+A +I  G  ++      VGT GYM+P
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAP 170

Query: 81  EYAIQGIFSIKSDVFSFGVLLLEI 104
           E      ++   D +  G L+ E+
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 55.0 bits (132), Expect = 3e-09
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 6/87 (6%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q   + +V T  Y
Sbjct: 120 GLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWY 173

Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +Q  ++   D++S G +  E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.1 bits (133), Expect = 3e-09
 Identities = 28/75 (37%), Positives = 46/75 (61%), Gaps = 7/75 (9%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-- 67
           ++++ +  GL Y+H   R +I+HRD+K +NIL+ KD   K++DFG+AR    ++      
Sbjct: 123 KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179

Query: 68  -TSRIVGTYGYMSPE 81
            T+R+V T  Y  PE
Sbjct: 180 YTNRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 54.9 bits (132), Expect = 4e-09
 Identities = 47/172 (27%), Positives = 81/172 (47%), Gaps = 34/172 (19%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL + + V   HRDL   NIL++ ++  K+SDFG++R      L+ +T
Sbjct: 109 VGMLRGIAAGMKYLSEMNYV---HRDLAARNILVNSNLVCKVSDFGLSRF-----LEDDT 160

Query: 69  SRIVGTYG--------YMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNR 113
           S    T          + +PE      F+  SDV+S+G+++ E+        WD+ ++  
Sbjct: 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQD 219

Query: 114 TLELIDD----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
            +  I+     P   D  ++   L+      L C Q+  + RP    +V  L
Sbjct: 220 VINAIEQDYRLPPPMDCPTALHQLM------LDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 54.7 bits (131), Expect = 4e-09
 Identities = 35/100 (35%), Positives = 56/100 (56%), Gaps = 10/100 (10%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I   + + L YLH    ++IIHRDLK  N+LL  D + K++DFG++       LQ   S 
Sbjct: 115 ICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRDS- 169

Query: 71  IVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIA 105
            +GT  +M+PE  +        +  K+D++S G+ L+E+A
Sbjct: 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 54.6 bits (131), Expect = 4e-09
 Identities = 33/104 (31%), Positives = 59/104 (56%), Gaps = 9/104 (8%)

Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
            LL+W  +      IA+G+ YL ++   R++HR+L   NILL  D   +I+DFG+A +  
Sbjct: 110 RLLNWCVQ------IAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160

Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            ++ +   S       +M+ E  + G ++ +SDV+S+GV + E+
Sbjct: 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 4e-09
 Identities = 26/73 (35%), Positives = 38/73 (52%), Gaps = 10/73 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP----KISDFGMARICGGNELQ--ANT 68
           I  G+ YLH      ++HRDLK +NIL+  +       KI D G+AR+     L+  A+ 
Sbjct: 117 ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADL 172

Query: 69  SRIVGTYGYMSPE 81
             +V T  Y +PE
Sbjct: 173 DPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 54.7 bits (131), Expect = 5e-09
 Identities = 33/89 (37%), Positives = 53/89 (59%), Gaps = 7/89 (7%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTY 75
           Q L +LH     ++IHRD+K  NILL  D + K++DFG  A+I      Q+  S +VGT 
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTP 179

Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +M+PE   +  +  K D++S G++ +E+
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 54.2 bits (130), Expect = 5e-09
 Identities = 40/105 (38%), Positives = 56/105 (53%), Gaps = 13/105 (12%)

Query: 6   VTRVRIIEGIAQ---GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           VT   I E + Q   G+ YL + +    +HRDL   N+LL      KISDFG+++  G +
Sbjct: 92  VTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148

Query: 63  E--LQANTSRIVGTY--GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           E   +A T    G +   + +PE      FS KSDV+SFGVL+ E
Sbjct: 149 ENYYKAKTH---GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 54.3 bits (130), Expect = 6e-09
 Identities = 36/112 (32%), Positives = 60/112 (53%), Gaps = 15/112 (13%)

Query: 2   LLDWVTRVR--------IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D V++ R        + E + Q L YLH      +IHRD+K  +ILL  D   K+SDF
Sbjct: 105 LTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDF 161

Query: 54  GM-ARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G  A+I   ++       +VGT  +M+PE   +  +  + D++S G++++E+
Sbjct: 162 GFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 54.2 bits (130), Expect = 6e-09
 Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 6/90 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   S+ + IHRDL   NIL+ ++   KI+DFG++R   G E+    +     
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+ E     +++  SDV+S+GVLL EI
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.4 bits (131), Expect = 6e-09
 Identities = 33/85 (38%), Positives = 47/85 (55%), Gaps = 10/85 (11%)

Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH      II+RDLK  N+LLD   + K++DFG A+     ++   T  + GT  Y++P
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184

Query: 81  EYAIQGIFSIKS-DVFSFGVLLLEI 104
           E  IQ     K+ D ++ GVLL E 
Sbjct: 185 E-VIQSKGHGKAVDWWTMGVLLYEF 208

Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 6e-09
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 10/91 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      I++RDLK  NILLDK+ + K++DFG A+     +L+  T  + GT
Sbjct: 110 IVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGT 161

Query: 75  YGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
             Y++PE  IQ     K+ D ++ G+L+ E+
Sbjct: 162 PEYLAPE-VIQSKGHNKAVDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 53.9 bits (129), Expect = 8e-09
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 12/107 (11%)

Query: 4   DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE 63
           +W+    I   I +GL +LHQ+   ++IHRD+K  N+LL ++   K+ DFG++       
Sbjct: 111 EWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165

Query: 64  LQANTSRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIA 105
            + NT   +GT  +M+PE           +  KSD++S G+  +E+A
Sbjct: 166 GRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 210

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 37/108 (34%), Positives = 59/108 (54%), Gaps = 13/108 (12%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR---- 57
           L + VTR +    I +G+ YLH      I+HRD+K +NIL D   N K+ DFG ++    
Sbjct: 103 LTENVTR-KYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158

Query: 58  IC-GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           IC  G  +++    + GT  +MSPE      +  K+D++S G  ++E+
Sbjct: 159 ICLSGTGMKS----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 53.7 bits (130), Expect = 1e-08
 Identities = 34/92 (36%), Positives = 47/92 (51%), Gaps = 19/92 (20%)

Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANT--SRIVGTYGY 77
           Y+H  S   +IHRDLK SNILL+ D   K++DFG+AR +    E   N   +  V T  Y
Sbjct: 122 YIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178

Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLW 109
            +PE     I  + S  ++ GV       D+W
Sbjct: 179 RAPE-----IL-LGSTRYTKGV-------DMW 197

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.5 bits (129), Expect = 1e-08
 Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           + +GL Y+H      +IHRDLK SN+L+++D   +I DFGMAR
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 38/109 (34%), Positives = 56/109 (51%), Gaps = 9/109 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN-ELQANTSRIVG 73
           IA  L YLH    + I++RDLK  NILLD   +  ++DFG+   C  N E    TS   G
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL---CKENIEHNGTTSTFCG 158

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL--WTSNRTLELIDD 120
           T  Y++PE   +  +    D +  G +L E+ + L  + S  T E+ D+
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 207

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 10/100 (10%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I+ G   GL +LH     RIIHRD+K +NILL  +   K+ DFG++       L+ NTS 
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188

Query: 71  IVGTYGYMSPEY-----AIQGIFSIKSDVFSFGVLLLEIA 105
            VGT  +M+PE           +  + DV+S G+  +E+ 
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.3 bits (128), Expect = 1e-08
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 5/90 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      +++RDLK+ N++LDKD + KI+DFG+ +   G    A      GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 53.1 bits (127), Expect = 1e-08
 Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 10/94 (10%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           + L YLH+    +IIHRDLK  NIL   D + K++DFG++       +Q   S  +GT  
Sbjct: 114 EALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDS-FIGTPY 168

Query: 77  YMSPEYAI-----QGIFSIKSDVFSFGVLLLEIA 105
           +M+PE  +        +  K+DV+S G+ L+E+A
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 5/90 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  L YLH+     II+RDLK+ N+LLD + + K++D+GM +   G      TS   GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 159

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D ++ GVL+ E+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEM 189

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 52.8 bits (126), Expect = 2e-08
 Identities = 38/108 (35%), Positives = 59/108 (54%), Gaps = 13/108 (12%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR---- 57
           L + VTR +    I +G+ YLH      I+HRD+K +NIL D   N K+ DFG ++    
Sbjct: 103 LTESVTR-KYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158

Query: 58  IC-GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           IC  G  +++    + GT  +MSPE      +  K+DV+S G  ++E+
Sbjct: 159 ICMSGTGIRS----VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (126), Expect = 2e-08
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 13/108 (12%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR---- 57
           L + VTR R    I QG+ YLH      I+HRD+K +NIL D   N K+ DFG ++    
Sbjct: 103 LTENVTR-RYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158

Query: 58  IC-GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           IC  G  +++    + GT  +MSPE      +  K+DV+S    ++E+
Sbjct: 159 ICMSGTGIKS----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 28/71 (39%), Positives = 38/71 (53%), Gaps = 8/71 (11%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           ++  I +GL Y+H      IIHRDLK SNI +++D   KI DFG+AR           + 
Sbjct: 123 LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTG 174

Query: 71  IVGTYGYMSPE 81
            V T  Y +PE
Sbjct: 175 YVATRWYRAPE 185

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.8 bits (127), Expect = 2e-08
 Identities = 34/88 (38%), Positives = 50/88 (56%), Gaps = 8/88 (9%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 183

Query: 78  MSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            +PE  I G+ +    D++S G ++ E+
Sbjct: 184 RAPE-VILGMGYKENVDIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 52.8 bits (126), Expect = 2e-08
 Identities = 32/89 (35%), Positives = 53/89 (59%), Gaps = 7/89 (7%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTY 75
           Q L +LH     ++IHRD+K  N+LL  D + K++DFG  A+I      Q+  S +VGT 
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTP 179

Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +M+PE   +  +  K D++S G++ +E+
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 52.3 bits (125), Expect = 3e-08
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)

Query: 16  AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 75
           AQ +L       + I++RDLK  N+LLDKD   K++DFG A++     +   T  + GT 
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTP 192

Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            Y++PE  +       +D ++ G+ + EI
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEI 221

Length = 340

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 52.3 bits (125), Expect = 3e-08
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH  S   +++RDLK+ N++LDKD + KI+DFG+ +   G +  A      GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 52.1 bits (125), Expect = 3e-08
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 9/91 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I +GL Y+H      ++HRDLK SNIL++++ + KI DFG+ARI          +  V T
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVST 168

Query: 75  YGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
             Y +PE  +    + ++ D++S G +  E+
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 52.3 bits (125), Expect = 3e-08
 Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 10/103 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L +LH+     II+RDLK+ N+LLD D + K++D+GM +   G      TS   GT
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGT 159

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI-----AWDLWTSN 112
             Y++PE      +    D ++ GVL+ E+      +D+ T N
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 3e-08
 Identities = 32/116 (27%), Positives = 50/116 (43%), Gaps = 27/116 (23%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA------------------ 56
           IA+ +L L    ++  IHRD+K  NIL+D D + K++DFG+                   
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166

Query: 57  RICGGNELQANTSR---------IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
            +   N L                VGT  Y++PE      + ++ D +S GV+L E
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 52.1 bits (125), Expect = 3e-08
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 111 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 165

Query: 77  YMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 51.9 bits (124), Expect = 3e-08
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 3/97 (3%)

Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA 66
             ++++E  A G+ YL        IHRDL   N L+ +    KISDFGM+R        +
Sbjct: 95  ELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS 151

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
                     + +PE    G +S +SDV+SFG+LL E
Sbjct: 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 51.7 bits (124), Expect = 4e-08
 Identities = 38/108 (35%), Positives = 56/108 (51%), Gaps = 7/108 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA  L YLH    + II+RDLK  NILLD   +  ++DFG+ +   G E    TS   GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL--WTSNRTLELIDD 120
             Y++PE   +  +    D +  G +L E+ + L  + S  T E+ D+
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN 207

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.5 bits (123), Expect = 4e-08
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 6/97 (6%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++  ++ G+ YL   +    +HRDL   N+LL      KISDFG+++  G ++     
Sbjct: 98  VELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYK 153

Query: 69  SRIVGTY--GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           +R  G +   + +PE      FS +SDV+S+G+ + E
Sbjct: 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 51.7 bits (124), Expect = 5e-08
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 9/92 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           I+  L +LH+     II+RDLK+ N+LLD + + K++D+GM +  I  G+     TS   
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFC 157

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           GT  Y++PE      +    D ++ GVL+ E+
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 51.2 bits (123), Expect = 6e-08
 Identities = 31/64 (48%), Positives = 39/64 (60%), Gaps = 5/64 (7%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           GL YLH+     IIHRDLKVSN+LL      KI+DFG+AR   G   +  T ++V T  Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWY 174

Query: 78  MSPE 81
            +PE
Sbjct: 175 RAPE 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (123), Expect = 6e-08
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 7/93 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN--TSRIV 72
           IA+ +L L    +  I++RDLK  NILLD   +  + DFG+++      L  N  T+   
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK----ANLTDNKTTNTFC 157

Query: 73  GTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
           GT  Y++PE  + +  ++   D +S GVL+ E+
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 51.1 bits (122), Expect = 7e-08
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 7/95 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RIC--GGNELQANTSRI 71
           I  G+ YLH      ++HRD+K +N++L  +   K+ DFG A R+   G +   +N  + 
Sbjct: 111 ILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167

Query: 72  V-GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
           + GT  +M+PE   +  +  KSD++S G  + E+A
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMA 202

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 51.2 bits (123), Expect = 7e-08
 Identities = 25/72 (34%), Positives = 32/72 (44%), Gaps = 4/72 (5%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
             I  + Q + Y H      IIHRD+K  NIL+ +    K+ DFG AR          T 
Sbjct: 104 SYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160

Query: 70  RIVGTYGYMSPE 81
             V T  Y +PE
Sbjct: 161 -YVATRWYRAPE 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 51.1 bits (122), Expect = 7e-08
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 5/94 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A  + YLH    + II+RDLK  NILLD   +  ++DFG+ +   G E +  TS   GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y++PE   +  +    D +  G +L E+ + L
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 7e-08
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT-SRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+ + + KI DFG+ARI           +  V 
Sbjct: 115 ILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      K+ D++S G +L E+
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 51.2 bits (122), Expect = 8e-08
 Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 5/90 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH     +I++RDLK+ N++LDKD + KI+DFG+ +   G    A      GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGT 158

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 50.7 bits (121), Expect = 9e-08
 Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 8/93 (8%)

Query: 15  IAQGLLYL--HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRI 71
           I +G+ YL   QY     +HRDL   N+L++ +   KI DFG+ + I    E       +
Sbjct: 118 ICKGMDYLGSRQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172

Query: 72  VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
                + +PE  IQ  F I SDV+SFGV L E+
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 46.5 bits (111), Expect = 9e-08
 Identities = 19/48 (39%), Positives = 30/48 (62%), Gaps = 2/48 (4%)

Query: 163 NEAATLLPPKQPAFSYVRNTV--TSTSSTGKTEDCSINQVTISLLEAR 208
           +E   +  PKQP F   R+     S+SST + E  ++NQVT+S+++AR
Sbjct: 1   SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 50.4 bits (120), Expect = 1e-07
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 12/107 (11%)

Query: 4   DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE 63
           DW+    I   I +GL +LH +   ++IHRD+K  N+LL ++   K+ DFG++       
Sbjct: 121 DWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175

Query: 64  LQANTSRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIA 105
            + NT   +GT  +M+PE           +  +SD++S G+  +E+A
Sbjct: 176 GRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (121), Expect = 1e-07
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 2/90 (2%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
            A+ L  L    +  +I+RDLK  NILLD   +  + DFG+ ++   ++ + NT    GT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE  +   ++   D ++ GVLL E+
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 1e-07
 Identities = 31/95 (32%), Positives = 45/95 (47%), Gaps = 3/95 (3%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I   + + L YLH      IIHRD+K  NI LD+  N  + DFG A     +        
Sbjct: 190 IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246

Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             GT    SPE      +  K+D++S G++L E++
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 5/91 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 73
           +A+G+ +L   +    +HRDL   N+LL +    KI DFG+AR I   +   +  S  + 
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
              +M+PE     +++  SDV+S+G+LL EI
Sbjct: 303 V-KWMAPESIFDNLYTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 50.4 bits (120), Expect = 1e-07
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 5/90 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      +++RD+K+ N++LDKD + KI+DFG+ +   G    A      GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.4 bits (120), Expect = 1e-07
 Identities = 38/118 (32%), Positives = 56/118 (47%), Gaps = 19/118 (16%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR    N +   T  +V  Y Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-Y 188

Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEIA-----------WDLWTSNRTLELIDDPVLE 124
            +PE  +   +    D++S G ++ E+             D W  N+ +E +  P  E
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW--NKVIEQLGTPSAE 244

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 50.2 bits (120), Expect = 1e-07
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 8/91 (8%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTY 75
           +G+ + H+    R++HRDLK  N+L++K    K++DFG+AR  G   +  NT S  V T 
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTL 164

Query: 76  GYMSPEYAIQG-IFSIKSDVFSFGVLLLEIA 105
            Y +P+  +    +S   D++S G ++ E+ 
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 50.0 bits (119), Expect = 1e-07
 Identities = 36/112 (32%), Positives = 59/112 (52%), Gaps = 15/112 (13%)

Query: 2   LLDWVTRVRIIE--------GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D VT  R+ E         + + L  LH      +IHRD+K  +ILL  D   K+SDF
Sbjct: 104 LTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDF 160

Query: 54  GM-ARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G  A++    E+    S +VGT  +M+PE   +  +  + D++S G++++E+
Sbjct: 161 GFCAQV--SKEVPRRKS-LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 2e-07
 Identities = 29/82 (35%), Positives = 44/82 (53%), Gaps = 8/82 (9%)

Query: 22  LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 81
           LH+      IHRDLK  N L+D   + K++DFG+++  G     AN+  +VG+  YM+PE
Sbjct: 117 LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY-ANS--VVGSPDYMAPE 168

Query: 82  YAIQGIFSIKSDVFSFGVLLLE 103
                 +    D +S G +L E
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYE 190

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 49.7 bits (119), Expect = 2e-07
 Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 5/72 (6%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           +II    Q + + H+++    IHRD+K  NIL+ K    K+ DFG ARI  G     + +
Sbjct: 104 KIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYT 158

Query: 70  RIVGTYGYMSPE 81
             V T  Y +PE
Sbjct: 159 DYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 49.6 bits (118), Expect = 2e-07
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL YLH   +   +HRD+K +NILL  + + K++DFG+A         A     +GT  
Sbjct: 117 QGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPY 171

Query: 77  YMSPEYAI---QGIFSIKSDVFSFGVLLLEIA 105
           +M+PE A     G ++   D+++ G+  +E+A
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 49.6 bits (118), Expect = 2e-07
 Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 4/88 (4%)

Query: 16  AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 75
           A G+ YL   +    IHRDL   N L+ ++   KISDFGM+R        ++  + +   
Sbjct: 103 AAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PI 158

Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
            + +PE    G +S +SDV+S+G+LL E
Sbjct: 159 KWTAPEALNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 49.7 bits (118), Expect = 2e-07
 Identities = 37/112 (33%), Positives = 60/112 (53%), Gaps = 15/112 (13%)

Query: 2   LLDWVTRVRIIE--------GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D VT  R+ E         + + L YLH      +IHRD+K  +ILL  D   K+SDF
Sbjct: 106 LTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDF 162

Query: 54  GM-ARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G  A++    E+    S +VGT  +M+PE   +  +  + D++S G++++E+
Sbjct: 163 GFCAQV--SKEVPKRKS-LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 125 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 176

Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 49.8 bits (119), Expect = 2e-07
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 7/92 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVG 73
           I +G+ Y H +   R++HRDLK  N+L+D+  N  K++DFG+AR   G  ++  T  +V 
Sbjct: 111 ILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV- 165

Query: 74  TYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEI 104
           T  Y +PE  +    +S   D++S G +  E+
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEM 197

Length = 294

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 49.7 bits (119), Expect = 2e-07
 Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN--ELQANTSRIV 72
           I  GL Y+H      ++HRDLK  N+L++ D   KI DFG+AR    N  E     +  V
Sbjct: 114 ILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 73  GTYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
            T  Y +PE  +      K+ DV+S G +L E+
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 49.4 bits (118), Expect = 2e-07
 Identities = 31/89 (34%), Positives = 52/89 (58%), Gaps = 5/89 (5%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL Y H+ +    +HRD+K SNILL+     K++DFG+AR+    E +  T++++ T  
Sbjct: 127 EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLW 182

Query: 77  YMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
           Y  PE  + +  +    DV+S G +L E+
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 49.3 bits (117), Expect = 3e-07
 Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 25/152 (16%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTY 75
           QGL YLH   +   +HRD+K +NILL  + + K++DFG+ A+I       A     +GT 
Sbjct: 117 QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTP 170

Query: 76  GYMSPEYAI---QGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELIDD-----P 121
            +M+PE A    +G ++   D+++ G+  +E+A      +DL    R L L+       P
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL-HPMRALFLMTKSNFQPP 229

Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
            L+D+         +V +AL    ++   RPT
Sbjct: 230 KLKDKMKWSNSFHHFVKMAL---TKNPKKRPT 258

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.8 bits (119), Expect = 3e-07
 Identities = 41/175 (23%), Positives = 72/175 (41%), Gaps = 27/175 (15%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L W  R +I  GIA+ L +LH      ++  +L    I++D    P +            
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLP 829

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE------------------I 104
            L    ++   +  Y++PE       + KSD++ FG++L+E                  +
Sbjct: 830 GLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV 889

Query: 105 AWDLWT-SNRTLELIDDPVLEDEYSSKQ-MLLRYVNIALLCVQESADDRPTMNDV 157
            W  +  S+  L++  DP +  + S  Q  ++  +N+AL C       RP  NDV
Sbjct: 890 EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944

Length = 968

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 49.2 bits (117), Expect = 3e-07
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 6/98 (6%)

Query: 9   VRIIEG-IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN 67
           VR   G I   L +LH   ++ I++RD+K+ NILLD + +  ++DFG+++     E +  
Sbjct: 107 VRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KER 162

Query: 68  TSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
           T    GT  YM+PE    +G      D +S G+L+ E+
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 3e-07
 Identities = 31/96 (32%), Positives = 57/96 (59%), Gaps = 8/96 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           +A+ +L +    ++  +HRD+K  N+LLDK+ + +++DFG   R+     +Q+N +  VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165

Query: 74  TYGYMSPEY--AIQ---GIFSIKSDVFSFGVLLLEI 104
           T  Y+SPE   A++   G +  + D +S GV + E+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 49.2 bits (117), Expect = 4e-07
 Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 7/108 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA  L YLH    + I++RDLK  NILLD   +  ++DFG+ +   G      T+   GT
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGT 159

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL--WTSNRTLELIDD 120
             Y++PE   +  +    D +  G +L E+ + L  +      E+ D+
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN 207

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.8 bits (116), Expect = 5e-07
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 73
           I Q +  +H   +  I+HRD+K  N+L+  +   K+ DFG AR +  G+   AN +  V 
Sbjct: 106 IYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVA 163

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
           T  Y SPE  +   +    D++S G +L E++
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELS 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 48.9 bits (116), Expect = 5e-07
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191

Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.5 bits (115), Expect = 5e-07
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 10/93 (10%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           GL +LH     + IHRD+K +NILL  +   K+ DFG++       L+ NTS  VGT  +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 190

Query: 78  MSPEY-----AIQGIFSIKSDVFSFGVLLLEIA 105
           M+PE       +   +  + DV+S G+  +E+ 
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELG 223

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.5 bits (115), Expect = 6e-07
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 184

Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 48.3 bits (116), Expect = 6e-07
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 22/107 (20%)

Query: 8   RVR-IIEGIAQGLLYLHQ--YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL 64
            +R II  I QGL ++H+  +      HRDLK  N+L+      KI+DFG+AR     E+
Sbjct: 100 VIRSIIYQILQGLAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR-----EI 149

Query: 65  QANTSR-----IVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIA 105
           +   SR      V T  Y +PE  ++   +S   D+++ G ++ E+ 
Sbjct: 150 R---SRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELY 193

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 48.5 bits (115), Expect = 6e-07
 Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 8/106 (7%)

Query: 6   VTRVRIIEG-----IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
             R R  E        + +L L    ++ II+RD+K+ NILLD + +  ++DFG+++   
Sbjct: 97  SQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156

Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEI 104
            +E++   S   GT  YM+P+    G        D +S GVL+ E+
Sbjct: 157 EDEVERAYS-FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 48.1 bits (115), Expect = 7e-07
 Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 22/99 (22%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL Y+H      ++HRDLK SN+LL+ + + KI DFG+AR    +E     +  V T
Sbjct: 117 LLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171

Query: 75  YGYMSPEY---------AIQGIFSIKSDVFSFGVLLLEI 104
             Y +PE          AI        DV+S G +  E+
Sbjct: 172 RWYRAPELLLNCSEYTTAI--------DVWSVGCIFAEL 202

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.1 bits (114), Expect = 9e-07
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 3/90 (3%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A G+ +L   +    +HRDL   N+L+ +    KI DFG+AR    +    +       
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++  SDV+SFG+LL EI
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 47.8 bits (114), Expect = 9e-07
 Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 18/108 (16%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN--- 67
           I+  I  GL  LH++     +HRDL  +NI ++     KI+DFG+AR  G          
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 68  ----------TSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
                     TS++V T  Y +PE  +    +    D++S G +  E+
Sbjct: 181 DETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227

Length = 335

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 47.9 bits (114), Expect = 1e-06
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 9/92 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           I+  L +LHQ     II+RDLK  NILLD   + K++DFG+ +  I  G      T    
Sbjct: 109 ISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFC 161

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           GT  YM+PE  ++       D +S G L+ ++
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDM 193

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.1 bits (112), Expect = 2e-06
 Identities = 28/91 (30%), Positives = 50/91 (54%), Gaps = 7/91 (7%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           +G+ + H++    ++HRDLK  N+L+DK     KI+D G+ R      +++ T  IV T 
Sbjct: 121 KGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIV-TL 175

Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
            Y +PE  +    +S   D++S G +  E++
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.9 bits (111), Expect = 2e-06
 Identities = 29/88 (32%), Positives = 48/88 (54%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           Q +L L +    +++HRDLK +NI L      K+ DFG ++    +      S   GT  
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236

Query: 77  YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           Y++PE   +  +S K+D++S GV+L E+
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYEL 264

Length = 478

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.5 bits (110), Expect = 2e-06
 Identities = 30/98 (30%), Positives = 58/98 (59%), Gaps = 8/98 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           IA+ +L +H   ++  +HRD+K  N+LLD + + +++DFG   ++     +Q++ +  VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165

Query: 74  TYGYMSPEY--AIQ---GIFSIKSDVFSFGVLLLEIAW 106
           T  Y+SPE   A++   G +  + D +S GV + E+ +
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY 203

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 46.6 bits (110), Expect = 3e-06
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 9/95 (9%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  + +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR     +     + 
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTG 174

Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 46.3 bits (110), Expect = 3e-06
 Identities = 28/90 (31%), Positives = 52/90 (57%), Gaps = 6/90 (6%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL + H +    ++HRDLK  N+L++K+   K++DFG+AR   G  ++  ++ +V T  
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVRCYSAEVV-TLW 164

Query: 77  YMSPEYAIQG-IFSIKSDVFSFGVLLLEIA 105
           Y  P+      ++S   D++S G +  E+A
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELA 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 46.3 bits (110), Expect = 4e-06
 Identities = 29/78 (37%), Positives = 40/78 (51%), Gaps = 5/78 (6%)

Query: 31  IHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY----AIQG 86
           IHRD+K  N+LLDK  + K++DFG       N +       VGT  Y+SPE        G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 87  IFSIKSDVFSFGVLLLEI 104
            +  + D +S GV L E+
Sbjct: 223 YYGRECDWWSVGVFLYEM 240

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.0 bits (109), Expect = 5e-06
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)

Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI 58
             V+ I  +A  L YLH++    IIHRDLK  N+L+  + + K++DFG++++
Sbjct: 105 MAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 45.7 bits (108), Expect = 5e-06
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 9/88 (10%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR        A  +  V T  Y
Sbjct: 129 GLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWY 180

Query: 78  MSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
            +PE  +  +   ++ D++S G ++ E+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEM 208

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 45.3 bits (107), Expect = 6e-06
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR     +  +  +  V T
Sbjct: 127 MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVT 178

Query: 75  YGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
             Y +PE  +  + ++   D++S G ++ E+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEM 209

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 45.1 bits (107), Expect = 7e-06
 Identities = 29/103 (28%), Positives = 49/103 (47%), Gaps = 6/103 (5%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD  + +     ++  L YL      R +HRD+   N+L+      K+ DFG++R     
Sbjct: 104 LDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160

Query: 63  EL-QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
              +A+  ++     +M+PE      F+  SDV+ FGV + EI
Sbjct: 161 SYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 45.2 bits (107), Expect = 7e-06
 Identities = 19/43 (44%), Positives = 30/43 (69%), Gaps = 4/43 (9%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARI 58
           +GL Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARI
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 45.2 bits (107), Expect = 8e-06
 Identities = 29/96 (30%), Positives = 54/96 (56%), Gaps = 7/96 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+ +L +H   ++  +HRD+K  N+L+D+  + K++DFG A     N+   N+   VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGT 166

Query: 75  YGYMSPEY------AIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE         +G + ++ D +S GV+  E+
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 44.7 bits (106), Expect = 9e-06
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 19/165 (11%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L + T++ +     +GL  L++Y+     +++L   + L+ ++   KI       IC G 
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKI-------ICHGL 169

Query: 63  E--LQANTSRIVGTYGYMSPEYAIQGIFS---IKSDVFSFGVLLLEI-AWDLWTSNRTLE 116
           E  L +   + V    Y S +  +  IFS   IK D++S GV+L EI    +   N T +
Sbjct: 170 EKILSSPPFKNVNFMVYFSYKM-LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK 228

Query: 117 LIDDPVLEDEYSSKQML---LRYVNIALLCVQESADDRPTMNDVV 158
            I D ++    S K  L   L    I   C    +  RP + +++
Sbjct: 229 EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 1e-05
 Identities = 32/125 (25%), Positives = 51/125 (40%), Gaps = 36/125 (28%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM------------ARICGGN 62
           IA+ +L +    ++  IHRD+K  N+LLD   + K+SDFG+             RI    
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 63  ELQANTSRI------------------------VGTYGYMSPEYAIQGIFSIKSDVFSFG 98
                   I                        VGT  Y++PE  +Q  ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 99  VLLLE 103
           V++ E
Sbjct: 227 VIMYE 231

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 30/105 (28%), Positives = 52/105 (49%), Gaps = 8/105 (7%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGG 61
           LD     + +  I +G+ + H ++   IIHRD+K  NIL+ +    K+ DFG AR +   
Sbjct: 97  LDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
            E+  +    V T  Y +PE  +    +    D+++ G L+ E+ 
Sbjct: 154 GEVYTD---YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 44.7 bits (105), Expect = 1e-05
 Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 5/100 (5%)

Query: 5   WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL 64
             TR  I++ +   + Y+H     ++IHRD+K+ NI L+ D    + DFG A +    E 
Sbjct: 267 KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTA-MPFEKER 321

Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +A     VGT    SPE      +   +D++S G++LL++
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 44.6 bits (105), Expect = 1e-05
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 7/94 (7%)

Query: 16  AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGT 74
           A+ +L L     + +IHRD+K  N+LLDK  + K++DFG   ++     ++ +T+  VGT
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGT 206

Query: 75  YGYMSPEY----AIQGIFSIKSDVFSFGVLLLEI 104
             Y+SPE        G +  + D +S GV L E+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 8/93 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT-SRIVG 73
           I +GL Y H   R +++HRDLK  N+L+++    K++DFG+AR      +   T S  V 
Sbjct: 113 ILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVV 166

Query: 74  TYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEIA 105
           T  Y  P+  +    +S + D++  G +  E+A
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMA 199

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 44.5 bits (105), Expect = 2e-05
 Identities = 24/82 (29%), Positives = 43/82 (52%), Gaps = 8/82 (9%)

Query: 30  IIHRDLKVSNILL---DKDMNPKISDFGMARICGG----NELQAN-TSRIVGTYGYMSPE 81
           I+HRDLK  NI++       + K+ DFG+  +  G    +      T+ ++GT  Y +PE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159

Query: 82  YAIQGIFSIKSDVFSFGVLLLE 103
                  +  SD++++G++ LE
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.8 bits (103), Expect = 2e-05
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 6/96 (6%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I   + + + YLH+    RIIHRD+K  NI ++   +  + DFG A  C   ++ AN   
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA--CFPVDINANKYY 241

Query: 71  -IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
              GT    +PE   +  +    D++S G++L E+A
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277

Length = 391

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 43.5 bits (102), Expect = 3e-05
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 7/94 (7%)

Query: 16  AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGT 74
           A+ +L L     +  IHRD+K  N+LLDK  + K++DFG   ++     ++ +T+  VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGT 206

Query: 75  YGYMSPEY----AIQGIFSIKSDVFSFGVLLLEI 104
             Y+SPE        G +  + D +S GV L E+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 42.8 bits (101), Expect = 4e-05
 Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 18/100 (18%)

Query: 19  LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT---------- 68
           L YLH Y    I+HRDLK  N+L+    + K++DFG+++I G   L  N           
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI-GLMSLTTNLYEGHIEKDTR 169

Query: 69  ----SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
                ++ GT  Y++PE  ++  +    D ++ G++L E 
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEF 209

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 43.3 bits (102), Expect = 4e-05
 Identities = 31/134 (23%), Positives = 52/134 (38%), Gaps = 47/134 (35%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG------------- 61
           IA+    +    ++  IHRD+K  NIL+D+D + K++DFG+   C G             
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL---CTGFRWTHDSKYYQKG 163

Query: 62  -----------NELQANTSR--------------------IVGTYGYMSPEYAIQGIFSI 90
                       E                           +VGT  Y++PE  ++  ++ 
Sbjct: 164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 223

Query: 91  KSDVFSFGVLLLEI 104
             D +S GV+L E+
Sbjct: 224 LCDWWSVGVILYEM 237

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.9 bits (101), Expect = 4e-05
 Identities = 21/62 (33%), Positives = 35/62 (56%), Gaps = 10/62 (16%)

Query: 1   MLLDW------VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG 54
           ML+ +      VTR  + E +    L +    ++  IHRD+K  NIL+D+  + K+SDFG
Sbjct: 91  MLIKYDTFSEDVTRFYMAECV----LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFG 146

Query: 55  MA 56
           ++
Sbjct: 147 LS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 43.0 bits (101), Expect = 4e-05
 Identities = 41/177 (23%), Positives = 70/177 (39%), Gaps = 30/177 (16%)

Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA 66
              R+   +A GLL+LHQ      IH DL + N  L  D++ KI D+G+A      +   
Sbjct: 101 VLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157

Query: 67  NTSRIVGTYGYMSPEYAI---QGIFSIK----SDVFSFGVLLLEIA----------WDLW 109
                     +++PE      Q +        S+++S GV + E+            D  
Sbjct: 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ 217

Query: 110 TSNRTLE----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLT 162
              + +      +  P L+ +YS      R+  +   C  +  + RPT  +V  +LT
Sbjct: 218 VLKQVVREQDIKLPKPQLDLKYSD-----RWYEVMQFCWLDP-ETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 42.6 bits (101), Expect = 4e-05
 Identities = 30/88 (34%), Positives = 43/88 (48%), Gaps = 8/88 (9%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
            L ++H   R  I HRD+K  NIL+  D   K++DFG  R  G       T  I  T  Y
Sbjct: 112 SLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWY 164

Query: 78  MSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
            +PE  +  G +  K D+++ G +  EI
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEI 192

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 42.8 bits (101), Expect = 5e-05
 Identities = 19/40 (47%), Positives = 27/40 (67%), Gaps = 3/40 (7%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           GL Y HQ    R++HRDLK  N+L+ +    K++DFG+AR
Sbjct: 115 GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 42.5 bits (100), Expect = 6e-05
 Identities = 19/42 (45%), Positives = 26/42 (61%), Gaps = 3/42 (7%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI 58
           + L Y+H  +   + HRDLK  NIL + D   KI DFG+AR+
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 42.3 bits (99), Expect = 7e-05
 Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 8/91 (8%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTY 75
           +GL Y H   R +++HRDLK  N+L+++    K++DFG+AR      +   T S  V T 
Sbjct: 115 RGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTL 168

Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
            Y  P+  +    +S + D++  G +  E++
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMS 199

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 41.8 bits (98), Expect = 8e-05
 Identities = 35/113 (30%), Positives = 55/113 (48%), Gaps = 27/113 (23%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           ++ G+A G+ YL   S +  +H+ L    +L++ D+  KIS F          LQ + S 
Sbjct: 112 MLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--------RLQEDKSE 160

Query: 71  -IVGTYG------YMSPEYAIQ-GIFSIKSDVFSFGVLLLEIA-------WDL 108
            I  T        + +PE AIQ   FS  SDV+SFG+++ E+        WD+
Sbjct: 161 AIYTTMSGKSPVLWAAPE-AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 41.9 bits (98), Expect = 9e-05
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 8/91 (8%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTY 75
           +GL Y H   + +I+HRDLK  N+L+++    K++DFG+AR      +   T S  V T 
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTL 167

Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
            Y  P+  +    +S   D++  G +L E+A
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMA 198

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 41.9 bits (98), Expect = 9e-05
 Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 6/89 (6%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL Y+H      I+HRDLK  N+L+      K++DFG+AR       Q  +S +V T  
Sbjct: 114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-TLW 168

Query: 77  YMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
           Y  P+  +    +S   D++  G + +E+
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 41.6 bits (97), Expect = 1e-04
 Identities = 26/98 (26%), Positives = 55/98 (56%), Gaps = 8/98 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           +A+ ++ +    ++  +HRD+K  NIL+D + + +++DFG   ++     +Q++ +  VG
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VG 165

Query: 74  TYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIAW 106
           T  Y+SPE        +G +  + D +S GV + E+ +
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY 203

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 41.0 bits (97), Expect = 1e-04
 Identities = 24/72 (33%), Positives = 37/72 (51%), Gaps = 10/72 (13%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTS 69
           II  + + L  LH++    IIH D+K+ N+L D+  +   + D+G+ +I G        S
Sbjct: 114 IIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG------TPS 164

Query: 70  RIVGTYGYMSPE 81
              GT  Y SPE
Sbjct: 165 CYDGTLDYFSPE 176

Length = 267

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 41.1 bits (96), Expect = 2e-04
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 24/124 (19%)

Query: 2   LLDWVTR---------VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPK 49
           LLDW+ +          +II      L Y H  + + ++H DLK  NIL+   D  ++P 
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPV 275

Query: 50  IS-----DFGMARIC--GG--NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
            +     D    RIC  GG  +E  + T+ IV T  Y SPE  +   +   +D++S G +
Sbjct: 276 TNRALPPDPCRVRICDLGGCCDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCI 334

Query: 101 LLEI 104
           + E+
Sbjct: 335 IYEL 338

Length = 467

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 41.3 bits (96), Expect = 2e-04
 Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 37/175 (21%)

Query: 9   VRIIEGIAQGLLYLHQY----SRVRIIHRDLKVSNILLD-------------KDMN---- 47
           V I   +   L Y H      +  R++HRDLK  NI L               ++N    
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180

Query: 48  PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSI--KSDVFSFGVLLLEIA 105
            KI DFG+++  G   +++     VGT  Y SPE  +    S   KSD+++ G ++ E+ 
Sbjct: 181 AKIGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 106 ---WDLWTSNRTLELIDD----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
                   +N   +LI +    P L  +  SK++ +   N+  L    SA +RP+
Sbjct: 238 SGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNL----SAKERPS 288

Length = 1021

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 40.8 bits (96), Expect = 2e-04
 Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 10/102 (9%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQA-- 66
           I++ +   L Y+H       IHR +K S+ILL  D    +S    +   I  G   +   
Sbjct: 106 ILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 67  -NTSRIVGTYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEIA 105
                 V    ++SPE   Q +  ++ KSD++S G+   E+A
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELA 204

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 40.1 bits (93), Expect = 3e-04
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 8/92 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT-SRIVG 73
           + +GL Y+HQ     I+HRDLK  N+L+      K++DFG+AR      + ++T S  V 
Sbjct: 112 LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVV 165

Query: 74  TYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
           T  Y  P+  +    +S   D++  G + +E+
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.1 bits (93), Expect = 5e-04
 Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 9/77 (11%)

Query: 9   VRIIEGIA-QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQA 66
           + +I+G+  Q L  L +  R+ I+HRD+K  N+L+  D   KI DFG A  +C G     
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP 367

Query: 67  NTSRIVGTYGYMSPEYA 83
                   YG + P Y+
Sbjct: 368 -------LYGMLDPRYS 377

Length = 507

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.0 bits (93), Expect = 5e-04
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 39/126 (30%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG------------- 61
           IA+ +L +    ++  IHRD+K  N+LLD   + K+SDFG+   C G             
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL---CTGLKKAHRTEFYRNL 163

Query: 62  --------------NELQANTSR---------IVGTYGYMSPEYAIQGIFSIKSDVFSFG 98
                         ++ +A T +          VGT  Y++PE  +Q  ++   D +S G
Sbjct: 164 NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 99  VLLLEI 104
           V++ E+
Sbjct: 224 VIMYEM 229

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 39.9 bits (93), Expect = 5e-04
 Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 26/110 (23%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA---N 67
           I+ G  +GL YLHQ      IHR++K S+IL        IS  G+  + G + L +   N
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRN 154

Query: 68  TSRIVGTYGY----------MSPEYAIQGI--FSIKSDVFSFGVLLLEIA 105
             +    Y +          +SPE   Q +  +++KSD++S G+   E+A
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELA 204

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.5 bits (92), Expect = 7e-04
 Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 7/98 (7%)

Query: 12  IEGIAQGLL----YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN 67
           +  +A+ LL    Y+H      IIHRD+K  N+L++   +  + DFG A    G+     
Sbjct: 262 VTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 68  TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
              I GT    +PE      ++   D++S G+++ E A
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 38.9 bits (90), Expect = 0.001
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 39/126 (30%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG------------- 61
           IA+ +L +    ++  IHRD+K  N+LLD   + K+SDFG+   C G             
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL---CTGLKKAHRTEFYRNL 163

Query: 62  --------------NELQANTSR---------IVGTYGYMSPEYAIQGIFSIKSDVFSFG 98
                         ++ +A T +          VGT  Y++PE  +Q  ++   D +S G
Sbjct: 164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 99  VLLLEI 104
           V++ E+
Sbjct: 224 VIMYEM 229

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 38.4 bits (89), Expect = 0.001
 Identities = 23/56 (41%), Positives = 32/56 (57%), Gaps = 3/56 (5%)

Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA 56
           M  D  T  R+   IA GLL+LH+ +    IH DL + N LL  D+  KI D+G++
Sbjct: 95  MTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 38.1 bits (88), Expect = 0.002
 Identities = 30/107 (28%), Positives = 54/107 (50%), Gaps = 11/107 (10%)

Query: 9   VRIIEGIAQGLLY-----LHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGMARIC 59
           V++  G+ + LLY     +H      ++HRDLK +NIL+     +    KI+D G AR+ 
Sbjct: 103 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Query: 60  GGN-ELQANTSRIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
               +  A+   +V T+ Y +PE  +      K+ D+++ G +  E+
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.0 bits (86), Expect = 0.002
 Identities = 13/37 (35%), Positives = 17/37 (45%)

Query: 22  LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI 58
           LHQ   + + H DL   NIL+D      I D+  A  
Sbjct: 102 LHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 37.7 bits (87), Expect = 0.003
 Identities = 16/41 (39%), Positives = 27/41 (65%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM 55
           IA+    +    ++  IHRD+K  NIL+D+D + K++DFG+
Sbjct: 107 IAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 37.7 bits (87), Expect = 0.003
 Identities = 17/41 (41%), Positives = 27/41 (65%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM 55
           IA+  L +    ++  IHRD+K  NIL+D D + K++DFG+
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 37.4 bits (86), Expect = 0.003
 Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 40/194 (20%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGMARICGGN-ELQANTS 69
           I  G+ YLH      ++HRDLK +NIL+     +    KI+D G AR+     +  A+  
Sbjct: 117 ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI----------AWDLWTSN------ 112
            +V T+ Y +PE  +      K+ D+++ G +  E+            D+ TSN      
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233

Query: 113 --RTLELIDDPVLED--------EYSSKQMLLR---YVNIALLCVQESADDRPTMNDVVC 159
             R   ++  P  +D        EY + Q   R   Y N +L+   E    +P  +  V 
Sbjct: 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKP--DSKVF 291

Query: 160 MLTNEAATLLPPKQ 173
           +L  +  T+ P K+
Sbjct: 292 LLLQKLLTMDPTKR 305

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	208
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.97
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.97
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.97
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.96
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.96
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.96
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.96
KOG0578	550	consensus p21-activated serine/threonine protein k	99.96
KOG0198	313	consensus MEKK and related serine/threonine protei	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.96
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.95
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.95
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.95
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.95
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.95
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.95
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.95
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.95
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.95
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.95
PHA02882	294	putative serine/threonine kinase; Provisional	99.95
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.95
PHA02988	283	hypothetical protein; Provisional	99.95
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.95
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.95
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.95
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.95
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.95
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.95
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.95
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.95
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.95
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.95
PHA03212	391	serine/threonine kinase US3; Provisional	99.95
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.95
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.95
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.95
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.95
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.95
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.95
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.95
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.94
PHA03207	392	serine/threonine kinase US3; Provisional	99.94
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.94
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.94
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.94
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.94
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.94
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.94
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.94
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.94
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.94
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.94
PTZ00283	496	serine/threonine protein kinase; Provisional	99.94
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.94
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.94
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.94
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.94
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.94
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.94
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.94
PHA03211	461	serine/threonine kinase US3; Provisional	99.94
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.94
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.94
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.94
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.94
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.94
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.94
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.94
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.94
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.94
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.94
PTZ00267	478	NIMA-related protein kinase; Provisional	99.94
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.94
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.94
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.94
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.94
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.94
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.94
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.94
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.94
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.94
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.94
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.94
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.94
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.94
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.94
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.94
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.94
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.94
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.94
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.94
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.94
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.94
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.94
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.94
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.94
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.94
PTZ00284	467	protein kinase; Provisional	99.94
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.94
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.94
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.94
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.94
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.94
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.94
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.94
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.94
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.94
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.94
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.94
PTZ00036	440	glycogen synthase kinase; Provisional	99.94
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.94
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.94
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.93
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.93
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.93
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.93
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.93
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.93
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.93
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.93
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.93
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.93
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.93
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.93
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.93
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.93
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.93
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.93
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.93
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.93
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.93
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.93
PHA03209	357	serine/threonine kinase US3; Provisional	99.93
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.93
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.93
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.93
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.93
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.93
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.93
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.93
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.93
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.93
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.93
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.93
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.93
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.93
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.93
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.93
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.93
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.93
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.93
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.93
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.93
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.93
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.93
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.93
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.93
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.93
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.93
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.93
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.93
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.93
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.93
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.93
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.93
PHA03210	501	serine/threonine kinase US3; Provisional	99.93
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.93
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.93
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.93
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.93
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.93
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.93
KOG0589	426	consensus Serine/threonine protein kinase [General	99.93
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.93
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.93
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.93
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.93
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.93
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.93
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.93
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.93
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.93
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.93
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.92
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.92
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.92
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.92
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.92
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.92
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.92
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.92
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.92
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.92
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.92
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.92
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.92
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.92
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.92
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.92
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.92
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.92
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.92
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.92
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.92
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.92
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.92
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.92
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.92
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.92
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.92
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.92
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.92
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.92
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.92
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.92
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.92
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.92
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.92
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.92
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.92
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.92
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.92
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.92
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.92
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.92
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.92
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.92
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.92
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.92
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.92
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.92
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.92
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.92
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.92
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.92
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.92
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.91
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.91
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.91
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.91
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.91
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.91
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.91
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.91
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.91
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.91
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.91
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.91
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.91
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.91
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.91
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.91
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.91
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.91
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.91
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.91
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.91
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.91
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.91
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.91
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.91
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
KOG0610	459	consensus Putative serine/threonine protein kinase	99.91
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.91
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.91
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.91
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.91
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.91
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.91
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.91
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.91
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.91
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.91
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.91
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.91
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.91
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.91
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.91
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.91
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.91
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.91
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.91
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.91
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.91
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.91
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.91
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.91
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.91
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.91
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.91
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.91
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.91
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.91
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.91
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.91
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.91
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.91
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.91
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.91
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.91
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.91
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.91
KOG0605	550	consensus NDR and related serine/threonine kinases	99.91
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.91
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.91
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.9
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.9
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.9
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.9
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.9
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.9
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.9
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.9
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.9
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.9
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.9
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.9
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.9
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.9
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.9
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.9
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.9
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.9
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.9
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.9
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.9
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.9
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.9
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.9
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.9
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.9
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.9
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.9
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.9
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.9
KOG0584	632	consensus Serine/threonine protein kinase [General	99.9
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.9
PLN00009	294	cyclin-dependent kinase A; Provisional	99.9
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.9
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.89
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.89
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.89
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.89
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.89
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.89
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.89
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.89
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.89
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.89
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.89
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.89
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.88
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.88
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.88
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.88
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.87
KOG0586	596	consensus Serine/threonine protein kinase [General	99.87
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.87
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.87
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.86
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.86
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.86
KOG3653	534	consensus Transforming growth factor beta/activin	99.85
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.85
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.84
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.84
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.84
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.84
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.83
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.83
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.82
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.81
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.81
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.81
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.8
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.8
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.79
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.79
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.78
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.78
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.78
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
KOG1152	772	consensus Signal transduction serine/threonine kin	99.7
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.7
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.69
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.65
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.64
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.64
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.64
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.63
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.6
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.56
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.54
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.5
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.5
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.46
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.44
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.43
PRK09188	365	serine/threonine protein kinase; Provisional	99.21
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.17
PRK12274	218	serine/threonine protein kinase; Provisional	99.1
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.07
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.06
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.04
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.03
COG4248	637	Uncharacterized protein with protein kinase and he	98.73
smart00090	237	RIO RIO-like kinase.	98.68
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.64
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.63
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.55
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.54
PRK14879	211	serine/threonine protein kinase; Provisional	98.46
PRK10345	210	hypothetical protein; Provisional	98.45
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.43
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.39
KOG1243	690	consensus Protein kinase [General function predict	98.32
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.29
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.19
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.19
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.16
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	97.98
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.91
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.9
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	97.85
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	97.79
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	97.69
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.56
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	97.56
PRK09902	216	hypothetical protein; Provisional	97.54
KOG3087	229	consensus Serine/threonine protein kinase [General	97.46
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.03
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	96.79
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	96.56
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.54
COG0478	304	RIO-like serine/threonine protein kinase fused to	96.43
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	96.35
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	95.03
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.29
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.03
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	94.0
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	93.93
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	93.67
PF01636	239	APH: Phosphotransferase enzyme family This family	93.63
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	93.41
PRK05231	319	homoserine kinase; Provisional	93.04
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	92.86
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	92.78
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	92.57
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	92.54
COG2334	331	Putative homoserine kinase type II (protein kinase	92.21
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	91.77
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	91.72
KOG2268	465	consensus Serine/threonine protein kinase [Signal	91.58
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	90.98
PRK10271	188	thiK thiamine kinase; Provisional	90.92
COG0661	517	AarF Predicted unusual protein kinase [General fun	90.74
PLN02236	344	choline kinase	90.61
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	90.05
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	89.75
PRK06148	1013	hypothetical protein; Provisional	89.34
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	88.44
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	87.58
KOG1093	725	consensus Predicted protein kinase (contains TBC a	87.56
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	85.85
KOG0576	829	consensus Mitogen-activated protein kinase kinase	84.54
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	84.22
PRK09550	401	mtnK methylthioribose kinase; Reviewed	82.91
PRK11768	325	serine/threonine protein kinase; Provisional	82.85
PRK06149	972	hypothetical protein; Provisional	82.36
PHA03111	444	Ser/Thr kinase; Provisional	80.12

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=216.51  Aligned_cols=165  Identities=29%  Similarity=0.380  Sum_probs=133.4

Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC-CeEEeccccceecCCCcccccccccccCCCccC
Q 028458            1 MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGMARICGGNELQANTSRIVGTYGYMS   79 (208)
Q Consensus         1 ~~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~a   79 (208)
                      +.|++..+++|+.||+.|+.|||+.+.  |||||||+.|+|++.++ ++||+|||++.......  ...+...||+.|+|
T Consensus       137 ~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMA  212 (362)
T KOG0192|consen  137 RKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMA  212 (362)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccC
Confidence            368999999999999999999999973  89999999999999997 99999999998765432  11222578999999


Q ss_pred             cchhc--cCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--cC--CccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           80 PEYAI--QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--DD--PVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        80 pe~~~--~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      ||++.  ...|+.++|+||||+++|||+++..|+.......  ..  ........+...+..+..++.+||+.||.+||+
T Consensus       213 PEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~  292 (362)
T KOG0192|consen  213 PEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPS  292 (362)
T ss_pred             hhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCC
Confidence            99999  5689999999999999999999998887655311  00  011111234447778899999999999999999


Q ss_pred             HHHHHHHHhhhhhccC
Q 028458          154 MNDVVCMLTNEAATLL  169 (208)
Q Consensus       154 ~~~i~~~l~~~~~~~~  169 (208)
                      +.+|+..|+.+.....
T Consensus       293 f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  293 FLEIVSRLESIMSHIS  308 (362)
T ss_pred             HHHHHHHHHHHHHhhc
Confidence            9999999998765443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.1e-31  Score=221.62  Aligned_cols=155  Identities=24%  Similarity=0.384  Sum_probs=131.2

Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            1 MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         1 ~~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      |.|+..++..++.||+.|+.|||+.+   |+|||||..|++++.+..+||+|||++..+....  ....+..||+.|+||
T Consensus       113 k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAP  187 (592)
T KOG0575|consen  113 KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAP  187 (592)
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc--cccceecCCCcccCh
Confidence            57899999999999999999999999   9999999999999999999999999998875332  223346899999999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcc-cc-cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT-LE-LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      |++.....+..+||||+||++|-|+.|.+||... .+ ............|...+....++|..+|+.||.+||++++|+
T Consensus       188 EVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL  267 (592)
T KOG0575|consen  188 EVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVL  267 (592)
T ss_pred             hHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence            9999888999999999999999999999999754 22 222222222234556778889999999999999999999999


Q ss_pred             HH
Q 028458          159 CM  160 (208)
Q Consensus       159 ~~  160 (208)
                      ..
T Consensus       268 ~h  269 (592)
T KOG0575|consen  268 DH  269 (592)
T ss_pred             cC
Confidence            84

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-32  Score=212.20  Aligned_cols=151  Identities=30%  Similarity=0.462  Sum_probs=123.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      ++....-+++.+|++||.|||. .+   |+||||||.|+|++.+|.+||||||.+...-+.    ....+.||..|++||
T Consensus       175 i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPE  247 (364)
T KOG0581|consen  175 IPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPE  247 (364)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChh
Confidence            6677788999999999999995 66   999999999999999999999999998766443    234478999999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcc-------cccccCCcc-chhhhhHH-HHHHHHHHHhhccccCCCCCC
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT-------LELIDDPVL-EDEYSSKQ-MLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-------~~~~~~~~~-~~~~~~~~-~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      .+.+..|+.++||||||+.++|++.|++|....       .+++..... +....+.+ ++.+++.||..||+.||.+||
T Consensus       248 Ri~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~  327 (364)
T KOG0581|consen  248 RISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERP  327 (364)
T ss_pred             hhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCC
Confidence            999999999999999999999999998876543       111110111 11123443 788899999999999999999


Q ss_pred             CHHHHHHH
Q 028458          153 TMNDVVCM  160 (208)
Q Consensus       153 s~~~i~~~  160 (208)
                      +++|+++.
T Consensus       328 s~~qLl~H  335 (364)
T KOG0581|consen  328 SAKQLLQH  335 (364)
T ss_pred             CHHHHhcC
Confidence            99999874

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.2e-30  Score=206.92  Aligned_cols=153  Identities=22%  Similarity=0.328  Sum_probs=123.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC---CCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD---MNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      -+......-++.|++.|+.|||++|   |+||||||+|||+..+   ..+|++|||++...++...   ..+.+||+.|.
T Consensus       272 ~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sf---m~TlCGTpsYv  345 (475)
T KOG0615|consen  272 YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSF---MKTLCGTPSYV  345 (475)
T ss_pred             ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcccccee---hhhhcCCcccc
Confidence            3556677889999999999999999   9999999999999766   6789999999998865443   33478999999


Q ss_pred             CcchhccCC---CCCcchhHHHHHHHHHHHHhhhcCCcccccc-------cCCccchhhhhHHHHHHHHHHHhhccccCC
Q 028458           79 SPEYAIQGI---FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-------DDPVLEDEYSSKQMLLRYVNIALLCVQESA  148 (208)
Q Consensus        79 ape~~~~~~---~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  148 (208)
                      |||++....   +..++|+||+||++|-+++|..||-+.....       ..............+++..++|.+||..||
T Consensus       346 APEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP  425 (475)
T KOG0615|consen  346 APEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDP  425 (475)
T ss_pred             ChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCc
Confidence            999998765   3457899999999999999999985443221       111112223455677889999999999999


Q ss_pred             CCCCCHHHHHHH
Q 028458          149 DDRPTMNDVVCM  160 (208)
Q Consensus       149 ~~Rps~~~i~~~  160 (208)
                      ++||+++|+++.
T Consensus       426 ~~R~s~~eaL~h  437 (475)
T KOG0615|consen  426 ENRPSADEALNH  437 (475)
T ss_pred             ccCcCHHHHhcC
Confidence            999999999874

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.96  E-value=1.4e-29  Score=205.15  Aligned_cols=160  Identities=28%  Similarity=0.331  Sum_probs=124.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.+++.++.|+++||.|||+.+   ++||||||.||+++.++.++|+|||++................++..|+|||
T Consensus       170 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  246 (338)
T cd05102         170 PLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE  246 (338)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence            4778899999999999999999999   9999999999999999999999999987653322211122234457899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+.....  .    ......  ...+...+..+.+++.+||+.||++||++
T Consensus       247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~  324 (338)
T cd05102         247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR--MRAPENATPEIYRIMLACWQGDPKERPTF  324 (338)
T ss_pred             HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence            9988889999999999999999996 7766643211  0    110100  01233445678999999999999999999


Q ss_pred             HHHHHHHhhhhh
Q 028458          155 NDVVCMLTNEAA  166 (208)
Q Consensus       155 ~~i~~~l~~~~~  166 (208)
                      .++++.|+....
T Consensus       325 ~el~~~l~~~~~  336 (338)
T cd05102         325 SALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHHHh
Confidence            999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.9e-30  Score=209.69  Aligned_cols=158  Identities=34%  Similarity=0.446  Sum_probs=126.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+...+-+.++.||++|++||++++   +|||||.++||||+.+..+||+|||+++...+..+..... ..-++.|.|||
T Consensus       299 ~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~-~kfPIkWtAPE  374 (468)
T KOG0197|consen  299 LLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG-GKFPIKWTAPE  374 (468)
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCC-CCCCceecCHH
Confidence            3556778999999999999999999   9999999999999999999999999999655444322221 12367899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHh-hhc-CC-ccccc---cc-CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWD-LWT-SN-RTLEL---ID-DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~-~~~-~~-~~~~~---~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+..+.|+.++||||||+++||+++- ..| .+ ...+.   ++ .-.+   ..|..++..+++++..||..+|++|||+
T Consensus       375 a~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl---p~P~~CP~~vY~lM~~CW~~~P~~RPtF  451 (468)
T KOG0197|consen  375 ALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL---PRPEGCPDEVYELMKSCWHEDPEDRPTF  451 (468)
T ss_pred             HHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC---CCCCCCCHHHHHHHHHHhhCCcccCCCH
Confidence            99999999999999999999999973 333 22 22222   22 1222   3466788899999999999999999999


Q ss_pred             HHHHHHHhhhhh
Q 028458          155 NDVVCMLTNEAA  166 (208)
Q Consensus       155 ~~i~~~l~~~~~  166 (208)
                      +.+...|+.+..
T Consensus       452 ~~L~~~l~~~~~  463 (468)
T KOG0197|consen  452 ETLREVLEDFFT  463 (468)
T ss_pred             HHHHHHHHHhhh
Confidence            999998887753

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.7e-29  Score=192.15  Aligned_cols=160  Identities=25%  Similarity=0.344  Sum_probs=126.6

Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCC-CCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccC
Q 028458            1 MLLDWVTRVRIIEGIAQGLLYLHQYS-RVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS   79 (208)
Q Consensus         1 ~~l~~~~~~~i~~qi~~~l~~Lh~~~-~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~a   79 (208)
                      |.++..++++++.|++.||.++|.+- .+.+.||||||.||+++.+|.+||+|||++++..+....  ....+||+-|++
T Consensus       119 r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tf--A~S~VGTPyYMS  196 (375)
T KOG0591|consen  119 RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTF--AHSLVGTPYYMS  196 (375)
T ss_pred             ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHH--HHhhcCCCcccC
Confidence            46788999999999999999999932 123999999999999999999999999999987655433  234689999999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcc--ccc---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LEL---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      ||.+.+.+|+.++|+||+||++|||+.-..||...  .++   +.+....+ .....++.++..||..|+..||+.||+.
T Consensus       197 PE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~-~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  197 PERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP-LPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC-CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            99999999999999999999999998777666422  111   11121111 1125678899999999999999999997


Q ss_pred             HHHHHHHhh
Q 028458          155 NDVVCMLTN  163 (208)
Q Consensus       155 ~~i~~~l~~  163 (208)
                      -.++..+..
T Consensus       276 ~~~v~di~~  284 (375)
T KOG0591|consen  276 VPYVQDIQS  284 (375)
T ss_pred             chHHHHHHH
Confidence            666665544

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2e-29  Score=206.72  Aligned_cols=153  Identities=25%  Similarity=0.335  Sum_probs=127.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++..++..|+.+++.||+|||.++   |+|||||.+||+++.+|.+||+||||+..+.....  .....+||+.|+|||+
T Consensus       366 ~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEV  440 (550)
T KOG0578|consen  366 MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEV  440 (550)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhh
Confidence            678899999999999999999999   99999999999999999999999999987754443  2344689999999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccc-----ccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL-----ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +....|+.++||||||++.+||+-|..|.....     .++-....+....+...+..+.+|+.+||..|+++|+++.|+
T Consensus       441 vtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eL  520 (550)
T KOG0578|consen  441 VTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKEL  520 (550)
T ss_pred             hhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHH
Confidence            999999999999999999999999988765321     122211222223466677889999999999999999999999


Q ss_pred             HHH
Q 028458          158 VCM  160 (208)
Q Consensus       158 ~~~  160 (208)
                      ++.
T Consensus       521 L~H  523 (550)
T KOG0578|consen  521 LEH  523 (550)
T ss_pred             hcC
Confidence            984

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8e-30  Score=201.49  Aligned_cols=155  Identities=26%  Similarity=0.341  Sum_probs=124.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-CCCeEEeccccceecCC-CcccccccccccCCCccCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGMARICGG-NELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~~~ap   80 (208)
                      |+...+..+..|+++||+|||++|   ++|||||++||+++. ++.+||+|||.+..... ...........|++.|+||
T Consensus       114 l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maP  190 (313)
T KOG0198|consen  114 LPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAP  190 (313)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCc
Confidence            788899999999999999999999   999999999999999 79999999998876653 1111223346789999999


Q ss_pred             chhccCC-CCCcchhHHHHHHHHHHHHhhhcCCcc-------cccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           81 EYAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRT-------LELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        81 e~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |++..+. ....+|+|||||++.||++|..|+...       .........+  ..+...+.+..+|+..|++.||++||
T Consensus       191 Evi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P--~ip~~ls~~a~~Fl~~C~~~~p~~Rp  268 (313)
T KOG0198|consen  191 EVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP--EIPDSLSDEAKDFLRKCFKRDPEKRP  268 (313)
T ss_pred             hhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC--CCCcccCHHHHHHHHHHhhcCcccCc
Confidence            9998533 345999999999999999998776652       1111112111  45666788899999999999999999


Q ss_pred             CHHHHHHHHh
Q 028458          153 TMNDVVCMLT  162 (208)
Q Consensus       153 s~~~i~~~l~  162 (208)
                      |+.++++..-
T Consensus       269 ta~eLL~hpf  278 (313)
T KOG0198|consen  269 TAEELLEHPF  278 (313)
T ss_pred             CHHHHhhChh
Confidence            9999998743

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=5.2e-29  Score=205.62  Aligned_cols=171  Identities=27%  Similarity=0.366  Sum_probs=131.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      |+..+.+.|+.||++|+.|||.++   |||+|||..||++.++++|+|+|||++..-..-.-.....+..|...|+|||+
T Consensus       485 fdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEv  561 (678)
T KOG0193|consen  485 FDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEV  561 (678)
T ss_pred             hhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHH
Confidence            677889999999999999999999   99999999999999999999999999864322221222233457889999999


Q ss_pred             hcc---CCCCCcchhHHHHHHHHHHHHhhhcCCcc-cccc----cCC--ccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           83 AIQ---GIFSIKSDVFSFGVLLLEIAWDLWTSNRT-LELI----DDP--VLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        83 ~~~---~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-~~~~----~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      +..   .+|+.++|||+||+++|||++|.+|.... .+.+    ...  ..+......+.+..+.+|+..||+.++++||
T Consensus       562 IRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP  641 (678)
T KOG0193|consen  562 IRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERP  641 (678)
T ss_pred             HhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCc
Confidence            974   45899999999999999999999877522 1111    111  1111123445667899999999999999999


Q ss_pred             CHHHHHHHHhhhhhccCCCCCCCc
Q 028458          153 TMNDVVCMLTNEAATLLPPKQPAF  176 (208)
Q Consensus       153 s~~~i~~~l~~~~~~~~~p~~~~~  176 (208)
                      .+.+|+..|+.....++.-.++..
T Consensus       642 ~F~~il~~l~~l~~~~pki~RS~S  665 (678)
T KOG0193|consen  642 LFPQLLSKLEELLPSLPKINRSAS  665 (678)
T ss_pred             cHHHHHHHHHHhhhcccccccCcC
Confidence            999999999988765554455433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=205.11  Aligned_cols=155  Identities=29%  Similarity=0.319  Sum_probs=126.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc---------ccc--ccc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ---------ANT--SRI   71 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~---------~~~--~~~   71 (208)
                      |+..-..-++.||+.||+|||+.|   ||||||||+|||++.+++++|.|||.+..+......         ...  ..+
T Consensus       171 fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SF  247 (604)
T KOG0592|consen  171 FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSF  247 (604)
T ss_pred             chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccce
Confidence            455667789999999999999999   999999999999999999999999998776432211         111  347


Q ss_pred             ccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--cCCccchhhhhHHHHHHHHHHHhhccccCCC
Q 028458           72 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--DDPVLEDEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        72 ~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      +||..|.+||.+..+..+..+|+|+|||++|+|+.|.+||...-+..  +.........++..++.+.+||+++|-.||.
T Consensus       248 VGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~  327 (604)
T KOG0592|consen  248 VGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPS  327 (604)
T ss_pred             eeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCcc
Confidence            89999999999999999999999999999999999999986544432  2222222245666778899999999999999


Q ss_pred             CCCCHHHHHHH
Q 028458          150 DRPTMNDVVCM  160 (208)
Q Consensus       150 ~Rps~~~i~~~  160 (208)
                      +|.++.+|.+.
T Consensus       328 ~Rlt~~qIk~H  338 (604)
T KOG0592|consen  328 DRLTSQQIKAH  338 (604)
T ss_pred             ccccHHHHhhC
Confidence            99999998874

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.95  E-value=1.6e-28  Score=194.08  Aligned_cols=156  Identities=30%  Similarity=0.414  Sum_probs=123.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.+++.++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++................++..|+|||.
T Consensus       121 l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (283)
T cd05048         121 LDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEA  197 (283)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHH
Confidence            677888999999999999999999   99999999999999999999999999876543332222223345678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc--c---cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL--E---LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+....  +   .+......  ..+...+..+.+++.+||+.||.+||++.+
T Consensus       198 ~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~  275 (283)
T cd05048         198 ILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLL--PCPEDCPARVYALMIECWNEIPARRPRFKD  275 (283)
T ss_pred             hccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            988889999999999999999997 766653211  1   11111111  224456778999999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      |++.|+.
T Consensus       276 i~~~l~~  282 (283)
T cd05048         276 IHTRLRS  282 (283)
T ss_pred             HHHHHhc
Confidence            9999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.4e-28  Score=197.24  Aligned_cols=161  Identities=43%  Similarity=0.694  Sum_probs=127.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCC-Cccccccccc-ccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG-NELQANTSRI-VGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~-~~~~~~~a   79 (208)
                      .|+|..+++|+.++|+||.|||.....+|+|||||+.|||+|.+...|++|||++..... ...   .... .|+.+|++
T Consensus       170 ~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~---~~~~~~gt~gY~~  246 (361)
T KOG1187|consen  170 PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTS---VSTTVMGTFGYLA  246 (361)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccc---eeeecCCCCccCC
Confidence            579999999999999999999998866799999999999999999999999999966543 221   1112 67899999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcc--------------------cccccCCccchhhhh-HHHHHHHHH
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--------------------LELIDDPVLEDEYSS-KQMLLRYVN  138 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--------------------~~~~~~~~~~~~~~~-~~~~~~~~~  138 (208)
                      ||++..+..+.++||||||+++.|+++|..+....                    ...+.++.+...... ......+..
T Consensus       247 PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~  326 (361)
T KOG1187|consen  247 PEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAE  326 (361)
T ss_pred             hhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHH
Confidence            99999889999999999999999999877432211                    111222443311222 245667889


Q ss_pred             HHhhccccCCCCCCCHHHHHHHHhhhh
Q 028458          139 IALLCVQESADDRPTMNDVVCMLTNEA  165 (208)
Q Consensus       139 li~~~l~~~p~~Rps~~~i~~~l~~~~  165 (208)
                      +..+|++.+|.+||+|.++++.|+.+.
T Consensus       327 ~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  327 LALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            999999999999999999999996655

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.95  E-value=5.1e-28  Score=192.17  Aligned_cols=160  Identities=26%  Similarity=0.343  Sum_probs=126.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+++++.|++.|+.|||+++   ++|+||+|.||+++.++.++++|||++................++..|+|||.
T Consensus       120 ~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~  196 (291)
T cd05094         120 LGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES  196 (291)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHH
Confidence            688899999999999999999999   99999999999999999999999999876543322222222345678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+.....  .   +......  ......+..+.+++.+||+.+|++||++++
T Consensus       197 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  274 (291)
T cd05094         197 IMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL--ERPRVCPKEVYDIMLGCWQREPQQRLNIKE  274 (291)
T ss_pred             hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC--CCCccCCHHHHHHHHHHcccChhhCcCHHH
Confidence            988889999999999999999998 7777533221  1   1111111  112334567889999999999999999999


Q ss_pred             HHHHHhhhhhc
Q 028458          157 VVCMLTNEAAT  167 (208)
Q Consensus       157 i~~~l~~~~~~  167 (208)
                      +++.|+.+...
T Consensus       275 v~~~l~~~~~~  285 (291)
T cd05094         275 IYKILHALGKA  285 (291)
T ss_pred             HHHHHHHHHhh
Confidence            99999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.95  E-value=3.9e-28  Score=196.94  Aligned_cols=159  Identities=28%  Similarity=0.359  Sum_probs=124.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++|..+.+++.|++.||.|||+++   |+||||||.||+++.++.++|+|||++................++..|+|||
T Consensus       169 ~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  245 (337)
T cd05054         169 PLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  245 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence            4788999999999999999999999   9999999999999999999999999987653322222222334567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc--c----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL--E----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..++.++|+|||||++|++++ |..|+....  +    .+....  ....+.....++.+++.+||+.+|++||++
T Consensus       246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~  323 (337)
T cd05054         246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT--RMRAPEYATPEIYSIMLDCWHNNPEDRPTF  323 (337)
T ss_pred             HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC--CCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence            9988899999999999999999997 776653211  1    111000  001123345678899999999999999999


Q ss_pred             HHHHHHHhhhh
Q 028458          155 NDVVCMLTNEA  165 (208)
Q Consensus       155 ~~i~~~l~~~~  165 (208)
                      .++++.|+++-
T Consensus       324 ~ell~~l~~~~  334 (337)
T cd05054         324 SELVEILGDLL  334 (337)
T ss_pred             HHHHHHHHHHH
Confidence            99999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.95  E-value=5.3e-29  Score=195.29  Aligned_cols=152  Identities=23%  Similarity=0.256  Sum_probs=120.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+.=++.+|+.||.|||+++   |+|||+||+|||++.+|.++|+|||++...-..  .......+||+.|+|||+
T Consensus       122 F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--~~~t~tfcGT~eYmAPEi  196 (357)
T KOG0598|consen  122 FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--GDATRTFCGTPEYMAPEI  196 (357)
T ss_pred             cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC--CCccccccCCccccChHH
Confidence            456677889999999999999999   999999999999999999999999998753222  223344789999999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccc--ccccCCccch-hhhhHHHHHHHHHHHhhccccCCCCCC----CHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL--ELIDDPVLED-EYSSKQMLLRYVNIALLCVQESADDRP----TMN  155 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~  155 (208)
                      +.+..|+..+|+||||+++|+|++|..|+....  +..+...... ...+...+.+..+++..+|+.||++|-    ++.
T Consensus       197 l~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~  276 (357)
T KOG0598|consen  197 LLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAE  276 (357)
T ss_pred             HhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChH
Confidence            999999999999999999999999999885432  2222111111 122333667889999999999999994    566


Q ss_pred             HHHH
Q 028458          156 DVVC  159 (208)
Q Consensus       156 ~i~~  159 (208)
                      +|.+
T Consensus       277 ~ik~  280 (357)
T KOG0598|consen  277 EIKR  280 (357)
T ss_pred             Hhhc
Confidence            6544

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.95  E-value=3.1e-28  Score=200.11  Aligned_cols=158  Identities=25%  Similarity=0.344  Sum_probs=122.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++++++.|+++||.|||+++   ++||||||.||+++.++.++|+|||++................++..|+|||
T Consensus       208 ~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE  284 (374)
T cd05106         208 PLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE  284 (374)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHH
Confidence            3678899999999999999999999   9999999999999999999999999987654332211112223456799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc------ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL------IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......      .. ..... ..+...+.++.+++.+||+.||++||++
T Consensus       285 ~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~  362 (374)
T cd05106         285 SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK-RGYQM-SRPDFAPPEIYSIMKMCWNLEPTERPTF  362 (374)
T ss_pred             HhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH-cccCc-cCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            9988889999999999999999997 77776432211      11 00000 1122235678999999999999999999


Q ss_pred             HHHHHHHhhh
Q 028458          155 NDVVCMLTNE  164 (208)
Q Consensus       155 ~~i~~~l~~~  164 (208)
                      .++++.|+++
T Consensus       363 ~~l~~~l~~~  372 (374)
T cd05106         363 SQISQLIQRQ  372 (374)
T ss_pred             HHHHHHHHHH
Confidence            9999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.95  E-value=4e-28  Score=191.79  Aligned_cols=161  Identities=23%  Similarity=0.283  Sum_probs=124.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++++|||++................++..|++||
T Consensus       105 ~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE  181 (279)
T cd05111         105 SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE  181 (279)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHH
Confidence            4678899999999999999999998   9999999999999999999999999987654332211122234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.++.++.++|+||||+++|++++ |..|+......     +......  ..+...+..+.+++.+||..+|++||++.
T Consensus       182 ~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~  259 (279)
T cd05111         182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL--AQPQICTIDVYMVMVKCWMIDENVRPTFK  259 (279)
T ss_pred             HhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            9988889999999999999999997 77666432211     1100000  11112345678899999999999999999


Q ss_pred             HHHHHHhhhhhc
Q 028458          156 DVVCMLTNEAAT  167 (208)
Q Consensus       156 ~i~~~l~~~~~~  167 (208)
                      |+.+.|.....+
T Consensus       260 el~~~l~~~~~~  271 (279)
T cd05111         260 ELANEFTRMARD  271 (279)
T ss_pred             HHHHHHHHHHhC
Confidence            999999887643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.95  E-value=3.6e-28  Score=194.21  Aligned_cols=157  Identities=26%  Similarity=0.407  Sum_probs=119.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+.+++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++................++..|+|||.
T Consensus       135 ~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (304)
T cd05096         135 ISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWEC  211 (304)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHH
Confidence            677889999999999999999999   99999999999999999999999999876543332222222345678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHh--hhcCCcccc--cccC-------Ccc-chhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWD--LWTSNRTLE--LIDD-------PVL-EDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~--~~~~~~~~~--~~~~-------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      +.++.++.++|+||||+++|+|+++  ..|+.....  ....       ... .....+...+..+.+++.+||+.+|++
T Consensus       212 ~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~  291 (304)
T cd05096         212 ILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRE  291 (304)
T ss_pred             HhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchh
Confidence            9888899999999999999999863  344432211  1100       000 000112234567899999999999999


Q ss_pred             CCCHHHHHHHHh
Q 028458          151 RPTMNDVVCMLT  162 (208)
Q Consensus       151 Rps~~~i~~~l~  162 (208)
                      ||++.+|.+.|+
T Consensus       292 RPs~~~i~~~l~  303 (304)
T cd05096         292 RPSFSDIHAFLT  303 (304)
T ss_pred             CcCHHHHHHHHh
Confidence            999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.1e-28  Score=192.89  Aligned_cols=155  Identities=29%  Similarity=0.444  Sum_probs=121.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCC-Ccccccc-cccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG-NELQANT-SRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~-~~~~~~~~~~a   79 (208)
                      .|+...+..|+.++++||.|||++|   .||||+|+.||+++.+|.++|+|||++...-. ....... ..+.|++.|+|
T Consensus       122 Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmA  198 (516)
T KOG0582|consen  122 GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMA  198 (516)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccC
Confidence            3567788999999999999999999   99999999999999999999999998754432 2222222 45689999999


Q ss_pred             cchhcc--CCCCCcchhHHHHHHHHHHHHhhhcCCcccc------ccc-CCc-----cchhhhhHHHHHHHHHHHhhccc
Q 028458           80 PEYAIQ--GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE------LID-DPV-----LEDEYSSKQMLLRYVNIALLCVQ  145 (208)
Q Consensus        80 pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~-~~~-----~~~~~~~~~~~~~~~~li~~~l~  145 (208)
                      ||++.+  ..|+.++||||||++..|++.|..|+..-..      -++ .+.     .............+.++|..||+
T Consensus       199 PEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~  278 (516)
T KOG0582|consen  199 PEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLV  278 (516)
T ss_pred             hHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhh
Confidence            999543  4589999999999999999999988865421      111 111     11113344456689999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 028458          146 ESADDRPTMNDVVC  159 (208)
Q Consensus       146 ~~p~~Rps~~~i~~  159 (208)
                      .||++||++.++++
T Consensus       279 kDP~kRptAskLlk  292 (516)
T KOG0582|consen  279 KDPSKRPTASKLLK  292 (516)
T ss_pred             cCcccCCCHHHHhc
Confidence            99999999999887

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.95  E-value=5.4e-28  Score=191.71  Aligned_cols=151  Identities=23%  Similarity=0.303  Sum_probs=118.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++++|||++.......   ......++..|+|||.
T Consensus       107 ~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~  180 (290)
T cd07862         107 VPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEV  180 (290)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCCc---ccccccccccccChHH
Confidence            678899999999999999999999   9999999999999999999999999987654331   1223457889999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c----cC-----------------Ccc------chhhhhHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I----DD-----------------PVL------EDEYSSKQML  133 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~----~~-----------------~~~------~~~~~~~~~~  133 (208)
                      +.+..++.++|+||||+++|+|++|..++......  +    ..                 ...      ......+..+
T Consensus       181 ~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (290)
T cd07862         181 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID  260 (290)
T ss_pred             HhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCC
Confidence            98888999999999999999999888776432110  0    00                 000      0000112345


Q ss_pred             HHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          134 LRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       134 ~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ..+.+++.+||+.||++||++.++++
T Consensus       261 ~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         261 ELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHHHHHHHHHhccCchhcCCHHHHhc
Confidence            56789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.95  E-value=4.8e-28  Score=192.84  Aligned_cols=156  Identities=18%  Similarity=0.161  Sum_probs=121.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-----ccccccccCCCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-----ANTSRIVGTYGY   77 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~   77 (208)
                      .++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.........     .......|++.|
T Consensus       123 ~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y  199 (294)
T PHA02882        123 KNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYY  199 (294)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccc
Confidence            355667889999999999999998   999999999999999999999999998765321110     111223588999


Q ss_pred             cCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc---cc-------CCccchhhhhHHHHHHHHHHHhhccccC
Q 028458           78 MSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---ID-------DPVLEDEYSSKQMLLRYVNIALLCVQES  147 (208)
Q Consensus        78 ~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~~  147 (208)
                      +|||...+..++.++|+||||+++++|++|..|+......   +.       .............+..+.+++..||+.+
T Consensus       200 ~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (294)
T PHA02882        200 AGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLS  279 (294)
T ss_pred             cCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCC
Confidence            9999999888999999999999999999999888544110   00       0111111123344677889999999999


Q ss_pred             CCCCCCHHHHHHHH
Q 028458          148 ADDRPTMNDVVCML  161 (208)
Q Consensus       148 p~~Rps~~~i~~~l  161 (208)
                      |++||+++++.+.|
T Consensus       280 ~~~rp~~~~l~~~~  293 (294)
T PHA02882        280 YEEKPDYDALIKIF  293 (294)
T ss_pred             CCCCCCHHHHHHhh
Confidence            99999999999876

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.95  E-value=1e-28  Score=210.66  Aligned_cols=161  Identities=28%  Similarity=0.379  Sum_probs=136.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+-.+.+.|+.||+.|+.||-+..   +|||||..+|++|..+-.+||+|||+++.+-..++++....-.-+++|+|||
T Consensus       599 ~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppE  675 (774)
T KOG1026|consen  599 PLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE  675 (774)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHH
Confidence            3778899999999999999999998   9999999999999999999999999999887777776665545578999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCC-----cccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSN-----RTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+..++|+.++||||||+++||+++ |..|..     ...+.+.+..+  -..+.+++.+++.|+..||+.+|++||+++
T Consensus       676 sIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l--L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~  753 (774)
T KOG1026|consen  676 SILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL--LSCPENCPTEVYSLMLECWNENPKRRPSFK  753 (774)
T ss_pred             HhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc--ccCCCCCCHHHHHHHHHHhhcCcccCCCHH
Confidence            9999999999999999999999986 443332     22233333333  145778889999999999999999999999


Q ss_pred             HHHHHHhhhhhc
Q 028458          156 DVVCMLTNEAAT  167 (208)
Q Consensus       156 ~i~~~l~~~~~~  167 (208)
                      ||...|+.....
T Consensus       754 eI~~~L~~~~~~  765 (774)
T KOG1026|consen  754 EIHSRLQAWAQA  765 (774)
T ss_pred             HHHHHHHHHHhc
Confidence            999999987744

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=4.8e-28  Score=192.09  Aligned_cols=160  Identities=26%  Similarity=0.340  Sum_probs=124.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++++|||++................++..|+|||.
T Consensus       117 l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  193 (288)
T cd05093         117 LTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES  193 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHH
Confidence            788999999999999999999999   99999999999999999999999999876533222111222334678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+.....     .+......  ..+...+..+.+++.+||+.||.+||++.+
T Consensus       194 ~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  271 (288)
T cd05093         194 IMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL--QRPRTCPKEVYDLMLGCWQREPHMRLNIKE  271 (288)
T ss_pred             hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            988888999999999999999998 6666543211     11111100  112234567899999999999999999999


Q ss_pred             HHHHHhhhhhc
Q 028458          157 VVCMLTNEAAT  167 (208)
Q Consensus       157 i~~~l~~~~~~  167 (208)
                      +.+.|+.+...
T Consensus       272 v~~~l~~~~~~  282 (288)
T cd05093         272 IHSLLQNLAKA  282 (288)
T ss_pred             HHHHHHHHHHh
Confidence            99999988744

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=8.2e-28  Score=205.62  Aligned_cols=162  Identities=24%  Similarity=0.233  Sum_probs=128.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCc-cccc------ccccccCC
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE-LQAN------TSRIVGTY   75 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~------~~~~~~~~   75 (208)
                      |+..++++|+.|+++|+.+||... ++|||||||-+|||+..++.+||||||.+...-... ....      .-....|+
T Consensus       141 lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp  219 (738)
T KOG1989|consen  141 LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTP  219 (738)
T ss_pred             CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCc
Confidence            678899999999999999999996 569999999999999999999999999986432211 1110      01124588


Q ss_pred             CccCcchhc---cCCCCCcchhHHHHHHHHHHHHhhhcCCcc-cccccCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           76 GYMSPEYAI---QGIFSIKSDVFSFGVLLLEIAWDLWTSNRT-LELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        76 ~~~ape~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .|++||.+.   +...+.++|||+|||++|-|++...||+.. .-.+.+....- ...+.++..+.+||+.||+.||++|
T Consensus       220 ~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~-P~~p~ys~~l~~LI~~mL~~nP~~R  298 (738)
T KOG1989|consen  220 QYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSF-PPFPNYSDRLKDLIRTMLQPNPDER  298 (738)
T ss_pred             cccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccC-CCCccHHHHHHHHHHHHhccCcccC
Confidence            999999884   556899999999999999999999999776 22232222221 2236788899999999999999999


Q ss_pred             CCHHHHHHHHhhhhh
Q 028458          152 PTMNDVVCMLTNEAA  166 (208)
Q Consensus       152 ps~~~i~~~l~~~~~  166 (208)
                      |++-+++..+-++..
T Consensus       299 PnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  299 PNIYQVLEEIFELAN  313 (738)
T ss_pred             CCHHHHHHHHHHHhc
Confidence            999999999877653

>PHA02988 hypothetical protein; Provisional

Probab=99.95  E-value=3.8e-28  Score=192.51  Aligned_cols=156  Identities=20%  Similarity=0.242  Sum_probs=123.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC-CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+++++.|++.|+.|||+. +   ++||||||.||+++.++.++++|||++.......     ....++..|+||
T Consensus       118 ~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aP  189 (283)
T PHA02988        118 DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSY  189 (283)
T ss_pred             CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCH
Confidence            468889999999999999999985 6   8899999999999999999999999987543222     123567889999


Q ss_pred             chhcc--CCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCC--ccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQ--GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDP--VLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+  ..++.++|+||||+++|+|++|..|+.....  .....  .......+...+..+.+++.+||+.||++||++
T Consensus       190 E~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  269 (283)
T PHA02988        190 KMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNI  269 (283)
T ss_pred             HHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCH
Confidence            99876  6789999999999999999999988754321  11100  000111223456789999999999999999999


Q ss_pred             HHHHHHHhhhh
Q 028458          155 NDVVCMLTNEA  165 (208)
Q Consensus       155 ~~i~~~l~~~~  165 (208)
                      +++++.|+...
T Consensus       270 ~ell~~l~~~~  280 (283)
T PHA02988        270 KEILYNLSLYK  280 (283)
T ss_pred             HHHHHHHHHHH
Confidence            99999998875

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.95  E-value=4.5e-28  Score=190.30  Aligned_cols=157  Identities=25%  Similarity=0.351  Sum_probs=121.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++++|||++................++..|.+||.
T Consensus       109 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~  185 (272)
T cd05075         109 LPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES  185 (272)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHH
Confidence            678889999999999999999998   99999999999999999999999999877643332211222234668999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      ..+..++.++|+||||+++|++++ |..|+.....  .   +......  ..+...+..+.+++.+||+.+|++||++.+
T Consensus       186 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  263 (272)
T cd05075         186 LADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL--KQPPDCLDGLYSLMSSCWLLNPKDRPSFET  263 (272)
T ss_pred             ccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            988889999999999999999998 5555532111  0   1111000  112334567889999999999999999999


Q ss_pred             HHHHHhhh
Q 028458          157 VVCMLTNE  164 (208)
Q Consensus       157 i~~~l~~~  164 (208)
                      +++.|+.+
T Consensus       264 l~~~l~~~  271 (272)
T cd05075         264 LRCELEKA  271 (272)
T ss_pred             HHHHHHhh
Confidence            99999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.95  E-value=3.3e-28  Score=192.33  Aligned_cols=156  Identities=28%  Similarity=0.387  Sum_probs=120.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+.+   ++|+||||.||+++.++.++++|||++................++..|+|||.
T Consensus       121 ~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (283)
T cd05091         121 LEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEA  197 (283)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHH
Confidence            677888999999999999999998   99999999999999999999999999876533322221222344678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.++.++.++|+||||+++|+|++ |..++.....     .+......  ..+...+..+.+++..||+.+|.+||++++
T Consensus       198 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RP~~~~  275 (283)
T cd05091         198 IMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL--PCPDDCPAWVYTLMLECWNEFPSRRPRFKD  275 (283)
T ss_pred             HhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence            988889999999999999999997 5555432111     11111111  123445667899999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      |+..|+.
T Consensus       276 i~~~l~~  282 (283)
T cd05091         276 IHSRLRT  282 (283)
T ss_pred             HHHHhhC
Confidence            9999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.95  E-value=7.5e-28  Score=197.95  Aligned_cols=157  Identities=26%  Similarity=0.346  Sum_probs=121.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+++++.||+.||.|||+.+   ++|+||||.||+++.++.++++|||++................++..|+|||
T Consensus       210 ~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  286 (375)
T cd05104         210 ALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPE  286 (375)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChh
Confidence            4788999999999999999999998   9999999999999999999999999987654333222122223456799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc------cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE------LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+.....      .+.... .. ..+...+.++.+++.+||+.||++||++
T Consensus       287 ~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~  364 (375)
T cd05104         287 SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY-RM-LSPECAPSEMYDIMKSCWDADPLKRPTF  364 (375)
T ss_pred             HhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc-cC-CCCCCCCHHHHHHHHHHccCChhHCcCH
Confidence            9998889999999999999999997 6655533211      111000 00 1122235678899999999999999999


Q ss_pred             HHHHHHHhh
Q 028458          155 NDVVCMLTN  163 (208)
Q Consensus       155 ~~i~~~l~~  163 (208)
                      .++++.|++
T Consensus       365 ~eil~~l~~  373 (375)
T cd05104         365 KQIVQLIEQ  373 (375)
T ss_pred             HHHHHHHHh
Confidence            999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.4e-28  Score=197.20  Aligned_cols=151  Identities=22%  Similarity=0.259  Sum_probs=122.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC-CCeEEeccccceecC-CCcccccccccccCCCccCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICG-GNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~-~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~~~~~ap   80 (208)
                      +...++.+++.|+++|+.|||+.|   |+||||||+|++++.+ +.+||+|||++.... ...   ......|++.|+||
T Consensus       117 l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~---~l~t~cGsp~Y~aP  190 (370)
T KOG0583|consen  117 LKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDG---LLKTFCGSPAYAAP  190 (370)
T ss_pred             CChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCCCCC---cccCCCCCcccCCH
Confidence            566788999999999999999999   9999999999999999 999999999998873 222   23346899999999


Q ss_pred             chhccCC-C-CCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHH-HHHHHHHHhhccccCCCCCCCHH
Q 028458           81 EYAIQGI-F-SIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQM-LLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        81 e~~~~~~-~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      |++.+.. | ..++|+||+|+++|-|++|..||.+....  ...........+... +.++..++.+|+..||.+|+++.
T Consensus       191 Evl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~  270 (370)
T KOG0583|consen  191 EVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLL  270 (370)
T ss_pred             HHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHH
Confidence            9999877 7 48899999999999999999999863211  111011111223333 77889999999999999999999


Q ss_pred             HHHH
Q 028458          156 DVVC  159 (208)
Q Consensus       156 ~i~~  159 (208)
                      +|++
T Consensus       271 ~i~~  274 (370)
T KOG0583|consen  271 EILE  274 (370)
T ss_pred             HHhh
Confidence            9994

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-28  Score=195.71  Aligned_cols=154  Identities=23%  Similarity=0.289  Sum_probs=119.7

Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            1 MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         1 ~~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      |+|+...+..|+.||++||+|+|++|   +.|||+||+|||+..+..+||+|||+++.+.....+   +.++.|..|+||
T Consensus       105 r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY---TeYVSTRWYRAP  178 (538)
T KOG0661|consen  105 RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY---TEYVSTRWYRAP  178 (538)
T ss_pred             CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCCCc---chhhhcccccch
Confidence            57889999999999999999999999   999999999999998889999999999987655543   345789999999


Q ss_pred             chhcc-CCCCCcchhHHHHHHHHHHHHhh--hcCCccccc------------------------ccCCccch------hh
Q 028458           81 EYAIQ-GIFSIKSDVFSFGVLLLEIAWDL--WTSNRTLEL------------------------IDDPVLED------EY  127 (208)
Q Consensus        81 e~~~~-~~~~~~~Dv~slG~~~~~l~~~~--~~~~~~~~~------------------------~~~~~~~~------~~  127 (208)
                      |++.. +.|+...|+|++||+++|+.+-.  +|+....+.                        ..+..++.      ..
T Consensus       179 EvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~  258 (538)
T KOG0661|consen  179 EVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKD  258 (538)
T ss_pred             HHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHH
Confidence            99865 55899999999999999995322  222111110                        00011111      01


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ..+..+.++.++|.+|++.||.+||++.|+++.
T Consensus       259 L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  259 LLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            233356788899999999999999999999985

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.95  E-value=1.1e-27  Score=189.09  Aligned_cols=161  Identities=22%  Similarity=0.287  Sum_probs=124.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++................++..|++||
T Consensus       105 ~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE  181 (279)
T cd05109         105 RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE  181 (279)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHH
Confidence            3678899999999999999999999   9999999999999999999999999987664322211111123356799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      ...+..++.++|+||||+++|++++ |..|+......     +......  ..+...+..+.+++.+||+.||++||++.
T Consensus       182 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  259 (279)
T cd05109         182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL--PQPPICTIDVYMIMVKCWMIDSECRPRFR  259 (279)
T ss_pred             HhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC--CCCccCCHHHHHHHHHHcCCChhhCcCHH
Confidence            9988889999999999999999987 66665432211     1110000  11233456788999999999999999999


Q ss_pred             HHHHHHhhhhhc
Q 028458          156 DVVCMLTNEAAT  167 (208)
Q Consensus       156 ~i~~~l~~~~~~  167 (208)
                      ++++.|+.....
T Consensus       260 ~l~~~l~~~~~~  271 (279)
T cd05109         260 ELVDEFSRMARD  271 (279)
T ss_pred             HHHHHHHHhhcC
Confidence            999999877644

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.95  E-value=6.2e-28  Score=193.93  Aligned_cols=160  Identities=23%  Similarity=0.332  Sum_probs=123.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.||+.||.|||+++   ++|+||||+||+++.++.++|+|||++.................+..|++||.
T Consensus       106 ~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~  182 (316)
T cd05108         106 IGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES  182 (316)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHH
Confidence            577888999999999999999999   99999999999999999999999999986643322111111223567999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-c----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-L----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|++++ |..|+..... .    .......  ..+...+.++.+++.+||+.+|++||++.+
T Consensus       183 ~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~  260 (316)
T cd05108         183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--PQPPICTIDVYMIMVKCWMIDADSRPKFRE  260 (316)
T ss_pred             hccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence            988889999999999999999986 7766643211 1    1111000  112233457889999999999999999999


Q ss_pred             HHHHHhhhhhc
Q 028458          157 VVCMLTNEAAT  167 (208)
Q Consensus       157 i~~~l~~~~~~  167 (208)
                      ++..|......
T Consensus       261 l~~~l~~~~~~  271 (316)
T cd05108         261 LIIEFSKMARD  271 (316)
T ss_pred             HHHHHHHHHcC
Confidence            99999887643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.95  E-value=2.3e-27  Score=192.03  Aligned_cols=162  Identities=28%  Similarity=0.322  Sum_probs=124.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.++++++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++................++..|+|||.
T Consensus       131 l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  207 (334)
T cd05100         131 LTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEA  207 (334)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHH
Confidence            678899999999999999999999   99999999999999999999999999876543322211111233457999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcc--ccc---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRT--LEL---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ +..++...  .+.   +.....  ...+...+..+.+++.+||+.+|++||++.+
T Consensus       208 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e  285 (334)
T cd05100         208 LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTHELYMIMRECWHAVPSQRPTFKQ  285 (334)
T ss_pred             hccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence            988889999999999999999987 55544221  111   111100  0122334567889999999999999999999


Q ss_pred             HHHHHhhhhhccC
Q 028458          157 VVCMLTNEAATLL  169 (208)
Q Consensus       157 i~~~l~~~~~~~~  169 (208)
                      +++.|+++.....
T Consensus       286 ll~~l~~~~~~~~  298 (334)
T cd05100         286 LVEDLDRVLTVTS  298 (334)
T ss_pred             HHHHHHHHhhhcC
Confidence            9999998875443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.95  E-value=7.4e-28  Score=191.18  Aligned_cols=159  Identities=28%  Similarity=0.329  Sum_probs=122.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+++++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++................++..|+|||
T Consensus       128 ~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  204 (293)
T cd05053         128 TLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPE  204 (293)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHH
Confidence            4678899999999999999999998   9999999999999999999999999987654433222112223456799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc--c---cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL--E---LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|++++ |..|+....  +   .......  ...+...+..+.+++.+||+.+|++||++.
T Consensus       205 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  282 (293)
T cd05053         205 ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR--MEKPQNCTQELYHLMRDCWHEVPSQRPTFK  282 (293)
T ss_pred             HhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcCHH
Confidence            9888889999999999999999986 655543211  1   1110100  012223456788999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      ++++.|+.+.
T Consensus       283 eil~~l~~~~  292 (293)
T cd05053         283 QLVEDLDRML  292 (293)
T ss_pred             HHHHHHHHhh
Confidence            9999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.6e-27  Score=187.03  Aligned_cols=158  Identities=24%  Similarity=0.337  Sum_probs=122.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++++|||++.................+..|.+||
T Consensus       109 ~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  185 (273)
T cd05035         109 KLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE  185 (273)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHh
Confidence            3677888999999999999999998   9999999999999999999999999987664333222222223456799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+.....  .   ......  ...+...+..+.+++.+||+.||++||++.
T Consensus       186 ~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  263 (273)
T cd05035         186 SLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--LKQPEDCLDELYDLMYSCWRADPKDRPTFT  263 (273)
T ss_pred             hcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            9988889999999999999999998 6666533211  1   110100  012334566889999999999999999999


Q ss_pred             HHHHHHhhh
Q 028458          156 DVVCMLTNE  164 (208)
Q Consensus       156 ~i~~~l~~~  164 (208)
                      ++++.|+++
T Consensus       264 e~~~~l~~~  272 (273)
T cd05035         264 KLREVLENI  272 (273)
T ss_pred             HHHHHHHhh
Confidence            999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=4e-27  Score=194.53  Aligned_cols=155  Identities=21%  Similarity=0.250  Sum_probs=117.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.+++.++.||+.||.|||+.+   |+||||||.||+++.++.++|+|||++........ .......|+..|+|||
T Consensus       178 ~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE  253 (391)
T PHA03212        178 NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAGTIATNAPE  253 (391)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-cccccccCccCCCChh
Confidence            3678889999999999999999999   99999999999999999999999999865322111 1112246789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc----------------c----C-C-----ccc-----------
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI----------------D----D-P-----VLE-----------  124 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~----------------~----~-~-----~~~-----------  124 (208)
                      ++.+..++.++|+||||+++|+|++|..++.......                .    . +     .+.           
T Consensus       254 ~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (391)
T PHA03212        254 LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSS  333 (391)
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccC
Confidence            9988889999999999999999999875542211000                0    0 0     000           


Q ss_pred             -------hhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          125 -------DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       125 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                             ........+.++.++|.+||+.||++||+++|+++.
T Consensus       334 ~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        334 RKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             CCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                   000112345678899999999999999999999863

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.95  E-value=1.6e-27  Score=187.90  Aligned_cols=156  Identities=28%  Similarity=0.346  Sum_probs=121.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.++.|||+++   ++|+||+|.||+++.++.++++|||++................++..|+|||.
T Consensus       119 l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (280)
T cd05049         119 LTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPES  195 (280)
T ss_pred             ccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhh
Confidence            677888999999999999999999   99999999999999999999999999876533222111122234678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+.....     .+......  ..+...+..+.+++.+||+.||++||+++|
T Consensus       196 ~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e  273 (280)
T cd05049         196 IMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL--QRPRTCPSEVYDIMLGCWKRDPQQRINIKD  273 (280)
T ss_pred             hccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence            998889999999999999999997 7776532211     11111111  122345677899999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      +++.|++
T Consensus       274 il~~l~~  280 (280)
T cd05049         274 IHERLQK  280 (280)
T ss_pred             HHHHhhC
Confidence            9999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-27  Score=178.27  Aligned_cols=161  Identities=22%  Similarity=0.255  Sum_probs=124.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc---cc----cccccccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL---QA----NTSRIVGT   74 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~----~~~~~~~~   74 (208)
                      .++..++++|+.+|++||++||.... ++.|+||||.||++...+.+++.|||.+....-.-.   ..    .-.....+
T Consensus       123 ~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct  201 (302)
T KOG2345|consen  123 FVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCT  201 (302)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCC
Confidence            36788999999999999999999964 599999999999999999999999998865421110   00    00113468


Q ss_pred             CCccCcchhccC---CCCCcchhHHHHHHHHHHHHhhhcCCccccccc-------CCccchhhhhHHHHHHHHHHHhhcc
Q 028458           75 YGYMSPEYAIQG---IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-------DPVLEDEYSSKQMLLRYVNIALLCV  144 (208)
Q Consensus        75 ~~~~ape~~~~~---~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l  144 (208)
                      ..|+|||.+.-.   ..+.++|||||||++|.|+++..|++...+...       +..+.. .....++..+.++|++|+
T Consensus       202 ~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~-P~~~~yse~l~~lik~ml  280 (302)
T KOG2345|consen  202 IPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISI-PNSSRYSEALHQLIKSML  280 (302)
T ss_pred             CcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecccccc-CCCCCccHHHHHHHHHHh
Confidence            899999998643   468999999999999999999988876655322       111111 111226788999999999


Q ss_pred             ccCCCCCCCHHHHHHHHhhh
Q 028458          145 QESADDRPTMNDVVCMLTNE  164 (208)
Q Consensus       145 ~~~p~~Rps~~~i~~~l~~~  164 (208)
                      +.||.+||++.+++..+...
T Consensus       281 qvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  281 QVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             cCCcccCCCHHHHHHHHHhh
Confidence            99999999999999988654

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.95  E-value=1.1e-27  Score=189.20  Aligned_cols=156  Identities=26%  Similarity=0.342  Sum_probs=121.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.|+.|||+.+   ++|+||+|.||+++.++.++|+|||++................++..|+|||.
T Consensus       119 l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (280)
T cd05092         119 LTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPES  195 (280)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHH
Confidence            678899999999999999999999   99999999999999999999999999876543222111122234578999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+......     .....  ....+...+..+.+++.+||+.||++||++++
T Consensus       196 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~  273 (280)
T cd05092         196 ILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR--ELERPRTCPPEVYAIMQGCWQREPQQRMVIKD  273 (280)
T ss_pred             hccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            988889999999999999999997 66666432211     11010  00122345567889999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      +++.|++
T Consensus       274 l~~~l~~  280 (280)
T cd05092         274 IHSRLQA  280 (280)
T ss_pred             HHHHHhC
Confidence            9998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.95  E-value=3.8e-28  Score=190.08  Aligned_cols=157  Identities=30%  Similarity=0.389  Sum_probs=117.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++.+|+.|+++||.|||+.+   ++|++|+++||+++.++.+||+|||+.....................|.|||
T Consensus        99 ~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE  175 (259)
T PF07714_consen   99 PLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPE  175 (259)
T ss_dssp             TSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HH
T ss_pred             ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4789999999999999999999998   9999999999999999999999999998763332222222234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc--ccCC-ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL--IDDP-VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      .+....++.++||||||+++||+++ +..++......  .... .......+...+..+.+++..||+.+|++||++.++
T Consensus       176 ~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i  255 (259)
T PF07714_consen  176 VLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEI  255 (259)
T ss_dssp             HHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHH
Confidence            9998889999999999999999998 55555332111  1100 000012234456778999999999999999999999


Q ss_pred             HHHH
Q 028458          158 VCML  161 (208)
Q Consensus       158 ~~~l  161 (208)
                      ++.|
T Consensus       256 ~~~L  259 (259)
T PF07714_consen  256 LQEL  259 (259)
T ss_dssp             HHHH
T ss_pred             HhcC
Confidence            9876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.95  E-value=8e-28  Score=182.63  Aligned_cols=159  Identities=26%  Similarity=0.319  Sum_probs=127.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      |+.+...+|+.|+.++++|||..+   |+|||+||.||+++++..++++|||+++....+..   ....+||++|+|||.
T Consensus       120 lSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEt  193 (411)
T KOG0599|consen  120 LSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPET  193 (411)
T ss_pred             ecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCchh---HHHhcCCCcccChhh
Confidence            677888999999999999999999   99999999999999999999999999998754442   234689999999999


Q ss_pred             hcc------CCCCCcchhHHHHHHHHHHHHhhhcCCccccccc-----CCcc-chhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           83 AIQ------GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-----DPVL-EDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        83 ~~~------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      +..      ..|+..+|.|++|+++|-++.|-.|+....+.+.     .... -....-.+.+....++|.+||++||++
T Consensus       194 ikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~  273 (411)
T KOG0599|consen  194 IKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTK  273 (411)
T ss_pred             eeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchh
Confidence            864      3478999999999999999999988865544321     1111 111234556778899999999999999


Q ss_pred             CCCHHHHHHH--Hhhhhhc
Q 028458          151 RPTMNDVVCM--LTNEAAT  167 (208)
Q Consensus       151 Rps~~~i~~~--l~~~~~~  167 (208)
                      |.+++|+++.  +.++...
T Consensus       274 Ritake~LaHpff~q~~~~  292 (411)
T KOG0599|consen  274 RITAKEALAHPFFIQIAQQ  292 (411)
T ss_pred             cccHHHHhcChHHHHHHHh
Confidence            9999999874  4444433

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.95  E-value=1.2e-27  Score=189.62  Aligned_cols=152  Identities=26%  Similarity=0.295  Sum_probs=120.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+.+   ++||||||.||+++.++.++++|||++........   .....|+..|+|||
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE  171 (285)
T cd05631          98 GFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPE  171 (285)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHh
Confidence            3678889999999999999999999   99999999999999999999999999876543221   12245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCC-ccchhhhhHHHHHHHHHHHhhccccCCCCCCC--
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDP-VLEDEYSSKQMLLRYVNIALLCVQESADDRPT--  153 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps--  153 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......     +... .......+...+..+.+|+.+||+.||++||+  
T Consensus       172 ~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05631         172 VINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCR  251 (285)
T ss_pred             hhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCC
Confidence            999889999999999999999999999887543221     1000 00011223345667889999999999999997  


Q ss_pred             ---HHHHHH
Q 028458          154 ---MNDVVC  159 (208)
Q Consensus       154 ---~~~i~~  159 (208)
                         ++++++
T Consensus       252 ~~~~~~~~~  260 (285)
T cd05631         252 GNGAAGVKQ  260 (285)
T ss_pred             CCCHHHHhc
Confidence               778876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=6.6e-28  Score=200.92  Aligned_cols=158  Identities=25%  Similarity=0.282  Sum_probs=130.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+..++.+++.||+.|+.|+|..+   |+|||+||.|++++.++.+|++|||++..-.....   ..+.+|++.|++||
T Consensus       108 ~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl---LeTSCGSPHYA~PE  181 (786)
T KOG0588|consen  108 PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL---LETSCGSPHYAAPE  181 (786)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcc---ccccCCCcccCCch
Confidence            4677899999999999999999999   99999999999999999999999999977544443   33468899999999


Q ss_pred             hhccCCC-CCcchhHHHHHHHHHHHHhhhcCCccc--ccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           82 YAIQGIF-SIKSDVFSFGVLLLEIAWDLWTSNRTL--ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        82 ~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      ++.|.+| +.++||||.|++++.|++|..||++.-  .+..+........+..++.++.+|+.+|+.+||++|.+++||+
T Consensus       182 IV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~  261 (786)
T KOG0588|consen  182 IVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEIL  261 (786)
T ss_pred             hhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHh
Confidence            9999998 688999999999999999999997431  1121122222234667788899999999999999999999999


Q ss_pred             HH--Hhhhh
Q 028458          159 CM--LTNEA  165 (208)
Q Consensus       159 ~~--l~~~~  165 (208)
                      +.  |.+..
T Consensus       262 kHP~l~g~~  270 (786)
T KOG0588|consen  262 KHPFLSGYT  270 (786)
T ss_pred             hCchhhcCC
Confidence            96  44443

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.94  E-value=4.2e-28  Score=195.64  Aligned_cols=153  Identities=20%  Similarity=0.264  Sum_probs=120.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++........  ......|+..|+|||
T Consensus        91 ~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE  165 (323)
T cd05571          91 VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPE  165 (323)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccceecCccccChh
Confidence            4678888999999999999999999   99999999999999999999999999864321111  112245789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----CH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----TM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~  154 (208)
                      .+.+..++.++|+|||||++|+|++|..|+......  ...........+...+..+.++|.+||+.||++||     ++
T Consensus       166 ~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~  245 (323)
T cd05571         166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDA  245 (323)
T ss_pred             hhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCH
Confidence            998888999999999999999999999887543211  11000011122344567789999999999999999     79


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      +++++
T Consensus       246 ~~ll~  250 (323)
T cd05571         246 KEIME  250 (323)
T ss_pred             HHHHc
Confidence            99876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=2.6e-27  Score=195.84  Aligned_cols=156  Identities=26%  Similarity=0.337  Sum_probs=120.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.||+.||.|||+++   |+||||||.||+++.++.++|+|||++................|+..|+|||
T Consensus       181 ~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE  257 (392)
T PHA03207        181 PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPE  257 (392)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHh
Confidence            4788899999999999999999999   9999999999999999999999999987654433222223356889999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------------ccC-----Cc----------------cchhhh
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------------IDD-----PV----------------LEDEYS  128 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------------~~~-----~~----------------~~~~~~  128 (208)
                      .+.+..++.++|+|||||++|+|++|..|+......            ...     +.                ......
T Consensus       258 ~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (392)
T PHA03207        258 LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYT  337 (392)
T ss_pred             HhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCcc
Confidence            999888999999999999999999988776432110            000     00                000000


Q ss_pred             ------hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          129 ------SKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       129 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                            ...++.++.++|.+||..||++||++.|++..
T Consensus       338 ~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        338 IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                  01224567889999999999999999999885

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.4e-28  Score=192.32  Aligned_cols=152  Identities=25%  Similarity=0.356  Sum_probs=124.2

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchh
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA   83 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~   83 (208)
                      +...+.-++.+++.|+.|||.++   .+|||||+.||++..+|.++|+|||++....+.....  ..++||+.|+|||++
T Consensus       109 ~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI  183 (467)
T KOG0201|consen  109 DEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVI  183 (467)
T ss_pred             ccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc--ccccccccccchhhh
Confidence            44455667899999999999999   9999999999999999999999999997765444332  457899999999999


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc---cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458           84 IQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus        84 ~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      .+..|+.++|+||||++.+||+.|.+|.-+.+..-   .-+...+..........+.+|+..||..||+.||++.++++.
T Consensus       184 ~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  184 KQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            98899999999999999999999998886554421   111112223334667789999999999999999999998873

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.94  E-value=1.7e-27  Score=189.23  Aligned_cols=159  Identities=28%  Similarity=0.372  Sum_probs=120.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+.+   ++|+||||.||+++.++.++++|||++................++..|+|||
T Consensus       126 ~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  202 (296)
T cd05051         126 SLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE  202 (296)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHH
Confidence            4788899999999999999999998   9999999999999999999999999987654333222222234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH--hhhcCCcccc--ccc---CC-----ccchhhhhHHHHHHHHHHHhhccccCCC
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW--DLWTSNRTLE--LID---DP-----VLEDEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~--~~~~~~~~~~--~~~---~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      .+.+..++.++|+||||+++|++++  +..|+.....  ...   ..     .......+...+.++.+++.+||+.||+
T Consensus       203 ~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~  282 (296)
T cd05051         203 SVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEE  282 (296)
T ss_pred             HhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChh
Confidence            9988889999999999999999987  4444432111  000   00     0000011223446789999999999999


Q ss_pred             CCCCHHHHHHHHhh
Q 028458          150 DRPTMNDVVCMLTN  163 (208)
Q Consensus       150 ~Rps~~~i~~~l~~  163 (208)
                      +||++.++++.|++
T Consensus       283 ~Rpt~~el~~~L~~  296 (296)
T cd05051         283 DRPTFREIHLFLQR  296 (296)
T ss_pred             cCCCHHHHHHHhcC
Confidence            99999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=209.74  Aligned_cols=165  Identities=28%  Similarity=0.376  Sum_probs=133.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+..+-+.++.||++|..||++++   +|||||..+|+|++....+|++|||+++.+-...+........-+..|+|||
T Consensus       798 ~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PE  874 (1025)
T KOG1095|consen  798 NLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPE  874 (1025)
T ss_pred             CCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHH
Confidence            5788899999999999999999998   9999999999999999999999999998654444433333223467999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHh-hhcCCc--cccc----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWD-LWTSNR--TLEL----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~-~~~~~~--~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+..+.|+.++||||||+++||+++. ..|...  ..+.    .....+   ..+..++..++++|..||+.+|++||++
T Consensus       875 sl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL---~~P~~CP~~ly~lM~~CW~~~pe~RP~F  951 (1025)
T KOG1095|consen  875 SLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL---DPPSYCPEKLYQLMLQCWKHDPEDRPSF  951 (1025)
T ss_pred             HHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc---CCCCCCChHHHHHHHHHccCChhhCccH
Confidence            99999999999999999999999984 333322  2222    223333   3466778889999999999999999999


Q ss_pred             HHHHHHHhhhhhccCCCC
Q 028458          155 NDVVCMLTNEAATLLPPK  172 (208)
Q Consensus       155 ~~i~~~l~~~~~~~~~p~  172 (208)
                      ..|++.+.++.....+-.
T Consensus       952 ~~i~~q~~~i~~~~~~~~  969 (1025)
T KOG1095|consen  952 RTIVEQDPAISNAALGTI  969 (1025)
T ss_pred             HHHHhhhhhhhhhhccCc
Confidence            999999888776554433

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.94  E-value=3.4e-27  Score=189.83  Aligned_cols=153  Identities=29%  Similarity=0.340  Sum_probs=117.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  .......|+..|+|||
T Consensus        92 ~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE  166 (316)
T cd05592          92 RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPE  166 (316)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHH
Confidence            3567788899999999999999999   9999999999999999999999999987543222  1122346789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN-DVV  158 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~i~  158 (208)
                      .+.+..++.++|+|||||++|+|++|..|+.....  ............+...+.++.+++.+||+.||++||++. +++
T Consensus       167 ~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            99988899999999999999999999888753221  111000001112333456788999999999999999875 454


Q ss_pred             H
Q 028458          159 C  159 (208)
Q Consensus       159 ~  159 (208)
                      +
T Consensus       247 ~  247 (316)
T cd05592         247 Q  247 (316)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.94  E-value=2.5e-27  Score=181.94  Aligned_cols=152  Identities=20%  Similarity=0.352  Sum_probs=117.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++.....+++.|++.|+.|+|+++   ++||||||.||++..+|.+||||||+++....  .....+.++.|..|+|||.
T Consensus        98 ~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPEL  172 (396)
T KOG0593|consen   98 VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPEL  172 (396)
T ss_pred             CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhh
Confidence            456678899999999999999999   99999999999999999999999999987653  2223444677899999999


Q ss_pred             hcc-CCCCCcchhHHHHHHHHHHHHhh--hcCCcccccc------------------------cCCccchh-------hh
Q 028458           83 AIQ-GIFSIKSDVFSFGVLLLEIAWDL--WTSNRTLELI------------------------DDPVLEDE-------YS  128 (208)
Q Consensus        83 ~~~-~~~~~~~Dv~slG~~~~~l~~~~--~~~~~~~~~~------------------------~~~~~~~~-------~~  128 (208)
                      +.+ -.|+..+|||++||++.||++|.  ||.....+..                        ....++..       ..
T Consensus       173 LvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k  252 (396)
T KOG0593|consen  173 LVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERK  252 (396)
T ss_pred             hcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhh
Confidence            988 56899999999999999998875  3433221100                        00011110       11


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .+....-+.+|++.||+.||++|++.++++.
T Consensus       253 ~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  253 YPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            2333456789999999999999999998875

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.94  E-value=2e-27  Score=185.45  Aligned_cols=158  Identities=26%  Similarity=0.324  Sum_probs=122.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.|+.|||+++   ++|+||+|.||+++.++.++++|||++.......... ......++..|+||
T Consensus        91 ~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  167 (257)
T cd05116          91 HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP  167 (257)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCH
Confidence            3678889999999999999999999   9999999999999999999999999987654332111 11112234689999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+....++.++|+||||+++|++++ |..|+.....     .+.....  ...+...+.++.++|.+||+.||++||++
T Consensus       168 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~~~~~p~~Rp~~  245 (257)
T cd05116         168 ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER--MECPQRCPPEMYDLMKLCWTYGVDERPGF  245 (257)
T ss_pred             hHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHhccCchhCcCH
Confidence            99988888999999999999999997 7777653311     1111110  12233456778999999999999999999


Q ss_pred             HHHHHHHhhh
Q 028458          155 NDVVCMLTNE  164 (208)
Q Consensus       155 ~~i~~~l~~~  164 (208)
                      .+|.+.|+..
T Consensus       246 ~~i~~~l~~~  255 (257)
T cd05116         246 AVVELRLRNY  255 (257)
T ss_pred             HHHHHHHhcc
Confidence            9999999764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.94  E-value=6.8e-28  Score=184.32  Aligned_cols=141  Identities=25%  Similarity=0.280  Sum_probs=119.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+.-++.||+.||+|||+.+   |++||+||+|||+|.+|.+|+.|||++......     ..+.+||+.|+|||.
T Consensus       141 F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEi  212 (355)
T KOG0616|consen  141 FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEI  212 (355)
T ss_pred             CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHH
Confidence            566778889999999999999999   999999999999999999999999999886544     334689999999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      +...+|..++|.|+||+++|||+.|..||.....  ..+.........+.....++.+++..+|++|-++|
T Consensus       213 i~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  213 IQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             hhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            9999999999999999999999999999865433  22222222224566677788999999999999999

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.94  E-value=3.3e-27  Score=184.77  Aligned_cols=157  Identities=25%  Similarity=0.372  Sum_probs=121.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++++|.|||+.+   ++|+||+|+||+++.++.++++|||++.......... ......+..|.+||
T Consensus       100 ~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE  175 (263)
T cd05052         100 EVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPE  175 (263)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec-cCCCCCccccCCHH
Confidence            3678889999999999999999998   9999999999999999999999999987664432211 11122345799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcc--ccc---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRT--LEL---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+...  .+.   ... ... ...+...+..+.+++.+||+.+|++||++.
T Consensus       176 ~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~  253 (263)
T cd05052         176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYR-MERPEGCPPKVYELMRACWQWNPSDRPSFA  253 (263)
T ss_pred             HhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCC-CCCCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence            9988889999999999999999997 66555321  111   110 001 122334557789999999999999999999


Q ss_pred             HHHHHHhhh
Q 028458          156 DVVCMLTNE  164 (208)
Q Consensus       156 ~i~~~l~~~  164 (208)
                      ++++.|+.+
T Consensus       254 ~l~~~l~~~  262 (263)
T cd05052         254 EIHQAFETM  262 (263)
T ss_pred             HHHHHHHhh
Confidence            999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.94  E-value=2.8e-27  Score=191.44  Aligned_cols=162  Identities=22%  Similarity=0.234  Sum_probs=119.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-ccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++......... .......++..|+||
T Consensus        99 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aP  175 (338)
T cd07859          99 DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP  175 (338)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCH
Confidence            3678899999999999999999999   999999999999999999999999998754322111 111224678899999


Q ss_pred             chhcc--CCCCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccCCc------------------------cch
Q 028458           81 EYAIQ--GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDDPV------------------------LED  125 (208)
Q Consensus        81 e~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~~~------------------------~~~  125 (208)
                      |.+.+  ..++.++|+|||||++|+|++|..++......         ...+.                        ...
T Consensus       176 E~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  255 (338)
T cd07859         176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPF  255 (338)
T ss_pred             HHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCch
Confidence            99865  56889999999999999999998776322110         00000                        000


Q ss_pred             hhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhhhh
Q 028458          126 EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEAA  166 (208)
Q Consensus       126 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~~  166 (208)
                      .......+..+.+++.+||+.||++||+++|+++.  ++....
T Consensus       256 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         256 SQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            00001123457899999999999999999999974  554443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.94  E-value=2.9e-27  Score=188.99  Aligned_cols=160  Identities=26%  Similarity=0.316  Sum_probs=123.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.+++.++.|+++||.|||+.+   ++|+||||+||+++.++.++++|||++................++..|+|||.
T Consensus       134 ~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~  210 (304)
T cd05101         134 MTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEA  210 (304)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchh
Confidence            678889999999999999999999   99999999999999999999999999887654332222222234567999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcc--cc---cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRT--LE---LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|++++ |..++...  .+   .+....  ....+...+..+.+++.+||+.+|++||++.+
T Consensus       211 ~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e  288 (304)
T cd05101         211 LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH--RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQ  288 (304)
T ss_pred             hccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--cCCCCCCCCHHHHHHHHHHcccChhhCCCHHH
Confidence            988889999999999999999987 44443211  11   111000  00112334567889999999999999999999


Q ss_pred             HHHHHhhhhhc
Q 028458          157 VVCMLTNEAAT  167 (208)
Q Consensus       157 i~~~l~~~~~~  167 (208)
                      +++.|+++...
T Consensus       289 ~l~~l~~~~~~  299 (304)
T cd05101         289 LVEDLDRILTL  299 (304)
T ss_pred             HHHHHHHHHHh
Confidence            99999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2.1e-27  Score=201.52  Aligned_cols=154  Identities=21%  Similarity=0.263  Sum_probs=122.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++................|+..|+|||
T Consensus       139 ~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE  215 (496)
T PTZ00283        139 TFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE  215 (496)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHH
Confidence            3667788999999999999999999   9999999999999999999999999987654332222223356889999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--ccc---CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LID---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.....  ...   .....  ..+...+..+.+++.+||+.||.+||++.+
T Consensus       216 ~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~RPs~~e  293 (496)
T PTZ00283        216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD--PLPPSISPEMQEIVTALLSSDPKRRPSSSK  293 (496)
T ss_pred             HhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence            99988899999999999999999999887753211  111   00000  123445677899999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       294 ll~~  297 (496)
T PTZ00283        294 LLNM  297 (496)
T ss_pred             HHhC
Confidence            9863

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.94  E-value=3.8e-27  Score=187.63  Aligned_cols=159  Identities=27%  Similarity=0.375  Sum_probs=119.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++++|||++................++..|.+||
T Consensus       126 ~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  202 (296)
T cd05095         126 TISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE  202 (296)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHH
Confidence            3677889999999999999999999   9999999999999999999999999987654332211122223456799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH--hhhcCCccc--ccccCC--------ccchhhhhHHHHHHHHHHHhhccccCCC
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW--DLWTSNRTL--ELIDDP--------VLEDEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~--~~~~~~~~~--~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      ...++.++.++|+||||+++|+|++  +..|+....  +.+...        .......+...+..+.+++.+||+.||+
T Consensus       203 ~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  282 (296)
T cd05095         203 SILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAK  282 (296)
T ss_pred             HHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcc
Confidence            8888889999999999999999987  445553221  111000        0000011223446788999999999999


Q ss_pred             CCCCHHHHHHHHhh
Q 028458          150 DRPTMNDVVCMLTN  163 (208)
Q Consensus       150 ~Rps~~~i~~~l~~  163 (208)
                      +||++.++++.|++
T Consensus       283 ~Rp~~~~i~~~l~~  296 (296)
T cd05095         283 ERPSFQEIHATLLE  296 (296)
T ss_pred             cCCCHHHHHHHHhC
Confidence            99999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=4.2e-27  Score=186.07  Aligned_cols=161  Identities=26%  Similarity=0.317  Sum_probs=123.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccccc-ccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.|+.|||+++   ++|+||||.||+++.++.++++|||++........... .....++..|++|
T Consensus       103 ~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~P  179 (283)
T cd05080         103 KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV  179 (283)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCH
Confidence            3688899999999999999999999   99999999999999999999999999876543222111 1112345569999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc---CCcc---c------------hhhhhHHHHHHHHHHHhh
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID---DPVL---E------------DEYSSKQMLLRYVNIALL  142 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---~~~~---~------------~~~~~~~~~~~~~~li~~  142 (208)
                      |.+.+..++.++|+||||+++|+|++|..|+........   ....   .            ....+...+..+.+++.+
T Consensus       180 E~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  259 (283)
T cd05080         180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKN  259 (283)
T ss_pred             hHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHH
Confidence            999888889999999999999999998766543221110   0000   0            000122345688999999


Q ss_pred             ccccCCCCCCCHHHHHHHHhhhh
Q 028458          143 CVQESADDRPTMNDVVCMLTNEA  165 (208)
Q Consensus       143 ~l~~~p~~Rps~~~i~~~l~~~~  165 (208)
                      ||+.+|++||+++++++.|+.+.
T Consensus       260 cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         260 CWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             HhccChhhCCCHHHHHHHHHHhh
Confidence            99999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.94  E-value=2.3e-27  Score=188.25  Aligned_cols=159  Identities=27%  Similarity=0.355  Sum_probs=123.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.+++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++................++..|.|||
T Consensus       123 ~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE  199 (290)
T cd05045         123 ALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIE  199 (290)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHH
Confidence            3678899999999999999999998   9999999999999999999999999987653322211112223456899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+.....     ..... ... ..+...+..+.+++.+||+.+|++||+++
T Consensus       200 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~  277 (290)
T cd05045         200 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-YRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFA  277 (290)
T ss_pred             HHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCC-CCCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence            9988889999999999999999997 7666532211     11100 000 12333456788999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      ++++.|++..
T Consensus       278 ~i~~~l~~~~  287 (290)
T cd05045         278 DISKELEKMM  287 (290)
T ss_pred             HHHHHHHHHH
Confidence            9999998875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.94  E-value=1.9e-27  Score=187.48  Aligned_cols=156  Identities=26%  Similarity=0.371  Sum_probs=119.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+.+   ++|+||||.||+++.++.++++|||++................++..|+|||.
T Consensus       116 ~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05062         116 PSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  192 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhH
Confidence            467788999999999999999998   99999999999999999999999999875543332221122234667999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-c----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-L----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ +..|+..... .    .......  ..+...+..+.+++.+||+.+|++||++.|
T Consensus       193 ~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  270 (277)
T cd05062         193 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPSFLE  270 (277)
T ss_pred             hhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            988889999999999999999998 4555532211 0    0001110  122334567899999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      +++.|++
T Consensus       271 ~l~~l~~  277 (277)
T cd05062         271 IISSIKE  277 (277)
T ss_pred             HHHHhhC
Confidence            9998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.94  E-value=3.1e-27  Score=186.49  Aligned_cols=161  Identities=24%  Similarity=0.285  Sum_probs=124.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.+++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++................++..|+|||
T Consensus       113 ~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE  189 (280)
T cd05043         113 ALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALE  189 (280)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHH
Confidence            3678899999999999999999998   9999999999999999999999999987553332221112223456799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--cc---cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--LI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|++++ |..|+.....  ..   ... ... ......+..+.+++.+||+.+|++||++.
T Consensus       190 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~  267 (280)
T cd05043         190 SLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRL-AQPINCPDELFAVMACCWALDPEERPSFS  267 (280)
T ss_pred             HHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CCC-CCCCcCCHHHHHHHHHHcCCChhhCCCHH
Confidence            9988888999999999999999998 7777643211  10   000 000 11223456789999999999999999999


Q ss_pred             HHHHHHhhhhhc
Q 028458          156 DVVCMLTNEAAT  167 (208)
Q Consensus       156 ~i~~~l~~~~~~  167 (208)
                      ++++.|+.+...
T Consensus       268 ~~~~~l~~~~~~  279 (280)
T cd05043         268 QLVQCLTDFHAQ  279 (280)
T ss_pred             HHHHHHHHHHhc
Confidence            999999887643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.94  E-value=8.4e-28  Score=197.70  Aligned_cols=160  Identities=27%  Similarity=0.311  Sum_probs=132.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...-+.|..+|+.|+.|||.+.   |||||||..|||+..+..+||+|||-++.....   .....+.||..|+|||
T Consensus       208 ~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPE  281 (904)
T KOG4721|consen  208 PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPE  281 (904)
T ss_pred             ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHH
Confidence            3556677899999999999999999   999999999999999999999999988766443   2233478999999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc----CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID----DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +++..+.+.++||||||+++|||+++..|..+......    ..+.--...+..+++.+.-||++||+..|..||++++|
T Consensus       282 vIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqi  361 (904)
T KOG4721|consen  282 VIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQI  361 (904)
T ss_pred             HhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHH
Confidence            99999999999999999999999999988765544211    11111114567778889999999999999999999999


Q ss_pred             HHHHhhhhhc
Q 028458          158 VCMLTNEAAT  167 (208)
Q Consensus       158 ~~~l~~~~~~  167 (208)
                      +..|.-..+.
T Consensus       362 l~HldIa~pe  371 (904)
T KOG4721|consen  362 LLHLDIASPE  371 (904)
T ss_pred             HHHHhhcCHH
Confidence            9998766544

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.94  E-value=7.5e-27  Score=184.89  Aligned_cols=154  Identities=20%  Similarity=0.207  Sum_probs=118.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......... ......++..|+|||
T Consensus        96 ~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE  171 (287)
T cd07848          96 GVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPE  171 (287)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcH
Confidence            3677888999999999999999999   999999999999999999999999998765432211 112245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--------c-------------CCc-----cch--------hh
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--------D-------------DPV-----LED--------EY  127 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--------~-------------~~~-----~~~--------~~  127 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......-        .             ++.     ...        ..
T Consensus       172 ~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T cd07848         172 LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERR  251 (287)
T ss_pred             HHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHh
Confidence            9988889999999999999999999987764321100        0             000     000        00


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .....+..+.+++++||+.||++||+++++++
T Consensus       252 ~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         252 YLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            01124556899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=1.3e-26  Score=194.54  Aligned_cols=156  Identities=19%  Similarity=0.268  Sum_probs=116.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.+++.|+.|++.||.|||+++   |+||||||.||+++.++.++|+|||++................|+..|+|||
T Consensus       256 ~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE  332 (461)
T PHA03211        256 PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPE  332 (461)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHH
Confidence            4789999999999999999999999   9999999999999999999999999987654322221222346889999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccc-------------ccccCC-----ccch---hh-------------
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL-------------ELIDDP-----VLED---EY-------------  127 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------------~~~~~~-----~~~~---~~-------------  127 (208)
                      ++.+..++.++|+|||||++|+|+++..+.....             ..+...     ....   ..             
T Consensus       333 ~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  412 (461)
T PHA03211        333 VLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNR  412 (461)
T ss_pred             HHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhccc
Confidence            9998889999999999999999987643221100             000000     0000   00             


Q ss_pred             ----------hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          128 ----------SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       128 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                                ........+.+||.+||+.||.+||++.|+++.
T Consensus       413 ~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        413 RPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                      000123467889999999999999999999874

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.94  E-value=1.3e-26  Score=186.17  Aligned_cols=154  Identities=21%  Similarity=0.257  Sum_probs=113.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe----CCCCCeEEeccccceecCCCccc-ccccccccCCCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGY   77 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~----~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~   77 (208)
                      ++...+..++.||+.||.|||+++   ++||||||+||++    +..+.++|+|||++......... .......++..|
T Consensus       105 l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y  181 (317)
T cd07868         105 LPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY  181 (317)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccc
Confidence            677788999999999999999999   9999999999999    45678999999999765432211 112234678899


Q ss_pred             cCcchhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCc---------------------------cchh-hh
Q 028458           78 MSPEYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPV---------------------------LEDE-YS  128 (208)
Q Consensus        78 ~ape~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~---------------------------~~~~-~~  128 (208)
                      +|||.+.+. .++.++|+||+||++|+|++|..++....+......                           .... ..
T Consensus       182 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (317)
T cd07868         182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTL  261 (317)
T ss_pred             cCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhh
Confidence            999998764 478999999999999999999877643221110000                           0000 00


Q ss_pred             h---------------------HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          129 S---------------------KQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       129 ~---------------------~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .                     ......+.++|++||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         262 MKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             hhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0                     001234678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-27  Score=191.45  Aligned_cols=155  Identities=28%  Similarity=0.372  Sum_probs=123.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc---cccccccccCCCccC
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL---QANTSRIVGTYGYMS   79 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~~~a   79 (208)
                      |+..++.+|+.+++.||+|||.+|   |+||||||+|+|++.+|.+||+|||.+........   ........||+.|+|
T Consensus       207 ls~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~A  283 (576)
T KOG0585|consen  207 LSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFA  283 (576)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccc
Confidence            788999999999999999999999   99999999999999999999999999987633311   112233579999999


Q ss_pred             cchhccCC----CCCcchhHHHHHHHHHHHHhhhcCCccccc--cc---CCccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           80 PEYAIQGI----FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID---DPVLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        80 pe~~~~~~----~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      ||.+.++.    .+.+.|+|++|+++|.|++|..||......  .+   +..+.- ...+++...+.++|.+||..||++
T Consensus       284 PE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~f-P~~pe~~e~~kDli~~lL~KdP~~  362 (576)
T KOG0585|consen  284 PELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEF-PENPEINEDLKDLIKRLLEKDPEQ  362 (576)
T ss_pred             hHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccC-CCcccccHHHHHHHHHHhhcChhh
Confidence            99997743    368899999999999999999998655332  11   112111 112245677889999999999999


Q ss_pred             CCCHHHHHHHH
Q 028458          151 RPTMNDVVCML  161 (208)
Q Consensus       151 Rps~~~i~~~l  161 (208)
                      |.+..+|....
T Consensus       363 Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  363 RITLPDIKLHP  373 (576)
T ss_pred             eeehhhheecc
Confidence            99999887654

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.94  E-value=4.5e-27  Score=188.77  Aligned_cols=160  Identities=27%  Similarity=0.335  Sum_probs=123.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.++++++.|++.||.|||+.+   ++|+||||.||+++.++.++++|||++................++..|+|||.
T Consensus       131 l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  207 (314)
T cd05099         131 LSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEA  207 (314)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHH
Confidence            678899999999999999999998   99999999999999999999999999876543322221111223457999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc-----ccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL-----ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|++++ |..|+....     +.+.....  ...+...+.++.+++.+||+.+|++||++.+
T Consensus       208 ~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~  285 (314)
T cd05099         208 LFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR--MDKPSNCTHELYMLMRECWHAVPTQRPTFKQ  285 (314)
T ss_pred             HccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            988889999999999999999998 555543211     11111110  0123334567889999999999999999999


Q ss_pred             HHHHHhhhhhc
Q 028458          157 VVCMLTNEAAT  167 (208)
Q Consensus       157 i~~~l~~~~~~  167 (208)
                      +++.|.+....
T Consensus       286 ll~~l~~~~~~  296 (314)
T cd05099         286 LVEALDKVLAA  296 (314)
T ss_pred             HHHHHHHHHHH
Confidence            99999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.94  E-value=1.7e-27  Score=192.55  Aligned_cols=154  Identities=21%  Similarity=0.268  Sum_probs=120.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.||+.||.|||+++   ++||||||.||+++.++.++|+|||++........  ......|+..|+|||
T Consensus        91 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE  165 (328)
T cd05593          91 VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPE  165 (328)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccccccCCcCccChh
Confidence            4678889999999999999999999   99999999999999999999999999865322111  112245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----CH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----TM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.....  ............+...+.++.++|.+||+.||++|+     ++
T Consensus       166 ~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~  245 (328)
T cd05593         166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDA  245 (328)
T ss_pred             hhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCH
Confidence            99888899999999999999999999988753321  111111111122344567788999999999999997     89


Q ss_pred             HHHHHH
Q 028458          155 NDVVCM  160 (208)
Q Consensus       155 ~~i~~~  160 (208)
                      .++++.
T Consensus       246 ~~il~h  251 (328)
T cd05593         246 KEIMRH  251 (328)
T ss_pred             HHHhcC
Confidence            998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.94  E-value=3.4e-27  Score=183.47  Aligned_cols=155  Identities=26%  Similarity=0.294  Sum_probs=118.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.+++.++.|++.||.|||+++   ++|+||+|.||+++.++.++++|||++.................+..|+|||.
T Consensus        91 ~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  167 (252)
T cd05084          91 LKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA  167 (252)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchh
Confidence            678899999999999999999999   99999999999999999999999999875433221111111122456999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.++.++.++|+||||+++|++++ +..|+.....     .... ... ...+...+..+.+++.+||+.+|++||++.+
T Consensus       168 ~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  245 (252)
T cd05084         168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVR-LPCPELCPDAVYRLMERCWEYDPGQRPSFST  245 (252)
T ss_pred             hcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCC-CCCcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            988889999999999999999997 6555532211     1110 000 0123334567889999999999999999999


Q ss_pred             HHHHHh
Q 028458          157 VVCMLT  162 (208)
Q Consensus       157 i~~~l~  162 (208)
                      +++.|+
T Consensus       246 ~~~~l~  251 (252)
T cd05084         246 VHQELQ  251 (252)
T ss_pred             HHHHHh
Confidence            999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.9e-27  Score=186.14  Aligned_cols=155  Identities=28%  Similarity=0.389  Sum_probs=120.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++................++..|.|||.
T Consensus       116 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05032         116 PTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES  192 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHH
Confidence            577889999999999999999998   99999999999999999999999999876543332222222345678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc--cc---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL--EL---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+|+||+++|++++ |..++....  +.   .......  ..+...+..+.+++.+||+.+|++||++.+
T Consensus       193 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  270 (277)
T cd05032         193 LKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL--DLPENCPDKLLELMRMCWQYNPKMRPTFLE  270 (277)
T ss_pred             HhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            988889999999999999999997 666553211  11   1101000  122334677899999999999999999999


Q ss_pred             HHHHHh
Q 028458          157 VVCMLT  162 (208)
Q Consensus       157 i~~~l~  162 (208)
                      +++.|+
T Consensus       271 l~~~l~  276 (277)
T cd05032         271 IVSSLK  276 (277)
T ss_pred             HHHHhc
Confidence            999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.94  E-value=4.1e-27  Score=184.45  Aligned_cols=158  Identities=26%  Similarity=0.370  Sum_probs=122.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+++++.|++.|+.|||+.+   ++|+||+|.||+++.++.++++|||++................++..|.|||
T Consensus       102 ~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe  178 (266)
T cd05033         102 KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE  178 (266)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChh
Confidence            3678899999999999999999998   9999999999999999999999999988764222111111123456799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+|+||+++|++++ |..|+......     +....  ....+...+..+.+++.+||+.+|++||++.
T Consensus       179 ~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~  256 (266)
T cd05033         179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY--RLPPPMDCPSALYQLMLDCWQKDRNERPTFS  256 (266)
T ss_pred             hhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            9988889999999999999999986 76665332111     11000  0011233456788999999999999999999


Q ss_pred             HHHHHHhhh
Q 028458          156 DVVCMLTNE  164 (208)
Q Consensus       156 ~i~~~l~~~  164 (208)
                      ++++.|.++
T Consensus       257 ei~~~l~~~  265 (266)
T cd05033         257 QIVSTLDKM  265 (266)
T ss_pred             HHHHHHHhh
Confidence            999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.94  E-value=3.6e-27  Score=186.46  Aligned_cols=156  Identities=29%  Similarity=0.402  Sum_probs=120.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++...+.++.|++.||.|||+++   ++|+||+|+||+++.++.++++|||++................++..|.|||.
T Consensus       121 ~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (283)
T cd05090         121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEA  197 (283)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHH
Confidence            677888999999999999999999   99999999999999999999999999876543322222222344667999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+.....     .+......  ..+...+..+.+++.+||+.+|++||++.+
T Consensus       198 ~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~  275 (283)
T cd05090         198 IMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL--PCSEDCPPRMYSLMTECWQEGPSRRPRFKD  275 (283)
T ss_pred             hccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence            988889999999999999999998 7666532211     11111100  122334567889999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      +.+.|+.
T Consensus       276 i~~~l~~  282 (283)
T cd05090         276 IHTRLRS  282 (283)
T ss_pred             HHHHhhc
Confidence            9998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.94  E-value=8.1e-27  Score=184.70  Aligned_cols=151  Identities=23%  Similarity=0.273  Sum_probs=116.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++........   .....++..|+|||.
T Consensus       105 ~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~  178 (288)
T cd07863         105 LPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEV  178 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchH
Confidence            678889999999999999999999   99999999999999999999999999876542221   122356788999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------c---c--------------CCcc------chhhhhHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------I---D--------------DPVL------EDEYSSKQML  133 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~---~--------------~~~~------~~~~~~~~~~  133 (208)
                      +.+..++.++|+||||+++|+|++|..++......      .   .              ....      ......+..+
T Consensus       179 ~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (288)
T cd07863         179 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIE  258 (288)
T ss_pred             hhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcC
Confidence            98888999999999999999999887665322110      0   0              0000      0001112345


Q ss_pred             HHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          134 LRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       134 ~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ..+.+++.+||+.||++||++.+++.
T Consensus       259 ~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         259 ESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HHHHHHHHHHhccCcccCCCHHHHhc
Confidence            66789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.94  E-value=8.5e-27  Score=182.76  Aligned_cols=158  Identities=27%  Similarity=0.372  Sum_probs=120.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC-----CeEEeccccceecCCCcccccccccccCCCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-----NPKISDFGMARICGGNELQANTSRIVGTYGY   77 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~-----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~   77 (208)
                      +++.+++.++.|++.|+.|||+.+   ++|+||+|+||+++.++     .++++|||++................++..|
T Consensus       103 ~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y  179 (269)
T cd05044         103 LTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW  179 (269)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccc
Confidence            678889999999999999999998   99999999999999877     8999999998765433222111222345789


Q ss_pred             cCcchhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc--ccccCC-ccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           78 MSPEYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL--ELIDDP-VLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        78 ~ape~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      +|||.+.++.++.++|+||||+++|+|++ |..|+....  +..... .......+...+..+.+++.+||+.+|++||+
T Consensus       180 ~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~  259 (269)
T cd05044         180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPT  259 (269)
T ss_pred             cCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCC
Confidence            99999988889999999999999999997 776653221  111000 00011223345677899999999999999999


Q ss_pred             HHHHHHHHhh
Q 028458          154 MNDVVCMLTN  163 (208)
Q Consensus       154 ~~~i~~~l~~  163 (208)
                      ++++.+.|++
T Consensus       260 ~~~i~~~l~~  269 (269)
T cd05044         260 FDRIQEILQN  269 (269)
T ss_pred             HHHHHHHHhC
Confidence            9999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.94  E-value=5.1e-27  Score=198.55  Aligned_cols=152  Identities=21%  Similarity=0.218  Sum_probs=121.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.++..++.|++.||.|||+.+   |+||||||.||+++.++.++|+|||++................|+..|+|||.
T Consensus       166 l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~  242 (478)
T PTZ00267        166 FQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPEL  242 (478)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhH
Confidence            677788999999999999999999   99999999999999999999999999987644332222333568899999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--ccc---CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LID---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +.+..++.++|+|||||++|+|++|..|+.....  ...   .....  ..+...+..+.++|.+||+.+|++||+++++
T Consensus       243 ~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~  320 (478)
T PTZ00267        243 WERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD--PFPCPVSSGMKALLDPLLSKNPALRPTTQQL  320 (478)
T ss_pred             hCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence            9888899999999999999999999888743211  111   00000  1223455678999999999999999999998


Q ss_pred             HH
Q 028458          158 VC  159 (208)
Q Consensus       158 ~~  159 (208)
                      +.
T Consensus       321 l~  322 (478)
T PTZ00267        321 LH  322 (478)
T ss_pred             Hh
Confidence            65

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.94  E-value=4.7e-27  Score=186.21  Aligned_cols=156  Identities=26%  Similarity=0.400  Sum_probs=119.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||.++   ++|+||+|.||+++.++.++++|||++.................+..|.|||.
T Consensus       127 l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  203 (288)
T cd05050         127 LSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPES  203 (288)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHH
Confidence            677888999999999999999998   99999999999999999999999999876533322111122234567999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcc-ccc----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRT-LEL----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ +..|+... ...    +......  ..+...+..+.+++.+||+.+|++||++.|
T Consensus       204 ~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e  281 (288)
T cd05050         204 IFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSFAS  281 (288)
T ss_pred             HhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence            988889999999999999999986 55554321 111    1111110  112334567899999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      +++.|++
T Consensus       282 l~~~l~~  288 (288)
T cd05050         282 INRILQR  288 (288)
T ss_pred             HHHHhhC
Confidence            9999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.94  E-value=4.7e-27  Score=185.33  Aligned_cols=156  Identities=29%  Similarity=0.358  Sum_probs=118.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC---CeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+++++.||+.|+.|||+.+   ++|+||+|+||+++.++   .++++|||++.................+..|+
T Consensus       112 ~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~  188 (277)
T cd05036         112 SLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM  188 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhC
Confidence            3788899999999999999999999   99999999999998654   58999999987653322211111223346799


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc--c---cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL--E---LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+.+..++.++|+||||+++|+|++ |..|+....  +   .+.. .. ....+...+..+.+++.+||+.+|++||
T Consensus       189 aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp  266 (277)
T cd05036         189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG-GG-RLDPPKGCPGPVYRIMTDCWQHTPEDRP  266 (277)
T ss_pred             CHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CC-cCCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence            9999988889999999999999999986 766654321  1   1110 00 0122334556788999999999999999


Q ss_pred             CHHHHHHHHh
Q 028458          153 TMNDVVCMLT  162 (208)
Q Consensus       153 s~~~i~~~l~  162 (208)
                      ++.++++.|.
T Consensus       267 s~~~vl~~l~  276 (277)
T cd05036         267 NFATILERIQ  276 (277)
T ss_pred             CHHHHHHHhh
Confidence            9999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=9.4e-27  Score=181.95  Aligned_cols=156  Identities=30%  Similarity=0.426  Sum_probs=121.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.|+.+||+.+   ++|+||+|.||+++.++.++++|||++............ ....+..|+|||
T Consensus        99 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~aPE  174 (261)
T cd05068          99 ALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE-GAKFPIKWTAPE  174 (261)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccC-CCcCceeccCcc
Confidence            4688999999999999999999998   999999999999999999999999998876533221111 112235799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|++++ |..|+......     +... .. ...+...+..+.+++.+||+.+|++||+++
T Consensus       175 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~  252 (261)
T cd05068         175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YR-MPCPPGCPKELYDIMLDCWKEDPDDRPTFE  252 (261)
T ss_pred             ccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CC-CCCCCcCCHHHHHHHHHHhhcCcccCCCHH
Confidence            9988889999999999999999998 77665432211     1100 00 012334567789999999999999999999


Q ss_pred             HHHHHHhh
Q 028458          156 DVVCMLTN  163 (208)
Q Consensus       156 ~i~~~l~~  163 (208)
                      ++++.|+.
T Consensus       253 ~l~~~l~~  260 (261)
T cd05068         253 TLQWKLED  260 (261)
T ss_pred             HHHHHHhc
Confidence            99999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.94  E-value=2.2e-27  Score=191.50  Aligned_cols=153  Identities=20%  Similarity=0.279  Sum_probs=119.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++........  ......|+..|+|||
T Consensus        91 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE  165 (323)
T cd05595          91 VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPE  165 (323)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcc
Confidence            4678899999999999999999999   99999999999999999999999998764322111  112245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----CH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----TM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.....  ............+...+..+.++|.+||+.||++|+     ++
T Consensus       166 ~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~  245 (323)
T cd05595         166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA  245 (323)
T ss_pred             cccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCH
Confidence            99888899999999999999999999888753321  111001111122344567788999999999999998     88


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      .++++
T Consensus       246 ~~~l~  250 (323)
T cd05595         246 KEVME  250 (323)
T ss_pred             HHHHc
Confidence            88876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.94  E-value=7.5e-27  Score=181.68  Aligned_cols=156  Identities=30%  Similarity=0.373  Sum_probs=122.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++++|||.+................++..|+|||
T Consensus       101 ~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  177 (262)
T cd00192         101 TLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE  177 (262)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHH
Confidence            3688999999999999999999999   9999999999999999999999999988765433212222234577899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHh-hhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWD-LWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+....++.++|+|+||+++|+++++ ..|+.....     ......  ....+...+..+.+++.+||+.+|++||++.
T Consensus       178 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  255 (262)
T cd00192         178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--RLPKPEYCPDELYELMLSCWQLDPEDRPTFS  255 (262)
T ss_pred             HhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCccCChHHHHHHHHHccCCcccCcCHH
Confidence            99888899999999999999999984 656543311     011000  0022334467889999999999999999999


Q ss_pred             HHHHHHh
Q 028458          156 DVVCMLT  162 (208)
Q Consensus       156 ~i~~~l~  162 (208)
                      ++++.|+
T Consensus       256 ~l~~~l~  262 (262)
T cd00192         256 ELVERLE  262 (262)
T ss_pred             HHHHhhC
Confidence            9998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=9e-27  Score=185.37  Aligned_cols=158  Identities=25%  Similarity=0.338  Sum_probs=118.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++................++..|.|||.
T Consensus       126 ~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  202 (295)
T cd05097         126 VSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWES  202 (295)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhh
Confidence            577888999999999999999999   99999999999999999999999999876543322222222334668999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH--hhhcCCccc--ccccC------Cccc--hhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW--DLWTSNRTL--ELIDD------PVLE--DEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~--~~~~~~~~~--~~~~~------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      +.++.++.++|+||||+++++|++  +..|+....  +.+..      ....  ....+...+..+.+++.+||+.+|++
T Consensus       203 ~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  282 (295)
T cd05097         203 ILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKD  282 (295)
T ss_pred             hccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchh
Confidence            988889999999999999999987  334443211  11000      0000  00112224567899999999999999


Q ss_pred             CCCHHHHHHHHhh
Q 028458          151 RPTMNDVVCMLTN  163 (208)
Q Consensus       151 Rps~~~i~~~l~~  163 (208)
                      ||++++|++.|+.
T Consensus       283 RPs~~~i~~~l~~  295 (295)
T cd05097         283 RPTFNKIHHFLRE  295 (295)
T ss_pred             CcCHHHHHHHHhC
Confidence            9999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.94  E-value=1.6e-26  Score=181.00  Aligned_cols=159  Identities=22%  Similarity=0.291  Sum_probs=124.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|+++|+.|||+.+   ++|+||+|+||+++.++.++++|||++.........  .....++..|.|||
T Consensus       102 ~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape  176 (267)
T cd08229         102 LIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPE  176 (267)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCHH
Confidence            4678899999999999999999999   999999999999999999999999988765433221  11235677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc----ccCC--ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL----IDDP--VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......    ....  ...........+..+.+++.+||+.+|++||++.
T Consensus       177 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  256 (267)
T cd08229         177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDIT  256 (267)
T ss_pred             HhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHH
Confidence            998888899999999999999999998776422110    0000  0001011234566899999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      +|++.+++..
T Consensus       257 ~i~~~~~~~~  266 (267)
T cd08229         257 YVYDVAKRMH  266 (267)
T ss_pred             HHHHHHhhhc
Confidence            9999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.94  E-value=4.6e-27  Score=188.08  Aligned_cols=159  Identities=29%  Similarity=0.333  Sum_probs=122.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.++++++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++................++..|+|||.
T Consensus       137 l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~  213 (307)
T cd05098         137 LSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA  213 (307)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHH
Confidence            788899999999999999999998   99999999999999999999999999876543222111111223467999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc-c----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL-E----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+.... +    .+....  ....+...+..+.+++.+||+.+|++||++.+
T Consensus       214 ~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  291 (307)
T cd05098         214 LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ  291 (307)
T ss_pred             hccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC--CCCCCCcCCHHHHHHHHHHcccChhhCcCHHH
Confidence            988889999999999999999997 555543211 1    111010  00223345568889999999999999999999


Q ss_pred             HHHHHhhhhh
Q 028458          157 VVCMLTNEAA  166 (208)
Q Consensus       157 i~~~l~~~~~  166 (208)
                      +++.|.++..
T Consensus       292 vl~~l~~~~~  301 (307)
T cd05098         292 LVEDLDRILA  301 (307)
T ss_pred             HHHHHHHHHH
Confidence            9999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.94  E-value=1.1e-26  Score=181.91  Aligned_cols=157  Identities=22%  Similarity=0.328  Sum_probs=123.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++.........  .....++..|.|||.
T Consensus       103 ~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~  177 (267)
T cd08228         103 IPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPER  177 (267)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhHH--HhcCCCCccccChhh
Confidence            567788999999999999999999   999999999999999999999999998765433211  112356778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc----c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE----L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      +.+..++.++|+||||+++|+|++|..|+.....    .   +..... ........+..+.+++.+||+.+|++||++.
T Consensus       178 ~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~  256 (267)
T cd08228         178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY-PPLPTEHYSEKLRELVSMCIYPDPDQRPDIG  256 (267)
T ss_pred             hccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC-CCCChhhcCHHHHHHHHHHCCCCcccCcCHH
Confidence            9888889999999999999999998877643211    1   110111 1112234567799999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      ++++.+++..
T Consensus       257 ~vl~~~~~~~  266 (267)
T cd08228         257 YVHQIAKQMH  266 (267)
T ss_pred             HHHHHHHHhc
Confidence            9999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2e-27  Score=190.82  Aligned_cols=153  Identities=21%  Similarity=0.248  Sum_probs=117.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++||||||.||+++.++.++++|||++........  ......|+..|+|||
T Consensus        89 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE  163 (312)
T cd05585          89 RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPE  163 (312)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccCCcccCCHH
Confidence            3677888999999999999999999   99999999999999999999999999865322211  122346788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC---HHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT---MND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~  156 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.....  ............+...+..+.+++.+||+.||++||+   +.+
T Consensus       164 ~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e  243 (312)
T cd05585         164 LLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQE  243 (312)
T ss_pred             HHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence            99988899999999999999999999988753211  1110000111223445667889999999999999985   555


Q ss_pred             HHH
Q 028458          157 VVC  159 (208)
Q Consensus       157 i~~  159 (208)
                      ++.
T Consensus       244 ~l~  246 (312)
T cd05585         244 IKN  246 (312)
T ss_pred             HHc
Confidence            554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.94  E-value=1.4e-26  Score=181.00  Aligned_cols=156  Identities=30%  Similarity=0.470  Sum_probs=121.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++.......... .....++..|.|||.
T Consensus        99 ~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~  174 (260)
T cd05069          99 LKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEA  174 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc-cCCCccchhhCCHHH
Confidence            678889999999999999999998   9999999999999999999999999987654322111 111234567999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc--ccC--CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL--IDD--PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      ..+..++.++|+||||+++|++++ |..|+......  ...  .... ...+...+..+.+++.+||+.+|++||+++++
T Consensus       175 ~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  253 (260)
T cd05069         175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-MPCPQGCPESLHELMKLCWKKDPDERPTFEYI  253 (260)
T ss_pred             hccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCcccCHHHHHHHHHHccCCcccCcCHHHH
Confidence            988889999999999999999998 66665432211  000  0000 01233456778999999999999999999999


Q ss_pred             HHHHhh
Q 028458          158 VCMLTN  163 (208)
Q Consensus       158 ~~~l~~  163 (208)
                      ++.|+.
T Consensus       254 ~~~l~~  259 (260)
T cd05069         254 QSFLED  259 (260)
T ss_pred             HHHHhc
Confidence            999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.94  E-value=6.8e-27  Score=183.48  Aligned_cols=157  Identities=21%  Similarity=0.281  Sum_probs=121.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||............ .....++..|+|||
T Consensus       103 ~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE  178 (266)
T cd05064         103 QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT-TMSGKSPVLWAAPE  178 (266)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccchhc-ccCCCCceeecCHH
Confidence            3688899999999999999999999   9999999999999999999999999765532221111 11123456799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|++++ |..|+.....     .+.+...  ...+...+..+.+++..||+.+|++||+++
T Consensus       179 ~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~c~~~~p~~RP~~~  256 (266)
T cd05064         179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR--LPAPRNCPNLLHQLMLDCWQKERGERPRFS  256 (266)
T ss_pred             HHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHcCCCchhCCCHH
Confidence            9988889999999999999999764 7766643221     1111110  122344567789999999999999999999


Q ss_pred             HHHHHHhhh
Q 028458          156 DVVCMLTNE  164 (208)
Q Consensus       156 ~i~~~l~~~  164 (208)
                      +|.+.|++.
T Consensus       257 ~i~~~l~~~  265 (266)
T cd05064         257 QIHSILSKM  265 (266)
T ss_pred             HHHHHHHhh
Confidence            999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.94  E-value=1.2e-26  Score=185.30  Aligned_cols=152  Identities=22%  Similarity=0.284  Sum_probs=114.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++........  ......++..|+|||.
T Consensus       100 ~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~  174 (303)
T cd07869         100 LHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDV  174 (303)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHH
Confidence            567788999999999999999999   99999999999999999999999999865432211  1122356788999998


Q ss_pred             hccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccccc----------CCc------------cch-------hh-----
Q 028458           83 AIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID----------DPV------------LED-------EY-----  127 (208)
Q Consensus        83 ~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~----------~~~------------~~~-------~~-----  127 (208)
                      +.+. .++.++|+|||||++|+|++|..|+........          .+.            ...       ..     
T Consensus       175 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (303)
T cd07869         175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQA  254 (303)
T ss_pred             HcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHH
Confidence            8654 478899999999999999999888754321100          000            000       00     


Q ss_pred             -hhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          128 -SSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       128 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                       ........+.+++.+||+.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         255 WNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             00011246789999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.94  E-value=7.5e-27  Score=182.33  Aligned_cols=156  Identities=29%  Similarity=0.431  Sum_probs=121.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.|+.|||+.+   ++|+||+|.||+++.++.++++|||++...........  ...++..|++||
T Consensus       100 ~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~--~~~~~~~~~~PE  174 (261)
T cd05148         100 VLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS--DKKIPYKWTAPE  174 (261)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccccc--CCCCceEecCHH
Confidence            3678889999999999999999999   99999999999999999999999999876543322211  223456799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--cccC--CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--LIDD--PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+....++.++|+|+||+++|++++ |..|+.....  ....  ..... ..+...+..+.+++.+||+.+|++||++++
T Consensus       175 ~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~  253 (261)
T cd05148         175 AASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-PCPAKCPQEIYKIMLECWAAEPEDRPSFKA  253 (261)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            9988888999999999999999997 6666643221  1110  00000 122344567899999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      +++.|+.
T Consensus       254 l~~~L~~  260 (261)
T cd05148         254 LREELDN  260 (261)
T ss_pred             HHHHHhc
Confidence            9999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.94  E-value=7.1e-27  Score=182.55  Aligned_cols=155  Identities=29%  Similarity=0.425  Sum_probs=120.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++.......... .....++..|.|||.
T Consensus       100 ~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~  175 (261)
T cd05072         100 VLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEA  175 (261)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec-cCCCccceecCCHHH
Confidence            567788999999999999999998   9999999999999999999999999987664332211 111234567999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+.....     .+... ... ......+..+.+++.+||+.+|++||++++
T Consensus       176 ~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  253 (261)
T cd05072         176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRM-PRMENCPDELYDIMKTCWKEKAEERPTFDY  253 (261)
T ss_pred             hccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCC-CCCCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence            988888999999999999999997 7766643211     11100 000 112234567889999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      +.+.|+.
T Consensus       254 i~~~l~~  260 (261)
T cd05072         254 LQSVLDD  260 (261)
T ss_pred             HHHHHhc
Confidence            9999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=4.8e-27  Score=190.01  Aligned_cols=155  Identities=21%  Similarity=0.212  Sum_probs=117.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+.+   ++||||||.||+++.++.++|+|||++.......... .....|+..|+|||
T Consensus       101 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE  176 (332)
T cd05614         101 NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPE  176 (332)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCc-cccccCCccccCHH
Confidence            4678888999999999999999999   9999999999999999999999999987543222111 12246789999999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCC--
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRP--  152 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--  152 (208)
                      .+.+.. ++.++|+||||+++|+|++|..|+......     +..... .....+...+..+.+++.+||+.||++||  
T Consensus       177 ~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  256 (332)
T cd05614         177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGA  256 (332)
T ss_pred             HhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence            987654 788999999999999999999887432111     000000 00012233556788999999999999999  


Q ss_pred             ---CHHHHHHH
Q 028458          153 ---TMNDVVCM  160 (208)
Q Consensus       153 ---s~~~i~~~  160 (208)
                         +++++++.
T Consensus       257 ~~~~~~~~l~h  267 (332)
T cd05614         257 GPQGASEIKEH  267 (332)
T ss_pred             CCCCHHHHHcC
Confidence               67787753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.94  E-value=8.3e-27  Score=184.40  Aligned_cols=154  Identities=25%  Similarity=0.257  Sum_probs=120.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++.........  .....|+..|+|||
T Consensus        93 ~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~~~y~aPE  167 (280)
T cd05608          93 GFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPE  167 (280)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--ccccCCCcCccCHH
Confidence            3678889999999999999999999   999999999999999999999999998765433221  12245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc------cCCccchhhhhHHHHHHHHHHHhhccccCCCCCC---
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP---  152 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---  152 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.......      ..........+...+..+.+++.+||+.||++||   
T Consensus       168 ~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  247 (280)
T cd05608         168 LLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFR  247 (280)
T ss_pred             HhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence            9999899999999999999999999988875432111      1000011112334567789999999999999999   


Q ss_pred             --CHHHHHHH
Q 028458          153 --TMNDVVCM  160 (208)
Q Consensus       153 --s~~~i~~~  160 (208)
                        +++++++.
T Consensus       248 ~~~~~~~l~h  257 (280)
T cd05608         248 DGNCDGLRTH  257 (280)
T ss_pred             CCCHHHHhcC
Confidence              66777763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.94  E-value=5.6e-27  Score=189.54  Aligned_cols=150  Identities=23%  Similarity=0.221  Sum_probs=117.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++........     ...|+..|+|||.
T Consensus       115 ~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~  186 (329)
T PTZ00263        115 FPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF-----TLCGTPEYLAPEV  186 (329)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc-----eecCChhhcCHHH
Confidence            567778889999999999999999   99999999999999999999999999876543221     2457889999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC-----HH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT-----MN  155 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~  155 (208)
                      +.+..++.++|+|||||++|+|++|..|+.....  ............+...+..+.++|.+||+.||++|++     ++
T Consensus       187 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~  266 (329)
T PTZ00263        187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVA  266 (329)
T ss_pred             HcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHH
Confidence            9988899999999999999999999988754321  1110000000112234567889999999999999996     67


Q ss_pred             HHHHH
Q 028458          156 DVVCM  160 (208)
Q Consensus       156 ~i~~~  160 (208)
                      +++..
T Consensus       267 ~ll~h  271 (329)
T PTZ00263        267 DVKNH  271 (329)
T ss_pred             HHhcC
Confidence            77753

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.1e-27  Score=196.29  Aligned_cols=148  Identities=25%  Similarity=0.335  Sum_probs=126.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+.=|+..|+.||.|||++|   |||||||.+||++|..|.+||+|||++..--.  .+...+++.||+.|+|||
T Consensus       464 ~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g~~TsTfCGTpey~aPE  538 (694)
T KOG0694|consen  464 VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QGDRTSTFCGTPEFLAPE  538 (694)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC--CCCccccccCChhhcChh
Confidence            4677888899999999999999999   99999999999999999999999999875321  223456689999999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCC--cccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSN--RTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      ++.+..|+..+|+|+||+++|+|+.|..|+.  +..+..+....+....+..++.+...|++++|..+|++|--+
T Consensus       539 il~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  539 VLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             hhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            9999999999999999999999999998775  334445544555556788888999999999999999999743

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.7e-27  Score=186.81  Aligned_cols=151  Identities=23%  Similarity=0.243  Sum_probs=118.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++++|||++.......     ....|+..|+|||
T Consensus        97 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE  168 (291)
T cd05612          97 RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WTLCGTPEYLAPE  168 (291)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc-----ccccCChhhcCHH
Confidence            3677888999999999999999999   9999999999999999999999999987653221     1235788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC-----H
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT-----M  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......  ...........+...+..+.++|.+||+.||.+|++     +
T Consensus       169 ~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~  248 (291)
T cd05612         169 VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGA  248 (291)
T ss_pred             HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCH
Confidence            998888999999999999999999998887543211  110000011123334567889999999999999995     7


Q ss_pred             HHHHHH
Q 028458          155 NDVVCM  160 (208)
Q Consensus       155 ~~i~~~  160 (208)
                      +++++.
T Consensus       249 ~~~l~h  254 (291)
T cd05612         249 DDVKNH  254 (291)
T ss_pred             HHHhcC
Confidence            777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.1e-26  Score=181.17  Aligned_cols=158  Identities=27%  Similarity=0.364  Sum_probs=122.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccccc-ccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~ape   81 (208)
                      +++..++.++.|++.++.|||..+   ++|+||+|+||+++.++.++++|||++........... .....++..|.|||
T Consensus        92 ~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  168 (257)
T cd05060          92 IPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE  168 (257)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHH
Confidence            678899999999999999999998   99999999999999999999999999876543322111 11112345799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|++++ |..|+......     +...  .....+...+..+.+++.+||+.+|++||++.
T Consensus       169 ~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~  246 (257)
T cd05060         169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG--ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFS  246 (257)
T ss_pred             HhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC--CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence            9988889999999999999999997 77766432211     1100  00122333456788999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      ++++.|++..
T Consensus       247 ~l~~~l~~~~  256 (257)
T cd05060         247 ELESTFRRDP  256 (257)
T ss_pred             HHHHHHHhcc
Confidence            9999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.94  E-value=1.4e-26  Score=191.68  Aligned_cols=159  Identities=22%  Similarity=0.301  Sum_probs=124.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.+++.++.|+++||.|||+.+   ++|+||||.||+++.++.++++|||++................++..|+|||
T Consensus       233 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE  309 (400)
T cd05105         233 GLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE  309 (400)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence            4788899999999999999999999   9999999999999999999999999987654332222222234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc------cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE------LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+.....      .+.... . ...+...+..+.+++.+||+.+|++||++
T Consensus       310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~  387 (400)
T cd05105         310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGY-R-MAKPDHATQEVYDIMVKCWNSEPEKRPSF  387 (400)
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCC-C-CCCCccCCHHHHHHHHHHCccCHhHCcCH
Confidence            9988889999999999999999986 6666533211      011000 0 01233456778999999999999999999


Q ss_pred             HHHHHHHhhhh
Q 028458          155 NDVVCMLTNEA  165 (208)
Q Consensus       155 ~~i~~~l~~~~  165 (208)
                      .++.+.|++..
T Consensus       388 ~~l~~~l~~l~  398 (400)
T cd05105         388 LHLSDIVESLL  398 (400)
T ss_pred             HHHHHHHHHHc
Confidence            99999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.94  E-value=1.7e-26  Score=188.50  Aligned_cols=152  Identities=24%  Similarity=0.274  Sum_probs=117.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++........   .....++..|+|||.
T Consensus       116 l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~  189 (355)
T cd07874         116 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEV  189 (355)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCccc---cCCccccCCccCHHH
Confidence            567788899999999999999999   99999999999999999999999999876533221   122457889999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccC--------------------Cccchh-------
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDD--------------------PVLEDE-------  126 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~--------------------~~~~~~-------  126 (208)
                      +.+..++.++|+||||+++|+|++|..++......         ...                    +.....       
T Consensus       190 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (355)
T cd07874         190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP  269 (355)
T ss_pred             HcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcc
Confidence            98888999999999999999999988776422100         000                    000000       


Q ss_pred             --------hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          127 --------YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       127 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                              .........+.++|.+||+.||++|||+.|+++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         270 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             ccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                    0011123467899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.94  E-value=3.9e-26  Score=183.21  Aligned_cols=154  Identities=23%  Similarity=0.299  Sum_probs=114.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe----CCCCCeEEeccccceecCCCccc-ccccccccCCCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGY   77 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~----~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~   77 (208)
                      +++..+..++.|++.||.|||+.+   ++|+||||+||++    +.++.++|+|||++......... .......++..|
T Consensus       105 l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y  181 (317)
T cd07867         105 LPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY  181 (317)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccc
Confidence            677888999999999999999999   9999999999999    45678999999999766433221 112234568899


Q ss_pred             cCcchhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCc---------------------------------c
Q 028458           78 MSPEYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPV---------------------------------L  123 (208)
Q Consensus        78 ~ape~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~---------------------------------~  123 (208)
                      +|||.+.+. .++.++|+||||+++|+|++|..++....+......                                 +
T Consensus       182 ~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (317)
T cd07867         182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTL  261 (317)
T ss_pred             cCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhh
Confidence            999998764 478999999999999999999877643221110000                                 0


Q ss_pred             chh-----h-----------hhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          124 EDE-----Y-----------SSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       124 ~~~-----~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ...     .           ........+.+++.+||+.||.+|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         262 QKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             hhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            000     0           00011235778999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=3e-27  Score=188.00  Aligned_cols=154  Identities=23%  Similarity=0.367  Sum_probs=128.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      -|+..++..++.||.+|+.|+|+++   ++|||||..||++|.++.+|++|||++..+.....   ..+++|++-|.+||
T Consensus       149 ~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf---LqTFCGSPLYASPE  222 (668)
T KOG0611|consen  149 SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF---LQTFCGSPLYASPE  222 (668)
T ss_pred             cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccccH---HHHhcCCcccCCcc
Confidence            3678899999999999999999999   99999999999999999999999999987754443   34478999999999


Q ss_pred             hhccCCC-CCcchhHHHHHHHHHHHHhhhcCCc-ccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           82 YAIQGIF-SIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        82 ~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .+.+.+| +..+|.|+||+++|-++.|.+||.. .++.+......+.+..+..+.+..-+|+|||.+||++|.++.+|..
T Consensus       223 IvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  223 IVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             ccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence            9999988 6889999999999999999998853 3333322333343445555667789999999999999999999987


Q ss_pred             HH
Q 028458          160 ML  161 (208)
Q Consensus       160 ~l  161 (208)
                      ..
T Consensus       303 HW  304 (668)
T KOG0611|consen  303 HW  304 (668)
T ss_pred             hh
Confidence            53

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.94  E-value=1.1e-26  Score=175.46  Aligned_cols=154  Identities=22%  Similarity=0.275  Sum_probs=118.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+...+.+++.++++|++|||.++   |+|||+||.|++++.+|.+|++|||+++.++.........  +-+..|+|||
T Consensus        97 ~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~--V~TRWYRAPE  171 (318)
T KOG0659|consen   97 ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ--VVTRWYRAPE  171 (318)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc--eeeeeccChH
Confidence            5778889999999999999999999   9999999999999999999999999999887555433222  5578999999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhh--cCCccccc---------------------------c-cCCccchhhhhH
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLW--TSNRTLEL---------------------------I-DDPVLEDEYSSK  130 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~--~~~~~~~~---------------------------~-~~~~~~~~~~~~  130 (208)
                      .+.|.+ |+..+|+||.||++.||+.+.+  |.....+.                           + ..+.........
T Consensus       172 LLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~  251 (318)
T KOG0659|consen  172 LLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFP  251 (318)
T ss_pred             HhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccc
Confidence            988754 8999999999999999964332  21111110                           0 001111111233


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          131 QMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       131 ~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ....+..+++..|+..||.+|.++.|+++.
T Consensus       252 aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  252 AASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            345667899999999999999999999875

>PTZ00284 protein kinase; Provisional

Probab=99.94  E-value=1.9e-26  Score=194.66  Aligned_cols=154  Identities=19%  Similarity=0.212  Sum_probs=115.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCC----------------CeEEeccccceecCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDM----------------NPKISDFGMARICGGNEL   64 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~----------------~~~l~dfg~~~~~~~~~~   64 (208)
                      .+++..+..++.||+.||.|||+ .+   |+||||||.||+++..+                .+||+|||.+......  
T Consensus       227 ~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~--  301 (467)
T PTZ00284        227 PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS--  301 (467)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc--
Confidence            36788899999999999999998 47   99999999999998665                4899999987543211  


Q ss_pred             cccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccC--Cccc-------------
Q 028458           65 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDD--PVLE-------------  124 (208)
Q Consensus        65 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~--~~~~-------------  124 (208)
                         .....|+..|+|||.+.+..++.++|+|||||++|+|++|..++......     +..  ..++             
T Consensus       302 ---~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~  378 (467)
T PTZ00284        302 ---RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEAR  378 (467)
T ss_pred             ---cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHH
Confidence               12346789999999999999999999999999999999998877432110     000  0000             


Q ss_pred             ----------hhhhhH--------------HHHHHHHHHHhhccccCCCCCCCHHHHHH--HHhh
Q 028458          125 ----------DEYSSK--------------QMLLRYVNIALLCVQESADDRPTMNDVVC--MLTN  163 (208)
Q Consensus       125 ----------~~~~~~--------------~~~~~~~~li~~~l~~~p~~Rps~~~i~~--~l~~  163 (208)
                                ....+.              .....+.+||.+||+.||++||+++|+++  .|.+
T Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        379 LLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             HHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence                      000000              01245779999999999999999999998  4544

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.94  E-value=9.4e-27  Score=183.82  Aligned_cols=155  Identities=26%  Similarity=0.335  Sum_probs=120.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++.........   ....++..|+|||
T Consensus        91 ~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE  164 (277)
T cd05607          91 GLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPE  164 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee---eccCCCCCccCHH
Confidence            3677888999999999999999999   999999999999999999999999998766443221   1235678999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc-----CCccchh--hhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-----DPVLEDE--YSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+........     .......  ......+.++.+++.+||+.||++||++
T Consensus       165 ~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~  244 (277)
T cd05607         165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGS  244 (277)
T ss_pred             HHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCC
Confidence            99888899999999999999999999988754322110     0000000  1112356678999999999999999999


Q ss_pred             HHHHHHHh
Q 028458          155 NDVVCMLT  162 (208)
Q Consensus       155 ~~i~~~l~  162 (208)
                      +|+++.+.
T Consensus       245 ~~~~~~~~  252 (277)
T cd05607         245 REKNDDPR  252 (277)
T ss_pred             ccchhhhh
Confidence            77665443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.94  E-value=1.1e-26  Score=185.09  Aligned_cols=158  Identities=23%  Similarity=0.301  Sum_probs=121.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++.......   .......+..|+|||.
T Consensus       116 l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~  189 (297)
T cd05089         116 LTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIES  189 (297)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchh
Confidence            678889999999999999999998   9999999999999999999999999875422111   0111122456999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      ..+..++.++|+||||+++|+|++ |..|+.....  .   ..... . ...+...+..+.+|+.+||+.+|.+||++++
T Consensus       190 ~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  267 (297)
T cd05089         190 LNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-R-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQ  267 (297)
T ss_pred             hccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            988889999999999999999997 7776643211  1   11000 0 0112335567889999999999999999999


Q ss_pred             HHHHHhhhhhcc
Q 028458          157 VVCMLTNEAATL  168 (208)
Q Consensus       157 i~~~l~~~~~~~  168 (208)
                      +++.|+......
T Consensus       268 i~~~l~~~~~~~  279 (297)
T cd05089         268 ISVQLSRMLEAR  279 (297)
T ss_pred             HHHHHHHHHHhh
Confidence            999988776543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.94  E-value=2.1e-27  Score=191.70  Aligned_cols=154  Identities=20%  Similarity=0.269  Sum_probs=119.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.||+.||.|||+ .+   ++||||||+||+++.++.++|+|||++........  ......|+..|+||
T Consensus        91 ~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP  165 (325)
T cd05594          91 VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAP  165 (325)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCH
Confidence            46788999999999999999997 67   99999999999999999999999999865322111  11224578899999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----C
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----T  153 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s  153 (208)
                      |.+.+..++.++|+||||+++|+|++|..|+.....  ............+...+.++.+++.+||+.||++|+     +
T Consensus       166 E~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~  245 (325)
T cd05594         166 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDD  245 (325)
T ss_pred             HHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCC
Confidence            999888899999999999999999999888743221  111000111112334556788999999999999996     8


Q ss_pred             HHHHHHH
Q 028458          154 MNDVVCM  160 (208)
Q Consensus       154 ~~~i~~~  160 (208)
                      +.++++.
T Consensus       246 ~~~il~h  252 (325)
T cd05594         246 AKEIMQH  252 (325)
T ss_pred             HHHHhcC
Confidence            9998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=1.8e-26  Score=182.64  Aligned_cols=160  Identities=21%  Similarity=0.304  Sum_probs=121.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-ccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++++|||++......... .......++..|.||
T Consensus       105 ~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~ap  181 (284)
T cd05079         105 KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP  181 (284)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCH
Confidence            3688899999999999999999999   999999999999999999999999998765432211 111223456679999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccC------Ccc------------chhhhhHHHHHHHHHHHhh
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD------PVL------------EDEYSSKQMLLRYVNIALL  142 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~------~~~------------~~~~~~~~~~~~~~~li~~  142 (208)
                      |.+.+..++.++|+||||+++|+++++..++.........      ...            .........+..+.+|+.+
T Consensus       182 E~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  261 (284)
T cd05079         182 ECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRK  261 (284)
T ss_pred             HHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHH
Confidence            9998888899999999999999999865433221111000      000            0001122345678999999


Q ss_pred             ccccCCCCCCCHHHHHHHHhhh
Q 028458          143 CVQESADDRPTMNDVVCMLTNE  164 (208)
Q Consensus       143 ~l~~~p~~Rps~~~i~~~l~~~  164 (208)
                      ||+.+|++||+++++++.|+.+
T Consensus       262 ~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         262 CWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HccCCcccCcCHHHHHHHHHhh
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.94  E-value=1.5e-26  Score=180.67  Aligned_cols=160  Identities=24%  Similarity=0.279  Sum_probs=118.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccccc--ccccccCCCccCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN--TSRIVGTYGYMSP   80 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~~~~ap   80 (208)
                      +++...+.++.|+++||.|||+.+   ++|+||+|.||+++.++.++++|||++...........  .....++..|.||
T Consensus        95 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aP  171 (262)
T cd05058          95 PTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL  171 (262)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccCh
Confidence            466778899999999999999998   99999999999999999999999999875433221111  1112345679999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc---ccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---IDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      |...+..++.++|+||||+++|+|+++..++......   ...... .....+...+..+.+++..||+.+|++||++.+
T Consensus       172 E~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~  251 (262)
T cd05058         172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSE  251 (262)
T ss_pred             hHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            9998888999999999999999999865433211111   000000 000112223457889999999999999999999


Q ss_pred             HHHHHhhhh
Q 028458          157 VVCMLTNEA  165 (208)
Q Consensus       157 i~~~l~~~~  165 (208)
                      +++.|+++.
T Consensus       252 il~~l~~~~  260 (262)
T cd05058         252 LVSRIEQIF  260 (262)
T ss_pred             HHHHHHHHh
Confidence            999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.94  E-value=1.4e-26  Score=180.83  Aligned_cols=158  Identities=22%  Similarity=0.280  Sum_probs=121.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++..+++++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++.......... ......++..|+||
T Consensus        91 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  167 (257)
T cd05115          91 EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP  167 (257)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCH
Confidence            4678899999999999999999998   9999999999999999999999999987543322111 11111234679999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++|+||||+++|++++ |..|+......     +....  ....+...+..+.+++.+||+.+|++||++
T Consensus       168 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~  245 (257)
T cd05115         168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--RLDCPAECPPEMYALMKDCWIYKWEDRPNF  245 (257)
T ss_pred             HHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            99988888999999999999999985 77776432211     11000  011233445678899999999999999999


Q ss_pred             HHHHHHHhhh
Q 028458          155 NDVVCMLTNE  164 (208)
Q Consensus       155 ~~i~~~l~~~  164 (208)
                      .+|.+.|+..
T Consensus       246 ~~i~~~l~~~  255 (257)
T cd05115         246 AKVEERMRTY  255 (257)
T ss_pred             HHHHHHHhhh
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.94  E-value=1.2e-26  Score=180.83  Aligned_cols=158  Identities=28%  Similarity=0.318  Sum_probs=121.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||+|.||+++.++.++++|||++.......... ......++..|.||
T Consensus        93 ~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~p  169 (257)
T cd05040          93 HFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP  169 (257)
T ss_pred             cCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCH
Confidence            4688899999999999999999999   9999999999999999999999999987764322111 11123456789999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--cccC--CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--LIDD--PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      |.+.+..++.++|+||||+++|+|++ |..|+.....  ....  ........+...+..+.+++.+||+.+|++||++.
T Consensus       170 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  249 (257)
T cd05040         170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFA  249 (257)
T ss_pred             HHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHH
Confidence            99988889999999999999999997 7777632211  1100  00001012233456789999999999999999999


Q ss_pred             HHHHHHh
Q 028458          156 DVVCMLT  162 (208)
Q Consensus       156 ~i~~~l~  162 (208)
                      ++++.|.
T Consensus       250 ~~~~~l~  256 (257)
T cd05040         250 ALREFLP  256 (257)
T ss_pred             HHHHHhc
Confidence            9999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.94  E-value=1.7e-26  Score=185.81  Aligned_cols=152  Identities=26%  Similarity=0.316  Sum_probs=116.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++.......  .......|+..|+|||
T Consensus        92 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE  166 (316)
T cd05620          92 RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPE  166 (316)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCCCcCccCHH
Confidence            3677888999999999999999999   9999999999999999999999999876432111  1122346788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN-DVV  158 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~i~  158 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......  ...........+...+.++.+++.+||+.||++||++. ++.
T Consensus       167 ~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         167 ILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            999888999999999999999999998887533211  11000001111223456788999999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.94  E-value=1.5e-26  Score=184.89  Aligned_cols=157  Identities=25%  Similarity=0.343  Sum_probs=121.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.+++.++.|++.||.|||+++   ++|+||+|.||+++.++.++++|||++................++..|+|||.
T Consensus       138 l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  214 (302)
T cd05055         138 LTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES  214 (302)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhh
Confidence            688999999999999999999998   99999999999999999999999999876543322111122334678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc------cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE------LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      +.+..++.++|+||||+++|++++ |..|+.....      ..... ... ..+...+..+.+++.+||+.+|++||++.
T Consensus       215 ~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~  292 (302)
T cd05055         215 IFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG-YRM-AQPEHAPAEIYDIMKTCWDADPLKRPTFK  292 (302)
T ss_pred             hccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC-CcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence            988889999999999999999997 7766532211      11100 000 11223456788999999999999999999


Q ss_pred             HHHHHHhhh
Q 028458          156 DVVCMLTNE  164 (208)
Q Consensus       156 ~i~~~l~~~  164 (208)
                      ++++.|++.
T Consensus       293 ell~~l~~~  301 (302)
T cd05055         293 QIVQLIGKQ  301 (302)
T ss_pred             HHHHHHHhh
Confidence            999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=6.1e-27  Score=188.62  Aligned_cols=149  Identities=22%  Similarity=0.253  Sum_probs=114.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.||+.||.|||+.+   ++||||||.||+++.++.++|+|||++.......  .......|+..|+|||
T Consensus        92 ~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE  166 (321)
T cd05603          92 CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPE  166 (321)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCcccCCHH
Confidence            3566778889999999999999998   9999999999999999999999999876432211  1122345788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+|||||++|+|++|..|+.....  ............+......+.+++.+||+.+|.+|+++.
T Consensus       167 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            99888899999999999999999999988754321  111000011122334456788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.94  E-value=2.6e-26  Score=185.72  Aligned_cols=153  Identities=25%  Similarity=0.395  Sum_probs=117.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+  .++|+||||.||+++.++.++|+|||++.......    .....++..|+|||
T Consensus        99 ~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE  172 (331)
T cd06649          99 RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPE  172 (331)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHh
Confidence            3677888999999999999999863  29999999999999999999999999987553322    12245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--c---ccCCc--------------------------------c-
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--L---IDDPV--------------------------------L-  123 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~---~~~~~--------------------------------~-  123 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.....  .   +....                                . 
T Consensus       173 ~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (331)
T cd06649         173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMA  252 (331)
T ss_pred             HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchh
Confidence            99988899999999999999999999887642110  0   00000                                0 


Q ss_pred             ------------chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          124 ------------EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       124 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                                  .........+.++.+||.+||+.||++||+++++++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         253 IFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             HHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                        0000011245678999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.94  E-value=1.6e-26  Score=180.22  Aligned_cols=151  Identities=24%  Similarity=0.323  Sum_probs=118.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+++   ++|+||+|.||+++.++.++++|||++........     ...++..|.|||.
T Consensus        99 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~  170 (256)
T cd05082          99 LGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEA  170 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC-----CCccceeecCHHH
Confidence            678889999999999999999999   99999999999999999999999998875432221     1223457999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc--cc---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL--EL---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+|+||+++|+|++ |..|+....  +.   +... . ........+..+.+++.+||+.+|++||++.+
T Consensus       171 ~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  248 (256)
T cd05082         171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-Y-KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQ  248 (256)
T ss_pred             HccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-C-CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence            988888999999999999999997 666553211  11   1100 0 01122344567889999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      +++.|+.
T Consensus       249 l~~~l~~  255 (256)
T cd05082         249 LREQLEH  255 (256)
T ss_pred             HHHHHhc
Confidence            9999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.94  E-value=1.9e-26  Score=180.10  Aligned_cols=157  Identities=29%  Similarity=0.450  Sum_probs=120.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.+++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++.......... .....++..|+|||.
T Consensus        99 ~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~  174 (260)
T cd05070          99 LKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEA  174 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc-ccCCCCCccccChHH
Confidence            678899999999999999999998   9999999999999999999999999987654322111 111234567999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--cccCC-ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--LIDDP-VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      +.+..++.++|+||||+++|++++ |..|+.....  ..... .......+...+..+.+++.+||..+|++||+++++.
T Consensus       175 ~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             HhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence            988888999999999999999998 6666533211  11000 0000012334456789999999999999999999999


Q ss_pred             HHHhh
Q 028458          159 CMLTN  163 (208)
Q Consensus       159 ~~l~~  163 (208)
                      +.|+.
T Consensus       255 ~~l~~  259 (260)
T cd05070         255 SFLED  259 (260)
T ss_pred             HHHhc
Confidence            98875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.94  E-value=6.9e-27  Score=188.35  Aligned_cols=148  Identities=26%  Similarity=0.304  Sum_probs=115.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++.......  .......|+..|+|||
T Consensus        92 ~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE  166 (320)
T cd05590          92 RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPE  166 (320)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHH
Confidence            4677888999999999999999999   9999999999999999999999999976532211  1122346788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......  ...........+...+.++.+++.+||+.||++||++
T Consensus       167 ~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            998888999999999999999999999887543211  1100000011223356678899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.94  E-value=1.7e-26  Score=184.58  Aligned_cols=160  Identities=24%  Similarity=0.329  Sum_probs=122.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++................++..|++||
T Consensus       105 ~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE  181 (303)
T cd05110         105 NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE  181 (303)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHH
Confidence            3577888999999999999999998   9999999999999999999999999987654322211111223456899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc-c----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL-E----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|++++ |..|+.... .    ........  ..+...+.++.+++..||..+|++||+++
T Consensus       182 ~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~  259 (303)
T cd05110         182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL--PQPPICTIDVYMVMVKCWMIDADSRPKFK  259 (303)
T ss_pred             HhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            9988889999999999999999986 666653221 1    11100000  11222345788999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|+.+..
T Consensus       260 ~l~~~l~~~~~  270 (303)
T cd05110         260 ELAAEFSRMAR  270 (303)
T ss_pred             HHHHHHHHHHh
Confidence            99999988753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.94  E-value=1.7e-26  Score=193.57  Aligned_cols=153  Identities=19%  Similarity=0.244  Sum_probs=115.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC-CeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.||+.||.|||+.+   |+||||||.||+++.++ .++|+|||++........   .....++..|+||
T Consensus       166 ~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aP  239 (440)
T PTZ00036        166 ALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAP  239 (440)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCH
Confidence            3677788999999999999999999   99999999999998664 699999999876533221   1123567889999


Q ss_pred             chhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccCCc------------------cchh----hh
Q 028458           81 EYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDDPV------------------LEDE----YS  128 (208)
Q Consensus        81 e~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~~~------------------~~~~----~~  128 (208)
                      |.+.+. .++.++|+|||||++|+|++|..|+......         ...+.                  ....    ..
T Consensus       240 E~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  319 (440)
T PTZ00036        240 ELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVF  319 (440)
T ss_pred             HHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHh
Confidence            988654 5899999999999999999998777432110         00000                  0000    01


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      +...+.++.+||.+||+.||.+||++.|+++.
T Consensus       320 p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        320 PKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            11234678899999999999999999999864

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.94  E-value=1.4e-26  Score=189.22  Aligned_cols=152  Identities=25%  Similarity=0.283  Sum_probs=116.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........   .....++..|+|||.
T Consensus       120 ~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~  193 (359)
T cd07876         120 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM---MTPYVVTRYYRAPEV  193 (359)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccCcc---CCCCcccCCCCCchh
Confidence            567788899999999999999999   99999999999999999999999999865432211   122456788999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccC--------------------Cccchh-------
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDD--------------------PVLEDE-------  126 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~--------------------~~~~~~-------  126 (208)
                      +.+..++.++|+||||+++|+|++|..++......         ...                    +.....       
T Consensus       194 ~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (359)
T cd07876         194 ILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFP  273 (359)
T ss_pred             ccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcc
Confidence            98888999999999999999999998877532110         000                    000000       


Q ss_pred             --------hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          127 --------YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       127 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                              .........+.++|.+||+.||++||+++|+++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         274 DWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             ccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                    0000113457899999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.94  E-value=1.5e-26  Score=181.79  Aligned_cols=157  Identities=22%  Similarity=0.288  Sum_probs=120.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++....+++.|++.|+.|||+.+   ++|+||||+||+++.++.++++|||++................++..|++||.
T Consensus       110 l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~  186 (273)
T cd05074         110 LPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES  186 (273)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhH
Confidence            567788999999999999999998   99999999999999999999999999876543222111112234567999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +....++.++|+||||+++|++++ |..++......     +...  .........+..+.+++.+||+.+|++||++.+
T Consensus       187 ~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~  264 (273)
T cd05074         187 LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG--NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQH  264 (273)
T ss_pred             HhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            988888999999999999999998 55554322110     1100  000112234567899999999999999999999


Q ss_pred             HHHHHhhh
Q 028458          157 VVCMLTNE  164 (208)
Q Consensus       157 i~~~l~~~  164 (208)
                      +++.|+++
T Consensus       265 ~~~~l~~~  272 (273)
T cd05074         265 LRDQLELI  272 (273)
T ss_pred             HHHHHHhh
Confidence            99999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.93  E-value=9e-27  Score=187.91  Aligned_cols=154  Identities=25%  Similarity=0.326  Sum_probs=118.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++.......  .......|+..|+|||
T Consensus        97 ~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE  171 (324)
T cd05589          97 VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPE  171 (324)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHh
Confidence            4688899999999999999999999   9999999999999999999999999876432111  1122346788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----CH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----TM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.....  ............+...+..+.++|.+||+.||.+||     ++
T Consensus       172 ~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~  251 (324)
T cd05589         172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDA  251 (324)
T ss_pred             HhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCH
Confidence            99888899999999999999999999988753221  111000001112334566788999999999999999     56


Q ss_pred             HHHHHH
Q 028458          155 NDVVCM  160 (208)
Q Consensus       155 ~~i~~~  160 (208)
                      .++++.
T Consensus       252 ~~l~~~  257 (324)
T cd05589         252 EDVKKQ  257 (324)
T ss_pred             HHHhhC
Confidence            666653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.93  E-value=1.8e-26  Score=188.21  Aligned_cols=153  Identities=25%  Similarity=0.338  Sum_probs=116.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.||+.||.|||+++   ++||||||.||+++.++.++|+|||++.........  .....|+..|+|||.
T Consensus       165 ~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~  239 (353)
T PLN00034        165 ADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPER  239 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccccc--ccccccCccccCccc
Confidence            355677889999999999999999   999999999999999999999999998765432211  122467889999998


Q ss_pred             hccC-----CCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCC-ccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           83 AIQG-----IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDP-VLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        83 ~~~~-----~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      +...     ..+.++|+|||||++|+|++|..++......     .... ...........+.++.++|.+||+.||++|
T Consensus       240 ~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R  319 (353)
T PLN00034        240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKR  319 (353)
T ss_pred             cccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhC
Confidence            7432     2356899999999999999999887522110     0000 000111233456678999999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      |++.|+++.
T Consensus       320 pt~~ell~h  328 (353)
T PLN00034        320 WSAMQLLQH  328 (353)
T ss_pred             cCHHHHhcC
Confidence            999999985

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.93  E-value=8.6e-27  Score=187.59  Aligned_cols=154  Identities=25%  Similarity=0.280  Sum_probs=119.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++........  ......++..|+|||
T Consensus        92 ~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE  166 (318)
T cd05570          92 RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPE  166 (318)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCHH
Confidence            4788899999999999999999999   99999999999999999999999998864321111  112235788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH-----
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM-----  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......  ...........+...+..+.++|.+||+.||++||++     
T Consensus       167 ~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~  246 (318)
T cd05570         167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGE  246 (318)
T ss_pred             HhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCH
Confidence            999889999999999999999999998887532211  0000000111233456678999999999999999999     


Q ss_pred             HHHHHH
Q 028458          155 NDVVCM  160 (208)
Q Consensus       155 ~~i~~~  160 (208)
                      .++++.
T Consensus       247 ~~ll~~  252 (318)
T cd05570         247 QDIKGH  252 (318)
T ss_pred             HHHhcC
Confidence            888763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.93  E-value=4.7e-26  Score=178.33  Aligned_cols=158  Identities=28%  Similarity=0.451  Sum_probs=122.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||.+.......... .....++..|++||
T Consensus        98 ~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE  173 (262)
T cd05071          98 YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPE  173 (262)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc-ccCCcccceecCHh
Confidence            3678889999999999999999998   9999999999999999999999999987654332211 11223456799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--cccC--CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--LIDD--PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      ...+..++.++|+||||+++|++++ +..|+.....  ....  .... .......+..+.+++.+||+.+|++||++.+
T Consensus       174 ~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~  252 (262)
T cd05071         174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPCPPECPESLHDLMCQCWRKEPEERPTFEY  252 (262)
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-CCCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence            9988889999999999999999998 5555532211  1100  0000 0123445677899999999999999999999


Q ss_pred             HHHHHhhh
Q 028458          157 VVCMLTNE  164 (208)
Q Consensus       157 i~~~l~~~  164 (208)
                      +++.|+..
T Consensus       253 ~~~~l~~~  260 (262)
T cd05071         253 LQAFLEDY  260 (262)
T ss_pred             HHHHHHHh
Confidence            99998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=9.7e-27  Score=190.59  Aligned_cols=150  Identities=25%  Similarity=0.332  Sum_probs=118.7

Q ss_pred             HHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchhccC
Q 028458            7 TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG   86 (208)
Q Consensus         7 ~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~   86 (208)
                      ....+..|++.|+.++|+.|   |||.||||.|+++- .|.+||+|||.+.-+......-......||+.|++||.+...
T Consensus       461 ~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~  536 (677)
T KOG0596|consen  461 FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDM  536 (677)
T ss_pred             HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhc
Confidence            67789999999999999999   99999999999985 579999999999988766655555557899999999998532


Q ss_pred             C-----------CCCcchhHHHHHHHHHHHHhhhcCCcccc------cccCCccchhhhhHHHHHHHHHHHhhccccCCC
Q 028458           87 I-----------FSIKSDVFSFGVLLLEIAWDLWTSNRTLE------LIDDPVLEDEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        87 ~-----------~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      .           .++++|||||||++|+|++|..|++....      .+.++..+-++..-.....+.++++.||+.||+
T Consensus       537 ~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPk  616 (677)
T KOG0596|consen  537 SSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPK  616 (677)
T ss_pred             cccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcc
Confidence            2           46889999999999999999999876653      222332211111111112388999999999999


Q ss_pred             CCCCHHHHHHH
Q 028458          150 DRPTMNDVVCM  160 (208)
Q Consensus       150 ~Rps~~~i~~~  160 (208)
                      +||++.++++.
T Consensus       617 kR~si~eLLqh  627 (677)
T KOG0596|consen  617 KRWSIPELLQH  627 (677)
T ss_pred             cCCCcHHHhcC
Confidence            99999999874

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.93  E-value=1.1e-26  Score=186.85  Aligned_cols=153  Identities=27%  Similarity=0.359  Sum_probs=118.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........  ......|+..|+|||
T Consensus        92 ~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE  166 (316)
T cd05619          92 KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPE  166 (316)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCccccCHH
Confidence            4678888999999999999999999   99999999999999999999999999865322111  112245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN-DVV  158 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~i~  158 (208)
                      .+.+..++.++|+|||||++|+|++|..|+.....  ............+...+.++.+++.+||+.||++||++. ++.
T Consensus       167 ~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             HHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            99888899999999999999999999888743221  111001111112233456788999999999999999997 564


Q ss_pred             H
Q 028458          159 C  159 (208)
Q Consensus       159 ~  159 (208)
                      +
T Consensus       247 ~  247 (316)
T cd05619         247 Q  247 (316)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.93  E-value=1.9e-26  Score=182.93  Aligned_cols=160  Identities=26%  Similarity=0.389  Sum_probs=120.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++++|||++................++..|.|||.
T Consensus       116 ~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~  192 (288)
T cd05061         116 PTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES  192 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHH
Confidence            355678899999999999999999   99999999999999999999999999875543322222222234567999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-cccCCccch--hhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-LIDDPVLED--EYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      +.+..++.++|+||||+++|++++ +..|+..... .........  ...+...+..+.+++.+||+.+|++||++.+++
T Consensus       193 ~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  272 (288)
T cd05061         193 LKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV  272 (288)
T ss_pred             hccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            988889999999999999999997 5555532211 000000000  011223356789999999999999999999999


Q ss_pred             HHHhhhh
Q 028458          159 CMLTNEA  165 (208)
Q Consensus       159 ~~l~~~~  165 (208)
                      +.|+...
T Consensus       273 ~~l~~~~  279 (288)
T cd05061         273 NLLKDDL  279 (288)
T ss_pred             HHHHhhc
Confidence            9998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.93  E-value=2.6e-26  Score=178.29  Aligned_cols=155  Identities=25%  Similarity=0.298  Sum_probs=118.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.++.|||+++   ++|+||+|+||+++.++.++++|||++.................+..|+|||.
T Consensus        90 ~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~  166 (251)
T cd05041          90 LTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEA  166 (251)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHh
Confidence            567788999999999999999999   99999999999999999999999999876542222111111223456999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|++++ +..|+.....     .+...  .....+...+..+.+++.+||+.+|++||++.+
T Consensus       167 ~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e  244 (251)
T cd05041         167 LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG--YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSE  244 (251)
T ss_pred             hccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC--CCCCCCccCCHHHHHHHHHHhccChhhCcCHHH
Confidence            988889999999999999999998 5555432211     11100  011123344567899999999999999999999


Q ss_pred             HHHHHh
Q 028458          157 VVCMLT  162 (208)
Q Consensus       157 i~~~l~  162 (208)
                      +++.|.
T Consensus       245 ll~~l~  250 (251)
T cd05041         245 IYNELQ  250 (251)
T ss_pred             HHHHhh
Confidence            999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.93  E-value=3.4e-26  Score=181.62  Aligned_cols=152  Identities=20%  Similarity=0.246  Sum_probs=114.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.........  .....++..|+|||.
T Consensus       100 ~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~y~aPE~  174 (288)
T cd07871         100 MSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDV  174 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc--ccCceecccccChHH
Confidence            577888999999999999999999   999999999999999999999999998764322211  122356788999998


Q ss_pred             hcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cc-------c------------CC-----ccch------hhhh
Q 028458           83 AIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LI-------D------------DP-----VLED------EYSS  129 (208)
Q Consensus        83 ~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~-------~------------~~-----~~~~------~~~~  129 (208)
                      +.+ ..++.++|+||+|+++|+|++|..++.....  ..       .            ..     ..+.      ....
T Consensus       175 ~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (288)
T cd07871         175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHA  254 (288)
T ss_pred             hcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhC
Confidence            865 4578999999999999999999876632110  00       0            00     0000      0001


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ...+.++.+++.+||+.||.+|||++|+++
T Consensus       255 ~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         255 PRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            122456789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.93  E-value=1.9e-26  Score=179.71  Aligned_cols=154  Identities=28%  Similarity=0.400  Sum_probs=118.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+++   ++|+||+|.||+++.++.++++|||.+.......... .....++..|+|||.
T Consensus        97 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~  172 (256)
T cd05114          97 LSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEV  172 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec-cCCCCCchhhCChhh
Confidence            678889999999999999999999   9999999999999999999999999887653322211 111234567999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|++++ |..|+.....  .   +....  ....+...+..+.+++.+||+.+|++||++++
T Consensus       173 ~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~  250 (256)
T cd05114         173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF--RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAE  250 (256)
T ss_pred             cccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--CCCCCCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence            988888999999999999999998 6666543221  1   11000  00112223457899999999999999999999


Q ss_pred             HHHHHh
Q 028458          157 VVCMLT  162 (208)
Q Consensus       157 i~~~l~  162 (208)
                      +++.|.
T Consensus       251 l~~~l~  256 (256)
T cd05114         251 LLRAIT  256 (256)
T ss_pred             HHHhhC
Confidence            998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.6e-26  Score=180.20  Aligned_cols=155  Identities=27%  Similarity=0.360  Sum_probs=118.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|||++........... ....++..|.|||.
T Consensus        97 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~  172 (256)
T cd05059          97 LGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEV  172 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc-CCCCCCccccCHHH
Confidence            578889999999999999999999   99999999999999999999999998876543221111 11123457999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc--ccCC-ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL--IDDP-VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      +.+..++.++|+||||+++|++++ |..|+......  .... .......+...+..+.+++.+||+.+|++||++.+++
T Consensus       173 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l  252 (256)
T cd05059         173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLL  252 (256)
T ss_pred             hccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            988889999999999999999998 56665432111  1000 0000011233466789999999999999999999999


Q ss_pred             HHH
Q 028458          159 CML  161 (208)
Q Consensus       159 ~~l  161 (208)
                      +.|
T Consensus       253 ~~l  255 (256)
T cd05059         253 SQL  255 (256)
T ss_pred             HHh
Confidence            886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.93  E-value=2.9e-26  Score=178.53  Aligned_cols=153  Identities=26%  Similarity=0.357  Sum_probs=118.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|+++||.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......  .......++..|.|||
T Consensus        94 ~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE  168 (260)
T PF00069_consen   94 PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--ENFNPFVGTPEYMAPE  168 (260)
T ss_dssp             SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--SEBSSSSSSGGGSCHH
T ss_pred             ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--cccccccccccccccc
Confidence            5788999999999999999999999   9999999999999999999999999987641111  1222345678899999


Q ss_pred             hhc-cCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchh---hhhH------HHHHHHHHHHhhccccCCCCC
Q 028458           82 YAI-QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDE---YSSK------QMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        82 ~~~-~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~------~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+. +..++.++|+||||+++++|++|..|+......-........   ....      .....+.+++.+||+.||++|
T Consensus       169 ~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  248 (260)
T PF00069_consen  169 VLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQR  248 (260)
T ss_dssp             HHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGS
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHC
Confidence            998 778899999999999999999998777654100000000000   0000      012678999999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      |++.++++
T Consensus       249 ~~~~~l~~  256 (260)
T PF00069_consen  249 PSAEELLK  256 (260)
T ss_dssp             TTHHHHHT
T ss_pred             cCHHHHhc
Confidence            99999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.93  E-value=7.4e-27  Score=188.17  Aligned_cols=154  Identities=23%  Similarity=0.280  Sum_probs=118.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++........  ......|+..|+|||
T Consensus        92 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE  166 (321)
T cd05591          92 KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPE  166 (321)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCHH
Confidence            3677888999999999999999999   99999999999999999999999999865422211  112245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-------
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-------  152 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-------  152 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......  ...........+...+.++.+++..||+.||++|+       
T Consensus       167 ~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~  246 (321)
T cd05591         167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQG  246 (321)
T ss_pred             HHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCC
Confidence            998888999999999999999999999887543211  11000000011223456788999999999999999       


Q ss_pred             CHHHHHHH
Q 028458          153 TMNDVVCM  160 (208)
Q Consensus       153 s~~~i~~~  160 (208)
                      ++.++++.
T Consensus       247 ~~~~~~~h  254 (321)
T cd05591         247 GEDAIKQH  254 (321)
T ss_pred             CHHHHhcC
Confidence            77888754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=2.4e-26  Score=179.04  Aligned_cols=152  Identities=20%  Similarity=0.248  Sum_probs=114.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC-------CeEEeccccceecCCCcccccccccccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-------NPKISDFGMARICGGNELQANTSRIVGT   74 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~   74 (208)
                      .+++..++.++.|++.||.|||+++   ++|+||||.||+++.++       .++++|||++.......      ...+.
T Consensus        97 ~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~  167 (259)
T cd05037          97 NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE------ERVER  167 (259)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccccccccc------ccccC
Confidence            3678889999999999999999998   99999999999998877       79999999987653311      12345


Q ss_pred             CCccCcchhccC--CCCCcchhHHHHHHHHHHHHh-hhcCCccccc-ccCCccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           75 YGYMSPEYAIQG--IFSIKSDVFSFGVLLLEIAWD-LWTSNRTLEL-IDDPVLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        75 ~~~~ape~~~~~--~~~~~~Dv~slG~~~~~l~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      ..|+|||++.+.  .++.++|+||||+++|+++++ ..++...... ...........+......+.+++.+||..+|++
T Consensus       168 ~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  247 (259)
T cd05037         168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTK  247 (259)
T ss_pred             CCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCchHHHHHHHHHhccChhh
Confidence            679999998776  688999999999999999985 4444332110 000000000011111267889999999999999


Q ss_pred             CCCHHHHHHHHh
Q 028458          151 RPTMNDVVCMLT  162 (208)
Q Consensus       151 Rps~~~i~~~l~  162 (208)
                      ||++.++++.|+
T Consensus       248 Rpt~~~il~~l~  259 (259)
T cd05037         248 RPSFRAILRDLN  259 (259)
T ss_pred             CCCHHHHHHhcC
Confidence            999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.93  E-value=3.9e-26  Score=185.60  Aligned_cols=160  Identities=28%  Similarity=0.333  Sum_probs=121.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++....+++.|+++||.|||+.+   ++|+||||.||+++.++.++++|||++................++..|+|||
T Consensus       175 ~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  251 (343)
T cd05103         175 VLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  251 (343)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcH
Confidence            3678899999999999999999998   9999999999999999999999999987653222111111223456799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc--c----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL--E----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..++.++|+|+||+++|++++ |..|+....  .    ........  ..+...+..+.+++..||+.+|++||++
T Consensus       252 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~cl~~~p~~Rps~  329 (343)
T cd05103         252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTF  329 (343)
T ss_pred             HhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC--CCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence            9988889999999999999999986 655543211  0    00000000  1112234568899999999999999999


Q ss_pred             HHHHHHHhhhhh
Q 028458          155 NDVVCMLTNEAA  166 (208)
Q Consensus       155 ~~i~~~l~~~~~  166 (208)
                      .++++.|+.+..
T Consensus       330 ~eil~~l~~~~~  341 (343)
T cd05103         330 SELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHHHh
Confidence            999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=3.2e-26  Score=179.41  Aligned_cols=152  Identities=19%  Similarity=0.258  Sum_probs=112.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC-------eEEeccccceecCCCcccccccccccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN-------PKISDFGMARICGGNELQANTSRIVGT   74 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~-------~~l~dfg~~~~~~~~~~~~~~~~~~~~   74 (208)
                      .+++..+++++.|+++|+.|||+++   ++|+||+|+||+++.++.       ++++|||++......      ....++
T Consensus       101 ~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~  171 (262)
T cd05077         101 VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVER  171 (262)
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------cccccc
Confidence            3678889999999999999999999   999999999999986654       899999987654221      113456


Q ss_pred             CCccCcchhc-cCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-cccCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           75 YGYMSPEYAI-QGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        75 ~~~~ape~~~-~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      ..|+|||.+. +..++.++|+||||+++|+|++ +..|+..... ..................++.+++.+||+.||++|
T Consensus       172 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R  251 (262)
T cd05077         172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQR  251 (262)
T ss_pred             ccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChHHHHHHHHHHcCCChhhC
Confidence            7899999886 4568899999999999999985 5544432111 00000000000111224568899999999999999


Q ss_pred             CCHHHHHHHHh
Q 028458          152 PTMNDVVCMLT  162 (208)
Q Consensus       152 ps~~~i~~~l~  162 (208)
                      |++.+|++.|+
T Consensus       252 p~~~~il~~~~  262 (262)
T cd05077         252 PFFRAIMRDIN  262 (262)
T ss_pred             cCHHHHHHhcC
Confidence            99999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=3.5e-26  Score=180.79  Aligned_cols=159  Identities=23%  Similarity=0.291  Sum_probs=118.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ape   81 (208)
                      +++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++++|||++.......... ......++..|.|||
T Consensus       105 l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  181 (284)
T cd05081         105 LDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE  181 (284)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHH
Confidence            678899999999999999999999   9999999999999999999999999987654322111 111112334589999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc----cCC-c---cc-----------hhhhhHHHHHHHHHHHhh
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI----DDP-V---LE-----------DEYSSKQMLLRYVNIALL  142 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~----~~~-~---~~-----------~~~~~~~~~~~~~~li~~  142 (208)
                      .+.+..++.++|+||||+++++|+++..+........    ... .   ..           ........+..+.+++.+
T Consensus       182 ~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  261 (284)
T cd05081         182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKE  261 (284)
T ss_pred             HhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHH
Confidence            9988889999999999999999998644332111110    000 0   00           000112234678999999


Q ss_pred             ccccCCCCCCCHHHHHHHHhhh
Q 028458          143 CVQESADDRPTMNDVVCMLTNE  164 (208)
Q Consensus       143 ~l~~~p~~Rps~~~i~~~l~~~  164 (208)
                      ||+.+|++||+++++++.|+.+
T Consensus       262 cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         262 CWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HccCChhhCCCHHHHHHHHHhc
Confidence            9999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.93  E-value=1.2e-25  Score=175.91  Aligned_cols=157  Identities=22%  Similarity=0.314  Sum_probs=124.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.+++.++.|++.++.|||+.+   ++|+||+|+||+++.++.++++|||++.........  .....++..|.|||.
T Consensus       103 ~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~  177 (267)
T cd08224         103 IPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPER  177 (267)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHH
Confidence            577889999999999999999999   999999999999999999999999998765433211  112346778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc----cc---cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE----LI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      +.+..++.++|+|+||+++|++++|..|+.....    ..   ....... ......+..+.++|.+||..+|++||++.
T Consensus       178 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~  256 (267)
T cd08224         178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP-LPADHYSEELRDLVSRCINPDPEKRPDIS  256 (267)
T ss_pred             hccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC-CChhhcCHHHHHHHHHHcCCCcccCCCHH
Confidence            9888899999999999999999998877633211    11   1011111 11225566889999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      +|++.|+.+.
T Consensus       257 ~il~~~~~~~  266 (267)
T cd08224         257 YVLQVAKEMH  266 (267)
T ss_pred             HHHHHHHHhc
Confidence            9999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.93  E-value=4.9e-26  Score=186.38  Aligned_cols=152  Identities=26%  Similarity=0.282  Sum_probs=116.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++........   .....++..|+|||.
T Consensus       123 ~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~  196 (364)
T cd07875         123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEV  196 (364)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCCc---ccCCcccCCcCCHHH
Confidence            567788899999999999999999   99999999999999999999999999876543221   122456889999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------c---cC--------------------Cccchh-------
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------I---DD--------------------PVLEDE-------  126 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~---~~--------------------~~~~~~-------  126 (208)
                      +.+..++.++|+|||||++|+|++|..++......      +   ..                    +.....       
T Consensus       197 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (364)
T cd07875         197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP  276 (364)
T ss_pred             HhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCc
Confidence            99888999999999999999999998776422110      0   00                    000000       


Q ss_pred             --------hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          127 --------YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       127 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                              .........+.++|.+||+.||.+||+++++++.
T Consensus       277 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         277 DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             cccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                    0000112457899999999999999999999884

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.93  E-value=3.8e-26  Score=178.28  Aligned_cols=155  Identities=26%  Similarity=0.396  Sum_probs=119.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||.+.......... .....++..|.+||
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~~pe  171 (256)
T cd05113          96 RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPE  171 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee-cCCCccChhhCCHH
Confidence            3678889999999999999999999   9999999999999999999999999887654332211 11123456799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      ...+..++.++|+||||+++|+|++ |..|+.....     .+....  ....+...+..+.+++.+||+.+|++||++.
T Consensus       172 ~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~  249 (256)
T cd05113         172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL--RLYRPHLASEKVYAIMYSCWHEKAEERPTFQ  249 (256)
T ss_pred             HHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence            9988889999999999999999997 7766643211     111110  0011223456789999999999999999999


Q ss_pred             HHHHHHh
Q 028458          156 DVVCMLT  162 (208)
Q Consensus       156 ~i~~~l~  162 (208)
                      ++++.|+
T Consensus       250 ~ll~~~~  256 (256)
T cd05113         250 QLLSSIE  256 (256)
T ss_pred             HHHHhhC
Confidence            9998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=1.7e-26  Score=188.68  Aligned_cols=101  Identities=30%  Similarity=0.372  Sum_probs=87.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.||+.||.|||+.+   |+||||||.||+++.++.++|+|||++........   .....|+..|+|||
T Consensus       153 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE  226 (357)
T PHA03209        153 PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---FLGLAGTVETNAPE  226 (357)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCcc---cccccccccccCCe
Confidence            4788999999999999999999999   99999999999999999999999999865322211   12245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhh
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDL  108 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~  108 (208)
                      .+.+..++.++|+|||||++|+|+++.
T Consensus       227 ~~~~~~~~~~~DiwSlGvvl~ell~~~  253 (357)
T PHA03209        227 VLARDKYNSKADIWSAGIVLFEMLAYP  253 (357)
T ss_pred             ecCCCCCCchhhHHHHHHHHHHHHHcC
Confidence            998888999999999999999998743

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.93  E-value=7.5e-27  Score=188.28  Aligned_cols=149  Identities=24%  Similarity=0.262  Sum_probs=115.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   ++||||||.||+++.++.++|+|||++........  ......|+..|+|||
T Consensus        92 ~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE  166 (323)
T cd05575          92 SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPE  166 (323)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccccccCChhhcChh
Confidence            3667788899999999999999999   99999999999999999999999998764322111  122345788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccc--ccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL--ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++|..|+....  +................+..+.++|.+||+.||++||+++
T Consensus       167 ~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             hhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            9998889999999999999999999998875321  1111000001112233467788999999999999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.93  E-value=1.1e-26  Score=187.21  Aligned_cols=148  Identities=28%  Similarity=0.328  Sum_probs=115.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........  ......|+..|+|||
T Consensus        97 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE  171 (323)
T cd05616          97 RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPE  171 (323)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHH
Confidence            3677889999999999999999999   99999999999999999999999999865432111  122345788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..++.++|+|||||++|+|++|..|+.....  ............+...+.++.+++.+||+.+|++|++.
T Consensus       172 ~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            99988899999999999999999999988754321  11100000111233456778899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.93  E-value=2.9e-26  Score=180.17  Aligned_cols=154  Identities=25%  Similarity=0.296  Sum_probs=118.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++.......   .......+..|.|||.
T Consensus       109 l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~  182 (270)
T cd05047         109 LSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIES  182 (270)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchhh---hccCCCCccccCChHH
Confidence            678899999999999999999998   9999999999999999999999999875321110   0111122457999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc--c---cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL--E---LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +....++.++|+||||+++++|++ |..|+....  +   .+....  ....+...+..+.+++.+||+.+|.+||++.+
T Consensus       183 ~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  260 (270)
T cd05047         183 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ  260 (270)
T ss_pred             HccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC--CCCCCCcCCHHHHHHHHHHcccChhhCCCHHH
Confidence            988888999999999999999996 776663221  1   111000  00112234567889999999999999999999


Q ss_pred             HHHHHhhh
Q 028458          157 VVCMLTNE  164 (208)
Q Consensus       157 i~~~l~~~  164 (208)
                      +++.|+++
T Consensus       261 il~~l~~~  268 (270)
T cd05047         261 ILVSLNRM  268 (270)
T ss_pred             HHHHHHHh
Confidence            99999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.93  E-value=3.6e-26  Score=177.36  Aligned_cols=154  Identities=24%  Similarity=0.309  Sum_probs=118.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.+|.|||+.+   ++|+|++|+||+++.++.++++|||++.......... .....++..|+|||.
T Consensus        90 ~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~  165 (250)
T cd05085          90 LKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLKQIPIKWTAPEA  165 (250)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCCCCcccccCHHH
Confidence            578899999999999999999999   9999999999999999999999999986543322111 111233567999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|++++ |..|+......     +....  ....+...+..+.+++.+||+.+|++||++.+
T Consensus       166 ~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  243 (250)
T cd05085         166 LNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSE  243 (250)
T ss_pred             hccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence            988888999999999999999987 66665332111     11000  00112234567899999999999999999999


Q ss_pred             HHHHHh
Q 028458          157 VVCMLT  162 (208)
Q Consensus       157 i~~~l~  162 (208)
                      +.+.|.
T Consensus       244 l~~~l~  249 (250)
T cd05085         244 LQKELA  249 (250)
T ss_pred             HHHHhc
Confidence            999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=1.4e-26  Score=186.83  Aligned_cols=152  Identities=24%  Similarity=0.237  Sum_probs=117.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +....+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++........  ......|+..|+|||.
T Consensus        97 ~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  171 (323)
T cd05584          97 FMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEI  171 (323)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhh
Confidence            456677889999999999999999   99999999999999999999999999865322211  1122457889999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----CHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----TMN  155 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~  155 (208)
                      +.+..++.++|+||||+++|+|++|..|+......  ...........+...+..+.++|.+||+.+|++||     ++.
T Consensus       172 ~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  251 (323)
T cd05584         172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAA  251 (323)
T ss_pred             ccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHH
Confidence            98888899999999999999999999887543211  11000000112334456788999999999999999     788


Q ss_pred             HHHH
Q 028458          156 DVVC  159 (208)
Q Consensus       156 ~i~~  159 (208)
                      ++++
T Consensus       252 ~l~~  255 (323)
T cd05584         252 EVQS  255 (323)
T ss_pred             HHhc
Confidence            8776

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.93  E-value=1.1e-26  Score=187.84  Aligned_cols=153  Identities=22%  Similarity=0.260  Sum_probs=117.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++........  ......|+..|+|||
T Consensus        92 ~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE  166 (329)
T cd05618          92 KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPE  166 (329)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCccccCHH
Confidence            4677888999999999999999999   99999999999999999999999999864321111  112346788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc-----------CCccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-----------DPVLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      .+.+..++.++|+||||+++|+|++|..|+........           .........+...+..+.+++.+||+.||++
T Consensus       167 ~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~  246 (329)
T cd05618         167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKE  246 (329)
T ss_pred             HHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHH
Confidence            99988899999999999999999999888742111000           0000011123345567889999999999999


Q ss_pred             CCC------HHHHHH
Q 028458          151 RPT------MNDVVC  159 (208)
Q Consensus       151 Rps------~~~i~~  159 (208)
                      ||+      +.++++
T Consensus       247 R~~~~~~~~~~~i~~  261 (329)
T cd05618         247 RLGCHPQTGFADIQG  261 (329)
T ss_pred             cCCCCCCCCHHHHhc
Confidence            998      456654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.93  E-value=2.5e-26  Score=172.06  Aligned_cols=150  Identities=23%  Similarity=0.292  Sum_probs=119.5

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC---CCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      +...+..+..||+++|.|+|.++   |+|||+||.|+++..   ..-+||+|||++...+.....   ....|++.|++|
T Consensus       108 SEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~---~G~~GtP~fmaP  181 (355)
T KOG0033|consen  108 SEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW---HGFAGTPGYLSP  181 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCcccc---ccccCCCcccCH
Confidence            45567789999999999999999   999999999999954   345899999999887633322   235789999999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCc-c-ccccc---CCccchh-hhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-T-LELID---DPVLEDE-YSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~-~~~~~---~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |+++..+|+..+|+|+.|+++|-++.|..||.. . ..+.+   ....+-. .......++..+++++||..||.+|.++
T Consensus       182 Evvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta  261 (355)
T KOG0033|consen  182 EVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITA  261 (355)
T ss_pred             HHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccH
Confidence            999999999999999999999999999998865 2 22222   1111110 2344556788899999999999999999


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      .|.++
T Consensus       262 ~EAL~  266 (355)
T KOG0033|consen  262 DEALK  266 (355)
T ss_pred             HHHhC
Confidence            98765

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.3e-26  Score=177.99  Aligned_cols=166  Identities=23%  Similarity=0.276  Sum_probs=122.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      |+...+--++.|++.||+|+|+.+   ++|||+||.|++++.+..+|++|||+++...........+..+.|..|+|||.
T Consensus       122 L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPEl  198 (359)
T KOG0660|consen  122 LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPEL  198 (359)
T ss_pred             ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHH
Confidence            555666778899999999999999   99999999999999999999999999988754322222344677899999998


Q ss_pred             hc-cCCCCCcchhHHHHHHHHHHHHhhh--cCCccccccc-------C---------------------Cccch---hhh
Q 028458           83 AI-QGIFSIKSDVFSFGVLLLEIAWDLW--TSNRTLELID-------D---------------------PVLED---EYS  128 (208)
Q Consensus        83 ~~-~~~~~~~~Dv~slG~~~~~l~~~~~--~~~~~~~~~~-------~---------------------~~~~~---~~~  128 (208)
                      .. ...|+...|+||.||++.||++|..  |+.+....++       .                     +..++   ...
T Consensus       199 ll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~  278 (359)
T KOG0660|consen  199 LLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSI  278 (359)
T ss_pred             HhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHH
Confidence            75 4569999999999999999988764  3322211110       0                     00000   001


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HhhhhhccCCC
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEAATLLPP  171 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~~~~~~p  171 (208)
                      .++......+++.+||..||.+|+|++|+++.  |+........|
T Consensus       279 fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  279 FPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             cCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            11234567789999999999999999999984  66665444444

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.93  E-value=4.2e-26  Score=178.82  Aligned_cols=158  Identities=27%  Similarity=0.382  Sum_probs=121.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccc-cccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~~~~ap   80 (208)
                      .+++.+++.++.|++.|+.|||+.+   ++|+|++|.||+++.++.++++|||++............ .....+..|.||
T Consensus       103 ~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~P  179 (268)
T cd05063         103 EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP  179 (268)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCH
Confidence            3678899999999999999999999   999999999999999999999999998765432211111 111224579999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++|+||||+++|++++ |..|+.....     .+... . ........+..+.+++.+||+.+|++||++
T Consensus       180 E~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~-~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~  257 (268)
T cd05063         180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-F-RLPAPMDCPSAVYQLMLQCWQQDRARRPRF  257 (268)
T ss_pred             HHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-C-CCCCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence            99988888999999999999999986 7777632211     11100 0 101122345678899999999999999999


Q ss_pred             HHHHHHHhhh
Q 028458          155 NDVVCMLTNE  164 (208)
Q Consensus       155 ~~i~~~l~~~  164 (208)
                      .++++.|+++
T Consensus       258 ~~i~~~l~~~  267 (268)
T cd05063         258 VDIVNLLDKL  267 (268)
T ss_pred             HHHHHHHHhh
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=3.9e-26  Score=185.26  Aligned_cols=154  Identities=23%  Similarity=0.274  Sum_probs=117.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      |+..++..++.|++.||+|+|+.|   ++|||||..|||+|.+|.+||+|||++.++....... .+..+-|+.|+|||.
T Consensus       215 ft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPEL  290 (560)
T KOG0600|consen  215 FTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPEL  290 (560)
T ss_pred             cChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHH
Confidence            677899999999999999999999   9999999999999999999999999999876554333 233456899999999


Q ss_pred             hccCC-CCCcchhHHHHHHHHHHHHhhhcCCcccc--cc--------------cC-Cccc------h--------hhhhH
Q 028458           83 AIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LI--------------DD-PVLE------D--------EYSSK  130 (208)
Q Consensus        83 ~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~--------------~~-~~~~------~--------~~~~~  130 (208)
                      +.+.. |+..+|+||.||++.||+.|...+....+  .+              .. ..++      .        .+...
T Consensus       291 LLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~  370 (560)
T KOG0600|consen  291 LLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFK  370 (560)
T ss_pred             hcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhc
Confidence            98765 89999999999999999655432211000  00              00 0000      0        01122


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          131 QMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       131 ~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ..+....+|+..||..||.+|.++.++++.
T Consensus       371 ~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  371 DFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            335567789999999999999999998873

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.93  E-value=2.6e-26  Score=183.59  Aligned_cols=155  Identities=25%  Similarity=0.290  Sum_probs=118.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.+++.++.|++.|+.|||+.+   ++|+||||.||+++.++.++|+|||++.......   .......+..|.|||.
T Consensus       121 l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~  194 (303)
T cd05088         121 LSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIES  194 (303)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHH
Confidence            678889999999999999999999   9999999999999999999999999875321110   1111123457999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|++++ |..|+.....  .   .....  ....+...+..+.+++.+||+.+|++||++.+
T Consensus       195 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  272 (303)
T cd05088         195 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ  272 (303)
T ss_pred             HhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            988888999999999999999997 7776632211  1   11000  00112234567889999999999999999999


Q ss_pred             HHHHHhhhh
Q 028458          157 VVCMLTNEA  165 (208)
Q Consensus       157 i~~~l~~~~  165 (208)
                      ++..|+++.
T Consensus       273 il~~l~~~~  281 (303)
T cd05088         273 ILVSLNRML  281 (303)
T ss_pred             HHHHHHHHH
Confidence            999988764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.93  E-value=6.4e-27  Score=188.85  Aligned_cols=153  Identities=23%  Similarity=0.230  Sum_probs=117.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.||++||.|||+.+   ++||||||.||+++.++.++|+|||++........  ......|+..|+|||.
T Consensus        93 ~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~  167 (325)
T cd05602          93 FLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEV  167 (325)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCccccCHHH
Confidence            456677889999999999999999   99999999999999999999999999865322111  1223457889999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      +.+..++.++|+||||+++|+|++|..|+.....  ................+..+.+++.+||+.+|.+|+++.+.+..
T Consensus       168 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         168 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             HcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            9988899999999999999999999988753321  11100000111233456678899999999999999988754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.93  E-value=1.7e-26  Score=186.31  Aligned_cols=147  Identities=28%  Similarity=0.315  Sum_probs=114.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........  ......|+..|+|||.
T Consensus        98 ~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  172 (324)
T cd05587          98 FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEI  172 (324)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhh
Confidence            577888999999999999999999   99999999999999999999999998764321111  1223467899999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      +.+..++.++|+||||+++|+|++|..|+.....  ............+...+..+.+++.+||..||.+|++.
T Consensus       173 ~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         173 IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             hcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            9988899999999999999999999888753321  11100000111233455678899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.93  E-value=4.5e-26  Score=178.02  Aligned_cols=155  Identities=30%  Similarity=0.453  Sum_probs=121.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.+.+.++.|++.||+|||+.+   ++|+||+|+||+++.++.++++|||++........... ....++..|+|||.
T Consensus        99 ~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~pe~  174 (260)
T cd05067          99 LTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEA  174 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc-cCCcccccccCHHH
Confidence            678889999999999999999998   99999999999999999999999999876543222111 11234568999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--cc---cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--LI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|++++ |..|+.....  ..   ....  ....+...+..+.+++.+||..+|++||++++
T Consensus       175 ~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  252 (260)
T cd05067         175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY--RMPRPDNCPEELYELMRLCWKEKPEERPTFEY  252 (260)
T ss_pred             hccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            988888999999999999999998 7777642211  11   1000  00122334567999999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      ++..|+.
T Consensus       253 l~~~l~~  259 (260)
T cd05067         253 LRSVLED  259 (260)
T ss_pred             HHHHhhc
Confidence            9999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=6.1e-26  Score=177.26  Aligned_cols=155  Identities=24%  Similarity=0.258  Sum_probs=120.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccccc-ccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~ap   80 (208)
                      .++...+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++........... .....++..|+||
T Consensus       100 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  176 (263)
T cd06625         100 ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP  176 (263)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCc
Confidence            3567788999999999999999999   99999999999999999999999999876533221111 1223466789999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--c---CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--D---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      |.+.+..++.++|+||||+++|++++|..|+.......  .   ..... ...+...+..+.+++.+||..+|++||++.
T Consensus       177 E~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  255 (263)
T cd06625         177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-PQLPSHVSPDARNFLRRTFVENAKKRPSAE  255 (263)
T ss_pred             ceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-CCCCccCCHHHHHHHHHHhhcCcccCCCHH
Confidence            99998889999999999999999999988765432111  0   00011 122344567788999999999999999999


Q ss_pred             HHHHH
Q 028458          156 DVVCM  160 (208)
Q Consensus       156 ~i~~~  160 (208)
                      ++++.
T Consensus       256 ~ll~~  260 (263)
T cd06625         256 ELLRH  260 (263)
T ss_pred             HHhhC
Confidence            99864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.93  E-value=9.5e-26  Score=175.39  Aligned_cols=153  Identities=22%  Similarity=0.335  Sum_probs=120.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.|+.|||+.+   ++|+|++|.||+++.++.++++|||++.........  .....++..|.|||
T Consensus        95 ~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE  169 (256)
T cd06612          95 TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPE  169 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCccc--cccccCCccccCHH
Confidence            4678899999999999999999998   999999999999999999999999998766443211  12234677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+|+||+++|+|++|..|+.......     ..........+...+..+.+++.+||+.+|++||++.+
T Consensus       170 ~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~  249 (256)
T cd06612         170 VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQ  249 (256)
T ss_pred             HHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHH
Confidence            9988889999999999999999999987765332211     00011111123345567899999999999999999999


Q ss_pred             HHH
Q 028458          157 VVC  159 (208)
Q Consensus       157 i~~  159 (208)
                      +++
T Consensus       250 il~  252 (256)
T cd06612         250 LLQ  252 (256)
T ss_pred             Hhc
Confidence            986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.93  E-value=8.8e-26  Score=175.59  Aligned_cols=152  Identities=30%  Similarity=0.340  Sum_probs=120.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+++++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++..........  ....++..|+|||
T Consensus        97 ~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~aPE  171 (256)
T cd08529          97 PLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA--NTIVGTPYYLSPE  171 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccchh--hccccCccccCHH
Confidence            4677888999999999999999998   9999999999999999999999999887654332211  2235678899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +..+..++.++|+||||+++++|++|..|+......  .   ......  ......+..+.+++.+||+.+|++||++.+
T Consensus       172 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  249 (256)
T cd08529         172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP--PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQ  249 (256)
T ss_pred             HhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCccccCHHHHHHHHHHccCCcccCcCHHH
Confidence            998888899999999999999999998887543221  0   001111  122245677899999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       250 ll~~  253 (256)
T cd08529         250 LLRN  253 (256)
T ss_pred             HhhC
Confidence            9863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=5e-26  Score=177.28  Aligned_cols=152  Identities=24%  Similarity=0.345  Sum_probs=120.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.|+.|||+.+   ++|+||+|.||+++.++.++++|||.+........     ....+..|.|||
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape  169 (256)
T cd05039          98 VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPE  169 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCch
Confidence            4788899999999999999999999   99999999999999999999999999876532222     122356799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+..+.++.++|+||||++++++++ |..|+......     .... .. ...+...+..+.+++.+||..+|++||+++
T Consensus       170 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  247 (256)
T cd05039         170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YR-MEAPEGCPPEVYKVMKDCWELDPAKRPTFK  247 (256)
T ss_pred             hhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-CC-CCCccCCCHHHHHHHHHHhccChhhCcCHH
Confidence            9988888999999999999999986 66665332110     1100 00 012233457788999999999999999999


Q ss_pred             HHHHHHhh
Q 028458          156 DVVCMLTN  163 (208)
Q Consensus       156 ~i~~~l~~  163 (208)
                      ++++.|+.
T Consensus       248 ~l~~~l~~  255 (256)
T cd05039         248 QLREQLAL  255 (256)
T ss_pred             HHHHHHhc
Confidence            99999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=9.6e-26  Score=177.97  Aligned_cols=162  Identities=23%  Similarity=0.324  Sum_probs=123.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++................++..|++||.
T Consensus       106 ~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (279)
T cd05057         106 IGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES  182 (279)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHH
Confidence            678899999999999999999998   99999999999999999999999999876543222111111223467999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-cccCCcc--chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-LIDDPVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      +....++.++|+||||+++|++++ |..|+..... .+.....  .....+...+..+.+++.+||..+|.+||++.+++
T Consensus       183 ~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~  262 (279)
T cd05057         183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELI  262 (279)
T ss_pred             hhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            988888999999999999999997 7777643221 1000000  00011222345688999999999999999999999


Q ss_pred             HHHhhhhhc
Q 028458          159 CMLTNEAAT  167 (208)
Q Consensus       159 ~~l~~~~~~  167 (208)
                      +.|+.....
T Consensus       263 ~~l~~~~~~  271 (279)
T cd05057         263 NEFSKMARD  271 (279)
T ss_pred             HHHHHHHhC
Confidence            999987643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.93  E-value=5.6e-26  Score=188.12  Aligned_cols=160  Identities=24%  Similarity=0.301  Sum_probs=122.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++....+++.|++.||.|||+.+   ++|+||||.||+++.++.++++|||++................++..|++||
T Consensus       235 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE  311 (401)
T cd05107         235 ALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE  311 (401)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChH
Confidence            4788899999999999999999998   9999999999999999999999999987643222111112234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc--ccccC---CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL--ELIDD---PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+|+||+++|+|++ +..|+....  +....   ..... ..+...+..+.+++.+||+.+|++||+++
T Consensus       312 ~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~  390 (401)
T cd05107         312 SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFS  390 (401)
T ss_pred             HhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence            9988888999999999999999997 665553211  11000   00000 11223456789999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      +|++.|++..
T Consensus       391 ell~~L~~~~  400 (401)
T cd05107         391 QLVHLVGDLL  400 (401)
T ss_pred             HHHHHHHHHh
Confidence            9999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.93  E-value=1.9e-26  Score=186.41  Aligned_cols=153  Identities=23%  Similarity=0.287  Sum_probs=117.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++.......  .......|+..|+|||
T Consensus        92 ~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE  166 (329)
T cd05588          92 KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPE  166 (329)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCHH
Confidence            4778899999999999999999999   9999999999999999999999999876421111  1122346788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--c--------CCcc-chhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--D--------DPVL-EDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~--------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.......  .        .... .....+...+..+.+++.+||+.||.+
T Consensus       167 ~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~  246 (329)
T cd05588         167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKE  246 (329)
T ss_pred             HHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence            9998889999999999999999999998874211100  0        0000 000122334567889999999999999


Q ss_pred             CCC------HHHHHH
Q 028458          151 RPT------MNDVVC  159 (208)
Q Consensus       151 Rps------~~~i~~  159 (208)
                      |++      ++++++
T Consensus       247 R~~~~~~~~~~~i~~  261 (329)
T cd05588         247 RLGCHPQTGFRDIKS  261 (329)
T ss_pred             cCCCCCCCCHHHHhc
Confidence            997      667765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=6e-26  Score=179.06  Aligned_cols=159  Identities=25%  Similarity=0.299  Sum_probs=121.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-ccccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~ape   81 (208)
                      +++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||.+......... .......++..|.+||
T Consensus       106 ~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe  182 (284)
T cd05038         106 INLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE  182 (284)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcH
Confidence            688899999999999999999998   999999999999999999999999998776532211 1111123345699999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccC--------Ccc----------chhhhhHHHHHHHHHHHhhc
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD--------PVL----------EDEYSSKQMLLRYVNIALLC  143 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~--------~~~----------~~~~~~~~~~~~~~~li~~~  143 (208)
                      ...+..++.++|+|+||+++++|++|..++.........        ...          .....+...+..+.+++.+|
T Consensus       183 ~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  262 (284)
T cd05038         183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLC  262 (284)
T ss_pred             HHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHH
Confidence            998888899999999999999999987665432111100        000          00011223346788999999


Q ss_pred             cccCCCCCCCHHHHHHHHhhh
Q 028458          144 VQESADDRPTMNDVVCMLTNE  164 (208)
Q Consensus       144 l~~~p~~Rps~~~i~~~l~~~  164 (208)
                      |+.+|++||++.++++.|+++
T Consensus       263 l~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         263 WEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             hccChhhCCCHHHHHHHHhhc
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=3.9e-26  Score=178.34  Aligned_cols=151  Identities=18%  Similarity=0.229  Sum_probs=112.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC--------eEEeccccceecCCCcccccccccccC
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN--------PKISDFGMARICGGNELQANTSRIVGT   74 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~   74 (208)
                      +++..++.++.|++.|+.|||+++   ++|+||||.||+++.++.        ++++|||++......      ....++
T Consensus        97 ~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~  167 (258)
T cd05078          97 INISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLER  167 (258)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccccCCc------hhcccc
Confidence            678889999999999999999999   999999999999977654        588999987544321      123456


Q ss_pred             CCccCcchhccC-CCCCcchhHHHHHHHHHHHHhhh-cCCcccccccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           75 YGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIAWDLW-TSNRTLELIDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        75 ~~~~ape~~~~~-~~~~~~Dv~slG~~~~~l~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      ..|+|||.+.+. .++.++|+||||+++|++++|.. ++............ .....+.....++.+++.+||+.+|++|
T Consensus       168 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  247 (258)
T cd05078         168 IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFR  247 (258)
T ss_pred             CCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHHHHHHHhccChhhC
Confidence            789999998764 47889999999999999999853 33221111000000 0001122234578899999999999999


Q ss_pred             CCHHHHHHHHh
Q 028458          152 PTMNDVVCMLT  162 (208)
Q Consensus       152 ps~~~i~~~l~  162 (208)
                      |+++++++.|+
T Consensus       248 ps~~~il~~l~  258 (258)
T cd05078         248 PSFRAIIRDLN  258 (258)
T ss_pred             CCHHHHHHhcC
Confidence            99999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.93  E-value=1.1e-25  Score=182.90  Aligned_cols=151  Identities=23%  Similarity=0.278  Sum_probs=115.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++.......     ....++..|+|||
T Consensus       114 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE  185 (343)
T cd07878         114 KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM-----TGYVATRWYRAPE  185 (343)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCCc-----CCccccccccCch
Confidence            3678889999999999999999999   9999999999999999999999999987654322     2245788999999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cc-------cCCcc------------------c---hh---h
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LI-------DDPVL------------------E---DE---Y  127 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~-------~~~~~------------------~---~~---~  127 (208)
                      .+.+ ..++.++|+||||+++|+|++|..++.....  ..       .....                  .   ..   .
T Consensus       186 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (343)
T cd07878         186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKK  265 (343)
T ss_pred             HhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHH
Confidence            9876 4578999999999999999998876632210  00       00000                  0   00   0


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ........+.+++.+||+.||++||++.|+++.
T Consensus       266 ~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         266 IFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000112346789999999999999999999974

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.93  E-value=9e-26  Score=177.15  Aligned_cols=155  Identities=25%  Similarity=0.296  Sum_probs=112.3

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchh
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA   83 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~   83 (208)
                      ++.....++.|++.||.|||+.+   ++|+||||.||+++.++.++++|||++................++..|+|||..
T Consensus        98 ~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  174 (269)
T cd05042          98 QKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV  174 (269)
T ss_pred             cHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHH
Confidence            46677899999999999999999   999999999999999999999999987653222211111222345679999987


Q ss_pred             cc-------CCCCCcchhHHHHHHHHHHHH-hhhcCCccccc------cc--CCccchhhhhHHHHHHHHHHHhhccccC
Q 028458           84 IQ-------GIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL------ID--DPVLEDEYSSKQMLLRYVNIALLCVQES  147 (208)
Q Consensus        84 ~~-------~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~------~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~  147 (208)
                      ..       ..++.++|+||||+++|+|++ +..|+......      ..  ...+.........+..+.+++..|| .|
T Consensus       175 ~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~d  253 (269)
T cd05042         175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LD  253 (269)
T ss_pred             hhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cC
Confidence            53       346789999999999999998 55554332110      11  0111111223345566778999998 59


Q ss_pred             CCCCCCHHHHHHHHh
Q 028458          148 ADDRPTMNDVVCMLT  162 (208)
Q Consensus       148 p~~Rps~~~i~~~l~  162 (208)
                      |++||+++++++.|.
T Consensus       254 p~~Rpt~~~v~~~l~  268 (269)
T cd05042         254 PETRPTAEEVHELLT  268 (269)
T ss_pred             cccccCHHHHHHHhc
Confidence            999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.93  E-value=1.3e-25  Score=176.40  Aligned_cols=156  Identities=24%  Similarity=0.317  Sum_probs=113.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.|+.|||+.+   ++|+||||.||+++.++.++++|||++................++..|+|||.
T Consensus        97 ~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  173 (269)
T cd05087          97 PDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL  173 (269)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhH
Confidence            355677889999999999999999   99999999999999999999999999865433322222222345678999998


Q ss_pred             hccC-------CCCCcchhHHHHHHHHHHHH-hhhcCCccccc--c----c--CCccchhhhhHHHHHHHHHHHhhcccc
Q 028458           83 AIQG-------IFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL--I----D--DPVLEDEYSSKQMLLRYVNIALLCVQE  146 (208)
Q Consensus        83 ~~~~-------~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~--~----~--~~~~~~~~~~~~~~~~~~~li~~~l~~  146 (208)
                      +.+.       .++.++|+||||+++|++++ |..|+......  .    .  .............+..+.+++..|| .
T Consensus       174 ~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~  252 (269)
T cd05087         174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-L  252 (269)
T ss_pred             hccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-c
Confidence            8532       35789999999999999985 77665432110  0    0  0111111111223456788999999 6


Q ss_pred             CCCCCCCHHHHHHHHh
Q 028458          147 SADDRPTMNDVVCMLT  162 (208)
Q Consensus       147 ~p~~Rps~~~i~~~l~  162 (208)
                      +|++||++++|++.|+
T Consensus       253 ~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         253 QPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CcccCCCHHHHHHHhc
Confidence            8999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.93  E-value=4.1e-26  Score=187.36  Aligned_cols=155  Identities=25%  Similarity=0.327  Sum_probs=116.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++......... ......++..|+|||
T Consensus        99 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE  174 (372)
T cd07853          99 PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPE  174 (372)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCccc-cCCCCCcCCCcCCHH
Confidence            3678889999999999999999999   999999999999999999999999998765332211 112235678899999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccCCcc-------------------chh------
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDDPVL-------------------EDE------  126 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~~~~-------------------~~~------  126 (208)
                      .+.+.. ++.++|+|||||++|+|++|..++......         ...+..                   ...      
T Consensus       175 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (372)
T cd07853         175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLY  254 (372)
T ss_pred             HHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhc
Confidence            987644 788999999999999999998776432110         000000                   000      


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       127 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ......+..+.++|.+||+.||++||++.|+++.
T Consensus       255 ~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         255 TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0011124567899999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.93  E-value=1.3e-25  Score=176.37  Aligned_cols=160  Identities=21%  Similarity=0.262  Sum_probs=123.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++........... ....++..|+|||.
T Consensus       104 ~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~y~aPE~  179 (270)
T cd05056         104 LDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA-SKGKLPIKWMAPES  179 (270)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccceec-CCCCccccccChhh
Confidence            688899999999999999999998   99999999999999999999999999876543322111 11223457999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc--ccC-CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL--IDD-PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      +....++.++|+||||++++++++ |..|+......  ... ........+...+..+.+++.+||..+|++||++.+++
T Consensus       180 ~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~  259 (270)
T cd05056         180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELK  259 (270)
T ss_pred             hccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            888888999999999999999885 77766432211  100 00000012334456789999999999999999999999


Q ss_pred             HHHhhhhh
Q 028458          159 CMLTNEAA  166 (208)
Q Consensus       159 ~~l~~~~~  166 (208)
                      +.|+++..
T Consensus       260 ~~l~~~~~  267 (270)
T cd05056         260 AQLSDILQ  267 (270)
T ss_pred             HHHHHHHh
Confidence            99988653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.93  E-value=2.2e-26  Score=185.92  Aligned_cols=148  Identities=24%  Similarity=0.300  Sum_probs=114.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++........  ......|+..|+|||
T Consensus        92 ~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE  166 (327)
T cd05617          92 KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPE  166 (327)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceecccCCcccCCHH
Confidence            4778899999999999999999999   99999999999999999999999998865321111  112346788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc--------CCcc-chhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID--------DPVL-EDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~--------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      .+.+..++.++|+||||+++|+|++|..|+........        .... .....+...+..+.+++.+||+.||++|+
T Consensus       167 ~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~  246 (327)
T cd05617         167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERL  246 (327)
T ss_pred             HHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence            99988899999999999999999999988843211100        0000 00012333456788999999999999999


Q ss_pred             CH
Q 028458          153 TM  154 (208)
Q Consensus       153 s~  154 (208)
                      ++
T Consensus       247 ~~  248 (327)
T cd05617         247 GC  248 (327)
T ss_pred             CC
Confidence            84

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.3e-26  Score=188.48  Aligned_cols=154  Identities=22%  Similarity=0.311  Sum_probs=120.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCc------------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE------------------   63 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~------------------   63 (208)
                      .++...+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......                  
T Consensus        97 ~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (350)
T cd05573          97 VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV  173 (350)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccc
Confidence            4678889999999999999999999   9999999999999999999999999987654332                  


Q ss_pred             ---------ccccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccC--Cccchhh
Q 028458           64 ---------LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDD--PVLEDEY  127 (208)
Q Consensus        64 ---------~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~--~~~~~~~  127 (208)
                               .........|+..|+|||.+.+..++.++|+|||||++|+|++|..|+......     +..  ..... .
T Consensus       174 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-p  252 (350)
T cd05573         174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRF-P  252 (350)
T ss_pred             cccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccC-C
Confidence                     001112346788999999999989999999999999999999999887543211     100  00000 1


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCC-HHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPT-MNDVVCM  160 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps-~~~i~~~  160 (208)
                      .....+..+.++|..|+. +|.+||+ ++++++.
T Consensus       253 ~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         253 PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            111146778899999997 9999999 9999984

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.93  E-value=2.4e-26  Score=186.66  Aligned_cols=151  Identities=22%  Similarity=0.226  Sum_probs=120.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++.......     ....|+..|+|||
T Consensus       127 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE  198 (340)
T PTZ00426        127 RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT-----YTLCGTPEYIAPE  198 (340)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-----ceecCChhhcCHH
Confidence            4677888999999999999999999   9999999999999999999999999987654321     2246788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--cCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----CH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----TM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~  154 (208)
                      .+.+..++.++|+|||||++|+|++|..|+.......  ..........+...+..+.++|.+||+.||++|+     ++
T Consensus       199 ~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~  278 (340)
T PTZ00426        199 ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGA  278 (340)
T ss_pred             HHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCH
Confidence            9988889999999999999999999998876443211  1000000012333456788999999999999995     88


Q ss_pred             HHHHHH
Q 028458          155 NDVVCM  160 (208)
Q Consensus       155 ~~i~~~  160 (208)
                      +++++.
T Consensus       279 ~~~~~h  284 (340)
T PTZ00426        279 QNVKEH  284 (340)
T ss_pred             HHHHcC
Confidence            888774

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=6.7e-26  Score=179.64  Aligned_cols=153  Identities=27%  Similarity=0.284  Sum_probs=120.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++........   .....++..|+|||
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE  171 (285)
T cd05605          98 GFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPE  171 (285)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcH
Confidence            3678889999999999999999999   99999999999999999999999999876533221   11235788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCc-cchhhhhHHHHHHHHHHHhhccccCCCCCC---
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPV-LEDEYSSKQMLLRYVNIALLCVQESADDRP---  152 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---  152 (208)
                      .+.+..++.++|+||+|+++|++++|..|+......     +.... ......+...+..+.+++.+||+.||++||   
T Consensus       172 ~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05605         172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCR  251 (285)
T ss_pred             HhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCC
Confidence            998888999999999999999999998887543221     00000 001112334567789999999999999999   


Q ss_pred             --CHHHHHHH
Q 028458          153 --TMNDVVCM  160 (208)
Q Consensus       153 --s~~~i~~~  160 (208)
                        +++++++.
T Consensus       252 ~~~~~~l~~~  261 (285)
T cd05605         252 GEGAEEVKAH  261 (285)
T ss_pred             CCCHHHHhcC
Confidence              88888663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.93  E-value=6.6e-26  Score=177.89  Aligned_cols=159  Identities=23%  Similarity=0.357  Sum_probs=119.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccc---cCCCccC
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIV---GTYGYMS   79 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~---~~~~~~a   79 (208)
                      +++.+++.++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++................   .+..|.+
T Consensus       103 ~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~  179 (269)
T cd05065         103 FTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA  179 (269)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecC
Confidence            678889999999999999999999   9999999999999999999999999887654322211111111   1346999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc--ccCC-ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL--IDDP-VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      ||.+.+..++.++|+||||+++|++++ |..|+......  .... .......+...+..+.+++.+||+.+|++||+++
T Consensus       180 PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  259 (269)
T cd05065         180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFG  259 (269)
T ss_pred             HhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence            999988889999999999999999875 77666432111  0000 0000011234456788999999999999999999


Q ss_pred             HHHHHHhhh
Q 028458          156 DVVCMLTNE  164 (208)
Q Consensus       156 ~i~~~l~~~  164 (208)
                      +++..|++.
T Consensus       260 ~i~~~l~~~  268 (269)
T cd05065         260 QIVSTLDKM  268 (269)
T ss_pred             HHHHHHHhh
Confidence            999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.93  E-value=9.9e-26  Score=176.16  Aligned_cols=155  Identities=30%  Similarity=0.436  Sum_probs=120.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||.+.......... .....++..|+|||.
T Consensus        99 ~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~  174 (260)
T cd05073          99 QPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEA  174 (260)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCccc-ccCCcccccccCHhH
Confidence            577888999999999999999998   9999999999999999999999999987654322111 111234567999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc--c---cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL--I---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +....++.++|+||||+++|++++ |..|+......  .   ....  ........+..+.+++.+||+.+|++||++++
T Consensus       175 ~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  252 (260)
T cd05073         175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--RMPRPENCPEELYNIMMRCWKNRPEERPTFEY  252 (260)
T ss_pred             hccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--CCCCcccCCHHHHHHHHHHcccCcccCcCHHH
Confidence            988888999999999999999998 77666432111  1   1000  00122345567889999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      +.+.|+.
T Consensus       253 l~~~L~~  259 (260)
T cd05073         253 IQSVLDD  259 (260)
T ss_pred             HHHHHhc
Confidence            9999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=1.4e-25  Score=190.64  Aligned_cols=152  Identities=20%  Similarity=0.261  Sum_probs=112.5

Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchhc
Q 028458            5 WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI   84 (208)
Q Consensus         5 ~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~   84 (208)
                      ...+..++.||+.||.|||+++   |+||||||.||+++.++.++|+|||++..+...... ......|+..|+|||.+.
T Consensus       266 ~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~  341 (501)
T PHA03210        266 LKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILA  341 (501)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhc
Confidence            3456789999999999999999   999999999999999999999999999766433221 112246789999999999


Q ss_pred             cCCCCCcchhHHHHHHHHHHHHhhhcC-Cccc--------ccccC-----Cccc-----------------------hhh
Q 028458           85 QGIFSIKSDVFSFGVLLLEIAWDLWTS-NRTL--------ELIDD-----PVLE-----------------------DEY  127 (208)
Q Consensus        85 ~~~~~~~~Dv~slG~~~~~l~~~~~~~-~~~~--------~~~~~-----~~~~-----------------------~~~  127 (208)
                      +..++.++|+|||||++|+|+++..++ ....        +.+..     ...+                       ...
T Consensus       342 ~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~  421 (501)
T PHA03210        342 GDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLI  421 (501)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHH
Confidence            888999999999999999999876432 1110        00000     0000                       000


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      .....+.++.++|.+||+.||++||++.|++..
T Consensus       422 ~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        422 RNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            001123456778999999999999999999873

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.93  E-value=3e-26  Score=188.38  Aligned_cols=154  Identities=27%  Similarity=0.332  Sum_probs=131.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+...+..++.|+++||.|||+.+   |+|||+||.||+++.++.+|++|||+++-+.....  ......|++-|+|||
T Consensus        96 ~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~--vltsikGtPlYmAPE  170 (808)
T KOG0597|consen   96 KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS--VLTSIKGTPLYMAPE  170 (808)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCce--eeeeccCcccccCHH
Confidence            4677888999999999999999999   99999999999999999999999999988765442  334467899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCC--cccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSN--RTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ...+..|+..+|+||+||++||++.|.+||.  ...+++.....+....+.+....+..|++.+|..||.+|.+..+++.
T Consensus       171 lv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  171 LVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            9999999999999999999999999999984  33344433333443456688889999999999999999999999886


Q ss_pred             H
Q 028458          160 M  160 (208)
Q Consensus       160 ~  160 (208)
                      .
T Consensus       251 H  251 (808)
T KOG0597|consen  251 H  251 (808)
T ss_pred             C
Confidence            3

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=5.9e-26  Score=183.76  Aligned_cols=151  Identities=19%  Similarity=0.261  Sum_probs=119.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.....     ......|+..|+|||
T Consensus        97 ~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE  168 (333)
T cd05600          97 VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPE  168 (333)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChh
Confidence            3677888999999999999999999   99999999999999999999999999875533     122346788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--c---cc--CCccchhhh---hHHHHHHHHHHHhhccccCCCCC
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--L---ID--DPVLEDEYS---SKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~---~~--~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+.+..++.++|+|||||++|+|++|..|+.....  .   +.  ...+.....   ....+..+.+++.+||+.+|++|
T Consensus       169 ~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr  248 (333)
T cd05600         169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRF  248 (333)
T ss_pred             HhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhc
Confidence            99988999999999999999999999888743211  0   00  000110000   12346778899999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      |+++++++.
T Consensus       249 ~s~~~ll~h  257 (333)
T cd05600         249 GSLEDIKNH  257 (333)
T ss_pred             CCHHHHHhC
Confidence            999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.93  E-value=1.4e-25  Score=177.23  Aligned_cols=153  Identities=22%  Similarity=0.228  Sum_probs=114.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.++++|||++.........  .....++..|+|||
T Consensus        95 ~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  169 (284)
T cd07839          95 DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPD  169 (284)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCCCccccCCcChH
Confidence            3678899999999999999999999   999999999999999999999999998755332211  11234577899999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcCCcccccc-------------------------cC---Cccch----hhh
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-------------------------DD---PVLED----EYS  128 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-------------------------~~---~~~~~----~~~  128 (208)
                      .+.+.. ++.++|+||||+++|+|++|..|+.......                         ..   .....    ...
T Consensus       170 ~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (284)
T cd07839         170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNV  249 (284)
T ss_pred             HHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhh
Confidence            887644 6889999999999999999876642211100                         00   00000    011


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ....+..+.++|.+||+.||.+||+++++++
T Consensus       250 ~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         250 VPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            1224567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=8.1e-26  Score=176.49  Aligned_cols=157  Identities=30%  Similarity=0.428  Sum_probs=120.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++........... .....+..|+|||
T Consensus        99 ~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~y~~PE  174 (261)
T cd05034          99 KLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR-EGAKFPIKWTAPE  174 (261)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhhh-hccCCCccccCHH
Confidence            4678899999999999999999999   99999999999999999999999999877654221111 1122356799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc--ccC--CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL--IDD--PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+||||++++++++ |..|+......  ...  ..... ..+...+..+.+++.+||+.+|++||++++
T Consensus       175 ~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  253 (261)
T cd05034         175 AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-PRPPNCPEELYDLMLQCWDKDPEERPTFEY  253 (261)
T ss_pred             HhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence            9988888999999999999999998 77665322110  000  00000 112223567899999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      +.+.|+.
T Consensus       254 l~~~l~~  260 (261)
T cd05034         254 LQSFLED  260 (261)
T ss_pred             HHHHHhc
Confidence            9998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.93  E-value=8.9e-27  Score=188.01  Aligned_cols=152  Identities=22%  Similarity=0.233  Sum_probs=116.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+.+   ++||||||.||+++.++.++|+|||++........  ......|+..|+|||
T Consensus        92 ~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE  166 (325)
T cd05604          92 SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPE  166 (325)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHH
Confidence            3677888999999999999999999   99999999999999999999999999764321111  122345788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.....  .............+..+..+.+++.+|++.+|.+||++++.+
T Consensus       167 ~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         167 VIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             HHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            99988899999999999999999999888753311  111000000011223456778999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.93  E-value=9.9e-26  Score=176.98  Aligned_cols=153  Identities=25%  Similarity=0.313  Sum_probs=117.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.|+.|||+.+   ++|+|++|.||+++.++.++++|||++........  ......++..|+|||
T Consensus       107 ~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE  181 (272)
T cd06637         107 TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPE  181 (272)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHh
Confidence            3678889999999999999999998   99999999999999999999999999876432211  112245678899999


Q ss_pred             hhcc-----CCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCC----ccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           82 YAIQ-----GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDP----VLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        82 ~~~~-----~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      .+.+     ..++.++|+||||+++|+|++|..|+..........    ...........+..+.+++.+||+.+|.+||
T Consensus       182 ~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  261 (272)
T cd06637         182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP  261 (272)
T ss_pred             HhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCC
Confidence            9863     357889999999999999999988775432211000    0000011223456789999999999999999


Q ss_pred             CHHHHHH
Q 028458          153 TMNDVVC  159 (208)
Q Consensus       153 s~~~i~~  159 (208)
                      ++.++++
T Consensus       262 t~~~il~  268 (272)
T cd06637         262 TTEQLMK  268 (272)
T ss_pred             CHHHHhh
Confidence            9999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=2e-26  Score=187.16  Aligned_cols=154  Identities=27%  Similarity=0.322  Sum_probs=127.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+.+|+.|++.|+.|||++.   |+|||||..||++..++.++|+|||++...+....  ......||+.|++||
T Consensus       102 ~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPE  176 (426)
T KOG0589|consen  102 LFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPE  176 (426)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchh--hhheecCCCcccCHH
Confidence            4678889999999999999999887   99999999999999999999999999998766541  233468999999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcc--cccccC-CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDD-PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      .+.+.+|..++|+|+|||++|||++-.++|...  ..++.. ........+..+..++..+|..|++.+|..||++.+++
T Consensus       177 il~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL  256 (426)
T KOG0589|consen  177 ILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELL  256 (426)
T ss_pred             HhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHh
Confidence            999999999999999999999999877666322  111110 00011245666788899999999999999999999999


Q ss_pred             HH
Q 028458          159 CM  160 (208)
Q Consensus       159 ~~  160 (208)
                      ..
T Consensus       257 ~~  258 (426)
T KOG0589|consen  257 RR  258 (426)
T ss_pred             hC
Confidence            85

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.93  E-value=8.1e-26  Score=176.02  Aligned_cols=151  Identities=21%  Similarity=0.270  Sum_probs=119.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++....+.++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||.+.........  .....++..|+|||.
T Consensus        97 ~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~  171 (255)
T cd08219          97 FPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVPPEI  171 (255)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc--cccccCCccccCHHH
Confidence            567788999999999999999999   999999999999999999999999998765432211  112356788999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +.+..++.++|+||||+++|+|++|..|+......     .......  ..+...+..+.+++.+||+.||++||++.++
T Consensus       172 ~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  249 (255)
T cd08219         172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK--PLPSHYSYELRSLIKQMFKRNPRSRPSATTI  249 (255)
T ss_pred             HccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC--CCCcccCHHHHHHHHHHHhCCcccCCCHHHH
Confidence            98888899999999999999999998887543211     1101111  1233455678899999999999999999999


Q ss_pred             HHH
Q 028458          158 VCM  160 (208)
Q Consensus       158 ~~~  160 (208)
                      +..
T Consensus       250 l~~  252 (255)
T cd08219         250 LSR  252 (255)
T ss_pred             hhc
Confidence            864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.93  E-value=1.3e-25  Score=174.85  Aligned_cols=152  Identities=28%  Similarity=0.345  Sum_probs=120.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.++.+||+.+   ++|+||+|+||+++.++.++++|||++........  ......++..|+|||
T Consensus        98 ~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE  172 (257)
T cd08223          98 LLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPE  172 (257)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChh
Confidence            3678899999999999999999999   99999999999999999999999999876643221  112245678899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc-c----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE-L----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+|+||++++++++|..++..... .    .....+.  ..+...+..+.+++.+||+.+|++||++.+
T Consensus       173 ~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  250 (257)
T cd08223         173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP--PMPKDYSPELGELIATMLSKRPEKRPSVKS  250 (257)
T ss_pred             HhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCccccCHHHHHHHHHHhccCcccCCCHHH
Confidence            99888889999999999999999998876643211 1    1111111  123445678999999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       251 ~l~~  254 (257)
T cd08223         251 ILRQ  254 (257)
T ss_pred             HhcC
Confidence            8763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.93  E-value=1.5e-25  Score=178.59  Aligned_cols=153  Identities=22%  Similarity=0.323  Sum_probs=119.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++.........  .....++..|+|||.
T Consensus       113 ~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~  187 (296)
T cd06654         113 MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEV  187 (296)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCCccccCHHH
Confidence            577889999999999999999999   999999999999999999999999987654322211  112356788999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +.+..++.++|+|+||+++|+|++|..|+.......     ..........+...+..+.+++.+||..+|++||++.++
T Consensus       188 ~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ei  267 (296)
T cd06654         188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL  267 (296)
T ss_pred             HcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHH
Confidence            988888999999999999999999998875432210     000011101233455678899999999999999999999


Q ss_pred             HHH
Q 028458          158 VCM  160 (208)
Q Consensus       158 ~~~  160 (208)
                      ++.
T Consensus       268 l~~  270 (296)
T cd06654         268 LQH  270 (296)
T ss_pred             hhC
Confidence            983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.93  E-value=1.1e-25  Score=176.33  Aligned_cols=155  Identities=26%  Similarity=0.365  Sum_probs=120.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc----cccccccCCCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA----NTSRIVGTYGY   77 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~   77 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++..........    ......++..|
T Consensus       102 ~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y  178 (267)
T cd06628         102 AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW  178 (267)
T ss_pred             CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCc
Confidence            3677888999999999999999998   9999999999999999999999999987664221111    11123467889


Q ss_pred             cCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccC-CccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           78 MSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDD-PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        78 ~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      +|||.+.+..++.++|+|+||+++|++++|..|+......  +.. ........+...+..+.++|.+||+.||++||++
T Consensus       179 ~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  258 (267)
T cd06628         179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTA  258 (267)
T ss_pred             cChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCH
Confidence            9999998888899999999999999999998887543221  100 0000112234456778999999999999999999


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      .++++
T Consensus       259 ~~il~  263 (267)
T cd06628         259 AELLK  263 (267)
T ss_pred             HHHhh
Confidence            99876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.93  E-value=1.7e-25  Score=176.84  Aligned_cols=154  Identities=24%  Similarity=0.324  Sum_probs=117.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++++|||++........  ......++..|+|||
T Consensus        99 ~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE  173 (282)
T cd06643          99 PLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPE  173 (282)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccCHh
Confidence            3678899999999999999999999   99999999999999999999999999865432211  112235678899999


Q ss_pred             hhc-----cCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---cCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           82 YAI-----QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        82 ~~~-----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+.     +..++.++|+||||+++|+|++|..|+......  .   ..........+...+..+.++|.+||+.+|++|
T Consensus       174 ~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  253 (282)
T cd06643         174 VVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDAR  253 (282)
T ss_pred             hccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhC
Confidence            874     344678999999999999999998876543211  0   000000111233456778999999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      |++.++++.
T Consensus       254 p~~~~il~~  262 (282)
T cd06643         254 WTTTQLLQH  262 (282)
T ss_pred             cCHHHHhcC
Confidence            999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.93  E-value=1.4e-25  Score=175.93  Aligned_cols=153  Identities=27%  Similarity=0.391  Sum_probs=120.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      +++..+++++.|++.++.|||+ .+   ++|+||+|.||+++.++.++++|||.+.......   ......++..|++||
T Consensus       110 ~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe  183 (269)
T cd08528         110 FTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPE  183 (269)
T ss_pred             CCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChh
Confidence            5677889999999999999996 66   9999999999999999999999999987654332   122345678899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+||||+++|++++|..|+......     +....... ......+..+.+++.+||+.||++||++.|
T Consensus       184 ~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e  262 (269)
T cd08528         184 IVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-LPEGMYSEDVTDVITSCLTPDAEARPDIIQ  262 (269)
T ss_pred             hhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-CCcccCCHHHHHHHHHHCCCCCccCCCHHH
Confidence            998888999999999999999999998876443211     11111110 111134567889999999999999999999


Q ss_pred             HHHHHh
Q 028458          157 VVCMLT  162 (208)
Q Consensus       157 i~~~l~  162 (208)
                      +..+++
T Consensus       263 ~~~~~~  268 (269)
T cd08528         263 VSAMIS  268 (269)
T ss_pred             HHHHhc
Confidence            999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=6.3e-26  Score=188.55  Aligned_cols=147  Identities=20%  Similarity=0.203  Sum_probs=116.8

Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe-CCCCCeEEeccccceecCCCcccccccccccCCCccCcchhc
Q 028458            6 VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI   84 (208)
Q Consensus         6 ~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~   84 (208)
                      ..+..|+.||+.|+.|||.+|   ++|||+||.||++ +..+.++|+|||++.......   ...  .-+..|.|||+..
T Consensus       415 ~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~---~tp--~~t~~y~APEvl~  486 (612)
T KOG0603|consen  415 SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC---DTP--ALTLQYVAPEVLA  486 (612)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchhh---ccc--chhhcccChhhhc
Confidence            466789999999999999999   9999999999999 588999999999998765441   111  2267899999999


Q ss_pred             cCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc-CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458           85 QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus        85 ~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ...|+.++|+||||+++|+|++|..++.....-.+ ...+.........+....+++.+||+.||.+|+++.++...
T Consensus       487 ~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  487 IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            88999999999999999999999877643222110 01111111225567788999999999999999999999874

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.93  E-value=3e-25  Score=174.32  Aligned_cols=156  Identities=21%  Similarity=0.293  Sum_probs=110.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.....++.||+.||.|||+.+   ++|+||||+||+++.++.++++|||++................++..|+|||+
T Consensus        96 ~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  172 (268)
T cd05086          96 SQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL  172 (268)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchh
Confidence            345567789999999999999998   99999999999999999999999998754322111111122356788999998


Q ss_pred             hcc-------CCCCCcchhHHHHHHHHHHHHhh-hcCCccc--ccc----cC--CccchhhhhHHHHHHHHHHHhhcccc
Q 028458           83 AIQ-------GIFSIKSDVFSFGVLLLEIAWDL-WTSNRTL--ELI----DD--PVLEDEYSSKQMLLRYVNIALLCVQE  146 (208)
Q Consensus        83 ~~~-------~~~~~~~Dv~slG~~~~~l~~~~-~~~~~~~--~~~----~~--~~~~~~~~~~~~~~~~~~li~~~l~~  146 (208)
                      +..       ..++.++|+||||+++|+|+++. .|+....  +..    ..  ..+............+.+++..|| .
T Consensus       173 ~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~  251 (268)
T cd05086         173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-L  251 (268)
T ss_pred             cccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-h
Confidence            743       23467899999999999998754 3432211  100    00  011111122234567888999999 6


Q ss_pred             CCCCCCCHHHHHHHHh
Q 028458          147 SADDRPTMNDVVCMLT  162 (208)
Q Consensus       147 ~p~~Rps~~~i~~~l~  162 (208)
                      +|++||+++++++.|.
T Consensus       252 ~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         252 SPEKRATAEEVHRLLT  267 (268)
T ss_pred             CcccCCCHHHHHHHhc
Confidence            7999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=6.8e-27  Score=188.11  Aligned_cols=150  Identities=23%  Similarity=0.244  Sum_probs=116.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+.+   ++|+||||.||+++.++.++|+|||++........  ......|+..|+|||
T Consensus        94 ~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE  168 (318)
T cd05582          94 MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPE  168 (318)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHH
Confidence            3678899999999999999999999   99999999999999999999999999875433211  112245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......  ...........+...+..+.+++.+||+.||++||++.+
T Consensus       169 ~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             HHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            998888899999999999999999998887533211  110000000123345667889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.93  E-value=2.3e-25  Score=173.22  Aligned_cols=153  Identities=30%  Similarity=0.396  Sum_probs=119.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++++|||++............ ...++..|++||.
T Consensus       100 ~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~  175 (258)
T smart00219      100 LSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPES  175 (258)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHH
Confidence            688899999999999999999999   999999999999999999999999998776544322211 1235678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+|+||+++++|++ |..|+.....     .+.....  ...+...+..+.+++.+||+.+|++||++.+
T Consensus       176 ~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~  253 (258)
T smart00219      176 LKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--LPKPENCPPEIYKLMLQCWAEDPEDRPTFSE  253 (258)
T ss_pred             hccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--CCCCCcCCHHHHHHHHHHCcCChhhCcCHHH
Confidence            988888999999999999999998 5555532111     1111111  0123335677899999999999999999999


Q ss_pred             HHHHH
Q 028458          157 VVCML  161 (208)
Q Consensus       157 i~~~l  161 (208)
                      +++.|
T Consensus       254 ll~~l  258 (258)
T smart00219      254 LVEIL  258 (258)
T ss_pred             HHhhC
Confidence            98764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.93  E-value=1.6e-25  Score=181.30  Aligned_cols=152  Identities=24%  Similarity=0.390  Sum_probs=114.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC-CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.|+.|||+. +   ++|+||||+||+++.++.++|+|||++.......    .....++..|+||
T Consensus        99 ~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aP  171 (333)
T cd06650          99 RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSP  171 (333)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCH
Confidence            356778889999999999999975 5   9999999999999999999999999986543221    1223578899999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-cc----------------------------------CCccch
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-ID----------------------------------DPVLED  125 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-~~----------------------------------~~~~~~  125 (208)
                      |.+.+..++.++|+|||||++|++++|..|+...... ..                                  .+....
T Consensus       172 E~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (333)
T cd06650         172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAI  251 (333)
T ss_pred             HHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccH
Confidence            9998888999999999999999999988775422110 00                                  000000


Q ss_pred             -------------hhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          126 -------------EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       126 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                                   .......+.++.+|+.+||+.||++||++.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         252 FELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             HHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                         00000123567899999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.93  E-value=3.3e-25  Score=176.06  Aligned_cols=154  Identities=23%  Similarity=0.335  Sum_probs=117.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.++.|||+.+   ++|+|++|+||+++.++.++|+|||++.........  .....++..|+|||
T Consensus       106 ~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  180 (292)
T cd06644         106 GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR--RDSFIGTPYWMAPE  180 (292)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccccc--cceecCCccccCce
Confidence            3678899999999999999999998   999999999999999999999999987654322111  11234677899999


Q ss_pred             hhc-----cCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           82 YAI-----QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        82 ~~~-----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+.     ...++.++|+||||+++|+|++|..|+......     ...........+...+.++.+++.+||+.+|++|
T Consensus       181 ~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  260 (292)
T cd06644         181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETR  260 (292)
T ss_pred             eeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccC
Confidence            884     334678899999999999999998887543211     0001111111233445678899999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      |+++++++.
T Consensus       261 p~~~~il~~  269 (292)
T cd06644         261 PSAAQLLEH  269 (292)
T ss_pred             cCHHHHhcC
Confidence            999999763

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.92  E-value=1.3e-25  Score=177.44  Aligned_cols=151  Identities=25%  Similarity=0.393  Sum_probs=118.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.......    .....++..|+|||.
T Consensus        92 ~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~  164 (279)
T cd06619          92 IPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPER  164 (279)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCcee
Confidence            466778899999999999999999   9999999999999999999999999987653322    122456789999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCC-----------ccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDP-----------VLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      +.+..++.++|+||||+++|+|++|..|+..........           ...........+.++.+++.+||+.+|++|
T Consensus       165 ~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  244 (279)
T cd06619         165 ISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKER  244 (279)
T ss_pred             ecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhC
Confidence            988889999999999999999999988774322110000           000001122244578899999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      |+++++++.
T Consensus       245 p~~~eil~~  253 (279)
T cd06619         245 PAPENLMDH  253 (279)
T ss_pred             CCHHHHhcC
Confidence            999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.92  E-value=1.1e-25  Score=175.22  Aligned_cols=156  Identities=25%  Similarity=0.365  Sum_probs=118.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.++.|||+.+   ++|+||+|.||+++.++.++++|||.+........... ....++..|+|||.
T Consensus        97 ~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~~~aPe~  172 (256)
T cd05112          97 FSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS-TGTKFPVKWSSPEV  172 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccccc-CCCccchhhcCHhH
Confidence            577888999999999999999998   99999999999999999999999999876543322111 11223568999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--cccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--LIDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      +.++.++.++|+|+||+++|++++ |..|+.....  ....... .....+...+..+.+++.+||+.+|++||++.+++
T Consensus       173 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l  252 (256)
T cd05112         173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLL  252 (256)
T ss_pred             hccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence            988889999999999999999997 6666643211  1110000 00011122346788999999999999999999999


Q ss_pred             HHHh
Q 028458          159 CMLT  162 (208)
Q Consensus       159 ~~l~  162 (208)
                      +.|.
T Consensus       253 ~~l~  256 (256)
T cd05112         253 HQLA  256 (256)
T ss_pred             HhhC
Confidence            8873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.92  E-value=1.5e-25  Score=174.51  Aligned_cols=151  Identities=25%  Similarity=0.329  Sum_probs=118.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.|+.|||+.+   ++|+|++|.||+++.++.++++|||++........     ....+..|.|||.
T Consensus        97 ~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~y~~pe~  168 (254)
T cd05083          97 VSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-----NSKLPVKWTAPEA  168 (254)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCC-----CCCCCceecCHHH
Confidence            678888999999999999999998   99999999999999999999999999875432211     1123467999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.+.|+||||+++|+|++ |..|+.....     .+... ... ..+...+..+.+++.+||+.+|++||++++
T Consensus       169 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  246 (254)
T cd05083         169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRM-EPPEGCPADVYVLMTSCWETEPKKRPSFHK  246 (254)
T ss_pred             hccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CCC-CCCCcCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            988889999999999999999997 6666532211     11100 000 123345567889999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      +++.|++
T Consensus       247 l~~~l~~  253 (254)
T cd05083         247 LREKLEK  253 (254)
T ss_pred             HHHHHcc
Confidence            9999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=9.1e-25  Score=161.24  Aligned_cols=146  Identities=19%  Similarity=0.160  Sum_probs=114.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|++.++..++.|++.||.|||+.+         ||.||+++.++.+++  ||++.......       ..++..|+|||
T Consensus        13 ~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~aPE   74 (176)
T smart00750       13 PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMAPE   74 (176)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-------CCCcccccChH
Confidence            4899999999999999999999984         999999999999998  99887654321       24678999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc------CCccc----hhhhhHHHHH--HHHHHHhhccccCCC
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID------DPVLE----DEYSSKQMLL--RYVNIALLCVQESAD  149 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------~~~~~----~~~~~~~~~~--~~~~li~~~l~~~p~  149 (208)
                      .+.+..++.++||||||+++|+|++|..|+........      .....    ..........  .+.+++.+||+.+|+
T Consensus        75 ~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~  154 (176)
T smart00750       75 VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQ  154 (176)
T ss_pred             HhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccc
Confidence            99999999999999999999999999988754322110      00000    0011222333  689999999999999


Q ss_pred             CCCCHHHHHHHHhhhh
Q 028458          150 DRPTMNDVVCMLTNEA  165 (208)
Q Consensus       150 ~Rps~~~i~~~l~~~~  165 (208)
                      +||++.++++.+....
T Consensus       155 ~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      155 RREAANHYLAHCRALF  170 (176)
T ss_pred             cccCHHHHHHHHHHHH
Confidence            9999999999876653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.92  E-value=8.7e-26  Score=182.16  Aligned_cols=148  Identities=26%  Similarity=0.311  Sum_probs=115.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++........  ......|+..|+|||
T Consensus        97 ~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE  171 (323)
T cd05615          97 KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPE  171 (323)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCHH
Confidence            4678899999999999999999999   99999999999999999999999999865322211  112245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......  ...........+...+..+.+++.+||+.+|.+|++.
T Consensus       172 ~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            998888999999999999999999999887543211  1100000001233455678899999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.92  E-value=2e-25  Score=177.57  Aligned_cols=153  Identities=22%  Similarity=0.299  Sum_probs=118.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.++..++.|++.|+.|||+.+   ++|+||+|.||+++.++.++++|||++.........  .....++..|+|||.
T Consensus       115 l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~  189 (292)
T cd06658         115 MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEV  189 (292)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--CceeecCccccCHHH
Confidence            578889999999999999999998   999999999999999999999999988654322211  122356788999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccC--Cccch-hhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDD--PVLED-EYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~--~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +.+..++.++|+||||+++|++++|..|+......  ...  ..... .......+..+.+++.+||..||++||+++++
T Consensus       190 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i  269 (292)
T cd06658         190 ISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQEL  269 (292)
T ss_pred             HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHH
Confidence            98888899999999999999999998876532211  000  00000 01112345568899999999999999999999


Q ss_pred             HHH
Q 028458          158 VCM  160 (208)
Q Consensus       158 ~~~  160 (208)
                      ++.
T Consensus       270 l~~  272 (292)
T cd06658         270 LQH  272 (292)
T ss_pred             hhC
Confidence            975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.92  E-value=2.1e-25  Score=177.82  Aligned_cols=154  Identities=22%  Similarity=0.337  Sum_probs=120.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.|+.|||+.+   ++|+||+|.||+++.++.++++|||++.........  .....++..|+|||
T Consensus       111 ~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  185 (296)
T cd06655         111 CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPE  185 (296)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCCccccCcc
Confidence            3688899999999999999999999   999999999999999999999999987654332211  12235677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+||||+++|++++|..|+......     ...........+...+..+.++|.+||..||++||++.+
T Consensus       186 ~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~  265 (296)
T cd06655         186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKE  265 (296)
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHH
Confidence            998888899999999999999999998877543221     000001010123334567889999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       266 il~~  269 (296)
T cd06655         266 LLQH  269 (296)
T ss_pred             HhhC
Confidence            9974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.92  E-value=2.7e-25  Score=178.05  Aligned_cols=152  Identities=21%  Similarity=0.280  Sum_probs=114.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++.........  .....++..|.|||.
T Consensus       101 ~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~  175 (309)
T cd07872         101 MSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDV  175 (309)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCccc--cccccccccccCCHH
Confidence            677888999999999999999999   999999999999999999999999998754322211  112345788999998


Q ss_pred             hcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccc--c---c----cCC-----------------ccch------hhhh
Q 028458           83 AIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--L---I----DDP-----------------VLED------EYSS  129 (208)
Q Consensus        83 ~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~---~----~~~-----------------~~~~------~~~~  129 (208)
                      +.+ ..++.++|+||||+++|+|++|..++.....  .   +    ..+                 ....      ....
T Consensus       176 ~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (309)
T cd07872         176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHA  255 (309)
T ss_pred             HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhc
Confidence            865 4578999999999999999999876632211  0   0    000                 0000      0001


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ...+..+.++|.+||+.||.+||+++|+++
T Consensus       256 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         256 PRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             cCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            123456789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-25  Score=178.43  Aligned_cols=152  Identities=26%  Similarity=0.350  Sum_probs=116.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC------CCeEEeccccceecCCCcccccccccccCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD------MNPKISDFGMARICGGNELQANTSRIVGTY   75 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~   75 (208)
                      .++..++..++.|++.|+++||+++   |+||||||.||++...      ..+||+|||+++...+...   ..+..|++
T Consensus       105 ~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~---a~tlcGSp  178 (429)
T KOG0595|consen  105 RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM---AETLCGSP  178 (429)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH---HHHhhCCc
Confidence            4678899999999999999999999   9999999999999764      5689999999998764443   33468999


Q ss_pred             CccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccc--c---cccCCccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           76 GYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL--E---LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        76 ~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      -|+|||++....|+.++|+||+|+++|++++|..|+....  +   .++...-.....+......+.+++...++.++.+
T Consensus       179 lYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~  258 (429)
T KOG0595|consen  179 LYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKD  258 (429)
T ss_pred             cccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccc
Confidence            9999999999999999999999999999999998886221  1   1111111111233334445557777777888777


Q ss_pred             CCCHHHHHH
Q 028458          151 RPTMNDVVC  159 (208)
Q Consensus       151 Rps~~~i~~  159 (208)
                      |-++.+...
T Consensus       259 ~~~~~~~~~  267 (429)
T KOG0595|consen  259 RISFEDFFD  267 (429)
T ss_pred             cCchHHhhh
Confidence            776665443

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.92  E-value=3.6e-25  Score=173.57  Aligned_cols=154  Identities=23%  Similarity=0.295  Sum_probs=117.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-ccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......... .......++..|+||
T Consensus       102 ~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  178 (266)
T cd06651         102 ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP  178 (266)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCH
Confidence            3677888999999999999999998   999999999999999999999999998755322111 111223467889999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--cC--CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--DD--PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      |.+.+..++.++|+||||+++|++++|..|+.......  ..  ........+......+.+++ .||..+|++||+++|
T Consensus       179 E~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~e  257 (266)
T cd06651         179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEE  257 (266)
T ss_pred             HHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHH
Confidence            99988888999999999999999999988875432111  00  00001122344556677777 688899999999999


Q ss_pred             HHH
Q 028458          157 VVC  159 (208)
Q Consensus       157 i~~  159 (208)
                      +++
T Consensus       258 il~  260 (266)
T cd06651         258 LLR  260 (266)
T ss_pred             Hhc
Confidence            975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=3e-25  Score=173.16  Aligned_cols=153  Identities=24%  Similarity=0.333  Sum_probs=118.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++..++..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++........  ......++..|.+||
T Consensus        97 ~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe  171 (262)
T cd06613          97 PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPE  171 (262)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCch
Confidence            3677888999999999999999998   99999999999999999999999998866533211  111234677899999


Q ss_pred             hhccC---CCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccc--hhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           82 YAIQG---IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLE--DEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        82 ~~~~~---~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+.+.   .++.++|+|+||+++|+|++|..|+......     .......  ........+..+.+++.+||+.+|.+|
T Consensus       172 ~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  251 (262)
T cd06613         172 VAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR  251 (262)
T ss_pred             hhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhC
Confidence            98776   7889999999999999999998876543211     0001000  001233456778999999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      |++.+++.
T Consensus       252 pt~~~il~  259 (262)
T cd06613         252 PTATKLLQ  259 (262)
T ss_pred             CCHHHHhc
Confidence            99999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.92  E-value=4.7e-25  Score=171.37  Aligned_cols=173  Identities=23%  Similarity=0.258  Sum_probs=124.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+...++..+..|+++|++|||.++   |+|||||++|+++...|.+|++|||+++.+++...  ..+..+-|..|+|||
T Consensus       173 ~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k--~~T~lVVTLWYRaPE  247 (419)
T KOG0663|consen  173 PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK--PYTPLVVTLWYRAPE  247 (419)
T ss_pred             CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCcc--cCcceEEEeeecCHH
Confidence            3566788899999999999999999   99999999999999999999999999998876532  233356689999999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcC--------------------------CcccccccCCc--------cchh
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTS--------------------------NRTLELIDDPV--------LEDE  126 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~--------------------------~~~~~~~~~~~--------~~~~  126 (208)
                      .+.+.+ |+...|+||+||++.|++.+.+-+                          .......+...        +...
T Consensus       248 LLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~k  327 (419)
T KOG0663|consen  248 LLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKK  327 (419)
T ss_pred             HhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhh
Confidence            998755 899999999999999996443211                          11111111000        1110


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HhhhhhccCCCCCCCcccc
Q 028458          127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEAATLLPPKQPAFSYV  179 (208)
Q Consensus       127 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~~~~~~p~~~~~~~~  179 (208)
                      .......+.-.+++..++..||.+|.|+.|.++.  +.......+|.--|.++..
T Consensus       328 F~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k  382 (419)
T KOG0663|consen  328 FGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAK  382 (419)
T ss_pred             ccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccc
Confidence            1111133567789999999999999999999874  5544333333333444433

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.92  E-value=2.9e-25  Score=175.42  Aligned_cols=153  Identities=24%  Similarity=0.296  Sum_probs=114.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||
T Consensus        97 ~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  171 (285)
T cd07861          97 YMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV--YTHEVVTLWYRAPE  171 (285)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc--ccCCcccccccChH
Confidence            3678889999999999999999999   999999999999999999999999998755322211  11224567899999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccc---------cCC---------cc----------ch---hhhh
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------DDP---------VL----------ED---EYSS  129 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~~~---------~~----------~~---~~~~  129 (208)
                      .+.+. .++.++|+||||+++|+|++|..++.......         ...         ..          ..   ....
T Consensus       172 ~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (285)
T cd07861         172 VLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAV  251 (285)
T ss_pred             HhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhc
Confidence            88654 46889999999999999999987664321100         000         00          00   0001


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ...+.++.++|.+||+.||++||++++++.
T Consensus       252 ~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         252 KNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            123456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.92  E-value=1.6e-25  Score=177.38  Aligned_cols=152  Identities=28%  Similarity=0.453  Sum_probs=117.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC-CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||+|||+. +   ++|+||+|+||+++.++.++++|||++.........   ....++..|+||
T Consensus       103 ~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aP  176 (288)
T cd06616         103 VIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAP  176 (288)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc---ccccCccCccCH
Confidence            367788899999999999999975 7   999999999999999999999999998654322211   122467789999


Q ss_pred             chhccC---CCCCcchhHHHHHHHHHHHHhhhcCCccccc---cc------CCccchhhhhHHHHHHHHHHHhhccccCC
Q 028458           81 EYAIQG---IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---ID------DPVLEDEYSSKQMLLRYVNIALLCVQESA  148 (208)
Q Consensus        81 e~~~~~---~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p  148 (208)
                      |.+.+.   .++.++|+||||+++|++++|..|+......   ..      .+.+.. ......+..+.+++.+||+.+|
T Consensus       177 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p  255 (288)
T cd06616         177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSN-SEEREFSPSFVNFINLCLIKDE  255 (288)
T ss_pred             HHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCC-cCCCccCHHHHHHHHHHccCCh
Confidence            998766   5789999999999999999998887533211   10      011111 1122356678999999999999


Q ss_pred             CCCCCHHHHHHH
Q 028458          149 DDRPTMNDVVCM  160 (208)
Q Consensus       149 ~~Rps~~~i~~~  160 (208)
                      ++||+++++++.
T Consensus       256 ~~Rpt~~~i~~~  267 (288)
T cd06616         256 SKRPKYKELLEH  267 (288)
T ss_pred             hhCcCHHHHhcC
Confidence            999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.92  E-value=2.2e-25  Score=174.86  Aligned_cols=158  Identities=25%  Similarity=0.390  Sum_probs=121.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccc-cccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~~~~ap   80 (208)
                      .+++.+++.++.|++.|+.|||+++   ++|+||+|.||+++.++.++++|||++............ ....++..|.+|
T Consensus       102 ~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~p  178 (267)
T cd05066         102 QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP  178 (267)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCH
Confidence            3678889999999999999999999   999999999999999999999999998766433221111 111224579999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++|+|+||+++|++++ |..|+.....     .+.+. .. .......+..+.+++.+||+.+|++||++
T Consensus       179 e~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  256 (267)
T cd05066         179 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YR-LPAPMDCPAALHQLMLDCWQKDRNERPKF  256 (267)
T ss_pred             hHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-Cc-CCCCCCCCHHHHHHHHHHcccCchhCCCH
Confidence            99988889999999999999999875 7776643211     11111 00 01122345678899999999999999999


Q ss_pred             HHHHHHHhhh
Q 028458          155 NDVVCMLTNE  164 (208)
Q Consensus       155 ~~i~~~l~~~  164 (208)
                      .++++.|.+.
T Consensus       257 ~~i~~~l~~~  266 (267)
T cd05066         257 EQIVSILDKL  266 (267)
T ss_pred             HHHHHHHHhh
Confidence            9999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.92  E-value=4.4e-26  Score=184.20  Aligned_cols=154  Identities=20%  Similarity=0.322  Sum_probs=117.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++......... ......++..|+|||
T Consensus        98 ~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE  173 (330)
T cd05601          98 QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPE  173 (330)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHH
Confidence            3677888899999999999999999   999999999999999999999999998766433221 112235788999999


Q ss_pred             hhc------cCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c----cCCccchhhhhHHHHHHHHHHHhhccccCCC
Q 028458           82 YAI------QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I----DDPVLEDEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        82 ~~~------~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      .+.      ...++.++|+||||+++|+|++|..|+......  .    ..............+..+.+++..||+ +|.
T Consensus       174 ~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~  252 (330)
T cd05601         174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQK  252 (330)
T ss_pred             HhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-Chh
Confidence            986      345778999999999999999999887533211  0    000000001112345678899999998 999


Q ss_pred             CCCCHHHHHHH
Q 028458          150 DRPTMNDVVCM  160 (208)
Q Consensus       150 ~Rps~~~i~~~  160 (208)
                      +||++++++..
T Consensus       253 ~R~t~~~l~~h  263 (330)
T cd05601         253 ERLGYEGLCCH  263 (330)
T ss_pred             hCCCHHHHhCC
Confidence            99999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.92  E-value=1.5e-25  Score=176.95  Aligned_cols=152  Identities=23%  Similarity=0.316  Sum_probs=116.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|+++|+.|||+.+   ++|+|++|.||+++.++.++++|||++........  ......++..|+|||.
T Consensus       118 ~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~  192 (282)
T cd06636         118 LKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEV  192 (282)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhh
Confidence            566778899999999999999999   99999999999999999999999998765432211  1122456788999998


Q ss_pred             hc-----cCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccC----CccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           83 AI-----QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        83 ~~-----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      +.     ...++.++|+||||+++|+|++|..|+.........    ............+..+.++|.+||+.||.+||+
T Consensus       193 l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~  272 (282)
T cd06636         193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPS  272 (282)
T ss_pred             cCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcC
Confidence            75     345788999999999999999998887543211100    001111122345678899999999999999999


Q ss_pred             HHHHHH
Q 028458          154 MNDVVC  159 (208)
Q Consensus       154 ~~~i~~  159 (208)
                      +.|+++
T Consensus       273 ~~ell~  278 (282)
T cd06636         273 TEQLLK  278 (282)
T ss_pred             HHHHhc
Confidence            999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.92  E-value=1.8e-25  Score=178.29  Aligned_cols=154  Identities=22%  Similarity=0.314  Sum_probs=119.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++.........  .....++..|+|||
T Consensus       113 ~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  187 (297)
T cd06659         113 RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPE  187 (297)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccceecCccccCHH
Confidence            4678889999999999999999999   999999999999999999999999988654332211  12245678999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+||||+++++|++|..|+......     +..............+..+.+++.+||+.+|++||++++
T Consensus       188 ~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~  267 (297)
T cd06659         188 VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQE  267 (297)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence            998888999999999999999999998876432211     110000110112234566889999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       268 ll~~  271 (297)
T cd06659         268 LLDH  271 (297)
T ss_pred             HhhC
Confidence            9984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.92  E-value=1.8e-25  Score=177.20  Aligned_cols=151  Identities=26%  Similarity=0.299  Sum_probs=119.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++.........   ....|+..|+|||.
T Consensus        99 l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~  172 (285)
T cd05630          99 FEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGTVGYMAPEV  172 (285)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc---cCCCCCccccChHH
Confidence            677788999999999999999998   999999999999999999999999998665322211   12357889999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCcc------chhhhhHHHHHHHHHHHhhccccCCCCCCC---
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVL------EDEYSSKQMLLRYVNIALLCVQESADDRPT---  153 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---  153 (208)
                      +.+..++.++|+||||+++|+|++|..|+............      .........+..+.+++.+||+.||++||+   
T Consensus       173 ~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~  252 (285)
T cd05630         173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQG  252 (285)
T ss_pred             HcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCC
Confidence            99888999999999999999999999887643221100000      000122334567889999999999999999   


Q ss_pred             --HHHHHH
Q 028458          154 --MNDVVC  159 (208)
Q Consensus       154 --~~~i~~  159 (208)
                        ++|+++
T Consensus       253 ~~~~~~~~  260 (285)
T cd05630         253 GGAREVKE  260 (285)
T ss_pred             CchHHHHc
Confidence              888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.92  E-value=5.3e-25  Score=173.56  Aligned_cols=153  Identities=25%  Similarity=0.374  Sum_probs=119.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++........  ......++..|.|||.
T Consensus        98 ~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~  172 (277)
T cd06642          98 LEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEV  172 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHH
Confidence            577888999999999999999998   99999999999999999999999999876543221  1122346778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCcc---chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVL---EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      +.+..++.++|+||||++++++++|..|+............   .........+..+.+++.+||+.+|++||++.++++
T Consensus       173 ~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             hCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            98888899999999999999999998876533211100000   000122334567889999999999999999999998


Q ss_pred             H
Q 028458          160 M  160 (208)
Q Consensus       160 ~  160 (208)
                      .
T Consensus       253 ~  253 (277)
T cd06642         253 H  253 (277)
T ss_pred             h
Confidence            4

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.92  E-value=2.7e-25  Score=174.91  Aligned_cols=156  Identities=24%  Similarity=0.305  Sum_probs=119.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.+|.|||+.+   ++|+||+|+||+++.++.++++|||++.......... .....++..|++||
T Consensus       113 ~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~y~~PE  188 (275)
T cd05046         113 PLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK-LRNALIPLRWLAPE  188 (275)
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccccCcccccc-cCCceeEEeecChh
Confidence            4788999999999999999999999   9999999999999999999999999876443222111 11224456799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--cc---cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--LI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|++++ +..++.....  ..   ....... ......+..+.+++.+||+.+|++||++.
T Consensus       189 ~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~  267 (275)
T cd05046         189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL-PVPEGCPSRLYKLMTRCWAVNPKDRPSFS  267 (275)
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC-CCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence            9888888899999999999999998 5556533211  10   0001111 11223456788999999999999999999


Q ss_pred             HHHHHHh
Q 028458          156 DVVCMLT  162 (208)
Q Consensus       156 ~i~~~l~  162 (208)
                      ++++.|.
T Consensus       268 ~~l~~l~  274 (275)
T cd05046         268 ELVSALG  274 (275)
T ss_pred             HHHHHhc
Confidence            9999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.92  E-value=2.7e-25  Score=174.17  Aligned_cols=155  Identities=24%  Similarity=0.342  Sum_probs=116.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|+++|+.|||+.+   ++|+|++|.||+++.++.++++|||++........  ......++..|+|||
T Consensus       102 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE  176 (267)
T cd06646         102 PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPE  176 (267)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHh
Confidence            3577888999999999999999998   99999999999999999999999999876532211  111235677899999


Q ss_pred             hhc---cCCCCCcchhHHHHHHHHHHHHhhhcCCcccc-----cccCCccchh--hhhHHHHHHHHHHHhhccccCCCCC
Q 028458           82 YAI---QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE-----LIDDPVLEDE--YSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        82 ~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+.   ...++.++|+||||+++|+|++|..|+.....     ..........  ......+..+.+++.+||+.+|++|
T Consensus       177 ~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  256 (267)
T cd06646         177 VAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKR  256 (267)
T ss_pred             HcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhC
Confidence            874   33467899999999999999998876532211     1111111110  1122345678999999999999999


Q ss_pred             CCHHHHHHHH
Q 028458          152 PTMNDVVCML  161 (208)
Q Consensus       152 ps~~~i~~~l  161 (208)
                      |+++++++.|
T Consensus       257 p~~~~il~~l  266 (267)
T cd06646         257 PTAERLLTHL  266 (267)
T ss_pred             cCHHHHhcCC
Confidence            9999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.92  E-value=5.8e-25  Score=172.08  Aligned_cols=153  Identities=22%  Similarity=0.243  Sum_probs=113.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.|++.||.|||+.+   |+||||||.|++++.+|.+|++|||++.-......  .....++|..|+|||+
T Consensus       117 ~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEv  191 (323)
T KOG0594|consen  117 LPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEV  191 (323)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCcc--cccccEEEeeccCHHH
Confidence            455678999999999999999999   99999999999999999999999999975432221  1233467889999999


Q ss_pred             hccC-CCCCcchhHHHHHHHHHHHHhhhcC--Ccc------------------------cccccC--Cccc-hhhhhHHH
Q 028458           83 AIQG-IFSIKSDVFSFGVLLLEIAWDLWTS--NRT------------------------LELIDD--PVLE-DEYSSKQM  132 (208)
Q Consensus        83 ~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~--~~~------------------------~~~~~~--~~~~-~~~~~~~~  132 (208)
                      +.+. .|+...|+||+||++.||+++..-|  ...                        ....+.  +... ........
T Consensus       192 LlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~  271 (323)
T KOG0594|consen  192 LLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSIL  271 (323)
T ss_pred             hcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhc
Confidence            9887 5899999999999999997543211  111                        001110  0000 00111111


Q ss_pred             ---HHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          133 ---LLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       133 ---~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                         ..+..+++.+||+.+|.+|.|++.++..
T Consensus       272 ~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  272 PKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence               1367889999999999999999999885

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.92  E-value=8.9e-25  Score=172.66  Aligned_cols=153  Identities=22%  Similarity=0.267  Sum_probs=116.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.+|.|||+.+   ++|+||+|.||+++.++.++++|||++.........  .....++..|.+||
T Consensus        96 ~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE  170 (286)
T cd07847          96 GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--YTDYVATRWYRAPE  170 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCccc--ccCcccccccCCHH
Confidence            3688899999999999999999998   999999999999999999999999998776433211  11234567899999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---c---------------------CCccch-------hh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---D---------------------DPVLED-------EY  127 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---~---------------------~~~~~~-------~~  127 (208)
                      .+.+ ..++.++|+||||+++|+|++|..|+......  .   .                     ....+.       ..
T Consensus       171 ~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (286)
T cd07847         171 LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLES  250 (286)
T ss_pred             HHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHH
Confidence            9876 44788999999999999999998766422110  0   0                     000000       00


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .....+..+.+++.+||+.+|++||++.+++.
T Consensus       251 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         251 KFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            11234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.92  E-value=4e-25  Score=175.21  Aligned_cols=153  Identities=27%  Similarity=0.305  Sum_probs=119.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++........   .....++..|+|||
T Consensus        98 ~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE  171 (285)
T cd05632          98 GFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPE  171 (285)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChH
Confidence            3778899999999999999999999   99999999999999999999999998866432221   11235788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----cCCccc-hhhhhHHHHHHHHHHHhhccccCCCCCCC--
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----DDPVLE-DEYSSKQMLLRYVNIALLCVQESADDRPT--  153 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps--  153 (208)
                      .+.+..++.++|+||||+++|++++|..|+.......     ...... ........+..+.+|+..||+.||++||+  
T Consensus       172 ~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             HhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence            9988889999999999999999999988875432211     000000 00122334567889999999999999999  


Q ss_pred             ---HHHHHHH
Q 028458          154 ---MNDVVCM  160 (208)
Q Consensus       154 ---~~~i~~~  160 (208)
                         +++++..
T Consensus       252 ~~~~~~l~~~  261 (285)
T cd05632         252 EEGAGEVKRH  261 (285)
T ss_pred             ccChHHHHcC
Confidence               6677663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.8e-25  Score=187.67  Aligned_cols=150  Identities=29%  Similarity=0.364  Sum_probs=121.0

Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC-CCCCeEEeccccceecCCCcccccccccccCCCccCcchh
Q 028458            5 WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA   83 (208)
Q Consensus         5 ~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~   83 (208)
                      ..++--+..||++||.|||.+.   |||||||-+|++++ -.|.+|++|||-+.+...-  .....++.|+..|+|||++
T Consensus       674 Estm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTGTLQYMAPEvI  748 (1226)
T KOG4279|consen  674 ESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVI  748 (1226)
T ss_pred             hhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--CccccccccchhhhChHhh
Confidence            3455667899999999999998   99999999999996 4689999999988765322  2234457899999999999


Q ss_pred             ccCC--CCCcchhHHHHHHHHHHHHhhhcCCcccccc---cCC---ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           84 IQGI--FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---DDP---VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        84 ~~~~--~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      ..++  |+..+|||||||++.||++|++||......-   -+.   ...+ ..+.+++.+...||.+|...+|.+||++.
T Consensus       749 DqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP-~iPeelsaeak~FilrcFepd~~~R~sA~  827 (1226)
T KOG4279|consen  749 DQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHP-PIPEELSAEAKNFILRCFEPDPCDRPSAK  827 (1226)
T ss_pred             ccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCC-CCcHHHHHHHHHHHHHHcCCCcccCccHH
Confidence            8765  8999999999999999999999986543321   101   1111 45777888999999999999999999999


Q ss_pred             HHHHH
Q 028458          156 DVVCM  160 (208)
Q Consensus       156 ~i~~~  160 (208)
                      ++++.
T Consensus       828 ~LL~D  832 (1226)
T KOG4279|consen  828 DLLQD  832 (1226)
T ss_pred             HhccC
Confidence            99985

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-25  Score=186.39  Aligned_cols=153  Identities=26%  Similarity=0.372  Sum_probs=123.7

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchh
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA   83 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~   83 (208)
                      +-.-.+.|+.||.+|++||.+++   +|||||..+|+++..+..+|++|||+++++....+.....- .=++-|+|||.+
T Consensus       363 ~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGA-KFPIKWTAPEsL  438 (1157)
T KOG4278|consen  363 PAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGA-KFPIKWTAPESL  438 (1157)
T ss_pred             chhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCc-cCcccccCcccc
Confidence            33455789999999999999999   99999999999999999999999999999866554333221 115689999999


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHHhhh---cCCcccccc---c-CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           84 IQGIFSIKSDVFSFGVLLLEIAWDLW---TSNRTLELI---D-DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        84 ~~~~~~~~~Dv~slG~~~~~l~~~~~---~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      ....++.++|||+||+++||+++-.+   |..+..+..   + ...+   ..+..++..+++|++.||+.+|.+||+++|
T Consensus       439 AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM---~~PeGCPpkVYeLMraCW~WsPsDRPsFae  515 (1157)
T KOG4278|consen  439 AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM---DGPEGCPPKVYELMRACWNWSPSDRPSFAE  515 (1157)
T ss_pred             cccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc---cCCCCCCHHHHHHHHHHhcCCcccCccHHH
Confidence            99999999999999999999998543   333332222   1 1222   346778889999999999999999999999


Q ss_pred             HHHHHhh
Q 028458          157 VVCMLTN  163 (208)
Q Consensus       157 i~~~l~~  163 (208)
                      |.+.++.
T Consensus       516 iHqafEt  522 (1157)
T KOG4278|consen  516 IHQAFET  522 (1157)
T ss_pred             HHHHHHH
Confidence            9998876

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.92  E-value=5.9e-25  Score=174.45  Aligned_cols=154  Identities=25%  Similarity=0.313  Sum_probs=116.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++..........  ....++..|+|||
T Consensus       124 ~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE  198 (291)
T cd06639         124 RLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPE  198 (291)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccccc--cCccCCccccChh
Confidence            4678889999999999999999998   9999999999999999999999999987654322211  1234677899999


Q ss_pred             hhccCC-----CCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           82 YAIQGI-----FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        82 ~~~~~~-----~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+....     ++.++|+||||+++|+|++|..|+......     ...........+......+.++|.+||+.+|++|
T Consensus       199 ~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  278 (291)
T cd06639         199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEAR  278 (291)
T ss_pred             hhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhC
Confidence            875432     578999999999999999998776543211     1101111111123344568899999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      |++.++++.
T Consensus       279 ps~~~il~~  287 (291)
T cd06639         279 PSVTHLLEH  287 (291)
T ss_pred             cCHHHHhcC
Confidence            999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.92  E-value=1.5e-24  Score=170.94  Aligned_cols=153  Identities=22%  Similarity=0.229  Sum_probs=118.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++++|||.+........  ......++..|.+||
T Consensus        94 ~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE  168 (283)
T cd05118          94 GLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPE  168 (283)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCcH
Confidence            4678899999999999999999999   99999999999999999999999999877654331  111234567899999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccc--c-------ccC-----------------------Cccchhhh
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--L-------IDD-----------------------PVLEDEYS  128 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~-------~~~-----------------------~~~~~~~~  128 (208)
                      .+.+. .++.++|+|+||+++|++++|..++.....  .       ...                       ........
T Consensus       169 ~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (283)
T cd05118         169 LLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKL  248 (283)
T ss_pred             HHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHh
Confidence            98776 678999999999999999998765532111  0       000                       00000112


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ....+.++.++|.+||+.||.+||++.+++.
T Consensus       249 ~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         249 FPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            2345678999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.92  E-value=1.8e-24  Score=170.83  Aligned_cols=151  Identities=25%  Similarity=0.275  Sum_probs=117.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+.+   ++|+|++|+||+++.++.++++|||++.........   ....++..|+|||.
T Consensus       104 l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~  177 (287)
T cd07838         104 LPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEV  177 (287)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCccc---ccccccccccChHH
Confidence            688899999999999999999998   999999999999999999999999998765433211   11245778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------cc-----------------------CCccchhhhhHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------ID-----------------------DPVLEDEYSSKQML  133 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~-----------------------~~~~~~~~~~~~~~  133 (208)
                      +.+..++.++|+||||+++|+|+++..++......      ..                       ..............
T Consensus       178 ~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (287)
T cd07838         178 LLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEIC  257 (287)
T ss_pred             hccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhh
Confidence            98888999999999999999999887665322110      00                       00000001123445


Q ss_pred             HHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          134 LRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       134 ~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ..+.+++.+||+.||++||++++++.
T Consensus       258 ~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         258 EEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HHHHHHHHHHhccCCccCCCHHHHhc
Confidence            67889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=3.4e-26  Score=184.96  Aligned_cols=153  Identities=20%  Similarity=0.266  Sum_probs=114.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.||++||.|||+++   ++||||||+||+++.++.++|+|||++........  ......|+..|+|||
T Consensus        92 ~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE  166 (330)
T cd05586          92 RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPE  166 (330)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHH
Confidence            3677888999999999999999999   99999999999999999999999999865322211  122345788999999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchh-hhhHHHHHHHHHHHhhccccCCCCCC----C
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDE-YSSKQMLLRYVNIALLCVQESADDRP----T  153 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp----s  153 (208)
                      .+.+.. ++.++|+||||+++|+|++|..|+.....  .......... ......+..+.+++.+||+.||++||    +
T Consensus       167 ~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~  246 (330)
T cd05586         167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRD  246 (330)
T ss_pred             HHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCC
Confidence            987544 78999999999999999999888643211  1110000000 11122456788999999999999998    4


Q ss_pred             HHHHHH
Q 028458          154 MNDVVC  159 (208)
Q Consensus       154 ~~~i~~  159 (208)
                      +.++++
T Consensus       247 ~~~ll~  252 (330)
T cd05586         247 AVELKE  252 (330)
T ss_pred             HHHHhc
Confidence            666655

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.92  E-value=2.9e-25  Score=182.32  Aligned_cols=154  Identities=21%  Similarity=0.231  Sum_probs=117.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.|++.||.|||+.+   |+||||||.||+++.++.++|+|||++......... ......|++.|+|||.
T Consensus       139 l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~  214 (370)
T cd05596         139 IPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEV  214 (370)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHH
Confidence            566778889999999999999999   999999999999999999999999998765432211 1123467899999999


Q ss_pred             hccC----CCCCcchhHHHHHHHHHHHHhhhcCCccccc-----c-cCCccchhhhhHHHHHHHHHHHhhccccCCCC--
Q 028458           83 AIQG----IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----I-DDPVLEDEYSSKQMLLRYVNIALLCVQESADD--  150 (208)
Q Consensus        83 ~~~~----~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--  150 (208)
                      +.+.    .++.++|+|||||++|+|++|..|+......     + ..............+..+.++|.+||+.+|++  
T Consensus       215 ~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~  294 (370)
T cd05596         215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLG  294 (370)
T ss_pred             hccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccC
Confidence            8653    3788999999999999999999887543221     1 10000000111234677889999999999988  


Q ss_pred             CCCHHHHHHH
Q 028458          151 RPTMNDVVCM  160 (208)
Q Consensus       151 Rps~~~i~~~  160 (208)
                      |++++++++.
T Consensus       295 R~s~~ell~h  304 (370)
T cd05596         295 RNGVDEIKSH  304 (370)
T ss_pred             CCCHHHHhcC
Confidence            9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.92  E-value=1.3e-24  Score=172.92  Aligned_cols=154  Identities=22%  Similarity=0.264  Sum_probs=115.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|.|||
T Consensus        98 ~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  172 (298)
T cd07841          98 VLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPE  172 (298)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--ccccccceeeeCHH
Confidence            4788999999999999999999999   999999999999999999999999998776443211  11123466799999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c-------cCC---------------------ccchhhhhH
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I-------DDP---------------------VLEDEYSSK  130 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~-------~~~---------------------~~~~~~~~~  130 (208)
                      .+.+ ..++.++|+|+||++++++++|..++......  .       ..+                     .........
T Consensus       173 ~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (298)
T cd07841         173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFP  252 (298)
T ss_pred             HHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcc
Confidence            8854 35688999999999999999885443211110  0       000                     000000112


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          131 QMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       131 ~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ..+..+.++|.+||+.+|++||+++|+++.
T Consensus       253 ~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         253 AASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            235678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=7.4e-25  Score=171.84  Aligned_cols=153  Identities=25%  Similarity=0.350  Sum_probs=116.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++........  ......++..|+|||
T Consensus       109 ~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE  183 (275)
T cd06608         109 RLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPE  183 (275)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcCccccccccCHh
Confidence            3677888999999999999999999   99999999999999999999999999876533221  112235678899999


Q ss_pred             hhccC-----CCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           82 YAIQG-----IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        82 ~~~~~-----~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+...     .++.++|+|+||+++|++++|..|+......     +..............+..+.+++.+||..||++|
T Consensus       184 ~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  263 (275)
T cd06608         184 VIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQR  263 (275)
T ss_pred             HhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhC
Confidence            87542     3678899999999999999998887533211     0101111111123355678999999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      |++.++++
T Consensus       264 pt~~~ll~  271 (275)
T cd06608         264 PFMEELLE  271 (275)
T ss_pred             cCHHHHhc
Confidence            99999976

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.92  E-value=5.5e-25  Score=170.04  Aligned_cols=152  Identities=26%  Similarity=0.376  Sum_probs=119.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.++.+||..+   ++|+||+|.||+++.++.++|+|||.+........   .....++..|++||
T Consensus        94 ~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE  167 (253)
T cd05122          94 TLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPE  167 (253)
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHH
Confidence            5788899999999999999999998   99999999999999999999999999877654332   12245678899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccc--cc---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL--EL---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.+.|+|+||++++++++|..|+....  ..   ...............+..+.+++.+||+.||++||++.+
T Consensus       168 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~  247 (253)
T cd05122         168 VINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ  247 (253)
T ss_pred             HHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHH
Confidence            9988888999999999999999999987765431  10   000001110111112567899999999999999999999


Q ss_pred             HHH
Q 028458          157 VVC  159 (208)
Q Consensus       157 i~~  159 (208)
                      +++
T Consensus       248 ~l~  250 (253)
T cd05122         248 LLK  250 (253)
T ss_pred             Hhc
Confidence            875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=4.9e-25  Score=173.42  Aligned_cols=152  Identities=26%  Similarity=0.379  Sum_probs=120.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|||++........  ......++..|++||
T Consensus        94 ~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE  168 (274)
T cd06609          94 KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPE  168 (274)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccChh
Confidence            3678889999999999999999998   99999999999999999999999999877654321  122245677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHH-HHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQ-MLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+|+||+++|++++|..|+......     +... ... ..... .+..+.+++.+||..+|++||+++
T Consensus       169 ~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~  246 (274)
T cd06609         169 VIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPP-SLEGNKFSKPFKDFVSLCLNKDPKERPSAK  246 (274)
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCC-CCcccccCHHHHHHHHHHhhCChhhCcCHH
Confidence            998888999999999999999999998887532211     0100 010 11111 566789999999999999999999


Q ss_pred             HHHHH
Q 028458          156 DVVCM  160 (208)
Q Consensus       156 ~i~~~  160 (208)
                      ++++.
T Consensus       247 ~il~~  251 (274)
T cd06609         247 ELLKH  251 (274)
T ss_pred             HHhhC
Confidence            99873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=4.2e-25  Score=174.21  Aligned_cols=152  Identities=21%  Similarity=0.286  Sum_probs=110.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC-------CeEEeccccceecCCCcccccccccccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-------NPKISDFGMARICGGNELQANTSRIVGT   74 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~   74 (208)
                      .+++..++.++.|++.||.|||+++   ++|+||||.||+++..+       .++++|||++.......      ...++
T Consensus       113 ~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~  183 (274)
T cd05076         113 RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERVER  183 (274)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCcccccccccc------ccccC
Confidence            3678889999999999999999998   99999999999997543       37999999875432211      12356


Q ss_pred             CCccCcchhcc-CCCCCcchhHHHHHHHHHHHH-hhhcCCcccccccCCccc-hhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           75 YGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLELIDDPVLE-DEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        75 ~~~~ape~~~~-~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      ..|+|||.+.+ ..++.++|+||||+++|++++ |..|+............. ....+......+.++|.+||+.+|++|
T Consensus       184 ~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R  263 (274)
T cd05076         184 IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQR  263 (274)
T ss_pred             CcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhC
Confidence            78999998865 457899999999999999964 555553221100000000 001111223468899999999999999


Q ss_pred             CCHHHHHHHHh
Q 028458          152 PTMNDVVCMLT  162 (208)
Q Consensus       152 ps~~~i~~~l~  162 (208)
                      |+++++++.|+
T Consensus       264 ps~~~il~~L~  274 (274)
T cd05076         264 PSFRTILRDLT  274 (274)
T ss_pred             cCHHHHHHhhC
Confidence            99999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.92  E-value=7.5e-25  Score=174.65  Aligned_cols=153  Identities=23%  Similarity=0.327  Sum_probs=120.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++++|||++.........  .....++..|.+||.
T Consensus       112 ~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~  186 (297)
T cd06656         112 MDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEV  186 (297)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC--cCcccCCccccCHHH
Confidence            567889999999999999999998   999999999999999999999999998765433221  112346778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +.+..++.++|+|+||+++|++++|..|+.......     ..........+...+..+.+++.+||+.+|++||+++++
T Consensus       187 ~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  266 (297)
T cd06656         187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKEL  266 (297)
T ss_pred             HcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            988888999999999999999999988774322110     000111111234455678899999999999999999999


Q ss_pred             HHH
Q 028458          158 VCM  160 (208)
Q Consensus       158 ~~~  160 (208)
                      ++.
T Consensus       267 l~~  269 (297)
T cd06656         267 LQH  269 (297)
T ss_pred             hcC
Confidence            983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.92  E-value=1.1e-24  Score=177.76  Aligned_cols=152  Identities=25%  Similarity=0.297  Sum_probs=116.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++........   .....++..|+|||.
T Consensus       115 l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~  188 (353)
T cd07850         115 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEV  188 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHH
Confidence            567788899999999999999999   99999999999999999999999999876543322   112346778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccC--------------------Cccchh-------
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDD--------------------PVLEDE-------  126 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~--------------------~~~~~~-------  126 (208)
                      +.+..++.++|+||||+++|+|++|..++......         ...                    ......       
T Consensus       189 ~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (353)
T cd07850         189 ILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFP  268 (353)
T ss_pred             HhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCc
Confidence            98888999999999999999999987665321100         000                    000000       


Q ss_pred             ---------hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          127 ---------YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       127 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                               ......+..+.++|.+||+.||++||++.|+++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         269 DVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             ccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                     0011234567899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.92  E-value=7.1e-25  Score=174.14  Aligned_cols=152  Identities=23%  Similarity=0.240  Sum_probs=115.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++++|||++.........  .....++..|+|||
T Consensus       102 ~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE  176 (293)
T cd07843         102 PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWYRAPE  176 (293)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCccc--cccccccccccCch
Confidence            3688899999999999999999999   999999999999999999999999998766543211  11234567899999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcCCccccc--c------------------------c--------CCccchh
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I------------------------D--------DPVLEDE  126 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~------------------------~--------~~~~~~~  126 (208)
                      .+.+.. ++.++|+||||+++|+|++|..++......  .                        .        ...+.. 
T Consensus       177 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  255 (293)
T cd07843         177 LLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRK-  255 (293)
T ss_pred             hhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhc-
Confidence            887544 688999999999999999987665422100  0                        0        000000 


Q ss_pred             hhhHH-HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          127 YSSKQ-MLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       127 ~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ..+.. +...+.++|++||+.+|++||+++|++.
T Consensus       256 ~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         256 KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00111 3566889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.92  E-value=1.2e-24  Score=171.61  Aligned_cols=153  Identities=25%  Similarity=0.380  Sum_probs=120.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.....++.|++.|+.|||+.+   ++|+||+|.||+++.++.++++|||++.........  .....++..|.|||.
T Consensus        98 l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~apE~  172 (277)
T cd06640          98 FDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEV  172 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCccc--cccccCcccccCHhH
Confidence            567788899999999999999998   999999999999999999999999998765433211  112346778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--cC-CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--DD-PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      +.+..++.++|+||||+++|+|++|..|+.......  .. ............+..+.+++.+||+.+|++||++.++++
T Consensus       173 ~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         173 IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             hccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence            988888999999999999999999988775322110  00 000111234456778899999999999999999999977


Q ss_pred             H
Q 028458          160 M  160 (208)
Q Consensus       160 ~  160 (208)
                      .
T Consensus       253 ~  253 (277)
T cd06640         253 H  253 (277)
T ss_pred             C
Confidence            5

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.92  E-value=1.3e-24  Score=174.03  Aligned_cols=154  Identities=25%  Similarity=0.285  Sum_probs=115.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++.........  .....++..|.|||
T Consensus       104 ~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  178 (309)
T cd07845         104 PFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPE  178 (309)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChh
Confidence            4678899999999999999999999   999999999999999999999999998776433211  11123466799999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c------------------------cCCccchh------hh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I------------------------DDPVLEDE------YS  128 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~------------------------~~~~~~~~------~~  128 (208)
                      .+.+ ..++.++|+||||+++|+|++|..++......  .                        ........      ..
T Consensus       179 ~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (309)
T cd07845         179 LLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHK  258 (309)
T ss_pred             hhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHh
Confidence            8865 44789999999999999999988765321110  0                        00000000      00


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ....+..+.++|.+||+.||++||++++++..
T Consensus       259 ~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         259 FPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             ccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            11135667899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.92  E-value=5.4e-25  Score=172.47  Aligned_cols=153  Identities=22%  Similarity=0.318  Sum_probs=115.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++..++..++.|++.++.|||+.+   ++|+||+|.||+++.++.++++|||++........  ......++..|+|||
T Consensus       102 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE  176 (267)
T cd06645         102 PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKSFIGTPYWMAPE  176 (267)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc--ccccccCcccccChh
Confidence            3677889999999999999999999   99999999999999999999999999876543221  112245788999999


Q ss_pred             hhc---cCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---cCCccchhh--hhHHHHHHHHHHHhhccccCCCCC
Q 028458           82 YAI---QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---DDPVLEDEY--SSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        82 ~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+.   ...++.++|+||||+++|+|+++..|+......  .   .........  .....+..+.+++.+||+.+|++|
T Consensus       177 ~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  256 (267)
T cd06645         177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR  256 (267)
T ss_pred             hhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhC
Confidence            874   345788999999999999999988776432210  0   000000000  011234568899999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      |+++++++
T Consensus       257 ~~~~~ll~  264 (267)
T cd06645         257 PTAEKLLQ  264 (267)
T ss_pred             cCHHHHhc
Confidence            99999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.92  E-value=1.1e-24  Score=176.00  Aligned_cols=155  Identities=20%  Similarity=0.281  Sum_probs=113.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc-cc----cccccccCCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL-QA----NTSRIVGTYG   76 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~----~~~~~~~~~~   76 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+++.||+.......... ..    ......++..
T Consensus        97 ~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (327)
T cd08227          97 GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP  173 (327)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceec
Confidence            3678899999999999999999999   99999999999999999999999976433211110 00    0111234667


Q ss_pred             ccCcchhcc--CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--------------ccCCccch---------------
Q 028458           77 YMSPEYAIQ--GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--------------IDDPVLED---------------  125 (208)
Q Consensus        77 ~~ape~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------------~~~~~~~~---------------  125 (208)
                      |+|||.+.+  ..++.++|+|||||++|+|++|..|+......              .+......               
T Consensus       174 y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T cd08227         174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSG  253 (327)
T ss_pred             ccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCC
Confidence            999999876  35889999999999999999998876432100              00000000               


Q ss_pred             -------------------hhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          126 -------------------EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       126 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                                         ..........+.+++.+||+.||++||+++++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         254 LGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             CCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                               0011123457889999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.92  E-value=9.1e-25  Score=170.76  Aligned_cols=155  Identities=30%  Similarity=0.466  Sum_probs=119.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc--cccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~a   79 (208)
                      .+++..+..++.|++.|+.+||+.+   ++|+|++|+||+++.++.++++|||++..........  ......++..|++
T Consensus        98 ~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~  174 (267)
T cd06610          98 GLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA  174 (267)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcC
Confidence            3678889999999999999999999   9999999999999999999999999987654332221  1122356788999


Q ss_pred             cchhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccc--c----cC--CccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           80 PEYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I----DD--PVLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        80 pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~----~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      ||.+... .++.++|+|+||+++++|++|..|+......  .    ..  ............+..+.+++.+||+.||++
T Consensus       175 Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  254 (267)
T cd06610         175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSK  254 (267)
T ss_pred             hHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhh
Confidence            9998776 6789999999999999999998887543211  1    10  011110111245567889999999999999


Q ss_pred             CCCHHHHHH
Q 028458          151 RPTMNDVVC  159 (208)
Q Consensus       151 Rps~~~i~~  159 (208)
                      ||++.++++
T Consensus       255 Rp~~~~ll~  263 (267)
T cd06610         255 RPTAEELLK  263 (267)
T ss_pred             CcCHHHHhh
Confidence            999999876

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.92  E-value=4.8e-25  Score=172.39  Aligned_cols=152  Identities=27%  Similarity=0.401  Sum_probs=117.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .++...+..++.|++.++.|||+ .+   ++|+||+|+||+++.++.++++|||.+.........    ...++..|+||
T Consensus        96 ~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~y~~P  168 (265)
T cd06605          96 RIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK----TFVGTSSYMAP  168 (265)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh----cccCChhccCH
Confidence            35677888999999999999999 88   999999999999999999999999987654322111    14567789999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc-------cccCC-ccchhhhhHH-HHHHHHHHHhhccccCCCCC
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE-------LIDDP-VLEDEYSSKQ-MLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~-~~~~~~~~~~-~~~~~~~li~~~l~~~p~~R  151 (208)
                      |.+.+..++.++|+||||++++++++|..|+.....       ..... .......+.. .+..+.++|.+||..+|++|
T Consensus       169 E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  248 (265)
T cd06605         169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRER  248 (265)
T ss_pred             HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhC
Confidence            999888899999999999999999999887754321       00000 0000011222 56678999999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      |++.+++..
T Consensus       249 pt~~~ll~~  257 (265)
T cd06605         249 PSYKELLEH  257 (265)
T ss_pred             cCHHHHhhC
Confidence            999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.92  E-value=1.3e-24  Score=169.50  Aligned_cols=152  Identities=27%  Similarity=0.355  Sum_probs=120.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhc-----cCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLH-----QYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG   76 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh-----~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~   76 (208)
                      .+++..++.++.|++.||.|||     +.+   ++|+||+|.||+++.++.++++|||++..........  ....++..
T Consensus       101 ~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~--~~~~~~~~  175 (265)
T cd08217         101 YIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA--KTYVGTPY  175 (265)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccccCCcccc--cccccCCC
Confidence            3678889999999999999999     777   9999999999999999999999999987764433211  12356788


Q ss_pred             ccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           77 YMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        77 ~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      |.|||.+.+..++.++|+|+||+++++|++|..|+.....     .+......  ..+...+..+.+++.+||+.+|++|
T Consensus       176 ~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~R  253 (265)
T cd08217         176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR--RIPYRYSSELNEVIKSMLNVDPDKR  253 (265)
T ss_pred             ccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC--CCccccCHHHHHHHHHHccCCcccC
Confidence            9999999888889999999999999999999877653311     11111111  2234556788999999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      |++++|++.
T Consensus       254 p~~~~il~~  262 (265)
T cd08217         254 PSTEELLQL  262 (265)
T ss_pred             CCHHHHhhC
Confidence            999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.92  E-value=8.1e-25  Score=173.08  Aligned_cols=153  Identities=23%  Similarity=0.291  Sum_probs=115.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.|+.|||+.+   ++|+|++|+||+++.++.++++|||++.........  .....++..|+|||.
T Consensus       121 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~  195 (286)
T cd06638         121 MEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEV  195 (286)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCCc--cccccCCCcccChhh
Confidence            566778889999999999999998   999999999999999999999999998765432211  112357789999998


Q ss_pred             hcc-----CCCCCcchhHHHHHHHHHHHHhhhcCCcccc--ccc---CCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           83 AIQ-----GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LID---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        83 ~~~-----~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      +..     ..++.++|+||||+++|+|++|..|+.....  ...   .........+...+..+.+++.+||+.+|++||
T Consensus       196 ~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  275 (286)
T cd06638         196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP  275 (286)
T ss_pred             hchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCC
Confidence            753     3478899999999999999998877643321  110   000000011222345688999999999999999


Q ss_pred             CHHHHHHH
Q 028458          153 TMNDVVCM  160 (208)
Q Consensus       153 s~~~i~~~  160 (208)
                      ++.|+++.
T Consensus       276 s~~ell~~  283 (286)
T cd06638         276 TVSDLLQH  283 (286)
T ss_pred             CHHHHhhc
Confidence            99999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.92  E-value=1.1e-24  Score=176.47  Aligned_cols=161  Identities=24%  Similarity=0.280  Sum_probs=119.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++.......... ......++..|+||
T Consensus       102 ~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  178 (336)
T cd07849         102 HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP  178 (336)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccCh
Confidence            4678889999999999999999999   9999999999999999999999999987654322111 11223567889999


Q ss_pred             chhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccCC------------------------ccchh
Q 028458           81 EYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDDP------------------------VLEDE  126 (208)
Q Consensus        81 e~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~~------------------------~~~~~  126 (208)
                      |.+.+ ..++.++|+||||+++|+|++|..++......         ...+                        .....
T Consensus       179 E~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (336)
T cd07849         179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWN  258 (336)
T ss_pred             HHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHH
Confidence            98754 45789999999999999999998766322100         0000                        00000


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhhh
Q 028458          127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       127 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~  165 (208)
                      ...+..+..+.+++.+||+.+|++||++.++++.  ++...
T Consensus       259 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         259 KLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            0112234568899999999999999999999986  65554

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.92  E-value=5.7e-25  Score=173.84  Aligned_cols=152  Identities=24%  Similarity=0.251  Sum_probs=118.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++++|||++........    ....++..|+|||
T Consensus        93 ~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE  165 (279)
T cd05633          93 VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPE  165 (279)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc----cCcCCCcCccCHH
Confidence            4788899999999999999999999   99999999999999999999999999865432211    1235788999999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc----ccCCc-cchhhhhHHHHHHHHHHHhhccccCCCCCC---
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL----IDDPV-LEDEYSSKQMLLRYVNIALLCVQESADDRP---  152 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---  152 (208)
                      .+.. ..++.++|+||+|+++|++++|..|+......    ..... ......+...+.++.++|.+||..||++||   
T Consensus       166 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  245 (279)
T cd05633         166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCL  245 (279)
T ss_pred             HhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCC
Confidence            8864 45789999999999999999998887532211    11000 001122344567889999999999999999   


Q ss_pred             --CHHHHHHH
Q 028458          153 --TMNDVVCM  160 (208)
Q Consensus       153 --s~~~i~~~  160 (208)
                        +++++++.
T Consensus       246 ~~~~~~~~~h  255 (279)
T cd05633         246 GRGAQEVKEH  255 (279)
T ss_pred             CCCHHHHHhC
Confidence              59988884

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.92  E-value=1e-24  Score=172.41  Aligned_cols=153  Identities=22%  Similarity=0.304  Sum_probs=116.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.|+.|||+.+   ++|+|++|.||+++.++.++++|||++......... ......++..|+|||.
T Consensus        97 ~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~  172 (288)
T cd07833          97 LPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPEL  172 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCch
Confidence            678889999999999999999998   999999999999999999999999998765443321 1122456778999999


Q ss_pred             hccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccc--------------------c-cCC-----ccc--------hhh
Q 028458           83 AIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--------------------I-DDP-----VLE--------DEY  127 (208)
Q Consensus        83 ~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------------------~-~~~-----~~~--------~~~  127 (208)
                      +.+. .++.++|+|+||+++|++++|..++......                    . ...     ...        ...
T Consensus       173 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (288)
T cd07833         173 LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERR  252 (288)
T ss_pred             hcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHh
Confidence            9887 7889999999999999999987665321100                    0 000     000        000


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .+...+..+.++|++||..+|++||+++++++
T Consensus       253 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         253 YPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            11123677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.92  E-value=6.1e-25  Score=174.14  Aligned_cols=152  Identities=22%  Similarity=0.300  Sum_probs=117.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.++.|||+.+   ++|+||+|.||+++.++.++++|||++.........  .....++..|+|||.
T Consensus       112 ~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~  186 (285)
T cd06648         112 MNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEV  186 (285)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--cccccCCccccCHHH
Confidence            577888999999999999999999   999999999999999999999999987654332211  122356788999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +.+..++.++|+||||+++|++++|..|+......     +..............+..+.+++.+||+.+|++||++.++
T Consensus       187 ~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i  266 (285)
T cd06648         187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAEL  266 (285)
T ss_pred             hcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence            98888999999999999999999998776432111     0000000001122245678999999999999999999999


Q ss_pred             HH
Q 028458          158 VC  159 (208)
Q Consensus       158 ~~  159 (208)
                      ++
T Consensus       267 l~  268 (285)
T cd06648         267 LN  268 (285)
T ss_pred             cc
Confidence            86

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.92  E-value=3.8e-25  Score=173.14  Aligned_cols=154  Identities=23%  Similarity=0.271  Sum_probs=118.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc----cccccccccCCCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL----QANTSRIVGTYGYM   78 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~~~   78 (208)
                      +++..+..++.|++.++.|||+.+   ++|+||+|.||+++.++.++++|||++........    ........++..|+
T Consensus        99 ~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (265)
T cd06631          99 LPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM  175 (265)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCcccc
Confidence            567788899999999999999998   99999999999999999999999998865422111    11112235678899


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc-----CCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-----DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      |||.+.+..++.++|+|+||++++++++|..|+........     .........+...+..+.++|++||+.+|++||+
T Consensus       176 ~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  255 (265)
T cd06631         176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS  255 (265)
T ss_pred             ChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCC
Confidence            99999888889999999999999999999988754222110     0000001223345667899999999999999999


Q ss_pred             HHHHHH
Q 028458          154 MNDVVC  159 (208)
Q Consensus       154 ~~~i~~  159 (208)
                      +.+++.
T Consensus       256 ~~~~l~  261 (265)
T cd06631         256 ALQLLR  261 (265)
T ss_pred             HHHHhc
Confidence            999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.92  E-value=6.1e-25  Score=171.04  Aligned_cols=151  Identities=26%  Similarity=0.365  Sum_probs=120.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.++.|||+.+   ++|+||+|.||+++.++.++++|||++........  ......++..|.|||.
T Consensus        98 ~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~  172 (256)
T cd08221          98 FEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPEL  172 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhh
Confidence            678889999999999999999998   99999999999999999999999999876644332  1222456889999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cc---cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +.+..++.++|+||||+++|+|++|..++.....  ..   ......  ......+.++.+++.+||+.+|.+||+++++
T Consensus       173 ~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~l  250 (256)
T cd08221         173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT--PVVSVYSSELISLVHSLLQQDPEKRPTADEV  250 (256)
T ss_pred             cCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--CCccccCHHHHHHHHHHcccCcccCCCHHHH
Confidence            9887888999999999999999998776543211  11   111111  1123456678999999999999999999999


Q ss_pred             HHH
Q 028458          158 VCM  160 (208)
Q Consensus       158 ~~~  160 (208)
                      ++.
T Consensus       251 l~~  253 (256)
T cd08221         251 LDQ  253 (256)
T ss_pred             hhC
Confidence            875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.92  E-value=7.2e-25  Score=173.02  Aligned_cols=152  Identities=23%  Similarity=0.377  Sum_probs=116.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC-CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||++ +   ++|+||+|+||+++.++.++++|||++........   .....++..|.||
T Consensus        99 ~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aP  172 (283)
T cd06617          99 TIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA---KTIDAGCKPYMAP  172 (283)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccccc---cccccCCccccCh
Confidence            467889999999999999999997 7   99999999999999999999999999876532211   1223467789999


Q ss_pred             chhcc----CCCCCcchhHHHHHHHHHHHHhhhcCCccccc---ccCC--ccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           81 EYAIQ----GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---IDDP--VLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        81 e~~~~----~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      |.+.+    ..++.++|+|+||+++|+|++|..|+......   ....  ...........+..+.++|.+||+.+|++|
T Consensus       173 E~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  252 (283)
T cd06617         173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKER  252 (283)
T ss_pred             hhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhC
Confidence            98864    34678999999999999999998887532211   1000  000001122345678999999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      |+++++++
T Consensus       253 p~~~~il~  260 (283)
T cd06617         253 PNYPELLQ  260 (283)
T ss_pred             cCHHHHhc
Confidence            99999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.92  E-value=1.2e-24  Score=174.30  Aligned_cols=152  Identities=24%  Similarity=0.365  Sum_probs=115.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|+++||.|||+ .+   ++|+||+|+||+++.++.++++|||++.......    .....++..|+||
T Consensus        95 ~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aP  167 (308)
T cd06615          95 RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSP  167 (308)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcCccCh
Confidence            35778889999999999999997 46   9999999999999999999999999876543221    1224567899999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccC--Cccc-----------------------------
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDD--PVLE-----------------------------  124 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~--~~~~-----------------------------  124 (208)
                      |.+.+..++.++|+||||+++|++++|..|+......     ...  ....                             
T Consensus       168 E~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (308)
T cd06615         168 ERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIV  247 (308)
T ss_pred             hHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHh
Confidence            9998888899999999999999999998765311100     000  0000                             


Q ss_pred             ----hhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          125 ----DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       125 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                          ........+.++.+++.+||+.+|++||+++++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         248 NEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                000001134568899999999999999999999886

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.91  E-value=3.8e-24  Score=171.54  Aligned_cols=155  Identities=21%  Similarity=0.281  Sum_probs=115.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-----ccccccccCCCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-----ANTSRIVGTYGY   77 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~   77 (208)
                      ++......++.|++.||.|||+.+   ++|+||+|.||+++.++.++++||+.+.........     .......++..|
T Consensus        98 ~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  174 (314)
T cd08216          98 LPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW  174 (314)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccc
Confidence            567788899999999999999999   999999999999999999999999987654321110     011123456789


Q ss_pred             cCcchhccC--CCCCcchhHHHHHHHHHHHHhhhcCCcccccc------c--------CC-------cc-----------
Q 028458           78 MSPEYAIQG--IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------D--------DP-------VL-----------  123 (208)
Q Consensus        78 ~ape~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~--------~~-------~~-----------  123 (208)
                      +|||.+...  .++.++|+||||+++|+|++|..|+.......      .        ..       ..           
T Consensus       175 ~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
T cd08216         175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPN  254 (314)
T ss_pred             cCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccc
Confidence            999998653  47889999999999999999888775322100      0        00       00           


Q ss_pred             ----chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          124 ----EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       124 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                          ...........++.+++.+||+.||++||+++++++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         255 NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                0001122345678899999999999999999999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.91  E-value=1.4e-24  Score=171.46  Aligned_cols=155  Identities=21%  Similarity=0.235  Sum_probs=115.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++++|||++........ .......++..|+|||
T Consensus        95 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE  170 (286)
T cd07832          95 PLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPE  170 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCce
Confidence            4678899999999999999999999   99999999999999999999999999876543321 1112235678899999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccC-----------------------Cccchhhh
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDD-----------------------PVLEDEYS  128 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~-----------------------~~~~~~~~  128 (208)
                      .+.+.. ++.++|+|++|++++++++|..++......         ...                       ........
T Consensus       171 ~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (286)
T cd07832         171 LLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEI  250 (286)
T ss_pred             eeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHh
Confidence            886544 688999999999999999986544221100         000                       00000001


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ..+....+.+++.+||+.+|++||++++++..
T Consensus       251 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         251 FPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            11234778899999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.91  E-value=1.1e-24  Score=179.49  Aligned_cols=155  Identities=23%  Similarity=0.274  Sum_probs=114.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc-----------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL-----------------   64 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~-----------------   64 (208)
                      .++...+..++.|++.||.|||+.+   |+||||||.||+++.++.++|+|||++........                 
T Consensus        97 ~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (381)
T cd05626          97 VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP  173 (381)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCc
Confidence            3567788889999999999999999   99999999999999999999999998753211000                 


Q ss_pred             ----------------------------cccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc
Q 028458           65 ----------------------------QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE  116 (208)
Q Consensus        65 ----------------------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~  116 (208)
                                                  ........|+..|+|||.+.+..++.++|+|||||++|+|++|..|+.....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~  253 (381)
T cd05626         174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTP  253 (381)
T ss_pred             ccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCH
Confidence                                        0001124688999999999888899999999999999999999988754321


Q ss_pred             c------cc-CCccchhhhhHHHHHHHHHHHhhcc--ccCCCCCCCHHHHHHH
Q 028458          117 L------ID-DPVLEDEYSSKQMLLRYVNIALLCV--QESADDRPTMNDVVCM  160 (208)
Q Consensus       117 ~------~~-~~~~~~~~~~~~~~~~~~~li~~~l--~~~p~~Rps~~~i~~~  160 (208)
                      .      .. ...... ......+.++.++|.+|+  ..++..|+++++++..
T Consensus       254 ~~~~~~i~~~~~~~~~-~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         254 TETQLKVINWENTLHI-PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHHHHHHccccccCC-CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            1      10 000000 111234566778888844  5556669999999884

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.91  E-value=8.8e-25  Score=172.65  Aligned_cols=151  Identities=24%  Similarity=0.264  Sum_probs=118.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.|+.|||+.+   ++|+||+|.||+++.++.++++|||++.......    .....++..|+|||
T Consensus        93 ~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE  165 (278)
T cd05606          93 VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPE  165 (278)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcH
Confidence            4788999999999999999999998   9999999999999999999999999986543221    12235788999999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccc----c-CCccchhhhhHHHHHHHHHHHhhccccCCCCCC---
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI----D-DPVLEDEYSSKQMLLRYVNIALLCVQESADDRP---  152 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---  152 (208)
                      .+.++ .++.++|+||+|+++|+|++|..|+.......    . .........+...+..+.+++.+||..+|.+||   
T Consensus       166 ~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~  245 (278)
T cd05606         166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCL  245 (278)
T ss_pred             HhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCC
Confidence            98754 57899999999999999999988875432110    0 000001122333467889999999999999999   


Q ss_pred             --CHHHHHH
Q 028458          153 --TMNDVVC  159 (208)
Q Consensus       153 --s~~~i~~  159 (208)
                        ++.++++
T Consensus       246 ~~~~~~ll~  254 (278)
T cd05606         246 GRGAQEVKE  254 (278)
T ss_pred             CCCHHHHHh
Confidence              8999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-24  Score=167.23  Aligned_cols=153  Identities=20%  Similarity=0.222  Sum_probs=123.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC---CCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .++.+++-.|..||+.|+.|||+.+   |.||||||.|++...   +..+||+|||++....+...   .....-|+.|.
T Consensus       157 afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~---L~TPc~TPyYv  230 (400)
T KOG0604|consen  157 AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD---LMTPCFTPYYV  230 (400)
T ss_pred             cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCCcc---ccCCccccccc
Confidence            4788899999999999999999999   999999999999964   55689999999987543221   11223478899


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchh----------hhhHHHHHHHHHHHhhccccCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDE----------YSSKQMLLRYVNIALLCVQESA  148 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p  148 (208)
                      |||++...+|+...|+||+|+++|-|++|..||...+.....+-+...          ..-...++...++|+.+|..+|
T Consensus       231 aPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~P  310 (400)
T KOG0604|consen  231 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEP  310 (400)
T ss_pred             CHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCc
Confidence            999998889999999999999999999999999877665432322221          1233356778899999999999


Q ss_pred             CCCCCHHHHHHH
Q 028458          149 DDRPTMNDVVCM  160 (208)
Q Consensus       149 ~~Rps~~~i~~~  160 (208)
                      ++|-++.+++..
T Consensus       311 teRlTI~~~m~h  322 (400)
T KOG0604|consen  311 TERLTIEEVMDH  322 (400)
T ss_pred             hhheeHHHhhcC
Confidence            999999999874

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=2.3e-24  Score=169.27  Aligned_cols=155  Identities=26%  Similarity=0.364  Sum_probs=118.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++................++..|.+||
T Consensus       104 ~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE  180 (272)
T cd06629         104 RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE  180 (272)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHH
Confidence            3677888999999999999999998   9999999999999999999999999986543322111122235678899999


Q ss_pred             hhccCC--CCCcchhHHHHHHHHHHHHhhhcCCccccc--c----c---CCccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           82 YAIQGI--FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I----D---DPVLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        82 ~~~~~~--~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~----~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      .+....  ++.++|+||||++++++++|..|+......  .    .   ...... .....++..+.+++.+||+.+|++
T Consensus       181 ~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~  259 (272)
T cd06629         181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP-DVSMNLSPVALDFLNACFTINPDN  259 (272)
T ss_pred             HhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc-cccccCCHHHHHHHHHHhcCChhh
Confidence            987654  788999999999999999998776432211  0    0   001111 122335678899999999999999


Q ss_pred             CCCHHHHHHH
Q 028458          151 RPTMNDVVCM  160 (208)
Q Consensus       151 Rps~~~i~~~  160 (208)
                      ||+++++++.
T Consensus       260 Rps~~~il~~  269 (272)
T cd06629         260 RPTARELLQH  269 (272)
T ss_pred             CCCHHHHhhC
Confidence            9999998863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.91  E-value=2.4e-24  Score=169.90  Aligned_cols=151  Identities=21%  Similarity=0.223  Sum_probs=114.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.||.|||+.+   ++|+||+|+||+++. +.++++|||++.........   ....++..|.|||
T Consensus        96 ~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE  168 (282)
T cd07831          96 PLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPE  168 (282)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCChh
Confidence            4788999999999999999999999   999999999999999 99999999998765433221   1234677899999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccC----------------Cccch------hhhh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDD----------------PVLED------EYSS  129 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~----------------~~~~~------~~~~  129 (208)
                      .+.. ..++.++|+||||+++|+|+++..++......         ...                .....      ....
T Consensus       169 ~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (282)
T cd07831         169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLL  248 (282)
T ss_pred             HhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHc
Confidence            7654 44688999999999999999887666321100         000                00000      0112


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ...+..+.++|.+||+.+|++||+++++++
T Consensus       249 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         249 PNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            234678999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.91  E-value=2e-24  Score=171.57  Aligned_cols=153  Identities=20%  Similarity=0.235  Sum_probs=114.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-CCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.||++||.|||+.+   ++|+||+|.||+++. ++.++++|||++.........  .....++..|.||
T Consensus       106 ~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aP  180 (295)
T cd07837         106 PLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAP  180 (295)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCCh
Confidence            4688899999999999999999999   999999999999998 889999999988754322111  1112346789999


Q ss_pred             chhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccccc---------cCC------------------ccch---hhhh
Q 028458           81 EYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------DDP------------------VLED---EYSS  129 (208)
Q Consensus        81 e~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~~~------------------~~~~---~~~~  129 (208)
                      |.+.+ ..++.++|+|+||+++|+|++|..++.......         ..+                  ....   ....
T Consensus       181 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (295)
T cd07837         181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAV  260 (295)
T ss_pred             HHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhc
Confidence            98865 346899999999999999999887664221100         000                  0000   0011


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ...+..+.++|.+||+.||.+||++++++.
T Consensus       261 ~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         261 PDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             cccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            234567889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.91  E-value=7.7e-25  Score=166.39  Aligned_cols=149  Identities=28%  Similarity=0.454  Sum_probs=113.9

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchh
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA   83 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~   83 (208)
                      +..-.=++...+++||.||-.+.  .|+|||+||+||++|..|.+|+||||.+.+.-+...   .+...|-..|+|||.+
T Consensus       189 PE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---htrsAGC~~YMaPERi  263 (391)
T KOG0983|consen  189 PERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---HTRSAGCAAYMAPERI  263 (391)
T ss_pred             hHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc---cccccCCccccCcccc
Confidence            33444456667789999998876  399999999999999999999999999977643332   2223456789999998


Q ss_pred             ccC---CCCCcchhHHHHHHHHHHHHhhhcCCcc---cc----cccC--CccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           84 IQG---IFSIKSDVFSFGVLLLEIAWDLWTSNRT---LE----LIDD--PVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        84 ~~~---~~~~~~Dv~slG~~~~~l~~~~~~~~~~---~~----~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      ...   +|+.++||||||+.++|+++|.+|....   .+    ..++  +.++.   ....+.++++|+..||+.|+.+|
T Consensus       264 dp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~---~~gFSp~F~~fv~~CL~kd~r~R  340 (391)
T KOG0983|consen  264 DPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG---HMGFSPDFQSFVKDCLTKDHRKR  340 (391)
T ss_pred             CCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc---ccCcCHHHHHHHHHHhhcCcccC
Confidence            643   5899999999999999999999876431   11    1111  12211   22367889999999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      |.+.++++.
T Consensus       341 P~Y~~Ll~h  349 (391)
T KOG0983|consen  341 PKYNKLLEH  349 (391)
T ss_pred             cchHHHhcC
Confidence            999999874

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.91  E-value=5.3e-25  Score=176.95  Aligned_cols=145  Identities=28%  Similarity=0.306  Sum_probs=121.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...++-++.+|+.||++||...   ||+||+||.||++|+.|++.|+|+|++..+........   .+||.+|+|||
T Consensus       283 gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~---rvGT~GYMAPE  356 (591)
T KOG0986|consen  283 GFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRG---RVGTVGYMAPE  356 (591)
T ss_pred             CCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCcccc---ccCcccccCHH
Confidence            4778889999999999999999998   99999999999999999999999999998876654332   37899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCcc------chhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVL------EDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      ++..+.|+..+|.|+|||++|+|+.|..||....+.+....+      .....+...+++..+|.+.+|+.||.+|-
T Consensus       357 vl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RL  433 (591)
T KOG0986|consen  357 VLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRL  433 (591)
T ss_pred             HHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhc
Confidence            999999999999999999999999999888544333322111      22244566778899999999999999995

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.91  E-value=1.2e-24  Score=181.35  Aligned_cols=98  Identities=29%  Similarity=0.382  Sum_probs=86.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC--CCeEEeccccceecCCCcccccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD--MNPKISDFGMARICGGNELQANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~a   79 (208)
                      .|+...+..++.||+.||..||+.+   |||+||||+|||+...  ..+||+|||.+++......     ..+-+..|+|
T Consensus       285 Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRA  356 (586)
T KOG0667|consen  285 GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRA  356 (586)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCcce-----eeeecccccc
Confidence            5778899999999999999999999   9999999999999644  4689999999998765544     2345678999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHh
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWD  107 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~  107 (208)
                      ||++.+.+|+.+.|||||||+++||++|
T Consensus       357 PEVILGlpY~~~IDmWSLGCIlAEL~tG  384 (586)
T KOG0667|consen  357 PEVILGLPYDTAIDMWSLGCILAELFTG  384 (586)
T ss_pred             chhhccCCCCCccceeehhhhHHhHhcC
Confidence            9999999999999999999999999544

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.91  E-value=1.5e-24  Score=171.39  Aligned_cols=153  Identities=22%  Similarity=0.263  Sum_probs=114.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|+++||.|||+.+   ++|+|++|.||+++.++.++++|||++.........  .....++..|+|||
T Consensus        95 ~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE  169 (283)
T cd07835          95 GLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPE  169 (283)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCc
Confidence            4688899999999999999999998   999999999999999999999999998654322111  11124467899999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccC----------------------Ccc---chhhhh
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDD----------------------PVL---EDEYSS  129 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~----------------------~~~---~~~~~~  129 (208)
                      .+.+. .++.++|+||||+++|+|++|..++......      ...                      ...   ......
T Consensus       170 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (283)
T cd07835         170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVV  249 (283)
T ss_pred             eeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhc
Confidence            87654 4688999999999999999998765322110      000                      000   000111


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ...+..+.+++.+||+.+|++||+++++++
T Consensus       250 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         250 PNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            223467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.91  E-value=1.1e-24  Score=173.51  Aligned_cols=153  Identities=25%  Similarity=0.379  Sum_probs=115.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.++.|||+ .+   ++|+||+|.||+++.++.++|+|||++.........   ....++..|+||
T Consensus       110 ~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aP  183 (296)
T cd06618         110 PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAP  183 (296)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccCH
Confidence            36788889999999999999997 47   999999999999999999999999998665332211   112456789999


Q ss_pred             chhccCC----CCCcchhHHHHHHHHHHHHhhhcCCcccc---cc---cCCccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           81 EYAIQGI----FSIKSDVFSFGVLLLEIAWDLWTSNRTLE---LI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        81 e~~~~~~----~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      |.+.+..    ++.++|+||||+++|+|++|..|+.....   ..   ..............+..+.+++.+||+.||++
T Consensus       184 E~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  263 (296)
T cd06618         184 ERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRK  263 (296)
T ss_pred             hhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence            9987553    78899999999999999999888754211   10   00111100111124567899999999999999


Q ss_pred             CCCHHHHHHH
Q 028458          151 RPTMNDVVCM  160 (208)
Q Consensus       151 Rps~~~i~~~  160 (208)
                      ||+++++++.
T Consensus       264 Rp~~~~il~~  273 (296)
T cd06618         264 RPKYRELLQH  273 (296)
T ss_pred             CCCHHHHhcC
Confidence            9999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=6.1e-25  Score=179.80  Aligned_cols=154  Identities=21%  Similarity=0.220  Sum_probs=116.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc---------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA---------------   66 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~---------------   66 (208)
                      .++...+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++..........               
T Consensus        97 ~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (364)
T cd05599          97 TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD  173 (364)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccc
Confidence            3677889999999999999999999   9999999999999999999999999986542211000               


Q ss_pred             ---------------------cccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c----c
Q 028458           67 ---------------------NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I----D  119 (208)
Q Consensus        67 ---------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~----~  119 (208)
                                           ......|++.|+|||.+.+..++.++|+|||||++|+|++|..|+......  .    .
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~  253 (364)
T cd05599         174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIIN  253 (364)
T ss_pred             cccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHc
Confidence                                 001135789999999998888999999999999999999999887543211  0    0


Q ss_pred             -CCccchhhhhHHHHHHHHHHHhhccccCCCCCCC---HHHHHHH
Q 028458          120 -DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT---MNDVVCM  160 (208)
Q Consensus       120 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~i~~~  160 (208)
                       ...+.. ......+..+.++|.+|+. +|.+|++   ++++++.
T Consensus       254 ~~~~~~~-~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         254 WKETLQF-PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCccCC-CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence             000000 0111235677899999996 9999998   8888773

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.4e-25  Score=185.17  Aligned_cols=164  Identities=29%  Similarity=0.339  Sum_probs=125.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++..+++.++.+.+.||+|||+++   ++||||..+|+|+..++.+|++|||++.....  .........-+..|+|||
T Consensus       258 ~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~--~~~~~~~~klPirWLAPE  332 (474)
T KOG0194|consen  258 SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPE  332 (474)
T ss_pred             CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcc--eeeccccccCcceecChh
Confidence            3788999999999999999999999   99999999999999999999999999765431  111111123468999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHh-hhcCC-cc-ccc---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWD-LWTSN-RT-LEL---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~-~~~~~-~~-~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+..+.|+.++|||+||+++||++.. ..|.. .. .+.   +....... ..+...+..+..++.+||..+|++||+|.
T Consensus       333 tl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~-~~~~~~p~~~~~~~~~c~~~~p~~R~tm~  411 (474)
T KOG0194|consen  333 TLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM-PIPSKTPKELAKVMKQCWKKDPEDRPTMS  411 (474)
T ss_pred             hhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC-CCCCCCHHHHHHHHHHhccCChhhccCHH
Confidence            99999999999999999999999873 32221 11 111   10001111 22445667788899999999999999999


Q ss_pred             HHHHHHhhhhhccCCC
Q 028458          156 DVVCMLTNEAATLLPP  171 (208)
Q Consensus       156 ~i~~~l~~~~~~~~~p  171 (208)
                      ++.+.|+.+......+
T Consensus       412 ~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  412 TIKKKLEALEKKKEAF  427 (474)
T ss_pred             HHHHHHHHHHhccccc
Confidence            9999999988765554

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.91  E-value=2.1e-24  Score=174.81  Aligned_cols=156  Identities=22%  Similarity=0.268  Sum_probs=117.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc--cccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~a   79 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..........  ......++..|.|
T Consensus       103 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~  179 (334)
T cd07855         103 PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA  179 (334)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccC
Confidence            3678899999999999999999998   9999999999999999999999999987654322111  1122456788999


Q ss_pred             cchhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----------------------------ccC----Cccch
Q 028458           80 PEYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----------------------------IDD----PVLED  125 (208)
Q Consensus        80 pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----------------------------~~~----~~~~~  125 (208)
                      ||.+.+ ..++.++|+|+||+++|+|++|..++......                             .+.    .....
T Consensus       180 PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (334)
T cd07855         180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPW  259 (334)
T ss_pred             hHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCH
Confidence            998765 45789999999999999999888776322100                             000    00000


Q ss_pred             hhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          126 EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       126 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      .......+..+.++|++||+.+|++||++.+++..
T Consensus       260 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         260 SKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            01112346778999999999999999999999884

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.91  E-value=1.6e-24  Score=170.32  Aligned_cols=149  Identities=22%  Similarity=0.265  Sum_probs=118.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC-CeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++.++..++.|+++||.|||+.+   ++|+||+|.||+++.++ .++++|||++.......      ...++..|+||
T Consensus       105 ~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aP  175 (267)
T PHA03390        105 KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSP  175 (267)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------cCCCCCcccCh
Confidence            4688999999999999999999999   99999999999999888 89999999887654222      13467889999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc------cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC-
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT-  153 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-  153 (208)
                      |.+.+..++.++|+||||++++++++|..|+.......      ..............+..+.++|.+||+.+|.+||+ 
T Consensus       176 E~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~  255 (267)
T PHA03390        176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTN  255 (267)
T ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCch
Confidence            99988889999999999999999999988875332110      00001111223346678899999999999999995 


Q ss_pred             HHHHHH
Q 028458          154 MNDVVC  159 (208)
Q Consensus       154 ~~~i~~  159 (208)
                      ++++++
T Consensus       256 ~~~~l~  261 (267)
T PHA03390        256 YNEIIK  261 (267)
T ss_pred             HHHHhc
Confidence            688874

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.91  E-value=3.2e-24  Score=171.64  Aligned_cols=150  Identities=31%  Similarity=0.394  Sum_probs=116.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++.......      ...++..|+|||
T Consensus       111 ~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~------~~~~~~~y~aPE  181 (307)
T cd06607         111 PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN------SFVGTPYWMAPE  181 (307)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCC------CccCCccccCce
Confidence            4678889999999999999999998   9999999999999999999999999886543221      234677899999


Q ss_pred             hhc---cCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--c--CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAI---QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--D--DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.   .+.++.++|+|+||+++|+|++|..|+.......  .  .............+..+.+++.+||+.+|++||++
T Consensus       182 ~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  261 (307)
T cd06607         182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSS  261 (307)
T ss_pred             eeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCH
Confidence            874   3557889999999999999999987764322110  0  00000111123356678999999999999999999


Q ss_pred             HHHHHH
Q 028458          155 NDVVCM  160 (208)
Q Consensus       155 ~~i~~~  160 (208)
                      .+++..
T Consensus       262 ~~il~~  267 (307)
T cd06607         262 EELLKH  267 (307)
T ss_pred             HHHhcC
Confidence            999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.91  E-value=1.6e-24  Score=169.76  Aligned_cols=154  Identities=23%  Similarity=0.253  Sum_probs=118.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++..+++++.|++.+|.|||+++   ++|+||+|.||+++.++.++++|||++.......... ......++..|+||
T Consensus       102 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  178 (265)
T cd06652         102 ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP  178 (265)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccCh
Confidence            3577788999999999999999999   9999999999999999999999999887653222111 11223567889999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc--CC--ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID--DP--VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      |.+.+..++.++|+||||+++|++++|..|+........  ..  .......+......+.+++.+||. +|++||++++
T Consensus       179 E~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~  257 (265)
T cd06652         179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADE  257 (265)
T ss_pred             hhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHH
Confidence            999888889999999999999999999888754321110  00  000112344566778899999995 9999999999


Q ss_pred             HHH
Q 028458          157 VVC  159 (208)
Q Consensus       157 i~~  159 (208)
                      +++
T Consensus       258 il~  260 (265)
T cd06652         258 LLR  260 (265)
T ss_pred             Hhc
Confidence            875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.91  E-value=2e-24  Score=174.77  Aligned_cols=156  Identities=24%  Similarity=0.266  Sum_probs=116.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc--cccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~a   79 (208)
                      .+++..+..++.||+.||.|||+++   ++|+||||.||+++.++.++|+|||++..........  ......++..|.|
T Consensus       101 ~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~a  177 (332)
T cd07857         101 PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA  177 (332)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccC
Confidence            4678889999999999999999999   9999999999999999999999999987654322111  1122457888999


Q ss_pred             cchhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c------------------cCC----------ccch---
Q 028458           80 PEYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I------------------DDP----------VLED---  125 (208)
Q Consensus        80 pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~------------------~~~----------~~~~---  125 (208)
                      ||.+.+ ..++.++|+||||+++|++++|..++......  .                  ...          ....   
T Consensus       178 PE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (332)
T cd07857         178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPF  257 (332)
T ss_pred             cHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcch
Confidence            998765 45789999999999999999887766432100  0                  000          0000   


Q ss_pred             hhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          126 EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       126 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      .......+..+.+++.+||+.||++||++.++++.
T Consensus       258 ~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         258 ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00011124568899999999999999999998864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.91  E-value=2.6e-24  Score=166.89  Aligned_cols=155  Identities=26%  Similarity=0.328  Sum_probs=122.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.++.|||+.+   ++|+|++|+||+++.++.++++|||.+................++..|.+||
T Consensus        97 ~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE  173 (260)
T cd06606          97 KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE  173 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHh
Confidence            4678899999999999999999998   9999999999999999999999999988765544311122245678899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc---ccCCc--cchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---IDDPV--LEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+...+.++|+|+||++++++++|..|+......   .....  ......+...+..+.+++.+|++.+|++||++.+
T Consensus       174 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~  253 (260)
T cd06606         174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE  253 (260)
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHH
Confidence            998888899999999999999999988777543311   00000  0111223344678999999999999999999999


Q ss_pred             HHH
Q 028458          157 VVC  159 (208)
Q Consensus       157 i~~  159 (208)
                      +++
T Consensus       254 ll~  256 (260)
T cd06606         254 LLQ  256 (260)
T ss_pred             Hhh
Confidence            986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.91  E-value=2.2e-24  Score=172.28  Aligned_cols=155  Identities=20%  Similarity=0.231  Sum_probs=113.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc--ccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~a   79 (208)
                      .+++.++..++.|+++||.|||+.+   ++|+||+|.||+++.++.++++|||++.........  .......++..|+|
T Consensus       115 ~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~a  191 (310)
T cd07865         115 KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP  191 (310)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccC
Confidence            4688899999999999999999998   999999999999999999999999998765432211  11122345678999


Q ss_pred             cchhccCC-CCCcchhHHHHHHHHHHHHhhhcCCcccccc--------------------------cCCccchhh---h-
Q 028458           80 PEYAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--------------------------DDPVLEDEY---S-  128 (208)
Q Consensus        80 pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--------------------------~~~~~~~~~---~-  128 (208)
                      ||.+.+.. ++.++|+||||+++|+|++|..++.......                          .........   . 
T Consensus       192 PE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (310)
T cd07865         192 PELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVK  271 (310)
T ss_pred             cHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhH
Confidence            99886643 6889999999999999998876553221100                          000000000   0 


Q ss_pred             ----hHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          129 ----SKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       129 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                          .......+.++|.+||..||++||+++++++
T Consensus       272 ~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         272 ERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                0001245678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.2e-24  Score=169.91  Aligned_cols=154  Identities=24%  Similarity=0.346  Sum_probs=118.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.++.|||+.+   ++|+||+|+||+++.++.++++|||++.........  .....++..|.|||
T Consensus        97 ~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  171 (277)
T cd06917          97 PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPE  171 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--cccccCCcceeCHH
Confidence            4678889999999999999999999   999999999999999999999999998776543311  12235678899999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCc---cchhhhhH-HHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPV---LEDEYSSK-QMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.++ .++.++|+|+||+++|+|++|..|+...........   ........ ..+.++.+++.+||+.||++||++.+
T Consensus       172 ~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~  251 (277)
T cd06917         172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEE  251 (277)
T ss_pred             HhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            88654 468899999999999999999888754322110000   00001111 24567889999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      ++..
T Consensus       252 il~~  255 (277)
T cd06917         252 LLKS  255 (277)
T ss_pred             HhhC
Confidence            9873

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.91  E-value=1.8e-24  Score=173.27  Aligned_cols=155  Identities=21%  Similarity=0.218  Sum_probs=114.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC----CCCeEEeccccceecCCCccc-ccccccccCCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK----DMNPKISDFGMARICGGNELQ-ANTSRIVGTYG   76 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~----~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~   76 (208)
                      .++...+..++.|++.||.|||+.+   ++|+||+|+||+++.    ++.++++|||++......... .......++..
T Consensus       104 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  180 (316)
T cd07842         104 SIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW  180 (316)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCcccccc
Confidence            3567788899999999999999999   999999999999999    899999999998765433221 11122345778


Q ss_pred             ccCcchhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccccc------------------------------------
Q 028458           77 YMSPEYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID------------------------------------  119 (208)
Q Consensus        77 ~~ape~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------------------------------------  119 (208)
                      |+|||.+.+. .++.++|+||||+++++|++|..++........                                    
T Consensus       181 y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (316)
T cd07842         181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDT  260 (316)
T ss_pred             ccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchh
Confidence            9999988664 478899999999999999998877643221110                                    


Q ss_pred             ------CCccchhh----hhH--HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          120 ------DPVLEDEY----SSK--QMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       120 ------~~~~~~~~----~~~--~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                            ........    ...  .....+.+++.+||+.||++||++.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         261 LMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             hhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                  00000000    000  23346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.2e-24  Score=171.71  Aligned_cols=154  Identities=25%  Similarity=0.337  Sum_probs=117.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.++.|||+.+   ++|+||+|.||+++.++.++++|||++.........  .....++..|.+||
T Consensus        99 ~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE  173 (280)
T cd06611          99 GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPE  173 (280)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccccc--cceeecchhhcCHH
Confidence            4778899999999999999999999   999999999999999999999999987654322211  11235678899999


Q ss_pred             hhcc-----CCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           82 YAIQ-----GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        82 ~~~~-----~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+..     ..++.++|+||||+++|++++|..|+......     ...........+...+..+.+++..||+.+|.+|
T Consensus       174 ~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  253 (280)
T cd06611         174 VVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDR  253 (280)
T ss_pred             HHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhC
Confidence            8752     34677899999999999999998887543211     0100000101123445678899999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      |+++++++.
T Consensus       254 ps~~~il~~  262 (280)
T cd06611         254 PTAAELLKH  262 (280)
T ss_pred             cCHHHHhcC
Confidence            999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.91  E-value=2e-24  Score=172.30  Aligned_cols=152  Identities=18%  Similarity=0.223  Sum_probs=113.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++++|||++.........  .....++..|+|||.
T Consensus       101 ~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~  175 (301)
T cd07873         101 INMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDI  175 (301)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--ccccceeecccCcHH
Confidence            567788999999999999999999   999999999999999999999999998654322211  112245678999998


Q ss_pred             hccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccc--cc-------------------cC-----Cccchh------hhh
Q 028458           83 AIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LI-------------------DD-----PVLEDE------YSS  129 (208)
Q Consensus        83 ~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~-------------------~~-----~~~~~~------~~~  129 (208)
                      +.+. .++.++|+||||+++|+|++|..++.....  ..                   ..     ...+..      ...
T Consensus       176 ~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (301)
T cd07873         176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHA  255 (301)
T ss_pred             HhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhc
Confidence            8654 478899999999999999999876642211  00                   00     000000      001


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ...+..+.++|.+||+.||.+||+++|+++
T Consensus       256 ~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         256 PRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            123456789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=1.3e-24  Score=193.95  Aligned_cols=153  Identities=17%  Similarity=0.186  Sum_probs=108.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC-------------------CeEEeccccceecCCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-------------------NPKISDFGMARICGGN   62 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~-------------------~~~l~dfg~~~~~~~~   62 (208)
                      .+++.+++.++.||++||.|||+++   |+||||||.||+++..+                   .++++|||++......
T Consensus        76 ~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~  152 (793)
T PLN00181         76 SVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEIL  152 (793)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccc
Confidence            3788899999999999999999999   99999999999996544                   4555666655432110


Q ss_pred             c---cc-----------ccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc---CCccch
Q 028458           63 E---LQ-----------ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID---DPVLED  125 (208)
Q Consensus        63 ~---~~-----------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---~~~~~~  125 (208)
                      .   ..           .......++..|+|||.+.+..++.++|||||||++|||+++..++........   ....+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~  232 (793)
T PLN00181        153 SERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPP  232 (793)
T ss_pred             cccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcCh
Confidence            0   00           000113467789999999988999999999999999999987665543221111   001111


Q ss_pred             hhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          126 EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       126 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                        ...........++.+||+.+|.+||++.|+++
T Consensus       233 --~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        233 --QILLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             --hhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence              01111234568889999999999999999976

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.91  E-value=1.3e-24  Score=172.94  Aligned_cols=169  Identities=19%  Similarity=0.249  Sum_probs=126.3

Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCC-------------------
Q 028458            1 MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG-------------------   61 (208)
Q Consensus         1 ~~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~-------------------   61 (208)
                      |-++...+.=++.+|+-||+|||..|   ||+|||||+|||+.++|++.|+||.++..+..                   
T Consensus       174 ~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~  250 (459)
T KOG0610|consen  174 KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSC  250 (459)
T ss_pred             CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCccc
Confidence            34677788889999999999999999   99999999999999999999999988743311                   


Q ss_pred             ----------C---ccc----------------------ccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHH
Q 028458           62 ----------N---ELQ----------------------ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW  106 (208)
Q Consensus        62 ----------~---~~~----------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~  106 (208)
                                .   ...                      .....++||-.|+|||++++...+.++|+|+||+++|||++
T Consensus       251 ~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLy  330 (459)
T KOG0610|consen  251 RSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLY  330 (459)
T ss_pred             ccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHh
Confidence                      0   000                      00112468889999999999999999999999999999999


Q ss_pred             hhhcCCcccc-c-----c-cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC----HHHHHH--HHhhhhhccCCCCC
Q 028458          107 DLWTSNRTLE-L-----I-DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT----MNDVVC--MLTNEAATLLPPKQ  173 (208)
Q Consensus       107 ~~~~~~~~~~-~-----~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~i~~--~l~~~~~~~~~p~~  173 (208)
                      |..||...-. .     + +....+.   .+..+..+.+||+++|..||++|--    +.||-+  +++++..++-.-..
T Consensus       331 G~TPFKG~~~~~Tl~NIv~~~l~Fp~---~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~  407 (459)
T KOG0610|consen  331 GTTPFKGSNNKETLRNIVGQPLKFPE---EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCAR  407 (459)
T ss_pred             CCCCcCCCCchhhHHHHhcCCCcCCC---CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccC
Confidence            9988843221 1     1 1111211   2245577899999999999999987    777765  36766655444333


Q ss_pred             CC
Q 028458          174 PA  175 (208)
Q Consensus       174 ~~  175 (208)
                      |+
T Consensus       408 PP  409 (459)
T KOG0610|consen  408 PP  409 (459)
T ss_pred             CC
Confidence            33

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.91  E-value=8.9e-25  Score=178.95  Aligned_cols=156  Identities=22%  Similarity=0.220  Sum_probs=113.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc----------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ----------------   65 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~----------------   65 (208)
                      .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.........                
T Consensus        97 ~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~  173 (363)
T cd05628          97 TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF  173 (363)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccc
Confidence            4678889999999999999999999   999999999999999999999999998654321100                


Q ss_pred             -----------------ccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCcc--c
Q 028458           66 -----------------ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVL--E  124 (208)
Q Consensus        66 -----------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~--~  124 (208)
                                       .......|+..|+|||.+.+..++.++|+|||||++|+|++|..|+.....  .......  .
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~  253 (363)
T cd05628         174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKE  253 (363)
T ss_pred             cccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC
Confidence                             001124688999999999988899999999999999999999988853321  1110000  0


Q ss_pred             hhhhh--HHHHHHHHHHHhhccc--cCCCCCCCHHHHHHH
Q 028458          125 DEYSS--KQMLLRYVNIALLCVQ--ESADDRPTMNDVVCM  160 (208)
Q Consensus       125 ~~~~~--~~~~~~~~~li~~~l~--~~p~~Rps~~~i~~~  160 (208)
                      ....+  ...+..+.++|.+|+.  .++..||+++||++.
T Consensus       254 ~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         254 TLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             cccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            00011  1234567778877654  233356899999885

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.91  E-value=2.3e-24  Score=170.43  Aligned_cols=153  Identities=24%  Similarity=0.311  Sum_probs=115.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.++.|||+.+   ++|+|++|+||+++.++.++++|||++.........  .....++..|+|||
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  170 (286)
T cd07846          96 GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPE  170 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc--cCcccceeeccCcH
Confidence            3688999999999999999999998   999999999999999999999999998765433211  12234677899999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccc--------------------c---------CCcc----chhh
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--------------------D---------DPVL----EDEY  127 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--------------------~---------~~~~----~~~~  127 (208)
                      .+.+. .++.++|+||||+++|+|++|..++.......                    .         .+..    ....
T Consensus       171 ~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (286)
T cd07846         171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEK  250 (286)
T ss_pred             HhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHH
Confidence            88653 46788999999999999999876553211100                    0         0000    0000


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ..+..+..+.+++.+||+.+|++||++.++++
T Consensus       251 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         251 RFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            11234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.91  E-value=1e-24  Score=169.73  Aligned_cols=150  Identities=25%  Similarity=0.324  Sum_probs=118.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.+++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|||++.........  .....++..|.|||.
T Consensus        98 ~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~  172 (256)
T cd08218          98 FPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSPEI  172 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCccccCHHH
Confidence            577888999999999999999998   999999999999999999999999998765432211  112346778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--ccc---CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LID---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      ..+..++.++|+|+||++++++++|..++.....  ...   .....  ..+...+.++.++|.+||+.+|++||+++++
T Consensus       173 ~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~v  250 (256)
T cd08218         173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP--PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSI  250 (256)
T ss_pred             hCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC--CCcccCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence            9888889999999999999999998876642211  110   01110  1233456678999999999999999999999


Q ss_pred             HH
Q 028458          158 VC  159 (208)
Q Consensus       158 ~~  159 (208)
                      ++
T Consensus       251 l~  252 (256)
T cd08218         251 LE  252 (256)
T ss_pred             hh
Confidence            86

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.91  E-value=1.2e-24  Score=178.69  Aligned_cols=153  Identities=22%  Similarity=0.219  Sum_probs=115.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++......... ......|+..|+|||.
T Consensus       139 ~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~  214 (370)
T cd05621         139 VPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEV  214 (370)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCce-ecccCCCCcccCCHHH
Confidence            566788899999999999999999   999999999999999999999999998775432221 1123468899999999


Q ss_pred             hccCC----CCCcchhHHHHHHHHHHHHhhhcCCcccc-----cccCC--ccchhhhhHHHHHHHHHHHhhccccCCCC-
Q 028458           83 AIQGI----FSIKSDVFSFGVLLLEIAWDLWTSNRTLE-----LIDDP--VLEDEYSSKQMLLRYVNIALLCVQESADD-  150 (208)
Q Consensus        83 ~~~~~----~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~-  150 (208)
                      +.+..    ++.++|+||||+++|+|++|..|+.....     .+...  .... ......+..+.+++..|++.++.+ 
T Consensus       215 ~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~~~~s~~~~~li~~~L~~~~~r~  293 (370)
T cd05621         215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF-PEDVEISKHAKNLICAFLTDREVRL  293 (370)
T ss_pred             HhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC-CCcccCCHHHHHHHHHHccCchhcc
Confidence            86543    67899999999999999999988754321     11100  0100 111234567788999999866644 


Q ss_pred             -CCCHHHHHHH
Q 028458          151 -RPTMNDVVCM  160 (208)
Q Consensus       151 -Rps~~~i~~~  160 (208)
                       |+++.++++.
T Consensus       294 ~R~~~~e~l~h  304 (370)
T cd05621         294 GRNGVEEIKQH  304 (370)
T ss_pred             CCCCHHHHhcC
Confidence             8899999885

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.91  E-value=3.3e-24  Score=173.84  Aligned_cols=158  Identities=22%  Similarity=0.237  Sum_probs=119.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.
T Consensus       105 l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~  179 (337)
T cd07858         105 LSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPEL  179 (337)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCcc--cccccccccCccChHH
Confidence            577888999999999999999998   99999999999999999999999999876543321  1122346778999998


Q ss_pred             hcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccc--------------------cccCCc-------------cchhhh
Q 028458           83 AIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--------------------LIDDPV-------------LEDEYS  128 (208)
Q Consensus        83 ~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------------------~~~~~~-------------~~~~~~  128 (208)
                      +.. ..++.++|+|+||+++|+|++|..++.....                    .+....             ......
T Consensus       180 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (337)
T cd07858         180 LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARL  259 (337)
T ss_pred             HhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHH
Confidence            865 4588999999999999999988876632110                    000000             000011


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhhh
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~  165 (208)
                      ....+..+.++|++||+.+|++||+++++++.  ++...
T Consensus       260 ~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         260 FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            12345678899999999999999999999986  65543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.91  E-value=1.4e-24  Score=171.30  Aligned_cols=152  Identities=25%  Similarity=0.283  Sum_probs=117.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|||.+........   .....++..|++||
T Consensus        91 ~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~~PE  164 (277)
T cd05577          91 GFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPE  164 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccccCCCCcCCHH
Confidence            4678888999999999999999999   99999999999999999999999998866533111   12234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----c-cCCccchhhhhHHHHHHHHHHHhhccccCCCCCC---
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----I-DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP---  152 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---  152 (208)
                      .+.+..++.++|+|+||+++++|++|..|+......     + ..........+...+..+.++|.+||+.+|++||   
T Consensus       165 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  244 (277)
T cd05577         165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCR  244 (277)
T ss_pred             HhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCC
Confidence            998888899999999999999999998887543221     1 1001111122334567889999999999999999   


Q ss_pred             --CHHHHHH
Q 028458          153 --TMNDVVC  159 (208)
Q Consensus       153 --s~~~i~~  159 (208)
                        ++.+++.
T Consensus       245 ~~~~~~ll~  253 (277)
T cd05577         245 GGSADEVRE  253 (277)
T ss_pred             cccHHHHHh
Confidence              5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.91  E-value=1.4e-24  Score=169.63  Aligned_cols=152  Identities=25%  Similarity=0.306  Sum_probs=119.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++++|||++........   .....++..|++||
T Consensus        89 ~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE  162 (262)
T cd05572          89 LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPE  162 (262)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---cccccCCcCccChh
Confidence            3577888999999999999999998   99999999999999999999999999876644321   12235677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc----cccCCc--cchhhhhHHHHHHHHHHHhhccccCCCCCCC--
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE----LIDDPV--LEDEYSSKQMLLRYVNIALLCVQESADDRPT--  153 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps--  153 (208)
                      .+....++.++|+|+||+++|++++|..|+.....    ......  ......+...+..+.++|.+||+.+|++||+  
T Consensus       163 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~  242 (262)
T cd05572         163 IILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNL  242 (262)
T ss_pred             HhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCc
Confidence            98888889999999999999999999888754431    111000  0111223334678999999999999999999  


Q ss_pred             ---HHHHHH
Q 028458          154 ---MNDVVC  159 (208)
Q Consensus       154 ---~~~i~~  159 (208)
                         ++|+++
T Consensus       243 ~~~~~~l~~  251 (262)
T cd05572         243 KGGIKDIKK  251 (262)
T ss_pred             ccCHHHHhc
Confidence               777776

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.7e-24  Score=176.69  Aligned_cols=152  Identities=18%  Similarity=0.275  Sum_probs=124.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe-CCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .|....+.+++.||+.||.|+|+..   +|||||||.|+.+ ..-|.+||.|||++..+....   ......|++.|.||
T Consensus       114 Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~---kL~TsCGSLAYSAP  187 (864)
T KOG4717|consen  114 GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK---KLTTSCGSLAYSAP  187 (864)
T ss_pred             cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc---hhhcccchhhccCc
Confidence            4667788999999999999999998   9999999999876 456899999999998765433   23446889999999


Q ss_pred             chhccCCCC-CcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           81 EYAIQGIFS-IKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        81 e~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      |.+.+..|+ .++||||||+++|.+++|..||...-+-  .-...-.....+...+.++.++|..||..||++|.+.++|
T Consensus       188 EILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI  267 (864)
T KOG4717|consen  188 EILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEI  267 (864)
T ss_pred             hhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHH
Confidence            999999884 7799999999999999999998654321  1111122324577788899999999999999999999998


Q ss_pred             HH
Q 028458          158 VC  159 (208)
Q Consensus       158 ~~  159 (208)
                      ..
T Consensus       268 ~s  269 (864)
T KOG4717|consen  268 VS  269 (864)
T ss_pred             hc
Confidence            75

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=2.7e-24  Score=170.22  Aligned_cols=152  Identities=23%  Similarity=0.328  Sum_probs=117.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC-CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.|+.|||++ +   ++|+||+|.||+++.++.++++|||++........    ....++..|+||
T Consensus        98 ~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~aP  170 (286)
T cd06622          98 GIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA----KTNIGCQSYMAP  170 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc----ccCCCccCccCc
Confidence            478889999999999999999964 6   99999999999999999999999998865432221    123456789999


Q ss_pred             chhccCC------CCCcchhHHHHHHHHHHHHhhhcCCccccc--cc---C-CccchhhhhHHHHHHHHHHHhhccccCC
Q 028458           81 EYAIQGI------FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID---D-PVLEDEYSSKQMLLRYVNIALLCVQESA  148 (208)
Q Consensus        81 e~~~~~~------~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~---~-~~~~~~~~~~~~~~~~~~li~~~l~~~p  148 (208)
                      |.+.+..      ++.++|+||||+++|++++|..|+......  ..   . ........+...+.++.++|.+||+.+|
T Consensus       171 E~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  250 (286)
T cd06622         171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIP  250 (286)
T ss_pred             chhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCc
Confidence            9885543      478999999999999999998887432110  00   0 0001112344467788999999999999


Q ss_pred             CCCCCHHHHHHH
Q 028458          149 DDRPTMNDVVCM  160 (208)
Q Consensus       149 ~~Rps~~~i~~~  160 (208)
                      ++||++++++..
T Consensus       251 ~~Rp~~~~l~~~  262 (286)
T cd06622         251 NRRPTYAQLLEH  262 (286)
T ss_pred             ccCCCHHHHhcC
Confidence            999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.91  E-value=1e-24  Score=181.27  Aligned_cols=157  Identities=23%  Similarity=0.304  Sum_probs=127.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      |+..+...++.||+.|+.|||+..   ++||||..+||++....-+||+|||+++-+....+++.. ...-+.-|++||.
T Consensus       488 L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPES  563 (974)
T KOG4257|consen  488 LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPES  563 (974)
T ss_pred             chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccc
Confidence            566677889999999999999998   999999999999999999999999999988766665543 2233678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcc-----cccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRT-----LELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +..+.++.++|||.||+++||++. |..||...     ...+++.  +....+++++..++.++.+||+.+|.+||.+.+
T Consensus       564 INfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG--eRlP~P~nCPp~LYslmskcWayeP~kRPrfte  641 (974)
T KOG4257|consen  564 INFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG--ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTE  641 (974)
T ss_pred             cchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC--CCCCCCCCCChHHHHHHHHHhccCcccCCcHHH
Confidence            999999999999999999999975 54454321     1122211  122457778889999999999999999999999


Q ss_pred             HHHHHhhhh
Q 028458          157 VVCMLTNEA  165 (208)
Q Consensus       157 i~~~l~~~~  165 (208)
                      +...|..+.
T Consensus       642 i~~~lsdv~  650 (974)
T KOG4257|consen  642 IKAILSDVL  650 (974)
T ss_pred             HHHHHHHHH
Confidence            988776543

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.91  E-value=3.4e-24  Score=169.69  Aligned_cols=154  Identities=25%  Similarity=0.376  Sum_probs=119.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.+|.|||+.+   ++|+|++|.||+++.++.++++|||++........  ......++..|.+||
T Consensus       112 ~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE  186 (286)
T cd06614         112 RMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPE  186 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHh
Confidence            5788899999999999999999998   99999999999999999999999998765432211  111234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+|+||+++|++++|..|+.......     .............++..+.++|.+||+.+|.+||++.+
T Consensus       187 ~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  266 (286)
T cd06614         187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEE  266 (286)
T ss_pred             HhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHH
Confidence            9988888999999999999999999987765432110     00111111112235677899999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       267 il~~  270 (286)
T cd06614         267 LLQH  270 (286)
T ss_pred             HhhC
Confidence            9863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.91  E-value=3e-24  Score=168.10  Aligned_cols=155  Identities=25%  Similarity=0.380  Sum_probs=119.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC-CeEEeccccceecCCCcccc--cccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGMARICGGNELQA--NTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~   78 (208)
                      .+++.....++.|++.||.|||+++   ++|+||+|.||+++.++ .++++|||++..........  ......++..|.
T Consensus        99 ~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (268)
T cd06630          99 AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM  175 (268)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccccccccccee
Confidence            3677888999999999999999999   99999999999998775 58999999987654332111  112235678899


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--c---C--CccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--D---D--PVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~---~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      |||.+.+..++.++|+|++|++++++++|..|+.......  .   .  ........+...+.++.+++.+||..+|++|
T Consensus       176 ~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  255 (268)
T cd06630         176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDR  255 (268)
T ss_pred             CHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccC
Confidence            9999988888999999999999999999988775322110  0   0  0001112344566788999999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      |++.++++
T Consensus       256 ~~~~~ll~  263 (268)
T cd06630         256 PPSRELLK  263 (268)
T ss_pred             cCHHHHhc
Confidence            99999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.91  E-value=3.1e-24  Score=167.50  Aligned_cols=152  Identities=29%  Similarity=0.409  Sum_probs=121.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .++...+..++.|+++++.|||+ .+   ++|+||+|+||+++.++.++++|||++..........  ....++..|.||
T Consensus        95 ~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~p  169 (264)
T cd06623          95 KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NTFVGTVTYMSP  169 (264)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc--cceeecccccCH
Confidence            46788899999999999999999 98   9999999999999999999999999987664333221  123467789999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--------cccCCccchhhhhHH-HHHHHHHHHhhccccCCCCC
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--------LIDDPVLEDEYSSKQ-MLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~R  151 (208)
                      |.+.+..++.++|+|+||+++|++++|..|+.....        .+......  ..... .+..+.+++..||+.+|++|
T Consensus       170 E~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R  247 (264)
T cd06623         170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP--SLPAEEFSPEFRDFISACLQKDPKKR  247 (264)
T ss_pred             hhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC--CCCcccCCHHHHHHHHHHccCChhhC
Confidence            999888889999999999999999999887755421        00100110  12223 56789999999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      |++.++++.
T Consensus       248 ~~~~~ll~~  256 (264)
T cd06623         248 PSAAELLQH  256 (264)
T ss_pred             CCHHHHHhC
Confidence            999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5e-24  Score=171.09  Aligned_cols=153  Identities=20%  Similarity=0.201  Sum_probs=116.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-----------------
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-----------------   65 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-----------------   65 (208)
                      +++..+..++.|++++|.|||+.+   ++|+||||+||+++.++.++++|||++.........                 
T Consensus       100 l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (316)
T cd05574         100 LSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI  176 (316)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccccccccccccccccccccc
Confidence            677888999999999999999999   999999999999999999999999987654321100                 


Q ss_pred             ----------ccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhH
Q 028458           66 ----------ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSK  130 (208)
Q Consensus        66 ----------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~  130 (208)
                                .......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+......     +....... ....
T Consensus       177 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~  255 (316)
T cd05574         177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTF-PGSP  255 (316)
T ss_pred             chhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccC-CCcc
Confidence                      0111235677899999998888899999999999999999999887433211     00000000 1111


Q ss_pred             HHHHHHHHHHhhccccCCCCCCC----HHHHHH
Q 028458          131 QMLLRYVNIALLCVQESADDRPT----MNDVVC  159 (208)
Q Consensus       131 ~~~~~~~~li~~~l~~~p~~Rps----~~~i~~  159 (208)
                      ..+..+.+++.+||+.+|++||+    +++++.
T Consensus       256 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         256 PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            25678999999999999999999    666666

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.91  E-value=1.6e-24  Score=168.60  Aligned_cols=151  Identities=25%  Similarity=0.291  Sum_probs=118.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.++.|||+.+   ++|+||+|+||+++.++.++++|||++.......   ......++..|.+||.
T Consensus        99 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~  172 (258)
T cd06632          99 FPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEV  172 (258)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHH
Confidence            678888999999999999999999   9999999999999999999999999887654332   1122356778999999


Q ss_pred             hccCC-CCCcchhHHHHHHHHHHHHhhhcCCcccccc--cC-Cc-cchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--DD-PV-LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~~-~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +.... ++.++|+|+||+++|++++|..|+.......  .. .. ......+......+.+++.+||+.+|++||++.++
T Consensus       173 ~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~  252 (258)
T cd06632         173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAEL  252 (258)
T ss_pred             hcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHH
Confidence            87666 8899999999999999999988875433211  00 00 00111233445778899999999999999999998


Q ss_pred             HH
Q 028458          158 VC  159 (208)
Q Consensus       158 ~~  159 (208)
                      +.
T Consensus       253 l~  254 (258)
T cd06632         253 LE  254 (258)
T ss_pred             hc
Confidence            75

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.9e-24  Score=168.68  Aligned_cols=151  Identities=24%  Similarity=0.219  Sum_probs=116.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++.....      .....++..|.+||
T Consensus        93 ~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe  163 (260)
T cd05611          93 GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPE  163 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChh
Confidence            3677888999999999999999999   99999999999999999999999998865432      11234677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+|+||+++|++++|..|+......     ...... ........++..+.+++.+||+.+|++||++.
T Consensus       164 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~  243 (260)
T cd05611         164 TILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN  243 (260)
T ss_pred             hhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCC
Confidence            998877899999999999999999998876432111     000000 01012224567889999999999999999776


Q ss_pred             HHHHHH
Q 028458          156 DVVCML  161 (208)
Q Consensus       156 ~i~~~l  161 (208)
                      ++.+.|
T Consensus       244 ~~~~~l  249 (260)
T cd05611         244 GYQEIK  249 (260)
T ss_pred             cHHHHH
Confidence            555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.91  E-value=4.4e-24  Score=168.74  Aligned_cols=152  Identities=21%  Similarity=0.252  Sum_probs=113.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.|+.|||+.+   ++|+||+|.||+++.++.++++|||++.........  .....++..|.|||.
T Consensus        97 l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~  171 (284)
T cd07860          97 IPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEI  171 (284)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--cccccccccccCCeE
Confidence            678889999999999999999998   999999999999999999999999988654322211  112235678999998


Q ss_pred             hccCC-CCCcchhHHHHHHHHHHHHhhhcCCcccccc---------cCCc---------c-----------c--hhhhhH
Q 028458           83 AIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------DDPV---------L-----------E--DEYSSK  130 (208)
Q Consensus        83 ~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~~~~---------~-----------~--~~~~~~  130 (208)
                      +.+.. ++.++|+||||+++|++++|..++....+.-         ..+.         .           .  ......
T Consensus       172 ~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (284)
T cd07860         172 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVP  251 (284)
T ss_pred             EecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcc
Confidence            86654 5788999999999999999987653221100         0000         0           0  000011


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          131 QMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       131 ~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ..+..+.++|.+||+.||++||+++++++
T Consensus       252 ~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         252 PLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            23456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.91  E-value=5.5e-24  Score=169.36  Aligned_cols=154  Identities=22%  Similarity=0.327  Sum_probs=119.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.|+.|||+.+   ++|+|++|.||+++.++.++++|||++.........  .....++..|++||
T Consensus       111 ~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE  185 (293)
T cd06647         111 CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPE  185 (293)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc--cccccCChhhcCch
Confidence            3577888999999999999999999   999999999999999999999999987654332211  11234677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc---CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+....++.++|+|+||+++|++++|..|+......  ..   .............+..+.+++.+||..+|++||++++
T Consensus       186 ~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~  265 (293)
T cd06647         186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE  265 (293)
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence            998888899999999999999999998877533211  10   0000110112334567889999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      ++..
T Consensus       266 il~h  269 (293)
T cd06647         266 LLQH  269 (293)
T ss_pred             HhcC
Confidence            9985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.91  E-value=2.8e-24  Score=167.15  Aligned_cols=151  Identities=30%  Similarity=0.391  Sum_probs=117.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC-CCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..++.++.|++.++.|||+++   ++|+||+|.||+++.+ +.++++|||++.........   ....++..|+||
T Consensus        97 ~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~y~aP  170 (256)
T cd08220          97 LLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISP  170 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc---cccccCCcccCc
Confidence            3678889999999999999999999   9999999999999855 45799999998776433221   123467789999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cc---cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      |.+.+..++.++|+||||+++|+++++..++.....  ..   ......  ..+...+..+.+++.+||+.+|++||+++
T Consensus       171 E~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  248 (256)
T cd08220         171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA--PISDRYSPDLRQLILSMLNLDPSKRPQLS  248 (256)
T ss_pred             hhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC--CCCCCcCHHHHHHHHHHccCChhhCCCHH
Confidence            999888889999999999999999998776643211  00   000000  12233566788999999999999999999


Q ss_pred             HHHHH
Q 028458          156 DVVCM  160 (208)
Q Consensus       156 ~i~~~  160 (208)
                      ++++.
T Consensus       249 ~ll~~  253 (256)
T cd08220         249 QIMAQ  253 (256)
T ss_pred             HHhhC
Confidence            99863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.91  E-value=5.2e-24  Score=165.51  Aligned_cols=150  Identities=28%  Similarity=0.302  Sum_probs=120.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++........    ....++..|++||
T Consensus        99 ~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~----~~~~~~~~~~~Pe  171 (256)
T cd08530          99 LIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA----KTQIGTPHYMAPE  171 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCCc----ccccCCccccCHH
Confidence            3677888999999999999999999   99999999999999999999999999876544311    1134677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+|+||++++++++|..|+.....     ........  ......+.++.+++.+||+.+|++||++.+
T Consensus       172 ~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  249 (256)
T cd08530         172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP--PIPPIYSQDLQNFIRSMLQVKPKLRPNCDK  249 (256)
T ss_pred             HHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCchhhCHHHHHHHHHHcCCCcccCCCHHH
Confidence            99888889999999999999999999877643221     11111111  223356678999999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       250 ~l~~  253 (256)
T cd08530         250 ILAS  253 (256)
T ss_pred             HhcC
Confidence            9863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.91  E-value=4.4e-24  Score=188.52  Aligned_cols=161  Identities=23%  Similarity=0.248  Sum_probs=121.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc----------------c
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ----------------A   66 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~----------------~   66 (208)
                      +++..+++++.||++||.|||+++   ++||||||+||+++.++.++++|||++.........                .
T Consensus       110 lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t  186 (932)
T PRK13184        110 TSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT  186 (932)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccc
Confidence            456678899999999999999999   999999999999999999999999998765211100                0


Q ss_pred             cccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccc-hh--hhhHHHHHHHHHHHh
Q 028458           67 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLE-DE--YSSKQMLLRYVNIAL  141 (208)
Q Consensus        67 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~-~~--~~~~~~~~~~~~li~  141 (208)
                      ......|++.|+|||.+.+..++.++|+|||||++|+|++|..|+......  ....... ..  ......+..+.+++.
T Consensus       187 ~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~  266 (932)
T PRK13184        187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAM  266 (932)
T ss_pred             cCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHH
Confidence            011245889999999999888999999999999999999999887542211  1000000 00  011234567889999


Q ss_pred             hccccCCCCCC-CHHHHHHHHhhhhh
Q 028458          142 LCVQESADDRP-TMNDVVCMLTNEAA  166 (208)
Q Consensus       142 ~~l~~~p~~Rp-s~~~i~~~l~~~~~  166 (208)
                      +||+.||++|+ +++++.+.|+....
T Consensus       267 rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        267 KALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHHh
Confidence            99999999997 66777777776543

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.91  E-value=4.6e-24  Score=172.26  Aligned_cols=161  Identities=23%  Similarity=0.230  Sum_probs=121.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-ccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.+||+.+   ++|+||+|.||+++.++.++|+|||++......... .......++..|+||
T Consensus        99 ~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  175 (330)
T cd07834          99 PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP  175 (330)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCc
Confidence            4678889999999999999999999   999999999999999999999999998876543211 111223467789999


Q ss_pred             chhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccc---------c-----------cCC-------------ccchh
Q 028458           81 EYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------I-----------DDP-------------VLEDE  126 (208)
Q Consensus        81 e~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~-----------~~~-------------~~~~~  126 (208)
                      |.+.+. .++.++|+|+||+++|+|++|..++......         .           ...             .....
T Consensus       176 E~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (330)
T cd07834         176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLS  255 (330)
T ss_pred             eeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhH
Confidence            999877 7899999999999999999988766322110         0           000             00000


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhhh
Q 028458          127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       127 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~  165 (208)
                      ......+..+.++|.+||+.+|.+||++.++++.  +++..
T Consensus       256 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         256 KLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             HhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            0112245678899999999999999999999984  66554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.91  E-value=1.2e-25  Score=190.38  Aligned_cols=159  Identities=25%  Similarity=0.422  Sum_probs=127.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccccccccccc--CCCccCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVG--TYGYMSP   80 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~--~~~~~ap   80 (208)
                      +++-+.+.|+..|+.|++||-+-+   +|||||..+|||++.+..+|++|||+++...+.. ....+..-|  +++|+||
T Consensus       728 ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAP  803 (996)
T KOG0196|consen  728 FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAP  803 (996)
T ss_pred             eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC-CccccccCCccceeecCh
Confidence            566788999999999999999998   9999999999999999999999999999775444 222222112  5799999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCC--ccccccc----CCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSN--RTLELID----DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~--~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      |.+..++++.++|+||+|+++||+++ |+.|-.  ..++.++    .-.+   ..+.+++..+++|+..||+.|..+||.
T Consensus       804 EAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRL---PpPmDCP~aL~qLMldCWqkdR~~RP~  880 (996)
T KOG0196|consen  804 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRL---PPPMDCPAALYQLMLDCWQKDRNRRPK  880 (996)
T ss_pred             hHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCC---CCCCCCcHHHHHHHHHHHHHHhhcCCC
Confidence            99999999999999999999999874 543332  2233332    1222   347778889999999999999999999


Q ss_pred             HHHHHHHHhhhhhcc
Q 028458          154 MNDVVCMLTNEAATL  168 (208)
Q Consensus       154 ~~~i~~~l~~~~~~~  168 (208)
                      +.+|+..|.+.....
T Consensus       881 F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  881 FAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHHHHHHHHHhcCc
Confidence            999999998876543

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.91  E-value=2.3e-24  Score=177.07  Aligned_cols=154  Identities=21%  Similarity=0.202  Sum_probs=114.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.||+.||.|||+.+   |+||||||.||+++.++.++|+|||++.......... .....|+..|+|||.
T Consensus       139 ~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~  214 (371)
T cd05622         139 VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEV  214 (371)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc-ccCcccCccccCHHH
Confidence            566778889999999999999999   9999999999999999999999999987654322111 123468899999999


Q ss_pred             hccCC----CCCcchhHHHHHHHHHHHHhhhcCCccccc-----c-cCCccchhhhhHHHHHHHHHHHhhccccCCCC--
Q 028458           83 AIQGI----FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----I-DDPVLEDEYSSKQMLLRYVNIALLCVQESADD--  150 (208)
Q Consensus        83 ~~~~~----~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--  150 (208)
                      +.+..    ++.++|+|||||++|+|++|..|+......     + ..............+..+.++|..|+..++.+  
T Consensus       215 l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~  294 (371)
T cd05622         215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLG  294 (371)
T ss_pred             HhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcC
Confidence            86543    788999999999999999999888543211     1 10000000112245667889999999844433  


Q ss_pred             CCCHHHHHHH
Q 028458          151 RPTMNDVVCM  160 (208)
Q Consensus       151 Rps~~~i~~~  160 (208)
                      |++++++++.
T Consensus       295 r~~~~ei~~h  304 (371)
T cd05622         295 RNGVEEIKRH  304 (371)
T ss_pred             CCCHHHHhcC
Confidence            7799988875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=3.1e-24  Score=185.73  Aligned_cols=157  Identities=29%  Similarity=0.381  Sum_probs=124.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccccccccc-ccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRI-VGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~-~~~~~~~ap   80 (208)
                      .|+....+.++.||+.|++||++..   ++|||+..+||++..+..+|++|||+++.............. .-+..|+||
T Consensus       414 ~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmAp  490 (609)
T KOG0200|consen  414 ALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAP  490 (609)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCH
Confidence            4788899999999999999999998   999999999999999999999999999876555444322111 125679999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHh-hhcCCc---ccccc---c-CCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWD-LWTSNR---TLELI---D-DPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~-~~~~~~---~~~~~---~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |.+....|+.++||||||+++||+++- ..|-..   ..+..   . ...+   ..+..+..+++++++.||+.+|++||
T Consensus       491 Esl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~---~~P~~c~~eiY~iM~~CW~~~p~~RP  567 (609)
T KOG0200|consen  491 ESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRM---EQPEHCSDEIYDLMKSCWNADPEDRP  567 (609)
T ss_pred             HHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHhCCCcccCC
Confidence            999999999999999999999999873 333221   11111   1 1111   34556678899999999999999999


Q ss_pred             CHHHHHHHHhhh
Q 028458          153 TMNDVVCMLTNE  164 (208)
Q Consensus       153 s~~~i~~~l~~~  164 (208)
                      ++.++.+.|...
T Consensus       568 ~F~~~~~~~~~~  579 (609)
T KOG0200|consen  568 TFSECVEFFEKH  579 (609)
T ss_pred             CHHHHHHHHHHH
Confidence            999999999884

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.91  E-value=1e-24  Score=179.76  Aligned_cols=153  Identities=22%  Similarity=0.292  Sum_probs=113.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc-----------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL-----------------   64 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~-----------------   64 (208)
                      .++...+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++........                 
T Consensus        97 ~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~  173 (382)
T cd05625          97 IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF  173 (382)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccc
Confidence            3567778889999999999999999   99999999999999999999999998743210000                 


Q ss_pred             ----------------------------cccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc
Q 028458           65 ----------------------------QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE  116 (208)
Q Consensus        65 ----------------------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~  116 (208)
                                                  ........|++.|+|||.+.+..++.++|+|||||++|+|++|..|+.....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~  253 (382)
T cd05625         174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP  253 (382)
T ss_pred             cccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCH
Confidence                                        0001123578899999999988899999999999999999999988854321


Q ss_pred             c------cc-CCccchhhhhHHHHHHHHHHHhhccccCCCCCCC---HHHHHH
Q 028458          117 L------ID-DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT---MNDVVC  159 (208)
Q Consensus       117 ~------~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~i~~  159 (208)
                      .      .. ...... ......+..+.++|.+|+ .+|.+|++   +.++++
T Consensus       254 ~~~~~~i~~~~~~~~~-p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         254 LETQMKVINWQTSLHI-PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHHHHHccCCCcCC-CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            1      10 000000 112234566778888876 49999997   887775

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.91  E-value=2.4e-24  Score=166.39  Aligned_cols=142  Identities=18%  Similarity=0.066  Sum_probs=110.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++++|||.+........     ...++..|++||.
T Consensus        82 l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~y~aPE~  153 (237)
T cd05576          82 IPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-----GEAVENMYCAPEV  153 (237)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccc-----cCCcCccccCCcc
Confidence            678889999999999999999999   99999999999999999999999998765433211     1233567999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      +.+..++.++|+|++|+++|++++|..++......... .. ....+...+..+.+++.+||+.||++||++
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT-HT-TLNIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc-cc-ccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            88788899999999999999999987654322211110 00 001233455678899999999999999987

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.91  E-value=4e-24  Score=173.24  Aligned_cols=160  Identities=25%  Similarity=0.269  Sum_probs=118.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc---ccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ---ANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++.........   .......++..|+
T Consensus       103 ~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~  179 (337)
T cd07852         103 ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR  179 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhccccccccc
Confidence            3678888999999999999999998   999999999999999999999999988765332211   1112245678899


Q ss_pred             Ccchhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccccc---------cC------------------------Cccc
Q 028458           79 SPEYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------DD------------------------PVLE  124 (208)
Q Consensus        79 ape~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~~------------------------~~~~  124 (208)
                      |||.+.+ ..++.++|+||||+++|+|++|..++.......         ..                        ....
T Consensus       180 aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (337)
T cd07852         180 APEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKP  259 (337)
T ss_pred             CceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccc
Confidence            9998765 446889999999999999999987663211000         00                        0000


Q ss_pred             hhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhh
Q 028458          125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNE  164 (208)
Q Consensus       125 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~  164 (208)
                      ........+..+.++|.+||+.+|++||++.++++.  +++.
T Consensus       260 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         260 LDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             hhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            000111235678899999999999999999999985  4444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.91  E-value=4.9e-24  Score=170.34  Aligned_cols=155  Identities=21%  Similarity=0.250  Sum_probs=113.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccccc---------ccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN---------TSRIV   72 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~---------~~~~~   72 (208)
                      .+++..+..++.|+++||.|||+.+   ++|+||+|.||+++.++.++++|||++...........         .....
T Consensus       111 ~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (311)
T cd07866         111 KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV  187 (311)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccce
Confidence            3678899999999999999999999   99999999999999999999999999875533221111         11124


Q ss_pred             cCCCccCcchhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccc--------------------------c----CC
Q 028458           73 GTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--------------------------D----DP  121 (208)
Q Consensus        73 ~~~~~~ape~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--------------------------~----~~  121 (208)
                      ++..|.|||.+.+. .++.++|+||||+++|+|++|..++.......                          .    ..
T Consensus       188 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (311)
T cd07866         188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFT  267 (311)
T ss_pred             eccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCC
Confidence            56779999987654 47889999999999999999876653211100                          0    00


Q ss_pred             ccchh--hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          122 VLEDE--YSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       122 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .....  .........+.+++.+||+.||++||++.+++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         268 NYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00000  001122356789999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.91  E-value=1.4e-24  Score=192.61  Aligned_cols=155  Identities=25%  Similarity=0.339  Sum_probs=115.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCC----CceEeeCCCCCeeEeCC-----------------CCCeEEeccccceecC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSR----VRIIHRDLKVSNILLDK-----------------DMNPKISDFGMARICG   60 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~----~~i~h~~l~~~nil~~~-----------------~~~~~l~dfg~~~~~~   60 (208)
                      .|++..++.|+.||+.||.|||+.+.    ..|+|+||||.|||++.                 .+.++|+|||++....
T Consensus       114 ~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~  193 (1021)
T PTZ00266        114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG  193 (1021)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccc
Confidence            37888999999999999999998431    12999999999999953                 3458999999987654


Q ss_pred             CCcccccccccccCCCccCcchhcc--CCCCCcchhHHHHHHHHHHHHhhhcCCccccc---ccCCccchhhhhHHHHHH
Q 028458           61 GNELQANTSRIVGTYGYMSPEYAIQ--GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---IDDPVLEDEYSSKQMLLR  135 (208)
Q Consensus        61 ~~~~~~~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  135 (208)
                      ....   .....+++.|+|||.+.+  ..++.++|||||||++|+|++|..|+......   +..............+.+
T Consensus       194 ~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~e  270 (1021)
T PTZ00266        194 IESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKE  270 (1021)
T ss_pred             cccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHH
Confidence            3221   122467899999999864  34788999999999999999999887532211   110000000112234567


Q ss_pred             HHHHHhhccccCCCCCCCHHHHHH
Q 028458          136 YVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       136 ~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      +.+||..||+.+|.+||++.+++.
T Consensus       271 L~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        271 LNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHHHHHHHhcCChhHCcCHHHHhc
Confidence            899999999999999999999985

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.91  E-value=9.9e-25  Score=171.16  Aligned_cols=149  Identities=22%  Similarity=0.282  Sum_probs=111.0

Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC-CCeEEeccccceecCCCcccccccccccCCCccCcchhc
Q 028458            6 VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI   84 (208)
Q Consensus         6 ~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~   84 (208)
                      ..+.-+..||++||.|||+.+   |+||||||.|+++|.+ |.+||||||.+.........   .....+..|+|||.+.
T Consensus       125 ~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELif  198 (364)
T KOG0658|consen  125 LEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIF  198 (364)
T ss_pred             eeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHc
Confidence            344567899999999999998   9999999999999976 89999999999876433321   2234577899999998


Q ss_pred             cCC-CCCcchhHHHHHHHHHHHHhhhcC--Ccccc---------------c----------ccCCccchh----hhhHHH
Q 028458           85 QGI-FSIKSDVFSFGVLLLEIAWDLWTS--NRTLE---------------L----------IDDPVLEDE----YSSKQM  132 (208)
Q Consensus        85 ~~~-~~~~~Dv~slG~~~~~l~~~~~~~--~~~~~---------------~----------~~~~~~~~~----~~~~~~  132 (208)
                      +.. |+.+.|+||.||++.||+.|..-|  .+..+               .          ...+.+...    ......
T Consensus       199 ga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~  278 (364)
T KOG0658|consen  199 GATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRL  278 (364)
T ss_pred             CccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCC
Confidence            755 899999999999999997665322  11100               0          000111111    123345


Q ss_pred             HHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          133 LLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       133 ~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      +.+..+++.++++.+|++|-++.|++..
T Consensus       279 ~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  279 PPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            6778899999999999999999998874

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.91  E-value=5.2e-24  Score=167.06  Aligned_cols=151  Identities=27%  Similarity=0.362  Sum_probs=114.5

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-CCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +...+..++.|++.|+.|||+.+   ++|+||+|.||+++. .+.++|+|||++.........  .....++..|.|||.
T Consensus       106 ~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~  180 (268)
T cd06624         106 NEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEV  180 (268)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--cccCCCCccccChhh
Confidence            56778889999999999999998   999999999999976 678999999998765322211  112346788999999


Q ss_pred             hccCC--CCCcchhHHHHHHHHHHHHhhhcCCcccccc----cCCc-cchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           83 AIQGI--FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI----DDPV-LEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        83 ~~~~~--~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      +....  ++.++|+||||+++|++++|..|+.......    .... ......+......+.+++.+||+.+|++||++.
T Consensus       181 ~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  260 (268)
T cd06624         181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAH  260 (268)
T ss_pred             hccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHH
Confidence            86544  7889999999999999999987765322110    0000 000122334566788999999999999999999


Q ss_pred             HHHH
Q 028458          156 DVVC  159 (208)
Q Consensus       156 ~i~~  159 (208)
                      +++.
T Consensus       261 ~ll~  264 (268)
T cd06624         261 DLLQ  264 (268)
T ss_pred             HHHh
Confidence            9876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.91  E-value=1.7e-24  Score=168.85  Aligned_cols=158  Identities=24%  Similarity=0.278  Sum_probs=118.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc------ccccccccCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ------ANTSRIVGTY   75 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~   75 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++.........      .......++.
T Consensus        89 ~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (265)
T cd05579          89 SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP  165 (265)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCc
Confidence            3678889999999999999999999   999999999999999999999999987654332110      0112234677


Q ss_pred             CccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHH--HHHHHHHHHhhccccCCCCC
Q 028458           76 GYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQ--MLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        76 ~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~R  151 (208)
                      .|++||.......+.++|+|+||++++++++|..++......  ...........+..  .+..+.+++.+||+.+|++|
T Consensus       166 ~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  245 (265)
T cd05579         166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKR  245 (265)
T ss_pred             cccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhc
Confidence            899999998888899999999999999999998876433211  10000000011112  26778999999999999999


Q ss_pred             CCHHHHHHHHh
Q 028458          152 PTMNDVVCMLT  162 (208)
Q Consensus       152 ps~~~i~~~l~  162 (208)
                      |++.++.+.|+
T Consensus       246 pt~~~~~~~l~  256 (265)
T cd05579         246 LGAKSIEEIKN  256 (265)
T ss_pred             CCCccHHHHhc
Confidence            99966655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.91  E-value=4e-24  Score=169.61  Aligned_cols=153  Identities=22%  Similarity=0.269  Sum_probs=112.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|+++||.|||+.+   ++|+||+|.||+++.++.++++|||++..........  ....++..|.|||
T Consensus        99 ~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE  173 (291)
T cd07844          99 GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY--SNEVVTLWYRPPD  173 (291)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCccc--cccccccccCCcH
Confidence            3577889999999999999999999   9999999999999999999999999876542211111  1123467899999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc----------ccCC--------------------ccchhhh--
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL----------IDDP--------------------VLEDEYS--  128 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----------~~~~--------------------~~~~~~~--  128 (208)
                      .+.+ ..++.++|+||+|+++|+|++|..++......          ...+                    .......  
T Consensus       174 ~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (291)
T cd07844         174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLIN  253 (291)
T ss_pred             HhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHH
Confidence            8865 45788999999999999999998776432200          0000                    0000000  


Q ss_pred             -hHHHH--HHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          129 -SKQML--LRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       129 -~~~~~--~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                       .....  ..+.+++.+||+.+|++||++.+++.
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         254 HAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence             00111  56779999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.91  E-value=6.9e-24  Score=170.56  Aligned_cols=153  Identities=31%  Similarity=0.417  Sum_probs=118.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.++.|||+.+   ++|+||+|.||+++.++.++++|||++......      ....++..|.|||
T Consensus       121 ~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE  191 (317)
T cd06635         121 PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPE  191 (317)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc------ccccCCccccChh
Confidence            3678899999999999999999999   999999999999999999999999987654321      1234677899999


Q ss_pred             hhc---cCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           82 YAI---QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        82 ~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      .+.   .+.++.++|+||||+++|+|++|..|+......     ....... .......+..+.+++.+||+.+|.+||+
T Consensus       192 ~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt  270 (317)
T cd06635         192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-TLQSNEWSDYFRNFVDSCLQKIPQDRPT  270 (317)
T ss_pred             hhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC-CCCCccccHHHHHHHHHHccCCcccCcC
Confidence            874   355788999999999999999998876432211     0000000 0122334567889999999999999999


Q ss_pred             HHHHHHHHhhh
Q 028458          154 MNDVVCMLTNE  164 (208)
Q Consensus       154 ~~~i~~~l~~~  164 (208)
                      +.++++.+-..
T Consensus       271 ~~~il~~~~~~  281 (317)
T cd06635         271 SEELLKHMFVL  281 (317)
T ss_pred             HHHHHhChhhh
Confidence            99999865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.91  E-value=2.8e-24  Score=173.96  Aligned_cols=154  Identities=19%  Similarity=0.203  Sum_probs=114.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++......... ......|+..|+|||+
T Consensus        99 l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~  174 (332)
T cd05623          99 LPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEI  174 (332)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcc-eecccccCccccCHHH
Confidence            567788899999999999999999   999999999999999999999999998654322211 1122467899999999


Q ss_pred             hc-----cCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--ccc---CC--ccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           83 AI-----QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LID---DP--VLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        83 ~~-----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~---~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      +.     ...++.++|+||||+++|+|++|..|+.....  ...   ..  ...........+..+.+++++|+..++.+
T Consensus       175 ~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r  254 (332)
T cd05623         175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHR  254 (332)
T ss_pred             HhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhh
Confidence            86     24578899999999999999999988753321  110   00  00000112234667889999998765544


Q ss_pred             --CCCHHHHHHH
Q 028458          151 --RPTMNDVVCM  160 (208)
Q Consensus       151 --Rps~~~i~~~  160 (208)
                        |++++++++.
T Consensus       255 ~~r~~~~~~~~h  266 (332)
T cd05623         255 LGQNGIEDFKQH  266 (332)
T ss_pred             cCCCCHHHHhCC
Confidence              6789998875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.91  E-value=4.3e-24  Score=169.48  Aligned_cols=152  Identities=21%  Similarity=0.230  Sum_probs=112.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++.........  .....++..|+|||.
T Consensus       100 ~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~  174 (291)
T cd07870         100 LHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDV  174 (291)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCCce
Confidence            466778889999999999999999   999999999999999999999999988654322111  112345778999998


Q ss_pred             hccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccccC---------------------------Cccch--hhh----
Q 028458           83 AIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD---------------------------PVLED--EYS----  128 (208)
Q Consensus        83 ~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~---------------------------~~~~~--~~~----  128 (208)
                      +.+. .++.++|+||||+++|+|++|..++.........                           .....  ...    
T Consensus       175 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (291)
T cd07870         175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVV  254 (291)
T ss_pred             eecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhh
Confidence            8654 4788899999999999999998776432211000                           00000  000    


Q ss_pred             --hHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          129 --SKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       129 --~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                        .......+.+++.+|+..||++||++++++.
T Consensus       255 ~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         255 WKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence              0011346789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.91  E-value=3.6e-24  Score=171.57  Aligned_cols=150  Identities=31%  Similarity=0.399  Sum_probs=117.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.++.|||+.+   ++|+||+|.||+++.++.++++|||++.......      ...++..|+|||
T Consensus       111 ~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~y~aPE  181 (308)
T cd06634         111 PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPE  181 (308)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCcc------cccCCccccCHH
Confidence            3677889999999999999999998   9999999999999999999999999887653221      234677899999


Q ss_pred             hhc---cCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           82 YAI---QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        82 ~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      .+.   ...++.++|+||||+++|++++|..|+......     ...... ........+..+.++|.+||+.+|++||+
T Consensus       182 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~  260 (308)
T cd06634         182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PALQSGHWSEYFRNFVDSCLQKIPQDRPT  260 (308)
T ss_pred             HHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-CCcCcccccHHHHHHHHHHhhCCcccCCC
Confidence            874   345788999999999999999998776432110     010111 10123345667889999999999999999


Q ss_pred             HHHHHHHH
Q 028458          154 MNDVVCML  161 (208)
Q Consensus       154 ~~~i~~~l  161 (208)
                      +.+++..-
T Consensus       261 ~~~ll~~~  268 (308)
T cd06634         261 SEVLLKHR  268 (308)
T ss_pred             HHHHhhCc
Confidence            99999763

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.91  E-value=2.9e-24  Score=171.79  Aligned_cols=159  Identities=20%  Similarity=0.252  Sum_probs=117.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc-------------cccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL-------------QANT   68 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~-------------~~~~   68 (208)
                      .+++..+..++.|++.|+.|||+.+   ++|+||+|.||+++.++.++++|||++........             ....
T Consensus        97 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (305)
T cd05609          97 ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD  173 (305)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccc
Confidence            3577888999999999999999998   99999999999999999999999998753210000             0001


Q ss_pred             cccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccc--ccccC---CccchhhhhHHHHHHHHHHHhhc
Q 028458           69 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL--ELIDD---PVLEDEYSSKQMLLRYVNIALLC  143 (208)
Q Consensus        69 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~li~~~  143 (208)
                      ....++..|+|||.+.+..++.++|+||||+++|++++|..|+....  +....   ............+..+.++|.+|
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  253 (305)
T cd05609         174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRL  253 (305)
T ss_pred             cCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHH
Confidence            11345678999999988889999999999999999999987764221  11110   00000011123456789999999


Q ss_pred             cccCCCCCCCHHHHHHHHhh
Q 028458          144 VQESADDRPTMNDVVCMLTN  163 (208)
Q Consensus       144 l~~~p~~Rps~~~i~~~l~~  163 (208)
                      |+.+|++||+..++.+.|+.
T Consensus       254 l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         254 LRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hccChhhccCccCHHHHHhC
Confidence            99999999997666666655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.91  E-value=1.8e-24  Score=176.79  Aligned_cols=153  Identities=19%  Similarity=0.234  Sum_probs=115.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCC--------------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG--------------------   61 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~--------------------   61 (208)
                      .|+...+.-++.+++-||..||+.|   ++||||||+|+|+|..|++||+|||++.....                    
T Consensus       237 ~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~  313 (550)
T KOG0605|consen  237 TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEA  313 (550)
T ss_pred             cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccC
Confidence            4677788899999999999999999   99999999999999999999999999842210                    


Q ss_pred             --Ccccc---cc--------------------cccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc
Q 028458           62 --NELQA---NT--------------------SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE  116 (208)
Q Consensus        62 --~~~~~---~~--------------------~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~  116 (208)
                        .....   ..                    ...+||+.|+|||++.+..|+..+|+|||||++|||+.|.+||....-
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp  393 (550)
T KOG0605|consen  314 KPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETP  393 (550)
T ss_pred             CCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence              00000   00                    123689999999999999999999999999999999999999854321


Q ss_pred             ------ccc-CCccchhhhhHHHHHHHHHHHhhccccCCCCCCC---HHHHHH
Q 028458          117 ------LID-DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT---MNDVVC  159 (208)
Q Consensus       117 ------~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~i~~  159 (208)
                            ++. ...+.. ........+..++|.+|+. ||++|--   ++||-+
T Consensus       394 ~~T~rkI~nwr~~l~f-P~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  394 QETYRKIVNWRETLKF-PEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK  444 (550)
T ss_pred             HHHHHHHHHHhhhccC-CCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence                  110 001111 1122234678899999999 9999974   666655

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=8.2e-24  Score=167.71  Aligned_cols=150  Identities=33%  Similarity=0.467  Sum_probs=116.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++......++.|++.||.|||+.+   ++|+|++|.||+++.++.++++|||++........    ....++..|.+||.
T Consensus       102 l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~  174 (287)
T cd06621         102 IGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPER  174 (287)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCccccCHHH
Confidence            566778899999999999999999   99999999999999999999999999765432221    12345678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc-------ccc---C---Cccchh-hhhHHHHHHHHHHHhhccccCC
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE-------LID---D---PVLEDE-YSSKQMLLRYVNIALLCVQESA  148 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~---~---~~~~~~-~~~~~~~~~~~~li~~~l~~~p  148 (208)
                      +.+..++.++|+|+||+++|+|++|..|+.....       ...   .   ..+... ......+..+.+++.+||+.+|
T Consensus       175 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  254 (287)
T cd06621         175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDP  254 (287)
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCc
Confidence            9888899999999999999999999887754411       000   0   000000 0001234678899999999999


Q ss_pred             CCCCCHHHHHH
Q 028458          149 DDRPTMNDVVC  159 (208)
Q Consensus       149 ~~Rps~~~i~~  159 (208)
                      ++||++.|+++
T Consensus       255 ~~Rpt~~eil~  265 (287)
T cd06621         255 TRRPTPWDMLE  265 (287)
T ss_pred             ccCCCHHHHHh
Confidence            99999999998

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.6e-24  Score=178.18  Aligned_cols=154  Identities=19%  Similarity=0.226  Sum_probs=113.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc------------c---
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ------------A---   66 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~------------~---   66 (208)
                      .++...+..++.|++.||.|||+.+   ++||||||.||+++.++.++++|||++.........            .   
T Consensus        97 ~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~  173 (377)
T cd05629          97 TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI  173 (377)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccc
Confidence            3567778889999999999999999   999999999999999999999999998532110000            0   


Q ss_pred             ------------------------------cccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc
Q 028458           67 ------------------------------NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE  116 (208)
Q Consensus        67 ------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~  116 (208)
                                                    ......|+..|+|||.+.+..++.++|+|||||++|+|++|..|+.....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~  253 (377)
T cd05629         174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENS  253 (377)
T ss_pred             ccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCH
Confidence                                          00013578899999999888899999999999999999999988753221


Q ss_pred             --ccc---C--CccchhhhhHHHHHHHHHHHhhccccCCCCC---CCHHHHHHH
Q 028458          117 --LID---D--PVLEDEYSSKQMLLRYVNIALLCVQESADDR---PTMNDVVCM  160 (208)
Q Consensus       117 --~~~---~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---ps~~~i~~~  160 (208)
                        ...   .  ..+.- ......+..+.++|.+|+. +|.+|   +++.+++..
T Consensus       254 ~~~~~~i~~~~~~~~~-p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         254 HETYRKIINWRETLYF-PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             HHHHHHHHccCCccCC-CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence              110   0  00000 0111245678899999997 67665   599998875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.90  E-value=6.9e-24  Score=173.31  Aligned_cols=151  Identities=24%  Similarity=0.261  Sum_probs=125.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC----CCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD----MNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      ++...+..++.|++.++.|||+.|   ++|||+||+|+++...    +.++++|||++.....   ........|++.|+
T Consensus       132 ~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~  205 (382)
T KOG0032|consen  132 YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYV  205 (382)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCcccc
Confidence            677889999999999999999999   9999999999999643    4799999999998765   23344468999999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc------c-CCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------D-DPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      |||++....|+..+|+||+|+++|.|++|..||....+..      . +..... .........+.++|+.|+..||.+|
T Consensus       206 APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~-~~w~~is~~akd~i~~ll~~dp~~R  284 (382)
T KOG0032|consen  206 APEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS-EPWDDISESAKDFIRKLLEFDPRKR  284 (382)
T ss_pred             CchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC-CCccccCHHHHHHHHHhcccCcccC
Confidence            9999998999999999999999999999998886554321      1 111111 3344557788999999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      +++.++++.
T Consensus       285 ~ta~~~L~H  293 (382)
T KOG0032|consen  285 LTAAQALQH  293 (382)
T ss_pred             CCHHHHhcC
Confidence            999999994

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.90  E-value=1.1e-24  Score=179.17  Aligned_cols=155  Identities=21%  Similarity=0.247  Sum_probs=114.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc-----------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL-----------------   64 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~-----------------   64 (208)
                      .++...+..++.||+.||.|||+.+   |+||||||.||+++.++.++|+|||++..+.....                 
T Consensus        97 ~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~  173 (376)
T cd05598          97 IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP  173 (376)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccc
Confidence            3566778889999999999999999   99999999999999999999999998743210000                 


Q ss_pred             ------------------------cccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc---
Q 028458           65 ------------------------QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---  117 (208)
Q Consensus        65 ------------------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---  117 (208)
                                              ........|+..|+|||.+.+..++.++|+|||||++|+|++|..|+......   
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~  253 (376)
T cd05598         174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQ  253 (376)
T ss_pred             cccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHH
Confidence                                    00011236888999999999888999999999999999999999887543211   


Q ss_pred             --ccCCc-cchhhhhHHHHHHHHHHHhhccccCCCCCC---CHHHHHHH
Q 028458          118 --IDDPV-LEDEYSSKQMLLRYVNIALLCVQESADDRP---TMNDVVCM  160 (208)
Q Consensus       118 --~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~i~~~  160 (208)
                        +.... ..........+..+.++|.+|+ .+|.+|+   ++.++++.
T Consensus       254 ~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         254 LKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             HHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence              10000 0000111234556778888876 5999999   88998875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.90  E-value=3e-24  Score=170.47  Aligned_cols=150  Identities=23%  Similarity=0.264  Sum_probs=117.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.|+++||.|||+.+   ++|+||+|.||+++.++.++++|||++......     .....++..|++||
T Consensus        97 ~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE  168 (290)
T cd05580          97 RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPE  168 (290)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChh
Confidence            3677888999999999999999999   999999999999999999999999998765443     12235678899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----CH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----TM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~  154 (208)
                      .+.+...+.++|+|+||+++|+|++|..|+......  ...........+...+..+.+++.+||+.||.+|+     ++
T Consensus       169 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~  248 (290)
T cd05580         169 IILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGV  248 (290)
T ss_pred             hhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCH
Confidence            998888889999999999999999998876433211  11000001122334467888999999999999999     66


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      +++++
T Consensus       249 ~~l~~  253 (290)
T cd05580         249 NDIKN  253 (290)
T ss_pred             HHHHc
Confidence            66664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.90  E-value=7.6e-24  Score=172.10  Aligned_cols=156  Identities=24%  Similarity=0.281  Sum_probs=117.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++.......     ....++..|+|||
T Consensus       113 ~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE  184 (342)
T cd07879         113 PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPE  184 (342)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChh
Confidence            4677888999999999999999999   9999999999999999999999999876542211     1234567899999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c------------------cC----------Cccchhh---
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I------------------DD----------PVLEDEY---  127 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~------------------~~----------~~~~~~~---  127 (208)
                      .+.+ ..++.++|+||||+++|+|++|..++......  +                  ..          +......   
T Consensus       185 ~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (342)
T cd07879         185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFST  264 (342)
T ss_pred             hhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHH
Confidence            8866 45788999999999999999998776432110  0                  00          0000000   


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhhh
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~  165 (208)
                      ..+..+..+.++|.+||+.||++||++.+++..  ++...
T Consensus       265 ~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         265 LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            011234567899999999999999999999964  66654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.90  E-value=1.2e-23  Score=169.95  Aligned_cols=159  Identities=25%  Similarity=0.318  Sum_probs=114.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCc-ccc----cccccccCCCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE-LQA----NTSRIVGTYGY   77 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~----~~~~~~~~~~~   77 (208)
                      +++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++++||+......... ...    ......++..|
T Consensus        98 ~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  174 (328)
T cd08226          98 MSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPW  174 (328)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCc
Confidence            567788899999999999999998   9999999999999999999999997543221110 000    01112245679


Q ss_pred             cCcchhccC--CCCCcchhHHHHHHHHHHHHhhhcCCcccccc------cC-----------------------------
Q 028458           78 MSPEYAIQG--IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------DD-----------------------------  120 (208)
Q Consensus        78 ~ape~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~-----------------------------  120 (208)
                      ++||.+.+.  .++.++|+||||+++|++++|..|+.......      ..                             
T Consensus       175 ~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (328)
T cd08226         175 LSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGI  254 (328)
T ss_pred             cChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhccc
Confidence            999998764  36889999999999999999887764321100      00                             


Q ss_pred             ---------------CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhhh
Q 028458          121 ---------------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       121 ---------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~  165 (208)
                                     ..+. ..........+.+++++||+.||++||+++++++.  ++...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         255 GESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             ccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                           0000 01123356678999999999999999999999863  44443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.90  E-value=2.7e-24  Score=167.67  Aligned_cols=151  Identities=26%  Similarity=0.270  Sum_probs=118.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.|++++|.|||+++   ++|+||+|.||+++.++.++++|||++........   .....++..|++||
T Consensus        96 ~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~~PE  169 (258)
T cd05578          96 KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPE  169 (258)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCcc---ccccCCChhhcCHH
Confidence            4677889999999999999999998   99999999999999999999999999876543321   12234677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc----c-ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH--
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE----L-IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM--  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--  154 (208)
                      .+.+..++.++|+|+||+++|++++|..|+.....    . ...........+...+..+.++|.+||+.||.+||++  
T Consensus       170 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~  249 (258)
T cd05578         170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNL  249 (258)
T ss_pred             HHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccH
Confidence            99888889999999999999999999887654331    1 1100101112344456789999999999999999999  


Q ss_pred             HHHH
Q 028458          155 NDVV  158 (208)
Q Consensus       155 ~~i~  158 (208)
                      +|++
T Consensus       250 ~~l~  253 (258)
T cd05578         250 KDLK  253 (258)
T ss_pred             HHHh
Confidence            5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=1.8e-24  Score=181.65  Aligned_cols=152  Identities=28%  Similarity=0.305  Sum_probs=121.9

Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCcchh
Q 028458            5 WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSPEYA   83 (208)
Q Consensus         5 ~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ape~~   83 (208)
                      ......++.||+.|+.||.++.   +|||||..+|+++...-.+||+|||+.+-.+...... ......-+..|.|||.+
T Consensus       211 v~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsL  287 (1039)
T KOG0199|consen  211 VSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESL  287 (1039)
T ss_pred             HHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHh
Confidence            4456789999999999999998   9999999999999998899999999998776554433 33333446789999999


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHH-hhhcCCc-----ccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           84 IQGIFSIKSDVFSFGVLLLEIAW-DLWTSNR-----TLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        84 ~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +.++|+.++|+|+||+++|||++ |..|+..     ..+.+++.  +....+..++++++++++.||..+|.+||++..|
T Consensus       288 rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--erLpRPk~csedIY~imk~cWah~paDRptFsai  365 (1039)
T KOG0199|consen  288 RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAI  365 (1039)
T ss_pred             ccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc--ccCCCCCCChHHHHHHHHHhccCCccccccHHHH
Confidence            99999999999999999999997 4445532     22233311  1113477788899999999999999999999999


Q ss_pred             HHHH
Q 028458          158 VCML  161 (208)
Q Consensus       158 ~~~l  161 (208)
                      .+.+
T Consensus       366 r~~~  369 (1039)
T KOG0199|consen  366 REDL  369 (1039)
T ss_pred             HHhH
Confidence            8543

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.90  E-value=3.8e-24  Score=166.08  Aligned_cols=152  Identities=24%  Similarity=0.314  Sum_probs=119.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|||++........  ......++..|.|||
T Consensus        99 ~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe  173 (258)
T cd08215          99 PFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPE  173 (258)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcc--eecceeeeecccChh
Confidence            4678889999999999999999998   99999999999999999999999999876544321  112235677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cc---cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      ...+..++.++|+|++|++++++++|..++.....  ..   ......  ..+...+..+.+++.+||+.+|++||++.+
T Consensus       174 ~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  251 (258)
T cd08215         174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP--PIPSQYSSELRNLVSSLLQKDPEERPSIAQ  251 (258)
T ss_pred             HhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            99888889999999999999999998877643211  00   001111  122245567889999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       252 ll~~  255 (258)
T cd08215         252 ILQS  255 (258)
T ss_pred             HhcC
Confidence            8863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.90  E-value=6.5e-24  Score=165.76  Aligned_cols=154  Identities=26%  Similarity=0.337  Sum_probs=117.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccc--cccccCCCccCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT--SRIVGTYGYMSP   80 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~--~~~~~~~~~~ap   80 (208)
                      +++..+..++.|++.|+.|||+.+   ++|+||+|.||+++.++.++++|||++............  ....++..|++|
T Consensus        96 ~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~P  172 (264)
T cd06626          96 LDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP  172 (264)
T ss_pred             CChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccCh
Confidence            677888999999999999999999   999999999999999999999999998766433322111  123457789999


Q ss_pred             chhccCC---CCCcchhHHHHHHHHHHHHhhhcCCccccccc----CCccchhhhhH--HHHHHHHHHHhhccccCCCCC
Q 028458           81 EYAIQGI---FSIKSDVFSFGVLLLEIAWDLWTSNRTLELID----DPVLEDEYSSK--QMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        81 e~~~~~~---~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R  151 (208)
                      |.+.+..   ++.++|+|+||++++++++|..|+........    .........+.  ..+..+.+++.+||+.+|++|
T Consensus       173 E~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  252 (264)
T cd06626         173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKR  252 (264)
T ss_pred             hhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccC
Confidence            9987766   78999999999999999999888753311100    00000001111  225677899999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      |++.+++.
T Consensus       253 ~~~~~i~~  260 (264)
T cd06626         253 PTASELLQ  260 (264)
T ss_pred             CCHHHHhc
Confidence            99999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.4e-24  Score=177.95  Aligned_cols=154  Identities=23%  Similarity=0.345  Sum_probs=122.4

Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            1 MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         1 ~~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      ++|+..++--++.|++.||.|||+++   |||||||.-||++.-+|.++|+|||++-....  .......+.|++.|+||
T Consensus       125 r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAP  199 (1187)
T KOG0579|consen  125 RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAP  199 (1187)
T ss_pred             cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HHhhhccccCCcccccc
Confidence            46788888999999999999999999   99999999999999999999999998754321  11122347899999999


Q ss_pred             chhc-----cCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           81 EYAI-----QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        81 e~~~-----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      |+..     ..+|++++||||||+.+.+|+-+.+|....-.  .   +....-+....+..+...+.+|+.+||..||..
T Consensus       200 EVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~  279 (1187)
T KOG0579|consen  200 EVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRN  279 (1187)
T ss_pred             hheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCcc
Confidence            9863     46799999999999999999988777654321  1   111222222346677888999999999999999


Q ss_pred             CCCHHHHHH
Q 028458          151 RPTMNDVVC  159 (208)
Q Consensus       151 Rps~~~i~~  159 (208)
                      ||++.++++
T Consensus       280 Rp~aaqll~  288 (1187)
T KOG0579|consen  280 RPPAAQLLK  288 (1187)
T ss_pred             CCCHHHHhh
Confidence            999998876

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.90  E-value=8.3e-24  Score=167.38  Aligned_cols=153  Identities=27%  Similarity=0.392  Sum_probs=118.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.++.|||+ .+   ++|+||+|.||+++.++.++++|||++.......    .....++..|.||
T Consensus        99 ~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aP  171 (284)
T cd06620          99 PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSP  171 (284)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCH
Confidence            46788899999999999999997 46   9999999999999999999999999876542211    1224578899999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-------------ccCCcc--chhhhhHHHHHHHHHHHhhccc
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-------------IDDPVL--EDEYSSKQMLLRYVNIALLCVQ  145 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-------------~~~~~~--~~~~~~~~~~~~~~~li~~~l~  145 (208)
                      |.+.+..++.++|+||||+++|++++|..|+......             ......  .........+..+.+++.+||+
T Consensus       172 E~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  251 (284)
T cd06620         172 ERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLL  251 (284)
T ss_pred             HHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhc
Confidence            9998888899999999999999999998887543221             000000  0001112245678899999999


Q ss_pred             cCCCCCCCHHHHHHHH
Q 028458          146 ESADDRPTMNDVVCML  161 (208)
Q Consensus       146 ~~p~~Rps~~~i~~~l  161 (208)
                      .||++||++.|+++..
T Consensus       252 ~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         252 KDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCcccCcCHHHHhcCc
Confidence            9999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.90  E-value=6.7e-24  Score=168.89  Aligned_cols=153  Identities=20%  Similarity=0.265  Sum_probs=118.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.+++|||+.+   ++|+|++|.||+++.++.++++|||++.........  .....++..|++||.
T Consensus       113 ~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~pE~  187 (292)
T cd06657         113 MNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEL  187 (292)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccccccCccccCHHH
Confidence            577888999999999999999998   999999999999999999999999988765432211  122356788999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc--CCccchh-hhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID--DPVLEDE-YSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~--~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +.+..++.++|+|++|+++|++++|..|+......  ..  ....... ......+..+.+++.+||+.+|.+||++.++
T Consensus       188 ~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~l  267 (292)
T cd06657         188 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL  267 (292)
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHH
Confidence            98888899999999999999999988776432111  00  0001100 0122345668899999999999999999998


Q ss_pred             HHH
Q 028458          158 VCM  160 (208)
Q Consensus       158 ~~~  160 (208)
                      ++.
T Consensus       268 l~~  270 (292)
T cd06657         268 LKH  270 (292)
T ss_pred             hcC
Confidence            883

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.90  E-value=2.1e-23  Score=164.38  Aligned_cols=153  Identities=25%  Similarity=0.284  Sum_probs=115.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++++|||++.........  .....++..|+|||
T Consensus        94 ~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE  168 (282)
T cd07829          94 PLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPE  168 (282)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCccccCcCcCChH
Confidence            4678899999999999999999999   999999999999999999999999998765432211  11123456799999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccc-------------------------cCCccch------hhhh
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-------------------------DDPVLED------EYSS  129 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-------------------------~~~~~~~------~~~~  129 (208)
                      .+.+. .++.++|+|+||+++++++++..++.......                         .....+.      ....
T Consensus       169 ~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (282)
T cd07829         169 ILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL  248 (282)
T ss_pred             HhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhc
Confidence            98766 68899999999999999999876653321100                         0000000      0011


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      +..+..+.+++.+||..+|++||++.+++.
T Consensus       249 ~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         249 PRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.90  E-value=6.1e-24  Score=167.76  Aligned_cols=154  Identities=23%  Similarity=0.284  Sum_probs=115.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|+++|+.|||+.+   ++|+||+|.||+++.++.++++|||++......... ......++..|+|||
T Consensus        96 ~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE  171 (287)
T cd07840          96 KFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPE  171 (287)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cccccccccccCCce
Confidence            4678899999999999999999998   999999999999999999999999998766443211 111234567899999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccc---------cCC---------------------ccchh--hh
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------DDP---------------------VLEDE--YS  128 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~~~---------------------~~~~~--~~  128 (208)
                      .+.+. .++.++|+|+||+++|++++|..++.......         ...                     .....  ..
T Consensus       172 ~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T cd07840         172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREF  251 (287)
T ss_pred             eeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHH
Confidence            87653 47889999999999999999876653221100         000                     00000  00


Q ss_pred             hHH-HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          129 SKQ-MLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       129 ~~~-~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ... ++..+.+++++||+.+|++||+++++++
T Consensus       252 ~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         252 FKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111 2567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=7.1e-24  Score=164.43  Aligned_cols=153  Identities=25%  Similarity=0.296  Sum_probs=119.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.++.+||+.+   ++|+||+|.||+++.++.++++|||++.........  .....++..|.+||
T Consensus        95 ~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe  169 (254)
T cd06627          95 PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPE  169 (254)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHh
Confidence            3678889999999999999999999   999999999999999999999999998876543321  12235677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc---cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      ...+..++.++|+|++|++++++++|..|+.......   ..........+...+..+.+++.+||+.+|++||++.+++
T Consensus       170 ~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l  249 (254)
T cd06627         170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLL  249 (254)
T ss_pred             hhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHh
Confidence            9887778899999999999999999887764322110   0000000012233456788999999999999999999987


Q ss_pred             H
Q 028458          159 C  159 (208)
Q Consensus       159 ~  159 (208)
                      .
T Consensus       250 ~  250 (254)
T cd06627         250 K  250 (254)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.90  E-value=4.5e-24  Score=169.16  Aligned_cols=158  Identities=24%  Similarity=0.233  Sum_probs=118.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.....++.|++++|.|||+.+   ++|+||+|.||+++.++.++++|||++.......... .....++..|.+||.
T Consensus       102 ~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~  177 (288)
T cd05583         102 FTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEV  177 (288)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccccccccc-cccccCCccccCHHH
Confidence            567788899999999999999998   9999999999999999999999999886643322111 112346788999999


Q ss_pred             hccCC--CCCcchhHHHHHHHHHHHHhhhcCCcccccccCCc------cchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           83 AIQGI--FSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPV------LEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        83 ~~~~~--~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      +.+..  .+.++|+|+||+++|+|++|..|+...........      ......+...+..+.+++.+||+.+|++||++
T Consensus       178 ~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~  257 (288)
T cd05583         178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGA  257 (288)
T ss_pred             hcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCc
Confidence            87655  67899999999999999999887643211100000      00001223345678899999999999999999


Q ss_pred             HHHHHHHhhh
Q 028458          155 NDVVCMLTNE  164 (208)
Q Consensus       155 ~~i~~~l~~~  164 (208)
                      .++.+.|+..
T Consensus       258 ~~~~~~l~~~  267 (288)
T cd05583         258 NGADEIKNHP  267 (288)
T ss_pred             chHHHHhcCc
Confidence            8887776553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.9e-23  Score=169.02  Aligned_cols=154  Identities=20%  Similarity=0.225  Sum_probs=113.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.||+.||.|||+.+   ++||||||.||+++.++.++|+|||++.......... .....|+..|+|||.
T Consensus        99 ~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~  174 (331)
T cd05597          99 LPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ-SNVAVGTPDYISPEI  174 (331)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc-ccceeccccccCHHH
Confidence            567788999999999999999999   9999999999999999999999999987654322211 112357889999999


Q ss_pred             hcc-----CCCCCcchhHHHHHHHHHHHHhhhcCCcccc--c---c-c-CCccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           83 AIQ-----GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--L---I-D-DPVLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        83 ~~~-----~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~---~-~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      +..     ..++.++|+|||||++|+|++|..|+.....  .   + . .............+..+.+++++|+..++++
T Consensus       175 ~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r  254 (331)
T cd05597         175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETR  254 (331)
T ss_pred             HhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccc
Confidence            863     3467899999999999999999988753211  1   0 0 0001100112235667888999988654433


Q ss_pred             --CCCHHHHHHH
Q 028458          151 --RPTMNDVVCM  160 (208)
Q Consensus       151 --Rps~~~i~~~  160 (208)
                        |++++++++.
T Consensus       255 ~~r~~~~~~l~h  266 (331)
T cd05597         255 LGRNGLQDFKDH  266 (331)
T ss_pred             cCCCCHHHHhcC
Confidence              7899998886

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.90  E-value=7.7e-24  Score=181.78  Aligned_cols=149  Identities=21%  Similarity=0.176  Sum_probs=103.9

Q ss_pred             HHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-CCCeEEeccccceecCCCcccccccccccCCCccCcchhcc
Q 028458            7 TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ   85 (208)
Q Consensus         7 ~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~   85 (208)
                      .+..++.|++.||.|||+.+   |+||||||.||+++. ++.++|+|||++......... ......+++.|+|||.+..
T Consensus       256 ~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~  331 (566)
T PLN03225        256 IIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIM  331 (566)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhc
Confidence            35679999999999999998   999999999999985 578999999999755322211 1223467889999996642


Q ss_pred             C----------------------CCCCcchhHHHHHHHHHHHHhhhcCCcccccc----cCCc---------cchhhhhH
Q 028458           86 G----------------------IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI----DDPV---------LEDEYSSK  130 (208)
Q Consensus        86 ~----------------------~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~----~~~~---------~~~~~~~~  130 (208)
                      .                      .+..++|+|||||++|+|+++..+........    ....         ... ....
T Consensus       332 ~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~  410 (566)
T PLN03225        332 STQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-RASP  410 (566)
T ss_pred             cCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-ccch
Confidence            2                      23345699999999999998665543221110    0000         000 0000


Q ss_pred             H----------HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          131 Q----------MLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       131 ~----------~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      +          ......+||.+||+.||++||+++++++.
T Consensus       411 ~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        411 DLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             hhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence            0          01224479999999999999999999984

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.90  E-value=1e-23  Score=166.28  Aligned_cols=153  Identities=26%  Similarity=0.363  Sum_probs=119.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.++.+||+.+   ++|+||+|.||+++.++.++++|||++.........  .....++..|.+||.
T Consensus        98 ~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~  172 (277)
T cd06641          98 LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEV  172 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh--hccccCCccccChhh
Confidence            678889999999999999999999   999999999999999999999999998765432211  122356778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--cC-CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--DD-PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      +.+..++.++|+||||+++|++++|..|+.......  .. ............+..+.+++.+||+.+|.+||++.++++
T Consensus       173 ~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             hccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            988888899999999999999999988775322110  00 000010122334567889999999999999999999998


Q ss_pred             H
Q 028458          160 M  160 (208)
Q Consensus       160 ~  160 (208)
                      .
T Consensus       253 ~  253 (277)
T cd06641         253 H  253 (277)
T ss_pred             C
Confidence            4

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.90  E-value=1.5e-23  Score=168.38  Aligned_cols=149  Identities=29%  Similarity=0.403  Sum_probs=115.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.+++.++.|++.++.|||+.+   ++|+||+|.||+++.++.++++|||++.....      .....++..|+|||
T Consensus       117 ~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE  187 (313)
T cd06633         117 PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPE  187 (313)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChh
Confidence            4678899999999999999999999   99999999999999999999999998754321      12245677899999


Q ss_pred             hhc---cCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           82 YAI---QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        82 ~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      .+.   ...++.++|+||||+++|+|++|..|+.......     ....... ......+..+.+++.+||+.+|.+||+
T Consensus       188 ~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rp~  266 (313)
T cd06633         188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT-LQSNEWTDSFRGFVDYCLQKIPQERPA  266 (313)
T ss_pred             hccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCccccCHHHHHHHHHHccCChhhCcC
Confidence            874   3557889999999999999999987764322110     0000010 112234456889999999999999999


Q ss_pred             HHHHHHH
Q 028458          154 MNDVVCM  160 (208)
Q Consensus       154 ~~~i~~~  160 (208)
                      +.+++..
T Consensus       267 ~~~~l~~  273 (313)
T cd06633         267 SAELLRH  273 (313)
T ss_pred             HHHHhcC
Confidence            9999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.90  E-value=1.2e-23  Score=170.95  Aligned_cols=158  Identities=22%  Similarity=0.258  Sum_probs=115.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-CCCeEEeccccceecCCCccccc-ccccccCCCccCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSP   80 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~ap   80 (208)
                      +++..+..++.|+++||.|||+.+   ++|+||+|.||+++. ++.++++|||++........... .....++..|+||
T Consensus       111 l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  187 (342)
T cd07854         111 LSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP  187 (342)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCH
Confidence            677889999999999999999998   999999999999974 55789999999876533222111 1122457789999


Q ss_pred             chhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccccc------c--------------------------CCccchhh
Q 028458           81 EYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------D--------------------------DPVLEDEY  127 (208)
Q Consensus        81 e~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~--------------------------~~~~~~~~  127 (208)
                      |.+.. ..++.++|+||||+++|+|++|..|+.......      .                          ........
T Consensus       188 E~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (342)
T cd07854         188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRD  267 (342)
T ss_pred             HHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHH
Confidence            98754 457889999999999999999987774221100      0                          00000000


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhh
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTN  163 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~  163 (208)
                      .....+..+.+++.+||+.||++||++.+++..  ++.
T Consensus       268 ~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         268 LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            112244667899999999999999999999863  554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.90  E-value=1.3e-23  Score=170.09  Aligned_cols=155  Identities=19%  Similarity=0.204  Sum_probs=114.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++.......... .....|+..|+|||
T Consensus        98 ~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE  173 (331)
T cd05624          98 RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-SSVAVGTPDYISPE  173 (331)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee-eccccCCcccCCHH
Confidence            3567788899999999999999999   9999999999999999999999999987654332211 12245789999999


Q ss_pred             hhcc-----CCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cc---cC--CccchhhhhHHHHHHHHHHHhhccccCCC
Q 028458           82 YAIQ-----GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LI---DD--PVLEDEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        82 ~~~~-----~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~---~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      .+.+     +.++.++|+||||+++|+|++|..|+.....  ..   ..  ............+..+.+++.+|+..+++
T Consensus       174 ~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~  253 (331)
T cd05624         174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRER  253 (331)
T ss_pred             HHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchh
Confidence            9875     4578899999999999999999988753211  11   00  00110011223456788999999987655


Q ss_pred             C--CCCHHHHHHH
Q 028458          150 D--RPTMNDVVCM  160 (208)
Q Consensus       150 ~--Rps~~~i~~~  160 (208)
                      +  |++++++++.
T Consensus       254 ~~~~~~~~~~~~h  266 (331)
T cd05624         254 RLGQNGIEDFKKH  266 (331)
T ss_pred             hcCCCCHHHHhcC
Confidence            4  4578887753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.90  E-value=3e-23  Score=163.76  Aligned_cols=152  Identities=22%  Similarity=0.240  Sum_probs=114.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++.........   ....++..|.|||
T Consensus        95 ~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~aPE  168 (283)
T cd07830          95 PFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY---TDYVSTRWYRAPE  168 (283)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc---CCCCCcccccCce
Confidence            4688899999999999999999999   999999999999999999999999998765432221   1234577899999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccC-----------------Cccc------hhhh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDD-----------------PVLE------DEYS  128 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~-----------------~~~~------~~~~  128 (208)
                      .+.. ..++.++|+||||++++++++|..++......         ...                 ....      ....
T Consensus       169 ~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (283)
T cd07830         169 ILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQL  248 (283)
T ss_pred             eeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHH
Confidence            8754 44789999999999999999987655321100         000                 0000      0000


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .......+.+++++||+.+|++||+++|++.
T Consensus       249 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         249 IPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            1112467889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.90  E-value=7.8e-24  Score=186.25  Aligned_cols=148  Identities=26%  Similarity=0.413  Sum_probs=110.6

Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecC--------------C--Cccccccc
Q 028458            6 VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG--------------G--NELQANTS   69 (208)
Q Consensus         6 ~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~--------------~--~~~~~~~~   69 (208)
                      ...++++.||++||.|+|++|   +|||||||.||+++.++.+||+|||++....              +  .......+
T Consensus       697 d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~T  773 (1351)
T KOG1035|consen  697 DEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLT  773 (1351)
T ss_pred             HHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccc
Confidence            467899999999999999999   9999999999999999999999999997621              0  00111223


Q ss_pred             ccccCCCccCcchhccCC---CCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCccchh-hhhHHHHHHHHHH
Q 028458           70 RIVGTYGYMSPEYAIQGI---FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVLEDE-YSSKQMLLRYVNI  139 (208)
Q Consensus        70 ~~~~~~~~~ape~~~~~~---~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~l  139 (208)
                      ..+||.-|.|||.+.+..   |+.++|+||||+++.||+..   ++...++      ..++.++.. ....+....-.++
T Consensus       774 s~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~sl  850 (1351)
T KOG1035|consen  774 SQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSMERASILTNLRKGSIPEPADFFDPEHPEEASL  850 (1351)
T ss_pred             cccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchHHHHHHHHhcccCCCCCCcccccccchHHHHH
Confidence            467899999999997654   99999999999999999753   3322222      112222221 1122222334679


Q ss_pred             HhhccccCCCCCCCHHHHHH
Q 028458          140 ALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       140 i~~~l~~~p~~Rps~~~i~~  159 (208)
                      |++|++.||.+||++.|++.
T Consensus       851 I~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  851 IRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHhcCCCccCCCHHHHhh
Confidence            99999999999999999876

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.90  E-value=2.2e-23  Score=164.59  Aligned_cols=153  Identities=23%  Similarity=0.239  Sum_probs=114.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++.........  .....++..|++||
T Consensus        96 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE  170 (284)
T cd07836          96 ALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAPD  170 (284)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc--cccccccccccChH
Confidence            3688899999999999999999998   999999999999999999999999988654322111  11234567899999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc-------------------CC-------cc---chhhhh
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID-------------------DP-------VL---EDEYSS  129 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~-------------------~~-------~~---~~~~~~  129 (208)
                      .+.+. .++.++|+|+||+++|++++|..++......  ..                   ..       ..   ......
T Consensus       171 ~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (284)
T cd07836         171 VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLF  250 (284)
T ss_pred             HhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHh
Confidence            88654 4688999999999999999988766422110  00                   00       00   000011


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      +..+..+.+++.+||+.||.+||++.++++
T Consensus       251 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         251 PHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            233566889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.90  E-value=8.7e-24  Score=168.42  Aligned_cols=154  Identities=23%  Similarity=0.283  Sum_probs=114.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++......... ......++..|++||
T Consensus       112 ~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE  187 (302)
T cd07864         112 HFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPE  187 (302)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChH
Confidence            3678899999999999999999999   999999999999999999999999998765432211 111123466799999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccCCc------c---------c--------hhhh
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDDPV------L---------E--------DEYS  128 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~~~------~---------~--------~~~~  128 (208)
                      .+.+. .++.++|+|+||+++++|++|..++......         ...+.      .         .        ....
T Consensus       188 ~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd07864         188 LLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE  267 (302)
T ss_pred             HhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhh
Confidence            88653 4688999999999999999987666432110         00000      0         0        0000


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ....+..+.+++.+||+.+|++||++++++.
T Consensus       268 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         268 FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.90  E-value=1.8e-23  Score=161.42  Aligned_cols=102  Identities=30%  Similarity=0.423  Sum_probs=85.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC----CCeEEeccccceecCCCcccc-cccccccCCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD----MNPKISDFGMARICGGNELQA-NTSRIVGTYG   76 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~----~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~   76 (208)
                      -++-.....|+.||++|+.|||++.   ++||||||.||++..+    |.+|++|||+++.+.+..... .....+.|..
T Consensus       128 ~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiW  204 (438)
T KOG0666|consen  128 QLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIW  204 (438)
T ss_pred             cCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEE
Confidence            3566678899999999999999999   9999999999999877    899999999998876543222 1122355789


Q ss_pred             ccCcchhccCC-CCCcchhHHHHHHHHHHHH
Q 028458           77 YMSPEYAIQGI-FSIKSDVFSFGVLLLEIAW  106 (208)
Q Consensus        77 ~~ape~~~~~~-~~~~~Dv~slG~~~~~l~~  106 (208)
                      |+|||.+.+.. |+.+.|+|+.||++.||++
T Consensus       205 YRAPELLLGa~hYT~AiDvWAiGCIfaElLt  235 (438)
T KOG0666|consen  205 YRAPELLLGARHYTKAIDVWAIGCIFAELLT  235 (438)
T ss_pred             ecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence            99999998865 8999999999999999964

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.90  E-value=1.9e-23  Score=169.86  Aligned_cols=151  Identities=25%  Similarity=0.293  Sum_probs=115.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|+++||.|||+.+   ++|+||+|.||+++.++.++|+|||++.......     ....++..|+|||
T Consensus       114 ~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE  185 (343)
T cd07851         114 KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPE  185 (343)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccccccc-----cCCcccccccCHH
Confidence            4678899999999999999999998   9999999999999999999999999987653321     1234567899999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc-------CCc---------------------cch---hh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID-------DPV---------------------LED---EY  127 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~-------~~~---------------------~~~---~~  127 (208)
                      .+.+ ..++.++|+||||+++|++++|..++......  ..       ...                     ...   ..
T Consensus       186 ~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (343)
T cd07851         186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKE  265 (343)
T ss_pred             HHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHH
Confidence            8865 35788999999999999999998766322110  00       000                     000   00


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      .....+..+.++|.+||+.+|++||++.++++.
T Consensus       266 ~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         266 VFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            011235678899999999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.4e-24  Score=176.64  Aligned_cols=149  Identities=32%  Similarity=0.421  Sum_probs=120.4

Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            1 MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         1 ~~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      |.|-..++..|..+.+.||.|||+.+   .||||||.-||++...|.+||+|||.+.....      ...++||+.|+||
T Consensus       121 KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------AnsFvGTPywMAP  191 (948)
T KOG0577|consen  121 KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ANSFVGTPYWMAP  191 (948)
T ss_pred             ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc------hhcccCCccccch
Confidence            56778899999999999999999999   99999999999999999999999998866432      3347899999999


Q ss_pred             chhc---cCCCCCcchhHHHHHHHHHHHHhhhcCCc-c----cccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           81 EYAI---QGIFSIKSDVFSFGVLLLEIAWDLWTSNR-T----LELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        81 e~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |++.   .+.|+.++||||||++..+++-..+|-.. .    .-.+-... .+....++++..+++|+..||+.-|.+||
T Consensus       192 EVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-sPtLqs~eWS~~F~~Fvd~CLqKipqeRp  270 (948)
T KOG0577|consen  192 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQSNEWSDYFRNFVDSCLQKIPQERP  270 (948)
T ss_pred             hHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-CCCCCCchhHHHHHHHHHHHHhhCcccCC
Confidence            9985   46799999999999999999876655321 1    11111111 11134667888999999999999999999


Q ss_pred             CHHHHHH
Q 028458          153 TMNDVVC  159 (208)
Q Consensus       153 s~~~i~~  159 (208)
                      +.+++++
T Consensus       271 tse~ll~  277 (948)
T KOG0577|consen  271 TSEELLK  277 (948)
T ss_pred             cHHHHhh
Confidence            9997765

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.90  E-value=9.1e-24  Score=164.32  Aligned_cols=151  Identities=25%  Similarity=0.320  Sum_probs=116.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC-eEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN-PKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      +++..++.++.|++.|+.|||+.+   ++|+|++|.||+++.++. ++++|||.+.........  .....++..|.|||
T Consensus        98 ~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~ape  172 (257)
T cd08225          98 FSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--AYTCVGTPYYLSPE  172 (257)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCccc--ccccCCCccccCHH
Confidence            678899999999999999999998   999999999999988764 699999988765432211  11234678899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccc--cccc---CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL--ELID---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      ...+..++.++|+||||++++++++|..|+....  +...   .....  ......+..+.+++.+||+.+|++||++++
T Consensus       173 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~  250 (257)
T cd08225         173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA--PISPNFSRDLRSLISQLFKVSPRDRPSITS  250 (257)
T ss_pred             HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC--CCCCCCCHHHHHHHHHHhccChhhCcCHHH
Confidence            9988888999999999999999999987764321  1110   00100  112234567899999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       251 ll~~  254 (257)
T cd08225         251 ILKR  254 (257)
T ss_pred             HhhC
Confidence            9763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=8.4e-24  Score=175.57  Aligned_cols=151  Identities=23%  Similarity=0.342  Sum_probs=119.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC-CCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .++++...+|+.||++||.|||++. ++|+|||||=+|||++.+ |.+||+|+|++...+.....    ..+||+.|+||
T Consensus       139 ~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak----svIGTPEFMAP  213 (632)
T KOG0584|consen  139 RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK----SVIGTPEFMAP  213 (632)
T ss_pred             cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccccc----eeccCccccCh
Confidence            4677888999999999999999997 569999999999999865 88999999999776433322    25799999999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc------cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |... ..|...+||||||+++.||+++.+|--......      .....+. -...-...++.+||.+||.. .++|+++
T Consensus       214 EmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~-sl~kV~dPevr~fIekCl~~-~~~R~sa  290 (632)
T KOG0584|consen  214 EMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA-ALSKVKDPEVREFIEKCLAT-KSERLSA  290 (632)
T ss_pred             HHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH-HhhccCCHHHHHHHHHHhcC-chhccCH
Confidence            9885 789999999999999999999988765443321      1111111 11111245788999999999 9999999


Q ss_pred             HHHHHH
Q 028458          155 NDVVCM  160 (208)
Q Consensus       155 ~~i~~~  160 (208)
                      .|+++.
T Consensus       291 ~eLL~d  296 (632)
T KOG0584|consen  291 KELLKD  296 (632)
T ss_pred             HHHhhC
Confidence            999984

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.5e-23  Score=162.45  Aligned_cols=150  Identities=25%  Similarity=0.255  Sum_probs=116.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.....++.|++.|+.|||+.+   ++|+||+|.||+++.++.++++|||++........  ......++..|.+||
T Consensus        89 ~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe  163 (250)
T cd05123          89 RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPE  163 (250)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcCCccccChH
Confidence            3678889999999999999999998   99999999999999999999999999877543321  112235677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      ...+...+.++|+|+||+++|++++|..|+.....  ............+...+..+.+++++||..||++||++.+
T Consensus       164 ~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         164 VLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            99888888999999999999999999877744321  1110000111223334677889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.90  E-value=2.4e-23  Score=165.43  Aligned_cols=153  Identities=22%  Similarity=0.258  Sum_probs=112.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-CCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      +++..+..++.||+.||.|||+++   ++|+||+|+||+++. ++.++++|||++.........  .....++..|+|||
T Consensus        99 ~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE  173 (294)
T PLN00009         99 KNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAPE  173 (294)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCccc--cccCceeecccCHH
Confidence            356677889999999999999998   999999999999985 456899999998765332111  11234567899999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccc--c-------cCCc----------------------cchhhhh
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I-------DDPV----------------------LEDEYSS  129 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~-------~~~~----------------------~~~~~~~  129 (208)
                      .+.+. .++.++|+||||+++|+|++|..++......  .       ..+.                      .......
T Consensus       174 ~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (294)
T PLN00009        174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVV  253 (294)
T ss_pred             HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhC
Confidence            88664 4788999999999999999998776432110  0       0000                      0000011


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ...+..+.+++.+||+.+|++||++.++++.
T Consensus       254 ~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        254 PTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2234668899999999999999999999873

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.90  E-value=8.4e-24  Score=166.37  Aligned_cols=155  Identities=27%  Similarity=0.309  Sum_probs=119.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc----------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ----------------   65 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~----------------   65 (208)
                      .+++..+..++.|++.||.+||+.+   ++|+|++|.||+++.++.++++|||++.........                
T Consensus        98 ~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (280)
T cd05581          98 SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK  174 (280)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccc
Confidence            4788899999999999999999999   999999999999999999999999998765433221                


Q ss_pred             --ccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--cCCccchhhhhHHHHHHHHHHHh
Q 028458           66 --ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--DDPVLEDEYSSKQMLLRYVNIAL  141 (208)
Q Consensus        66 --~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~  141 (208)
                        .......++..|++||......++.++|+|+||++++++++|..|+.......  ..........+...+..+.+++.
T Consensus       175 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  254 (280)
T cd05581         175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIE  254 (280)
T ss_pred             cccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHH
Confidence              11122356788999999888888999999999999999999988775432211  00000000123344667899999


Q ss_pred             hccccCCCCCCCH----HHHHH
Q 028458          142 LCVQESADDRPTM----NDVVC  159 (208)
Q Consensus       142 ~~l~~~p~~Rps~----~~i~~  159 (208)
                      +||+.+|++||++    +++++
T Consensus       255 ~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         255 KLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHhcCCHhhCCCcccCHHHHhc
Confidence            9999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.89  E-value=4.2e-24  Score=174.73  Aligned_cols=154  Identities=21%  Similarity=0.235  Sum_probs=113.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc----------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ----------------   65 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~----------------   65 (208)
                      .++...+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++.........                
T Consensus        97 ~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (360)
T cd05627          97 TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF  173 (360)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccc
Confidence            3677788999999999999999999   999999999999999999999999987643211100                


Q ss_pred             -----------------ccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---cC--C
Q 028458           66 -----------------ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---DD--P  121 (208)
Q Consensus        66 -----------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---~~--~  121 (208)
                                       .......|+..|+|||.+.+..++.++|+|||||++|+|++|..|+......  .   ..  .
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~  253 (360)
T cd05627         174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKE  253 (360)
T ss_pred             cccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCC
Confidence                             0011235889999999999888999999999999999999999887543221  1   00  0


Q ss_pred             ccchhhhhHHHHHHHHHHHhhccccCCCCCCC---HHHHHHH
Q 028458          122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPT---MNDVVCM  160 (208)
Q Consensus       122 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~i~~~  160 (208)
                      ...- ......+..+.++|.+|+. ||.+|++   +.++++.
T Consensus       254 ~~~~-p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         254 TLVF-PPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             ceec-CCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            0000 0011234567888888774 9999985   5666653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-23  Score=163.59  Aligned_cols=170  Identities=22%  Similarity=0.298  Sum_probs=131.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      +++.....-+-.+|+.||.|||+++   |++||+|..|+++|.+|.+|+.|||++..-  ...+.....++|++.|+|||
T Consensus       264 ~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~g~t~kTFCGTPEYLAPE  338 (516)
T KOG0690|consen  264 VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKYGDTTKTFCGTPEYLAPE  338 (516)
T ss_pred             cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--ccccceeccccCChhhcCch
Confidence            4556666778889999999999999   999999999999999999999999998642  22333455689999999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----CH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----TM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~  154 (208)
                      ++....|+..+|+|.+|+++|||++|..|+.....  +..-..++....+.....+...++..+|..||.+|-     ++
T Consensus       339 VleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDa  418 (516)
T KOG0690|consen  339 VLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDA  418 (516)
T ss_pred             hhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhH
Confidence            99999999999999999999999999998854322  222222333345777778889999999999999993     56


Q ss_pred             HHHHHH--Hhhh------hhccCCCCCCCc
Q 028458          155 NDVVCM--LTNE------AATLLPPKQPAF  176 (208)
Q Consensus       155 ~~i~~~--l~~~------~~~~~~p~~~~~  176 (208)
                      +||.+.  +..+      .+++.||=.|..
T Consensus       419 kEi~~h~FF~~v~W~~~~~Kki~PPfKPqV  448 (516)
T KOG0690|consen  419 KEIMRHRFFASVDWEATYRKKIEPPFKPQV  448 (516)
T ss_pred             HHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence            666653  2322      245566655553

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.89  E-value=2.7e-23  Score=162.26  Aligned_cols=152  Identities=26%  Similarity=0.297  Sum_probs=116.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.|+.|||+.+   ++|+|++|+||+++. +.++++|||++.........  .....++..|.+||
T Consensus       102 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe  175 (260)
T cd08222         102 TLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDL--ATTFTGTPYYMSPE  175 (260)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCccc--ccCCCCCcCccCHH
Confidence            3678899999999999999999998   999999999999975 56999999998765332211  11234677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCC-ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDP-VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      ...+..++.++|+|+||+++|+++++..++......  .... .......+...+..+.++|.+||+.+|++||++.+++
T Consensus       176 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il  255 (260)
T cd08222         176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEIL  255 (260)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHh
Confidence            988878889999999999999999988776432111  0000 0001012345667889999999999999999999998


Q ss_pred             H
Q 028458          159 C  159 (208)
Q Consensus       159 ~  159 (208)
                      +
T Consensus       256 ~  256 (260)
T cd08222         256 R  256 (260)
T ss_pred             h
Confidence            6

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.89  E-value=4.7e-23  Score=167.66  Aligned_cols=151  Identities=26%  Similarity=0.299  Sum_probs=114.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++.......     ....++..|+|||
T Consensus       116 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE  187 (345)
T cd07877         116 KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPE  187 (345)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccccccc-----cccccCCCccCHH
Confidence            3678889999999999999999999   9999999999999999999999999986543221     1235677899999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc------C---Ccc----c----hhh--------------
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID------D---PVL----E----DEY--------------  127 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~------~---~~~----~----~~~--------------  127 (208)
                      .+.+ ..++.++|+||||+++|++++|..++......  ..      .   ..+    .    ...              
T Consensus       188 ~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (345)
T cd07877         188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN  267 (345)
T ss_pred             HHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhh
Confidence            8866 45788999999999999999988766321110  00      0   000    0    000              


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      .....+..+.++|.+|++.||++||++.+++..
T Consensus       268 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         268 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            000124467899999999999999999998875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.89  E-value=2e-23  Score=172.32  Aligned_cols=155  Identities=26%  Similarity=0.384  Sum_probs=124.8

Q ss_pred             HHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchhccC
Q 028458            7 TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG   86 (208)
Q Consensus         7 ~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~   86 (208)
                      ..++|+.||++|++||.+.+   ++|||+.+.|++++.+.++|++|||+++..-...++......+-+++|+|+|.+.-+
T Consensus       638 ~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg  714 (807)
T KOG1094|consen  638 PGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG  714 (807)
T ss_pred             hhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhc
Confidence            45789999999999999999   999999999999999999999999999877666666666666778999999999999


Q ss_pred             CCCCcchhHHHHHHHHHHHH--hhhcCCccccc---------ccCCccch-hhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           87 IFSIKSDVFSFGVLLLEIAW--DLWTSNRTLEL---------IDDPVLED-EYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        87 ~~~~~~Dv~slG~~~~~l~~--~~~~~~~~~~~---------~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      +++.++|+|+||+++||++.  ...|..+..+.         ........ ...+.-++..+++++.+||..|-++||++
T Consensus       715 kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsF  794 (807)
T KOG1094|consen  715 KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSF  794 (807)
T ss_pred             cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCH
Confidence            99999999999999999963  33333222111         11111110 01245567889999999999999999999


Q ss_pred             HHHHHHHhhh
Q 028458          155 NDVVCMLTNE  164 (208)
Q Consensus       155 ~~i~~~l~~~  164 (208)
                      +++...|...
T Consensus       795 e~lh~~lq~~  804 (807)
T KOG1094|consen  795 EQLHLFLQED  804 (807)
T ss_pred             HHHHHHHHHh
Confidence            9999988764

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=2.8e-23  Score=162.63  Aligned_cols=153  Identities=24%  Similarity=0.244  Sum_probs=118.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-ccccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~ape   81 (208)
                      +++....+++.|+++|+.|||+++   ++|+||+|.||+++.++.++++|||++......... .......++..|.|||
T Consensus       103 l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  179 (264)
T cd06653         103 LTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE  179 (264)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHh
Confidence            567788999999999999999999   999999999999999999999999998765322111 1112235678899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCcc--chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      .+.+..++.++|+||||++++++++|..|+......  +.....  .....+......+.+++.+||+ +|..||++.++
T Consensus       180 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~  258 (264)
T cd06653         180 VISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFL  258 (264)
T ss_pred             hhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHH
Confidence            998888899999999999999999998887543211  110000  1112355566789999999999 57999999987


Q ss_pred             HH
Q 028458          158 VC  159 (208)
Q Consensus       158 ~~  159 (208)
                      +.
T Consensus       259 ~~  260 (264)
T cd06653         259 LR  260 (264)
T ss_pred             hc
Confidence            65

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.89  E-value=5.8e-23  Score=166.28  Aligned_cols=156  Identities=21%  Similarity=0.244  Sum_probs=115.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc------------cccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ------------ANTS   69 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~------------~~~~   69 (208)
                      .++......++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||.+.........            ....
T Consensus       115 ~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (335)
T PTZ00024        115 RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT  191 (335)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccccc
Confidence            3577888999999999999999999   999999999999999999999999998765421110            0111


Q ss_pred             ccccCCCccCcchhccCC-CCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccCCc---c-------------
Q 028458           70 RIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDDPV---L-------------  123 (208)
Q Consensus        70 ~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~~~---~-------------  123 (208)
                      ...++..|.|||.+.+.. ++.++|+||||+++|+|++|..++......         ...+.   .             
T Consensus       192 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (335)
T PTZ00024        192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFT  271 (335)
T ss_pred             ccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccC
Confidence            123467899999987643 688999999999999999988766432110         00000   0             


Q ss_pred             ---ch--hhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          124 ---ED--EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       124 ---~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                         ..  .......+..+.+++.+||+.+|++||++++++..
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        272 PRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             cCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence               00  00011235678899999999999999999999974

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.89  E-value=7.5e-23  Score=166.35  Aligned_cols=157  Identities=23%  Similarity=0.236  Sum_probs=117.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++.......     ....++..|++||
T Consensus       114 ~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE  185 (343)
T cd07880         114 KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPE  185 (343)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccCc-----cccccCCcccCHH
Confidence            4678889999999999999999999   9999999999999999999999999987543221     1234567899999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccccc------cC-Cc-----------------------cch---hh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------DD-PV-----------------------LED---EY  127 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~-~~-----------------------~~~---~~  127 (208)
                      .+.+ ..++.++|+|+||+++|++++|..++.......      .. ..                       ...   ..
T Consensus       186 ~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (343)
T cd07880         186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRS  265 (343)
T ss_pred             HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHH
Confidence            8865 347889999999999999999987765321100      00 00                       000   00


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HHhhhhh
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVC--MLTNEAA  166 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~--~l~~~~~  166 (208)
                      .....+..+.++|.+|++.||++||++.+++.  .++....
T Consensus       266 ~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         266 LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             hccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence            01123456789999999999999999999995  4555543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=166.51  Aligned_cols=158  Identities=23%  Similarity=0.283  Sum_probs=126.6

Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchhc
Q 028458            5 WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI   84 (208)
Q Consensus         5 ~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~   84 (208)
                      --+.+.++.|++.|++|||..+   ++|.||..+|+++++...+|++|-.+++..-...+.+.......+..|+++|.+.
T Consensus       395 t~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~  471 (563)
T KOG1024|consen  395 TIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ  471 (563)
T ss_pred             HHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHh
Confidence            3466889999999999999999   9999999999999999999999998887654444444333334578899999999


Q ss_pred             cCCCCCcchhHHHHHHHHHHHH-hhhcCCcc--cc----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           85 QGIFSIKSDVFSFGVLLLEIAW-DLWTSNRT--LE----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        85 ~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~--~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      ...|+..+|+|+||+++|||++ |+.|-.+.  .+    ..+.-.+   ..+.++++++..++.-||...|++||++.|+
T Consensus       472 n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl---aQP~NCPDeLf~vMacCWallpeeRPsf~Ql  548 (563)
T KOG1024|consen  472 NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL---AQPFNCPDELFTVMACCWALLPEERPSFSQL  548 (563)
T ss_pred             hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee---cCCCCCcHHHHHHHHHHHhcCcccCCCHHHH
Confidence            9999999999999999999987 44333221  11    1122222   2477788999999999999999999999999


Q ss_pred             HHHHhhhhhcc
Q 028458          158 VCMLTNEAATL  168 (208)
Q Consensus       158 ~~~l~~~~~~~  168 (208)
                      ...|......+
T Consensus       549 v~cLseF~~ql  559 (563)
T KOG1024|consen  549 VICLSEFHTQL  559 (563)
T ss_pred             HHHHHHHHHHH
Confidence            99998876543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.89  E-value=1.1e-22  Score=185.14  Aligned_cols=158  Identities=23%  Similarity=0.412  Sum_probs=117.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++|..+.+++.|+++|+.|||......++|||+||.||+++.++..++. ++.......      .....++..|+|||
T Consensus       776 ~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE  848 (968)
T PLN00113        776 NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPE  848 (968)
T ss_pred             cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcc
Confidence            36899999999999999999994322229999999999999988877764 444322211      11124678899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-------------------ccCCccch-hhhhHHHHHHHHHHHh
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-------------------IDDPVLED-EYSSKQMLLRYVNIAL  141 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-------------------~~~~~~~~-~~~~~~~~~~~~~li~  141 (208)
                      ++.+..++.++||||||+++|||++|..|+......                   ..++.+.. .........++.+++.
T Consensus       849 ~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  928 (968)
T PLN00113        849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLAL  928 (968)
T ss_pred             cccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHH
Confidence            999888999999999999999999998876322110                   00011111 0122344556889999


Q ss_pred             hccccCCCCCCCHHHHHHHHhhhhh
Q 028458          142 LCVQESADDRPTMNDVVCMLTNEAA  166 (208)
Q Consensus       142 ~~l~~~p~~Rps~~~i~~~l~~~~~  166 (208)
                      +||+.||++||+++|+++.|+++..
T Consensus       929 ~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        929 HCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             hhCcCCchhCcCHHHHHHHHHHhhc
Confidence            9999999999999999999998764

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.89  E-value=6.1e-23  Score=165.95  Aligned_cols=150  Identities=23%  Similarity=0.289  Sum_probs=113.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++......++.|+++||.|||+.+   ++|+||+|.||+++.++.++++|||.+.......     ....++..|+|||.
T Consensus       105 ~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~  176 (328)
T cd07856         105 LEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEI  176 (328)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCCc-----CCCcccccccCcee
Confidence            456677889999999999999999   9999999999999999999999999887543221     12345678999998


Q ss_pred             hcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----------------------------ccCC----ccchhhh
Q 028458           83 AIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----------------------------IDDP----VLEDEYS  128 (208)
Q Consensus        83 ~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----------------------------~~~~----~~~~~~~  128 (208)
                      +.+ ..++.++|+|+||+++|++++|..++......                             ....    ..+....
T Consensus       177 ~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (328)
T cd07856         177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEK  256 (328)
T ss_pred             eeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHH
Confidence            765 45789999999999999999988765321110                             0000    0000001


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ....+..+.++|.+||+.+|++||++.+++..
T Consensus       257 ~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         257 FKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11234678899999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=2.2e-23  Score=155.45  Aligned_cols=151  Identities=24%  Similarity=0.267  Sum_probs=123.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++......+..|++.|+.|+|.++   ++||||||.|++++.++.+|++|||=+......    ......||..|+|||.
T Consensus       121 f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~----kR~tlcgt~dyl~pEm  193 (281)
T KOG0580|consen  121 FDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSN----KRKTLCGTLDYLPPEM  193 (281)
T ss_pred             ccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCC----CceeeecccccCCHhh
Confidence            455677889999999999999999   999999999999999999999999977654322    2334678999999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ..+..++..+|+|++|++.||++.|..||.....  ......--....+...+..+.++|.+|+..+|.+|....|+++.
T Consensus       194 v~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  194 VEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             cCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            9999999999999999999999999999865432  11111111113356677889999999999999999999998864

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.88  E-value=5.2e-23  Score=163.23  Aligned_cols=154  Identities=23%  Similarity=0.283  Sum_probs=114.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++++|||++......... ......++..|++||.
T Consensus       102 l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~  177 (290)
T cd05613         102 FKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDI  177 (290)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCChhh
Confidence            567788889999999999999999   999999999999999999999999998765432211 1122456788999999


Q ss_pred             hccC--CCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCC--
Q 028458           83 AIQG--IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRP--  152 (208)
Q Consensus        83 ~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--  152 (208)
                      +...  .++.++|+|+||+++|++++|..|+......     +..... .....+..++..+.+++.+||+.+|++||  
T Consensus       178 ~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~  257 (290)
T cd05613         178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGC  257 (290)
T ss_pred             ccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCC
Confidence            8653  3678899999999999999998876432110     000000 01112333556788999999999999997  


Q ss_pred             ---CHHHHHHH
Q 028458          153 ---TMNDVVCM  160 (208)
Q Consensus       153 ---s~~~i~~~  160 (208)
                         ++++++..
T Consensus       258 ~~~~~~~l~~~  268 (290)
T cd05613         258 GPSDADEIKKH  268 (290)
T ss_pred             CCCCHHHHHcC
Confidence               66777663

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.88  E-value=6.3e-23  Score=157.39  Aligned_cols=151  Identities=28%  Similarity=0.300  Sum_probs=118.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.+++.++.+||+.+   ++|+|++|.||+++.++.++++|||.+.......   ......+...|.+||.
T Consensus        84 ~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~  157 (244)
T smart00220       84 LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEV  157 (244)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHH
Confidence            577889999999999999999998   9999999999999999999999999988765432   1122346778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccc--ccc----cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL--ELI----DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      ..+..++.++|+|+||+++++++++..++....  ...    ..............+..+.+++.+||..+|++||++.+
T Consensus       158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  237 (244)
T smart00220      158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEE  237 (244)
T ss_pred             HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHH
Confidence            988888899999999999999999877664411  111    11111100001115567889999999999999999999


Q ss_pred             HHH
Q 028458          157 VVC  159 (208)
Q Consensus       157 i~~  159 (208)
                      +++
T Consensus       238 ~~~  240 (244)
T smart00220      238 ALQ  240 (244)
T ss_pred             Hhh
Confidence            986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.88  E-value=1.1e-23  Score=162.20  Aligned_cols=154  Identities=23%  Similarity=0.313  Sum_probs=126.8

Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            1 MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         1 ~~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      |.|+..++..++...++||+|||.-.   -+|||||.-||+++.+|..||+|||++......  ....+...|++.|+||
T Consensus       124 K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRNTVIGTPFWMAP  198 (502)
T KOG0574|consen  124 KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAP  198 (502)
T ss_pred             CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhCccccCcccccH
Confidence            57888999999999999999999988   899999999999999999999999998654321  1223446899999999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      |++..-.|...+|+||||+...||+-|.+|..+.+..-     ....-+....+...+.++.+|++.||-.+|++|.++-
T Consensus       199 EVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~  278 (502)
T KOG0574|consen  199 EVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTAL  278 (502)
T ss_pred             HHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHH
Confidence            99999999999999999999999999988876554421     1111111134667788999999999999999999998


Q ss_pred             HHHH
Q 028458          156 DVVC  159 (208)
Q Consensus       156 ~i~~  159 (208)
                      ++++
T Consensus       279 ~L~~  282 (502)
T KOG0574|consen  279 RLCE  282 (502)
T ss_pred             HHhh
Confidence            7765

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.88  E-value=1.6e-23  Score=185.25  Aligned_cols=154  Identities=24%  Similarity=0.280  Sum_probs=119.3

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCc--ccccccccccCCCccCcc
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~~~ape   81 (208)
                      +..-...+..|++.|+.|||++|   |||||+||.||+++.+|.+|++|||.+..+....  .........||+.|+|||
T Consensus      1332 dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPE 1408 (1509)
T KOG4645|consen 1332 DEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPE 1408 (1509)
T ss_pred             hhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCch
Confidence            34444567789999999999999   9999999999999999999999999998775542  112223457899999999


Q ss_pred             hhccCC---CCCcchhHHHHHHHHHHHHhhhcCCccccccc----CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGI---FSIKSDVFSFGVLLLEIAWDLWTSNRTLELID----DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~---~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      ++.+.+   ...++|||||||++.||++|..|+........    =..-..+..|..++..-.+||..||..||+.|.++
T Consensus      1409 vit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~ 1488 (1509)
T KOG4645|consen 1409 VITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTA 1488 (1509)
T ss_pred             hhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHH
Confidence            996543   57889999999999999999988754433211    00111112344577778899999999999999999


Q ss_pred             HHHHHH
Q 028458          155 NDVVCM  160 (208)
Q Consensus       155 ~~i~~~  160 (208)
                      .|+++.
T Consensus      1489 ~qlle~ 1494 (1509)
T KOG4645|consen 1489 SQLLEH 1494 (1509)
T ss_pred             HHHHHh
Confidence            888764

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.1e-22  Score=165.80  Aligned_cols=150  Identities=23%  Similarity=0.286  Sum_probs=120.2

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchh
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA   83 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~   83 (208)
                      +..+..-++.-+++|++|||.++   |++|||||.|++++.+|.+||.|||++..++....   .-++.||+.|.|||.+
T Consensus       518 dd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPEII  591 (732)
T KOG0614|consen  518 DDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPEII  591 (732)
T ss_pred             ccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCc---eeeecCCcccccchhh
Confidence            33445556677899999999999   99999999999999999999999999998865543   3347899999999999


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--c--CCccchhhhhHHHHHHHHHHHhhccccCCCCCCC-----H
Q 028458           84 IQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--D--DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT-----M  154 (208)
Q Consensus        84 ~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~  154 (208)
                      ..+..+..+|.|+||+++||+++|.+||.......  +  -.-++.-..+..+.....++|+++...+|.+|--     +
T Consensus       592 LnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI  671 (732)
T KOG0614|consen  592 LNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGI  671 (732)
T ss_pred             hccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCCh
Confidence            99999999999999999999999999985443321  1  0112222446667777889999999999999964     5


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      .+|.+
T Consensus       672 ~DIkk  676 (732)
T KOG0614|consen  672 NDIKK  676 (732)
T ss_pred             HHHHh
Confidence            56554

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.87  E-value=9.8e-23  Score=168.90  Aligned_cols=149  Identities=23%  Similarity=0.312  Sum_probs=124.8

Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchhcc
Q 028458            6 VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ   85 (208)
Q Consensus         6 ~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~   85 (208)
                      .++..++.|+++|++|||+++   |+|||||+.|++++.+-.+||+|||++.++....   .....+|++.|+|||.+.+
T Consensus       155 ~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g  228 (596)
T KOG0586|consen  155 KEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNG  228 (596)
T ss_pred             hhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccc---cccccCCCCCccChHhhcC
Confidence            567889999999999999999   9999999999999999999999999999875333   2334688999999999998


Q ss_pred             CCC-CCcchhHHHHHHHHHHHHhhhcCC-cccccccCCccchh-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458           86 GIF-SIKSDVFSFGVLLLEIAWDLWTSN-RTLELIDDPVLEDE-YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus        86 ~~~-~~~~Dv~slG~~~~~l~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ..| +.++|+|++|+++|-++.|..||. ..........+... ..+..+..++.++|+++|-.+|.+|+++++|.+.
T Consensus       229 ~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  229 KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             cccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            886 688999999999999999998875 33333443444433 3455567788899999999999999999999885

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=4.4e-22  Score=150.00  Aligned_cols=155  Identities=23%  Similarity=0.370  Sum_probs=115.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCc--ccccccccccCCCccCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTYGYMSP   80 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~~~ap   80 (208)
                      ++..++.+++.++++||.|+|...   |+|||+|+.|++++.+|.++++|||+++.+....  .....+..+.+..|++|
T Consensus       121 ~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrpp  197 (376)
T KOG0669|consen  121 FSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPP  197 (376)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCH
Confidence            567789999999999999999998   9999999999999999999999999996543222  22223445668999999


Q ss_pred             chhccCC-CCCcchhHHHHHHHHHHHHhh--------------------------hcCCcccccccCCccch---hh--h
Q 028458           81 EYAIQGI-FSIKSDVFSFGVLLLEIAWDL--------------------------WTSNRTLELIDDPVLED---EY--S  128 (208)
Q Consensus        81 e~~~~~~-~~~~~Dv~slG~~~~~l~~~~--------------------------~~~~~~~~~~~~~~~~~---~~--~  128 (208)
                      |.+.+.+ |+...|+|+.||++.+|+++.                          ||.-+...+.+...+++   ..  .
T Consensus       198 EllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rk  277 (376)
T KOG0669|consen  198 ELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRK  277 (376)
T ss_pred             HHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhh
Confidence            9998755 899999999999999995432                          33333333322221111   00  0


Q ss_pred             hHH------HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          129 SKQ------MLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       129 ~~~------~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ..+      -.++.++++..++..||.+|+++++++..
T Consensus       278 v~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  278 VKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             hhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            111      12367889999999999999999998864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.87  E-value=8.7e-23  Score=174.06  Aligned_cols=147  Identities=27%  Similarity=0.374  Sum_probs=114.8

Q ss_pred             HHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC---C--CCeEEeccccceecCCCcc-cccccccccCCCccCcc
Q 028458            8 RVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---D--MNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPE   81 (208)
Q Consensus         8 ~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~---~--~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~ape   81 (208)
                      .+.++.|+++||+|||+.+   |+||||||.||++..   +  ..++|+|||++....-... ........|+.+|.|||
T Consensus       608 ~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE  684 (903)
T KOG1027|consen  608 PISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPE  684 (903)
T ss_pred             HHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHH
Confidence            4678899999999999999   999999999999975   2  4679999999987753332 22234467899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHh-hhcCCcccccccC-----CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWD-LWTSNRTLELIDD-----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+........+|+++|||++|+.++| ..||++..+.--+     ..+.......+.  ...++|.+|++.+|..||++.
T Consensus       685 ~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~  762 (903)
T KOG1027|consen  685 QLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSAT  762 (903)
T ss_pred             HHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHH
Confidence            99988888899999999999999986 6788877665211     111111111112  677999999999999999999


Q ss_pred             HHHH
Q 028458          156 DVVC  159 (208)
Q Consensus       156 ~i~~  159 (208)
                      +|+.
T Consensus       763 ~VL~  766 (903)
T KOG1027|consen  763 DVLN  766 (903)
T ss_pred             HHhC
Confidence            8875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.86  E-value=1.6e-21  Score=150.97  Aligned_cols=152  Identities=27%  Similarity=0.279  Sum_probs=112.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++=.+...++.|++.|++|||+.+   |+||||||+||++..++.+|++|||++.......   ..+.++.+.-|+|||+
T Consensus       115 lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~---~mtpyVvtRyyrapev  188 (369)
T KOG0665|consen  115 LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF---MMTPYVVTRYYRAPEV  188 (369)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCccc---ccCchhheeeccCchh
Confidence            455677889999999999999999   9999999999999999999999999997654331   2233456778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcC--Ccc-----------------------------------------ccccc
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTS--NRT-----------------------------------------LELID  119 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~--~~~-----------------------------------------~~~~~  119 (208)
                      +.+..+...+|+||+||++.||+.|..-+  .+.                                         .+.+.
T Consensus       189 il~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fp  268 (369)
T KOG0665|consen  189 ILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFP  268 (369)
T ss_pred             eeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCC
Confidence            99988999999999999999996443211  100                                         00001


Q ss_pred             CCccchh-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          120 DPVLEDE-YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       120 ~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      +...... +........+.+++.+||-.||++|.|++++++.
T Consensus       269 D~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  269 DSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             cccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            0000000 0011122346789999999999999999999985

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.86  E-value=2.8e-22  Score=158.15  Aligned_cols=151  Identities=23%  Similarity=0.258  Sum_probs=112.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC--------------------CCCCeEEeccccceecCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD--------------------KDMNPKISDFGMARICGG   61 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~--------------------~~~~~~l~dfg~~~~~~~   61 (208)
                      .++...+..|+.|+++++++||+.+   ++|-||||.||++.                    .+..++++|||.+.+..+
T Consensus       188 ~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e  264 (415)
T KOG0671|consen  188 PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE  264 (415)
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc
Confidence            3667789999999999999999999   99999999999983                    133478999999877544


Q ss_pred             CcccccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcC--Cccccc------c---------c-----
Q 028458           62 NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTS--NRTLEL------I---------D-----  119 (208)
Q Consensus        62 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~--~~~~~~------~---------~-----  119 (208)
                      ..     +..+.|..|+|||++.+-+++..+|+||+||++.|+.+|..-|  .+..+.      +         .     
T Consensus       265 ~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~  339 (415)
T KOG0671|consen  265 HH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKE  339 (415)
T ss_pred             Cc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhH
Confidence            43     3356788999999999999999999999999999996665322  111110      0         0     


Q ss_pred             ----CCccc-------h--------hh-------hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          120 ----DPVLE-------D--------EY-------SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       120 ----~~~~~-------~--------~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                          ...++       +        ..       .......++.+|+++||..||.+|++++|++..
T Consensus       340 Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  340 KYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             hhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence                00000       0        00       011234568899999999999999999999863

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=6.4e-22  Score=158.12  Aligned_cols=142  Identities=29%  Similarity=0.331  Sum_probs=116.7

Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchhcc
Q 028458            6 VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ   85 (208)
Q Consensus         6 ~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~   85 (208)
                      ..++-++.+|+-||-+||++|   |++||||.+||+++..|.+|++|||++..--  .......++.|++.|+|||.+..
T Consensus       450 p~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~~~TTkTFCGTPdYiAPEIi~Y  524 (683)
T KOG0696|consen  450 PVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI--FDGVTTKTFCGTPDYIAPEIIAY  524 (683)
T ss_pred             chhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc--cCCcceeeecCCCcccccceEEe
Confidence            356778899999999999999   9999999999999999999999999986421  12223445789999999999999


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhhhcCCccc--ccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           86 GIFSIKSDVFSFGVLLLEIAWDLWTSNRTL--ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        86 ~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      .+|+..+|+|++|+++|||+.|..|+....  ++.....-.....+..++.+...+++..|...|.+|-
T Consensus       525 qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  525 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence            999999999999999999999998885433  3333233333356777888888999999999999993

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.85  E-value=6.4e-21  Score=154.08  Aligned_cols=167  Identities=29%  Similarity=0.381  Sum_probs=122.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC------CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY------SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY   75 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~------~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~   75 (208)
                      +++|....+|+..++.||+|||..      -+++|+|||||.+|||+..++++.|+|||++..+............+||.
T Consensus       303 tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~  382 (534)
T KOG3653|consen  303 TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTR  382 (534)
T ss_pred             cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhh
Confidence            579999999999999999999953      23469999999999999999999999999998776444333333478999


Q ss_pred             CccCcchhccCC------CCCcchhHHHHHHHHHHHHhhh-------cCCcc---cccccCC----------------cc
Q 028458           76 GYMSPEYAIQGI------FSIKSDVFSFGVLLLEIAWDLW-------TSNRT---LELIDDP----------------VL  123 (208)
Q Consensus        76 ~~~ape~~~~~~------~~~~~Dv~slG~~~~~l~~~~~-------~~~~~---~~~~~~~----------------~~  123 (208)
                      +|+|||++.+.-      .-.+.||||+|.++|||+++-.       |+...   .+....+                .+
T Consensus       383 RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~  462 (534)
T KOG3653|consen  383 RYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKI  462 (534)
T ss_pred             hhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCC
Confidence            999999986533      2256999999999999975321       11100   0111111                11


Q ss_pred             chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhhhhhcc
Q 028458          124 EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATL  168 (208)
Q Consensus       124 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~  168 (208)
                      +..........-+++.+..||..|++-|-|+.=+.+++.+.....
T Consensus       463 p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  463 PDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             hhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            111112223456889999999999999999998888888876443

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-21  Score=166.07  Aligned_cols=161  Identities=24%  Similarity=0.302  Sum_probs=126.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      |--...+.|+.||++|+.|||.+.   ++||||..+|+|+..-..+|+.|||++................-.+.|+|-|.
T Consensus       795 igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~  871 (1177)
T KOG1025|consen  795 IGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALES  871 (1177)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHH
Confidence            344577899999999999999998   99999999999999999999999999987654443332222233578999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hh-hcCCcccccccCCccch--hhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DL-WTSNRTLELIDDPVLED--EYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      +..+.|+.++|||+||+++||+++ |. +.++...+.+.+....+  ...++....+++.++.+||..|+..||.++++.
T Consensus       872 i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  872 IRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             hhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence            999999999999999999999986 33 33343333333211111  134677788999999999999999999999999


Q ss_pred             HHHhhhhh
Q 028458          159 CMLTNEAA  166 (208)
Q Consensus       159 ~~l~~~~~  166 (208)
                      ..+.+...
T Consensus       952 ~~fs~~ar  959 (1177)
T KOG1025|consen  952 EEFSRMAR  959 (1177)
T ss_pred             HHHHHHhc
Confidence            99887654

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.84  E-value=1.3e-22  Score=153.66  Aligned_cols=146  Identities=29%  Similarity=0.423  Sum_probs=108.0

Q ss_pred             HHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchhcc--CC
Q 028458           10 RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ--GI   87 (208)
Q Consensus        10 ~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~--~~   87 (208)
                      +|..-.+.||.||-..-  .|+|||+||+||+++..|.+||||||.+...-+...   .+.-.|-..|+|||.+..  ..
T Consensus       171 ~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~g  245 (361)
T KOG1006|consen  171 HITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKG  245 (361)
T ss_pred             heeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH---hhhccCCccccChhccCCccCC
Confidence            33344567999998765  499999999999999999999999998754422211   111234568999999864  34


Q ss_pred             CCCcchhHHHHHHHHHHHHhhhcCCcccccc---------cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           88 FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        88 ~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      |+.++|+||||+++||+++|.+|-......+         +.+.+.......+....+.++|..|+..|..+||++.++.
T Consensus       246 yDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk  325 (361)
T KOG1006|consen  246 YDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLK  325 (361)
T ss_pred             cchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhh
Confidence            8999999999999999999987753322211         2223322233444677899999999999999999999988


Q ss_pred             HH
Q 028458          159 CM  160 (208)
Q Consensus       159 ~~  160 (208)
                      +.
T Consensus       326 ~~  327 (361)
T KOG1006|consen  326 KF  327 (361)
T ss_pred             cC
Confidence            74

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.7e-20  Score=150.71  Aligned_cols=164  Identities=26%  Similarity=0.342  Sum_probs=123.8

Q ss_pred             ccHHHHHHHHHHHHHHHHhhc-----cCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCc--ccccccccccCC
Q 028458            3 LDWVTRVRIIEGIAQGLLYLH-----QYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTY   75 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh-----~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~   75 (208)
                      ++....++++..++.||+|||     .+|++.|.|||||..||++..++.+.++|+|++....+..  .....+..+||.
T Consensus       305 v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTK  384 (513)
T KOG2052|consen  305 VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTK  384 (513)
T ss_pred             CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCcccee
Confidence            567788999999999999999     4566779999999999999999999999999998765442  233345578999


Q ss_pred             CccCcchhccCC------CCCcchhHHHHHHHHHHHHhh----------hcCCcc------cccc--------cCCccch
Q 028458           76 GYMSPEYAIQGI------FSIKSDVFSFGVLLLEIAWDL----------WTSNRT------LELI--------DDPVLED  125 (208)
Q Consensus        76 ~~~ape~~~~~~------~~~~~Dv~slG~~~~~l~~~~----------~~~~~~------~~~~--------~~~~~~~  125 (208)
                      +|+|||++...-      -...+||||||+++||++-+-          .|+.+.      .+.+        ..+.++.
T Consensus       385 RYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipn  464 (513)
T KOG2052|consen  385 RYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPN  464 (513)
T ss_pred             eccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCc
Confidence            999999986422      135699999999999996321          111111      1111        1233333


Q ss_pred             hhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhhhhh
Q 028458          126 EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAA  166 (208)
Q Consensus       126 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l~~~~~  166 (208)
                      ..........+.++++.||..||.-|-++--|-+.|.++..
T Consensus       465 rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  465 RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            34445556678899999999999999999999998888763

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.84  E-value=3.6e-22  Score=163.60  Aligned_cols=150  Identities=23%  Similarity=0.329  Sum_probs=121.8

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC---CCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD---MNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      +...-.-++.||+.||+|||.++   |+|+||||.|+++...   ..+||||||+++.+++.....   ..+|++.|+||
T Consensus       662 ~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr---sVVGTPAYLaP  735 (888)
T KOG4236|consen  662 PERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR---SVVGTPAYLAP  735 (888)
T ss_pred             hHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh---hhcCCccccCH
Confidence            34444557789999999999999   9999999999999754   458999999999998766432   35789999999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccC----CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      |+++...|.+..|+||.|+++|--+.|.+||+...+.-++    ..+-+.....+++....++|..+|++.-.+|.+.++
T Consensus       736 EVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk  815 (888)
T KOG4236|consen  736 EVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDK  815 (888)
T ss_pred             HHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHh
Confidence            9999999999999999999999999999999876554332    122222334556677889999999999999999986


Q ss_pred             HHH
Q 028458          157 VVC  159 (208)
Q Consensus       157 i~~  159 (208)
                      .+.
T Consensus       816 ~ls  818 (888)
T KOG4236|consen  816 SLS  818 (888)
T ss_pred             hcc
Confidence            554

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=3.9e-21  Score=168.49  Aligned_cols=159  Identities=22%  Similarity=0.239  Sum_probs=116.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++..-+.-|+..|+-||.-||+-|   +|||||||+||++|..|+++|+|||.+-.+..... ......+||+-|++||+
T Consensus       172 ~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~-V~s~~aVGTPDYISPEv  247 (1317)
T KOG0612|consen  172 LPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT-VRSSVAVGTPDYISPEV  247 (1317)
T ss_pred             ChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc-EEeccccCCCCccCHHH
Confidence            455566778899999999999999   99999999999999999999999998876642221 12234689999999999


Q ss_pred             hc----c-CCCCCcchhHHHHHHHHHHHHhhhcCCcc--cc----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           83 AI----Q-GIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LE----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        83 ~~----~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      +.    + +.|+..+|+||+|+++|||++|..||...  .+    .+.....-..+.....+..+.+||+..+. +|+.|
T Consensus       248 Lqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~R  326 (1317)
T KOG0612|consen  248 LQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVR  326 (1317)
T ss_pred             HHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-Chhhh
Confidence            85    2 55899999999999999999999998532  11    11110011001123366778889988775 67777


Q ss_pred             CC---HHHHHHH--Hhhhhh
Q 028458          152 PT---MNDVVCM--LTNEAA  166 (208)
Q Consensus       152 ps---~~~i~~~--l~~~~~  166 (208)
                      -.   ++++...  ++++..
T Consensus       327 Lgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  327 LGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             cccccHHHHHhCccccCCCh
Confidence            76   8777663  555543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.1e-20  Score=147.76  Aligned_cols=144  Identities=24%  Similarity=0.319  Sum_probs=115.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+...+.-+..+|+-||.|||+.|   |++||+|.+|++++..|.+||.|+|++..--  ......+++.|++.|.|||
T Consensus       347 klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l--~~gd~tstfcgtpnyiape  421 (593)
T KOG0695|consen  347 KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNYIAPE  421 (593)
T ss_pred             cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC--CCCcccccccCCCcccchh
Confidence            4677778888999999999999999   9999999999999999999999999986431  2233456688999999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccc------------hhhhhHHHHHHHHHHHhhccccCCC
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE------------DEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      .+++..|...+|+|+||++++||+.|..|+...-  .+++...            +...+..++-+...+++..|+.||+
T Consensus       422 ilrgeeygfsvdwwalgvlmfemmagrspfdivg--m~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~  499 (593)
T KOG0695|consen  422 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG--MDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPK  499 (593)
T ss_pred             hhcccccCceehHHHHHHHHHHHHcCCCCcceec--CCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcH
Confidence            9999999999999999999999999988875432  1111111            1123444556677899999999999


Q ss_pred             CCC
Q 028458          150 DRP  152 (208)
Q Consensus       150 ~Rp  152 (208)
                      +|-
T Consensus       500 erl  502 (593)
T KOG0695|consen  500 ERL  502 (593)
T ss_pred             Hhc
Confidence            983

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=7.5e-21  Score=153.29  Aligned_cols=157  Identities=27%  Similarity=0.368  Sum_probs=120.3

Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC---CCCeEEeccccceecCCCccccc-----ccccc
Q 028458            1 MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGMARICGGNELQAN-----TSRIV   72 (208)
Q Consensus         1 ~~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~-----~~~~~   72 (208)
                      |+++..++..|+.||+.||.||.... .+|+|.||||.||++..   -|.+|+.|||++..+....+...     .+...
T Consensus       563 klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgA  641 (775)
T KOG1151|consen  563 KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGA  641 (775)
T ss_pred             hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccC
Confidence            56788999999999999999999986 45999999999999954   36789999999998865554432     34467


Q ss_pred             cCCCccCcchhccC----CCCCcchhHHHHHHHHHHHHhhhcCCccccc---ccC-Cccch----hhhhHHHHHHHHHHH
Q 028458           73 GTYGYMSPEYAIQG----IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---IDD-PVLED----EYSSKQMLLRYVNIA  140 (208)
Q Consensus        73 ~~~~~~ape~~~~~----~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~-~~~~~----~~~~~~~~~~~~~li  140 (208)
                      |++.|+|||.+.-+    +.+.++||||.|++||..++|..||+.....   ++. ..+..    ...-+........||
T Consensus       642 GTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFI  721 (775)
T KOG1151|consen  642 GTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFI  721 (775)
T ss_pred             ceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHH
Confidence            89999999998644    3689999999999999999999998754332   111 11110    011222345678999


Q ss_pred             hhccccCCCCCCCHHHHH
Q 028458          141 LLCVQESADDRPTMNDVV  158 (208)
Q Consensus       141 ~~~l~~~p~~Rps~~~i~  158 (208)
                      ++||++.-++|.+..++.
T Consensus       722 RRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  722 RRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             HHHHHhhhhhhhhHHHHc
Confidence            999999999998876654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.82  E-value=1.1e-19  Score=136.09  Aligned_cols=125  Identities=36%  Similarity=0.575  Sum_probs=107.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-CCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.++++++.+||+.+   ++|+|++|.||+++. .+.++++|||.+........  ......+...|.+|
T Consensus        88 ~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p  162 (215)
T cd00180          88 KLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAP  162 (215)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccCh
Confidence            3678889999999999999999999   999999999999998 88999999999876644321  11123456789999


Q ss_pred             chhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           81 EYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        81 e~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      |..... .++.+.|+|++|++++++                             ..+.+++..|++.+|++||+++++++
T Consensus       163 e~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~  213 (215)
T cd00180         163 EVLLGKGYYSEKSDIWSLGVILYEL-----------------------------PELKDLIRKMLQKDPEKRPSAKEILE  213 (215)
T ss_pred             hHhcccCCCCchhhhHHHHHHHHHH-----------------------------HHHHHHHHHHhhCCcccCcCHHHHhh
Confidence            998776 778999999999999998                             57889999999999999999999986


Q ss_pred             H
Q 028458          160 M  160 (208)
Q Consensus       160 ~  160 (208)
                      .
T Consensus       214 ~  214 (215)
T cd00180         214 H  214 (215)
T ss_pred             C
Confidence            4

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.81  E-value=1.2e-19  Score=153.14  Aligned_cols=153  Identities=20%  Similarity=0.190  Sum_probs=106.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.+|.|||+.+   ++||||||.||+++.++.++++|||++.......... ......++.|.+||.
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEE  381 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhh
Confidence            467788999999999999999998   9999999999999999999999999986543322111 111223678999998


Q ss_pred             hccCC--------------------C--CCcchhHHHHHHHHHHHHhhhcCCccccccc-------C----------Ccc
Q 028458           83 AIQGI--------------------F--SIKSDVFSFGVLLLEIAWDLWTSNRTLELID-------D----------PVL  123 (208)
Q Consensus        83 ~~~~~--------------------~--~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-------~----------~~~  123 (208)
                      +....                    +  ....|+||+||++++|+++............       .          ...
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            75322                    1  1346999999999999987642211110000       0          000


Q ss_pred             chhhhhHHHHHHHHHHHhhccccCC---CCCCCHHHHHHH
Q 028458          124 EDEYSSKQMLLRYVNIALLCVQESA---DDRPTMNDVVCM  160 (208)
Q Consensus       124 ~~~~~~~~~~~~~~~li~~~l~~~p---~~Rps~~~i~~~  160 (208)
                      . ............+++.+||..+|   .+|+|++|+++.
T Consensus       462 ~-~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        462 D-FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             C-cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0 01122234667899999999866   689999999863

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.81  E-value=1e-19  Score=153.34  Aligned_cols=154  Identities=25%  Similarity=0.264  Sum_probs=116.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC----CCCeEEeccccceecCCCcccccccccccCCCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK----DMNPKISDFGMARICGGNELQANTSRIVGTYGY   77 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~   77 (208)
                      .|+..+.+.++..++.|+.|||.+|   |+||||||.||++..    ....||+|||.++...+..   .....+||..|
T Consensus       116 GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~Y  189 (732)
T KOG4250|consen  116 GLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEY  189 (732)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhh
Confidence            5788899999999999999999999   999999999999843    2346999999998876554   23446899999


Q ss_pred             cCcchhc-cCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----------c-------------CCc------cc-h
Q 028458           78 MSPEYAI-QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----------D-------------DPV------LE-D  125 (208)
Q Consensus        78 ~ape~~~-~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----------~-------------~~~------~~-~  125 (208)
                      ++||... .+.|+..+|.||||+++|+.++|..||......-           .             +..      ++ .
T Consensus       190 LhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p  269 (732)
T KOG4250|consen  190 LHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQP  269 (732)
T ss_pred             cChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCc
Confidence            9999987 4889999999999999999999998874322210           0             000      00 1


Q ss_pred             hhhhHHHHHHHHHHHhhccccCCCCCC--CHHHHHHHH
Q 028458          126 EYSSKQMLLRYVNIALLCVQESADDRP--TMNDVVCML  161 (208)
Q Consensus       126 ~~~~~~~~~~~~~li~~~l~~~p~~Rp--s~~~i~~~l  161 (208)
                      ..........+...+..+|..+|.+|.  ...+....+
T Consensus       270 ~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~  307 (732)
T KOG4250|consen  270 NHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEV  307 (732)
T ss_pred             ccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHH
Confidence            112334455677888999999999998  554444433

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.7e-20  Score=143.03  Aligned_cols=155  Identities=25%  Similarity=0.313  Sum_probs=109.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      |+...+.-++.||+.||+|||+.+   |.||||||-|++++.+..+|++|||+++.......... +..+.+-.|+|||.
T Consensus       153 Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM-TqEVVTQYYRAPEi  228 (449)
T KOG0664|consen  153 LTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM-THEVVTQYYRAPEL  228 (449)
T ss_pred             CCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhhhh-HHHHHHHHhccHHH
Confidence            444556678899999999999999   99999999999999999999999999987654443322 23345667999999


Q ss_pred             hccCC-CCCcchhHHHHHHHHHHHHhhhcCC-----cccc----cccCCccchh--------------------------
Q 028458           83 AIQGI-FSIKSDVFSFGVLLLEIAWDLWTSN-----RTLE----LIDDPVLEDE--------------------------  126 (208)
Q Consensus        83 ~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~-----~~~~----~~~~~~~~~~--------------------------  126 (208)
                      +-+.. |+...|+||.||++.|++-.+.-+.     ...+    +...+.++..                          
T Consensus       229 LMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYt  308 (449)
T KOG0664|consen  229 LMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYK  308 (449)
T ss_pred             hhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceee
Confidence            97654 8999999999999999964332211     0000    0111111000                          


Q ss_pred             -hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 028458          127 -YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML  161 (208)
Q Consensus       127 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l  161 (208)
                       ..+..-......++..++..||++|.+-.+.+..+
T Consensus       309 lsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  309 IASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             ecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence             00111122345688899999999999999888764

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.80  E-value=1e-19  Score=131.11  Aligned_cols=153  Identities=22%  Similarity=0.273  Sum_probs=111.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.|++.|+.++|+.+   +.|||+||.|++++.+|.+|++|||+++-++-....  .+..+.+..|+||.+
T Consensus        98 ~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrc--ysaevvtlwyrppdv  172 (292)
T KOG0662|consen   98 LDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDV  172 (292)
T ss_pred             CCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEe--eeceeeeeeccCcce
Confidence            567788899999999999999999   999999999999999999999999999766544322  122345789999999


Q ss_pred             hccCC-CCCcchhHHHHHHHHHHHHhh---hcCCccccccc-------------------------CCccchhh----hh
Q 028458           83 AIQGI-FSIKSDVFSFGVLLLEIAWDL---WTSNRTLELID-------------------------DPVLEDEY----SS  129 (208)
Q Consensus        83 ~~~~~-~~~~~Dv~slG~~~~~l~~~~---~~~~~~~~~~~-------------------------~~~~~~~~----~~  129 (208)
                      +.+.+ |+...|+||.||++.|+.-..   +|..+..+...                         -+..+...    .-
T Consensus       173 lfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqiv  252 (292)
T KOG0662|consen  173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIV  252 (292)
T ss_pred             eeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHh
Confidence            98766 789999999999999995322   22222111100                         00000000    11


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      +.....-.++++.++..+|.+|.++++.++.
T Consensus       253 p~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  253 PKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             hhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1222334589999999999999999988763

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.80  E-value=1.6e-19  Score=158.31  Aligned_cols=88  Identities=15%  Similarity=0.188  Sum_probs=65.2

Q ss_pred             cCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--ccc---CCccchhhhhHHHHHHHHHHHhhccccC
Q 028458           73 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LID---DPVLEDEYSSKQMLLRYVNIALLCVQES  147 (208)
Q Consensus        73 ~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~  147 (208)
                      |+..|+|||++.+..++.++|+|||||++|+|++|..|+.....  ...   ................+.+++.+||..|
T Consensus       542 GT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~d  621 (669)
T cd05610         542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMD  621 (669)
T ss_pred             eCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccC
Confidence            47789999999988899999999999999999999887743211  110   0111111112234556788999999999


Q ss_pred             CCCCCCHHHHHHH
Q 028458          148 ADDRPTMNDVVCM  160 (208)
Q Consensus       148 p~~Rps~~~i~~~  160 (208)
                      |.+||++.++++.
T Consensus       622 P~~R~ta~e~l~h  634 (669)
T cd05610         622 PTKRAGLKELKQH  634 (669)
T ss_pred             hhHCcCHHHHHhC
Confidence            9999999999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.79  E-value=1.2e-19  Score=133.08  Aligned_cols=103  Identities=32%  Similarity=0.424  Sum_probs=82.3

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchh
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA   83 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~   83 (208)
                      +..-.=+|+..+..|+.|||++-  .++|||+||.||+++..|.+|+||||.+....+.-...   .-.|-..|+|||.+
T Consensus       146 pE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt---~daGCkpYmaPEri  220 (282)
T KOG0984|consen  146 PEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT---MDAGCKPYMAPERI  220 (282)
T ss_pred             chHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH---HhcCCCccCChhhc
Confidence            44455688999999999999987  49999999999999999999999999986543222111   11334579999988


Q ss_pred             cc----CCCCCcchhHHHHHHHHHHHHhhhcC
Q 028458           84 IQ----GIFSIKSDVFSFGVLLLEIAWDLWTS  111 (208)
Q Consensus        84 ~~----~~~~~~~Dv~slG~~~~~l~~~~~~~  111 (208)
                      ..    ..|+.++|+||||+.+.||+.+.+|-
T Consensus       221 ~~e~n~~gY~vksDvWSLGItmiElA~lr~PY  252 (282)
T KOG0984|consen  221 NPELNQKGYSVKSDVWSLGITMIEMAILRFPY  252 (282)
T ss_pred             CcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence            54    35899999999999999999877664

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.5e-19  Score=137.58  Aligned_cols=176  Identities=17%  Similarity=0.239  Sum_probs=118.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC--CCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK--DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      +-.....+++.|+++||.|||+++   +||||||.+||++-.  -.++||||||.....+..-..     ......|.+|
T Consensus       118 igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~-----~~~~~~y~~p  189 (378)
T KOG1345|consen  118 IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY-----LEYVNNYHAP  189 (378)
T ss_pred             ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceehh-----hhhhcccCCc
Confidence            345567899999999999999999   999999999999943  247999999988665432211     1224568899


Q ss_pred             chhccCC-----CCCcchhHHHHHHHHHHHHhhhcCCcccccccC-----------CccchhhhhHHHHHHHHHHHhhcc
Q 028458           81 EYAIQGI-----FSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD-----------PVLEDEYSSKQMLLRYVNIALLCV  144 (208)
Q Consensus        81 e~~~~~~-----~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~l  144 (208)
                      |.+...+     .....|+|.||++++++++|.+|+...- ..+.           -....+.........+.++.++-+
T Consensus       190 e~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~l  268 (378)
T KOG1345|consen  190 ELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSL  268 (378)
T ss_pred             HHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhc
Confidence            8775322     3577999999999999999998886221 1110           011111112224567788999999


Q ss_pred             ccCCCCCCCHHHHHHHHhhhh--hccCCCCCCCcccccccccccc
Q 028458          145 QESADDRPTMNDVVCMLTNEA--ATLLPPKQPAFSYVRNTVTSTS  187 (208)
Q Consensus       145 ~~~p~~Rps~~~i~~~l~~~~--~~~~~p~~~~~~~~~~~~~~~~  187 (208)
                      ..++++|=.+.++-++.....  ..+...+.+...++.|..+.+.
T Consensus       269 t~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee~~~tn~d~~S~  313 (378)
T KOG1345|consen  269 TPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEEDYYTNIDTASK  313 (378)
T ss_pred             CCcccccchhHHHHHHHHHHHHHhhhccccChhhccccccCCcch
Confidence            999999955555544443322  2334456666666666555444

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.78  E-value=5.3e-19  Score=151.89  Aligned_cols=152  Identities=23%  Similarity=0.335  Sum_probs=121.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +.|..+.-|+..++.|+.|||.+.   ++|||+|-.||+++.++.+||+|||++........  ...+..|++.|+|||+
T Consensus       120 l~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEV  194 (953)
T KOG0587|consen  120 LKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEV  194 (953)
T ss_pred             hhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecccc--cccCcCCCccccccee
Confidence            567778889999999999999998   99999999999999999999999999865532221  2334689999999999


Q ss_pred             hccCC-----CCCcchhHHHHHHHHHHHHhhhcCCccccc---ccCCcc--chhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           83 AIQGI-----FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---IDDPVL--EDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        83 ~~~~~-----~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      +....     |+..+|+||||++..||.-|.+|.-+-+..   +..+.-  +....+....+++.++|..||..|.++||
T Consensus       195 iac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP  274 (953)
T KOG0587|consen  195 IACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRP  274 (953)
T ss_pred             eecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCc
Confidence            97543     788999999999999998888777544332   111111  11133677889999999999999999999


Q ss_pred             CHHHHHH
Q 028458          153 TMNDVVC  159 (208)
Q Consensus       153 s~~~i~~  159 (208)
                      +..++++
T Consensus       275 ~~~~ll~  281 (953)
T KOG0587|consen  275 STEELLK  281 (953)
T ss_pred             chhhhcc
Confidence            9988775

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=5e-19  Score=147.95  Aligned_cols=144  Identities=24%  Similarity=0.299  Sum_probs=103.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecC---CCccccc------------
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG---GNELQAN------------   67 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~---~~~~~~~------------   67 (208)
                      |....+.-++.++..|+++.|+-|   +|||||||+|||+|.+|.+||.|||++..++   +.+++..            
T Consensus       726 FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~  802 (1034)
T KOG0608|consen  726 FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPS  802 (1034)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCc
Confidence            455667778889999999999999   9999999999999999999999999985432   1111000            


Q ss_pred             -------------------------ccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc------
Q 028458           68 -------------------------TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE------  116 (208)
Q Consensus        68 -------------------------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------  116 (208)
                                               ....+|+..|+|||++....|+..+|+|+.|+++|+|++|..||.....      
T Consensus       803 ~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~k  882 (1034)
T KOG0608|consen  803 PEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYK  882 (1034)
T ss_pred             hhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceee
Confidence                                     0124689999999999988899999999999999999999988854322      


Q ss_pred             ccc-CCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458          117 LID-DPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus       117 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+. ...+. .....+.+.+..++|.++. .++++|
T Consensus       883 v~nw~~~l~-~~~~~~ls~e~~~li~kLc-~sad~R  916 (1034)
T KOG0608|consen  883 VINWRNFLH-IPYQGNLSKEALDLIQKLC-CSADSR  916 (1034)
T ss_pred             eeehhhccc-cccccccCHHHHHHHHHHh-cChhhh
Confidence            211 11111 1234445566666665543 234455

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.78  E-value=1.1e-19  Score=148.75  Aligned_cols=97  Identities=25%  Similarity=0.340  Sum_probs=82.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC-CCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      |.......++.|+.-||.+|-..|   ++|.||||+|||++.. ..+||||||.+.+........    +..+..|.|||
T Consensus       533 L~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPE  605 (752)
T KOG0670|consen  533 LHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEITP----YLVSRFYRAPE  605 (752)
T ss_pred             eeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccccccccH----HHHHHhccCcc
Confidence            445677889999999999999999   9999999999999865 567999999998876554322    23356799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW  106 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~  106 (208)
                      ++.|.+|+...|+||.||++||+.+
T Consensus       606 IiLG~~yd~~iD~WSvgctLYElYt  630 (752)
T KOG0670|consen  606 IILGLPYDYPIDTWSVGCTLYELYT  630 (752)
T ss_pred             eeecCcccCCccceeeceeeEEeec
Confidence            9999999999999999999999843

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.78  E-value=9.9e-19  Score=135.86  Aligned_cols=155  Identities=23%  Similarity=0.240  Sum_probs=112.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC---CeEEeccccceecCCCccccc-----cccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKISDFGMARICGGNELQAN-----TSRIVG   73 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~-----~~~~~~   73 (208)
                      -++..++.++..+|+.||.+||.+|   |.|||+||.||+.....   -+||+||.+...+........     ....+|
T Consensus       172 ~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvG  248 (463)
T KOG0607|consen  172 HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVG  248 (463)
T ss_pred             hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCccc
Confidence            3567789999999999999999999   99999999999986543   379999988755432222111     123467


Q ss_pred             CCCccCcchhc-----cCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--------------------cccCCccch-hh
Q 028458           74 TYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--------------------LIDDPVLED-EY  127 (208)
Q Consensus        74 ~~~~~ape~~~-----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------------------~~~~~~~~~-~~  127 (208)
                      +..|+|||+..     ...|+.+.|.||||+++|-|+.|..||...-.                    .+++...+- ..
T Consensus       249 SAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdk  328 (463)
T KOG0607|consen  249 SAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDK  328 (463)
T ss_pred             chhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChh
Confidence            88999999874     23478999999999999999999888732211                    111111100 01


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .-..++....+++..++..++.+|-++.+++.
T Consensus       329 dWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  329 DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            12234566778999999999999999998887

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=5.8e-19  Score=151.94  Aligned_cols=161  Identities=20%  Similarity=0.243  Sum_probs=125.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc--ccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~a   79 (208)
                      .+...++..++.|++.|+.|||+.|   +.|||+|++|+++..+|.++++|||.+..+....-.  .......|+.+|+|
T Consensus       416 ~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~a  492 (601)
T KOG0590|consen  416 KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLA  492 (601)
T ss_pred             ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcC
Confidence            3567788899999999999999999   999999999999999999999999998765433322  23334678889999


Q ss_pred             cchhccCCCC-CcchhHHHHHHHHHHHHhhhcCCccccccc-----------CCccchhhhhHHHHHHHHHHHhhccccC
Q 028458           80 PEYAIQGIFS-IKSDVFSFGVLLLEIAWDLWTSNRTLELID-----------DPVLEDEYSSKQMLLRYVNIALLCVQES  147 (208)
Q Consensus        80 pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~~  147 (208)
                      ||.+.+..|. ...|+|+.|+++..|..+.+++......-+           .............+.....+|.+||+.|
T Consensus       493 pE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~  572 (601)
T KOG0590|consen  493 PEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLD  572 (601)
T ss_pred             cccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCC
Confidence            9999988884 669999999999999988877643322211           1122222345556677889999999999


Q ss_pred             CCCCCCHHHHHHH--Hhhhh
Q 028458          148 ADDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       148 p~~Rps~~~i~~~--l~~~~  165 (208)
                      |.+|.++++|++.  ++.+.
T Consensus       573 P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  573 PTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             hhheecHHHHhhChHhhhcc
Confidence            9999999999984  45443

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.76  E-value=2.2e-18  Score=128.47  Aligned_cols=152  Identities=17%  Similarity=0.257  Sum_probs=109.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC-CCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      |+.-.+.-++.|+++||.|+|+.|   |.|||+||.|++++.. -.++|+|+|++.+.....-   .+..+.+.-|--||
T Consensus       129 l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e---YnVRVASRyfKGPE  202 (338)
T KOG0668|consen  129 LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPE  202 (338)
T ss_pred             hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCce---eeeeeehhhcCCch
Confidence            445567788999999999999999   9999999999999865 4589999999988754432   22234455567799


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcCCcccccccC---------------------Cccchhh------------
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD---------------------PVLEDEY------------  127 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~---------------------~~~~~~~------------  127 (208)
                      .+.... |+...|+|||||++..|++...||.......++                     ..+++..            
T Consensus       203 LLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w  282 (338)
T KOG0668|consen  203 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPW  282 (338)
T ss_pred             heeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccH
Confidence            887644 789999999999999998776665322110000                     0000000            


Q ss_pred             --h----hHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          128 --S----SKQ-MLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       128 --~----~~~-~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                        .    ... ..++..+++.++|..|-++|++++|++..
T Consensus       283 ~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  283 SRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence              0    000 12567789999999999999999999873

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=3.2e-18  Score=134.11  Aligned_cols=137  Identities=18%  Similarity=0.241  Sum_probs=98.5

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchh
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA   83 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~   83 (208)
                      ....++.+..|+++.+++||..|   ++|+||+|+|++++.+|.++|+||+.....+.....     ...+..|.|||..
T Consensus       143 ~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~  214 (288)
T PF14531_consen  143 AFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELE  214 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhh
Confidence            34556778899999999999999   999999999999999999999999887665443322     1224678999977


Q ss_pred             ccC--------CCCCcchhHHHHHHHHHHHHhhhcCCcccccccCC-ccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           84 IQG--------IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDP-VLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        84 ~~~--------~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      ...        .++.+.|.|+||+++|.|+++..|++......... ...   .+.++++.+..+|..+|+.||.+|
T Consensus       215 ~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~~f~---~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  215 SCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEWDFS---RCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGGGGT---TSS---HHHHHHHHHHT-SSGGGS
T ss_pred             hhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccccch---hcCCcCHHHHHHHHHHccCCcccC
Confidence            542        36888999999999999999999998766555433 222   233889999999999999999988

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.70  E-value=8.4e-18  Score=139.24  Aligned_cols=102  Identities=27%  Similarity=0.440  Sum_probs=89.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++..++.-|+.||+.|+++||+++   |+|||||-.|+.++.+|.++|+|||.+....++...    .++||..|.|||+
T Consensus       667 m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ksgpfd----~f~gtv~~aapev  739 (772)
T KOG1152|consen  667 MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFD----VFVGTVDYAAPEV  739 (772)
T ss_pred             cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcCCCcc----eeeeeccccchhh
Confidence            567788999999999999999999   999999999999999999999999998776555433    3688999999999


Q ss_pred             hccCCC-CCcchhHHHHHHHHHHHHhhhcC
Q 028458           83 AIQGIF-SIKSDVFSFGVLLLEIAWDLWTS  111 (208)
Q Consensus        83 ~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~  111 (208)
                      +.+.+| +..-|+|++|+++|-+++...|.
T Consensus       740 l~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  740 LGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             hCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            999887 56689999999999887665554

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=5e-17  Score=132.26  Aligned_cols=88  Identities=18%  Similarity=0.235  Sum_probs=63.7

Q ss_pred             cCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcc--------------------------------------
Q 028458           73 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--------------------------------------  114 (208)
Q Consensus        73 ~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--------------------------------------  114 (208)
                      .|..|++||++.+..|+..+|+||++|+++||++|.+-|...                                      
T Consensus       413 QTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFn  492 (590)
T KOG1290|consen  413 QTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFN  492 (590)
T ss_pred             hhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhc
Confidence            356799999999999999999999999999997665433111                                      


Q ss_pred             ----ccccc--------CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          115 ----LELID--------DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       115 ----~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                          ...+.        +...+......+...++.+|+.-||+.+|++||++.++++.
T Consensus       493 r~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h  550 (590)
T KOG1290|consen  493 RRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH  550 (590)
T ss_pred             cccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence                00000        01111212344556788999999999999999999999864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.69  E-value=2.6e-16  Score=127.05  Aligned_cols=177  Identities=18%  Similarity=0.154  Sum_probs=126.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC-----CCeEEeccccceecC---CCc---cccc--c
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-----MNPKISDFGMARICG---GNE---LQAN--T   68 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~-----~~~~l~dfg~~~~~~---~~~---~~~~--~   68 (208)
                      .++..+.++++.|++.+|++||+.|   ++||||||.|+++...     ..+.+.|||+++...   ...   ....  .
T Consensus       118 ~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~  194 (322)
T KOG1164|consen  118 RFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQK  194 (322)
T ss_pred             CcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCc
Confidence            4678899999999999999999999   9999999999999765     358999999998332   111   1111  1


Q ss_pred             cccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchh---h----hhHHHHHHHHHHHh
Q 028458           69 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDE---Y----SSKQMLLRYVNIAL  141 (208)
Q Consensus        69 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~---~----~~~~~~~~~~~li~  141 (208)
                      ....||.+|.++....+...+++.|+||++.++.++..|..|+...............   .    .....+..+.++..
T Consensus       195 ~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (322)
T KOG1164|consen  195 GLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILE  274 (322)
T ss_pred             cCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHH
Confidence            2345899999999999999999999999999999999887665332211000000000   0    11123345667777


Q ss_pred             hccccCCCCCCCHHHHHHHHhhhhhccCCCCCCCcccccc
Q 028458          142 LCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRN  181 (208)
Q Consensus       142 ~~l~~~p~~Rps~~~i~~~l~~~~~~~~~p~~~~~~~~~~  181 (208)
                      .+-..+..++|+...+...|+............++.+...
T Consensus       275 ~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~  314 (322)
T KOG1164|consen  275 YIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVK  314 (322)
T ss_pred             HhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccc
Confidence            7777999999999999999988776654444455554433

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.65  E-value=9.6e-17  Score=131.85  Aligned_cols=145  Identities=29%  Similarity=0.373  Sum_probs=107.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCc----ccccccccccCCCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYM   78 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~~~   78 (208)
                      .++.....++.|++.++.|   ++   .+|+|+||.||+...+..++++|||+........    .....+...|+..|+
T Consensus       356 ~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~Ym  429 (516)
T KOG1033|consen  356 RSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYM  429 (516)
T ss_pred             cchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccC
Confidence            4677889999999999999   77   9999999999999999999999999986654433    222334467899999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhh-cC--CcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLW-TS--NRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      +||.+.+..|+.++|+|+||++++|++.... .+  ......+.+..+++ ....+.+. -+.|+.+++...|.+||++.
T Consensus       430 sPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~-~~~~d~p~-e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  430 SPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPP-EFLQDYPE-EYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             CHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCCh-HHhhcCcH-HHHHHHHhcCCCcccCchHH
Confidence            9999999999999999999999999975211 11  11111222233332 22222222 35799999999999999443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=6.6e-16  Score=123.50  Aligned_cols=155  Identities=23%  Similarity=0.229  Sum_probs=110.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC--CC--CCeEEeccccceecCCCcccccc----cccccC
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD--KD--MNPKISDFGMARICGGNELQANT----SRIVGT   74 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~--~~--~~~~l~dfg~~~~~~~~~~~~~~----~~~~~~   74 (208)
                      .+..+..-|+.|+++|+.|||++|   +.|||+|.+||++.  ++  ..+.++|||.+--..+.......    -..-|.
T Consensus       338 ~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGN  414 (598)
T KOG4158|consen  338 RSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGN  414 (598)
T ss_pred             CchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCc
Confidence            466778889999999999999999   99999999999993  33  45788999986433322221111    112345


Q ss_pred             CCccCcchhccCC------CCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCccchhhhhHHHHHHHHHHHhh
Q 028458           75 YGYMSPEYAIQGI------FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVLEDEYSSKQMLLRYVNIALL  142 (208)
Q Consensus        75 ~~~~ape~~~~~~------~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~  142 (208)
                      ...+|||+....+      ...++|.|+.|.+.||++....||...-+.      .++..++  ..+...+..+.+++..
T Consensus       415 a~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP--alp~~vpp~~rqlV~~  492 (598)
T KOG4158|consen  415 AKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP--ALPSRVPPVARQLVFD  492 (598)
T ss_pred             ceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC--CCcccCChHHHHHHHH
Confidence            6679999886433      357899999999999998877777653221      1212222  2344556778899999


Q ss_pred             ccccCCCCCCCHHHHHHHHh
Q 028458          143 CVQESADDRPTMNDVVCMLT  162 (208)
Q Consensus       143 ~l~~~p~~Rps~~~i~~~l~  162 (208)
                      +|+.||++|++.+-....|.
T Consensus       493 lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  493 LLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HhcCCccccCCccHHHhHHH
Confidence            99999999999876555543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.64  E-value=2e-16  Score=126.53  Aligned_cols=156  Identities=23%  Similarity=0.326  Sum_probs=108.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC-CCeEEeccccceecCC--------------Ccc--
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGG--------------NEL--   64 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~-~~~~l~dfg~~~~~~~--------------~~~--   64 (208)
                      .++..++..++..++.||.++|++|   |+|||+||.|++.+.. +.-.|+|||++.....              ...  
T Consensus       128 ~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~  204 (418)
T KOG1167|consen  128 SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAM  204 (418)
T ss_pred             cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccc
Confidence            4677889999999999999999999   9999999999999754 5678999999862100              000  


Q ss_pred             ------------------cc--cc------cccccCCCccCcchhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccc-
Q 028458           65 ------------------QA--NT------SRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE-  116 (208)
Q Consensus        65 ------------------~~--~~------~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-  116 (208)
                                        ..  ..      -...||++|+|||++.. ...+.+.|+||.|+++..++++.+|+..... 
T Consensus       205 g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd  284 (418)
T KOG1167|consen  205 GKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDD  284 (418)
T ss_pred             cCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccc
Confidence                              00  00      01358899999999854 4468899999999999988655544321100 


Q ss_pred             ------------------------c--ccC-C-------------c-------------cchhhhhHHHHHHHHHHHhhc
Q 028458          117 ------------------------L--IDD-P-------------V-------------LEDEYSSKQMLLRYVNIALLC  143 (208)
Q Consensus       117 ------------------------~--~~~-~-------------~-------------~~~~~~~~~~~~~~~~li~~~  143 (208)
                                              .  +.. .             .             ..........+..+++++.+|
T Consensus       285 ~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~  364 (418)
T KOG1167|consen  285 ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKC  364 (418)
T ss_pred             cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHH
Confidence                                    0  000 0             0             000011111234678999999


Q ss_pred             cccCCCCCCCHHHHHHH
Q 028458          144 VQESADDRPTMNDVVCM  160 (208)
Q Consensus       144 l~~~p~~Rps~~~i~~~  160 (208)
                      +..||.+|.+++++++.
T Consensus       365 le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  365 LELNPQKRITAEDALKH  381 (418)
T ss_pred             ccCChhhcccHHHHhcC
Confidence            99999999999999873

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.64  E-value=5.7e-16  Score=128.79  Aligned_cols=164  Identities=21%  Similarity=0.328  Sum_probs=118.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++|..+..+..++++|+.|||...  .-+|+.++..|++++....+|+.|||+....................-|.|||
T Consensus        44 ~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPe  121 (484)
T KOG1023|consen   44 KLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPE  121 (484)
T ss_pred             CccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHH
Confidence            3688899999999999999999986  23999999999999999999999999976653211111111122346799999


Q ss_pred             hhccCC-------CCCcchhHHHHHHHHHHHHhhhcCCcccccc---------cC---Cccchhhh-hHHHHHHHHHHHh
Q 028458           82 YAIQGI-------FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------DD---PVLEDEYS-SKQMLLRYVNIAL  141 (208)
Q Consensus        82 ~~~~~~-------~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~~---~~~~~~~~-~~~~~~~~~~li~  141 (208)
                      .+....       .+.++|+||||++++|+++...++.......         .+   ....+... .......+..++.
T Consensus       122 llr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~  201 (484)
T KOG1023|consen  122 LLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVA  201 (484)
T ss_pred             HhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHH
Confidence            987642       3567999999999999998766554321111         10   11111111 1133446889999


Q ss_pred             hccccCCCCCCCHHHHHHHHhhhhhc
Q 028458          142 LCVQESADDRPTMNDVVCMLTNEAAT  167 (208)
Q Consensus       142 ~~l~~~p~~Rps~~~i~~~l~~~~~~  167 (208)
                      .||..+|.+||+++++...++.....
T Consensus       202 ~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  202 RCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             HhcccChhhCccHHHHHhhhhhhccc
Confidence            99999999999999999988877643

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.63  E-value=1.2e-15  Score=115.99  Aligned_cols=107  Identities=33%  Similarity=0.436  Sum_probs=89.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.....++.+++.++.+||+.+   ++|+|+++.|++++.++.++++|||.+......... ......+...|++||.
T Consensus        95 ~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~  170 (225)
T smart00221       95 LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEV  170 (225)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhH
Confidence            677888999999999999999998   999999999999999999999999998776543200 1122345678999999


Q ss_pred             h-ccCCCCCcchhHHHHHHHHHHHHhhhcCCc
Q 028458           83 A-IQGIFSIKSDVFSFGVLLLEIAWDLWTSNR  113 (208)
Q Consensus        83 ~-~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~  113 (208)
                      + ....++.++|+|+||++++++++|..|+..
T Consensus       171 ~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      171 LLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             hcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            8 556677899999999999999998887743

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=2.5e-16  Score=138.11  Aligned_cols=135  Identities=20%  Similarity=0.298  Sum_probs=103.0

Q ss_pred             HHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCc--------ccc-----cccccccCCCccCcc
Q 028458           15 IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE--------LQA-----NTSRIVGTYGYMSPE   81 (208)
Q Consensus        15 i~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~--------~~~-----~~~~~~~~~~~~ape   81 (208)
                      ++.+++|||..+   |+|||+||+|.++..-|.+|+.|||+++......        ..+     ...+.+|++.|+|||
T Consensus       152 mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe  228 (1205)
T KOG0606|consen  152 MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE  228 (1205)
T ss_pred             hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence            467899999999   9999999999999999999999999986532111        000     112347899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcc-----cccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT-----LELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      ++....|+..+|+|++|+++|+++.|..++...     ...+........+.....+.++.+++.++|..+|.+|-
T Consensus       229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            999999999999999999999999887766443     22221122222233455567788999999999999995

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.60  E-value=2e-15  Score=133.01  Aligned_cols=158  Identities=18%  Similarity=0.199  Sum_probs=110.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceec--CCCcccccc---cccccCCCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARIC--GGNELQANT---SRIVGTYGY   77 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~--~~~~~~~~~---~~~~~~~~~   77 (208)
                      |...++.-|+.|++.||..+|..|   |.|||||..||++..=+++.|+||...+..  .+.....-.   .+...-..|
T Consensus       117 L~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCY  193 (1431)
T KOG1240|consen  117 LVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCY  193 (1431)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeee
Confidence            345678899999999999999999   999999999999999999999999765432  111111100   001112479


Q ss_pred             cCcchhccCC-----------CCCcchhHHHHHHHHHHHHhhhcCCccccccc--CC-ccchhhhhHHH-HHHHHHHHhh
Q 028458           78 MSPEYAIQGI-----------FSIKSDVFSFGVLLLEIAWDLWTSNRTLELID--DP-VLEDEYSSKQM-LLRYVNIALL  142 (208)
Q Consensus        78 ~ape~~~~~~-----------~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~-~~~~~~li~~  142 (208)
                      +|||.+....           .+.+.||+|+||++.|+++.+.|....-++..  .. ..........+ ...++++|..
T Consensus       194 iAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~  273 (1431)
T KOG1240|consen  194 IAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKIEDVSLRNLILS  273 (1431)
T ss_pred             cChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhCcCccHHHHHHH
Confidence            9999885421           46789999999999999986554443333321  11 11111112221 2368899999


Q ss_pred             ccccCCCCCCCHHHHHHHHhh
Q 028458          143 CVQESADDRPTMNDVVCMLTN  163 (208)
Q Consensus       143 ~l~~~p~~Rps~~~i~~~l~~  163 (208)
                      |++.||++|-++++.++.-++
T Consensus       274 Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  274 MIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             HHccCchhccCHHHHHHhhhc
Confidence            999999999999999987555

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.56  E-value=3.2e-15  Score=125.78  Aligned_cols=150  Identities=24%  Similarity=0.326  Sum_probs=111.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+..++.-+++..+++++|||+.+   -+|||||-.||++...|.++++|||.+-.+.-.- . ....+.|++.|+|||
T Consensus       108 plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-~-KrksfiGtpywmapE  182 (829)
T KOG0576|consen  108 PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-A-KRKSFIGTPYWMAPE  182 (829)
T ss_pred             cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-h-hhhcccCCccccchh
Confidence            4566778888899999999999999   8999999999999999999999999876553111 1 122368999999999


Q ss_pred             hhc---cCCCCCcchhHHHHHHHHHHHHhhhcCCcccc----------cccCCccchhhhhHHHHHHHHHHHhhccccCC
Q 028458           82 YAI---QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE----------LIDDPVLEDEYSSKQMLLRYVNIALLCVQESA  148 (208)
Q Consensus        82 ~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  148 (208)
                      +..   .+.|...+|+|++|+...|+.--..|-.+.+.          ..+.+.+   ........-+.+|++.++..+|
T Consensus       183 vaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l---kDk~kws~~fh~fvK~altknp  259 (829)
T KOG0576|consen  183 VAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL---KDKTKWSEFFHNFVKGALTKNP  259 (829)
T ss_pred             HHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc---cCCccchHHHHHHHHHHhcCCC
Confidence            874   45588899999999998887433333222221          1111122   1233445668899999999999


Q ss_pred             CCCCCHHHHHH
Q 028458          149 DDRPTMNDVVC  159 (208)
Q Consensus       149 ~~Rps~~~i~~  159 (208)
                      ++||+++.++.
T Consensus       260 KkRptaeklL~  270 (829)
T KOG0576|consen  260 KKRPTAEKLLQ  270 (829)
T ss_pred             ccCCChhhhee
Confidence            99999986654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.54  E-value=7.5e-15  Score=112.40  Aligned_cols=152  Identities=22%  Similarity=0.276  Sum_probs=114.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEE--eccccceecCCCcccccccccccCCCccCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKI--SDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l--~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      ++-.++++++.+++.|+.|||+... .|....++...+++|.+.+.++  +|-.++....-+         .-.+.|++|
T Consensus       286 vd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfqe~gr---------~y~pawmsp  355 (448)
T KOG0195|consen  286 VDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGR---------AYSPAWMSP  355 (448)
T ss_pred             EecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeeecccc---------ccCcccCCH
Confidence            4567899999999999999999963 3667788999999998876554  454433221111         114679999


Q ss_pred             chhccCC---CCCcchhHHHHHHHHHHHHhhhcCCccc--ccccCCccchh--hhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           81 EYAIQGI---FSIKSDVFSFGVLLLEIAWDLWTSNRTL--ELIDDPVLEDE--YSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        81 e~~~~~~---~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      |.++..+   .-+.+|+|||++++||+.+...||.+..  +...+..+++.  ..++..+..+.+++.-|+..||.+||.
T Consensus       356 ealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpk  435 (448)
T KOG0195|consen  356 EALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPK  435 (448)
T ss_pred             HHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCC
Confidence            9997655   3477999999999999999988875542  22222333321  357778888999999999999999999


Q ss_pred             HHHHHHHHhhh
Q 028458          154 MNDVVCMLTNE  164 (208)
Q Consensus       154 ~~~i~~~l~~~  164 (208)
                      ++.|+-.|++.
T Consensus       436 fdmivpilekm  446 (448)
T KOG0195|consen  436 FDMIVPILEKM  446 (448)
T ss_pred             cceehhhHHHh
Confidence            99999998864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.50  E-value=2.4e-13  Score=106.63  Aligned_cols=161  Identities=17%  Similarity=0.176  Sum_probs=125.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-----CCCeEEeccccceecCCCccccc-----cccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-----DMNPKISDFGMARICGGNELQAN-----TSRI   71 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-----~~~~~l~dfg~~~~~~~~~~~~~-----~~~~   71 (208)
                      -++..+.+.++.|++.-++|+|++.   +|+|||||+|+|+..     ...+.++|||++...........     ....
T Consensus       120 ~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSL  196 (449)
T KOG1165|consen  120 RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSL  196 (449)
T ss_pred             cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccccc
Confidence            4677899999999999999999999   999999999999963     34589999999987755443322     2235


Q ss_pred             ccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--------cc-c-CCccchhhhhHHHHHHHHHHHh
Q 028458           72 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--------LI-D-DPVLEDEYSSKQMLLRYVNIAL  141 (208)
Q Consensus        72 ~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~-~-~~~~~~~~~~~~~~~~~~~li~  141 (208)
                      .||.+|++-....++..+++.|+-+||.++.+++-|..|+....-        .+ + ....+-...+.+.+.++..-+.
T Consensus       197 sGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~  276 (449)
T KOG1165|consen  197 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLR  276 (449)
T ss_pred             ccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHH
Confidence            688999998888899999999999999999999888776643211        11 1 1223333567778888888888


Q ss_pred             hccccCCCCCCCHHHHHHHHhhhh
Q 028458          142 LCVQESADDRPTMNDVVCMLTNEA  165 (208)
Q Consensus       142 ~~l~~~p~~Rps~~~i~~~l~~~~  165 (208)
                      ..-..+-.+-|+.+-+...+..+-
T Consensus       277 yvR~L~F~E~PDYdylr~Lf~dvl  300 (449)
T KOG1165|consen  277 YVRRLDFFETPDYDYLRKLFDDVL  300 (449)
T ss_pred             HHHhcCcccCCCHHHHHHHHHHHH
Confidence            888999999999988777665543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.50  E-value=1.1e-13  Score=109.68  Aligned_cols=156  Identities=28%  Similarity=0.325  Sum_probs=115.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC-CeEEeccccceecCCCcccc----cccccccCCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGMARICGGNELQA----NTSRIVGTYG   76 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~   76 (208)
                      .++......++.|++.++.|+|..+   ++|||+||.|++++..+ .++++|||.+..........    ......++..
T Consensus        97 ~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~  173 (384)
T COG0515          97 PLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG  173 (384)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccc
Confidence            4667788999999999999999999   99999999999999988 69999999987554333221    2234578899


Q ss_pred             ccCcchhcc---CCCCCcchhHHHHHHHHHHHHhhhcCCcccc-----c----ccCCccc--hhhhh----HHHHHHHHH
Q 028458           77 YMSPEYAIQ---GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE-----L----IDDPVLE--DEYSS----KQMLLRYVN  138 (208)
Q Consensus        77 ~~ape~~~~---~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~----~~~~~~~--~~~~~----~~~~~~~~~  138 (208)
                      |.+||.+.+   ..+....|+|++|+++++++.+..|+.....     .    +......  .....    ......+.+
T Consensus       174 ~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (384)
T COG0515         174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASD  253 (384)
T ss_pred             cCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHH
Confidence            999999987   5678999999999999999888877543331     0    0000000  00001    111246778


Q ss_pred             HHhhccccCCCCCCCHHHHHHH
Q 028458          139 IALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       139 li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ++..++..+|..|.+..+....
T Consensus       254 ~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         254 LLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHHHhcCchhcCCHHHHhhc
Confidence            9999999999999988877764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.46  E-value=1.9e-14  Score=120.55  Aligned_cols=137  Identities=21%  Similarity=0.272  Sum_probs=109.3

Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchhc
Q 028458            5 WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI   84 (208)
Q Consensus         5 ~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~   84 (208)
                      +.....+...++-++.++|+.+   ++|+|+|+.||+++.+|.+++.|||+++..-.....      .|+..|+|||+++
T Consensus        96 ~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~------cgt~eymApEI~~  166 (612)
T KOG0603|consen   96 ELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA------CGTYEYRAPEIIN  166 (612)
T ss_pred             HHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc------ccchhhhhhHhhh
Confidence            3445567778888999999999   999999999999999999999999998765333222      6789999999987


Q ss_pred             cCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           85 QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        85 ~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                        .....+|.|+||++.+++++|..|+..  +............+......+..++..+...+|..|--.
T Consensus       167 --gh~~a~D~ws~gvl~felltg~~pf~~--~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  167 --GHLSAADWWSFGVLAFELLTGTLPFGG--DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             --ccCCcccchhhhhhHHHHhhCCCCCch--HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence              456789999999999999999998876  222211111224577788888899999999999999643

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=1e-12  Score=116.87  Aligned_cols=157  Identities=15%  Similarity=0.115  Sum_probs=110.7

Q ss_pred             CCccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC-------CCCCeEEeccccceecCCCccccccccccc
Q 028458            1 MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-------KDMNPKISDFGMARICGGNELQANTSRIVG   73 (208)
Q Consensus         1 ~~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~-------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~   73 (208)
                      |.++|-..+-++.|++..+++||..+   |||+||||+|+++.       ....++|+|||.+..+.--..........+
T Consensus       789 ~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~  865 (974)
T KOG1166|consen  789 KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWH  865 (974)
T ss_pred             CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeec
Confidence            56788899999999999999999999   99999999999994       234589999998865432222212222345


Q ss_pred             CCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--cCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           74 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--DDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        74 ~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      +-.+.++|...++++++++|.|+|+.+++-|++|.+-. ..-...  ....+.+ ....++   +.+|+..+|..|-..=
T Consensus       866 td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~~g~~~~~~~~~~R-y~~~~~---W~~~F~~lLN~~~~~~  940 (974)
T KOG1166|consen  866 TDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VKNGSSWMVKTNFPR-YWKRDM---WNKFFDLLLNPDCDTL  940 (974)
T ss_pred             cccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hcCCcceeccccchh-hhhHHH---HHHHHHHHhCcCcccc
Confidence            66788999999999999999999999999999998755 111111  1111221 333333   3356667777444445


Q ss_pred             CCHHHHHHHHhhhh
Q 028458          152 PTMNDVVCMLTNEA  165 (208)
Q Consensus       152 ps~~~i~~~l~~~~  165 (208)
                      |...++...|++..
T Consensus       941 p~l~~lr~~~~~~~  954 (974)
T KOG1166|consen  941 PNLQELRTELEEVL  954 (974)
T ss_pred             hhHHHHHHHHHHHH
Confidence            67777777776654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.43  E-value=1.7e-13  Score=103.24  Aligned_cols=163  Identities=17%  Similarity=0.166  Sum_probs=123.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC---CCeEEeccccceecCCCcccc-----ccccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD---MNPKISDFGMARICGGNELQA-----NTSRIVG   73 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~   73 (208)
                      -++..+.+-++.|++.-++|+|..+   ++||||||+|++..-+   ..+.++|||++..........     ......|
T Consensus       107 ~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltG  183 (341)
T KOG1163|consen  107 RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTG  183 (341)
T ss_pred             hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccce
Confidence            4677889999999999999999999   9999999999998644   357899999998764332221     2233568


Q ss_pred             CCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc----------CCccchhhhhHHHHHHHHHHHhhc
Q 028458           74 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID----------DPVLEDEYSSKQMLLRYVNIALLC  143 (208)
Q Consensus        74 ~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~  143 (208)
                      |.+|++-....+...+.+.|+-|+|.++.++--|..|+....-..+          .........+...+.++.-.+..|
T Consensus       184 TaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~  263 (341)
T KOG1163|consen  184 TARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYC  263 (341)
T ss_pred             eeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHH
Confidence            8899888877777889999999999998888767666643322111          111222245666788899999999


Q ss_pred             cccCCCCCCCHHHHHHHHhhhhhc
Q 028458          144 VQESADDRPTMNDVVCMLTNEAAT  167 (208)
Q Consensus       144 l~~~p~~Rps~~~i~~~l~~~~~~  167 (208)
                      -..--++-|+..-+.+.++-+-..
T Consensus       264 R~L~F~E~Pdy~ylrqlFriLfr~  287 (341)
T KOG1163|consen  264 RGLGFEEKPDYMYLRQLFRILFRT  287 (341)
T ss_pred             hhcCCCCCCcHHHHHHHHHHHHhh
Confidence            999999999999888877665433

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.21  E-value=1.7e-11  Score=99.96  Aligned_cols=75  Identities=20%  Similarity=0.235  Sum_probs=59.6

Q ss_pred             HHHHHHHHHHHHhhccCCCCceEeeCC-CCCeeEeCCCCCeEEeccccceecCCCccccc------ccccccCCCccCcc
Q 028458            9 VRIIEGIAQGLLYLHQYSRVRIIHRDL-KVSNILLDKDMNPKISDFGMARICGGNELQAN------TSRIVGTYGYMSPE   81 (208)
Q Consensus         9 ~~i~~qi~~~l~~Lh~~~~~~i~h~~l-~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------~~~~~~~~~~~ape   81 (208)
                      ..++.|++++|.|||+.+   |+|||| ||.||+++.++.++|+|||++...........      .....++..|.+||
T Consensus       114 ~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe  190 (365)
T PRK09188        114 PAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD  190 (365)
T ss_pred             HHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence            578899999999999999   999999 99999999889999999999987654331111      12245667789999


Q ss_pred             hhccC
Q 028458           82 YAIQG   86 (208)
Q Consensus        82 ~~~~~   86 (208)
                      .+...
T Consensus       191 ~~~~~  195 (365)
T PRK09188        191 ALTPR  195 (365)
T ss_pred             cCChh
Confidence            88643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=4.4e-11  Score=94.10  Aligned_cols=154  Identities=19%  Similarity=0.167  Sum_probs=99.8

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceec--CCCcccccccccccCCCccCcc
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~--~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      ....-.+|+.||++||.|||+.. ++|+|+++.-+.+++..+|.+++.--......  -+...........+.++|.+|+
T Consensus       174 ~~~~wkkw~tqIlsal~yLhs~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~  252 (458)
T KOG1266|consen  174 FQKAWKKWCTQILSALSYLHSCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPE  252 (458)
T ss_pred             hHHHHHHHHHHHHhhhhhhhccC-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCC
Confidence            34455789999999999999997 45999999999999999988887542211111  0111111122234567788888


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcC-CcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTS-NRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .=...+....+|||+||+...+|..+.... +..-............. .-....-..++..|++-.|..||+|++++.
T Consensus       253 sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~-~len~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  253 SGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII-GLENGLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             cCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee-eccCccccCcCcccccCCCCCCcchhhhhc
Confidence            765556678899999999999998766542 22222221111111000 000011236899999999999999998765

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.10  E-value=1.5e-10  Score=87.01  Aligned_cols=102  Identities=20%  Similarity=0.148  Sum_probs=72.2

Q ss_pred             HHHHHHHHHHHHhhccCCCCceEeeCC-CCCeeEeCCCCCeEEeccccceecCCCccc----c-c------ccccccCCC
Q 028458            9 VRIIEGIAQGLLYLHQYSRVRIIHRDL-KVSNILLDKDMNPKISDFGMARICGGNELQ----A-N------TSRIVGTYG   76 (208)
Q Consensus         9 ~~i~~qi~~~l~~Lh~~~~~~i~h~~l-~~~nil~~~~~~~~l~dfg~~~~~~~~~~~----~-~------~~~~~~~~~   76 (208)
                      ..++.|++.+|.++|.+|   ++|+|| ||.||+++.++.++|+|||++.........    . .      .........
T Consensus        94 ~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~  170 (218)
T PRK12274         94 LAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPA  170 (218)
T ss_pred             HHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCC
Confidence            467889999999999999   999999 799999999999999999999865433311    0 0      000112344


Q ss_pred             ccCcchhccC-CCC-CcchhHHHHHHHHHHHHhhhcCCc
Q 028458           77 YMSPEYAIQG-IFS-IKSDVFSFGVLLLEIAWDLWTSNR  113 (208)
Q Consensus        77 ~~ape~~~~~-~~~-~~~Dv~slG~~~~~l~~~~~~~~~  113 (208)
                      ++.|+...-- ..+ ...+.++.|+.+|.++++..+...
T Consensus       171 ~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        171 ALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             CCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            5555543221 122 456788999999999998766544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.07  E-value=2.5e-11  Score=105.06  Aligned_cols=152  Identities=22%  Similarity=0.257  Sum_probs=114.4

Q ss_pred             HHHHHHHHHHHHHHHhhc-cCCCCceEeeCCCCCeeEeCCCC-CeEEeccccceecCC-Cccccccccccc-CCCccCcc
Q 028458            6 VTRVRIIEGIAQGLLYLH-QYSRVRIIHRDLKVSNILLDKDM-NPKISDFGMARICGG-NELQANTSRIVG-TYGYMSPE   81 (208)
Q Consensus         6 ~~~~~i~~qi~~~l~~Lh-~~~~~~i~h~~l~~~nil~~~~~-~~~l~dfg~~~~~~~-~~~~~~~~~~~~-~~~~~ape   81 (208)
                      ..+-.++.|+..++.|+| ..+   +.|+|++|+|.+++..+ .+++.|||++..... ...........| +..|.|||
T Consensus       123 ~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E  199 (601)
T KOG0590|consen  123 SSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPE  199 (601)
T ss_pred             cchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcc
Confidence            345678899999999999 888   99999999999999999 999999999987665 333333333567 89999999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcCCccccccc-------CCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-------DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      ...+.. .....|+|+.|+++.-++.|..++........       ..................+++.+++..+|..|.+
T Consensus       200 ~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s  279 (601)
T KOG0590|consen  200 HLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS  279 (601)
T ss_pred             cccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccc
Confidence            987743 46789999999999999988877654333221       1101011233445566778999999999999999


Q ss_pred             HHHHHHH
Q 028458          154 MNDVVCM  160 (208)
Q Consensus       154 ~~~i~~~  160 (208)
                      .+++...
T Consensus       280 ~~~~~~d  286 (601)
T KOG0590|consen  280 IEELKLD  286 (601)
T ss_pred             ccccccc
Confidence            9877653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.06  E-value=2e-10  Score=85.87  Aligned_cols=54  Identities=20%  Similarity=0.158  Sum_probs=48.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhh-ccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceec
Q 028458            2 LLDWVTRVRIIEGIAQGLLYL-HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARIC   59 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~L-h~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~   59 (208)
                      .++..+...++.|++.+|.++ |+.+   ++|||+||.||+++ ++.++++|||++...
T Consensus       113 ~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         113 PLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            356778899999999999999 6888   99999999999998 478999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.04  E-value=3.5e-10  Score=84.60  Aligned_cols=54  Identities=28%  Similarity=0.290  Sum_probs=48.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecC
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG   60 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~   60 (208)
                      ++..+..+++.|++.++.++|+ .|   ++|+|+||.||+++ ++.++++|||++....
T Consensus       114 ~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         114 LEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            4556788999999999999999 88   99999999999998 7899999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.03  E-value=8.4e-11  Score=89.84  Aligned_cols=77  Identities=19%  Similarity=0.301  Sum_probs=58.6

Q ss_pred             HHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchhccCCCC
Q 028458           10 RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS   89 (208)
Q Consensus        10 ~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~   89 (208)
                      ..+.+++.++..+|..|   ++|+|++|.|++++.++ ++++|||......+....              ..+.....+.
T Consensus       139 ~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~  200 (232)
T PRK10359        139 DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYG  200 (232)
T ss_pred             HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhc
Confidence            34669999999999999   99999999999999888 999999977544221111              0123344456


Q ss_pred             CcchhHHHHHHHHHH
Q 028458           90 IKSDVFSFGVLLLEI  104 (208)
Q Consensus        90 ~~~Dv~slG~~~~~l  104 (208)
                      .++|+|+||+.+..+
T Consensus       201 ~~~di~~lg~~~~~~  215 (232)
T PRK10359        201 IKNEIKDLGYYLLIY  215 (232)
T ss_pred             ccccccceeEeehHH
Confidence            789999999987665

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.73  E-value=1.9e-07  Score=76.35  Aligned_cols=162  Identities=18%  Similarity=0.187  Sum_probs=112.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      .+|...++.+..++.+...||..|   .+-+|+++.|+++.+.+.+.|.|-.......+...   ..+.+|...|++||.
T Consensus       114 ~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~---~~cpVg~~eftPPEl  187 (637)
T COG4248         114 CAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTL---HLCPVGVSEFTPPEL  187 (637)
T ss_pred             cccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccCCce---EecccCccccCCHHH
Confidence            578899999999999999999999   89999999999999999999998655444433322   223467789999997


Q ss_pred             hc-----cCCCCCcchhHHHHHHHHHHHHh-hhcCCcccccccC--------------------C---ccchhhhhHHHH
Q 028458           83 AI-----QGIFSIKSDVFSFGVLLLEIAWD-LWTSNRTLELIDD--------------------P---VLEDEYSSKQML  133 (208)
Q Consensus        83 ~~-----~~~~~~~~Dv~slG~~~~~l~~~-~~~~~~~~~~~~~--------------------~---~~~~~~~~~~~~  133 (208)
                      ..     +-.-+...|.+.||+++++++.| ..|..........                    .   .-+......-.+
T Consensus       188 Q~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lp  267 (637)
T COG4248         188 QTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLP  267 (637)
T ss_pred             hccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcC
Confidence            65     22346778999999999999886 3333211111100                    0   000101122234


Q ss_pred             HHHHHHHhhccccC--CCCCCCHHHHHHHHhhhhhccCC
Q 028458          134 LRYVNIALLCVQES--ADDRPTMNDVVCMLTNEAATLLP  170 (208)
Q Consensus       134 ~~~~~li~~~l~~~--p~~Rps~~~i~~~l~~~~~~~~~  170 (208)
                      .++..+..+|....  ++-||+++.-+..|......+.+
T Consensus       268 p~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         268 PDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            66778888887654  67899999877777665544443

>smart00090 RIO RIO-like kinase

Probab=98.68  E-value=3.2e-08  Score=76.58  Aligned_cols=53  Identities=21%  Similarity=0.209  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecC
Q 028458            5 WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG   60 (208)
Q Consensus         5 ~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~   60 (208)
                      ..+...++.|++.++.+||+.+  .++|+|+||.||+++ ++.++++|||.+...+
T Consensus       147 ~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      147 EEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            3456789999999999999986  399999999999999 7889999999876544

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.65  E-value=8.4e-09  Score=88.26  Aligned_cols=147  Identities=18%  Similarity=0.248  Sum_probs=100.3

Q ss_pred             HHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCc-cccc-----c-cccccCCCccCcchh
Q 028458           11 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE-LQAN-----T-SRIVGTYGYMSPEYA   83 (208)
Q Consensus        11 i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~-----~-~~~~~~~~~~ape~~   83 (208)
                      =+.+++.|+.++|...  .+||++|.|.+|.++.++..|+++|+++....... ....     . ....-...|.+||++
T Consensus       104 nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  104 NLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            3455668999999886  49999999999999999999999999876543311 1110     0 011234579999999


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHH-hhhcC---Ccccc---cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           84 IQGIFSIKSDVFSFGVLLLEIAW-DLWTS---NRTLE---LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        84 ~~~~~~~~~Dv~slG~~~~~l~~-~~~~~---~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+...+.++|++|+|+++|.+.. |.+-.   +....   ..............+.+.++.+=+.+++..+...||++..
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~  261 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL  261 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence            88778899999999999998862 32211   11100   0011111111233556778888899999999999997766


Q ss_pred             HHH
Q 028458          157 VVC  159 (208)
Q Consensus       157 i~~  159 (208)
                      +..
T Consensus       262 l~~  264 (700)
T KOG2137|consen  262 LLS  264 (700)
T ss_pred             hhc
Confidence            544

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.64  E-value=3e-08  Score=76.83  Aligned_cols=47  Identities=30%  Similarity=0.377  Sum_probs=42.4

Q ss_pred             HHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceec
Q 028458           10 RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARIC   59 (208)
Q Consensus        10 ~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~   59 (208)
                      ..+.|++.++.+||+.|   |+|+||||.||+++.++.++++|||.+...
T Consensus       146 ~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        146 EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence            34678999999999999   999999999999998889999999987654

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.63  E-value=4.8e-08  Score=73.45  Aligned_cols=50  Identities=26%  Similarity=0.305  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceec
Q 028458            7 TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARIC   59 (208)
Q Consensus         7 ~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~   59 (208)
                      ....++.+++.++.++|+.+   ++|+|++|.||+++.++.++++|||.+...
T Consensus       126 ~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         126 DPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             cHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence            34578899999999999999   999999999999999999999999988554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.55  E-value=1.3e-07  Score=79.64  Aligned_cols=152  Identities=20%  Similarity=0.209  Sum_probs=108.0

Q ss_pred             ccHHHHHHHHHHHHH----HHHhhccCCCCceEeeCCCCCeeEeCCC-CCeEEeccccceecCCCcccccc---cccccC
Q 028458            3 LDWVTRVRIIEGIAQ----GLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGGNELQANT---SRIVGT   74 (208)
Q Consensus         3 l~~~~~~~i~~qi~~----~l~~Lh~~~~~~i~h~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~---~~~~~~   74 (208)
                      ++......++.+...    |+.++|..+   ++|-+++|.|++...+ ..+++.|||+...++........   .+..+.
T Consensus       215 ~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~  291 (524)
T KOG0601|consen  215 LPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGD  291 (524)
T ss_pred             CCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCC
Confidence            344556667777777    999999998   9999999999999988 77899999999888765533322   122567


Q ss_pred             CCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcc----cccccCCccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           75 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT----LELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        75 ~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      ..|.+||.. .+-++...|++++|.++.+...+.......    -....+.. .+.+........+...+..|+..+|-.
T Consensus       292 ~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~  369 (524)
T KOG0601|consen  292 CIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEFCEGGSSSLRSVTSQMLDEDPRL  369 (524)
T ss_pred             ceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-CchhhhcCcchhhhhHHHHhcCcchhh
Confidence            789999976 456688899999999999887654322111    01111111 122344444555666999999999999


Q ss_pred             CCCHHHHHH
Q 028458          151 RPTMNDVVC  159 (208)
Q Consensus       151 Rps~~~i~~  159 (208)
                      |++.+.+..
T Consensus       370 ~~~~q~~~~  378 (524)
T KOG0601|consen  370 RLTAQILTA  378 (524)
T ss_pred             hhHHHHHhc
Confidence            999876655

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.54  E-value=9.8e-08  Score=70.85  Aligned_cols=50  Identities=26%  Similarity=0.221  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceec
Q 028458            6 VTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARIC   59 (208)
Q Consensus         6 ~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~   59 (208)
                      ..+.+++.+++.++.++|. .+   ++|+|++|.||+++ ++.++++|||.+...
T Consensus       114 ~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         114 EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence            4567899999999999999 88   99999999999999 889999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.46  E-value=2.2e-07  Score=70.28  Aligned_cols=48  Identities=31%  Similarity=0.450  Sum_probs=43.6

Q ss_pred             HHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458            7 TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus         7 ~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      ....++.+++.++.+||+.+   ++|+|++|.||+++ ++.++++|||.+..
T Consensus        96 ~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         96 EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            45689999999999999999   99999999999999 77899999997654

>PRK10345 hypothetical protein; Provisional

Probab=98.45  E-value=2e-07  Score=70.77  Aligned_cols=43  Identities=28%  Similarity=0.397  Sum_probs=35.9

Q ss_pred             HHHHHHHHHHH-HhhccCCCCceEeeCCCCCeeEeCC----CCCeEEeccc
Q 028458            9 VRIIEGIAQGL-LYLHQYSRVRIIHRDLKVSNILLDK----DMNPKISDFG   54 (208)
Q Consensus         9 ~~i~~qi~~~l-~~Lh~~~~~~i~h~~l~~~nil~~~----~~~~~l~dfg   54 (208)
                      ..++.|++.++ +|||+++   |+||||||.||+++.    ++.++|+|++
T Consensus       107 ~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345        107 VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            35677888777 9999999   999999999999974    3479999944

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.43  E-value=2.9e-07  Score=69.02  Aligned_cols=45  Identities=31%  Similarity=0.520  Sum_probs=41.8

Q ss_pred             HHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           10 RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        10 ~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++.|++.+|.+||+.+   ++|+|++|.|++++ ++.++++|||++..
T Consensus        94 ~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        94 ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            78999999999999999   99999999999999 78899999998654

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.39  E-value=2.6e-07  Score=79.76  Aligned_cols=48  Identities=25%  Similarity=0.483  Sum_probs=43.4

Q ss_pred             HHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458            7 TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus         7 ~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      ....++.|++.+|.+||+.+   ++|||+||.||++ .++.++++|||++..
T Consensus       429 ~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        429 GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            35778999999999999999   9999999999999 577899999998765

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.32  E-value=3.3e-06  Score=72.54  Aligned_cols=93  Identities=13%  Similarity=0.173  Sum_probs=65.7

Q ss_pred             HHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchhccCCC
Q 028458            9 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIF   88 (208)
Q Consensus         9 ~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~   88 (208)
                      .--+.||+.||.+||..+  .++|+++....|+++..|..+|++|.++.....-..  ........-.|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            445689999999998555  399999999999999999999999988765422111  000111122355665443222 


Q ss_pred             CCcchhHHHHHHHHHHHHh
Q 028458           89 SIKSDVFSFGVLLLEIAWD  107 (208)
Q Consensus        89 ~~~~Dv~slG~~~~~l~~~  107 (208)
                       -..|.|.|||++++++-|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             347999999999999876

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.29  E-value=6.5e-07  Score=80.15  Aligned_cols=143  Identities=24%  Similarity=0.227  Sum_probs=107.1

Q ss_pred             HHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCC-------------------------Ccc
Q 028458           10 RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG-------------------------NEL   64 (208)
Q Consensus        10 ~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~-------------------------~~~   64 (208)
                      ..+..+..++++||...   +.|++++|.|++....+..++.+|+.....+.                         ...
T Consensus       908 s~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l  984 (1205)
T KOG0606|consen  908 SPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQL  984 (1205)
T ss_pred             chhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCcccccccccccccc
Confidence            45566778999999997   89999999999999999999999873321110                         000


Q ss_pred             cc----cccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc-----cccCCccchhhhhHHHHHH
Q 028458           65 QA----NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE-----LIDDPVLEDEYSSKQMLLR  135 (208)
Q Consensus        65 ~~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  135 (208)
                      ..    ......++..|.+||...+......+|+|+.|+++.+.++|..+++....     -+-...+.+...+...++.
T Consensus       985 ~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~ 1064 (1205)
T KOG0606|consen  985 SADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYE 1064 (1205)
T ss_pred             ccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChh
Confidence            00    01224578899999999999989999999999999999999888764322     1222333444456667788


Q ss_pred             HHHHHhhccccCCCCCCCHH
Q 028458          136 YVNIALLCVQESADDRPTMN  155 (208)
Q Consensus       136 ~~~li~~~l~~~p~~Rps~~  155 (208)
                      ..+++...+..+|.+|-.+.
T Consensus      1065 aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1065 AQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhhhhhhccCchhccCcc
Confidence            88999999999999998776

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.19  E-value=8.7e-07  Score=74.79  Aligned_cols=150  Identities=21%  Similarity=0.161  Sum_probs=101.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC-CCeEEeccccceecCCCcccccccccccCCCc-cCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGY-MSP   80 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~-~ap   80 (208)
                      ++....+++..|++.++.++|+..   ++|.|++|+||++..+ +..++.||+.+....  .....  ....+..| .++
T Consensus       363 ~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~--~~~~~--~~~~~r~~p~~~  435 (524)
T KOG0601|consen  363 LDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLA--FSSGV--FHHIDRLYPIAE  435 (524)
T ss_pred             cCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccc--eeccc--ccccccccccch
Confidence            455677889999999999999998   9999999999999876 677899998875321  00000  01112223 345


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCc--ccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR--TLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      .......+..++|+++||..+.+.+++..-...  ....+.......   .+.....+..+.+.++..++..||.+.+..
T Consensus       436 ~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~---~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~  512 (524)
T KOG0601|consen  436 ILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPN---LPGLKLQLQVLLKVMINPDRKRRPSAVELS  512 (524)
T ss_pred             hhccccccccccccccccccccccccCcccCcccccceeeecccccC---CCchHHhhhhhhhhhcCCccccchhhhhhc
Confidence            444556678899999999999998877642222  222222222221   222236677889999999999999998876


Q ss_pred             HHHh
Q 028458          159 CMLT  162 (208)
Q Consensus       159 ~~l~  162 (208)
                      ....
T Consensus       513 ~~~~  516 (524)
T KOG0601|consen  513 LHSE  516 (524)
T ss_pred             ccch
Confidence            6543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.19  E-value=3.5e-06  Score=59.52  Aligned_cols=53  Identities=32%  Similarity=0.320  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccce
Q 028458            5 WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR   57 (208)
Q Consensus         5 ~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~   57 (208)
                      ......++.++++++.+||......++|+|+++.|++++..+.+++.||+.+.
T Consensus        85 ~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          85 EEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            35667889999999999998521129999999999999988899999999764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.16  E-value=3.9e-06  Score=62.89  Aligned_cols=51  Identities=16%  Similarity=0.085  Sum_probs=43.3

Q ss_pred             HHHHHHHHHHHHHHHhh-ccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecC
Q 028458            6 VTRVRIIEGIAQGLLYL-HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG   60 (208)
Q Consensus         6 ~~~~~i~~qi~~~l~~L-h~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~   60 (208)
                      .+...+..|++.++..| |+.+   ++|+|+++.||++. ++.+.++|||.+....
T Consensus       124 ~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         124 EEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            34567789999999988 8888   99999999999997 4679999999876653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=97.98  E-value=1e-05  Score=58.82  Aligned_cols=48  Identities=33%  Similarity=0.302  Sum_probs=39.5

Q ss_pred             HHHHHHHHHHHHhhccCC--CCceEeeCCCCCeeEeCCCCCeEEeccccce
Q 028458            9 VRIIEGIAQGLLYLHQYS--RVRIIHRDLKVSNILLDKDMNPKISDFGMAR   57 (208)
Q Consensus         9 ~~i~~qi~~~l~~Lh~~~--~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~   57 (208)
                      ..++.++++++..||..+  ...++|+|+++.||+++ ++.++++||+.+.
T Consensus        86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            356789999999999987  11249999999999998 5679999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.91  E-value=1.5e-05  Score=60.32  Aligned_cols=53  Identities=32%  Similarity=0.379  Sum_probs=46.3

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC---CeEEeccccceec
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKISDFGMARIC   59 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~---~~~l~dfg~~~~~   59 (208)
                      +......++.+++..+.-||..|   ++|+|+++.||+++.++   .+.++||+.+...
T Consensus       116 ~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  116 DPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             chhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            34567789999999999999999   99999999999998886   7899999876653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.90  E-value=1.7e-05  Score=62.43  Aligned_cols=50  Identities=26%  Similarity=0.347  Sum_probs=43.7

Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-------CCCeEEecccccee
Q 028458            6 VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-------DMNPKISDFGMARI   58 (208)
Q Consensus         6 ~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-------~~~~~l~dfg~~~~   58 (208)
                      ..+..++.+++..+..||..|   ++|+|+++.||+++.       +..+.++||+.+..
T Consensus       138 ~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        138 RLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            456689999999999999999   999999999999975       46789999997754

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=97.85  E-value=0.00019  Score=60.52  Aligned_cols=133  Identities=18%  Similarity=0.196  Sum_probs=97.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++....+.++.|+..||.++|+.|   +.-+-+.+.+|+++++.++++...|..........              +|  
T Consensus       390 ~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~--------------~~--  450 (655)
T KOG3741|consen  390 APEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT--------------EP--  450 (655)
T ss_pred             chHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCC--------------cc--
Confidence            466788999999999999999999   88899999999999998999988877655433321              11  


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML  161 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l  161 (208)
                      +.+   -.+-|.-.||.++.-|++|............   .........++.++++++......++++ -++.+++.++
T Consensus       451 le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~---s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  451 LES---QQQNDLRDLGLLLLALATGTENSNRTDSTQS---SHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             hhH---HhhhhHHHHHHHHHHHhhcccccccccchHH---HHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence            111   1346888999999999998665433222211   1112456677888999999999999987 6777777654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=97.79  E-value=3.7e-05  Score=56.59  Aligned_cols=47  Identities=28%  Similarity=0.440  Sum_probs=40.6

Q ss_pred             HHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceec
Q 028458            9 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARIC   59 (208)
Q Consensus         9 ~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~   59 (208)
                      ..++..+..-+.-||..|   |+|+|+.++|+.+.... +.++|||+..+-
T Consensus        95 ~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          95 PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence            457778888899999999   99999999999997664 899999998653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=97.69  E-value=7.8e-05  Score=62.85  Aligned_cols=49  Identities=27%  Similarity=0.276  Sum_probs=41.8

Q ss_pred             HHHHHHHHH-HHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecC
Q 028458            9 VRIIEGIAQ-GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG   60 (208)
Q Consensus         9 ~~i~~qi~~-~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~   60 (208)
                      .+++.+++. .+..+|..|   ++|+|++|.||+++.++.++++|||++....
T Consensus       259 ~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       259 KALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            456666666 478899998   9999999999999999999999999987664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.56  E-value=0.00017  Score=53.74  Aligned_cols=50  Identities=34%  Similarity=0.484  Sum_probs=37.7

Q ss_pred             HHHHHHHHHHHHHHh-hccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecC
Q 028458            7 TRVRIIEGIAQGLLY-LHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG   60 (208)
Q Consensus         7 ~~~~i~~qi~~~l~~-Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~   60 (208)
                      ....++.+++..+.. +|..|   ++|+|+++.||+++.+ .+.++|||.+....
T Consensus       107 ~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  107 EPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             THHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             hHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            455677888885555 57888   9999999999999877 89999999876643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=97.56  E-value=0.00011  Score=41.83  Aligned_cols=44  Identities=52%  Similarity=0.746  Sum_probs=38.5

Q ss_pred             hhccCCCCCCCccccccccccccCCCCc--cccccceeeeeecccC
Q 028458          165 AATLLPPKQPAFSYVRNTVTSTSSTGKT--EDCSINQVTISLLEAR  208 (208)
Q Consensus       165 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  208 (208)
                      ...++.|++|.|...+......+++.+.  ..+|+|++|++.+++|
T Consensus         3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence            3578999999999999988877777666  8899999999999998

; GO: 0004674 protein serine/threonine kinase activity

>PRK09902 hypothetical protein; Provisional

Probab=97.54  E-value=0.00013  Score=55.20  Aligned_cols=52  Identities=15%  Similarity=0.160  Sum_probs=44.9

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC--eEEecccccee
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN--PKISDFGMARI   58 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~--~~l~dfg~~~~   58 (208)
                      +...+..++.+++..+.-||+.|   +.|+|+.++||+++.++.  +.++||..+..
T Consensus       126 ~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        126 SDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             chHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            44566799999999999999999   999999999999986666  88999976543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=97.46  E-value=0.00022  Score=52.63  Aligned_cols=47  Identities=38%  Similarity=0.588  Sum_probs=40.0

Q ss_pred             HHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC---CeEEecccccee
Q 028458            9 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKISDFGMARI   58 (208)
Q Consensus         9 ~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~---~~~l~dfg~~~~   58 (208)
                      ..++..+.+.+.-||.++   ++|+||..+||++..++   .+.+.|||++..
T Consensus       116 ~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  116 AELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            577888889999999999   99999999999986543   358999998764

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.03  E-value=0.0016  Score=48.58  Aligned_cols=55  Identities=18%  Similarity=0.109  Sum_probs=48.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccce
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR   57 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~   57 (208)
                      -+|..+.+|+.++++.+.+|+..-...+...|++++|+.++.++.+++.|.....
T Consensus        56 ~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   56 SPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence            3799999999999999999998554459999999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=96.79  E-value=0.0017  Score=49.44  Aligned_cols=43  Identities=26%  Similarity=0.324  Sum_probs=36.6

Q ss_pred             HHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccce
Q 028458           11 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR   57 (208)
Q Consensus        11 i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~   57 (208)
                      +...+.+++..||+.|   ++|+|..|.|+++..++ +.+.||+...
T Consensus       140 ~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             HHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECcccc
Confidence            4566788999999999   99999999999998654 8899997543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=96.56  E-value=0.0021  Score=55.52  Aligned_cols=40  Identities=20%  Similarity=0.287  Sum_probs=33.3

Q ss_pred             HHhhccCCCCceEeeCCCCCeeEeCCCC----CeEEeccccceecCC
Q 028458           19 LLYLHQYSRVRIIHRDLKVSNILLDKDM----NPKISDFGMARICGG   61 (208)
Q Consensus        19 l~~Lh~~~~~~i~h~~l~~~nil~~~~~----~~~l~dfg~~~~~~~   61 (208)
                      +..+...|   ++|+|++|.||+++.++    .++++|||+......
T Consensus       273 ~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 FTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            34445677   99999999999999887    899999999877643

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.54  E-value=0.0056  Score=56.58  Aligned_cols=146  Identities=18%  Similarity=0.183  Sum_probs=94.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCC---eeEeCCCCCeEEe--ccccceecCCCcccccccccccCCCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVS---NILLDKDMNPKIS--DFGMARICGGNELQANTSRIVGTYGY   77 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~---nil~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~~~   77 (208)
                      ++..+...+..+..+|+.|+|+..   ..|.-+..+   +-..+..+.....  ||+.+...........   ...+..+
T Consensus       283 i~~~~~r~~~~~~~~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~  356 (1351)
T KOG1035|consen  283 IPLETLRILHQKLLEGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIR  356 (1351)
T ss_pred             cCHHHHHHHHHHHhhhHHHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCcccc
Confidence            455667778889999999999997   666666665   4444555666655  8887766544332221   1223456


Q ss_pred             cCcchhccCCCC--CcchhHHHHHHHHHHHHhhhcCCcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           78 MSPEYAIQGIFS--IKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        78 ~ape~~~~~~~~--~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+++......+.  ...|+|.+|.....+..+............       ..+........+....|+..+.++|.++.
T Consensus       357 ~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~-------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~  429 (1351)
T KOG1035|consen  357 NADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVS-------LLDVLSTSELLDALPKCLDEDSEERLSAL  429 (1351)
T ss_pred             ccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchhh-------hhccccchhhhhhhhhhcchhhhhccchh
Confidence            677766655544  446999999998888665544332111111       11111111566788999999999999999


Q ss_pred             HHHHHH
Q 028458          156 DVVCML  161 (208)
Q Consensus       156 ~i~~~l  161 (208)
                      +++...
T Consensus       430 ~ll~~~  435 (1351)
T KOG1035|consen  430 ELLTHP  435 (1351)
T ss_pred             hhhhch
Confidence            998864

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=96.43  E-value=0.0058  Score=47.96  Aligned_cols=50  Identities=24%  Similarity=0.244  Sum_probs=39.9

Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458            6 VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus         6 ~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      ...-.++..|+.-+..+-..|   ++|+|+++-||+++.+|.+.++||-.+..
T Consensus       202 en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         202 ENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             cCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCccccc
Confidence            344556666777666666777   99999999999999999999999975544

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=96.35  E-value=0.0094  Score=44.94  Aligned_cols=29  Identities=21%  Similarity=0.448  Sum_probs=24.9

Q ss_pred             ceEeeCCCCCeeEeCC--CCCeEEeccccce
Q 028458           29 RIIHRDLKVSNILLDK--DMNPKISDFGMAR   57 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~--~~~~~l~dfg~~~   57 (208)
                      .++|+|+.+.||+++.  ++.+.++||+.+.
T Consensus       175 ~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         175 GLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             EEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence            4899999999999988  5668899998654

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=95.03  E-value=0.04  Score=42.79  Aligned_cols=50  Identities=26%  Similarity=0.309  Sum_probs=41.7

Q ss_pred             HHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecC
Q 028458            7 TRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG   60 (208)
Q Consensus         7 ~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~   60 (208)
                      +...+..++++.+.-|-. .+   +||+||+.=||++. .+.+.++|++.+....
T Consensus       167 e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         167 EAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             hHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            466777888888888877 55   99999999999999 7789999999876543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.29  E-value=0.084  Score=43.50  Aligned_cols=54  Identities=24%  Similarity=0.271  Sum_probs=46.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      ...|.+.++++++.+..+.-+..+=  ..-||++.-.||+++ +|.+.|+||.+++.
T Consensus       317 ~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         317 ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence            4578899999999988887777665  488999999999999 89999999998874

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.03  E-value=0.058  Score=41.46  Aligned_cols=39  Identities=26%  Similarity=0.255  Sum_probs=33.0

Q ss_pred             HHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEecccc
Q 028458           16 AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM   55 (208)
Q Consensus        16 ~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~   55 (208)
                      +++|...|+..+ +.+|+|..|+||+-|..|.+|+.|-+.
T Consensus       151 i~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhh
Confidence            467888896653 499999999999999999999999653

The function of this family is unknown.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=94.00  E-value=0.12  Score=39.47  Aligned_cols=29  Identities=28%  Similarity=0.394  Sum_probs=25.1

Q ss_pred             ceEeeCCCCCeeEeCC-CCCeEEeccccce
Q 028458           29 RIIHRDLKVSNILLDK-DMNPKISDFGMAR   57 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~-~~~~~l~dfg~~~   57 (208)
                      .++|+|+.+.||+++. ++.+.++||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            4999999999999997 4779999998653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=93.93  E-value=0.088  Score=40.49  Aligned_cols=29  Identities=28%  Similarity=0.401  Sum_probs=24.8

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEeccccce
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMAR   57 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~   57 (208)
                      .++|+|+.+.|++++.+....++||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            48999999999999877666799998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=93.67  E-value=0.097  Score=42.00  Aligned_cols=28  Identities=39%  Similarity=0.516  Sum_probs=25.2

Q ss_pred             eEeeCCCCCeeEeCCCCCeEEeccccce
Q 028458           30 IIHRDLKVSNILLDKDMNPKISDFGMAR   57 (208)
Q Consensus        30 i~h~~l~~~nil~~~~~~~~l~dfg~~~   57 (208)
                      ++|+|+.+.|++++.++.+.++||+.+.
T Consensus       189 l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       189 VIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCCCCcCcEEEECCceEEEeeccccc
Confidence            9999999999999988777899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=93.63  E-value=0.11  Score=39.32  Aligned_cols=30  Identities=43%  Similarity=0.485  Sum_probs=20.2

Q ss_pred             ceEeeCCCCCeeEeC-CCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLD-KDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~-~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.||+++ .++.+.++||+.+..
T Consensus       167 ~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  167 VLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             EEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             EEEEeccccccceeeeccceeEEEecccceE
Confidence            499999999999999 556667999986543

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=93.41  E-value=0.23  Score=39.62  Aligned_cols=29  Identities=34%  Similarity=0.393  Sum_probs=25.3

Q ss_pred             ceEeeCCCCCeeEeCCC----CCeEEeccccce
Q 028458           29 RIIHRDLKVSNILLDKD----MNPKISDFGMAR   57 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~----~~~~l~dfg~~~   57 (208)
                      .++|+|+.+.||+++.+    +.+.++||+.+.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            49999999999999874    789999998653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=93.04  E-value=0.18  Score=40.55  Aligned_cols=29  Identities=34%  Similarity=0.416  Sum_probs=25.0

Q ss_pred             eEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           30 IIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        30 i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      ++|+|+.+.||+++.+....++||+.++.
T Consensus       189 liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        189 VIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cCCCCCCCCcEEEECCceEEEEecccccC
Confidence            99999999999998776668999987643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=92.86  E-value=0.14  Score=40.70  Aligned_cols=28  Identities=39%  Similarity=0.509  Sum_probs=25.1

Q ss_pred             eEeeCCCCCeeEeCCCCCeEEeccccce
Q 028458           30 IIHRDLKVSNILLDKDMNPKISDFGMAR   57 (208)
Q Consensus        30 i~h~~l~~~nil~~~~~~~~l~dfg~~~   57 (208)
                      ++|+|+.+.|++++.++.+.+.||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhc
Confidence            9999999999999988777899998654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=92.78  E-value=0.2  Score=37.81  Aligned_cols=30  Identities=40%  Similarity=0.536  Sum_probs=20.9

Q ss_pred             ceEeeCCCCCeeEe-CCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILL-DKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~-~~~~~~~l~dfg~~~~   58 (208)
                      .+.|+|+.+.||++ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            49999999999999 7888999999987643

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=92.57  E-value=0.31  Score=38.51  Aligned_cols=48  Identities=19%  Similarity=0.254  Sum_probs=36.1

Q ss_pred             HHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           10 RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        10 ~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      +.+..+-.++.-.+..- ..++|+|+.+.|++.+..+.++|+||..+..
T Consensus       136 ~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         136 KKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            34455555666666551 1389999999999999989999999987654

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=92.54  E-value=0.28  Score=39.18  Aligned_cols=27  Identities=30%  Similarity=0.436  Sum_probs=23.4

Q ss_pred             eEeeCCCCCeeEeCCCCCeEEeccccce
Q 028458           30 IIHRDLKVSNILLDKDMNPKISDFGMAR   57 (208)
Q Consensus        30 i~h~~l~~~nil~~~~~~~~l~dfg~~~   57 (208)
                      ++|+|+.+.|++++. +.+.++||+.+.
T Consensus       189 liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       189 FCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             eEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            899999999999987 568899998543

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.21  E-value=0.43  Score=38.93  Aligned_cols=28  Identities=43%  Similarity=0.644  Sum_probs=24.6

Q ss_pred             eEeeCCCCCeeEeCCCCC-eEEeccccce
Q 028458           30 IIHRDLKVSNILLDKDMN-PKISDFGMAR   57 (208)
Q Consensus        30 i~h~~l~~~nil~~~~~~-~~l~dfg~~~   57 (208)
                      ++|+|+.+.||+++.+.. +.+.||+.++
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            899999999999998874 8899998654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=91.77  E-value=0.14  Score=39.54  Aligned_cols=29  Identities=24%  Similarity=0.328  Sum_probs=25.3

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEeccccce
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMAR   57 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~   57 (208)
                      .++|+|+.+.|++++.++.+.|+||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            49999999999999987778899998653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=91.72  E-value=0.16  Score=39.01  Aligned_cols=28  Identities=18%  Similarity=0.288  Sum_probs=24.7

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEeccccce
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMAR   57 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~   57 (208)
                      .++|+|+.|.|++++.++ +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            479999999999999887 9999998654

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=91.58  E-value=0.3  Score=39.87  Aligned_cols=47  Identities=19%  Similarity=0.261  Sum_probs=38.3

Q ss_pred             HHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458            9 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus         9 ~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      -++...+..-|.-|...|   +||+|++--||+++.++.++++||-....
T Consensus       205 ~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  205 PTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             HHHHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEeechHhhc
Confidence            345555666677888888   99999999999999999999999965443

>TIGR02721 ycfN_thiK thiamine kinase

Probab=90.98  E-value=0.19  Score=39.17  Aligned_cols=29  Identities=21%  Similarity=0.275  Sum_probs=24.8

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.|++++.++ +.++||+.+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            489999999999998876 78999987643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10271 thiK thiamine kinase; Provisional

Probab=90.92  E-value=0.21  Score=37.19  Aligned_cols=29  Identities=17%  Similarity=0.248  Sum_probs=25.0

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      ..+|+|+.|.|+++..++ ++++||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            379999999999998777 88999987754

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=90.74  E-value=0.42  Score=41.38  Aligned_cols=40  Identities=28%  Similarity=0.302  Sum_probs=33.4

Q ss_pred             HHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCC
Q 028458           19 LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG   61 (208)
Q Consensus        19 l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~   61 (208)
                      +..+-..|   ++|.|..|-|++++.+|.+.+.|||.......
T Consensus       278 ~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         278 LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            44444456   99999999999999999999999999877654

>PLN02236 choline kinase

Probab=90.61  E-value=0.56  Score=38.44  Aligned_cols=30  Identities=30%  Similarity=0.468  Sum_probs=25.3

Q ss_pred             ceEeeCCCCCeeEeCC-CCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDK-DMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~   58 (208)
                      .++|+|+++.||+++. ++.+.++||.++..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            4999999999999976 46799999987643

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=90.05  E-value=0.5  Score=37.94  Aligned_cols=30  Identities=23%  Similarity=0.379  Sum_probs=26.4

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.++|++++.++.+.++||..++.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            399999999999999988899999986643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=89.75  E-value=0.27  Score=38.98  Aligned_cols=30  Identities=30%  Similarity=0.583  Sum_probs=24.5

Q ss_pred             ceEeeCCCCCeeEeCCCCC-eEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMN-PKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~-~~l~dfg~~~~   58 (208)
                      .++|+|+.+.|++++.++. ..++||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4999999999999987454 57999987643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK06148 hypothetical protein; Provisional

Probab=89.34  E-value=0.7  Score=43.48  Aligned_cols=29  Identities=41%  Similarity=0.536  Sum_probs=24.4

Q ss_pred             eEeeCCCCCeeEeCCCC--C-eEEecccccee
Q 028458           30 IIHRDLKVSNILLDKDM--N-PKISDFGMARI   58 (208)
Q Consensus        30 i~h~~l~~~nil~~~~~--~-~~l~dfg~~~~   58 (208)
                      ++|+|+.+.||+++.++  . .-++|||.+..
T Consensus       205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        205 VIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            99999999999998774  3 45999997754

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=88.44  E-value=0.46  Score=38.50  Aligned_cols=32  Identities=19%  Similarity=0.431  Sum_probs=28.1

Q ss_pred             CCceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           27 RVRIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        27 ~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      ...++|+|+.+.|++++....+-++||+.+..
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            44699999999999999988899999998754

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=87.58  E-value=0.54  Score=35.15  Aligned_cols=29  Identities=28%  Similarity=0.439  Sum_probs=23.5

Q ss_pred             ceEeeCCCCCeeEeCCCC-----CeEEeccccce
Q 028458           29 RIIHRDLKVSNILLDKDM-----NPKISDFGMAR   57 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~-----~~~l~dfg~~~   57 (208)
                      .++|||+.+.|+++..++     .+.+.||..+.
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            499999999999997543     57899998653

subfamily of choline kinases

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=87.56  E-value=0.58  Score=40.48  Aligned_cols=69  Identities=19%  Similarity=0.219  Sum_probs=42.3

Q ss_pred             CCcchhHHHHHHHHHHHHhhhcCCcccc--cc---------cCC---ccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           89 SIKSDVFSFGVLLLEIAWDLWTSNRTLE--LI---------DDP---VLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        89 ~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~---------~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      ..++|||++|.++.++..|...+.....  ..         +..   ..........++..++++...|+...|..||..
T Consensus       109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~  188 (725)
T KOG1093|consen  109 GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP  188 (725)
T ss_pred             CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence            3689999999999998655433321111  00         000   001112344456778899999999999998755


Q ss_pred             HHH
Q 028458          155 NDV  157 (208)
Q Consensus       155 ~~i  157 (208)
                      .++
T Consensus       189 ~~~  191 (725)
T KOG1093|consen  189 MEL  191 (725)
T ss_pred             hHH
Confidence            443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=85.85  E-value=1.9  Score=35.05  Aligned_cols=30  Identities=23%  Similarity=0.361  Sum_probs=25.4

Q ss_pred             ceEeeCCCCCeeEeCC-CCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDK-DMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~   58 (208)
                      .+.|+|+.+.||+++. ++.++++||+.+..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4899999999999974 46899999987643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=84.54  E-value=0.58  Score=41.37  Aligned_cols=86  Identities=23%  Similarity=0.221  Sum_probs=60.8

Q ss_pred             HHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchhccCCCCC
Q 028458           11 IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSI   90 (208)
Q Consensus        11 i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~   90 (208)
                      ++..-.+++.++|+.-   =+|+|    ||+... +..+.++|+.........   ......++..|.+||....+.+..
T Consensus       341 ~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~  409 (829)
T KOG0576|consen  341 PLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDG  409 (829)
T ss_pred             hhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhccccccc
Confidence            3444456788898874   47777    666544 568889998765543222   223356788999999999999999


Q ss_pred             cchhHHHHHHHHHHHHh
Q 028458           91 KSDVFSFGVLLLEIAWD  107 (208)
Q Consensus        91 ~~Dv~slG~~~~~l~~~  107 (208)
                      ..|+|++|.--.++.-+
T Consensus       410 ~p~~~~~~~~~~~~ap~  426 (829)
T KOG0576|consen  410 CPDSGSLAVSAIQMAPG  426 (829)
T ss_pred             CCCccCCCcchhhcCCC
Confidence            99999999765566433

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=84.22  E-value=0.7  Score=37.92  Aligned_cols=15  Identities=47%  Similarity=0.640  Sum_probs=13.6

Q ss_pred             ceEeeCCCCCeeEeC
Q 028458           29 RIIHRDLKVSNILLD   43 (208)
Q Consensus        29 ~i~h~~l~~~nil~~   43 (208)
                      ..+|-||||+||++-
T Consensus       299 nF~H~DLKPdNILiF  313 (434)
T PF05445_consen  299 NFLHVDLKPDNILIF  313 (434)
T ss_pred             eeeecccCcCcEEEe
Confidence            499999999999994

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=82.91  E-value=2.2  Score=35.76  Aligned_cols=29  Identities=24%  Similarity=0.438  Sum_probs=24.4

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.||++..+ .++++|+.++..
T Consensus       224 ~l~HgDl~~gni~~~~~-~~~viD~E~a~~  252 (401)
T PRK09550        224 ALLHGDLHTGSIFVTEE-ETKVIDPEFAFY  252 (401)
T ss_pred             ceeeccCCcccEEeeCC-CcEEEecccccc
Confidence            39999999999999766 589999986543

>PRK11768 serine/threonine protein kinase; Provisional

Probab=82.85  E-value=2  Score=34.86  Aligned_cols=26  Identities=38%  Similarity=0.549  Sum_probs=22.2

Q ss_pred             eEeeCCCCCeeEeCCCCCeEEeccccce
Q 028458           30 IIHRDLKVSNILLDKDMNPKISDFGMAR   57 (208)
Q Consensus        30 i~h~~l~~~nil~~~~~~~~l~dfg~~~   57 (208)
                      ++|+|+.+.||+++ + .+.++||+.+.
T Consensus       198 liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        198 RLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            89999999999995 3 57889998764

>PRK06149 hypothetical protein; Provisional

Probab=82.36  E-value=1.9  Score=40.53  Aligned_cols=29  Identities=24%  Similarity=0.373  Sum_probs=23.5

Q ss_pred             eEeeCCCCCeeEeCCCC--C---eEEecccccee
Q 028458           30 IIHRDLKVSNILLDKDM--N---PKISDFGMARI   58 (208)
Q Consensus        30 i~h~~l~~~nil~~~~~--~---~~l~dfg~~~~   58 (208)
                      +||+|+...||+++.+.  .   ..++|||.+..
T Consensus       210 ~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~  243 (972)
T PRK06149        210 AVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR  243 (972)
T ss_pred             ccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence            99999999999998652  2   47899997643

>PHA03111 Ser/Thr kinase; Provisional

Probab=80.12  E-value=4.1  Score=33.54  Aligned_cols=36  Identities=28%  Similarity=0.209  Sum_probs=21.7

Q ss_pred             HHHHHHHHHHHhh-ccCCCCceEeeCCCCCeeEeCCC
Q 028458           10 RIIEGIAQGLLYL-HQYSRVRIIHRDLKVSNILLDKD   45 (208)
Q Consensus        10 ~i~~qi~~~l~~L-h~~~~~~i~h~~l~~~nil~~~~   45 (208)
                      -+..||+--.-.+ .-.+-...+|-||||+||++-+.
T Consensus       283 fifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        283 FIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             HHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            4556665433122 22211249999999999999543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	208
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-25
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-25
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-24
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-24
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-20
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-20
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-20
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-13
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-07
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-07
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-07
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-07
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-07
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-07
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-07
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-07
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-07
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-07
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-07
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-07
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-07
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-06
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-06
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-06
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-06
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-06
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-06
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-06
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-06
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-06
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-06
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-06
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-06
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-06
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-06
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-06
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-06
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-06
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-06
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-06
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-06
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-05
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-05
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
3soa_A	444	Full-Length Human Camkii Length = 444		1e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-05
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-04
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-04
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-04
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-04
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		6e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 67/185 (36%), Positives = 102/185 (55%), Gaps = 24/185 (12%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LDW  R RI  G A+GL YLH +   +IIHRD+K +NILLD++    + DFG+A++    
Sbjct: 136 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 195
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI-----AWDL--------- 108
           +     + + GT G+++PEY   G  S K+DVF +GV+LLE+     A+DL         
Sbjct: 196 DXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 254
Query: 109 ----WTSN----RTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM 160
               W       + LE + D  L+  Y  ++ + + + +ALLC Q S  +RP M++VV M
Sbjct: 255 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEE-VEQLIQVALLCTQSSPMERPKMSEVVRM 313
Query: 161 LTNEA 165
           L  + 
Sbjct: 314 LEGDG 318

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  110 bits (275), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 66/185 (35%), Positives = 101/185 (54%), Gaps = 24/185 (12%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LDW  R RI  G A+GL YLH +   +IIHRD+K +NILLD++    + DFG+A++    
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI-----AWDL--------- 108
           +     + + G  G+++PEY   G  S K+DVF +GV+LLE+     A+DL         
Sbjct: 188 DXHVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 109 ----WTSN----RTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM 160
               W       + LE + D  L+  Y  ++ + + + +ALLC Q S  +RP M++VV M
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEE-VEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 161 LTNEA 165
           L  + 
Sbjct: 306 LEGDG 310

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/183 (39%), Positives = 104/183 (56%), Gaps = 28/183 (15%)
Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
           M + W  R+ I  G A+GL YLH  +   IIHRD+K  NILLD++  PKI+DFG+++   
Sbjct: 134 MSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--K 188
Query: 61  GNEL-QANTSRIV-GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI-------------- 104
           G EL Q +   +V GT GY+ PEY I+G  + KSDV+SFGV+L E+              
Sbjct: 189 GTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 105 -----AWDLWTSNR-TLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
                 W + + N   LE I DP L D+    + L ++ + A+ C+  S++DRP+M DV+
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRP-ESLRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 159 CML 161
             L
Sbjct: 308 WKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/183 (39%), Positives = 104/183 (56%), Gaps = 28/183 (15%)
Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
           M + W  R+ I  G A+GL YLH  +   IIHRD+K  NILLD++  PKI+DFG+++   
Sbjct: 134 MSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--K 188
Query: 61  GNEL-QANTSRIV-GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI-------------- 104
           G EL Q +   +V GT GY+ PEY I+G  + KSDV+SFGV+L E+              
Sbjct: 189 GTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 105 -----AWDLWTSNR-TLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
                 W + + N   LE I DP L D+    + L ++ + A+ C+  S++DRP+M DV+
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRP-ESLRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 159 CML 161
             L
Sbjct: 308 WKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/132 (43%), Positives = 76/132 (57%), Gaps = 17/132 (12%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L W  R +I +G A G+ +LH+      IHRD+K +NILLD+    KISDFG+AR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPV 122
                 SRIVGT  YM+PE A++G  + KSD++SFGV+LLEI   L            P 
Sbjct: 187 AQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGL------------PA 233
Query: 123 LEDEYSSKQMLL 134
           + DE+   Q+LL
Sbjct: 234 V-DEHREPQLLL 244

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 56/132 (42%), Positives = 75/132 (56%), Gaps = 17/132 (12%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L W  R +I +G A G+ +LH+      IHRD+K +NILLD+    KISDFG+AR     
Sbjct: 121 LSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPV 122
                 SRIVGT  Y +PE A++G  + KSD++SFGV+LLEI   L            P 
Sbjct: 178 AQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGL------------PA 224
Query: 123 LEDEYSSKQMLL 134
           + DE+   Q+LL
Sbjct: 225 V-DEHREPQLLL 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 56/132 (42%), Positives = 75/132 (56%), Gaps = 17/132 (12%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L W  R +I +G A G+ +LH+      IHRD+K +NILLD+    KISDFG+AR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPV 122
                  RIVGT  YM+PE A++G  + KSD++SFGV+LLEI   L            P 
Sbjct: 187 AQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGL------------PA 233
Query: 123 LEDEYSSKQMLL 134
           + DE+   Q+LL
Sbjct: 234 V-DEHREPQLLL 244

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 56/132 (42%), Positives = 75/132 (56%), Gaps = 17/132 (12%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L W  R +I +G A G+ +LH+      IHRD+K +NILLD+    KISDFG+AR     
Sbjct: 124 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPV 122
                  RIVGT  YM+PE A++G  + KSD++SFGV+LLEI   L            P 
Sbjct: 181 AQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGL------------PA 227
Query: 123 LEDEYSSKQMLL 134
           + DE+   Q+LL
Sbjct: 228 V-DEHREPQLLL 238

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 95/174 (54%), Gaps = 21/174 (12%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICG 60
           +LD  T   I+  + +GL YLH+  +   IHRD+K  NILL +D + +I+DFG+ A +  
Sbjct: 112 VLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLAT 168
Query: 61  GNELQANTSR--IVGTYGYMSPEY--AIQGIFSIKSDVFSFGVLLLEIA-----WDLWTS 111
           G ++  N  R   VGT  +M+PE    ++G +  K+D++SFG+  +E+A     +  +  
Sbjct: 169 GGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATGAAPYHKYPP 227
Query: 112 NRTLELI---DDPVLEDEYSSKQMLLRY----VNIALLCVQESADDRPTMNDVV 158
            + L L    D P LE     K+ML +Y      +  LC+Q+  + RPT  +++
Sbjct: 228 MKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 95/174 (54%), Gaps = 21/174 (12%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICG 60
           +LD  T   I+  + +GL YLH+  +   IHRD+K  NILL +D + +I+DFG+ A +  
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173
Query: 61  GNELQANTSR--IVGTYGYMSPEY--AIQGIFSIKSDVFSFGVLLLEIA-----WDLWTS 111
           G ++  N  R   VGT  +M+PE    ++G +  K+D++SFG+  +E+A     +  +  
Sbjct: 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATGAAPYHKYPP 232
Query: 112 NRTLELI---DDPVLEDEYSSKQMLLRY----VNIALLCVQESADDRPTMNDVV 158
            + L L    D P LE     K+ML +Y      +  LC+Q+  + RPT  +++
Sbjct: 233 MKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 289 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 344
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 400
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 289 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 344
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 400
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 289 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 344
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 400
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 73.2 bits (178), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 372 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 427
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 483
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 532

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 120 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-P 175
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 231
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 232 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 113 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-P 168
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 169 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 224
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 225 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 273

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 120 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 175
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 231
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 232 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 116 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 171
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 172 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 227
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 228 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 276

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 178
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 234
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 235 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 112 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 167
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 168 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 223
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 224 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 272

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 178
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 234
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 235 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 114 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 169
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 170 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 225
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 226 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 274

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 178
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 234
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 235 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-P 178
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 234
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 235 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 178
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 234
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 235 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 178
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 234
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 235 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 178
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 234
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 235 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 84/169 (49%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+ R+   NE  A        
Sbjct: 290 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF-P 345
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 346 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 401
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 402 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQXQPG 450

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 16/169 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ Y+    R+  +HRDL  +NIL+ +++  K++DFG+AR+   NE  A        
Sbjct: 123 IASGMAYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 178
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT--LELIDDPVLEDEYSSKQM 132
             + +PE A+ G F+IKSDV+SFG+LL E+     T  R     +++  VL+      +M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELT----TKGRVPYPGMVNREVLDQVERGYRM 234
Query: 133 LL------RYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 235 PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 83/171 (48%), Gaps = 20/171 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A G+ Y+    R+  IHRDL+ +NIL+   +  KI+DFG+AR+   NE  A        
Sbjct: 114 VAAGMAYIE---RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-P 169
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLE------IAWDLWTSNRTLELIDD----PVLE 124
             + +PE A+ G F+IKSDV+SFG+LL E      + +    +   LE ++     P  +
Sbjct: 170 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQ 229
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
           D   S   L+      + C ++  ++RPT   +   L +      P  QP 
Sbjct: 230 DCPISLHELM------IHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPG 274

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+   NE  A        
Sbjct: 123 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 179
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 180 -KWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 234
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 235 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 271

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+   NE  A        
Sbjct: 124 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 180
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 181 -KWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 235
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 236 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 272

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+   NE  A        
Sbjct: 118 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-P 173
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 229
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+   NE  A        
Sbjct: 126 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-P 181
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 182 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 237
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 238 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 274

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+   NE  A        
Sbjct: 124 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-P 179
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 180 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 235
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 236 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 272

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+   NE  A        
Sbjct: 119 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-P 174
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 175 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 230
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 231 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 267

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+   NE  A        
Sbjct: 120 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-P 175
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 176 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 231
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 232 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 268

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+   NE  A        
Sbjct: 128 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-P 183
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 184 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 239
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 240 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 276

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+   NE  A        
Sbjct: 118 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-P 173
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 229
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+   NE  A        
Sbjct: 127 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-P 182
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 183 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 238
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 239 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 275

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+   NE  A        
Sbjct: 118 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 175 -KWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 229
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 55/90 (61%), Gaps = 4/90 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ Y+    R   IHRDL+ +N+L+ + +  KI+DFG+AR+   NE  A        
Sbjct: 119 IAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI 175
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + +PE    G F+IKSDV+SFG+LL EI
Sbjct: 176 -KWTAPEAINFGCFTIKSDVWSFGILLYEI 204

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+   NE  A        
Sbjct: 113 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-P 168
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 169 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 224
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 225 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 261

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 69/128 (53%), Gaps = 24/128 (18%)
Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-----DKDMNP---KISD 52
           +L++W  +      IA+G+ YLH  + V IIHRDLK SNIL+     + D++    KI+D
Sbjct: 106 ILVNWAVQ------IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159
Query: 53  FGMARICGGNELQANTS-RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTS 111
           FG+AR     E    T     G Y +M+PE     +FS  SDV+S+GVLL    W+L T 
Sbjct: 160 FGLAR-----EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLL----WELLTG 210
Query: 112 NRTLELID 119
                 ID
Sbjct: 211 EVPFRGID 218

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 61/103 (59%), Gaps = 3/103 (2%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD   R+ +   +A+G+ YLH  +   I+HRDLK  N+L+DK    K+ DFG++R+    
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRNPP-IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASX 192
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
            L +  +   GT  +M+PE       + KSDV+SFGV+L E+A
Sbjct: 193 FLXSKXA--AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 56/90 (62%), Gaps = 4/90 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ Q +    IHRDL+ +NIL+   +  KI+DFG+AR+   NE  A        
Sbjct: 120 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-P 175
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + +PE    G F+IKSDV+SFG+LL+EI
Sbjct: 176 IKWTAPEAINFGSFTIKSDVWSFGILLMEI 205

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 62/103 (60%), Gaps = 3/103 (2%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD   R+ +   +A+G+ YLH  +   I+HR+LK  N+L+DK    K+ DFG++R+    
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRNPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
            L + ++   GT  +M+PE       + KSDV+SFGV+L E+A
Sbjct: 193 FLSSKSA--AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 56/90 (62%), Gaps = 4/90 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ Q +    IHRDL+ +NIL+   +  KI+DFG+AR+   NE  A        
Sbjct: 293 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-P 348
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + +PE    G F+IKSDV+SFG+LL+EI
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEI 378

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 75/153 (49%), Gaps = 24/153 (15%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ Y+    R   IHRDL+ +N+L+ + +  KI+DFG+AR+   NE  A        
Sbjct: 118 IAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-P 173
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDP---------VLED 125
             + +PE    G F+IKS+V+SFG+LL EI         T   I  P          L  
Sbjct: 174 IKWTAPEAINFGCFTIKSNVWSFGILLYEIV--------TYGKIPYPGRTNADVMSALSQ 225
Query: 126 EYSSKQMLL---RYVNIALLCVQESADDRPTMN 155
            Y   +M        +I  +C +E A++RPT +
Sbjct: 226 GYRMPRMENCPDELYDIMKMCWKEKAEERPTFD 258

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHR+L+ +NIL+   ++ KI+DFG+AR+   NE  A        
Sbjct: 114 IAEGMAFIEERN---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-P 169
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 170 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 225
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 226 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 262

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 16/157 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+    E  A        
Sbjct: 118 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKF-P 173
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR-TLELIDDPVLEDEYSSKQML 133
             + +PE    G F+IKSDV+SFG+LL EI     T  R     + +P +         +
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLERGYRM 229
Query: 134 LRYVN-------IALLCVQESADDRPTMNDVVCMLTN 163
           +R  N       +  LC +E  +DRPT + +  +L +
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 83/164 (50%), Gaps = 18/164 (10%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD      I+  I +GL YLH   +   IHRD+K +N+LL +    K++DFG+A      
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSN-----RTLEL 117
           +++ NT   VGT  +M+PE   Q  +  K+D++S G+  +E+A      +     + L L
Sbjct: 158 QIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 215
Query: 118 I---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
           I   + P LE  YS  + L  +V     C+ +    RPT  +++
Sbjct: 216 IPKNNPPTLEGNYS--KPLKEFVEA---CLNKEPSFRPTAKELL 254

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 83/164 (50%), Gaps = 18/164 (10%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD      I+  I +GL YLH   +   IHRD+K +N+LL +    K++DFG+A      
Sbjct: 121 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 177
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSN-----RTLEL 117
           +++ NT   VGT  +M+PE   Q  +  K+D++S G+  +E+A      +     + L L
Sbjct: 178 QIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 235
Query: 118 I---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
           I   + P LE  YS  + L  +V     C+ +    RPT  +++
Sbjct: 236 IPKNNPPTLEGNYS--KPLKEFVEA---CLNKEPSFRPTAKELL 274

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 40/102 (39%), Positives = 57/102 (55%), Gaps = 4/102 (3%)
Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA 66
           TR    E I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA
Sbjct: 134 TRFYTAE-IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             +  VGT  Y+SPE   +   S  SD+++ G ++ ++   L
Sbjct: 190 RANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGL 231

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 18/156 (11%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I+  I +GL YLH     R IHRD+K +N+LL +  + K++DFG+A      +++ N   
Sbjct: 121 ILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX-- 175
Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSN-----RTLELIDD---PV 122
            VGT  +M+PE   Q  +  K+D++S G+  +E+A     ++     R L LI     P 
Sbjct: 176 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT 235
Query: 123 LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
           LE ++S       +      C+ +    RPT  +++
Sbjct: 236 LEGQHSKP-----FKEFVEACLNKDPRFRPTAKELL 266

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 74/140 (52%), Gaps = 17/140 (12%)
Query: 23  HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 82
           H +SR R++HRD+K +N+ +      K+ D G+ R        A++  +VGT  YMSPE 
Sbjct: 151 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 207
Query: 83  AIQGIFSIKSDVFSFGVLLLEIA----------WDLWTSNRTLELIDDPVLEDEYSSKQM 132
             +  ++ KSD++S G LL E+A           +L++  + +E  D P L  ++ S++ 
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE- 266
Query: 133 LLRYVNIALLCVQESADDRP 152
           L + VN   +C+    + RP
Sbjct: 267 LRQLVN---MCINPDPEKRP 283

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 85/179 (47%), Gaps = 15/179 (8%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +++   IA G+ YL+     + +HRDL   N ++  D   KI DFGM R     +     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDDPV 122
            + +    +M+PE    G+F+  SD++SFGV+L EI       +   ++ + L+ + D  
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 123 LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRN 181
             D+        R  ++  +C Q + + RPT  ++V +L ++    L P  P  S+  +
Sbjct: 250 YLDQ--PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD----LHPSFPEVSFFHS 302

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 18/164 (10%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD      I+  I +GL YLH   +   IHRD+K +N+LL +    K++DFG+A      
Sbjct: 116 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSN-----RTLEL 117
           +++ N    VGT  +M+PE   Q  +  K+D++S G+  +E+A      +     + L L
Sbjct: 173 QIKRNX--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 230
Query: 118 I---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
           I   + P LE  YS  + L  +V     C+ +    RPT  +++
Sbjct: 231 IPKNNPPTLEGNYS--KPLKEFVEA---CLNKEPSFRPTAKELL 269

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 18/164 (10%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD      I+  I +GL YLH   +   IHRD+K +N+LL +    K++DFG+A      
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSN-----RTLEL 117
           +++ N    VGT  +M+PE   Q  +  K+D++S G+  +E+A      +     + L L
Sbjct: 158 QIKRNX--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 215
Query: 118 I---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
           I   + P LE  YS  + L  +V     C+ +    RPT  +++
Sbjct: 216 IPKNNPPTLEGNYS--KPLKEFVEA---CLNKEPSFRPTAKELL 254

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 15/179 (8%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +++   IA G+ YL+     + +HRDL   N ++  D   KI DFGM R     +     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDDPV 122
            + +    +M+PE    G+F+  SD++SFGV+L EI       +   ++ + L+ + D  
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 123 LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRN 181
             D+        R  ++  +C Q +   RPT  ++V +L ++    L P  P  S+  +
Sbjct: 250 YLDQ--PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----LHPSFPEVSFFHS 302

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 15/179 (8%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +++   IA G+ YL+     + +HRDL   N ++  D   KI DFGM R     +     
Sbjct: 130 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 186
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDDPV 122
            + +    +M+PE    G+F+  SD++SFGV+L EI       +   ++ + L+ + D  
Sbjct: 187 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 246
Query: 123 LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRN 181
             D+        R  ++  +C Q +   RPT  ++V +L ++    L P  P  S+  +
Sbjct: 247 YLDQ--PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----LHPSFPEVSFFHS 299

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 119 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/91 (45%), Positives = 55/91 (60%), Gaps = 7/91 (7%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVG 73
           I  GL +LH      I++RDLK+ NILLDKD + KI+DFGM   C  N L  A T+   G
Sbjct: 128 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNEFCG 181
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T  Y++PE  +   ++   D +SFGVLL E+
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 212

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 116 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 206

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 118 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 208

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
             +  I  G+LYLH +    I+HRDL +SN+LL ++MN KI+DFG+A        +  T 
Sbjct: 116 HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT- 171
Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
            + GT  Y+SPE A +    ++SDV+S G + 
Sbjct: 172 -LCGTPNYISPEIATRSAHGLESDVWSLGCMF 202

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGL 231

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 232

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 4/102 (3%)
Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA 66
           TR    E I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA
Sbjct: 135 TRFYTAE-IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 190
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             +  VGT  Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 191 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 232

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 4/102 (3%)
Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA 66
           TR    E I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA
Sbjct: 139 TRFYTAE-IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 194
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             +  VGT  Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 195 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 236

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 123 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 213

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 4/102 (3%)
Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA 66
           TR    E I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA
Sbjct: 137 TRFYTAE-IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 192
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             +  VGT  Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 193 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 234

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N ++ +D   KI DFGM R     +      + +  
Sbjct: 132 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 188
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELI-DDPVLEDEY 127
             +MSPE    G+F+  SDV+SFGV+L EIA      +   ++ + L  + +  +L+   
Sbjct: 189 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 248
Query: 128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNE 164
           +   MLL  +    +C Q +   RP+  +++  +  E
Sbjct: 249 NCPDMLLELMR---MCWQYNPKMRPSFLEIISSIKEE 282

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 57/112 (50%), Gaps = 15/112 (13%)
Query: 5   WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL 64
           W  RV   + IA G+ YLH    + IIHRDL   N L+ ++ N  ++DFG+AR+    + 
Sbjct: 107 WSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163
Query: 65  QANTSR------------IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           Q    R            +VG   +M+PE      +  K DVFSFG++L EI
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/91 (45%), Positives = 55/91 (60%), Gaps = 7/91 (7%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVG 73
           I  GL +LH      I++RDLK+ NILLDKD + KI+DFGM   C  N L  A T+   G
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNXFCG 180
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T  Y++PE  +   ++   D +SFGVLL E+
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 211

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
             Y+SPE   +      SD+++ G ++ ++   L
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 228

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 34/75 (45%), Positives = 47/75 (62%), Gaps = 2/75 (2%)
Query: 30  IIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 89
           ++HRDLK +N+ LD   N K+ DFG+ARI   +E  A     VGT  YMSPE   +  ++
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSPEQMNRMSYN 194
Query: 90  IKSDVFSFGVLLLEI 104
            KSD++S G LL E+
Sbjct: 195 EKSDIWSLGCLLYEL 209

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 61/103 (59%), Gaps = 14/103 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA----RICGGNEL 64
           + I    AQG+ YLH  S   IIHRDLK +NI L +D+  KI DFG+A    R  G ++ 
Sbjct: 127 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 183
Query: 65  QANTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI 104
           +    ++ G+  +M+PE      +  +S +SDV++FG++L E+
Sbjct: 184 E----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 222

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 61/103 (59%), Gaps = 14/103 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA----RICGGNEL 64
           + I    AQG+ YLH  S   IIHRDLK +NI L +D+  KI DFG+A    R  G ++ 
Sbjct: 134 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 190
Query: 65  QANTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI 104
           +    ++ G+  +M+PE      +  +S +SDV++FG++L E+
Sbjct: 191 E----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 229

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 34/75 (45%), Positives = 47/75 (62%), Gaps = 2/75 (2%)
Query: 30  IIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 89
           ++HRDLK +N+ LD   N K+ DFG+ARI   +   A T   VGT  YMSPE   +  ++
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYN 194
Query: 90  IKSDVFSFGVLLLEI 104
            KSD++S G LL E+
Sbjct: 195 EKSDIWSLGCLLYEL 209

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 61/103 (59%), Gaps = 14/103 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA----RICGGNEL 64
           + I    AQG+ YLH  S   IIHRDLK +NI L +D+  KI DFG+A    R  G ++ 
Sbjct: 135 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 191
Query: 65  QANTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI 104
           +    ++ G+  +M+PE      +  +S +SDV++FG++L E+
Sbjct: 192 E----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 230

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 15/179 (8%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +++   IA G+ YL+     + +HRDL   N ++  D   KI DFGM R     +     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 189
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDDPV 122
            + +    +M+PE    G+F+  SD++SFGV+L EI       +   ++ + L+ + D  
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 123 LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRN 181
             D+        R  ++  +C Q +   RPT  ++V +L ++    L P  P  S+  +
Sbjct: 250 YLDQ--PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----LHPSFPEVSFFHS 302

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 61/103 (59%), Gaps = 14/103 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA----RICGGNEL 64
           + I    AQG+ YLH  S   IIHRDLK +NI L +D+  KI DFG+A    R  G ++ 
Sbjct: 107 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 163
Query: 65  QANTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI 104
           +    ++ G+  +M+PE      +  +S +SDV++FG++L E+
Sbjct: 164 E----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 61/103 (59%), Gaps = 14/103 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA----RICGGNEL 64
           + I    AQG+ YLH  S   IIHRDLK +NI L +D+  KI DFG+A    R  G ++ 
Sbjct: 135 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 191
Query: 65  QANTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI 104
           +    ++ G+  +M+PE      +  +S +SDV++FG++L E+
Sbjct: 192 E----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 230

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 63/109 (57%), Gaps = 14/109 (12%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA----RI 58
            + +  + I    AQG+ YLH  S   IIHRDLK +NI L +D+  KI DFG+A    R 
Sbjct: 103 FEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 159
Query: 59  CGGNELQANTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI 104
            G ++ +    ++ G+  +M+PE      +  +S +SDV++FG++L E+
Sbjct: 160 SGSHQFE----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 204

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + I    AQG+ YLH  S   IIHRDLK +NI L +D+  KI DFG+A +          
Sbjct: 112 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 168
Query: 69  SRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI 104
            ++ G+  +M+PE      +  +S +SDV++FG++L E+
Sbjct: 169 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 207

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + I    AQG+ YLH  S   IIHRDLK +NI L +D+  KI DFG+A +          
Sbjct: 107 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 69  SRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI 104
            ++ G+  +M+PE      +  +S +SDV++FG++L E+
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + I    AQG+ YLH  S   IIHRDLK +NI L +D+  KI DFG+A +          
Sbjct: 112 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 168
Query: 69  SRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI 104
            ++ G+  +M+PE      +  +S +SDV++FG++L E+
Sbjct: 169 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 207

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + I    AQG+ YLH  S   IIHRDLK +NI L +D+  KI DFG+A +          
Sbjct: 107 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 69  SRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI 104
            ++ G+  +M+PE      +  +S +SDV++FG++L E+
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 19/158 (12%)
Query: 16  AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGT 74
           +QG+ YLH      +IHRDLK  N+LL       KI DFG A  C   ++Q + +   G+
Sbjct: 113 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA--C---DIQTHMTNNKGS 167
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYS----SK 130
             +M+PE      +S K DVFS+G++L    W++ T  +  + I  P     ++    ++
Sbjct: 168 AAWMAPEVFEGSNYSEKCDVFSWGIIL----WEVITRRKPFDEIGGPAFRIMWAVHNGTR 223
Query: 131 QMLLRYV-----NIALLCVQESADDRPTMNDVVCMLTN 163
             L++ +     ++   C  +    RP+M ++V ++T+
Sbjct: 224 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 261

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N ++ +D   KI DFGM R     +      + +  
Sbjct: 141 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 197
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             +MSPE    G+F+  SDV+SFGV+L EIA
Sbjct: 198 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 59/95 (62%), Gaps = 5/95 (5%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +++ I +GL YLH   +   IHRD+K +N+LL +  + K++DFG+A      +++ NT  
Sbjct: 125 MLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-- 179
Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
            VGT  +M+PE   Q  +  K+D++S G+  +E+A
Sbjct: 180 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELA 214

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/104 (40%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 6   VTRVRIIEGIA---QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG-- 60
           +T  R IE IA   Q L + HQ     IIHRD+K +NIL+      K+ DFG+AR     
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADS 169
Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           GN +   T+ ++GT  Y+SPE A       +SDV+S G +L E+
Sbjct: 170 GNSVX-QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 15/179 (8%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +++   IA G+ YL+     + +HRDL   N ++  D   KI DFGM R     +     
Sbjct: 132 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDDPV 122
            + +    +M+PE    G+F+  SD++SFGV+L EI       +   ++ + L+ + D  
Sbjct: 189 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 248
Query: 123 LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRN 181
             D+        R  ++  +C Q +   RPT  ++V +L ++    L P  P  S+  +
Sbjct: 249 YLDQ--PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----LHPSFPEVSFFHS 301

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 55/90 (61%), Gaps = 14/90 (15%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA+G+ ++ Q +    IHRDL+ +NIL+   +  KI+DFG+AR+     ++         
Sbjct: 287 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK--------- 334
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + +PE    G F+IKSDV+SFG+LL+EI
Sbjct: 335 --WTAPEAINFGSFTIKSDVWSFGILLMEI 362

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 19/158 (12%)
Query: 16  AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGT 74
           +QG+ YLH      +IHRDLK  N+LL       KI DFG A  C   ++Q + +   G+
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA--C---DIQTHMTNNKGS 166
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYS----SK 130
             +M+PE      +S K DVFS+G++L    W++ T  +  + I  P     ++    ++
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIIL----WEVITRRKPFDEIGGPAFRIMWAVHNGTR 222
Query: 131 QMLLRYV-----NIALLCVQESADDRPTMNDVVCMLTN 163
             L++ +     ++   C  +    RP+M ++V ++T+
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 83/166 (50%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GI  G+ YL   S V   HRDL   NIL++ ++  K+SDFGM+R+   +   A T
Sbjct: 134 VGMLRGIGSGMKYLSDMSAV---HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 190
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + +PE      F+  SDV+S+G+++ E+        WD+ ++   ++ I++
Sbjct: 191 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVIKAIEE 249
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+   DRP    +V ML
Sbjct: 250 GYRLPPPMDCPIALHQLMLD-------CWQKERSDRPKFGQIVNML 288

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 15/179 (8%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +++   IA G+ YL+     + +HRDL   N ++  D   KI DFGM R           
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKG 189
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDDPV 122
            + +    +M+PE    G+F+  SD++SFGV+L EI       +   ++ + L+ + D  
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 123 LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRN 181
             D+        R  ++  +C Q +   RPT  ++V +L ++    L P  P  S+  +
Sbjct: 250 YLDQ--PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----LHPSFPEVSFFHS 302

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 24/154 (15%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +  G  QGL YLH ++   +IHRD+K  NILL +    K+ DFG A I       A  + 
Sbjct: 159 VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANX 209
Query: 71  IVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIAW---DLWTSNRTLELI-----D 119
            VGT  +M+PE  +   +G +  K DV+S G+  +E+A     L+  N    L      +
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269
Query: 120 DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
            P L+  + S+     + N    C+Q+   DRPT
Sbjct: 270 SPALQSGHWSEY----FRNFVDSCLQKIPQDRPT 299

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 15/148 (10%)
Query: 23  HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 82
           H    ++IIHRD+K SNILLD+  N K+ DFG   I G        +R  G   YM+PE 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPER 196
Query: 83  ----AIQGIFSIKSDVFSFGVLLLEIA--------WDLWTSNRTLELIDDPVLEDEYSSK 130
               A +  + ++SDV+S G+ L E+A        W+      T  +  DP        +
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256
Query: 131 QMLLRYVNIALLCVQESADDRPTMNDVV 158
           +    ++N   LC+ +    RP   +++
Sbjct: 257 EFSPSFINFVNLCLTKDESKRPKYKELL 284

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 83/166 (50%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GI  G+ YL   S V   HRDL   NIL++ ++  K+SDFGM+R+   +   A T
Sbjct: 113 VGMLRGIGSGMKYLSDMSYV---HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 169
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + +PE      F+  SDV+S+G+++ E+        WD+ ++   ++ I++
Sbjct: 170 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVIKAIEE 228
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+   DRP    +V ML
Sbjct: 229 GYRLPPPMDCPIALHQLMLD-------CWQKERSDRPKFGQIVNML 267

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 83/166 (50%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GI  G+ YL   S V   HRDL   NIL++ ++  K+SDFGM+R+   +   A T
Sbjct: 119 VGMLRGIGSGMKYLSDMSYV---HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 175
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + +PE      F+  SDV+S+G+++ E+        WD+ ++   ++ I++
Sbjct: 176 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVIKAIEE 234
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+   DRP    +V ML
Sbjct: 235 GYRLPPPMDCPIALHQLMLD-------CWQKERSDRPKFGQIVNML 273

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 85/179 (47%), Gaps = 15/179 (8%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +++   IA G+ YL+     + +HR+L   N ++  D   KI DFGM R     +     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 189
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDDPV 122
            + +    +M+PE    G+F+  SD++SFGV+L EI       +   ++ + L+ + D  
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 249
Query: 123 LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRN 181
             D+        R  ++  +C Q + + RPT  ++V +L ++    L P  P  S+  +
Sbjct: 250 YLDQ--PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD----LHPSFPEVSFFHS 302

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/104 (39%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 6   VTRVRIIEGIA---QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG-- 60
           +T  R IE IA   Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           GN +   T+ ++GT  Y+SPE A       +SDV+S G +L E+
Sbjct: 170 GNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/104 (39%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 6   VTRVRIIEGIA---QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG-- 60
           +T  R IE IA   Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           GN +   T+ ++GT  Y+SPE A       +SDV+S G +L E+
Sbjct: 170 GNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG+AR+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT 206
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + SPE      F+  SDV+S+G++L E+        W++ ++   ++ +D+
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE 265
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 266 GYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/104 (39%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 6   VTRVRIIEGIA---QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG-- 60
           +T  R IE IA   Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           GN +   T+ ++GT  Y+SPE A       +SDV+S G +L E+
Sbjct: 170 GNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/104 (39%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 6   VTRVRIIEGIA---QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG-- 60
           +T  R IE IA   Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           GN +   T+ ++GT  Y+SPE A       +SDV+S G +L E+
Sbjct: 170 GNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 85/179 (47%), Gaps = 15/179 (8%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +++   IA G+ YL+     + +HR+L   N ++  D   KI DFGM R     +     
Sbjct: 134 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDDPV 122
            + +    +M+PE    G+F+  SD++SFGV+L EI       +   ++ + L+ + D  
Sbjct: 191 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 250
Query: 123 LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRN 181
             D+        R  ++  +C Q + + RPT  ++V +L ++    L P  P  S+  +
Sbjct: 251 YLDQ--PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD----LHPSFPEVSFFHS 303

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N ++ +D   KI DFGM R     +      + +  
Sbjct: 147 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             +MSPE    G+F+  SDV+SFGV+L EIA
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N ++ +D   KI DFGM R     +      + +  
Sbjct: 140 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             +MSPE    G+F+  SDV+SFGV+L EIA
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N ++ +D   KI DFGM R     +      + +  
Sbjct: 147 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             +MSPE    G+F+  SDV+SFGV+L EIA
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N ++ +D   KI DFGM R     +      + +  
Sbjct: 134 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             +MSPE    G+F+  SDV+SFGV+L EIA
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 24/154 (15%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +  G  QGL YLH ++   +IHRD+K  NILL +    K+ DFG A I       A  + 
Sbjct: 120 VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANX 170
Query: 71  IVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIAW---DLWTSNRTLELI-----D 119
            VGT  +M+PE  +   +G +  K DV+S G+  +E+A     L+  N    L      +
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230
Query: 120 DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
            P L+  + S+     + N    C+Q+   DRPT
Sbjct: 231 SPALQSGHWSEY----FRNFVDSCLQKIPQDRPT 260

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N ++ +D   KI DFGM R     +      + +  
Sbjct: 141 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 197
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             +MSPE    G+F+  SDV+SFGV+L EIA
Sbjct: 198 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N ++ +D   KI DFGM R     +      + +  
Sbjct: 138 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             +MSPE    G+F+  SDV+SFGV+L EIA
Sbjct: 195 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 225

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N ++ +D   KI DFGM R     +      + +  
Sbjct: 137 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 193
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             +MSPE    G+F+  SDV+SFGV+L EIA
Sbjct: 194 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 224

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N ++ +D   KI DFGM R     +      + +  
Sbjct: 140 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             +MSPE    G+F+  SDV+SFGV+L EIA
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/75 (44%), Positives = 46/75 (61%), Gaps = 2/75 (2%)
Query: 30  IIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 89
           ++HRDLK +N+ LD   N K+ DFG+ARI   N   +     VGT  YMSPE   +  ++
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSPEQMNRMSYN 194
Query: 90  IKSDVFSFGVLLLEI 104
            KSD++S G LL E+
Sbjct: 195 EKSDIWSLGCLLYEL 209

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 11/156 (7%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N ++ +D   KI DFGM R     +      + +  
Sbjct: 169 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 225
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELIDDPVLEDEYS 128
             +MSPE    G+F+  SDV+SFGV+L EIA      +   ++ + L  + +  L D+  
Sbjct: 226 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 285
Query: 129 SKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNE 164
           +   +L    +  +C Q +   RP+  +++  +  E
Sbjct: 286 NCPDML--FELMRMCWQYNPKMRPSFLEIISSIKEE 319

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL+     + +HRDL   N  + +D   KI DFGM R     +      + +  
Sbjct: 134 IADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELI-DDPVLEDEY 127
             +MSPE    G+F+  SDV+SFGV+L EIA      +   ++ + L  + +  +L+   
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 250
Query: 128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNE 164
           +   MLL  +    +C Q +   RP+  +++  +  E
Sbjct: 251 NCPDMLLELMR---MCWQYNPKMRPSFLEIISSIKEE 284

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 51/91 (56%), Gaps = 7/91 (7%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I  GL +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    G
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAG 351
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T G+M+PE  +   +    D F+ GV L E+
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEM 382

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/104 (39%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 6   VTRVRIIEGIA---QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG-- 60
           +T  R IE IA   Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     
Sbjct: 130 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 186
Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           GN +   T+ ++GT  Y+SPE A       +SDV+S G +L E+
Sbjct: 187 GNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 229

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 86/175 (49%), Gaps = 22/175 (12%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA----RICGGNEL 64
           + I    A+G+ YLH  S   IIHRDLK +NI L +D   KI DFG+A    R  G ++ 
Sbjct: 123 IDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 65  QANTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI-AWDLWTSN-----RTL 115
           +    ++ G+  +M+PE         +S +SDV++FG++L E+    L  SN     + +
Sbjct: 180 E----QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235
Query: 116 ELIDDPVLEDEYSS--KQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATL 168
           E++    L  + S        R   +   C+++  D+RP+   ++  +   A  L
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAREL 290

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 51/91 (56%), Gaps = 7/91 (7%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I  GL +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    G
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAG 351
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T G+M+PE  +   +    D F+ GV L E+
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEM 382

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 51/91 (56%), Gaps = 7/91 (7%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I  GL +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    G
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAG 351
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T G+M+PE  +   +    D F+ GV L E+
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEM 382

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + SPE      F+  SDV+S+G++L E+        W++ ++   ++ +D+
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE 265
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 266 GYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 51/91 (56%), Gaps = 7/91 (7%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I  GL +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    G
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAG 351
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T G+M+PE  +   +    D F+ GV L E+
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEM 382

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 86/175 (49%), Gaps = 22/175 (12%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA----RICGGNEL 64
           + I    A+G+ YLH  S   IIHRDLK +NI L +D   KI DFG+A    R  G ++ 
Sbjct: 111 IDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQF 167
Query: 65  QANTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI-AWDLWTSN-----RTL 115
           +    ++ G+  +M+PE         +S +SDV++FG++L E+    L  SN     + +
Sbjct: 168 E----QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 223
Query: 116 ELIDDPVLEDEYSS--KQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATL 168
           E++    L  + S        R   +   C+++  D+RP+   ++  +   A  L
Sbjct: 224 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAREL 278

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R+   +   A T
Sbjct: 121 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + SPE      F+  SDV+S+G++L E+        W++ ++   ++ +D+
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE 236
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 237 GYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 275

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R+   +   A T
Sbjct: 138 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 194
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + SPE      F+  SDV+S+G++L E+        W++ ++   ++ +D+
Sbjct: 195 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE 253
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 254 GYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 292

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R+   +   A T
Sbjct: 148 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 204
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + SPE      F+  SDV+S+G++L E+        W++ ++   ++ +D+
Sbjct: 205 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE 263
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 264 GYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 302

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R+   +   A T
Sbjct: 121 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + SPE      F+  SDV+S+G++L E+        W++ ++   ++ +D+
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE 236
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 237 GYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 275

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + SPE      F+  SDV+S+G++L E+        W++ ++   ++ +D+
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE 265
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 266 GYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + SPE      F+  SDV+S+G++L E+        W++ ++   ++ +D+
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE 265
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 266 GYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + SPE      F+  SDV+S+G++L E+        W++ ++   ++ +D+
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE 265
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 266 GYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + SPE      F+  SDV+S+G++L E+        W++ ++   ++ +D+
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE 265
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 266 GYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + SPE      F+  SDV+S+G++L E+        W++ ++   ++ +D+
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE 265
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 266 GYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + SPE      F+  SDV+S+G++L E+        W++ ++   ++ +D+
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE 265
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 266 GYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 22/166 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA----RICGGNEL 64
           + I    A+G+ YLH  S   IIHRDLK +NI L +D   KI DFG+A    R  G ++ 
Sbjct: 123 IDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 65  QANTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI-AWDLWTSN-----RTL 115
           +    ++ G+  +M+PE         +S +SDV++FG++L E+    L  SN     + +
Sbjct: 180 E----QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235
Query: 116 ELIDDPVLEDEYSS--KQMLLRYVNIALLCVQESADDRPTMNDVVC 159
           E++    L  + S        R   +   C+++  D+RP+   ++ 
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 85/166 (51%), Gaps = 24/166 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG+ R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + SPE      F+  SDV+S+G++L E+        W++ ++   ++ +D+
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDE 265
Query: 121 -----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                P ++   +  Q++L        C Q+  ++RP    +V +L
Sbjct: 266 GYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 60/104 (57%), Gaps = 9/104 (8%)
Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
           +LL+W  +      IA+G++YL +    R++HRDL   N+L+    + KI+DFG+AR+  
Sbjct: 141 LLLNWCVQ------IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 191
Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G+E + N         +M+ E      F+ +SDV+S+GV + E+
Sbjct: 192 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 235

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 60/104 (57%), Gaps = 9/104 (8%)
Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
           +LL+W  +      IA+G++YL +    R++HRDL   N+L+    + KI+DFG+AR+  
Sbjct: 118 LLLNWCVQ------IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 168
Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G+E + N         +M+ E      F+ +SDV+S+GV + E+
Sbjct: 169 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 212

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 18/168 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT
Sbjct: 123 VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 176
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLW----TSNRTLELI-DDPVLEDEYSS 129
             YM+PE      +S++SD++S G+ L+E+A   +       + LE I   PV++ E   
Sbjct: 177 RSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGE 236
Query: 130 KQMLLRYVNIALLCVQ-ESADDRPTMN--DVVCMLTNEAATLLPPKQP 174
              +          V     D RP M   +++  + NE     PPK P
Sbjct: 237 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEP----PPKLP 280

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 92/164 (56%), Gaps = 26/164 (15%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           +I   I + L +LH  S++ +IHRD+K SN+L++     K+ DFG++    G  + +   
Sbjct: 157 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVDSVAK 210
Query: 70  RI-VGTYGYMSPEYA----IQGIFSIKSDVFSFGVLLLEIA-----WDLWTS--NRTLEL 117
            I  G   YM+PE       Q  +S+KSD++S G+ ++E+A     +D W +   +  ++
Sbjct: 211 TIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 270
Query: 118 IDDPVLE---DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
           +++P  +   D++S++     +V+    C+++++ +RPT  +++
Sbjct: 271 VEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPTYPELM 309

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 22/165 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN-ELQAN 67
           V ++ GIA G+ YL   + +  +HRDL   NIL++ ++  K+SDFG++R+   + E    
Sbjct: 150 VGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 68  TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           TS       + +PE      F+  SDV+SFG+++ E+        W+L +++  ++ I+D
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAIND 265
Query: 121 ----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
               P   D  S+   L+      + C Q+    RP   D+V +L
Sbjct: 266 GFRLPTPMDCPSAIYQLM------MQCWQQERARRPKFADIVSIL 304

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 108 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 108 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 108 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 109 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 107 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 108 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 108 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 108 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 165 KMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 108 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 108 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 165 KMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 108 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 165 KMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 108 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 109 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 166 KMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 109 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 108 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 165 KMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 60/98 (61%), Gaps = 14/98 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
            RII+ +  G+ Y+H+++   I+HRDLK  NILL   +KD + KI DFG++  C     Q
Sbjct: 124 ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS-TC----FQ 175
Query: 66  ANTSRI--VGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
            NT     +GT  Y++PE  ++G +  K DV+S GV+L
Sbjct: 176 QNTKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 109 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 109 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 109 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 109 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 108 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R    +  G++YLH    + I HRD+K  N+LLD+  N KISDFG+A +   N  +   +
Sbjct: 109 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 70  RIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLL-----EIAWD 107
           ++ GT  Y++PE   +  F  +  DV+S G++L      E+ WD
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ +D   KI+DFG+AR     +    T+     
Sbjct: 159 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLP 215
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     I++ +SDV+SFGVLL EI
Sbjct: 216 VKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ +D   KI+DFG+AR     +    T+     
Sbjct: 144 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 200
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     I++ +SDV+SFGVLL EI
Sbjct: 201 VKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD V  + + E I +G+ Y+H     ++IHRDLK SNI L      KI DFG+      +
Sbjct: 133 LDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 189
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---ID 119
                 +R  GT  YMSPE      +  + D+++ G++L E+     T+  T +    + 
Sbjct: 190 ---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR 246
Query: 120 DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLT 162
           D ++ D +  K+  L         + +  +DRP  ++++  LT
Sbjct: 247 DGIISDIFDKKEKTL-----LQKLLSKKPEDRPNTSEILRTLT 284

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ +D   KI+DFG+AR     +    T+     
Sbjct: 148 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 204
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     I++ +SDV+SFGVLL EI
Sbjct: 205 VKWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 60/92 (65%), Gaps = 8/92 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT
Sbjct: 175 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 228
Query: 75  YGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
             YMSPE  +QG  +S++SD++S G+ L+E+A
Sbjct: 229 RSYMSPER-LQGTHYSVQSDIWSMGLSLVEMA 259

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 81/186 (43%), Gaps = 38/186 (20%)
Query: 2   LLDWVTR------------VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPK 49
           L DW+ R            + I   IA+ + +LH      ++HRDLK SNI    D   K
Sbjct: 148 LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVK 204
Query: 50  ISDFGMARICGGNELQ----------ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGV 99
           + DFG+      +E +          A     VGT  YMSPE      +S K D+FS G+
Sbjct: 205 VGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGL 264
Query: 100 LLLEIAWDLWTSNRTLELIDD------PVL-EDEYSSKQMLLRYVNIALLCVQESADDRP 152
           +L E+ +   T    + +I D      P+L   +Y  + M+++ +      +  S  +RP
Sbjct: 265 ILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDM------LSPSPTERP 318
Query: 153 TMNDVV 158
              D++
Sbjct: 319 EATDII 324

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ +D   KI+DFG+AR     +    T+     
Sbjct: 152 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 208
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     I++ +SDV+SFGVLL EI
Sbjct: 209 VKWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 14/103 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA----RICGGNEL 64
           + I    AQG+ YLH  +   IIHRD+K +NI L + +  KI DFG+A    R  G  ++
Sbjct: 135 IDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191
Query: 65  QANTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEI 104
           +  T  ++    +M+PE         FS +SDV+S+G++L E+
Sbjct: 192 EQPTGSVL----WMAPEVIRMQDNNPFSFQSDVYSYGIVLYEL 230

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 60/98 (61%), Gaps = 14/98 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
            RII+ +  G+ Y+H+++   I+HRDLK  NILL   +KD + KI DFG++  C     Q
Sbjct: 124 ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS-TC----FQ 175
Query: 66  ANTSRI--VGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
            NT     +GT  Y++PE  ++G +  K DV+S GV+L
Sbjct: 176 QNTKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ +D   KI+DFG+AR     +    T+     
Sbjct: 159 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 215
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     I++ +SDV+SFGVLL EI
Sbjct: 216 VKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 60/98 (61%), Gaps = 14/98 (14%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
            RII+ +  G+ Y+H+++   I+HRDLK  NILL   +KD + KI DFG++  C     Q
Sbjct: 124 ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS-TC----FQ 175
Query: 66  ANTSRI--VGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
            NT     +GT  Y++PE  ++G +  K DV+S GV+L
Sbjct: 176 QNTKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ +D   KI+DFG+AR     +    T+     
Sbjct: 159 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 215
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     I++ +SDV+SFGVLL EI
Sbjct: 216 VKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ +D   KI+DFG+AR     +    T+     
Sbjct: 159 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 215
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     I++ +SDV+SFGVLL EI
Sbjct: 216 VKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 4/98 (4%)
Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA 66
           T +     I  G+ + H    +RI+HRD+K  NIL+D +   KI DFG+A+      L  
Sbjct: 112 TAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-T 167
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            T+ ++GT  Y SPE A        +D++S G++L E+
Sbjct: 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEM 205

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ +D   KI+DFG+AR     +    T+     
Sbjct: 151 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 207
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     I++ +SDV+SFGVLL EI
Sbjct: 208 VKWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 33/174 (18%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQ-------YSRVRIIHRDLKVSNILLDKDMNPKISDFG 54
           ++ W     I E +A+GL YLH+         +  I HRD+K  N+LL  ++   I+DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 55  MARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVF------SFGVLLLEIAWDL 108
           +A      +   +T   VGT  YM+PE  ++G  + + D F      + G++L E+A   
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 109 WTSNRTL---------ELIDDPVLEDE-----YSSKQMLLR-----YVNIALLC 143
             ++  +         E+   P LED      +  K+ +LR     +  +A+LC
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC 289

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 57/91 (62%), Gaps = 6/91 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 166
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             YMSPE      +S++SD++S G+ L+E+A
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   S  + IHRDL   NILL ++   KI DFG+AR    N            
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     I+S KSDV+S+GVLL EI
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEI 294

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 57/91 (62%), Gaps = 6/91 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 166
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             YMSPE      +S++SD++S G+ L+E+A
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 57/91 (62%), Gaps = 6/91 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT
Sbjct: 140 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 193
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             YMSPE      +S++SD++S G+ L+E+A
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 57/91 (62%), Gaps = 6/91 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 166
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             YMSPE      +S++SD++S G+ L+E+A
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 57/91 (62%), Gaps = 6/91 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 166
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             YMSPE      +S++SD++S G+ L+E+A
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 57/91 (62%), Gaps = 6/91 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 166
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             YMSPE      +S++SD++S G+ L+E+A
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 57/91 (62%), Gaps = 6/91 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT
Sbjct: 132 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 185
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             YMSPE      +S++SD++S G+ L+E+A
Sbjct: 186 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 216

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ +D   KI+DFG+AR     +    T+     
Sbjct: 200 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 256
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     I++ +SDV+SFGVLL EI
Sbjct: 257 VKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 54/90 (60%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     +   NT+     
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLP 222
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 139 ISSAMEYL---EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI 195
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 196 -KWTAPESLAYNTFSIKSDVWAFGVLLWEIA 225

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 29/158 (18%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+QG+ YL   + ++++HRDL   NIL+ +    KISDFG++R     +     S+    
Sbjct: 159 ISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIP 215
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA---------------WDLWTSNRTLELID 119
             +M+ E     I++ +SDV+SFGVLL EI                ++L  +   +E  D
Sbjct: 216 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPD 275
Query: 120 DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
           +        S++M      + L C ++  D RP   D+
Sbjct: 276 N-------CSEEM----YRLMLQCWKQEPDKRPVFADI 302

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +G+ YL + S   +IHRDL   N L+ ++   K+SDFGM R    ++  ++T      
Sbjct: 112 VCEGMAYLEEAS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 168
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWD--LWTSNRTLELIDDPVLED------E 126
             + SPE      +S KSDV+SFGVL+ E+  +  +   NR+    +  V+ED       
Sbjct: 169 -KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTGFRL 223
Query: 127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
           Y  +        I   C +E  +DRP  + ++  L   AA+ L
Sbjct: 224 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAIAASGL 266

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 56/91 (61%), Gaps = 6/91 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G  +    +  VGT
Sbjct: 116 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDEMANEFVGT 169
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             YMSPE      +S++SD++S G+ L+E+A
Sbjct: 170 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 200

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 90/160 (56%), Gaps = 28/160 (17%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           +I   I + L +LH  S++ +IHRD+K SN+L++     K+ DFG++       L  + +
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVA 165
Query: 70  RIV--GTYGYMSPEYA----IQGIFSIKSDVFSFGVLLLEIA-----WDLWTS--NRTLE 116
           + +  G   YM+PE       Q  +S+KSD++S G+ ++E+A     +D W +   +  +
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ 225
Query: 117 LIDDPVLE---DEYSSKQMLLRYVNIALLCVQESADDRPT 153
           ++++P  +   D++S++     +V+    C+++++ +RPT
Sbjct: 226 VVEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPT 260

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 118 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI 174
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 175 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 204

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 50/85 (58%), Gaps = 5/85 (5%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QG+ YLH     R+IHRDLK+ N+ L+ DM+ KI DFG+A     +  +  T  + GT  
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPN 207
Query: 77  YMSPEYAIQGIFSIKSDVFSFGVLL 101
           Y++PE   +   S + D++S G +L
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCIL 232

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 29/158 (18%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+QG+ YL   + ++++HRDL   NIL+ +    KISDFG++R     +     S+    
Sbjct: 159 ISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIP 215
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA---------------WDLWTSNRTLELID 119
             +M+ E     I++ +SDV+SFGVLL EI                ++L  +   +E  D
Sbjct: 216 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPD 275
Query: 120 DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
           +        S++M      + L C ++  D RP   D+
Sbjct: 276 N-------CSEEM----YRLMLQCWKQEPDKRPVFADI 302

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 153 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 203
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 204 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 246

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/86 (39%), Positives = 52/86 (60%), Gaps = 7/86 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTY 75
           QG+ YLH     R+IHRDLK+ N+ L+ DM+ KI DFG+A +I    E + +   + GT 
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD---LCGTP 206
Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLL 101
            Y++PE   +   S + D++S G +L
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCIL 232

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 129 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 179
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 180 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 222

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 119 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 125 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 182 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 119 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 113 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 206

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 52/88 (59%), Gaps = 11/88 (12%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR---IVG 73
           QG+ YLH     R+IHRDLK+ N+ L+ DM+ KI DFG+A      +++ +  R   + G
Sbjct: 137 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCG 188
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           T  Y++PE   +   S + D++S G +L
Sbjct: 189 TPNYIAPEVLCKKGHSFEVDIWSLGCIL 216

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 52/88 (59%), Gaps = 11/88 (12%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR---IVG 73
           QG+ YLH     R+IHRDLK+ N+ L+ DM+ KI DFG+A      +++ +  R   + G
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKXLCG 204
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           T  Y++PE   +   S + D++S G +L
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCIL 232

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 7/92 (7%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           +A+G+ +L   S    +HRDL   N+L+      KI DFG+AR  +   N +    +R+ 
Sbjct: 181 VAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL- 236
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
               +M+PE   +GI++IKSDV+S+G+LL EI
Sbjct: 237 -PVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 119 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 29/158 (18%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+QG+ YL + S   ++HRDL   NIL+ +    KISDFG++R     +     S+    
Sbjct: 159 ISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIP 215
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA---------------WDLWTSNRTLELID 119
             +M+ E     I++ +SDV+SFGVLL EI                ++L  +   +E  D
Sbjct: 216 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPD 275
Query: 120 DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
           +        S++M      + L C ++  D RP   D+
Sbjct: 276 N-------CSEEM----YRLMLQCWKQEPDKRPVFADI 302

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 119 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 116 LLNWCVQ------IAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 166
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 167 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 209

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 122 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 172
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 173 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 120 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 170
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 171 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 213

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 125 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 175
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 176 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 218

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 122 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 172
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 173 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 119 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 120 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 177 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 122 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 172
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 173 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 215

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 120 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 170
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 171 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 213

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 126 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 219

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 125 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 182 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 123 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 173
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 174 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 216

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 120 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 177 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 126 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 219

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 264 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 298

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 121 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 171
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 172 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 124 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 181 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 210

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 121 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 171
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 172 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 122 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 172
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 173 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 215

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 126 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 219

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 264 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 298

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G 
Sbjct: 144 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 194
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 195 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 237

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 120 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 177 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 122 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 178
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 179 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 208

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 133 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 189
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 190 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 219

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 125 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 181
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 182 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 122 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 178
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 179 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 208

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 125 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 182 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 125 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 182 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 273 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 307

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 120 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 177 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 120 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 177 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 273 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 307

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 45/212 (21%)
Query: 4   DWVTRVRIIEGIAQGLLYLH------QYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           DWV+  R+   + +GL YLH       + +  I HRDL   N+L+  D    ISDFG++ 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 58  ICGGNEL----QANTSRI--VGTYGYMSPEYAIQGIFSIKS--------DVFSFGVLLLE 103
              GN L    + + + I  VGT  YM+PE  ++G  +++         D+++ G+    
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGL---- 223
Query: 104 IAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
           I W+++   R  +L     +  EY              +  Q    + PT  D+  +++ 
Sbjct: 224 IYWEIFM--RCTDLFPGESV-PEYQ-------------MAFQTEVGNHPTFEDMQVLVSR 267
Query: 164 EAATLLPPKQPAFSYVRNTVTSTSSTGKTEDC 195
           E      PK P  ++  N++   S     EDC
Sbjct: 268 EKQR---PKFPE-AWKENSLAVRSLKETIEDC 295

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 120 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 177 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 11/100 (11%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++  IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R        A+ 
Sbjct: 148 VHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADY 200
Query: 69  SRIVGT----YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +++G       +M+PE  + G FSI SD++S+GV+L E+
Sbjct: 201 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 118 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 175 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 204

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 121 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 177
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 178 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 207

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 273 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 307

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 11/100 (11%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++  IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R        A+ 
Sbjct: 131 VHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADY 183
Query: 69  SRIVGT----YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +++G       +M+PE  + G FSI SD++S+GV+L E+
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 55/83 (66%), Gaps = 6/83 (7%)
Query: 23  HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 82
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 307 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 361
Query: 83  AIQGI-FSIKSDVFSFGVLLLEI 104
             +G+ +   +D FS G +L ++
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKL 384

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 55/83 (66%), Gaps = 6/83 (7%)
Query: 23  HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 82
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 307 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 361
Query: 83  AIQGI-FSIKSDVFSFGVLLLEI 104
             +G+ +   +D FS G +L ++
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKL 384

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 118 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 175 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 204

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 55/83 (66%), Gaps = 6/83 (7%)
Query: 23  HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 82
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 307 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 361
Query: 83  AIQGI-FSIKSDVFSFGVLLLEI 104
             +G+ +   +D FS G +L ++
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKL 384

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 55/83 (66%), Gaps = 6/83 (7%)
Query: 23  HQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 82
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 306 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 360
Query: 83  AIQGI-FSIKSDVFSFGVLLLEI 104
             +G+ +   +D FS G +L ++
Sbjct: 361 LQKGVAYDSSADWFSLGCMLFKL 383

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 58/95 (61%), Gaps = 5/95 (5%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I++   +GL YLH    +R IHRD+K  NILL+ + + K++DFG+A      +  A  + 
Sbjct: 130 ILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNX 184
Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
           ++GT  +M+PE   +  ++  +D++S G+  +E+A
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMA 219

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 73/145 (50%), Gaps = 23/145 (15%)
Query: 3   LDWVTRVRIIEGIAQGLLYLH-----QYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           LD V+ +RI+  IA GL +LH        +  I HRDLK  NIL+ K+    I+D G+A 
Sbjct: 131 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 190
Query: 58  IC--GGNELQANTSRIVGTYGYMSPEYAIQGI------FSIKSDVFSFGVLLLEIAWDLW 109
           +     N+L    +  VGT  YM+PE   + I         + D+++FG++L E+A  + 
Sbjct: 191 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM- 249
Query: 110 TSNRTLE---------LIDDPVLED 125
            SN  +E         + +DP  ED
Sbjct: 250 VSNGIVEDYKPPFYDVVPNDPSFED 274

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 73/145 (50%), Gaps = 23/145 (15%)
Query: 3   LDWVTRVRIIEGIAQGLLYLH-----QYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           LD V+ +RI+  IA GL +LH        +  I HRDLK  NIL+ K+    I+D G+A 
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161
Query: 58  ICGG--NELQANTSRIVGTYGYMSPEYAIQGI------FSIKSDVFSFGVLLLEIAWDLW 109
           +     N+L    +  VGT  YM+PE   + I         + D+++FG++L E+A  + 
Sbjct: 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM- 220
Query: 110 TSNRTLE---------LIDDPVLED 125
            SN  +E         + +DP  ED
Sbjct: 221 VSNGIVEDYKPPFYDVVPNDPSFED 245

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 73/145 (50%), Gaps = 23/145 (15%)
Query: 3   LDWVTRVRIIEGIAQGLLYLH-----QYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           LD V+ +RI+  IA GL +LH        +  I HRDLK  NIL+ K+    I+D G+A 
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161
Query: 58  ICGG--NELQANTSRIVGTYGYMSPEYAIQGI------FSIKSDVFSFGVLLLEIAWDLW 109
           +     N+L    +  VGT  YM+PE   + I         + D+++FG++L E+A  + 
Sbjct: 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM- 220
Query: 110 TSNRTLE---------LIDDPVLED 125
            SN  +E         + +DP  ED
Sbjct: 221 VSNGIVEDYKPPFYDVVPNDPSFED 245

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLP 213
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 273 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 307

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFXRRLKEGTRMRA 268
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 269 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 303

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 6   VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGN 62
           V   RII  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++      
Sbjct: 126 VDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--- 179
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           E        +GT  Y++PE  + G +  K DV+S GV+L
Sbjct: 180 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 57/90 (63%), Gaps = 5/90 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A GL +LH    + II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT
Sbjct: 139 LALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGT 193
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             YM+PE   +   S  +D +S+GVL+ E+
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEM 223

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 264 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 298

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 263
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 264 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 298

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ YL   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 137 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 253
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 254 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 273 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 307

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ YL   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 141 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAK 197
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 257
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 258 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ YL   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 142 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 258
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 259 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     +    T+     
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     +    T+     
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG A++ G 
Sbjct: 119 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 169
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 6   VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGN 62
           V   RII  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++      
Sbjct: 149 VDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--- 202
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           E        +GT  Y++PE  + G +  K DV+S GV+L
Sbjct: 203 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 240

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ YL   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 141 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 197
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 257
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 258 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 159 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 215
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 216 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 274
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 275 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 309

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 6   VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGN 62
           V   RII  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++      
Sbjct: 150 VDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--- 203
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           E        +GT  Y++PE  + G +  K DV+S GV+L
Sbjct: 204 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 241

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ YL   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 142 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 258
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 259 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 268
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 269 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 303

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG A++ G 
Sbjct: 121 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 171
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 172 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG A++ G 
Sbjct: 123 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 173
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 174 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 216

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ YL   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 161 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 217
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 218 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 277
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 278 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 318

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     +    T+     
Sbjct: 212 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 268
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 269 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 317
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 318 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 352

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ YL   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 139 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 195
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 256 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 315
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 316 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 350

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG A++ G 
Sbjct: 126 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 176
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 219

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 322
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 323 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 357

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ YL   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 134 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 190
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 191 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 250
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 251 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 291

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ YL   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 140 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 196
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 256
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 257 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG A++ G 
Sbjct: 121 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 171
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 172 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 194 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 251 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 309
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 310 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 344

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           I   L++LH      II+RDLK+ N+LLD + + K++DFGM +  IC G      T+   
Sbjct: 133 IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG----VTTATFC 185
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           GT  Y++PE   + ++    D ++ GVLL E+
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEM 217

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR    +            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE---------- 124
             +M+PE     +++I+SDV+SFGVLL EI + L  S      ID+              
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGASPYPGVKIDEEFCRRLKEGTRMRA 324
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +Y++ +M        L C       RPT +++V  L N
Sbjct: 325 PDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEHLGN 359

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL      R++HRDL   N+L+    + KI+DFG A++ G 
Sbjct: 121 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 171
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            E + +         +M+ E  +  I++ +SDV+S+GV + E+
Sbjct: 172 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A        
Sbjct: 121 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI 177
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 178 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 207

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 86/165 (52%), Gaps = 22/165 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GI+ G+ YL   S +  +HRDL   NIL++ ++  K+SDFG++R+   +   A T
Sbjct: 127 VGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 183
Query: 69  SRIVG-TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD 120
           +R       + +PE      F+  SDV+S+G+++ E+        W++ T+   ++ +++
Sbjct: 184 TRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEM-TNQDVIKAVEE 242
Query: 121 ----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
               P   D  ++   L+      L C Q+  + RP  +++V ML
Sbjct: 243 GYRLPSPMDCPAALYQLM------LDCWQKERNSRPKFDEIVNML 281

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+   A        
Sbjct: 122 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI 178
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 179 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 208

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     +    T+     
Sbjct: 158 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 214
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 215 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     +    T+     
Sbjct: 153 LARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 209
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 210 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     +    T+     
Sbjct: 155 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 211
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 212 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     +    T+     
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     +    T+     
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ YL   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 160 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 216
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 217 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 276
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 277 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 317

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ +L   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 140 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 196
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 256
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 257 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     +    T+     
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ +L   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 147 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 203
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 204 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 263
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 264 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 304

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     +    T+     
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 6   VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGN 62
           V   RII  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++      
Sbjct: 132 VDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--- 185
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           E        +GT  Y++PE  + G +  K DV+S GV+L
Sbjct: 186 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 223

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ +L   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 142 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 258
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 259 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ +L   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 142 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 258
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 259 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     +    T+     
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ +L   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 143 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 199
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 259
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 260 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 300

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 53/89 (59%), Gaps = 7/89 (7%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTY 75
           Q L +LH     ++IHRD+K  NILL  D + K++DFG  A+I      Q+  S +VGT 
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSEMVGTP 180
Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +M+PE   +  +  K D++S G++ +E+
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 54/99 (54%), Gaps = 10/99 (10%)
Query: 6   VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGN 62
           V   RII  +  G+ Y H   + +I+HRDLK  N+LL+   KD N +I DFG++      
Sbjct: 126 VDAARIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--- 179
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           E        +GT  Y++PE  + G +  K DV+S GV+L
Sbjct: 180 EASKKXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           +AQG+ +L   +    IHRD+   N+LL      KI DFG+AR  +   N +    +R+ 
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 228
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD---PVLEDEYSS 129
               +M+PE     +++++SDV+S+G+LL EI + L  +     L++     +++D Y  
Sbjct: 229 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEI-FSLGLNPYPGILVNSKFYKLVKDGYQM 286
Query: 130 KQMLLRYVNIALL---CVQESADDRPTMNDVVCMLTNEA 165
            Q      NI  +   C       RPT   +   L  +A
Sbjct: 287 AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           +AQG+ +L   +    IHRD+   N+LL      KI DFG+AR  +   N +    +R+ 
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 228
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD---PVLEDEYSS 129
               +M+PE     +++++SDV+S+G+LL EI + L  +     L++     +++D Y  
Sbjct: 229 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEI-FSLGLNPYPGILVNSKFYKLVKDGYQM 286
Query: 130 KQMLLRYVNIALL---CVQESADDRPTMNDVVCMLTNEA 165
            Q      NI  +   C       RPT   +   L  +A
Sbjct: 287 AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           +AQG+ +L   +    IHRD+   N+LL      KI DFG+AR  +   N +    +R+ 
Sbjct: 167 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 222
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD---PVLEDEYSS 129
               +M+PE     +++++SDV+S+G+LL EI + L  +     L++     +++D Y  
Sbjct: 223 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEI-FSLGLNPYPGILVNSKFYKLVKDGYQM 280
Query: 130 KQMLLRYVNIALL---CVQESADDRPTMNDVVCMLTNEA 165
            Q      NI  +   C       RPT   +   L  +A
Sbjct: 281 AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 319

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ +L   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 201 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 317
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 318 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           +AQG+ +L   +    IHRD+   N+LL      KI DFG+AR  +   N +    +R+ 
Sbjct: 161 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 216
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD---PVLEDEYSS 129
               +M+PE     +++++SDV+S+G+LL EI + L  +     L++     +++D Y  
Sbjct: 217 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEI-FSLGLNPYPGILVNSKFYKLVKDGYQM 274
Query: 130 KQMLLRYVNIALL---CVQESADDRPTMNDVVCMLTNEA 165
            Q      NI  +   C       RPT   +   L  +A
Sbjct: 275 AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 313

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           +AQG+ +L   +    IHRD+   N+LL      KI DFG+AR  +   N +    +R+ 
Sbjct: 175 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 230
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD---PVLEDEYSS 129
               +M+PE     +++++SDV+S+G+LL EI + L  +     L++     +++D Y  
Sbjct: 231 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEI-FSLGLNPYPGILVNSKFYKLVKDGYQM 288
Query: 130 KQMLLRYVNIALL---CVQESADDRPTMNDVVCMLTNEA 165
            Q      NI  +   C       RPT   +   L  +A
Sbjct: 289 AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 327

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 53/89 (59%), Gaps = 7/89 (7%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTY 75
           Q L +LH     ++IHRD+K  NILL  D + K++DFG  A+I      Q+  S +VGT 
Sbjct: 128 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSXMVGTP 181
Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +M+PE   +  +  K D++S G++ +E+
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 210

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ +L   +  + +HRDL   N +LD+    K++DFG+AR     E  +  N +   
Sbjct: 143 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAK 199
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW-------DLWTSNRTLELIDD-PVLE 124
               +M+ E      F+ KSDV+SFGVLL E+         D+ T + T+ L+    +L+
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 259
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
            EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 260 PEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 300

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 5/87 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I  G  YLH   R R+IHRDLK+ N+ L++D+  KI DFG+A     +  +  T  + GT
Sbjct: 130 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGT 184
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLL 101
             Y++PE   +   S + DV+S G ++
Sbjct: 185 PNYIAPEVLSKKGHSFEVDVWSIGCIM 211

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 53/89 (59%), Gaps = 7/89 (7%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTY 75
           Q L +LH     ++IHRD+K  NILL  D + K++DFG  A+I      Q+  S +VGT 
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSXMVGTP 180
Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +M+PE   +  +  K D++S G++ +E+
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQ--------YSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           ++ W     + E +++GL YLH+          +  I HRD K  N+LL  D+   ++DF
Sbjct: 108 IITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADF 167
Query: 54  GMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR 113
           G+A      +   +T   VGT  YM+PE  ++G  + + D F   + +  +   LW    
Sbjct: 168 GLAVRFEPGKPPGDTHGQVGTRRYMAPE-VLEGAINFQRDAF-LRIDMYAMGLVLWELVS 225
Query: 114 TLELIDDPVLEDEY 127
             +  D PV  DEY
Sbjct: 226 RCKAADGPV--DEY 237

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           +AQG+ +L   +    IHRD+   N+LL      KI DFG+AR  +   N +    +R+ 
Sbjct: 169 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 224
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD---PVLEDEYSS 129
               +M+PE     +++++SDV+S+G+LL EI + L  +     L++     +++D Y  
Sbjct: 225 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEI-FSLGLNPYPGILVNSKFYKLVKDGYQM 282
Query: 130 KQMLLRYVNIALL---CVQESADDRPTMNDVVCMLTNEA 165
            Q      NI  +   C       RPT   +   L  +A
Sbjct: 283 AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 321

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHR+L   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 327 ISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-P 382
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 5/87 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I  G  YLH   R R+IHRDLK+ N+ L++D+  KI DFG+A     +  +  T  + GT
Sbjct: 126 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGT 180
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLL 101
             Y++PE   +   S + DV+S G ++
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIM 207

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 53/89 (59%), Gaps = 7/89 (7%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTY 75
           Q L +LH     ++IHRD+K  NILL  D + K++DFG  A+I      Q+  S +VGT 
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTP 180
Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +M+PE   +  +  K D++S G++ +E+
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 5/87 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I  G  YLH   R R+IHRDLK+ N+ L++D+  KI DFG+A     +  +  T  + GT
Sbjct: 126 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGT 180
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLL 101
             Y++PE   +   S + DV+S G ++
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIM 207

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 6/88 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V T  
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLW 184
Query: 77  YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           Y +PE  +Q  ++   D++S G +  E+
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 6/88 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V T  
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLW 184
Query: 77  YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           Y +PE  +Q  ++   D++S G +  E+
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 57/122 (46%), Gaps = 13/122 (10%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ--- 65
           + I   IA+ + +LH      ++HRDLK SNI    D   K+ DFG+      +E +   
Sbjct: 121 LHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 66  -------ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI 118
                  A  +  VGT  YMSPE      +S K D+FS G++L E+ +   T    +  +
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTL 237
Query: 119 DD 120
            D
Sbjct: 238 TD 239

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 59/103 (57%), Gaps = 9/103 (8%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL+W  +      IA+G+ YL     VR++HRDL   N+L+    + KI+DFG+AR+   
Sbjct: 121 LLNWCMQ------IAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 171
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +E + +         +M+ E  ++  F+ +SDV+S+GV + E+
Sbjct: 172 DETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWEL 214

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 6/88 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V T  
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLW 184
Query: 77  YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           Y +PE  +Q  ++   D++S G +  E+
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +G+ YL +     +IHRDL   N L+ ++   K+SDFGM R    ++  ++T      
Sbjct: 110 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWD--LWTSNRTLELIDDPVLED------E 126
             + SPE      +S KSDV+SFGVL+ E+  +  +   NR+    +  V+ED       
Sbjct: 167 -KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTGFRL 221
Query: 127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
           Y  +        I   C +E  +DRP  + ++  L   A + L
Sbjct: 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 264

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + I + IA G++YL   +    +HRDL   N L+ +++  KI DFGM+R     +     
Sbjct: 131 LHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 187
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELI-DDP 121
              +    +M PE  +   F+ +SDV+S GV+L EI       W   ++N  +E I    
Sbjct: 188 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247
Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEA 165
           VL+   +  Q +     + L C Q     R  +  +  +L N A
Sbjct: 248 VLQRPRTCPQEVY---ELMLGCWQREPHMRKNIKGIHTLLQNLA 288

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +G+ YL +     +IHRDL   N L+ ++   K+SDFGM R    ++  ++T      
Sbjct: 112 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 168
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWD--LWTSNRTLELIDDPVLED------E 126
             + SPE      +S KSDV+SFGVL+ E+  +  +   NR+    +  V+ED       
Sbjct: 169 -KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTGFRL 223
Query: 127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
           Y  +        I   C +E  +DRP  + ++  L   A + L
Sbjct: 224 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 266

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  + YL    +   IHR+L   N L+ ++   K++DFG++R+  G+   A+       
Sbjct: 366 ISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-P 421
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
             + +PE      FSIKSDV++FGVLL EIA
Sbjct: 422 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 452

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 22/166 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL + S V   HRDL   NIL++ ++  K+SDFG++R    N      
Sbjct: 121 VGMLRGIASGMRYLAEMSYV---HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTE 177
Query: 69  SRIVG---TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELI 118
           +  +G      + +PE      F+  SD +S+G+++ E+        WD+   +    + 
Sbjct: 178 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE 237
Query: 119 DD---PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
            D   P   D  +S   L+      L C Q+  + RP    VV  L
Sbjct: 238 QDYRLPPPPDCPTSLHQLM------LDCWQKDRNARPRFPQVVSAL 277

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD V  + + E I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---ID 119
                  R  GT  YMSPE      +  + D+++ G++L E+     T+  T +    + 
Sbjct: 176 ---GKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR 232
Query: 120 DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLT 162
           D ++ D +  K+  L         + +  +DRP  ++++  LT
Sbjct: 233 DGIISDIFDKKEKTL-----LQKLLSKKPEDRPNTSEILRTLT 270

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 50/91 (54%), Gaps = 8/91 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I  GL  LH   R RI++RDLK  NILLD   + +ISD G+A  +  G  ++      VG
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VG 347
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T GYM+PE      ++   D ++ G LL E+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 57/101 (56%), Gaps = 12/101 (11%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ G+  G+ YL   S +  +HRDL   N+L+D ++  K+SDFG++R+   +   A T
Sbjct: 154 VGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210
Query: 69  SRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +    T G     + +PE      FS  SDV+SFGV++ E+
Sbjct: 211 T----TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV 247

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 50/91 (54%), Gaps = 8/91 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I  GL  LH   R RI++RDLK  NILLD   + +ISD G+A  +  G  ++      VG
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VG 347
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T GYM+PE      ++   D ++ G LL E+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   +I+DFG+AR     +    T+     
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLP 222
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+PE     +++ +SDV+SFGVL+ EI
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +  
Sbjct: 144 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 200
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M PE  +   F+ +SDV+SFGV+L EI
Sbjct: 201 IRWMPPESILYRKFTTESDVWSFGVVLWEI 230

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 59/111 (53%), Gaps = 13/111 (11%)
Query: 2   LLDWVTRVR--------IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D V++VR        + E + Q L YLH      +IHRD+K  +ILL  D   K+SDF
Sbjct: 129 LTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDF 185
Query: 54  GMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G       +        +VGT  +M+PE   + +++ + D++S G++++E+
Sbjct: 186 GFCAQISKD--VPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +G+ YL +     +IHRDL   N L+ ++   K+SDFGM R    ++  ++T      
Sbjct: 113 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWD--LWTSNRTLELIDDPVLED------E 126
             + SPE      +S KSDV+SFGVL+ E+  +  +   NR+    +  V+ED       
Sbjct: 170 -KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTGFRL 224
Query: 127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
           Y  +        I   C +E  +DRP  + ++  L   A + L
Sbjct: 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 11/90 (12%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR---I 71
           I  G  YLH   R R+IHRDLK+ N+ L++D+  KI DFG+A      +++ +  R   +
Sbjct: 148 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVL 199
Query: 72  VGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
            GT  Y++PE   +   S + DV+S G ++
Sbjct: 200 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 229

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +G+ YL +     +IHRDL   N L+ ++   K+SDFGM R    ++  ++T      
Sbjct: 115 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 171
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWD--LWTSNRTLELIDDPVLED------E 126
             + SPE      +S KSDV+SFGVL+ E+  +  +   NR+    +  V+ED       
Sbjct: 172 -KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTGFRL 226
Query: 127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
           Y  +        I   C +E  +DRP  + ++  L   A + L
Sbjct: 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 269

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 11/90 (12%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR---I 71
           I  G  YLH   R R+IHRDLK+ N+ L++D+  KI DFG+A      +++ +  R   +
Sbjct: 150 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVL 201
Query: 72  VGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
            GT  Y++PE   +   S + DV+S G ++
Sbjct: 202 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 11/90 (12%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR---I 71
           I  G  YLH   R R+IHRDLK+ N+ L++D+  KI DFG+A      +++ +  R   +
Sbjct: 124 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVL 175
Query: 72  VGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
            GT  Y++PE   +   S + DV+S G ++
Sbjct: 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 54/91 (59%), Gaps = 7/91 (7%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 73
           I+ GL +LH+     II+RDLK+ N++LD + + KI+DFGM   C  + +   T+R   G
Sbjct: 129 ISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKEHMMDGVTTREFCG 182
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T  Y++PE      +    D +++GVLL E+
Sbjct: 183 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 213

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +  
Sbjct: 138 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 194
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M PE  +   F+ +SDV+SFGV+L EI
Sbjct: 195 IRWMPPESILYRKFTTESDVWSFGVVLWEI 224

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 22/166 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL + S V   HRDL   NIL++ ++  K+SDFG++R    N      
Sbjct: 119 VGMLRGIASGMRYLAEMSYV---HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY 175
Query: 69  SRIVG---TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELI 118
           +  +G      + +PE      F+  SD +S+G+++ E+        WD+   +    + 
Sbjct: 176 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE 235
Query: 119 DD---PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
            D   P   D  +S   L+      L C Q+  + RP    VV  L
Sbjct: 236 QDYRLPPPPDCPTSLHQLM------LDCWQKDRNARPRFPQVVSAL 275

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 70/161 (43%), Gaps = 9/161 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +  
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI---AWDLWTSNRTLELIDDPVLEDEYSSKQ 131
             +M PE  +   F+ +SDV+SFGV+L EI       W      E ID      E    +
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR 283
Query: 132 MLLRYV-NIALLCVQESADDRPTMNDVVCMLTNEAATLLPP 171
                V  I   C Q     R ++ DV   L  +A    PP
Sbjct: 284 ACPPEVYAIMRGCWQREPQQRHSIKDVHARL--QALAQAPP 322

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +G+ YL +     +IHRDL   N L+ ++   K+SDFGM R    ++  ++T      
Sbjct: 132 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 188
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWD--LWTSNRTLELIDDPVLED------E 126
             + SPE      +S KSDV+SFGVL+ E+  +  +   NR+    +  V+ED       
Sbjct: 189 -KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTGFRL 243
Query: 127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
           Y  +        I   C +E  +DRP  + ++  L   A + L
Sbjct: 244 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 286

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 59/105 (56%), Gaps = 10/105 (9%)
Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMAR 57
           M  + V    II+ +  G+ YLH+++   I+HRDLK  N+LL   +KD   KI DFG++ 
Sbjct: 131 MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 58  ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLL 102
           +    E Q      +GT  Y++PE  ++  +  K DV+S GV+L 
Sbjct: 188 VF---ENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILF 228

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQAN 67
           ++  I+  L YLH+    RIIHRDLK  NI+L    + +  KI D G A+     EL   
Sbjct: 127 LLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--- 180
Query: 68  TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
            +  VGT  Y++PE   Q  +++  D +SFG L  E
Sbjct: 181 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFE 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQAN 67
           ++  I+  L YLH+    RIIHRDLK  NI+L    + +  KI D G A+     EL   
Sbjct: 126 LLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--- 179
Query: 68  TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
            +  VGT  Y++PE   Q  +++  D +SFG L  E
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFE 215

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 57/101 (56%), Gaps = 12/101 (11%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ G+  G+ YL   S +  +HRDL   N+L+D ++  K+SDFG++R+   +   A T
Sbjct: 154 VGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 69  SRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +    T G     + +PE      FS  SDV+SFGV++ E+
Sbjct: 211 T----TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV 247

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 20/154 (12%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +G+ +L  +   + IHRDL   N L+D+D+  K+SDFGM R    ++  ++    VGT
Sbjct: 113 VCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGT 165
Query: 75  ---YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWT-SNRTLELIDDPVLE 124
                + +PE      +S KSDV++FG+L+ E+       +DL+T S   L++     L 
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY 225
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
             + +   + +   I   C  E  + RPT   ++
Sbjct: 226 RPHLASDTIYQ---IMYSCWHELPEKRPTFQQLL 256

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 25/141 (17%)
Query: 29  RIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYAIQG 86
           + +HRDL   N L++     K+SDFG++R    +E    TS +   +   +  PE  +  
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETSSVGSKFPVRWSPPEVLMYS 196
Query: 87  IFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD------PVLEDEYSSKQMLL 134
            FS KSD+++FGVL+ EI       ++ +T++ T E I        P L  E        
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-------- 248
Query: 135 RYVNIALLCVQESADDRPTMN 155
           +   I   C  E AD+RPT  
Sbjct: 249 KVYTIMYSCWHEKADERPTFK 269

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/94 (40%), Positives = 59/94 (62%), Gaps = 10/94 (10%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSR 70
            + + +G+ YLH     +IIHRD+K SN+L+ +D + KI+DFG++    G + L +NT  
Sbjct: 143 FQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT-- 197
Query: 71  IVGTYGYMSPE--YAIQGIFSIKS-DVFSFGVLL 101
            VGT  +M+PE     + IFS K+ DV++ GV L
Sbjct: 198 -VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 55/90 (61%), Gaps = 2/90 (2%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+  L L     + II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             YM+PE   +   +  +D +SFGVL+ E+
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEM 219

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 25/141 (17%)
Query: 29  RIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYAIQG 86
           + +HRDL   N L++     K+SDFG++R    +E    TS +   +   +  PE  +  
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYS 180
Query: 87  IFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD------PVLEDEYSSKQMLL 134
            FS KSD+++FGVL+ EI       ++ +T++ T E I        P L  E        
Sbjct: 181 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-------- 232
Query: 135 RYVNIALLCVQESADDRPTMN 155
           +   I   C  E AD+RPT  
Sbjct: 233 KVYTIMYSCWHEKADERPTFK 253

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 24/165 (14%)
Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           +LDW  ++          L L      +I+HRD+K  NI L KD   ++ DFG+AR+   
Sbjct: 127 ILDWFVQI---------CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-- 175
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI-----AWDLWT-SNRTL 115
           N         +GT  Y+SPE      ++ KSD+++ G +L E+     A++  +  N  L
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235
Query: 116 ELIDD--PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
           ++I    P +   YS     LR +   L   + +  DRP++N ++
Sbjct: 236 KIISGSFPPVSLHYSYD---LRSLVSQLF--KRNPRDRPSVNSIL 275

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 25/141 (17%)
Query: 29  RIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYAIQG 86
           + +HRDL   N L++     K+SDFG++R    +E    TS +   +   +  PE  +  
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYS 196
Query: 87  IFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD------PVLEDEYSSKQMLL 134
            FS KSD+++FGVL+ EI       ++ +T++ T E I        P L  E        
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-------- 248
Query: 135 RYVNIALLCVQESADDRPTMN 155
           +   I   C  E AD+RPT  
Sbjct: 249 KVYTIMYSCWHEKADERPTFK 269

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 25/141 (17%)
Query: 29  RIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYAIQG 86
           + +HRDL   N L++     K+SDFG++R    +E    TS +   +   +  PE  +  
Sbjct: 131 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYS 187
Query: 87  IFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD------PVLEDEYSSKQMLL 134
            FS KSD+++FGVL+ EI       ++ +T++ T E I        P L  E        
Sbjct: 188 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-------- 239
Query: 135 RYVNIALLCVQESADDRPTMN 155
           +   I   C  E AD+RPT  
Sbjct: 240 KVYTIMYSCWHEKADERPTFK 260

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 25/141 (17%)
Query: 29  RIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYAIQG 86
           + +HRDL   N L++     K+SDFG++R    +E    TS +   +   +  PE  +  
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYS 176
Query: 87  IFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD------PVLEDEYSSKQMLL 134
            FS KSD+++FGVL+ EI       ++ +T++ T E I        P L  E        
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-------- 228
Query: 135 RYVNIALLCVQESADDRPTMN 155
           +   I   C  E AD+RPT  
Sbjct: 229 KVYTIMYSCWHEKADERPTFK 249

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 25/141 (17%)
Query: 29  RIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYAIQG 86
           + +HRDL   N L++     K+SDFG++R    +E    TS +   +   +  PE  +  
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYS 181
Query: 87  IFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD------PVLEDEYSSKQMLL 134
            FS KSD+++FGVL+ EI       ++ +T++ T E I        P L  E        
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-------- 233
Query: 135 RYVNIALLCVQESADDRPTMN 155
           +   I   C  E AD+RPT  
Sbjct: 234 KVYTIMYSCWHEKADERPTFK 254

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 55/90 (61%), Gaps = 2/90 (2%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+  L L     + II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             YM+PE   +   +  +D +SFGVL+ E+
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEM 219

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 55/90 (61%), Gaps = 2/90 (2%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+  L L     + II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT
Sbjct: 133 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 190
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             YM+PE   +   +  +D +SFGVL+ E+
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEM 220

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/116 (35%), Positives = 60/116 (51%), Gaps = 10/116 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I   + Y HQ    RI+HRDLK  N+LLD DMN KI+DFG +     G +L A      G
Sbjct: 123 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA----FCG 175
Query: 74  TYGYMSPE-YAIQGIFSIKSDVFSFGVLLLE-IAWDLWTSNRTLELIDDPVLEDEY 127
              Y +PE +  +     + DV+S GV+L   ++  L    + L+ + + VL  +Y
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 231

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 7/91 (7%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 73
           IA GL +L       II+RDLK+ N++LD + + KI+DFGM   C  N     T++   G
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKENIWDGVTTKXFCG 504
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T  Y++PE      +    D ++FGVLL E+
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 53/89 (59%), Gaps = 7/89 (7%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTY 75
           Q L +LH     ++IHR++K  NILL  D + K++DFG  A+I      Q+  S +VGT 
Sbjct: 128 QALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTP 181
Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +M+PE   +  +  K D++S G++ +E+
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 210

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD     R+ + I  G+ Y H++    ++HRDLK  N+LLD  MN KI+DFG++ +    
Sbjct: 113 LDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169
Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFS-IKSDVFSFGVLL 101
           E    +    G+  Y +PE     +++  + D++S GV+L
Sbjct: 170 EFLRXS---CGSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 89/164 (54%), Gaps = 28/164 (17%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           +I   I + L +LH  S++ +IHRD+K SN+L++     K  DFG++       L  + +
Sbjct: 140 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS-----GYLVDDVA 192
Query: 70  RIV--GTYGYMSPEYA----IQGIFSIKSDVFSFGVLLLEIA-----WDLWTS--NRTLE 116
           + +  G   Y +PE       Q  +S+KSD++S G+  +E+A     +D W +   +  +
Sbjct: 193 KDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQ 252
Query: 117 LIDDPVLE---DEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
           ++++P  +   D++S++     +V+    C+++++ +RPT  ++
Sbjct: 253 VVEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPTYPEL 291

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 64/139 (46%), Gaps = 21/139 (15%)
Query: 29  RIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIF 88
           + +HRDL   N L++     K+SDFG++R    +E  ++         +  PE  +   F
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYSKF 183
Query: 89  SIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD------PVLEDEYSSKQMLLRY 136
           S KSD+++FGVL+ EI       ++ +T++ T E I        P L  E        + 
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE--------KV 235
Query: 137 VNIALLCVQESADDRPTMN 155
             I   C  E AD+RPT  
Sbjct: 236 YTIMYSCWHEKADERPTFK 254

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 46/77 (59%), Gaps = 9/77 (11%)
Query: 30  IIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYAIQGI 87
            +HRDL   N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   +  
Sbjct: 129 FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREAA 181
Query: 88  FSIKSDVFSFGVLLLEI 104
           FS KSDV+SFG+LL EI
Sbjct: 182 FSTKSDVWSFGILLWEI 198

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/116 (35%), Positives = 60/116 (51%), Gaps = 10/116 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I   + Y HQ     I+HRDLK  N+LLD DMN KI+DFG +     GN+L A      G
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA----FCG 174
Query: 74  TYGYMSPE-YAIQGIFSIKSDVFSFGVLLLE-IAWDLWTSNRTLELIDDPVLEDEY 127
              Y +PE +  +     + DV+S GV+L   ++  L    + L+ + + VL  +Y
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 84/170 (49%), Gaps = 32/170 (18%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   + +  +HRDL   NIL++ ++  K+SDFG++R+     ++ + 
Sbjct: 148 VGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-----IEDDP 199
Query: 69  SRIVGTYG------YMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTL 115
             +  T G      + +PE      F+  SDV+S+G+++ E+        WD+ ++   +
Sbjct: 200 EAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVI 258
Query: 116 ELIDD----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           + I++    P   D  +    L+      L C Q+   +RP    +V +L
Sbjct: 259 KAIEEGYRLPAPMDCPAGLHQLM------LDCWQKERAERPKFEQIVGIL 302

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 67/159 (42%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMAR    +  +
Sbjct: 135 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 187
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A+  R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 188 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 247
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 248 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 284

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   + +  +HRDL   NIL++ ++  K+SDFG++R    +      
Sbjct: 138 VGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 194
Query: 69  SRIVG---TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELI 118
           +  +G      + +PE      F+  SDV+S+G+++ E+        WD+ T+   +  I
Sbjct: 195 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-TNQDVINAI 253
Query: 119 DD-----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           +      P ++   +  Q++L        C Q+  + RP    +V  L
Sbjct: 254 EQDYRLPPPMDCPSALHQLMLD-------CWQKDRNHRPKFGQIVNTL 294

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 67/159 (42%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMAR    +  +
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 210
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A+  R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 270
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 271 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 307

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 67/159 (42%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMAR    +  +
Sbjct: 144 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 196
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A+  R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 256
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 257 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 293

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 67/159 (42%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMAR    +  +
Sbjct: 143 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 195
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A+  R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 256 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 292

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 67/159 (42%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMAR    +  +
Sbjct: 143 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 195
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A+  R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 256 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 292

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 67/159 (42%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMAR    +  +
Sbjct: 144 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 196
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A+  R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 256
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 257 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 293

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 67/159 (42%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMAR    +  +
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 210
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A+  R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 270
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 271 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 307

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 66/159 (41%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMAR    +  +
Sbjct: 161 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 213
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A   R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 214 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 273
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 274 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 310

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 66/159 (41%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMAR    +  +
Sbjct: 184 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 236
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A   R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 237 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 297 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 333

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 67/159 (42%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMAR    +  +
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 210
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A+  R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 270
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 271 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 307

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 67/159 (42%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMAR    +  +
Sbjct: 150 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 202
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A+  R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 203 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 262
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 263 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 299

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + I   IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R     +     
Sbjct: 136 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
              +    +M PE  +   F+ +SDV+SFGV+L EI
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 67/159 (42%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMAR    +  +
Sbjct: 160 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 212
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A+  R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 213 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 272
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 273 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 309

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 73
           I +G+ YLH       IHRDL   N+LLD D   KI DFG+A+ +  G+E          
Sbjct: 143 ICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDS 199
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
              + +PE   +  F   SDV+SFGV L E+
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 58/121 (47%), Gaps = 20/121 (16%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I   + Y HQ    RI+HRDLK  N+LLD DMN KI+DFG +     G +L         
Sbjct: 120 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCG---- 172
Query: 74  TYGYMSPEYAIQGIFSIKS------DVFSFGVLLLE-IAWDLWTSNRTLELIDDPVLEDE 126
                SP YA   +F  K       DV+S GV+L   ++  L    + L+ + + VL  +
Sbjct: 173 -----SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 227
Query: 127 Y 127
           Y
Sbjct: 228 Y 228

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQAN 67
           +I  +   + YLH   R+ I+HRDLK  N+L    D++    ISDFG++++ G  ++   
Sbjct: 125 LIRQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDV--- 178
Query: 68  TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
            S   GT GY++PE   Q  +S   D +S GV+
Sbjct: 179 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 7/91 (7%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 73
           IA GL +L       II+RDLK+ N++LD + + KI+DFGM   C  N     T++   G
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKENIWDGVTTKXFCG 183
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           T  Y++PE      +    D ++FGVLL E+
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 46/77 (59%), Gaps = 9/77 (11%)
Query: 30  IIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYAIQGI 87
            +HRDL   N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   +  
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKK 362
Query: 88  FSIKSDVFSFGVLLLEI 104
           FS KSDV+SFG+LL EI
Sbjct: 363 FSTKSDVWSFGILLWEI 379

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 12/95 (12%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE-----LQANTS 69
           I +G+ YL      R +HRDL   NIL++ + + KI+DFG+A++   ++      +   S
Sbjct: 123 ICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 179
Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            I     + +PE     IFS +SDV+SFGV+L E+
Sbjct: 180 PIF----WYAPESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 67/159 (42%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMAR    +  +
Sbjct: 170 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 222
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A+  R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 223 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 282
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 283 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 319

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 46/77 (59%), Gaps = 9/77 (11%)
Query: 30  IIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYAIQGI 87
            +HRDL   N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   +  
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKK 175
Query: 88  FSIKSDVFSFGVLLLEI 104
           FS KSDV+SFG+LL EI
Sbjct: 176 FSTKSDVWSFGILLWEI 192

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 58/121 (47%), Gaps = 20/121 (16%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I   + Y HQ     I+HRDLK  N+LLD DMN KI+DFG +     GN+L         
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---- 174
Query: 74  TYGYMSPEYAIQGIFSIKS------DVFSFGVLLLE-IAWDLWTSNRTLELIDDPVLEDE 126
                SP YA   +F  K       DV+S GV+L   ++  L    + L+ + + VL  +
Sbjct: 175 -----SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229
Query: 127 Y 127
           Y
Sbjct: 230 Y 230

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 12/95 (12%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE-----LQANTS 69
           I +G+ YL      R +HRDL   NIL++ + + KI+DFG+A++   ++      +   S
Sbjct: 124 ICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 180
Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            I     + +PE     IFS +SDV+SFGV+L E+
Sbjct: 181 PIF----WYAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 58/121 (47%), Gaps = 20/121 (16%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I   + Y HQ     I+HRDLK  N+LLD DMN KI+DFG +     GN+L         
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---- 174
Query: 74  TYGYMSPEYAIQGIFSIKS------DVFSFGVLLLE-IAWDLWTSNRTLELIDDPVLEDE 126
                SP YA   +F  K       DV+S GV+L   ++  L    + L+ + + VL  +
Sbjct: 175 -----SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229
Query: 127 Y 127
           Y
Sbjct: 230 Y 230

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 12/95 (12%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE-----LQANTS 69
           I +G+ YL      R +HRDL   NIL++ + + KI+DFG+A++   ++      +   S
Sbjct: 136 ICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            I     + +PE     IFS +SDV+SFGV+L E+
Sbjct: 193 PIF----WYAPESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   S+ + IHRDL   NIL+ ++   KI+DFG++R   G E+    +     
Sbjct: 141 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 194
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+ E     +++  SDV+S+GVLL EI
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWEI 224

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 12/95 (12%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE-----LQANTS 69
           I +G+ YL      R +HRDL   NIL++ + + KI+DFG+A++   ++      +   S
Sbjct: 120 ICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176
Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            I     + +PE     IFS +SDV+SFGV+L E+
Sbjct: 177 PIF----WYAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 58/121 (47%), Gaps = 20/121 (16%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I   + Y HQ     I+HRDLK  N+LLD DMN KI+DFG +     GN+L         
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---- 174
Query: 74  TYGYMSPEYAIQGIFSIKS------DVFSFGVLLLE-IAWDLWTSNRTLELIDDPVLEDE 126
                SP YA   +F  K       DV+S GV+L   ++  L    + L+ + + VL  +
Sbjct: 175 -----SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229
Query: 127 Y 127
           Y
Sbjct: 230 Y 230

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   S+ + IHRDL   NIL+ ++   KI+DFG++R   G E+    +     
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+ E     +++  SDV+S+GVLL EI
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 46/77 (59%), Gaps = 9/77 (11%)
Query: 30  IIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYAIQGI 87
            +HRDL   N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   +  
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKK 190
Query: 88  FSIKSDVFSFGVLLLEI 104
           FS KSDV+SFG+LL EI
Sbjct: 191 FSTKSDVWSFGILLWEI 207

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 58/121 (47%), Gaps = 20/121 (16%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I   + Y HQ     I+HRDLK  N+LLD DMN KI+DFG +     GN+L         
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCG---- 174
Query: 74  TYGYMSPEYAIQGIFSIKS------DVFSFGVLLLE-IAWDLWTSNRTLELIDDPVLEDE 126
                SP YA   +F  K       DV+S GV+L   ++  L    + L+ + + VL  +
Sbjct: 175 -----SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229
Query: 127 Y 127
           Y
Sbjct: 230 Y 230

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI-CGGNELQANT 68
           R  + I   + Y H++   +I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ + 
Sbjct: 117 RFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 173
Query: 69  SRIVGTYGYMSPEYAIQGIFS-IKSDVFSFGVLL 101
               G+  Y +PE     +++  + DV+S GV+L
Sbjct: 174 ----GSPNYAAPEVISGKLYAGPEVDVWSCGVIL 203

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 58/121 (47%), Gaps = 20/121 (16%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I   + Y HQ     I+HRDLK  N+LLD DMN KI+DFG +     GN+L         
Sbjct: 123 IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCG---- 175
Query: 74  TYGYMSPEYAIQGIFSIKS------DVFSFGVLLLE-IAWDLWTSNRTLELIDDPVLEDE 126
                SP YA   +F  K       DV+S GV+L   ++  L    + L+ + + VL  +
Sbjct: 176 -----SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
Query: 127 Y 127
           Y
Sbjct: 231 Y 231

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI-CGGNELQANT 68
           R  + I   + Y H++   +I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ + 
Sbjct: 107 RFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 163
Query: 69  SRIVGTYGYMSPEYAIQGIFS-IKSDVFSFGVLL 101
               G+  Y +PE     +++  + DV+S GV+L
Sbjct: 164 ----GSPNYAAPEVISGKLYAGPEVDVWSCGVIL 193

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 58/121 (47%), Gaps = 20/121 (16%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I   + Y HQ     I+HRDLK  N+LLD DMN KI+DFG +     GN+L         
Sbjct: 115 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---- 167
Query: 74  TYGYMSPEYAIQGIFSIKS------DVFSFGVLLLE-IAWDLWTSNRTLELIDDPVLEDE 126
                SP YA   +F  K       DV+S GV+L   ++  L    + L+ + + VL  +
Sbjct: 168 -----SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 222
Query: 127 Y 127
           Y
Sbjct: 223 Y 223

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI-CGGNELQANT 68
           R  + I   + Y H++   +I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ + 
Sbjct: 116 RFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 172
Query: 69  SRIVGTYGYMSPEYAIQGIFS-IKSDVFSFGVLL 101
               G+  Y +PE     +++  + DV+S GV+L
Sbjct: 173 ----GSPNYAAPEVISGKLYAGPEVDVWSCGVIL 202

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTS 69
           I   +A G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R I   +  +A+ +
Sbjct: 179 IARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN 235
Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +    +M PE      ++ +SDV+++GV+L EI
Sbjct: 236 DAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI-CGGNELQANT 68
           R  + I   + Y H++   +I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ + 
Sbjct: 111 RFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 167
Query: 69  SRIVGTYGYMSPEYAIQGIFS-IKSDVFSFGVLL 101
               G+  Y +PE     +++  + DV+S GV+L
Sbjct: 168 ----GSPNYAAPEVISGKLYAGPEVDVWSCGVIL 197

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 12/107 (11%)
Query: 4   DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE 63
           +W+    I   I +GL +LHQ+   ++IHRD+K  N+LL ++   K+ DFG++       
Sbjct: 129 EWI--AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183
Query: 64  LQANTSRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIA 105
            + NT   +GT  +M+PE           +  KSD++S G+  +E+A
Sbjct: 184 GRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/87 (39%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
            L YLH      II+RDLK  NILLDK+ + KI+DFG A+      +   T  + GT  Y
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDY 169
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           ++PE      ++   D +SFG+L+ E+
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEM 196

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 114 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 168
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 169 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 110 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 164
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 165 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 209

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 111 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 165
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 166 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 111 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 165
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 166 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 109 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 163
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 164 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 208

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 142 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 196
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 197 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 115 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 169
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 170 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 214

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 118 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 172
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 173 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 217

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 114 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 168
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 169 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 116 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 170
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 171 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 215

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 114 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 168
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 169 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 117 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 171
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 172 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 129 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 183
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 184 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++    
Sbjct: 129 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-- 183
Query: 63  ELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Q      V   G     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 184 --QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 73
           I +G+ YLH       IHR+L   N+LLD D   KI DFG+A+ +  G+E          
Sbjct: 126 ICEGMAYLHS---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
              + +PE   +  F   SDV+SFGV L E+
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 55/89 (61%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL YLHQ+    I+HRDLK +N+LLD++   K++DFG+A+  G    +A   ++V T  
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYXHQVV-TRW 177
Query: 77  YMSPEYAIQG-IFSIKSDVFSFGVLLLEI 104
           Y +PE      ++ +  D+++ G +L E+
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAEL 206

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 73
           I +G+ YLH       IHR+L   N+LLD D   KI DFG+A+ +  G+E          
Sbjct: 126 ICEGMAYLHA---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
              + +PE   +  F   SDV+SFGV L E+
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 56/107 (52%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++   +
Sbjct: 111 IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167
Query: 63  E-----LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +      +   S I     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 168 KEFFKVKEPGESPIF----WYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 9/109 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN-ELQANTSRIVG 73
           IA  L YLH    + I++RDLK  NILLD   +  ++DFG+   C  N E  + TS   G
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL---CKENIEHNSTTSTFCG 201
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL--WTSNRTLELIDD 120
           T  Y++PE   +  +    D +  G +L E+ + L  + S  T E+ D+
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 250

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + ++  ++ G+ YL + +    +HRDL   N+LL      KISDFG+++    +E     
Sbjct: 114 IELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NXYK 169
Query: 69  SRIVGTY--GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           ++  G +   + +PE      FS KSDV+SFGVL+ E
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 67/159 (42%), Gaps = 22/159 (13%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL +      IHRD+   N LL         KI DFGMA+    +  +
Sbjct: 144 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYR 196
Query: 66  ANTSRIVG----TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           A+  R  G       +M PE  ++GIF+ K+D +SFGVLL EI       +   ++   L
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 256
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
           E +      D    K        I   C Q   +DRP  
Sbjct: 257 EFVTSGGRMD--PPKNCPGPVYRIMTQCWQHQPEDRPNF 293

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 6/97 (6%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + ++  ++ G+ YL +      +HRDL   N+LL      KISDFG+++    +E     
Sbjct: 130 IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYK 185
Query: 69  SRIVGTY--GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           ++  G +   + +PE      FS KSDV+SFGVL+ E
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 6/97 (6%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + ++  ++ G+ YL +      +HRDL   N+LL      KISDFG+++    +E     
Sbjct: 130 IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYK 185
Query: 69  SRIVGTY--GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           ++  G +   + +PE      FS KSDV+SFGVL+ E
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 6/88 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q   + +V T  
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVVVTLW 184
Query: 77  YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           Y +PE  +Q  ++   D++S G +  E+
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 6/97 (6%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + ++  ++ G+ YL +      +HRDL   N+LL      KISDFG+++    +E     
Sbjct: 110 IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYK 165
Query: 69  SRIVGTY--GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           ++  G +   + +PE      FS KSDV+SFGVL+ E
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 6/88 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q   + +V T  
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALAPVVVTLW 176
Query: 77  YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           Y +PE  +Q  ++   D++S G +  E+
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 6/97 (6%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + ++  ++ G+ YL +      +HRDL   N+LL      KISDFG+++    +E     
Sbjct: 128 IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYK 183
Query: 69  SRIVGTY--GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           ++  G +   + +PE      FS KSDV+SFGVL+ E
Sbjct: 184 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 220

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 59/116 (50%), Gaps = 10/116 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I   + Y HQ     I+HRDLK  N+LLD D N KI+DFG +     GN+L A      G
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCG 174
Query: 74  TYGYMSPE-YAIQGIFSIKSDVFSFGVLLLE-IAWDLWTSNRTLELIDDPVLEDEY 127
              Y +PE +  +     + DV+S GV+L   ++  L    + L+ + + VL  +Y
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 6/97 (6%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + ++  ++ G+ YL +      +HRDL   N+LL      KISDFG+++    +E     
Sbjct: 108 IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYK 163
Query: 69  SRIVGTY--GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           ++  G +   + +PE      FS KSDV+SFGVL+ E
Sbjct: 164 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 200

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG--GNELQANTSRIV 72
           +A+G+ +L   +    IHRDL   NILL      KI DFG+AR      N +    +R+ 
Sbjct: 177 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL- 232
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTS--------NRTLELIDDP--V 122
               +M+PE     +++ +SDV+S+G+ L E+ + L +S        ++  ++I +   +
Sbjct: 233 -PVKWMAPESIFNCVYTFESDVWSYGIFLWEL-FSLGSSPYPGMPVDSKFYKMIKEGFRM 290
Query: 123 LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNE 164
           L  E++  +M     +I   C       RPT   +V ++  +
Sbjct: 291 LSPEHAPAEMY----DIMKTCWDADPLKRPTFKQIVQLIEKQ 328

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 6/97 (6%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + ++  ++ G+ YL +      +HRDL   N+LL      KISDFG+++    +E     
Sbjct: 114 IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYK 169
Query: 69  SRIVGTY--GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           ++  G +   + +PE      FS KSDV+SFGVL+ E
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + ++  ++ G+ YL + +    +HRDL   N+LL      KISDFG+++    +E     
Sbjct: 120 IELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYK 175
Query: 69  SRIVGTY--GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           ++  G +   + +PE      FS KSDV+SFGVL+ E
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 73
           I +G+ YLH       IHR L   N+LLD D   KI DFG+A+ +  G+E          
Sbjct: 121 ICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 177
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
              + +PE   +  F   SDV+SFGV L E+
Sbjct: 178 PVFWYAPECLKECKFYYASDVWSFGVTLYEL 208

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 221

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 221

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 73
           I +G+ YLH       IHR L   N+LLD D   KI DFG+A+ +  G+E          
Sbjct: 120 ICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 176
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
              + +PE   +  F   SDV+SFGV L E+
Sbjct: 177 PVFWYAPECLKECKFYYASDVWSFGVTLYEL 207

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  L YLH+     II+RDLK+ N+LLD + + K++D+GM +   G      TS   GT
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 184
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D ++ GVL+ E+
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEM 214

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 221

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   S+ + IHR+L   NIL+ ++   KI+DFG++R   G E+    +     
Sbjct: 148 VARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 201
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             +M+ E     +++  SDV+S+GVLL EI
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWEI 231

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI-CGGNELQANT 68
           R  + I   + Y H++   +I+HRDLK  N+LLD ++N KI+DFG++ I   GN L+ + 
Sbjct: 112 RFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC 168
Query: 69  SRIVGTYGYMSPEYAIQGIFS-IKSDVFSFGVLL 101
               G+  Y +PE     +++  + DV+S G++L
Sbjct: 169 ----GSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 13/95 (13%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +    IHRDL   NILL      KI DFG+AR     +++ +++ +V  
Sbjct: 170 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKNDSNYVVKG 221
Query: 75  YG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
                  +M+PE     +++ +SDV+S+G+ L E+
Sbjct: 222 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 256

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH  S   +++RDLK+ N++LDKD + KI+DFG+ +   G +  A      GT
Sbjct: 260 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 315
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 316 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 345

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 138 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 226

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 81/165 (49%), Gaps = 28/165 (16%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +    IHRDL   NILL      KI DFG+AR     +++ +++ +V  
Sbjct: 177 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKNDSNYVVKG 228
Query: 75  YG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTS--------NRTLELIDDP 121
                  +M+PE     +++ +SDV+S+G+ L E+ + L +S        ++  ++I + 
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL-FSLGSSPYPGMPVDSKFYKMIKEG 287
Query: 122 --VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNE 164
             +L  E++  +M     +I   C       RPT   +V ++  +
Sbjct: 288 FRMLSPEHAPAEMY----DIMKTCWDADPLKRPTFKQIVQLIEKQ 328

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 139 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 227

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 130 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 218

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH  S   +++RDLK+ N++LDKD + KI+DFG+ +   G +  A      GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 312
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 342

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 81/165 (49%), Gaps = 28/165 (16%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +    IHRDL   NILL      KI DFG+AR     +++ +++ +V  
Sbjct: 172 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKNDSNYVVKG 223
Query: 75  YG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTS--------NRTLELIDDP 121
                  +M+PE     +++ +SDV+S+G+ L E+ + L +S        ++  ++I + 
Sbjct: 224 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL-FSLGSSPYPGMPVDSKFYKMIKEG 282
Query: 122 --VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNE 164
             +L  E++  +M     +I   C       RPT   +V ++  +
Sbjct: 283 FRMLSPEHAPAEMY----DIMKTCWDADPLKRPTFKQIVQLIEKQ 323

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 221

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 141 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 229

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 221

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 81/165 (49%), Gaps = 28/165 (16%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +    IHRDL   NILL      KI DFG+AR     +++ +++ +V  
Sbjct: 154 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKNDSNYVVKG 205
Query: 75  YG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTS--------NRTLELIDDP 121
                  +M+PE     +++ +SDV+S+G+ L E+ + L +S        ++  ++I + 
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL-FSLGSSPYPGMPVDSKFYKMIKEG 264
Query: 122 --VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNE 164
             +L  E++  +M     +I   C       RPT   +V ++  +
Sbjct: 265 FRMLSPEHAPAEMY----DIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 223

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 153 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 241

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 131 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 219

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  L YLH+     II+RDLK+ N+LLD + + K++D+GM +   G      TS   GT
Sbjct: 115 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 169
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D ++ GVL+ E+
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEM 199

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           ++  ++ G+ YL + +    +HRDL   N+LL      KISDFG+++  G ++    T+R
Sbjct: 115 LLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTAR 170
Query: 71  IVGTY--GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
             G +   + +PE      FS +SDV+S+GV + E
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 205

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 131 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 219

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 153 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 241

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q     +V T  
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALDPVVVTLW 176
Query: 77  YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           Y +PE  +Q  ++   D++S G +  E+
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 79/168 (47%), Gaps = 26/168 (15%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++ GIA G+ YL   + +  +HR L   NIL++ ++  K+SDFG++R    +      
Sbjct: 112 VGMLRGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 168
Query: 69  SRIVG---TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELI 118
           +  +G      + +PE      F+  SDV+S+G+++ E+        WD+ T+   +  I
Sbjct: 169 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-TNQDVINAI 227
Query: 119 DD-----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           +      P ++   +  Q++L        C Q+  + RP    +V  L
Sbjct: 228 EQDYRLPPPMDCPSALHQLMLD-------CWQKDRNHRPKFGQIVNTL 268

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  L YLH+     II+RDLK+ N+LLD + + K++D+GM +   G      TS   GT
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 216
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D ++ GVL+ E+
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEM 246

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  L YLH+     II+RDLK+ N+LLD + + K++D+GM +   G      TS   GT
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 173
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D ++ GVL+ E+
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEM 203

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH  S   +++RDLK+ N++LDKD + KI+DFG+ +   G +  A      GT
Sbjct: 117 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGT 172
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 173 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 202

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH  S   +++RDLK+ N++LDKD + KI+DFG+ +   G +  A      GT
Sbjct: 119 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGT 174
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 175 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 204

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I + L YL +  +  +IHRD+K SNILLD+    K+ DFG   I G         R  G 
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDRSAGC 187
Query: 75  YGYMSPEY-----AIQGIFSIKSDVFSFGVLLLEIA 105
             YM+PE        +  + I++DV+S G+ L+E+A
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V 
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 223

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/73 (38%), Positives = 47/73 (64%), Gaps = 8/73 (10%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANT 68
           +I+  + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG + ++  G +L++  
Sbjct: 128 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS-- 182
Query: 69  SRIVGTYGYMSPE 81
             + GT  Y++PE
Sbjct: 183 --VCGTPSYLAPE 193

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH  S   +++RDLK+ N++LDKD + KI+DFG+ +   G +  A      GT
Sbjct: 118 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGT 173
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 203

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNIL---LDKDMNPKISDFGMARICGGNELQA 66
           R+I  +   + YLH    + I+HRDLK  N+L   LD+D    ISDFG++++    +  +
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGS 173
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
             S   GT GY++PE   Q  +S   D +S GV+
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           II+ +     Y+H  +   I HRD+K SNIL+DK+   K+SDFG +      +++   SR
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG--SR 211
Query: 71  IVGTYGYMSPEYAIQ--GIFSIKSDVFSFGVLLLEIAWDL 108
             GTY +M PE+          K D++S G+ L  + +++
Sbjct: 212 --GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNIL---LDKDMNPKISDFGMARICGGNELQA 66
           R+I  +   + YLH    + I+HRDLK  N+L   LD+D    ISDFG++++    +  +
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGS 173
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
             S   GT GY++PE   Q  +S   D +S GV+
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNIL---LDKDMNPKISDFGMARICGGNELQA 66
           R+I  +   + YLH    + I+HRDLK  N+L   LD+D    ISDFG++++    +  +
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGS 173
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
             S   GT GY++PE   Q  +S   D +S GV+
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 49/87 (56%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S GV++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEM 218

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 11/110 (10%)
Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNEL 64
           T VR +  IA G+ YL   S    IHRDL   N +L +DM   ++DFG++R    G    
Sbjct: 138 TLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRT 114
           Q   S++     +++ E     ++++ SDV++FGV +    W++ T  +T
Sbjct: 195 QGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTM----WEIMTRGQT 238

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 13/116 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQ-----YSRVRIIHRDLKVSNILLDKDMNPKISDFGMA- 56
           LD  + +++      GL +LH        +  I HRDLK  NIL+ K+    I+D G+A 
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190
Query: 57  -RICGGNELQANTSRIVGTYGYMSPEYAIQGIFS------IKSDVFSFGVLLLEIA 105
             I   NE+    +  VGT  YM PE   + +        I +D++SFG++L E+A
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 46/209 (22%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP----KISDFGMARICGGNEL 64
           +R+I+ I +G+ YLHQ +   I+H DLK  NILL   + P    KI DFGM+R  G    
Sbjct: 134 IRLIKQILEGVYYLHQNN---IVHLDLKPQNILL-SSIYPLGDIKIVDFGMSRKIGH--- 186
Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE 124
                 I+GT  Y++PE       +  +D+++ G+    IA+ L T           V E
Sbjct: 187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGI----IAYMLLTHTSPF------VGE 236
Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL---PPKQP------A 175
           D   +      Y+NI+ + V  S +   T + V  + T+   +LL   P K+P      +
Sbjct: 237 DNQET------YLNISQVNVDYSEE---TFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287
Query: 176 FSYVRN-------TVTSTSSTGKTEDCSI 197
            S+++            TSS+ +T+D S+
Sbjct: 288 HSWLQQWDFENLFHPEETSSSSQTQDHSV 316

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 49/87 (56%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S GV++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEM 218

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 10/99 (10%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE----L 64
           + ++  ++ G+ YL + +    +HRDL   N+LL      KISDFG+++    +E     
Sbjct: 473 IELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 529
Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           Q +    V  Y   +PE      FS KSDV+SFGVL+ E
Sbjct: 530 QTHGKWPVKWY---APECINYYKFSSKSDVWSFGVLMWE 565

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNIL---LDKDMNPKISDFGMARICGGNELQA 66
           R+I  +   + YLH    + I+HRDLK  N+L   LD+D    ISDFG++++    +  +
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGS 173
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
             S   GT GY++PE   Q  +S   D +S GV+
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG-NELQANTSRIVG 73
           I +GL Y+H      ++HRDLK SN+L++   + KI DFG+ARI    ++     +  V 
Sbjct: 153 ILRGLKYIHS---ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 241

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +          V 
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVG 73
           I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +          V 
Sbjct: 138 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 74  TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
           T  Y +PE  +      KS D++S G +L E+
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 226

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 10/99 (10%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE----L 64
           + ++  ++ G+ YL + +    +HRDL   N+LL      KISDFG+++    +E     
Sbjct: 472 IELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528
Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           Q +    V  Y   +PE      FS KSDV+SFGVL+ E
Sbjct: 529 QTHGKWPVKWY---APECINYYKFSSKSDVWSFGVLMWE 564

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/73 (38%), Positives = 46/73 (63%), Gaps = 8/73 (10%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANT 68
           +I+  + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG + ++  G +L+   
Sbjct: 128 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR--- 181
Query: 69  SRIVGTYGYMSPE 81
             + GT  Y++PE
Sbjct: 182 -EVCGTPSYLAPE 193

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 12/107 (11%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D +  ++    I +G+ YL      R IHR+L   NIL++ +   KI DFG+ ++   +
Sbjct: 112 IDHIKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD 168
Query: 63  E-----LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +      +   S I     + +PE   +  FS+ SDV+SFGV+L E+
Sbjct: 169 KEYYKVKEPGESPIF----WYAPESLTESKFSVASDVWSFGVVLYEL 211

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 13/93 (13%)
Query: 19  LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA---RICGGNELQANTSRIVGTY 75
           L +LH      ++H D+K +NI L      K+ DFG+       G  E+Q    R     
Sbjct: 170 LAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR----- 221
Query: 76  GYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL 108
            YM+PE  +QG +   +DVFS G+ +LE+A ++
Sbjct: 222 -YMAPEL-LQGSYGTAADVFSLGLTILEVACNM 252

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q     +V T  
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALFPVVVTLW 176
Query: 77  YMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           Y +PE  +Q  ++   D++S G +  E+
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/73 (38%), Positives = 46/73 (63%), Gaps = 8/73 (10%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANT 68
           +I+  + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG + ++  G +L+   
Sbjct: 115 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR--- 168
Query: 69  SRIVGTYGYMSPE 81
             + GT  Y++PE
Sbjct: 169 -EVCGTPSYLAPE 180

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 7/93 (7%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R+ + I   + Y H++    ++HRDLK  N+LLD  MN KI+DFG++ +    E   ++ 
Sbjct: 115 RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC 171
Query: 70  RIVGTYGYMSPEYAIQGIFS-IKSDVFSFGVLL 101
              G+  Y +PE     +++  + D++S GV+L
Sbjct: 172 ---GSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
            L YLH     +IIHRDLK  NIL   D + K++DFG++       +Q   S  +GT  +
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRXIQRRDS-FIGTPYW 201
Query: 78  MSPEYAI-----QGIFSIKSDVFSFGVLLLEIA 105
           M+PE  +        +  K+DV+S G+ L+E+A
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL----QANTSR 70
           +A+G+ YL   +  + +HRDL   N +LD+    K++DFG+AR     E     Q   +R
Sbjct: 133 VARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +   +  +      +  F+ KSDV+SFGVLL E+
Sbjct: 190 LPVKWTALESLQTYR--FTTKSDVWSFGVLLWEL 221

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 10/93 (10%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
            L YLH     +IIHRDLK  NIL   D + K++DFG++               +GT  +
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDXFIGTPYW 201
Query: 78  MSPEYAI-----QGIFSIKSDVFSFGVLLLEIA 105
           M+PE  +        +  K+DV+S G+ L+E+A
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 6/91 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-IC-GGNELQANTSRIVGT 74
           +GL Y+H     ++IHRDLK SN+L++++   KI DFGMAR +C    E Q   +  V T
Sbjct: 170 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 75  YGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
             Y +PE  +    ++   D++S G +  E+
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEM 257

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 10/93 (10%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
            L YLH     +IIHRDLK  NIL   D + K++DFG++               +GT  +
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYW 201
Query: 78  MSPEYAI-----QGIFSIKSDVFSFGVLLLEIA 105
           M+PE  +        +  K+DV+S G+ L+E+A
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 6/91 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-IC-GGNELQANTSRIVGT 74
           +GL Y+H     ++IHRDLK SN+L++++   KI DFGMAR +C    E Q   +  V T
Sbjct: 169 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 75  YGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
             Y +PE  +    ++   D++S G +  E+
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEM 256

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVG 73
           I +GL YLH     +I+HRD+K  N+L++      KISDFG ++   G  +   T    G
Sbjct: 131 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTG 185
Query: 74  TYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEIA 105
           T  YM+PE   +G   +   +D++S G  ++E+A
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA 219

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           R+ + I   + Y H++    ++HRDLK  N+LLD  MN KI+DFG++ +    E    + 
Sbjct: 115 RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 171
Query: 70  RIVGTYGYMSPEYAIQGIFS-IKSDVFSFGVLL 101
              G+  Y +PE     +++  + D++S GV+L
Sbjct: 172 ---GSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 86/188 (45%), Gaps = 37/188 (19%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMN----PKISDFGMAR 57
           + W  ++R++  IA G+ Y+ Q     I+HRDL+  NI L   D N     K++DFG+++
Sbjct: 119 IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
Query: 58  ICGGNELQANTSRIVGTYGYMSPEY--AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL 115
                +   + S ++G + +M+PE   A +  ++ K+D +SF ++L    + + T     
Sbjct: 178 -----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL----YTILTGEGPF 228
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM-NDVVCMLTNEAATLL---PP 171
                    DEYS       Y  I  + +      RPT+  D    L N         P 
Sbjct: 229 ---------DEYS-------YGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPK 272
Query: 172 KQPAFSYV 179
           K+P FSY+
Sbjct: 273 KRPHFSYI 280

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 57/117 (48%), Gaps = 22/117 (18%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR------------ 57
           R+   I + L Y+H      IIHRDLK  NI +D+  N KI DFG+A+            
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 58  ---ICGGNELQANTSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEIAWDLWT 110
              + G ++   N +  +GT  Y++ E     G ++ K D++S G++  E+ +   T
Sbjct: 177 SQNLPGSSD---NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR    N +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   ++   D++S G ++ E+
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGEL 218

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPEVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 71/138 (51%), Gaps = 24/138 (17%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR---ICGGNELQA 66
           R+++ +  GL Y+H   R +I+HRD+K +N+L+ +D   K++DFG+AR   +   ++   
Sbjct: 129 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 67  NTSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLED 125
             +R+V T  Y  PE  + +  +    D++  G ++ E    +WT +        P+++ 
Sbjct: 186 YXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAE----MWTRS--------PIMQG 232
Query: 126 EYSSKQMLLRYVNIALLC 143
                Q+ L    I+ LC
Sbjct: 233 NTEQHQLAL----ISQLC 246

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 12/96 (12%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNEL 64
           + ++ I  G+ YLH     RI H DLK  NI LLDK++ NP+I   DFG+A +I  GNE 
Sbjct: 119 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 175
Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
           +     I GT  +++PE        +++D++S GV+
Sbjct: 176 K----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 57/118 (48%), Gaps = 22/118 (18%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR------------ 57
           R+   I + L Y+H      IIHRDLK  NI +D+  N KI DFG+A+            
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 58  ---ICGGNELQANTSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEIAWDLWTS 111
              + G ++   N +  +GT  Y++ E     G ++ K D++S G++  E+ +   T 
Sbjct: 177 SQNLPGSSD---NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 159 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 210
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + +++  D++S G ++ E+
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAEL 245

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 12/96 (12%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNEL 64
           + ++ I  G+ YLH     RI H DLK  NI LLDK++ NP+I   DFG+A +I  GNE 
Sbjct: 112 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168
Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
           +     I GT  +++PE        +++D++S GV+
Sbjct: 169 K----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 57/104 (54%), Gaps = 9/104 (8%)
Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
           +LL+W  +      IA+G+ YL ++    ++HR+L   N+LL      +++DFG+A +  
Sbjct: 134 LLLNWGVQ------IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 184
Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            ++ Q   S       +M+ E    G ++ +SDV+S+GV + E+
Sbjct: 185 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWEL 228

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVG 73
           I +GL YLH     +I+HRD+K  N+L++      KISDFG ++   G  +   T    G
Sbjct: 117 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTG 171
Query: 74  TYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEIA 105
           T  YM+PE   +G   +   +D++S G  ++E+A
Sbjct: 172 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA 205

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 168
Query: 77  YMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 169 YRAPEILLGXKYYSTAVDIWSLGCIFAEM 197

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 71/138 (51%), Gaps = 24/138 (17%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR---ICGGNELQA 66
           R+++ +  GL Y+H   R +I+HRD+K +N+L+ +D   K++DFG+AR   +   ++   
Sbjct: 128 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 67  NTSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLED 125
             +R+V T  Y  PE  + +  +    D++  G ++ E    +WT +        P+++ 
Sbjct: 185 YXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAE----MWTRS--------PIMQG 231
Query: 126 EYSSKQMLLRYVNIALLC 143
                Q+ L    I+ LC
Sbjct: 232 NTEQHQLAL----ISQLC 245

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQANT 68
           I+ I + +L+ HQ     ++HRDLK  N+LL    K    K++DFG+A    G+  Q   
Sbjct: 109 IQQILEAVLHCHQMG---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD--QQAW 163
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
               GT GY+SPE   +  +    D+++ GV+L
Sbjct: 164 FGFAGTPGYLSPEVLRKEAYGKPVDIWACGVIL 196

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 167
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 196

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 71/138 (51%), Gaps = 24/138 (17%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR---ICGGNELQA 66
           R+++ +  GL Y+H   R +I+HRD+K +N+L+ +D   K++DFG+AR   +   ++   
Sbjct: 129 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 67  NTSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLED 125
             +R+V T  Y  PE  + +  +    D++  G ++ E    +WT +        P+++ 
Sbjct: 186 YXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAE----MWTRS--------PIMQG 232
Query: 126 EYSSKQMLLRYVNIALLC 143
                Q+ L    I+ LC
Sbjct: 233 NTEQHQLAL----ISQLC 246

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 176 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 229
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEM 256

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 168
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 197

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 167
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 196

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 12/96 (12%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNEL 64
           + ++ I  G+ YLH     RI H DLK  NI LLDK++ NP+I   DFG+A +I  GNE 
Sbjct: 133 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 189
Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
           +     I GT  +++PE        +++D++S GV+
Sbjct: 190 K----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 221

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 121 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 175
Query: 77  YMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 176 YRAPEILLGXKYYSTAVDIWSLGCIFAEM 204

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 184
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEM 211

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 167
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 196

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
             ++  ++ G+ YL + +    +HR+L   N+LL      KISDFG+++  G ++    T
Sbjct: 439 AELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYT 494
Query: 69  SRIVGTY--GYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           +R  G +   + +PE      FS +SDV+S+GV + E
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 531

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 168
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 197

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 57/104 (54%), Gaps = 9/104 (8%)
Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
           +LL+W  +      IA+G+ YL ++    ++HR+L   N+LL      +++DFG+A +  
Sbjct: 116 LLLNWGVQ------IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166
Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            ++ Q   S       +M+ E    G ++ +SDV+S+GV + E+
Sbjct: 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWEL 210

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 167
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 196

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 71/138 (51%), Gaps = 24/138 (17%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR---ICGGNELQA 66
           R+++ +  GL Y+H   R +I+HRD+K +N+L+ +D   K++DFG+AR   +   ++   
Sbjct: 129 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 67  NTSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLED 125
             +R+V T  Y  PE  + +  +    D++  G ++ E    +WT +        P+++ 
Sbjct: 186 YXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAE----MWTRS--------PIMQG 232
Query: 126 EYSSKQMLLRYVNIALLC 143
                Q+ L    I+ LC
Sbjct: 233 NTEQHQLAL----ISQLC 246

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 118 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 172
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 168
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 197

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 115 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 169
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 198

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/72 (37%), Positives = 44/72 (61%), Gaps = 8/72 (11%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTS 69
           I+  + + + +LH  +   I+HRDLK  NILLD +M  ++SDFG +  +  G +L+    
Sbjct: 205 IMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---- 257
Query: 70  RIVGTYGYMSPE 81
            + GT GY++PE
Sbjct: 258 ELCGTPGYLAPE 269

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 185
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEM 212

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 137 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 190
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEM 217

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 121 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 175
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 204

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 192
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEM 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 192
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEM 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 184
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEM 211

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 57/112 (50%), Gaps = 15/112 (13%)
Query: 2   LLDWVTRVRIIE--------GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D VT  R+ E         + + L YLH      +IHRD+K  +ILL  D   K+SDF
Sbjct: 129 LTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDF 185
Query: 54  GMARICGGNELQANTSR-IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G    C     +    + +VGT  +M+PE   +  +  + D++S G++++E+
Sbjct: 186 G---FCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 234

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNIL-LDKDMNPKI--SDFGMARICGGNELQAN 67
           +I+ +   + YLH+     I+HRDLK  N+L L  + N KI  +DFG++++    E    
Sbjct: 111 VIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGI 163
Query: 68  TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
            S   GT GY++PE   Q  +S   D +S GV+
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 185
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEM 212

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAEL 216

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 37/188 (19%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMN----PKISDFGMAR 57
           + W  ++R++  IA G+ Y+ Q     I+HRDL+  NI L   D N     K++DFG ++
Sbjct: 119 IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177
Query: 58  ICGGNELQANTSRIVGTYGYMSPEY--AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL 115
                +   + S ++G + +M+PE   A +  ++ K+D +SF ++L    + + T     
Sbjct: 178 -----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL----YTILTGEGPF 228
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM-NDVVCMLTNEAATLL---PP 171
                    DEYS       Y  I  + +      RPT+  D    L N         P 
Sbjct: 229 ---------DEYS-------YGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPK 272
Query: 172 KQPAFSYV 179
           K+P FSY+
Sbjct: 273 KRPHFSYI 280

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 192
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEM 219

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 47/87 (54%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR    N +   T  +V  Y Y
Sbjct: 136 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMM--TPYVVTRY-Y 189
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGEL 216

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 176 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 229
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEM 256

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 10/94 (10%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQAN 67
           I++ +  G  YLH+++   I+HRDLK  N+LL+   +D   KI DFG++      E+   
Sbjct: 126 IMKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGK 179
Query: 68  TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
               +GT  Y++PE  ++  +  K DV+S GV+L
Sbjct: 180 MKERLGTAYYIAPE-VLRKKYDEKCDVWSCGVIL 212

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA 66
           T ++++   A G+ YL        IHRDL   N L+ +    KISDFGM+R        A
Sbjct: 214 TLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAA 270
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           +         + +PE    G +S +SDV+SFG+LL E
Sbjct: 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA 66
           T ++++   A G+ YL        IHRDL   N L+ +    KISDFGM+R        A
Sbjct: 214 TLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           +         + +PE    G +S +SDV+SFG+LL E
Sbjct: 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMA 233

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 10/94 (10%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQAN 67
           I++ +  G  YLH+++   I+HRDLK  N+LL+   +D   KI DFG++      E+   
Sbjct: 109 IMKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGK 162
Query: 68  TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
               +GT  Y++PE  ++  +  K DV+S GV+L
Sbjct: 163 MKERLGTAYYIAPE-VLRKKYDEKCDVWSCGVIL 195

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 56/112 (50%), Gaps = 15/112 (13%)
Query: 2   LLDWVTRVRIIE--------GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D VT  R+ E         + Q L  LH      +IHRD+K  +ILL  D   K+SDF
Sbjct: 235 LTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDF 291
Query: 54  GMARICGGNELQANTSR-IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G    C     +    + +VGT  +M+PE   +  +  + D++S G++++E+
Sbjct: 292 G---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 340

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 114 QGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLW 168
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 197

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 48/87 (55%), Gaps = 9/87 (10%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTY 75
           G+ Y H    ++I HRDLK+ N LLD    P  KI DFG ++    + L +     VGT 
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 181
Query: 76  GYMSPEYAIQGIFSIK-SDVFSFGVLL 101
            Y++PE  ++  +  K +DV+S GV L
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTL 208

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 14/96 (14%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGT 74
           + L +LH     RIIHRDLK  N+L+  + + +++DFG++       L+    R   +GT
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGT 180
Query: 75  YGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIA 105
             +M+PE  +        +  K+D++S G+ L+E+A
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 14/96 (14%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGT 74
           + L +LH     RIIHRDLK  N+L+  + + +++DFG++       L+    R   +GT
Sbjct: 120 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGT 172
Query: 75  YGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIA 105
             +M+PE  +        +  K+D++S G+ L+E+A
Sbjct: 173 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 208

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 62/153 (40%), Gaps = 23/153 (15%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ YL      R IHRDL   N+LL      KI DFG+ R    N+        R V
Sbjct: 130 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 186
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD-----P 121
             + + +PE      FS  SD + FGV L E+       W     ++ L  ID      P
Sbjct: 187 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
             ED            N+ + C     +DRPT 
Sbjct: 246 RPEDCPQD------IYNVMVQCWAHKPEDRPTF 272

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 62/153 (40%), Gaps = 23/153 (15%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIV 72
           +A+G+ YL      R IHRDL   N+LL      KI DFG+ R    N+        R V
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 176
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD-----P 121
             + + +PE      FS  SD + FGV L E+       W     ++ L  ID      P
Sbjct: 177 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
             ED            N+ + C     +DRPT 
Sbjct: 236 RPEDCPQD------IYNVMVQCWAHKPEDRPTF 262

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 53/89 (59%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +G+ + HQ+   RI+HRDLK  N+L++ D   K++DFG+AR   G  +++ T  +V T  
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV-TLW 184
Query: 77  YMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
           Y +P+  +    +S   D++S G +  E+
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEM 213

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL  +   KI+DFG +       + A +SR 
Sbjct: 118 ITELANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRR 167
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 168 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 203

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 53/89 (59%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +G+ + HQ+   RI+HRDLK  N+L++ D   K++DFG+AR   G  +++ T  +V T  
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV-TLW 184
Query: 77  YMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
           Y +P+  +    +S   D++S G +  E+
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEM 213

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 137 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTG 188
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 137 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTG 188
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 177
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      +++RD+K+ N++LDKD + KI+DFG+ +   G    A      GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 168
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 62/153 (40%), Gaps = 23/153 (15%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIV 72
           +A+G+ YL      R IHRDL   N+LL      KI DFG+ R    N+        R V
Sbjct: 124 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD-----P 121
             + + +PE      FS  SD + FGV L E+       W     ++ L  ID      P
Sbjct: 181 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239
Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
             ED            N+ + C     +DRPT 
Sbjct: 240 RPEDCPQD------IYNVMVQCWAHKPEDRPTF 266

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 49/85 (57%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+++D+    K++DFG+A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      +++RD+K+ N++LDKD + KI+DFG+ +   G    A      GT
Sbjct: 119 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 173
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 203

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL  +   KI+DFG +       + A +SR 
Sbjct: 118 ITELANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRR 167
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 168 DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 203

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 137 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTG 188
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 49/87 (56%), Gaps = 9/87 (10%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTY 75
           G+ Y H    +++ HRDLK+ N LLD    P  KI+DFG ++    + L +     VGT 
Sbjct: 127 GVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTP 180
Query: 76  GYMSPEYAIQGIFSIK-SDVFSFGVLL 101
            Y++PE  ++  +  K +DV+S GV L
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTL 207

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 56/112 (50%), Gaps = 15/112 (13%)
Query: 2   LLDWVTRVRIIE--------GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D VT  R+ E         + Q L  LH      +IHRD+K  +ILL  D   K+SDF
Sbjct: 113 LTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDF 169
Query: 54  GMARICGGNELQANTSR-IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G    C     +    + +VGT  +M+PE   +  +  + D++S G++++E+
Sbjct: 170 G---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 218

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 140 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 189
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 190 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 225

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 135 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 186
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD---MNPKISDFGMARIC 59
            D      I++ I  G+ YLH+++   I+HRD+K  NILL+     +N KI DFG++   
Sbjct: 143 FDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 60  GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
             +         +GT  Y++PE  ++  ++ K DV+S GV++
Sbjct: 200 SKD---YKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 131 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 180
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 181 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 135 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 186
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 143 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 196
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEM 223

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT-SRIVG 73
           + QGL + H+    +I+HRDLK  N+L++K    K+ DFG+AR  G   +  NT S  V 
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG---IPVNTFSSEVV 170
Query: 74  TYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEI 104
           T  Y +P+  +    +S   D++S G +L E+
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      +++RD+K+ N++LDKD + KI+DFG+ +   G    A      GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 168
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 140 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 189
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 190 DDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +   T  +V  Y Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 185
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEM 212

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      +++RD+K+ N++LDKD + KI+DFG+ +   G    A      GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGT 168
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 62/153 (40%), Gaps = 23/153 (15%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIV 72
           +A+G+ YL      R IHRDL   N+LL      KI DFG+ R    N+        R V
Sbjct: 130 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD-----P 121
             + + +PE      FS  SD + FGV L E+       W     ++ L  ID      P
Sbjct: 187 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
             ED            N+ + C     +DRPT 
Sbjct: 246 RPEDCPQD------IYNVMVQCWAHKPEDRPTF 272

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 62/153 (40%), Gaps = 23/153 (15%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIV 72
           +A+G+ YL      R IHRDL   N+LL      KI DFG+ R    N+        R V
Sbjct: 124 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD-----P 121
             + + +PE      FS  SD + FGV L E+       W     ++ L  ID      P
Sbjct: 181 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239
Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
             ED            N+ + C     +DRPT 
Sbjct: 240 RPEDCPQD------IYNVMVQCWAHKPEDRPTF 266

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 62/153 (40%), Gaps = 23/153 (15%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIV 72
           +A+G+ YL      R IHRDL   N+LL      KI DFG+ R    N+        R V
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD-----P 121
             + + +PE      FS  SD + FGV L E+       W     ++ L  ID      P
Sbjct: 177 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
             ED            N+ + C     +DRPT 
Sbjct: 236 RPEDCPQD------IYNVMVQCWAHKPEDRPTF 262

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 141 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 192
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 227

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 56/112 (50%), Gaps = 15/112 (13%)
Query: 2   LLDWVTRVRIIE--------GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D VT  R+ E         + Q L  LH      +IHRD+K  +ILL  D   K+SDF
Sbjct: 115 LTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDF 171
Query: 54  GMARICGGNELQANTSR-IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G    C     +    + +VGT  +M+PE   +  +  + D++S G++++E+
Sbjct: 172 G---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      +++RD+K+ N++LDKD + KI+DFG+ +   G    A      GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 168
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      +++RD+K+ N++LDKD + KI+DFG+ +   G    A      GT
Sbjct: 117 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 171
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 172 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 201

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 137 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 188
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 127 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 178
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 213

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 119 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 168
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 169 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 204

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 177
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 127 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 178
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 213

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 56/112 (50%), Gaps = 15/112 (13%)
Query: 2   LLDWVTRVRIIE--------GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D VT  R+ E         + Q L  LH      +IHRD+K  +ILL  D   K+SDF
Sbjct: 104 LTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDF 160
Query: 54  GMARICGGNELQANTSR-IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G    C     +    + +VGT  +M+PE   +  +  + D++S G++++E+
Sbjct: 161 G---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 132 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 183
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 114 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 163
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 164 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 199

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 135 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 186
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      +++RD+K+ N++LDKD + KI+DFG+ +   G    A      GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 168
Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             Y++PE      +    D +  GV++ E+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 129 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 180
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 215

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 117 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 166
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 167 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 202

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 114 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 163
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 164 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 199

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 177
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 140 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 191
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 226

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 119 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 168
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 169 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 204

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 115 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 164
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 165 DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 132 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 183
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 115 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 164
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 128 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 179
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 214

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 132 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 183
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 135 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 186
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 177
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 62/153 (40%), Gaps = 23/153 (15%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIV 72
           +A+G+ YL      R IHRDL   N+LL      KI DFG+ R    N+        R V
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTLELIDD-----P 121
             + + +PE      FS  SD + FGV L E+       W     ++ L  ID      P
Sbjct: 177 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
             ED            N+ + C     +DRPT 
Sbjct: 236 RPEDCPQD------IYNVMVQCWAHKPEDRPTF 262

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 142 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 193
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 228

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 114 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 163
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 164 TELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 199

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 142 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 193
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 228

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMA 233

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 136 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 187
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 56/112 (50%), Gaps = 15/112 (13%)
Query: 2   LLDWVTRVRIIE--------GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D VT  R+ E         + Q L  LH      +IHRD+K  +ILL  D   K+SDF
Sbjct: 158 LTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDF 214
Query: 54  GMARICGGNELQANTSR-IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G    C     +    + +VGT  +M+PE   +  +  + D++S G++++E+
Sbjct: 215 G---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 263

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 116 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 165
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 166 XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 201

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 136 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 187
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 142 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 193
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 228

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMA 233

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMA 233

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 114 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 163
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 164 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 199

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 132 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTG 183
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 119 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 168
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 169 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 204

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMA 233

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 56/112 (50%), Gaps = 15/112 (13%)
Query: 2   LLDWVTRVRIIE--------GIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D VT  R+ E         + Q L  LH      +IHRD+K  +ILL  D   K+SDF
Sbjct: 108 LTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDF 164
Query: 54  GMARICGGNELQANTSR-IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           G    C     +    + +VGT  +M+PE   +  +  + D++S G++++E+
Sbjct: 165 G---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 213

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 141 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 192
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 227

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 153 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 204
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 239

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 136 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTG 187
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 149 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 200
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 235

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 58/125 (46%), Gaps = 22/125 (17%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR------------ 57
           R+   I + L Y+H      IIHR+LK  NI +D+  N KI DFG+A+            
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 58  ---ICGGNELQANTSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEIAWDLWTSNR 113
              + G ++   N +  +GT  Y++ E     G ++ K D +S G++  E  +   T   
Sbjct: 177 SQNLPGSSD---NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXE 233
Query: 114 TLELI 118
            + ++
Sbjct: 234 RVNIL 238

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 136 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 187
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 149 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 200
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 235

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 150 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 201
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQANT 68
           ++ I + + YLH+     I+HRDLK  N+L      D   KI+DFG+++I    E Q   
Sbjct: 154 VKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLM 207
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
             + GT GY +PE      +  + D++S G++
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGII 239

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLAGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 117 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 166
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 167 AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 202

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 57/110 (51%), Gaps = 13/110 (11%)
Query: 9   VRIIEGIAQGLLYLH-----QYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARIC--GG 61
           +R+    A GL +LH        +  I HRD K  N+L+  ++   I+D G+A +   G 
Sbjct: 108 LRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGS 167
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIF-----SIK-SDVFSFGVLLLEIA 105
           + L    +  VGT  YM+PE   + I      S K +D+++FG++L EIA
Sbjct: 168 DYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 150 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 201
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +       V T  Y
Sbjct: 140 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVP---FVVTRYY 193
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEM 220

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR    +E+      
Sbjct: 153 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT-DDEMXG---- 204
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 239

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +      +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--EPEVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE--LQANTSRIV 72
           I +G+ YL      + +HRDL   N+L++ +   KI DFG+ +    ++        R  
Sbjct: 135 ICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 191
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + Y +PE  +Q  F I SDV+SFGV L E+
Sbjct: 192 PVFWY-APECLMQSKFYIASDVWSFGVTLHEL 222

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 113 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 162
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 163 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 198

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 119 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 168
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 169 XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 204

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQANT 68
           I  I + + ++HQ+    I+HRDLK  N+LL    K    K++DFG+A    G E QA  
Sbjct: 136 IHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG-EQQAWF 191
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
               GT GY+SPE   +  +    D+++ GV+L
Sbjct: 192 G-FAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE--LQANTSRIV 72
           I +G+ YL      + +HRDL   N+L++ +   KI DFG+ +    ++        R  
Sbjct: 123 ICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 179
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + Y +PE  +Q  F I SDV+SFGV L E+
Sbjct: 180 PVFWY-APECLMQSKFYIASDVWSFGVTLHEL 210

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP---KISDFGMARICGGNELQANT 68
           I+ I + +L+ HQ     ++HRDLK  N+LL   +     K++DFG+A    G   Q   
Sbjct: 127 IQQILEAVLHCHQMG---VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAW 181
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
               GT GY+SPE   +  +    D+++ GV+L
Sbjct: 182 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 214

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 117 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 166
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 167 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 202

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 111 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 160
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 161 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 196

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 118 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 167
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 168 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 114 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 163
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 164 AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 199

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 9/87 (10%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTY 75
           G+ Y H    +++ HRDLK+ N LLD    P  KI DFG ++    + L +     VGT 
Sbjct: 126 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 179
Query: 76  GYMSPEYAIQGIFSIK-SDVFSFGVLL 101
            Y++PE  ++  +  K +DV+S GV L
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTL 206

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 117 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 166
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 167 DDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 202

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 114 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 163
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 164 TXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 199

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 9/87 (10%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTY 75
           G+ Y H    +++ HRDLK+ N LLD    P  KI DFG ++    + L +     VGT 
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 180
Query: 76  GYMSPEYAIQGIFSIK-SDVFSFGVLL 101
            Y++PE  ++  +  K +DV+S GV L
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTL 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 117 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 166
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 167 XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 202

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 12/97 (12%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP----KISDFGMARICGGNEL 64
             +++ +   L Y H      ++H+DLK  NIL  +D +P    KI DFG+A +   +E 
Sbjct: 127 AELMKQMMNALAYFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEH 182
Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
             N +   GT  YM+PE   + + + K D++S GV++
Sbjct: 183 STNAA---GTALYMAPEVFKRDV-TFKCDIWSAGVVM 215

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 114 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 163
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 164 XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 199

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR    +E+      
Sbjct: 150 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT-DDEMXG---- 201
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLXGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 168
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 197

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 37/188 (19%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMN----PKISDFGMAR 57
           + W  ++R++  IA G+ Y+ Q     I+HRDL+  NI L   D N     K++DF +++
Sbjct: 119 IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177
Query: 58  ICGGNELQANTSRIVGTYGYMSPEY--AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL 115
                +   + S ++G + +M+PE   A +  ++ K+D +SF ++L    + + T     
Sbjct: 178 -----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL----YTILTGEGPF 228
Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM-NDVVCMLTNEAATLL---PP 171
                    DEYS       Y  I  + +      RPT+  D    L N         P 
Sbjct: 229 ---------DEYS-------YGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPK 272
Query: 172 KQPAFSYV 179
           K+P FSY+
Sbjct: 273 KRPHFSYI 280

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 114 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 168
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 197

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMA 233

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 168
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 197

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 151 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 202
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 203 EIILSKGYNKAVDWWALGVLIYEMA 227

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 200
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMA 225

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 46/96 (47%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 119 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 168
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE         K D++S GVL  E 
Sbjct: 169 TTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEF 204

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 117 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 171
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 167
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 196

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 168
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 197

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+++D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  I   ++   D ++ GVL+ E+A
Sbjct: 208 EIIISKGYNKAVDWWALGVLIYEMA 232

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMA 233

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 115 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 169
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 198

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMA 233

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 116 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 170
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 199

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 171
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 200

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 200
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMA 225

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 167
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 196

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 14/116 (12%)
Query: 21  YLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTY 182
Query: 78  MSPEYAIQ---GIFSIKSDVFSFGVLLLEI--AWDLWTSNRTLELIDDPVLEDEYS 128
           ++PE  +      ++   D +S GV+L      +  ++ +RT   + D +   +Y+
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 115 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 169
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 198

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMA 233

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 116 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 170
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 115 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 169
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 198

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 14/116 (12%)
Query: 21  YLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTY 182
Query: 78  MSPEYAIQ---GIFSIKSDVFSFGVLLLEI--AWDLWTSNRTLELIDDPVLEDEYS 128
           ++PE  +      ++   D +S GV+L      +  ++ +RT   + D +   +Y+
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 171
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 116 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 170
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 199

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 171
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 200

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 116 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 170
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 199

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMA 233

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMA 233

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 49/85 (57%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+      ++  T  + GT  Y++P
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 228
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMA 253

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 14/116 (12%)
Query: 21  YLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y
Sbjct: 128 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTY 181
Query: 78  MSPEYAIQ---GIFSIKSDVFSFGVLLLEI--AWDLWTSNRTLELIDDPVLEDEYS 128
           ++PE  +      ++   D +S GV+L      +  ++ +RT   + D +   +Y+
Sbjct: 182 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 237

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 14/116 (12%)
Query: 21  YLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTY 182
Query: 78  MSPEYAIQ---GIFSIKSDVFSFGVLLLEI--AWDLWTSNRTLELIDDPVLEDEYS 128
           ++PE  +      ++   D +S GV+L      +  ++ +RT   + D +   +Y+
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 168
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 197

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 14/116 (12%)
Query: 21  YLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y
Sbjct: 135 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTY 188
Query: 78  MSPEYAIQ---GIFSIKSDVFSFGVLLLEI--AWDLWTSNRTLELIDDPVLEDEYS 128
           ++PE  +      ++   D +S GV+L      +  ++ +RT   + D +   +Y+
Sbjct: 189 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 244

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 118 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 172
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 115 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 169
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 198

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 143 YLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 194
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMA 219

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 142 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAP 193
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 194 EIILSKGYNKAVDWWALGVLIYEMA 218

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 171
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 200

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAP 208
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMA 233

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 49/85 (57%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+++D+    +++DFG+A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLW 171
Query: 77  YMSPEYAIQ-GIFSIKSDVFSFGVLLLEI 104
           Y +PE  +    +S   D++S G +  E+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 200

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 45/93 (48%), Gaps = 7/93 (7%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRI 71
           I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +  C     +  T  +
Sbjct: 115 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTT--L 167
Query: 72  VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 168 SGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 46/84 (54%), Gaps = 9/84 (10%)
Query: 30  IIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL--------QANTSRIVGTYGYMSPE 81
           +IHRDLK SN+L++ + + K+ DFG+ARI   +          Q+  +  V T  Y +PE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 82  YAI-QGIFSIKSDVFSFGVLLLEI 104
             +    +S   DV+S G +L E+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 49/85 (57%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+      ++  T  + GT  Y++P
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 228
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMA 253

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 176 ----NIFGTPAFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 6/87 (6%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +      +V  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--EPEVVTRY-Y 191
Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 192 RAPEVILGMGYKENVDLWSVGCIMGEM 218

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 46/84 (54%), Gaps = 9/84 (10%)
Query: 30  IIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL--------QANTSRIVGTYGYMSPE 81
           +IHRDLK SN+L++ + + K+ DFG+ARI   +          Q+  +  V T  Y +PE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 82  YAI-QGIFSIKSDVFSFGVLLLEI 104
             +    +S   DV+S G +L E+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           ++  + +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR     +     + 
Sbjct: 128 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTG 179
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 214

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI D+G+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 56/103 (54%), Gaps = 6/103 (5%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L+ VT    +  +  G+ Y H     R++HRDLK  N+L++++   KI+DFG+AR   G 
Sbjct: 97  LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGI 152
Query: 63  ELQANTSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
            ++  T  IV T  Y +P+  +    +S   D++S G +  E+
Sbjct: 153 PVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 49/85 (57%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+      ++  T  + GT  Y++P
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYLAP 228
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMA 253

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+++D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 49/89 (55%), Gaps = 9/89 (10%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR     +     +  V T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRW 193
Query: 77  YMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
           Y +PE  +  + ++   D++S G ++ E+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI++FG +       + A +SR 
Sbjct: 116 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRR 165
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 166 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 201

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 49/89 (55%), Gaps = 9/89 (10%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR     +     +  V T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRW 193
Query: 77  YMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
           Y +PE  +  + ++   D++S G ++ E+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 9/84 (10%)
Query: 30  IIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL--------QANTSRIVGTYGYMSPE 81
           +IHRDLK SN+L++ + + K+ DFG+ARI   +          Q+     V T  Y +PE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 82  YAI-QGIFSIKSDVFSFGVLLLEI 104
             +    +S   DV+S G +L E+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     ++IHRD+K  N+LL      KI+DFG +       + A +SR 
Sbjct: 114 ITELANALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRR 163
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 164 AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 199

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 14/116 (12%)
Query: 21  YLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y
Sbjct: 268 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTY 321
Query: 78  MSPEYAIQ---GIFSIKSDVFSFGVLLLEI--AWDLWTSNRTLELIDDPVLEDEYS 128
           ++PE  +      ++   D +S GV+L      +  ++ +RT   + D +   +Y+
Sbjct: 322 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 377

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP---KISDFGMARICGGNELQANT 68
           I+ I + +L+ HQ     ++HR+LK  N+LL   +     K++DFG+A    G   Q   
Sbjct: 116 IQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAW 170
Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
               GT GY+SPE   +  +    D+++ GV+L
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 14/116 (12%)
Query: 21  YLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y
Sbjct: 254 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTY 307
Query: 78  MSPEYAIQ---GIFSIKSDVFSFGVLLLEI--AWDLWTSNRTLELIDDPVLEDEYS 128
           ++PE  +      ++   D +S GV+L      +  ++ +RT   + D +   +Y+
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 6/103 (5%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L+ VT    +  +  G+ Y H     R++HRDLK  N+L++++   KI+DFG+AR   G 
Sbjct: 97  LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GI 152
Query: 63  ELQANTSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
            ++  T  +V T  Y +P+  +    +S   D++S G +  E+
Sbjct: 153 PVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 6/103 (5%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L+ VT    +  +  G+ Y H     R++HRDLK  N+L++++   KI+DFG+AR   G 
Sbjct: 97  LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GI 152
Query: 63  ELQANTSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
            ++  T  +V T  Y +P+  +    +S   D++S G +  E+
Sbjct: 153 PVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ ++A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYQMA 232

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+ R           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 54/101 (53%), Gaps = 7/101 (6%)
Query: 7   TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNEL 64
           T ++ +  IA G+ YL   S    +HRDL   N +L  DM   ++DFG+++    G    
Sbjct: 148 TLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR 204
Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
           Q   +++     +++ E     +++ KSDV++FGV + EIA
Sbjct: 205 QGRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 175 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 205

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 175 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 205

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR- 70
           I  +A  L Y H     R+IHRD+K  N+LL      KI++FG +       + A +SR 
Sbjct: 117 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRR 166
Query: 71  --IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
             + GT  Y+ PE     +   K D++S GVL  E 
Sbjct: 167 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 202

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 16  AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 75
           A+ +L L     +  IHRD+K  N+LLDK  + K++DFG   +    E        VGT 
Sbjct: 175 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTP 233
Query: 76  GYMSPE----YAIQGIFSIKSDVFSFGVLLLEI 104
            Y+SPE        G +  + D +S GV L E+
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 17/97 (17%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQANT 68
           I+ I + + Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N 
Sbjct: 110 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVND 159
Query: 69  SR----IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           S       GT GY+SPE   +  +S   D+++ GV+L
Sbjct: 160 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 196

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 17/97 (17%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQANT 68
           I+ I + + Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N 
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVND 160
Query: 69  SR----IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           S       GT GY+SPE   +  +S   D+++ GV+L
Sbjct: 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 17/97 (17%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQANT 68
           I+ I + + Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N 
Sbjct: 134 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVND 183
Query: 69  SR----IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           S       GT GY+SPE   +  +S   D+++ GV+L
Sbjct: 184 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 16  AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGT 74
           A+ +L L     + +IHRD+K  N+LLDK  + K++DFG   ++     +  +T+  VGT
Sbjct: 181 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA--VGT 238
Query: 75  YGYMSPE----YAIQGIFSIKSDVFSFGVLLLEI 104
             Y+SPE        G +  + D +S GV L E+
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 272

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 16  AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 75
           A+ +L L     +  IHRD+K  N+LLDK  + K++DFG   +    E        VGT 
Sbjct: 180 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTP 238
Query: 76  GYMSPE----YAIQGIFSIKSDVFSFGVLLLEI 104
            Y+SPE        G +  + D +S GV L E+
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 271

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 16  AQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 75
           A+ +L L     +  IHRD+K  N+LLDK  + K++DFG   +    E        VGT 
Sbjct: 180 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTP 238
Query: 76  GYMSPE----YAIQGIFSIKSDVFSFGVLLLEI 104
            Y+SPE        G +  + D +S GV L E+
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 271

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 29  RIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY--AIQG 86
           RIIHRD+K  NILLD+  +  I+DF +A +    E Q  T  + GT  YM+PE   + +G
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKPYMAPEMFSSRKG 191
Query: 87  I-FSIKSDVFSFGVLLLEI 104
             +S   D +S GV   E+
Sbjct: 192 AGYSFAVDWWSLGVTAYEL 210

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 17/97 (17%)
Query: 12  IEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQANT 68
           I+ I + + Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N 
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVND 160
Query: 69  SR----IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           S       GT GY+SPE   +  +S   D+++ GV+L
Sbjct: 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 61/125 (48%), Gaps = 21/125 (16%)
Query: 2   LLDWVTRVRI-IEGI-------AQGLLYLHQ-----YSRVRIIHRDLKVSNILLDKDMNP 48
           L D++ R  + +EG+       A GL +LH        +  I HRDLK  NIL+ K+   
Sbjct: 127 LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186
Query: 49  KISDFGMA--RICGGNELQANTSRIVGTYGYMSPEY-----AIQGIFSIK-SDVFSFGVL 100
            I+D G+A       + +    +  VGT  YM+PE       ++   S K +D+++ G++
Sbjct: 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 246
Query: 101 LLEIA 105
             EIA
Sbjct: 247 FWEIA 251

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 61/125 (48%), Gaps = 21/125 (16%)
Query: 2   LLDWVTRVRI-IEGI-------AQGLLYLHQ-----YSRVRIIHRDLKVSNILLDKDMNP 48
           L D++ R  + +EG+       A GL +LH        +  I HRDLK  NIL+ K+   
Sbjct: 89  LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 148
Query: 49  KISDFGMA--RICGGNELQANTSRIVGTYGYMSPEY-----AIQGIFSIK-SDVFSFGVL 100
            I+D G+A       + +    +  VGT  YM+PE       ++   S K +D+++ G++
Sbjct: 149 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 208
Query: 101 LLEIA 105
             EIA
Sbjct: 209 FWEIA 213

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 61/125 (48%), Gaps = 21/125 (16%)
Query: 2   LLDWVTRVRI-IEGI-------AQGLLYLHQ-----YSRVRIIHRDLKVSNILLDKDMNP 48
           L D++ R  + +EG+       A GL +LH        +  I HRDLK  NIL+ K+   
Sbjct: 114 LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 173
Query: 49  KISDFGMA--RICGGNELQANTSRIVGTYGYMSPEY-----AIQGIFSIK-SDVFSFGVL 100
            I+D G+A       + +    +  VGT  YM+PE       ++   S K +D+++ G++
Sbjct: 174 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 233
Query: 101 LLEIA 105
             EIA
Sbjct: 234 FWEIA 238

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI  FG+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM-NPKIS--DFGMA-RICGGNELQ 65
            ++ I  G+ YLH    ++I H DLK  NI LLD+++  P+I   DFG+A +I  GNE +
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 8/91 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP---KISDFGMARICGGNELQANTSRI 71
           I + L Y H  +   IIHRD+K  N+LL    N    K+ DFG+A   G + L A     
Sbjct: 139 ILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR-- 193
Query: 72  VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLL 102
           VGT  +M+PE   +  +    DV+  GV+L 
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 61/125 (48%), Gaps = 21/125 (16%)
Query: 2   LLDWVTRVRI-IEGI-------AQGLLYLHQ-----YSRVRIIHRDLKVSNILLDKDMNP 48
           L D++ R  + +EG+       A GL +LH        +  I HRDLK  NIL+ K+   
Sbjct: 88  LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147
Query: 49  KISDFGMA--RICGGNELQANTSRIVGTYGYMSPEY-----AIQGIFSIK-SDVFSFGVL 100
            I+D G+A       + +    +  VGT  YM+PE       ++   S K +D+++ G++
Sbjct: 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207
Query: 101 LLEIA 105
             EIA
Sbjct: 208 FWEIA 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 61/125 (48%), Gaps = 21/125 (16%)
Query: 2   LLDWVTRVRI-IEGI-------AQGLLYLHQ-----YSRVRIIHRDLKVSNILLDKDMNP 48
           L D++ R  + +EG+       A GL +LH        +  I HRDLK  NIL+ K+   
Sbjct: 94  LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 153
Query: 49  KISDFGMA--RICGGNELQANTSRIVGTYGYMSPEY-----AIQGIFSIK-SDVFSFGVL 100
            I+D G+A       + +    +  VGT  YM+PE       ++   S K +D+++ G++
Sbjct: 154 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 213
Query: 101 LLEIA 105
             EIA
Sbjct: 214 FWEIA 218

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 61/125 (48%), Gaps = 21/125 (16%)
Query: 2   LLDWVTRVRI-IEGI-------AQGLLYLHQ-----YSRVRIIHRDLKVSNILLDKDMNP 48
           L D++ R  + +EG+       A GL +LH        +  I HRDLK  NIL+ K+   
Sbjct: 91  LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 150
Query: 49  KISDFGMA--RICGGNELQANTSRIVGTYGYMSPEY-----AIQGIFSIK-SDVFSFGVL 100
            I+D G+A       + +    +  VGT  YM+PE       ++   S K +D+++ G++
Sbjct: 151 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 210
Query: 101 LLEIA 105
             EIA
Sbjct: 211 FWEIA 215

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 47/85 (55%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
              +   ++   D ++ GVL+ E+A
Sbjct: 208 AIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           I+  L +LHQ     II+RDLK  NI+L+   + K++DFG+ +  I  G      T    
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT----VTHXFC 182
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           GT  YM+PE  ++   +   D +S G L+ ++
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDM 214

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 73
           I + + YL     +  +HRD+ V NIL+      K+ DFG++R I   +  +A+ +R+  
Sbjct: 134 ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-- 188
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI-----AWDLWTSNRTLELIDDPVLED-EY 127
              +MSPE      F+  SDV+ F V + EI         W  N+  ++I   VLE  + 
Sbjct: 189 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIG--VLEKGDR 244
Query: 128 SSKQMLLRYVNIALL--CVQESADDRPTMNDVVCMLTN 163
             K  L   V   L+  C      DRP   ++VC L++
Sbjct: 245 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 282

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           I+  L +LHQ     II+RDLK  NI+L+   + K++DFG+ +  I  G      T    
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT----VTHTFC 182
Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           GT  YM+PE  ++   +   D +S G L+ ++
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDM 214

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 73
           I + + YL     +  +HRD+ V NIL+      K+ DFG++R I   +  +A+ +R+  
Sbjct: 118 ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-- 172
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI-----AWDLWTSNRTLELIDDPVLED-EY 127
              +MSPE      F+  SDV+ F V + EI         W  N+  ++I   VLE  + 
Sbjct: 173 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIG--VLEKGDR 228
Query: 128 SSKQMLLRYVNIALL--CVQESADDRPTMNDVVCMLTN 163
             K  L   V   L+  C      DRP   ++VC L++
Sbjct: 229 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 266

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 30  IIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 86
           I+HRDLK  N+LL    K    K++DFG+A    G+  Q       GT GY+SPE   + 
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD--QQAWFGFAGTPGYLSPEVLRKD 181
Query: 87  IFSIKSDVFSFGVLL 101
            +    D+++ GV+L
Sbjct: 182 PYGKPVDMWACGVIL 196

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 30  IIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 86
           I+HRDLK  N+LL    K    K++DFG+A    G+  Q       GT GY+SPE   + 
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD--QQAWFGFAGTPGYLSPEVLRKD 181
Query: 87  IFSIKSDVFSFGVLL 101
            +    D+++ GV+L
Sbjct: 182 PYGKPVDMWACGVIL 196

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DF +AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 73
           I + + YL     +  +HRD+ V NIL+      K+ DFG++R I   +  +A+ +R+  
Sbjct: 122 ICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-- 176
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI-----AWDLWTSNRTLELIDDPVLED-EY 127
              +MSPE      F+  SDV+ F V + EI         W  N+  ++I   VLE  + 
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIG--VLEKGDR 232
Query: 128 SSKQMLLRYVNIALL--CVQESADDRPTMNDVVCMLTN 163
             K  L   V   L+  C      DRP   ++VC L++
Sbjct: 233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 9/87 (10%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTY 75
           G+ Y H    +++ HRDLK+ N LLD    P  KI  FG ++    + L +     VGT 
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTP 180
Query: 76  GYMSPEYAIQGIFSIK-SDVFSFGVLL 101
            Y++PE  ++  +  K +DV+S GV L
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTL 207

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR           + 
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLAR-----HTDDEMTG 181
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 9/89 (10%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR     +  +     V T  
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRW 190
Query: 77  YMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
           Y +PE  +  + ++   D++S G ++ E+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEM 219

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL--DKDMNP-KISDFGM-ARICGGNEL 64
            RI++ +   + Y H   ++ + HRDLK  N L   D   +P K+ DFG+ AR   G  +
Sbjct: 109 ARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165
Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           +      VGT  Y+SP+  ++G++  + D +S GV++
Sbjct: 166 RTK----VGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 9/87 (10%)
Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTY 75
           G+ Y H    +++ HRDLK+ N LLD    P  KI  FG ++    + L +     VGT 
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTP 180
Query: 76  GYMSPEYAIQGIFSIK-SDVFSFGVLL 101
            Y++PE  ++  +  K +DV+S GV L
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTL 207

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL--DKDMNP-KISDFGM-ARICGGNEL 64
            RI++ +   + Y H   ++ + HRDLK  N L   D   +P K+ DFG+ AR   G  +
Sbjct: 126 ARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 182
Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           +      VGT  Y+SP+  ++G++  + D +S GV++
Sbjct: 183 RTK----VGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 214

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 15/98 (15%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNIL-LDKDMNP---KISDFGMARICGGNELQA 66
           ++  I + + YLH      ++HRDLK SNIL +D+  NP   +I DFG A+     +L+A
Sbjct: 126 VLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAK-----QLRA 177
Query: 67  NTSRIVG---TYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
               ++    T  +++PE   +  +    D++S G+LL
Sbjct: 178 ENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 47/85 (55%), Gaps = 8/85 (9%)
Query: 21  YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT   ++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEALAP 207
Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  +   ++   D ++ GVL+ E+A
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMA 232

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           ++  + +GL Y+H      ++HRDLK  N+ +++D   KI DFG+AR        A  + 
Sbjct: 131 LVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTG 182
Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            V T  Y +PE  +  + ++   D++S G ++ E+
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 15/98 (15%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNIL-LDKDMNP---KISDFGMARICGGNELQA 66
           ++  I + + YLH      ++HRDLK SNIL +D+  NP   +I DFG A+     +L+A
Sbjct: 126 VLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAK-----QLRA 177
Query: 67  NTSRIVG---TYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
               ++    T  +++PE   +  +    D++S G+LL
Sbjct: 178 ENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 9/89 (10%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL Y+H      ++HRDLK  N+ +++D   KI DFG+AR        A  +  V T  
Sbjct: 155 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRW 206
Query: 77  YMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
           Y +PE  +  + ++   D++S G ++ E+
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEM 235

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL + H  +   ++HRDLK  N+L++++   K++DFG+AR   G  ++  ++ +V T
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLAR-AFGIPVRCYSAEVV-T 164
Query: 75  YGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIA 105
             Y  P+      ++S   D++S G +  E+A
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + + +L L    ++ II+RD+K+ NILLD + +  ++DFG+++    +E +       GT
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGT 223
Query: 75  YGYMSPEYAIQGIFSIKS--DVFSFGVLLLEI 104
             YM+P+    G        D +S GVL+ E+
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 7/92 (7%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVG 73
           I +GL +LH  +   IIHRDLK  NI +       KI D G+A +   +  +A    ++G
Sbjct: 138 ILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIG 192
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
           T  + +PE   +  +    DV++FG   LE A
Sbjct: 193 TPEFXAPE-XYEEKYDESVDVYAFGXCXLEXA 223

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 15/94 (15%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNIL-LDKDMNP---KISDFGMARICGGNELQANTSR 70
           I + + YLH      ++HRDLK SNIL +D+  NP   +I DFG A+     +L+A    
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK-----QLRAENGL 176
Query: 71  IVG---TYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           ++    T  +++PE   +  +    D++S GVLL
Sbjct: 177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNIL-LDKDMNP-KISDFGMARICGGNE-LQAN 67
            ++ I +G+ ++HQ   + I+H DLK  NIL +++D    KI DFG+AR     E L+ N
Sbjct: 192 FMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248
Query: 68  TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                GT  +++PE       S  +D++S GV+
Sbjct: 249 ----FGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           +A+ ++ +    ++  +HRD+K  NIL+D + + +++DFG   ++     +Q++ +  VG
Sbjct: 181 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VG 238
Query: 74  TYGYMSPEY-----AIQGIFSIKSDVFSFGVLLLEIAW 106
           T  Y+SPE        +G +  + D +S GV + E+ +
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 15/94 (15%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNIL-LDKDMNP---KISDFGMARICGGNELQANTSR 70
           I + + YLH      ++HRDLK SNIL +D+  NP   +I DFG A+     +L+A    
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK-----QLRAENGL 176
Query: 71  IVG---TYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           +     T  +++PE   +  +    D++S GVLL
Sbjct: 177 LXTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 54/97 (55%), Gaps = 6/97 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I + +L +    ++  +HRD+K  N+LLD + + +++DFG   +   ++    +S  VGT
Sbjct: 181 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGT 239
Query: 75  YGYMSPE--YAIQ---GIFSIKSDVFSFGVLLLEIAW 106
             Y+SPE   A++   G +  + D +S GV + E+ +
Sbjct: 240 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY 276

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 15  IAQGLLYLHQYSRV-------RIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQA 66
           +A  +LY +Q S         R +HRD+   N+L+  +   K+ DFG++R +      +A
Sbjct: 110 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKA 169
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +  ++     +M+PE      F+  SDV+ FGV + EI
Sbjct: 170 SKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEI 205

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 54/97 (55%), Gaps = 6/97 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I + +L +    ++  +HRD+K  N+LLD + + +++DFG   +   ++    +S  VGT
Sbjct: 197 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGT 255
Query: 75  YGYMSPE--YAIQ---GIFSIKSDVFSFGVLLLEIAW 106
             Y+SPE   A++   G +  + D +S GV + E+ +
Sbjct: 256 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY 292

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 75/172 (43%), Gaps = 28/172 (16%)
Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPK--ISDFGMARICGGNELQAN 67
           +I + I +G+ YLH      I+H+DLK  N+  D   N K  I+DFG+  I G   LQA 
Sbjct: 134 QIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD---NGKVVITDFGLFSISG--VLQAG 185
Query: 68  TS----RIV-GTYGYMSPEYAIQ---------GIFSIKSDVFSFGVLLLEIAWDLWT-SN 112
                 RI  G   +++PE   Q           FS  SDVF+ G +  E+    W    
Sbjct: 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
Query: 113 RTLELIDDPV---LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           +  E I   +   ++   S   M     +I L C     ++RPT   ++ ML
Sbjct: 246 QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 22/107 (20%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK--DMNP-KISDFGMARICGGNELQAN 67
           +++ +A  L +LH      I HRDLK  NIL +    ++P KI DFG+     G +L  +
Sbjct: 116 VVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLG---SGIKLNGD 169
Query: 68  TSRI--------VGTYGYMSPEYA-----IQGIFSIKSDVFSFGVLL 101
            S I         G+  YM+PE          I+  + D++S GV+L
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 15  IAQGLLYLHQYSRV-------RIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQA 66
           +A  +LY +Q S         R +HRD+   N+L+  +   K+ DFG++R +      +A
Sbjct: 110 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 169
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +  ++     +M+PE      F+  SDV+ FGV + EI
Sbjct: 170 SKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEI 205

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 15  IAQGLLYLHQYSRV-------RIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQA 66
           +A  +LY +Q S         R +HRD+   N+L+  +   K+ DFG++R +      +A
Sbjct: 110 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 169
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +  ++     +M+PE      F+  SDV+ FGV + EI
Sbjct: 170 SKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEI 205

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 221
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 250

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 57/116 (49%), Gaps = 26/116 (22%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG-------NE 63
           I+  +  G  ++H+     IIHRDLK +N LL++D + K+ DFG+AR           N+
Sbjct: 134 ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 64  LQAN--------------TSRIVGTYGYMSPEYA-IQGIFSIKSDVFSFGVLLLEI 104
           L+ N              TS +V T  Y +PE   +Q  ++   D++S G +  E+
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 15  IAQGLLYLHQYSRV-------RIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQA 66
           +A  +LY +Q S         R +HRD+   N+L+  +   K+ DFG++R +      +A
Sbjct: 107 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 166
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +  ++     +M+PE      F+  SDV+ FGV + EI
Sbjct: 167 SKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEI 202

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 15  IAQGLLYLHQYSRV-------RIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQA 66
           +A  +LY +Q S         R +HRD+   N+L+  +   K+ DFG++R +      +A
Sbjct: 112 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 171
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +  ++     +M+PE      F+  SDV+ FGV + EI
Sbjct: 172 SKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEI 207

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 15  IAQGLLYLHQYSRV-------RIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQA 66
           +A  +LY +Q S         R +HRD+   N+L+  +   K+ DFG++R +      +A
Sbjct: 138 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 197
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +  ++     +M+PE      F+  SDV+ FGV + EI
Sbjct: 198 SKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEI 233

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 15  IAQGLLYLHQYSRV-------RIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQA 66
           +A  +LY +Q S         R +HRD+   N+L+  +   K+ DFG++R +      +A
Sbjct: 113 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 172
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +  ++     +M+PE      F+  SDV+ FGV + EI
Sbjct: 173 SKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEI 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 15  IAQGLLYLHQYSRV-------RIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQA 66
           +A  +LY +Q S         R +HRD+   N+L+  +   K+ DFG++R +      +A
Sbjct: 115 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 174
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +  ++     +M+PE      F+  SDV+ FGV + EI
Sbjct: 175 SKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEI 210

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 152 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 206
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 207 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 235

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 141 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 195
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 196 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 224

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 199
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 200 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 228

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 10/96 (10%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
             I+  I   + +LH ++   I HRD+K  N+L    +KD   K++DFG A+    N LQ
Sbjct: 112 AEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 168
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                   T  Y++PE      +    D++S GV++
Sbjct: 169 TPCY----TPYYVAPEVLGPEKYDKSCDMWSLGVIM 200

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 55/117 (47%), Gaps = 13/117 (11%)
Query: 19  LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 78
           LL LH      ++HRDL   NILL  + +  I DF +AR    +   AN +  V    Y 
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYR 200
Query: 79  SPEYAIQ-GIFSIKSDVFSFGVLLLEI--------AWDLWTS-NRTLELIDDPVLED 125
           +PE  +Q   F+   D++S G ++ E+            +   N+ +E++  P +ED
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 13/97 (13%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
            +E +A  L Y H+    ++IHRD+K  N+L+      KI+DFG +       + A + R
Sbjct: 119 FMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLR 168
Query: 71  ---IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
              + GT  Y+ PE         K D++  GVL  E 
Sbjct: 169 RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEF 205

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 55/117 (47%), Gaps = 13/117 (11%)
Query: 19  LLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 78
           LL LH      ++HRDL   NILL  + +  I DF +AR    +   AN +  V    Y 
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYR 200
Query: 79  SPEYAIQ-GIFSIKSDVFSFGVLLLEI--------AWDLWTS-NRTLELIDDPVLED 125
           +PE  +Q   F+   D++S G ++ E+            +   N+ +E++  P +ED
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 21/114 (18%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-------------KDMNPKISDFGM 55
           + ++  IA G+ +LH    ++IIHRDLK  NIL+              +++   ISDFG+
Sbjct: 136 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 56  ARI--CGGNELQANTSRIVGTYGYMSPEY---AIQGIFSIKSDVFSFGVLLLEI 104
            +    G    + N +   GT G+ +PE    + +   +   D+FS G +   I
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYI 246

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 221
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 250

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 13/97 (13%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
            +E +A  L Y H+    ++IHRD+K  N+L+      KI+DFG +       + A + R
Sbjct: 120 FMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLR 169
Query: 71  ---IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
              + GT  Y+ PE         K D++  GVL  E 
Sbjct: 170 RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEF 206

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 21/114 (18%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-------------KDMNPKISDFGM 55
           + ++  IA G+ +LH    ++IIHRDLK  NIL+              +++   ISDFG+
Sbjct: 136 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 56  ARI--CGGNELQANTSRIVGTYGYMSPEY---AIQGIFSIKSDVFSFGVLLLEI 104
            +    G    + N +   GT G+ +PE    + +   +   D+FS G +   I
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYI 246

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 169 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 223
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 224 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 252

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 199
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 200 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 228

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I+E +A  L+Y H     ++IHRD+K  N+LL      KI+DFG +       L+  T  
Sbjct: 128 IMEELADALMYCHG---KKVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKT-- 180
Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           + GT  Y+ PE     + + K D++  GVL  E+
Sbjct: 181 MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYEL 214

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 134 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 188
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 189 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 217

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 187
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 161 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 215
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 216 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 244

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARIC----GGNELQANTSRI 71
           +GL YLH  SR RI+H D+K  N+LL  D  +  + DFG A +C    G  +       I
Sbjct: 196 EGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGLGKSLLTGDYI 251
Query: 72  VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            GT  +M+PE  +      K DV+S   ++L +
Sbjct: 252 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHM 284

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM---NPKISDFGMAR-ICGGNELQ 65
            I+ I  G+ YLH     +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 177 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 10/96 (10%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
             I+  I   + +LH ++   I HRD+K  N+L    +KD   K++DFG A+    N LQ
Sbjct: 131 AEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 187
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                   T  Y++PE      +    D++S GV++
Sbjct: 188 TPCY----TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 171 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 225
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 226 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 254

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 187
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 187
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 45/88 (51%), Gaps = 18/88 (20%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-------------KDMNPKISDFGM 55
           + ++  IA G+ +LH    ++IIHRDLK  NIL+              +++   ISDFG+
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 56  ARI--CGGNELQANTSRIVGTYGYMSPE 81
            +    G +  + N +   GT G+ +PE
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPE 202

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 187
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 137 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 191
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 192 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 138 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 192
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 193 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 221

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 146 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 200
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 201 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 229

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + +GL + H  +   ++HRDLK  N+L++++   K+++FG+AR   G  ++  ++ +V T
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-T 164
Query: 75  YGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIA 105
             Y  P+      ++S   D++S G +  E+A
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 212 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 266
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 267 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 295

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 15  IAQGLLYLHQYSRV-------RIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQA 66
           +A  +LY +Q S         R +HRD+   N+L+  +   K+ DFG++R +      +A
Sbjct: 490 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +  ++     +M+PE      F+  SDV+ FGV + EI
Sbjct: 550 SKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEI 585

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 187
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT-SRIVG 73
           + +GL Y H   R +++HRDLK  N+L+++    K++DFG+AR      +   T    V 
Sbjct: 109 LLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVV 162
Query: 74  TYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
           T  Y  P+  +    +S + D++  G +  E+A
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMA 195

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGG 61
           LD+    + +  I  G+ + H ++   IIHRD+K  NIL+ +    K+ DFG AR +   
Sbjct: 121 LDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177
Query: 62  NELQANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            E+  +    V T  Y +PE  +  + +    DV++ G L+ E+
Sbjct: 178 GEVYDDE---VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 187
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTY 75
           + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 187
Query: 76  GYMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
            Y +PE       ++   DV+S G +L E+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 13/95 (13%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARIC------GGNELQANTS 69
           +GL YLH  SR RI+H D+K  N+LL  D  +  + DFG A +C      G + L  +  
Sbjct: 177 EGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGLGKDLLTGDY- 231
Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            I GT  +M+PE  +      K DV+S   ++L +
Sbjct: 232 -IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHM 265

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM---NPKISDFGMAR-ICGGNELQ 65
            I+ I  G+ YLH     +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 177 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM---NPKISDFGMAR-ICGGNELQ 65
            I+ I  G+ YLH     +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 177 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM---NPKISDFGMAR-ICGGNELQ 65
            I+ I  G+ YLH     +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 177 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 10/98 (10%)
Query: 15  IAQGLLYLHQYSRV-------RIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQA 66
           +A  +LY +Q S         R +HRD+   N+L+      K+ DFG++R +      +A
Sbjct: 110 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKA 169
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +  ++     +M+PE      F+  SDV+ FGV + EI
Sbjct: 170 SKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEI 205

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM---NPKISDFGMAR-ICGGNELQ 65
            I+ I  G+ YLH     +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 177 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 12/95 (12%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNI-LLDKDM---NPKISDFGMAR-ICGGNELQ 65
            I+ I  G+ YLH     +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL 100
                I GT  +++PE        +++D++S GV+
Sbjct: 177 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 42/79 (53%), Gaps = 9/79 (11%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-----DKDMNPKISDFGMA-RICGGN 62
           + +++    GL +LH    + I+HRDLK  NIL+        +   ISDFG+  ++  G 
Sbjct: 121 ITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 63  ELQANTSRIVGTYGYMSPE 81
              +  S + GT G+++PE
Sbjct: 178 HSFSRRSGVPGTEGWIAPE 196

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 67/128 (52%), Gaps = 16/128 (12%)
Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFG-MARICGGNELQANTSRIVG 73
           I   L YLH    + +++ DLK  NI+L ++   K+ D G ++RI        +   + G
Sbjct: 191 ILPALSYLHS---IGLVYNDLKPENIMLTEEQL-KLIDLGAVSRIN-------SFGYLYG 239
Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSN-RTLELI--DDPVLEDEYSSK 130
           T G+ +PE    G  ++ +D+++ G  L  +  DL T N R ++ +  DDPVL+   S  
Sbjct: 240 TPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYG 298
Query: 131 QMLLRYVN 138
           ++L R ++
Sbjct: 299 RLLRRAID 306

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 6/89 (6%)
Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           Q + + H+++    IHRD+K  NIL+ K    K+ DFG AR+  G     +    V T  
Sbjct: 113 QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRW 167
Query: 77  YMSPEYAIQGI-FSIKSDVFSFGVLLLEI 104
           Y SPE  +    +    DV++ G +  E+
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAEL 196

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 18/88 (20%)
Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-------------KDMNPKISDFGM 55
           + ++  IA G+ +LH    ++IIHRDLK  NIL+              +++   ISDFG+
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 56  ARI--CGGNELQANTSRIVGTYGYMSPE 81
            +    G    + N +   GT G+ +PE
Sbjct: 175 CKKLDSGQXXFRXNLNNPSGTSGWRAPE 202

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 10/98 (10%)
Query: 15  IAQGLLYLHQYSRV-------RIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQA 66
           +A  +LY +Q S         R +HRD+   N+L+      K+ DFG++R +      +A
Sbjct: 490 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKA 549
Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
           +  ++     +M+PE      F+  SDV+ FGV + EI
Sbjct: 550 SKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEI 585

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 21/53 (39%), Positives = 33/53 (62%), Gaps = 3/53 (5%)
Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE 63
           I+  +  G  ++H+     IIHRDLK +N LL++D + KI DFG+AR    ++
Sbjct: 136 ILYNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	208
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-78
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-74
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-63
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-55
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-43
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-37
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-36
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-35
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-35
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-34
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-33
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-32
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-32
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-31
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-30
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-29
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-28
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-28
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-26
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-26
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-25
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-23
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-23
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-23
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-22
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-22
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-21
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-21
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-21
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-21
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-21
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-21
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-21
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-20
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-20
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-20
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-20
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-20
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-20
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-20
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-20
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-20
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-20
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-20
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-20
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-20
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-19
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-19
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-19
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-19
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-19
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-18
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-18
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-18
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-18
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-17
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-17
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-17
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-17
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-17
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-17
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-17
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-17
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-17
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-17
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-17
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-17
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-16
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-16
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-16
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-16
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-16
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-16
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-15
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-15
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-15
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-15
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-14
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-14
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-14
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-14
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-14
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-14
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-14
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-14
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-14
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-14
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-13
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-12
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-12
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-12
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-12
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-11
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-09
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-09
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-09
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  235 bits (603), Expect = 2e-78
 Identities = 63/184 (34%), Positives = 92/184 (50%), Gaps = 25/184 (13%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L W  R +I +G A G+ +LH+      IHRD+K +NILLD+    KISDFG+AR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------------------ 104
                TSRIVGT  YM+PE  ++G  + KSD++SFGV+LLEI                  
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245

Query: 105 -AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
              ++    +T+E   D  + D   S  +     ++A  C+ E  + RP +  V  +L  
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMND-ADSTSV-EAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

Query: 164 EAAT 167
             A+
Sbjct: 304 MTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  225 bits (577), Expect = 4e-74
 Identities = 64/186 (34%), Positives = 97/186 (52%), Gaps = 26/186 (13%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LDW  R RI  G A+GL YLH +   +IIHRD+K +NILLD++    + DFG+A++    
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------------------ 104
           +    T  + GT G+++PEY   G  S K+DVF +GV+LLE+                  
Sbjct: 188 DTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 105 -----AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC 159
                   L    +   L+ D  L+  Y  +++  + + +ALLC Q S  +RP M++VV 
Sbjct: 247 MLLDWVKGLLKEKKLEALV-DVDLQGNYKDEEV-EQLIQVALLCTQSSPMERPKMSEVVR 304

Query: 160 MLTNEA 165
           ML  + 
Sbjct: 305 MLEGDG 310

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  198 bits (505), Expect = 2e-63
 Identities = 65/179 (36%), Positives = 99/179 (55%), Gaps = 24/179 (13%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           + W  R+ I  G A+GL YLH  +   IIHRD+K  NILLD++  PKI+DFG+++     
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------------------ 104
           +    ++ + GT GY+ PEY I+G  + KSDV+SFGV+L E+                  
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

Query: 105 -AW-DLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
             W     +N  LE I DP L D+   + +  ++ + A+ C+  S++DRP+M DV+  L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESL-RKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  177 bits (452), Expect = 2e-55
 Identities = 47/198 (23%), Positives = 78/198 (39%), Gaps = 37/198 (18%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQ-------YSRVRIIHRDLKVSNILLDKDMNPKISDFGM 55
           + W     I E +A+GL YLH+         +  I HRD+K  N+LL  ++   I+DFG+
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177

Query: 56  ARICGGNELQANTSRIVGTYGYMSPEYAIQGI-----FSIKSDVFSFGVLLLEIA----- 105
           A      +   +T   VGT  YM+PE     I       ++ D+++ G++L E+A     
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

Query: 106 ------------WDLWTSNRTLELID--------DPVLEDEYSSKQMLLRYVNIALLCVQ 145
                        +    + +LE +          PVL D +     +         C  
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297

Query: 146 ESADDRPTMNDVVCMLTN 163
             A+ R +   V   +T 
Sbjct: 298 HDAEARLSAGCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  146 bits (370), Expect = 4e-43
 Identities = 45/220 (20%), Positives = 74/220 (33%), Gaps = 47/220 (21%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQ------YSRVRIIHRDLKVSNILLDKDMNPKISDFGMA 56
            DWV+  R+   + +GL YLH       + +  I HRDL   N+L+  D    ISDFG++
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 57  RICGGN------ELQANTSRIVGTYGYMSPEYAIQGI-------FSIKSDVFSFGVLLLE 103
               GN      E        VGT  YM+PE     +          + D+++ G++  E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

Query: 104 IA-------------------WDLWTSNRTLELIDD--------PVLEDEYSSKQMLLR- 135
           I                         ++ T E +          P   + +    + +R 
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 136 YVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
                  C  + A+ R T       +          K  +
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  130 bits (328), Expect = 5e-37
 Identities = 46/188 (24%), Positives = 82/188 (43%), Gaps = 33/188 (17%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD   R+ +   +A+G+ YLH      I+HR+LK  N+L+DK    K+ DFG++R+    
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL---------------LEIAWD 107
            L + ++   GT  +M+PE       + KSDV+SFGV+L                ++   
Sbjct: 193 FLSSKSA--AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 250

Query: 108 LWTSNRTLELIDD--PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEA 165
           +    + LE+  +  P +         ++        C       RP+   ++ +L    
Sbjct: 251 VGFKCKRLEIPRNLNPQVAA-------IIEG------CWTNEPWKRPSFATIMDLLRPLI 297

Query: 166 ATLLPPKQ 173
            + +PP  
Sbjct: 298 KSAVPPPN 305

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  128 bits (325), Expect = 1e-36
 Identities = 48/176 (27%), Positives = 73/176 (41%), Gaps = 20/176 (11%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
             W  RV   + IA G+ YLH  +   IIHRDL   N L+ ++ N  ++DFG+AR+    
Sbjct: 105 YPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161

Query: 63  ELQANTSR------------IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI-----A 105
           + Q    R            +VG   +M+PE      +  K DVFSFG++L EI     A
Sbjct: 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221

Query: 106 WDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
              +        ++     D Y        +  I + C     + RP+   +   L
Sbjct: 222 DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  125 bits (316), Expect = 3e-35
 Identities = 44/199 (22%), Positives = 77/199 (38%), Gaps = 27/199 (13%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN-PKISDFGMARICGG 61
                 +      +QG+ YLH      +IHRDLK  N+LL       KI DFG A     
Sbjct: 99  YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---- 154

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---- 117
            ++Q + +   G+  +M+PE      +S K DVFS+G++L E+         T       
Sbjct: 155 -DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI--------TRRKPFDE 205

Query: 118 IDDPVLEDEYSSKQML---------LRYVNIALLCVQESADDRPTMNDVVCMLTNEAATL 168
           I  P     ++                  ++   C  +    RP+M ++V ++T+     
Sbjct: 206 IGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

Query: 169 LPPKQPAFSYVRNTVTSTS 187
               +P     ++++    
Sbjct: 266 PGADEPLQYPCQHSLPPGE 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  122 bits (308), Expect = 2e-34
 Identities = 49/184 (26%), Positives = 75/184 (40%), Gaps = 38/184 (20%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--------KISDFG 54
           +     V     IA+G+ YLH  + V IIHRDLK SNIL+ + +          KI+DFG
Sbjct: 102 IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161

Query: 55  MARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL------------- 101
           +AR       +       G Y +M+PE     +FS  SDV+S+GVLL             
Sbjct: 162 LARE----WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

Query: 102 --LEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC 159
             L +A+ +  +   L +                  +  +   C       RP+  +++ 
Sbjct: 218 DGLAVAYGVAMNKLALPIPST-----------CPEPFAKLMEDCWNPDPHSRPSFTNILD 266

Query: 160 MLTN 163
            LT 
Sbjct: 267 QLTT 270

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  122 bits (307), Expect = 4e-34
 Identities = 41/178 (23%), Positives = 74/178 (41%), Gaps = 30/178 (16%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
            +    + I    A+G+ YLH      IIHRDLK +NI L +D   KI DFG+A      
Sbjct: 117 FEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173

Query: 63  ELQANTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEIA-------------- 105
                  ++ G+  +M+PE         +S +SDV++FG++L E+               
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

Query: 106 --WDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
               +   + + +L        +        R   +   C+++  D+RP+   ++  +
Sbjct: 234 IIEMVGRGSLSPDLSKVRSNCPK--------RMKRLMAECLKKKRDERPSFPRILAEI 283

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  119 bits (300), Expect = 5e-33
 Identities = 50/199 (25%), Positives = 80/199 (40%), Gaps = 39/199 (19%)

Query: 3   LDWVTRVRIIEGIAQGLLYLH-----QYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           LD V+ +RI+  IA GL +LH        +  I HRDLK  NIL+ K+    I+D G+A 
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161

Query: 58  I---CGGNELQANTSRIVGTYGYMSPE------YAIQGIFSIKSDVFSFGVLLLEIAW-- 106
           +           N  R VGT  YM+PE               + D+++FG++L E+A   
Sbjct: 162 MHSQSTNQLDVGNNPR-VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

Query: 107 --------------DLWTSNRTLELIDD--------PVLEDEYSSKQMLLRYVNIALLCV 144
                         D+  ++ + E +          P + + + S   L     +   C 
Sbjct: 221 VSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECW 280

Query: 145 QESADDRPTMNDVVCMLTN 163
            ++   R T   +   LT 
Sbjct: 281 YQNPSARLTALRIKKTLTK 299

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  118 bits (297), Expect = 9e-33
 Identities = 39/185 (21%), Positives = 75/185 (40%), Gaps = 41/185 (22%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-----DMNPKISDFGMAR 57
           + W  ++R++  IA G+ Y+       I+HRDL+  NI L        +  K++DFG+++
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

Query: 58  ICGGNELQANTSRIVGTYGYMSPE--YAIQGIFSIKSDVFSFGVLLLEI----------- 104
                +   + S ++G + +M+PE   A +  ++ K+D +SF ++L  I           
Sbjct: 178 -----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

Query: 105 ------AWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
                    +        + +D              R  N+  LC       RP  + +V
Sbjct: 233 YGKIKFINMIREEGLRPTIPED-----------CPPRLRNVIELCWSGDPKKRPHFSYIV 281

Query: 159 CMLTN 163
             L+ 
Sbjct: 282 KELSE 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  117 bits (296), Expect = 1e-32
 Identities = 31/178 (17%), Positives = 64/178 (35%), Gaps = 39/178 (21%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +D    V+    +A+G+ +LH    + I    L   ++++D+DM  +IS   +       
Sbjct: 108 VDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFS---- 162

Query: 63  ELQANTSRIVGTYGYMSPEYAIQG----IFSIKSDVFSFGVLL---------------LE 103
                +   +    +++PE A+Q          +D++SF VLL               +E
Sbjct: 163 ---FQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME 218

Query: 104 IAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           I   +        +              +      +  +C+ E    RP  + +V +L
Sbjct: 219 IGMKVALEGLRPTIPPG-----------ISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  117 bits (294), Expect = 6e-32
 Identities = 50/198 (25%), Positives = 78/198 (39%), Gaps = 37/198 (18%)

Query: 3   LDWVTRVRIIEGIAQGLLYLH-----QYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           LD  + +++      GL +LH        +  I HRDLK  NIL+ K+    I+D G+A 
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190

Query: 58  IC--GGNELQANTSRIVGTYGYMSPE------YAIQGIFSIKSDVFSFGVLLLEIA---- 105
                 NE+    +  VGT  YM PE              I +D++SFG++L E+A    
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250

Query: 106 ------------WDLWTSNRTLELIDD--------PVLEDEYSSKQMLLRYVNIALLCVQ 145
                        DL  S+ + E + +        P   + +SS + L +   +   C  
Sbjct: 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310

Query: 146 ESADDRPTMNDVVCMLTN 163
            +   R T   V   L  
Sbjct: 311 HNPASRLTALRVKKTLAK 328

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  115 bits (291), Expect = 2e-31
 Identities = 45/192 (23%), Positives = 73/192 (38%), Gaps = 28/192 (14%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD     +I + I +G+ YLH      I+H+DLK  N+  D +    I+DFG+  I G  
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182

Query: 63  ELQANTSRI---VGTYGYMSPE---------YAIQGIFSIKSDVFSFGVLLLEIAWDLWT 110
           +      ++    G   +++PE            +  FS  SDVF+ G +     ++L  
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW----YELHA 238

Query: 111 -----SNRTLELIDDPVLED---EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLT 162
                  +  E I   +        S   M     +I L C     ++RPT   ++ ML 
Sbjct: 239 REWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

Query: 163 NEAATLLPPKQP 174
                      P
Sbjct: 299 KLPKRNRRLSHP 310

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  112 bits (283), Expect = 3e-30
 Identities = 45/199 (22%), Positives = 74/199 (37%), Gaps = 39/199 (19%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQ-----YSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           +     +++    A GL +LH        +  I HRDLK  NIL+ K+    I+D G+A 
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195

Query: 58  I---CGGNELQANTSRIVGTYGYMSPE------YAIQGIFSIKSDVFSFGVLLLEIAW-- 106
                      A   R VGT  YM+PE               ++D+++ G++  EIA   
Sbjct: 196 RHDSATDTIDIAPNHR-VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 254

Query: 107 --------------DLWTSNRTLELIDD--------PVLEDEYSSKQMLLRYVNIALLCV 144
                         DL  S+ ++E +          P + + + S + L     I   C 
Sbjct: 255 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECW 314

Query: 145 QESADDRPTMNDVVCMLTN 163
             +   R T   +   L+ 
Sbjct: 315 YANGAARLTALRIKKTLSQ 333

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  112 bits (281), Expect = 4e-30
 Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 24/164 (14%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
            I   IA+ + +LH      ++HRDLK SNI    D   K+ DFG+      +E +    
Sbjct: 168 HIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224

Query: 70  ----------RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID 119
                       VGT  YMSPE      +S K D+FS G++L E+ +   T    + +I 
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIIT 284

Query: 120 D------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
           D      P+L  +   ++       +    +  S  +RP   D+
Sbjct: 285 DVRNLKFPLLFTQKYPQE-----HMMVQDMLSPSPTERPEATDI 323

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  109 bits (275), Expect = 1e-29
 Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 18/153 (11%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
            + E I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      N+ +    
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTR- 180

Query: 70  RIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIAWDLWT---SNRTLELIDDPVLED 125
              GT  YMSPE  I    +  + D+++ G++L E+     T   +++    + D ++ D
Sbjct: 181 -SKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISD 238

Query: 126 EYSSK-QMLLRYVNIALLCVQESADDRPTMNDV 157
            +  K + LL+        + +  +DRP  +++
Sbjct: 239 IFDKKEKTLLQ------KLLSKKPEDRPNTSEI 265

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  106 bits (267), Expect = 3e-28
 Identities = 44/165 (26%), Positives = 69/165 (41%), Gaps = 26/165 (15%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT- 68
            I   IA+ + +LH      ++HRDLK SNI    D   K+ DFG+      +E +    
Sbjct: 122 HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 69  ---------SRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI 118
                    +  VGT  YMSPE  I G  +S K D+FS G++L E+ +   T    +  +
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTL 237

Query: 119 DD------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
            D      P L  +    +       +    +  S  +RP   ++
Sbjct: 238 TDVRNLKFPPLFTQKYPCE-----YVMVQDMLSPSPMERPEAINI 277

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  106 bits (267), Expect = 4e-28
 Identities = 36/150 (24%), Positives = 59/150 (39%), Gaps = 20/150 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
               L +LH      ++H D+K +NI L      K+ DFG+    G            G 
Sbjct: 166 TLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-GEV--QEGD 219

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA--WDLWTSNRTL----ELIDDPVLEDEYS 128
             YM+PE  +QG +   +DVFS G+ +LE+A   +L           +    P      S
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLS 278

Query: 129 SK-QMLLRYVNIALLCVQESADDRPTMNDV 157
           S+ + +L       + ++     R T   +
Sbjct: 279 SELRSVLV------MMLEPDPKLRATAEAL 302

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  101 bits (255), Expect = 6e-26
 Identities = 43/176 (24%), Positives = 71/176 (40%), Gaps = 29/176 (16%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L   T ++++   A G+ YL        IHRDL   N L+ +    KISDFGM+R     
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTL 115
              A+         + +PE    G +S +SDV+SFG+LL E          +  ++ +T 
Sbjct: 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-LSNQQTR 325

Query: 116 ELIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
           E ++       P L  +  +           +   C       RP+ + +   L +
Sbjct: 326 EFVEKGGRLPCPELCPDAVF----------RLMEQCWAYEPGQRPSFSTIYQELQS 371

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  100 bits (251), Expect = 9e-26
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 25/156 (16%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +   L ++H     R++HRD+K +N+ +      K+ D G+ R        A++  +VGT
Sbjct: 145 LCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

Query: 75  YGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA-----WDLWTSNRTLELID-------DP 121
             YMSPE  I    ++ KSD++S G LL E+A     +     N    L          P
Sbjct: 200 PYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPP 257

Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
           +  D YS +   LR   +  +C+    + RP +  V
Sbjct: 258 LPSDHYSEE---LR--QLVNMCINPDPEKRPDVTYV 288

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  100 bits (251), Expect = 1e-25
 Identities = 46/185 (24%), Positives = 82/185 (44%), Gaps = 22/185 (11%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L ++H     +I+HRD+K  NI L KD   ++ DFG+AR+       A     +GT
Sbjct: 134 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188

Query: 75  YGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA-----WDLWTSNRTLELI---DDPVLED 125
             Y+SPE   +   ++ KSD+++ G +L E+      ++  +    +  I     P +  
Sbjct: 189 PYYLSPE-ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSL 247

Query: 126 EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEAATLLPPKQPAFSYVRNTV 183
            YS     LR  ++     + +  DRP++N ++    +       L P+  A  +   T 
Sbjct: 248 HYSYD---LR--SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTF 302

Query: 184 TSTSS 188
           +   S
Sbjct: 303 SKFGS 307

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 98.5 bits (246), Expect = 3e-25
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 26/159 (16%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG--GNELQAN 67
           +I   I + L +LH  S++ +IHRD+K SN+L++     K+ DFG   I G   +++  +
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFG---ISGYLVDDVAKD 167

Query: 68  TSRIVGTYGYMSPE----YAIQGIFSIKSDVFSFGVLLLEIAW------DLWTSNRTLEL 117
                G   YM+PE       Q  +S+KSD++S G+ ++E+A          T  + L+ 
Sbjct: 168 ID--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ 225

Query: 118 I---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
           +     P L  +  S +  + + +    C+++++ +RPT
Sbjct: 226 VVEEPSPQLPADKFSAEF-VDFTS---QCLKKNSKERPT 260

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 95.8 bits (239), Expect = 3e-24
 Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 6/94 (6%)

Query: 15  IAQGLLYLHQ--YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIV 72
           +   L   H+       ++HRDLK +N+ LD   N K+ DFG+ARI   +   A T   V
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FV 177

Query: 73  GTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
           GT  YMSPE  +  + ++ KSD++S G LL E+ 
Sbjct: 178 GTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELC 210

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 95.7 bits (238), Expect = 9e-24
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 18/175 (10%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL---QA 66
           ++   + +GL YL    + +I+HRD+K SNIL++     K+ DFG++      +L    A
Sbjct: 135 KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLIDSMA 187

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDL--WTSNRTLELIDDPVLE 124
           N+   VGT  YMSPE      +S++SD++S G+ L+E+A            EL      +
Sbjct: 188 NS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245

Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPTMN--DVVCMLTNEAATLLPPKQPAFS 177
            E  + +   R         +   D RP M   +++  + NE    LP     FS
Sbjct: 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGV--FS 298

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 96.9 bits (241), Expect = 1e-23
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 28/167 (16%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V +   IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A  
Sbjct: 366 VDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422

Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELIDD-- 120
                   + +PE A+ G F+IKSDV+SFG+LL E+       +    +   L+ ++   
Sbjct: 423 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 481

Query: 121 ----PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
               P    E  +          ++   C ++  ++RPT   +   L
Sbjct: 482 RMPCPPECPESLH----------DLMCQCWRKEPEERPTFEYLQAFL 518

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 96.3 bits (240), Expect = 1e-23
 Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 36/171 (21%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +     IA+G+ ++    +   IHRDL+ +NIL+   +  KI+DFG+AR+   NE  A  
Sbjct: 287 IDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343

Query: 69  SRIVGT---YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELI 118
               G      + +PE    G F+IKSDV+SFG+LL+EI            ++   +  +
Sbjct: 344 ----GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRAL 398

Query: 119 DD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           +       P    E+ Y          NI + C +   ++RPT   +  +L
Sbjct: 399 ERGYRMPRPENCPEELY----------NIMMRCWKNRPEERPTFEYIQSVL 439

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 95.1 bits (237), Expect = 1e-23
 Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 40/209 (19%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
              +  V ++ GIA G+ YL   + +  +HRDL   NIL++ ++  K+SDFG++R+   +
Sbjct: 144 FSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

Query: 63  ELQANTSRIVGTYG------YMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLW 109
                T+      G      + +PE      F+  SDV+SFG+++ E+        W+  
Sbjct: 201 PEATYTTS-----GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-L 254

Query: 110 TSNRTLELIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           +++  ++ I+D      P+      Y           + + C Q+    RP   D+V +L
Sbjct: 255 SNHEVMKAINDGFRLPTPMDCPSAIY----------QLMMQCWQQERARRPKFADIVSIL 304

Query: 162 TNEAATLLPPKQPAFSYVRNTVTSTSSTG 190
                     K  A    R ++   S++G
Sbjct: 305 DKLIRAPDSLKTLADFDPRVSIRLPSTSG 333

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 93.9 bits (234), Expect = 2e-23
 Identities = 40/171 (23%), Positives = 69/171 (40%), Gaps = 32/171 (18%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARIC---------- 59
           R+   I + L Y+H      IIHRDLK  NI +D+  N KI DFG+A+            
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 60  --GGNELQANTSRIVGTYGYMSPE-YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE 116
                    N +  +GT  Y++ E     G ++ K D++S G++  E+ +   T    + 
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN 236

Query: 117 LID---------DPVLEDEYSSKQ-MLLRYVNIALLCVQESADDRPTMNDV 157
           ++           P  +D     +  ++R      L +    + RP    +
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIR------LLIDHDPNKRPGARTL 281

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 95.2 bits (237), Expect = 3e-23
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 28/167 (16%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V +   IA G+ Y+    R+  +HRDL+ +NIL+ +++  K++DFG+AR+   NE  A  
Sbjct: 283 VDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339

Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELIDD-- 120
                   + +PE A+ G F+IKSDV+SFG+LL E+       +    +   L+ ++   
Sbjct: 340 GAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 398

Query: 121 ----PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
               P    E  +          ++   C ++  ++RPT   +   L
Sbjct: 399 RMPCPPECPESLH----------DLMCQCWRKEPEERPTFEYLQAFL 435

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 93.9 bits (234), Expect = 3e-23
 Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 40/182 (21%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
              +  V ++ G+  G+ YL   S +  +HRDL   N+L+D ++  K+SDFG++R+   +
Sbjct: 148 FTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

Query: 63  ELQANTSRIVGTYG------YMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLW 109
              A T+      G      + +PE      FS  SDV+SFGV++ E+        W+  
Sbjct: 205 PDAAYTTT-----GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-M 258

Query: 110 TSNRTLELIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           T+   +  +++      P+      +           + L C  +    RP  + +V +L
Sbjct: 259 TNRDVISSVEEGYRLPAPMGCPHALH----------QLMLDCWHKDRAQRPRFSQIVSVL 308

Query: 162 TN 163
             
Sbjct: 309 DA 310

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 92.7 bits (231), Expect = 4e-23
 Identities = 36/181 (19%), Positives = 62/181 (34%), Gaps = 38/181 (20%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +       ++  ++ G+ YL        +HRDL   N+LL      KISDFG+++  G +
Sbjct: 107 IPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163

Query: 63  ELQANTSRIVGTYG------YMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWT 110
           +                   + +PE      FS +SDV+S+GV + E        +    
Sbjct: 164 DSYYTARS-----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

Query: 111 SNRTLELIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLT 162
               +  I+       P     + Y           +   C     +DRP    V   + 
Sbjct: 219 GPEVMAFIEQGKRMECPPECPPELY----------ALMSDCWIYKWEDRPDFLTVEQRMR 268

Query: 163 N 163
            
Sbjct: 269 A 269

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 95.2 bits (237), Expect = 4e-23
 Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 28/167 (16%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + +   I+  + YL    +   IHR+L   N L+ ++   K++DFG++R+  G+   A+ 
Sbjct: 321 LYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377

Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELIDD-- 120
                   + +PE      FSIKSDV++FGVLL EIA      +     ++  EL++   
Sbjct: 378 GAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 436

Query: 121 ----PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
               P    E  Y           +   C Q +  DRP+  ++    
Sbjct: 437 RMERPEGCPEKVY----------ELMRACWQWNPSDRPSFAEIHQAF 473

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 93.1 bits (232), Expect = 5e-23
 Identities = 44/182 (24%), Positives = 79/182 (43%), Gaps = 43/182 (23%)

Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
            LL+W         IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G
Sbjct: 118 YLLNWCV------QIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

Query: 61  GNELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLW 109
             E + +        G     +M+ E  +  I++ +SDV+S+GV + E+       +D  
Sbjct: 169 AEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

Query: 110 TSNRTLELIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
            ++    +++       P +   D Y           I   C    AD RP   +++   
Sbjct: 224 PASEISSILEKGERLPQPPICTIDVY----------MIMRKCWMIDADSRPKFRELIIEF 273

Query: 162 TN 163
           + 
Sbjct: 274 SK 275

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 92.7 bits (231), Expect = 5e-23
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 4/101 (3%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L   T +     I  G+ + H    +RI+HRD+K  NIL+D +   KI DFG+A+     
Sbjct: 108 LSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
            L   T+ ++GT  Y SPE A        +D++S G++L E
Sbjct: 165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYE 204

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 92.8 bits (231), Expect = 1e-22
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 32/178 (17%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
              +  V ++ GIA G+ YL   S +  +HRDL   NIL++ ++  K+SDFG+ R+   +
Sbjct: 144 FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200

Query: 63  ELQANTSRIVGT---YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNR 113
              A T+R  G      + SPE      F+  SDV+S+G++L E+       +   ++  
Sbjct: 201 PEAAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

Query: 114 TLELIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            ++ +D+      P+      Y           + L C Q+  ++RP    +V +L  
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALY----------QLMLDCWQKDRNNRPKFEQIVSILDK 306

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 92.0 bits (229), Expect = 1e-22
 Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 26/160 (16%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG--GNELQAN 67
           ++   I + L YL    +  +IHRD+K SNILLD+    K+ DFG   I G   ++   +
Sbjct: 128 KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKD 182

Query: 68  TSRIVGTYGYMSPE-----YAIQGIFSIKSDVFSFGVLLLEIA-----WDLWTSN-RTLE 116
            S   G   YM+PE        +  + I++DV+S G+ L+E+A     +    ++   L 
Sbjct: 183 RS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT 240

Query: 117 LI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
            +   + P+L            +V     C+ +    RP 
Sbjct: 241 KVLQEEPPLLPGHMGFSGDFQSFVK---DCLTKDHRKRPK 277

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 91.2 bits (227), Expect = 2e-22
 Identities = 46/180 (25%), Positives = 65/180 (36%), Gaps = 39/180 (21%)

Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
            L  +         +A+G+ YL      R IHRDL   N+LL      KI DFG+ R   
Sbjct: 122 TLSRYAV------QVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172

Query: 61  GNELQANTSRIVGT---YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTS 111
            N+              + + +PE      FS  SD + FGV L E+       W     
Sbjct: 173 QNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230

Query: 112 NRTLELIDD-------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLT 162
           ++ L  ID        P    +D Y          N+ + C     +DRPT   +   L 
Sbjct: 231 SQILHKIDKEGERLPRPEDCPQDIY----------NVMVQCWAHKPEDRPTFVALRDFLL 280

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 91.6 bits (228), Expect = 2e-22
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 27/161 (16%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           +I     + L +L     ++IIHRD+K SNILLD+  N K+ DFG   I G  +L  + +
Sbjct: 129 KITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG---ISG--QLVDSIA 181

Query: 70  R--IVGTYGYMSPE----YAIQGIFSIKSDVFSFGVLLLEIAW------DLWTSNRTLEL 117
           +    G   YM+PE     A +  + ++SDV+S G+ L E+A          +    L  
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ 241

Query: 118 I---DDPVLEDEYSSK--QMLLRYVNIALLCVQESADDRPT 153
           +   D P L +    +     + +VN   LC+ +    RP 
Sbjct: 242 VVKGDPPQLSNSEEREFSPSFINFVN---LCLTKDESKRPK 279

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 91.2 bits (227), Expect = 3e-22
 Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 4/95 (4%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V I+  I   L   H        HRD+K  NIL+  D    + DFG+A      +L    
Sbjct: 137 VAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-L 192

Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
              VGT  YM+PE   +   + ++D+++   +L E
Sbjct: 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYE 227

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 90.4 bits (225), Expect = 3e-22
 Identities = 40/175 (22%), Positives = 66/175 (37%), Gaps = 38/175 (21%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + ++  ++ G+ YL        +HRDL   N+LL      KISDFG+++    +E     
Sbjct: 120 IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 176

Query: 69  SRIVGTYG------YMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLE 116
                         + +PE      FS KSDV+SFGVL+ E        +     +    
Sbjct: 177 QT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 231

Query: 117 LIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
           +++       P     + Y          ++  LC     ++RP    V   L N
Sbjct: 232 MLEKGERMGCPAGCPREMY----------DLMNLCWTYDVENRPGFAAVELRLRN 276

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 92.0 bits (229), Expect = 4e-22
 Identities = 40/176 (22%), Positives = 67/176 (38%), Gaps = 38/176 (21%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L     ++    + + + YL        +HRDL   N+L+ +D   K+SDFG+ +     
Sbjct: 286 LGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----- 337

Query: 63  ELQANTSRIVGTYGY--MSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNR 113
             +A++++  G       +PE   +  FS KSDV+SFG+LL EI                
Sbjct: 338 --EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKD 394

Query: 114 TLELIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
            +  ++       P       Y          ++   C    A  RPT   +   L
Sbjct: 395 VVPRVEKGYKMDAPDGCPPAVY----------DVMKNCWHLDAATRPTFLQLREQL 440

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 89.9 bits (224), Expect = 4e-22
 Identities = 39/181 (21%), Positives = 63/181 (34%), Gaps = 52/181 (28%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V     I + + YL     +  +HRD+ V NIL+      K+ DFG++R     +     
Sbjct: 116 VLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----- 167

Query: 69  SRIVGTYGY------------MSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWT 110
                   Y            MSPE      F+  SDV+ F V + EI       +    
Sbjct: 168 --------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219

Query: 111 SNRTLELIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLT 162
           +   + +++       P L     Y           +   C      DRP   ++VC L+
Sbjct: 220 NKDVIGVLEKGDRLPKPDLCPPVLY----------TLMTRCWDYDPSDRPRFTELVCSLS 269

Query: 163 N 163
           +
Sbjct: 270 D 270

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 92.3 bits (229), Expect = 5e-22
 Identities = 36/190 (18%), Positives = 65/190 (34%), Gaps = 32/190 (16%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +       ++  ++ G+ YL        +HR+L   N+LL      KISDFG+++  G +
Sbjct: 433 IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489

Query: 63  ELQANTSRIVGT---YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNR 113
           +                + +PE      FS +SDV+S+GV + E        +       
Sbjct: 490 DSYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

Query: 114 TLELIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEA 165
            +  I+       P     + Y           +   C     +DRP    V   +    
Sbjct: 548 VMAFIEQGKRMECPPECPPELY----------ALMSDCWIYKWEDRPDFLTVEQRMRACY 597

Query: 166 ATLLPPKQPA 175
            +L    +  
Sbjct: 598 YSLASKVEGG 607

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 89.2 bits (222), Expect = 6e-22
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 34/170 (20%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + +   + +G+ YL       +IHRDL   N L+ ++   K+SDFGM R    ++  ++T
Sbjct: 107 LGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163

Query: 69  SRIVGT---YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELID 119
               GT     + SPE      +S KSDV+SFGVL+ E+       ++  +++  +E I 
Sbjct: 164 ----GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219

Query: 120 D------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                  P L     Y           I   C +E  +DRP  + ++  L
Sbjct: 220 TGFRLYKPRLASTHVY----------QIMNHCWRERPEDRPAFSRLLRQL 259

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 89.6 bits (223), Expect = 7e-22
 Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 34/170 (20%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + +   IA+G+ ++        IHRDL+ +NIL+   ++ KI+DFG+AR+   NE    T
Sbjct: 112 LDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---T 165

Query: 69  SRIVGTYGY--MSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELID 119
           +R    +     +PE    G F+IKSDV+SFG+LL EI            T+   ++ ++
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLE 224

Query: 120 D------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                  P    E+ Y           +  LC +E  +DRPT + +  +L
Sbjct: 225 RGYRMVRPDNCPEELY----------QLMRLCWKERPEDRPTFDYLRSVL 264

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 88.8 bits (221), Expect = 1e-21
 Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 34/170 (20%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + +   + +G+ +L      + IHRDL   N L+D+D+  K+SDFGM R    ++  ++ 
Sbjct: 107 LEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163

Query: 69  SRIVGT---YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELID 119
               GT     + +PE      +S KSDV++FG+L+ E+       +DL+T++  +  + 
Sbjct: 164 ----GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

Query: 120 D------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                  P L  +  Y           I   C  E  + RPT   ++  +
Sbjct: 220 QGHRLYRPHLASDTIY----------QIMYSCWHELPEKRPTFQQLLSSI 259

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 89.2 bits (222), Expect = 1e-21
 Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 36/177 (20%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +  V  + +   I+  + YL    +   IHRDL   N L+ ++   K++DFG++R+  G+
Sbjct: 108 VSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

Query: 63  ELQANTSRIVGT---YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSN 112
              A+     G      + +PE      FSIKSDV++FGVLL EIA             +
Sbjct: 165 TYTAHA----GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLS 219

Query: 113 RTLELIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           +  EL++       P    E  Y           +   C Q +  DRP+  ++    
Sbjct: 220 QVYELLEKDYRMERPEGCPEKVY----------ELMRACWQWNPSDRPSFAEIHQAF 266

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 89.7 bits (223), Expect = 1e-21
 Identities = 49/217 (22%), Positives = 81/217 (37%), Gaps = 48/217 (22%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL + +       I +G+ YL      R +HRDL   NIL++ + + KI+DFG+A++   
Sbjct: 129 LLLYSS------QICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL--- 176

Query: 62  NELQANTSRIVGTYG------YMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLW 109
             L  +    V          + +PE     IFS +SDV+SFGV+L E+           
Sbjct: 177 --LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234

Query: 110 TSNRTLELIDDPVLEDEYSSKQMLLRYV-----------------NIALLCVQESADDRP 152
                +   +  V      +   LL  +                  +  LC   S  DRP
Sbjct: 235 AEFLRMMGCERDVP-----ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289

Query: 153 TMNDVVCMLTNEAATLLPPKQPAFSYVRNTVTSTSST 189
           + + +   L    +     +  AF+        + S 
Sbjct: 290 SFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSF 326

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 89.2 bits (222), Expect = 1e-21
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 4/102 (3%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGG 61
           +     + +I    Q L + H   +  IIHRD+K +NI++      K+ DFG+AR I   
Sbjct: 113 MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
                 T+ ++GT  Y+SPE A       +SDV+S G +L E
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 88.4 bits (220), Expect = 2e-21
 Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 34/170 (20%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + + + + + + YL      + +HRDL   N L++     K+SDFG++R    +E  ++ 
Sbjct: 123 LEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179

Query: 69  SRIVGT---YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELID 119
               G+     +  PE  +   FS KSD+++FGVL+ EI       ++ +T++ T E I 
Sbjct: 180 ----GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235

Query: 120 D------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                  P L  E  Y           I   C  E AD+RPT   ++  +
Sbjct: 236 QGLRLYRPHLASEKVY----------TIMYSCWHEKADERPTFKILLSNI 275

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 88.5 bits (220), Expect = 2e-21
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 35/172 (20%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +     +A+G+ YL   +  + +HRDL   N +LD+    K++DFG+AR    +      
Sbjct: 131 IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEY 183

Query: 69  SRIVGTYG------YMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTL 115
             +    G      +M+ E      F+ KSDV+SFGVLL E+         D   +    
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDIT 242

Query: 116 ELIDD------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
             +        P    EY    +   Y  + L C    A+ RP+ +++V  +
Sbjct: 243 VYLLQGRRLLQP----EYCPDPL---Y-EVMLKCWHPKAEMRPSFSELVSRI 286

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 88.5 bits (220), Expect = 2e-21
 Identities = 45/171 (26%), Positives = 70/171 (40%), Gaps = 42/171 (24%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR     ++  +   +   
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKG 208

Query: 75  YG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSS 129
                  +M+PE     +++I+SDV+SFGVLL EI         +L     P        
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF--------SLGASPYP----GVKI 256

Query: 130 KQMLLRYV-----------------NIALLCVQESADDRPTMNDVVCMLTN 163
            +   R +                    L C       RPT +++V  L N
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 88.1 bits (219), Expect = 2e-21
 Identities = 35/188 (18%), Positives = 70/188 (37%), Gaps = 46/188 (24%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
            L +         I +G+ YL      + +HRDL   N+L++ +   KI DFG+ +    
Sbjct: 128 QLKYAV------QICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA--- 175

Query: 62  NELQANTSRIVGTYG------YMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWT---SN 112
             ++ +               + +PE  +Q  F I SDV+SFGV L     +L T   S+
Sbjct: 176 --IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL----HELLTYCDSD 229

Query: 113 RTLELIDDPVLEDEYS--SKQMLLRYV-----------------NIALLCVQESADDRPT 153
            +   +   ++   +   +   L+  +                  +   C +    +R +
Sbjct: 230 SSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTS 289

Query: 154 MNDVVCML 161
             +++   
Sbjct: 290 FQNLIEGF 297

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 88.0 bits (219), Expect = 3e-21
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 37/174 (21%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           V ++  IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R     E+ A  
Sbjct: 131 VHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAAD 182

Query: 69  SRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNR-TL 115
              +         +M+PE  + G FSI SD++S+GV+L E+             SN+  +
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVV 240

Query: 116 ELIDD------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
           E+I +      P    +     +   Y  + + C  E    RP   D+   L  
Sbjct: 241 EMIRNRQVLPCP----DDCPAWV---Y-ALMIECWNEFPSRRPRFKDIHSRLRA 286

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 88.5 bits (220), Expect = 3e-21
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 43/182 (23%)

Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
            LL+W         IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G
Sbjct: 118 YLLNWCV------QIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

Query: 61  GNELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLW 109
             E + +        G     +M+ E  +  I++ +SDV+S+GV + E+       +D  
Sbjct: 169 AEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

Query: 110 TSNRTLELIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
            ++    +++       P +   D Y           I + C    AD RP   +++   
Sbjct: 224 PASEISSILEKGERLPQPPICTIDVY----------MIMVKCWMIDADSRPKFRELIIEF 273

Query: 162 TN 163
           + 
Sbjct: 274 SK 275

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 89.9 bits (223), Expect = 3e-21
 Identities = 22/95 (23%), Positives = 42/95 (44%), Gaps = 11/95 (11%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +  +  I   L YLH    + +++ DLK  NI+L ++   K+ D G              
Sbjct: 185 IAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------F 234

Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
             + GT G+ +PE   +   ++ +D+++ G  L  
Sbjct: 235 GYLYGTPGFQAPEIV-RTGPTVATDIYTVGRTLAA 268

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 88.6 bits (220), Expect = 3e-21
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 10/95 (10%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
            II+ +     Y+H  +   I HRD+K SNIL+DK+   K+SDFG +      +++   S
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GS 210

Query: 70  RIVGTYGYMSPEYAIQGIFSI---KSDVFSFGVLL 101
              GTY +M PE       S    K D++S G+ L
Sbjct: 211 --RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICL 242

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 88.2 bits (219), Expect = 3e-21
 Identities = 44/182 (24%), Positives = 71/182 (39%), Gaps = 38/182 (20%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +   + I +G+ YLH       IHRDL   N+LLD D   KI DFG+A+           
Sbjct: 137 LLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR- 192

Query: 69  SRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWT---SNRTLELIDD 120
              V   G     + +PE   +  F   SDV+SFGV L    ++L T   S+++      
Sbjct: 193 ---VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL----YELLTHCDSSQSPPTKFL 245

Query: 121 PVLEDEYS--SKQMLLRYV-----------------NIALLCVQESADDRPTMNDVVCML 161
            ++       +   L   +                 ++   C +  A  RPT  +++ +L
Sbjct: 246 ELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

Query: 162 TN 163
             
Sbjct: 306 KT 307

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 87.7 bits (218), Expect = 3e-21
 Identities = 46/172 (26%), Positives = 76/172 (44%), Gaps = 33/172 (19%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + I   IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R     ++ +  
Sbjct: 136 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTD 187

Query: 69  SRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLEL 117
              VG +      +M PE  +   F+ +SDV+SFGV+L EI       W   ++   +E 
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 247

Query: 118 IDD------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
           I        P        K++   Y ++ L C Q     R  + ++  +L  
Sbjct: 248 ITQGRVLERP----RVCPKEV---Y-DVMLGCWQREPQQRLNIKEIYKILHA 291

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 88.1 bits (219), Expect = 4e-21
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 26/161 (16%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 73
           +A+G+ +L   +    IHRDL   NILL      KI DFG+AR I   +      +  + 
Sbjct: 154 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL- 209

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD------ 120
              +M+PE     +++ +SDV+S+G+ L E+          +   ++  ++I +      
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS 269

Query: 121 PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           P    E++  +M   Y +I   C       RPT   +V ++
Sbjct: 270 P----EHAPAEM---Y-DIMKTCWDADPLKRPTFKQIVQLI 302

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 87.3 bits (217), Expect = 4e-21
 Identities = 42/187 (22%), Positives = 70/187 (37%), Gaps = 39/187 (20%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL + +       I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++   
Sbjct: 116 LLQYTS------QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKV--- 163

Query: 62  NELQANTSRIVGTYG------YMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL 115
             L  +               + +PE   +  FS+ SDV+SFGV+L E+   +  S    
Sbjct: 164 --LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 221

Query: 116 ELIDDPVLEDEYS--SKQMLLRYV-----------------NIALLCVQESADDRPTMND 156
                 +  D+        L+  +                  I   C   + + RP+  D
Sbjct: 222 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD 281

Query: 157 VVCMLTN 163
           +   +  
Sbjct: 282 LALRVDQ 288

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 86.9 bits (216), Expect = 5e-21
 Identities = 35/181 (19%), Positives = 61/181 (33%), Gaps = 52/181 (28%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +     ++  L YL      R +HRD+   N+L+  +   K+ DFG++R    +      
Sbjct: 119 ILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----- 170

Query: 69  SRIVGTYGY------------MSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWT 110
                   Y            M+PE      F+  SDV+ FGV + EI       +    
Sbjct: 171 --------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

Query: 111 SNRTLELIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLT 162
           +N  +  I++      P       Y          ++   C       RP   ++   L+
Sbjct: 223 NNDVIGRIENGERLPMPPNCPPTLY----------SLMTKCWAYDPSRRPRFTELKAQLS 272

Query: 163 N 163
            
Sbjct: 273 T 273

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 87.7 bits (218), Expect = 6e-21
 Identities = 43/171 (25%), Positives = 70/171 (40%), Gaps = 43/171 (25%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     ++         T
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYKKTT 217

Query: 75  YG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSS 129
            G     +M+PE     +++ +SDV+SFGVL+ EI         TL     P +      
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF--------TLGGSPYPGI-----P 264

Query: 130 KQMLLRYV-----------------NIALLCVQESADDRPTMNDVVCMLTN 163
            + L + +                  +   C       RPT   +V  L  
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 88.2 bits (219), Expect = 6e-21
 Identities = 43/171 (25%), Positives = 70/171 (40%), Gaps = 43/171 (25%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ ++   KI+DFG+AR     ++         T
Sbjct: 212 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYKKTT 263

Query: 75  YG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSS 129
            G     +M+PE     +++ +SDV+SFGVL+ EI         TL     P +      
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF--------TLGGSPYPGI-----P 310

Query: 130 KQMLLRYV-----------------NIALLCVQESADDRPTMNDVVCMLTN 163
            + L + +                  +   C       RPT   +V  L  
Sbjct: 311 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 87.7 bits (218), Expect = 6e-21
 Identities = 40/170 (23%), Positives = 67/170 (39%), Gaps = 44/170 (25%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTS---- 69
           +A+G+ +L        +HRDL   N+L+      KI DFG+AR I   +      +    
Sbjct: 181 VAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 237

Query: 70  -RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYS 128
            +      +M+PE   +GI++IKSDV+S+G+LL EI         +L +   P       
Sbjct: 238 VK------WMAPESLFEGIYTIKSDVWSYGILLWEIF--------SLGVNPYP----GIP 279

Query: 129 SKQMLLRYV-----------------NIALLCVQESADDRPTMNDVVCML 161
                 + +                  I   C    +  RP+  ++   L
Sbjct: 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 87.7 bits (218), Expect = 7e-21
 Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 26/161 (16%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 73
           +AQG+ +L   +    IHRD+   N+LL      KI DFG+AR I   +      +  + 
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 228

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD------ 120
              +M+PE     +++++SDV+S+G+LL EI          +  +++  +L+ D      
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 288

Query: 121 PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           P     ++ K +   Y +I   C       RPT   +   L
Sbjct: 289 P----AFAPKNI---Y-SIMQACWALEPTHRPTFQQICSFL 321

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 87.3 bits (217), Expect = 7e-21
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 43/169 (25%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTS---- 69
           I+QG+ YL   + ++++HRDL   NIL+ +    KISDFG++R +   +     +     
Sbjct: 159 ISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIP 215

Query: 70  -RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWT---------SNRTLELID 119
            +      +M+ E     I++ +SDV+SFGVLL EI     T               L +
Sbjct: 216 VK------WMAIESLFDHIYTTQSDVWSFGVLLWEIV----TLGGNPYPGIPPE--RLFN 263

Query: 120 DPVLED-------EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
             +L+        +  S++M   Y  + L C ++  D RP   D+   L
Sbjct: 264 --LLKTGHRMERPDNCSEEM---Y-RLMLQCWKQEPDKRPVFADISKDL 306

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 87.0 bits (216), Expect = 1e-20
 Identities = 39/181 (21%), Positives = 73/181 (40%), Gaps = 43/181 (23%)

Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
           +LL+W         IA+G+ YL       ++HR+L   N+LL      +++DFG+A +  
Sbjct: 116 LLLNWGV------QIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166

Query: 61  GNELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLW 109
            ++ Q   S            +M+ E    G ++ +SDV+S+GV + E+       +   
Sbjct: 167 PDDKQLLYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221

Query: 110 TSNRTLELIDD------PVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                 +L++       P +   D Y           + + C     + RPT  ++    
Sbjct: 222 RLAEVPDLLEKGERLAQPQICTIDVY----------MVMVKCWMIDENIRPTFKELANEF 271

Query: 162 T 162
           T
Sbjct: 272 T 272

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 86.6 bits (215), Expect = 1e-20
 Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 37/174 (21%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + +   +A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     ++ +  
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTD 212

Query: 69  SRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNR-TL 115
              VG        +M PE  +   F+ +SDV+SFGV+L EI        + L  SN   +
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--SNTEAI 270

Query: 116 ELIDD------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
           + I        P         ++   Y  I   C Q     R ++ DV   L  
Sbjct: 271 DCITQGRELERP----RACPPEV---Y-AIMRGCWQREPQQRHSIKDVHARLQA 316

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 86.7 bits (215), Expect = 1e-20
 Identities = 42/187 (22%), Positives = 70/187 (37%), Gaps = 39/187 (20%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGG 61
           LL + +       I +G+ YL      R IHRDL   NIL++ +   KI DFG+ ++   
Sbjct: 147 LLQYTS------QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKV--- 194

Query: 62  NELQANTSRIVGTYG------YMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL 115
             L  +               + +PE   +  FS+ SDV+SFGV+L E+   +  S    
Sbjct: 195 --LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 252

Query: 116 ELIDDPVLEDEYS--SKQMLLRYV-----------------NIALLCVQESADDRPTMND 156
                 +  D+        L+  +                  I   C   + + RP+  D
Sbjct: 253 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD 312

Query: 157 VVCMLTN 163
           +   +  
Sbjct: 313 LALRVDQ 319

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 87.4 bits (216), Expect = 2e-20
 Identities = 17/107 (15%), Positives = 38/107 (35%), Gaps = 9/107 (8%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L    R+++   + + L  LH Y    ++H  L+  +I+LD+     ++ F       G 
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-DGA 263

Query: 63  ELQANTSRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEI 104
              +   R        +            + +   D ++ G+ +  I
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 85.8 bits (213), Expect = 2e-20
 Identities = 41/171 (23%), Positives = 66/171 (38%), Gaps = 33/171 (19%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +     +A+G+ YL   +  + +HRDL   N +LD+    K++DFG+AR     E     
Sbjct: 127 ISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY---Y 180

Query: 69  SRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLE 116
           S     +      + + E      F+ KSDV+SFGVLL E+          +        
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTH 239

Query: 117 LIDD------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
            +        P    EY    +   Y  +   C +     RPT   +V  +
Sbjct: 240 FLAQGRRLPQP----EYCPDSL---Y-QVMQQCWEADPAVRPTFRVLVGEV 282

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 86.2 bits (214), Expect = 2e-20
 Identities = 40/198 (20%), Positives = 72/198 (36%), Gaps = 33/198 (16%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           VR +  IA G+ YL   S    IHRDL   N +L +DM   ++DFG++R     ++ +  
Sbjct: 140 VRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGD 191

Query: 69  SRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLEL 117
               G        +++ E     ++++ SDV++FGV + EI       +    +      
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251

Query: 118 IDD------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPP 171
           +        P        +++   Y ++   C       RP+   +   L N    L   
Sbjct: 252 LIGGNRLKQP----PECMEEV---Y-DLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303

Query: 172 KQPAFSYVRNTVTSTSST 189
                    N   +    
Sbjct: 304 STSQDPLYINIERAHHHH 321

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 85.3 bits (212), Expect = 2e-20
 Identities = 38/168 (22%), Positives = 67/168 (39%), Gaps = 34/168 (20%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           ++    + + + YL        +HRDL   N+L+ +D   K+SDFG+ +       +A++
Sbjct: 120 LKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASS 169

Query: 69  SRIVGTYGY--MSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELID 119
           ++  G       +PE   +  FS KSDV+SFG+LL EI                 +  ++
Sbjct: 170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVE 228

Query: 120 D------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
                  P    +     +   Y  +   C    A  RP+   +   L
Sbjct: 229 KGYKMDAP----DGCPPAV---Y-EVMKNCWHLDAAMRPSFLQLREQL 268

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 86.7 bits (215), Expect = 2e-20
 Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 33/171 (19%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +     +A+G+ +L   +  + +HRDL   N +LD+    K++DFG+AR     E  +  
Sbjct: 195 IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 251

Query: 69  SRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLE 116
           ++   T       +M+ E      F+ KSDV+SFGVLL E+         D   +     
Sbjct: 252 NK---TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITV 307

Query: 117 LIDD------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
            +        P    EY    +   Y  + L C    A+ RP+ +++V  +
Sbjct: 308 YLLQGRRLLQP----EYCPDPL---Y-EVMLKCWHPKAEMRPSFSELVSRI 350

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 85.5 bits (212), Expect = 2e-20
 Identities = 37/149 (24%), Positives = 68/149 (45%), Gaps = 20/149 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGGNELQANTSRIVG 73
           I +GL +LH      IIHRDLK  NI +     + KI D G+A +   +        ++G
Sbjct: 138 ILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIG 192

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRTLELI----DDPVLE 124
           T  +M+PE   +  +    DV++FG+ +LE+A     +    +   +         P   
Sbjct: 193 TPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251

Query: 125 DEYSSKQMLLRYVNIALLCVQESADDRPT 153
           D+ +  ++      I   C++++ D+R +
Sbjct: 252 DKVAIPEV----KEIIEGCIRQNKDERYS 276

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 85.8 bits (213), Expect = 2e-20
 Identities = 47/204 (23%), Positives = 83/204 (40%), Gaps = 44/204 (21%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +     +A+G+ YL   S+ + IHRDL   NIL+ ++   KI+DFG++R  G       T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199

Query: 69  S-----RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLE 116
                 R      +M+ E     +++  SDV+S+GVLL EI          +  +    E
Sbjct: 200 MGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCA--E 249

Query: 117 LIDDPVLEDEYS-------SKQMLLRYVNIALLCVQESADDRPTMNDVVC----MLTNEA 165
           L +   L   Y          ++   Y ++   C +E   +RP+   ++     ML    
Sbjct: 250 LYE--KLPQGYRLEKPLNCDDEV---Y-DLMRQCWREKPYERPSFAQILVSLNRMLEERK 303

Query: 166 ATLLPPKQPAFSYVRNTVTSTSST 189
             +       F+Y     ++  + 
Sbjct: 304 TYVNTTLYEKFTYAGIDCSAEEAA 327

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 86.7 bits (215), Expect = 3e-20
 Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 13/96 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A+G+ YL   +  + IHRDL   N+L+ +D   KI+DFG+AR     ++         T
Sbjct: 200 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTT 251

Query: 75  YG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
            G     +M+PE     I++ +SDV+SFGVLL EI 
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 85.4 bits (212), Expect = 3e-20
 Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 17/101 (16%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + + +  +HQ+    I+H DLK +N L+      K+ DFG+A     +         VGT
Sbjct: 136 MLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 75  YGYMSPEYAIQGI------------FSIKSDVFSFGVLLLE 103
             YM PE AI+ +             S KSDV+S G +L  
Sbjct: 192 VNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 85.6 bits (212), Expect = 4e-20
 Identities = 44/205 (21%), Positives = 77/205 (37%), Gaps = 37/205 (18%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           +I     + + ++H   +  IIHRDLKV N+LL      K+ DFG A         + ++
Sbjct: 140 KIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198

Query: 70  RI----------VGTYGYMSPE----YAIQGIFSIKSDVFSFGVLLLEIAW--------- 106
           +             T  Y +PE    Y+   I   K D+++ G +L  + +         
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGA 257

Query: 107 DLWTSNRTLELIDDPVLEDEYSSK-QMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEA 165
            L   N    +           +    L+R        +Q + ++R ++ +VV  L   A
Sbjct: 258 KLRIVNGKYSIPPHDT----QYTVFHSLIRA------MLQVNPEERLSIAEVVHQLQEIA 307

Query: 166 ATL-LPPKQPAFSYVRNTVTSTSST 189
           A   + PK P    +       S+T
Sbjct: 308 AARNVNPKSPITELLEQNGGYGSAT 332

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 84.6 bits (210), Expect = 5e-20
 Identities = 33/183 (18%), Positives = 65/183 (35%), Gaps = 54/183 (29%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--------KISDFGMARICG 60
           + + + +A  + +L       +IH ++   NILL ++ +         K+SD G++    
Sbjct: 116 LEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-- 170

Query: 61  GNELQANTSRIVGTYGY------MSPEYAIQ--GIFSIKSDVFSFGVLLLEIA------W 106
                     ++           + PE  I+     ++ +D +SFG  L EI        
Sbjct: 171 ----------VLPKDILQERIPWVPPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219

Query: 107 DLWTSNRTLELIDD------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM 160
               S R L+  +D      P   +            N+   C+    D RP+   ++  
Sbjct: 220 SALDSQRKLQFYEDRHQLPAPKAAELA----------NLINNCMDYEPDHRPSFRAIIRD 269

Query: 161 LTN 163
           L +
Sbjct: 270 LNS 272

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.0 bits (211), Expect = 5e-20
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 35/173 (20%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           ++ +  IA G+ YL   S    +HRDL   N +L  DM   ++DFG+++     ++ +  
Sbjct: 150 LKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGD 201

Query: 69  SRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLE 116
               G        +++ E     +++ KSDV++FGV + EIA         +  ++   +
Sbjct: 202 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNHEMYD 260

Query: 117 LIDD------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +        P    E    ++   Y  I   C +    DRPT + +   L  
Sbjct: 261 YLLHGHRLKQP----EDCLDEL---Y-EIMYSCWRTDPLDRPTFSVLRLQLEK 305

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 85.0 bits (211), Expect = 5e-20
 Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 33/164 (20%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA G+ YL   +  + +HRDL   N ++ +D   KI DFGM R     ++        G 
Sbjct: 147 IADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGG 198

Query: 75  YGY-----MSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELIDD--- 120
            G      MSPE    G+F+  SDV+SFGV+L EIA      +   ++ + L  + +   
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258

Query: 121 ---PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
              P    +     +   +  +  +C Q +   RP+  +++  +
Sbjct: 259 LDKP----DNCPDML---F-ELMRMCWQYNPKMRPSFLEIISSI 294

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 86.1 bits (213), Expect = 6e-20
 Identities = 34/167 (20%), Positives = 64/167 (38%), Gaps = 24/167 (14%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +     ++  L YL      R +HRD+   N+L+  +   K+ DFG++R    +     +
Sbjct: 494 ILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550

Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELIDD-- 120
              +    +M+PE      F+  SDV+ FGV + EI       +    +N  +  I++  
Sbjct: 551 KGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 609

Query: 121 ----PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
               P          +   Y ++   C       RP   ++   L+ 
Sbjct: 610 RLPMP----PNCPPTL---Y-SLMTKCWAYDPSRRPRFTELKAQLST 648

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 85.4 bits (211), Expect = 6e-20
 Identities = 24/175 (13%), Positives = 55/175 (31%), Gaps = 38/175 (21%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L    R+++   + + L  LH Y    ++H  L+  +I+LD+     ++ F      G  
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-- 257

Query: 63  ELQANTSRIVGTYGYMSPEYAI-----------QGIFSIKSDVFSFGVLLLEIAWDLWT- 110
                      + G+  PE              + + +   D ++ G+++    + +W  
Sbjct: 258 ----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI----YWIWCA 309

Query: 111 ----SNRTLELIDDPVLEDEY---SSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
               +        + +           + LL       L      +DR      +
Sbjct: 310 DLPITKDAALGGSEWIFRSCKNIPQPVRALLE----GFLRYP--KEDRLLPLQAM 358

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 85.1 bits (211), Expect = 7e-20
 Identities = 41/172 (23%), Positives = 71/172 (41%), Gaps = 33/172 (19%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           + I   +A G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R      + +  
Sbjct: 177 LCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYSAD 228

Query: 69  SRIVGTYGY-----MSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLEL 117
                         M PE      ++ +SDV+++GV+L EI       +        +  
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 288

Query: 118 IDD------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
           + D      P    E    ++   Y N+  LC  +   DRP+   +  +L  
Sbjct: 289 VRDGNILACP----ENCPLEL---Y-NLMRLCWSKLPADRPSFCSIHRILQR 332

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 84.7 bits (210), Expect = 7e-20
 Identities = 36/175 (20%), Positives = 64/175 (36%), Gaps = 34/175 (19%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
            ++ GI +GL  +H        HRDLK +NILL  +  P + D G       +   +  +
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194

Query: 70  RIV-------GTYGYMSPE----YAIQGIFSIKSDVFSFGVLLLEIAW------DLWTSN 112
             +        T  Y +PE     +   I   ++DV+S G +L  + +       ++   
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253

Query: 113 RTLELI-----DDPVLEDEYSSK-QMLLRYVNIALLCVQESADDRPTMNDVVCML 161
            ++ L        P     +SS    LL         +      RP +  ++  L
Sbjct: 254 DSVALAVQNQLSIP-QSPRHSSALWQLLNS------MMTVDPHQRPHIPLLLSQL 301

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 85.3 bits (211), Expect = 8e-20
 Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 17/101 (16%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + + +  +HQ+    I+H DLK +N L+  D   K+ DFG+A     +         VG 
Sbjct: 164 MLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219

Query: 75  YGYMSPEYAIQGI------------FSIKSDVFSFGVLLLE 103
             YM PE AI+ +             S KSDV+S G +L  
Sbjct: 220 VNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 84.8 bits (210), Expect = 9e-20
 Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 17/101 (16%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           + + +  +HQ+    I+H DLK +N L+      K+ DFG+A     +         VGT
Sbjct: 117 MLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 75  YGYMSPEYAIQGI------------FSIKSDVFSFGVLLLE 103
             YM PE AI+ +             S KSDV+S G +L  
Sbjct: 173 VNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 212

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 82.6 bits (205), Expect = 2e-19
 Identities = 36/95 (37%), Positives = 56/95 (58%), Gaps = 11/95 (11%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
             +  I  G+LYLH +    I+HRDL +SN+LL ++MN KI+DFG+A      +L+    
Sbjct: 116 HFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHE 167

Query: 70  R---IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           +   + GT  Y+SPE A +    ++SDV+S G + 
Sbjct: 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMF 202

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 83.6 bits (206), Expect = 2e-19
 Identities = 10/104 (9%), Positives = 26/104 (25%), Gaps = 10/104 (9%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
              +    +   + +    L       ++H      N+ +  D    + D       G  
Sbjct: 191 EGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-- 245

Query: 63  ELQANTSRIVGTYGYMSPEYAIQG--IFSIKSDVFSFGVLLLEI 104
                         Y   E+       F+   + +  G+ +  +
Sbjct: 246 ---TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 82.4 bits (204), Expect = 3e-19
 Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 24/154 (15%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I+  I +GL YLH     + IHRD+K +N+LL +    K++DFG+A      +++ NT  
Sbjct: 124 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-- 178

Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELI---DDP 121
            VGT  +M+PE   Q  +  K+D++S G+  +E+A       +L    + L LI   + P
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNPP 237

Query: 122 VLEDEYSS--KQMLLRYVNIALLCVQESADDRPT 153
            LE  YS   K+ +         C+ +    RPT
Sbjct: 238 TLEGNYSKPLKEFV-------EACLNKEPSFRPT 264

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 82.3 bits (204), Expect = 4e-19
 Identities = 35/112 (31%), Positives = 60/112 (53%), Gaps = 18/112 (16%)

Query: 2   LLDWVTRVRIIEGIAQ--------GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           +++  T   + E  A+        G+ YLH     +IIHRD+K SN+L+ +D + KI+DF
Sbjct: 125 VMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 54  GMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSI----KSDVFSFGVLL 101
           G++    G++   + +  VGT  +M+PE ++     I      DV++ GV L
Sbjct: 182 GVSNEFKGSDALLSNT--VGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTL 230

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 82.4 bits (204), Expect = 6e-19
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 11/95 (11%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
             +  I  G  YLH+    R+IHRDLK+ N+ L++D+  KI DFG+A      +++ +  
Sbjct: 145 YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGE 196

Query: 70  R---IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           R   + GT  Y++PE   +   S + DV+S G ++
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 82.4 bits (204), Expect = 6e-19
 Identities = 46/168 (27%), Positives = 68/168 (40%), Gaps = 26/168 (15%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL        IHRD+   N LL         KI DFGMAR     ++ 
Sbjct: 184 LHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIY 235

Query: 66  ANTSRIVGTYGY-----MSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRT 114
                  G         M PE  ++GIF+ K+D +SFGVLL EI       +   ++   
Sbjct: 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295

Query: 115 LELIDD-PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           LE +     ++   +    +  Y  I   C Q   +DRP    ++  +
Sbjct: 296 LEFVTSGGRMDPPKNCPGPV--Y-RIMTQCWQHQPEDRPNFAIILERI 340

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 81.5 bits (202), Expect = 6e-19
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 11/95 (11%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
             +  I  G  YLH+    R+IHRDLK+ N+ L++D+  KI DFG+A      +++ +  
Sbjct: 119 YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGE 170

Query: 70  R---IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           R   + GT  Y++PE   +   S + DV+S G ++
Sbjct: 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 82.3 bits (203), Expect = 7e-19
 Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 26/161 (16%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 73
           +A+G+ +L   +  + IHRDL   NILL +    KI DFG+AR I    +        + 
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL- 257

Query: 74  TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTLELIDD------ 120
              +M+PE     +++I+SDV+SFGVLL EI          +         + +      
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 317

Query: 121 PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           P    +Y++ +M   Y    L C       RPT +++V  L
Sbjct: 318 P----DYTTPEM---Y-QTMLDCWHGEPSQRPTFSELVEHL 350

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 81.6 bits (202), Expect = 9e-19
 Identities = 50/180 (27%), Positives = 69/180 (38%), Gaps = 50/180 (27%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGMARICGGNELQ 65
           + +   IA G  YL        IHRD+   N LL         KI DFGMAR     ++ 
Sbjct: 143 LHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIY 194

Query: 66  ANTSRIVGTYGY-----MSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD 120
             +    G         M PE  ++GIF+ K+D +SFGVLL EI         +L  +  
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------SLGYM-- 244

Query: 121 PVLEDEYS--SKQMLLRYV-----------------NIALLCVQESADDRPTMNDVVCML 161
           P     Y   S Q +L +V                  I   C Q   +DRP    ++  +
Sbjct: 245 P-----YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 82.1 bits (203), Expect = 1e-18
 Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 12/104 (11%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-----DKDMNPKISDFGMARIC-GGNE 63
            +++    GL +LH      I+HRDLK  NIL+        +   ISDFG+ +    G  
Sbjct: 122 TLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178

Query: 64  LQANTSRIVGTYGYMSPEY---AIQGIFSIKSDVFSFGVLLLEI 104
             +  S + GT G+++PE      +   +   D+FS G +   +
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 79.7 bits (197), Expect = 3e-18
 Identities = 30/166 (18%), Positives = 60/166 (36%), Gaps = 43/166 (25%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-------------------KISDFGM 55
           + +GL Y+H    + ++H D+K SNI + +   P                   KI D G 
Sbjct: 124 VGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 56  ARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS--IKSDVFSFGVLLLEIA--WDLWTS 111
                      +     G   +++ E  +Q  ++   K+D+F+  + ++  A    L  +
Sbjct: 181 VTRIS------SPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233

Query: 112 NRTLELI---DDPVLEDEYSSK-QMLLRYVNIALLCVQESADDRPT 153
                 I     P +    S +   LL+      + +    + RP+
Sbjct: 234 GDQWHEIRQGRLPRIPQVLSQEFTELLK------VMIHPDPERRPS 273

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 79.4 bits (196), Expect = 6e-18
 Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 9/96 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSR--- 70
             +GL YLH     RI+H D+K  N+LL  D +   + DFG A     + L  +      
Sbjct: 159 ALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215

Query: 71  IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
           I GT  +M+PE  + G     K D++S   ++L + 
Sbjct: 216 IPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLHML 250

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 79.8 bits (197), Expect = 8e-18
 Identities = 37/90 (41%), Positives = 48/90 (53%), Gaps = 7/90 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I  GL +LHQ     II+RDLK  N+LLD D N +ISD G+A      + +       GT
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGT 352

Query: 75  YGYMSPEYAIQGIFSIKS-DVFSFGVLLLE 103
            G+M+PE  + G     S D F+ GV L E
Sbjct: 353 PGFMAPE-LLLGEEYDFSVDYFALGVTLYE 381

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 79.0 bits (195), Expect = 9e-18
 Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 18/104 (17%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGMARICGGNELQ 65
            ++  +  G+ +L +     I+HR++K  NI+     D     K++DFG AR    +E  
Sbjct: 116 IVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ- 171

Query: 66  ANTSRIVGTYGYMSPE--------YAIQGIFSIKSDVFSFGVLL 101
             +  + GT  Y+ P+           Q  +    D++S GV  
Sbjct: 172 FVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 78.4 bits (194), Expect = 1e-17
 Identities = 35/89 (39%), Positives = 51/89 (57%), Gaps = 3/89 (3%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
             Y+SPE   +      SD+++ G ++ +
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQ 224

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.9 bits (197), Expect = 1e-17
 Identities = 35/90 (38%), Positives = 55/90 (61%), Gaps = 8/90 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I  GL ++H      +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT
Sbjct: 301 IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGT 353

Query: 75  YGYMSPEYAIQGIFSIKS-DVFSFGVLLLE 103
           +GYM+PE   +G+    S D FS G +L +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFK 383

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 78.1 bits (193), Expect = 1e-17
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 26/169 (15%)

Query: 2   LLDWVTRVRIIEG-IA-------QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D VT   + EG IA       Q L +LH     ++IHRD+K  NILL  D + K++DF
Sbjct: 104 LTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 160

Query: 54  GMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WD 107
           G        + + +T  +VGT  +M+PE   +  +  K D++S G++ +E+        +
Sbjct: 161 GFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218

Query: 108 LWTSNRTLELIDD---PVLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
                R L LI     P L++      +   ++N    C++   + R +
Sbjct: 219 E-NPLRALYLIATNGTPELQNPEKLSAIFRDFLN---RCLEMDVEKRGS 263

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 79.1 bits (195), Expect = 1e-17
 Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 18/104 (17%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGMARICGGNELQ 65
            ++  +  G+ +L +     I+HR++K  NI+     D     K++DFG AR    +E  
Sbjct: 116 IVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ- 171

Query: 66  ANTSRIVGTYGYMSPE--------YAIQGIFSIKSDVFSFGVLL 101
             +  + GT  Y+ P+           Q  +    D++S GV  
Sbjct: 172 FVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 78.2 bits (193), Expect = 2e-17
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 18/152 (11%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I++   +GL YLH     R IHRD+K  NILL+ + + K++DFG+A        + NT  
Sbjct: 130 ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-- 184

Query: 71  IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELI---DDP 121
           ++GT  +M+PE   +  ++  +D++S G+  +E+A       D+    R + +I     P
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI-HPMRAIFMIPTNPPP 243

Query: 122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
                         +V     C+ +S + R T
Sbjct: 244 TFRKPELWSDNFTDFVK---QCLVKSPEQRAT 272

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 79.3 bits (195), Expect = 2e-17
 Identities = 35/90 (38%), Positives = 47/90 (52%), Gaps = 9/90 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQANTSRI 71
           I+  L YLH+    RIIHRDLK  NI+L    + +  KI D G A+     EL       
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEF-- 183

Query: 72  VGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           VGT  Y++PE   Q  +++  D +SFG L 
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 77.7 bits (192), Expect = 2e-17
 Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 29/155 (18%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGGNELQANTSRIVG 73
           I +GL YLH     +I+HRD+K  N+L++      KISDFG ++   G      T    G
Sbjct: 131 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTG 185

Query: 74  TYGYMSPEYAIQGI---FSIKSDVFSFGVLLLEIA------WDLWTSNRTLELI----DD 120
           T  YM+PE  I      +   +D++S G  ++E+A      ++L      +  +      
Sbjct: 186 TLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH 244

Query: 121 PVLEDEYSS--KQMLLRYVNIALLCVQESADDRPT 153
           P + +  S+  K  +L+       C +   D R  
Sbjct: 245 PEIPESMSAEAKAFILK-------CFEPDPDKRAC 272

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 77.3 bits (191), Expect = 2e-17
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 12/98 (12%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
           +I+  + + +  LH+     I+HRDLK  NILLD DMN K++DFG +      E      
Sbjct: 128 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LR 181

Query: 70  RIVGTYGYMSPE------YAIQGIFSIKSDVFSFGVLL 101
            + GT  Y++PE            +  + D++S GV++
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 77.3 bits (191), Expect = 2e-17
 Identities = 31/94 (32%), Positives = 43/94 (45%), Gaps = 7/94 (7%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
             I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +     +       
Sbjct: 113 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D- 166

Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
            + GT  Y+ PE     +   K D++S GVL  E
Sbjct: 167 -LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 199

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 78.2 bits (193), Expect = 3e-17
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 10/95 (10%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
           RII  +  G+ Y+H+     I+HRDLK  N+LL    KD N +I DFG++     ++   
Sbjct: 130 RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM- 185

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                +GT  Y++PE  + G +  K DV+S GV+L
Sbjct: 186 --KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 77.4 bits (191), Expect = 3e-17
 Identities = 43/169 (25%), Positives = 82/169 (48%), Gaps = 26/169 (15%)

Query: 2   LLDWVTRVRIIEG-IA-------QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           L D V++VR+ E  IA       Q L YLH      +IHRD+K  +ILL  D   K+SDF
Sbjct: 129 LTDIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDF 185

Query: 54  GMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WD 107
           G       +  +  +  +VGT  +M+PE   + +++ + D++S G++++E+       + 
Sbjct: 186 GFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243

Query: 108 LWTSNRTLELIDD---PVLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
             +  + ++ + D   P L++ +    +L  ++      +     +R T
Sbjct: 244 D-SPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE---RMLVRDPQERAT 288

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 77.8 bits (192), Expect = 4e-17
 Identities = 32/95 (33%), Positives = 55/95 (57%), Gaps = 10/95 (10%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
            I++ I  G+ YLH+++   I+HRD+K  NILL   +  +N KI DFG++     +    
Sbjct: 150 NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                +GT  Y++PE  ++  ++ K DV+S GV++
Sbjct: 206 --RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 77.5 bits (191), Expect = 4e-17
 Identities = 30/114 (26%), Positives = 51/114 (44%), Gaps = 25/114 (21%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-------------KDMNPKISDFGMA 56
            ++  IA G+ +LH    ++IIHRDLK  NIL+              +++   ISDFG+ 
Sbjct: 119 SLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175

Query: 57  RICGGNE--LQANTSRIVGTYGYMSPE-------YAIQGIFSIKSDVFSFGVLL 101
           +     +   + N +   GT G+ +PE          +   +   D+FS G + 
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 77.8 bits (192), Expect = 5e-17
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 10/95 (10%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
            II+ +  G+ YLH+++   I+HRDLK  N+LL   +KD   KI DFG++ +    +   
Sbjct: 140 VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--- 193

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                +GT  Y++PE  ++  +  K DV+S GV+L
Sbjct: 194 KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 77.9 bits (192), Expect = 5e-17
 Identities = 34/89 (38%), Positives = 46/89 (51%), Gaps = 6/89 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I  GL  LH+    RI++RDLK  NILLD   + +ISD G+A      +        VGT
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
            GYM+PE      ++   D ++ G LL E
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYE 377

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 77.1 bits (190), Expect = 5e-17
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 12/98 (12%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
            I+  + + + +LH      I+HRDLK  NILLD +M  ++SDFG +      E      
Sbjct: 204 SIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LR 257

Query: 70  RIVGTYGYMSPE------YAIQGIFSIKSDVFSFGVLL 101
            + GT GY++PE            +  + D+++ GV+L
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 76.6 bits (189), Expect = 5e-17
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 24/160 (15%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I   I +GL +LHQ+   ++IHRD+K  N+LL ++   K+ DFG++        + NT  
Sbjct: 134 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-- 188

Query: 71  IVGTYGYMSPE-----YAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELI- 118
            +GT  +M+PE           +  KSD++S G+  +E+A       D+    R L LI 
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIP 247

Query: 119 --DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND 156
               P L+ +  SK+      +    C+ ++   RP    
Sbjct: 248 RNPAPRLKSKKWSKKF----QSFIESCLVKNHSQRPATEQ 283

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 76.0 bits (187), Expect = 1e-16
 Identities = 29/98 (29%), Positives = 42/98 (42%), Gaps = 9/98 (9%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL--DKDMNPKISDFGMARICGGNELQAN 67
            I+  I   L YLH      I HRD+K  N L   +K    K+ DFG+++          
Sbjct: 172 NIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228

Query: 68  T--SRIVGTYGYMSPE--YAIQGIFSIKSDVFSFGVLL 101
              +   GT  +++PE        +  K D +S GVLL
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 76.6 bits (189), Expect = 1e-16
 Identities = 37/95 (38%), Positives = 56/95 (58%), Gaps = 10/95 (10%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
           RII+ +  G+ Y+H++    I+HRDLK  NILL   +KD + KI DFG++     N    
Sbjct: 125 RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM- 180

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                +GT  Y++PE  ++G +  K DV+S GV+L
Sbjct: 181 --KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 74.2 bits (183), Expect = 3e-16
 Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 10/95 (10%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
            +++ +   L Y H      ++H+DLK  NIL          KI DFG+A +   +E   
Sbjct: 128 ELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           N     GT  YM+PE   +   + K D++S GV++
Sbjct: 185 N---AAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 74.2 bits (183), Expect = 3e-16
 Identities = 37/95 (38%), Positives = 57/95 (60%), Gaps = 10/95 (10%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
           RII+ +  G+ Y+H+++   I+HRDLK  NILL   +KD + KI DFG++     N    
Sbjct: 125 RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                +GT  Y++PE  ++G +  K DV+S GV+L
Sbjct: 180 -MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 74.2 bits (183), Expect = 3e-16
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 10/95 (10%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
           RI++ +   + Y H+     + HRDLK  N L      D   K+ DFG+A      ++  
Sbjct: 110 RIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM- 165

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                VGT  Y+SP+  ++G++  + D +S GV++
Sbjct: 166 --RTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 74.3 bits (183), Expect = 3e-16
 Identities = 54/155 (34%), Positives = 81/155 (52%), Gaps = 23/155 (14%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICGGNELQANTSR--IVG 73
           +GL YLH   +   IHRD+K  NILL +D + +I+DFG+ A +  G ++  N  R   VG
Sbjct: 132 EGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 74  TYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA------WDLWTSNRTLELI---DDPVL 123
           T  +M+PE   Q   +  K+D++SFG+  +E+A             + L L    D P L
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY-PPMKVLMLTLQNDPPSL 247

Query: 124 EDEYSSKQMLLRYVN-----IALLCVQESADDRPT 153
           E     K+ML +Y       I+ LC+Q+  + RPT
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMIS-LCLQKDPEKRPT 281

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 74.7 bits (184), Expect = 4e-16
 Identities = 32/97 (32%), Positives = 45/97 (46%), Gaps = 19/97 (19%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +   L YL      RIIHRD+K  NILLD+  +  I+DF +A +          + + GT
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177

Query: 75  YGYMSPEYAIQGIFSIKS--------DVFSFGVLLLE 103
             YM+PE     +FS +         D +S GV   E
Sbjct: 178 KPYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYE 209

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 74.3 bits (183), Expect = 4e-16
 Identities = 37/90 (41%), Positives = 48/90 (53%), Gaps = 11/90 (12%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARIC-GGNELQANTSRIVG 73
           I   + Y HQ    RI+HRDLK  N+LLD DMN KI+DFG +     G +L  +     G
Sbjct: 123 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAF--CG 175

Query: 74  TYGYMSPEYAIQGIFSI--KSDVFSFGVLL 101
              Y +PE   QG      + DV+S GV+L
Sbjct: 176 APPYAAPE-LFQGKKYDGPEVDVWSLGVIL 204

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 73.0 bits (180), Expect = 7e-16
 Identities = 29/94 (30%), Positives = 42/94 (44%), Gaps = 7/94 (7%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
             +E +A  L Y H+    ++IHRD+K  N+L+      KI+DFG +           T 
Sbjct: 118 TFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTM 172

Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
              GT  Y+ PE         K D++  GVL  E
Sbjct: 173 --CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYE 204

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 73.0 bits (179), Expect = 2e-15
 Identities = 25/102 (24%), Positives = 45/102 (44%), Gaps = 10/102 (9%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT-- 68
           I++G+ + L Y+H       +HR +K S+IL+  D    +S          +  +     
Sbjct: 133 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189

Query: 69  ---SRIVGTYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEIA 105
                 V    ++SPE   Q +  +  KSD++S G+   E+A
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 72.2 bits (178), Expect = 2e-15
 Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 10/95 (10%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
            +I+ +   + YLH+     I+HRDLK  N+L    +++    I+DFG++++     +  
Sbjct: 110 LVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST 166

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                 GT GY++PE   Q  +S   D +S GV+ 
Sbjct: 167 ----ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 72.4 bits (178), Expect = 2e-15
 Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 10/95 (10%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
            I+  I   + +LH      I HRD+K  N+L    +KD   K++DFG A+    N LQ 
Sbjct: 132 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ- 187

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                  T  Y++PE      +    D++S GV++
Sbjct: 188 ---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 72.4 bits (178), Expect = 2e-15
 Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 26/155 (16%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +  G  QGL YLH +    +IHRD+K  NILL +    K+ DFG A         AN+  
Sbjct: 159 VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS-- 209

Query: 71  IVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELI--- 118
            VGT  +M+PE      +G +  K DV+S G+  +E+A      +++  +   L  I   
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQN 268

Query: 119 DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
           + P L+  + S+     +V+    C+Q+   DRPT
Sbjct: 269 ESPALQSGHWSEY-FRNFVD---SCLQKIPQDRPT 299

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 72.0 bits (177), Expect = 4e-15
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-DKDMNP-KISDFGMARICGGNELQA 66
           +  ++ I +G+ ++HQ     I+H DLK  NIL  ++D    KI DFG+AR     E   
Sbjct: 190 ILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                 GT  +++PE       S  +D++S GV+ 
Sbjct: 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 71.2 bits (175), Expect = 4e-15
 Identities = 28/100 (28%), Positives = 54/100 (54%), Gaps = 10/100 (10%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           +   + + L +LH     RIIHRDLK  N+L+  + + +++DFG++        + ++  
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-- 176

Query: 71  IVGTYGYMSPE-----YAIQGIFSIKSDVFSFGVLLLEIA 105
            +GT  +M+PE           +  K+D++S G+ L+E+A
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 71.6 bits (176), Expect = 4e-15
 Identities = 30/95 (31%), Positives = 44/95 (46%), Gaps = 8/95 (8%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
             +  I + L Y H      IIHRD+K   +LL   +     K+  FG+A   G + L A
Sbjct: 134 HYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                VGT  +M+PE   +  +    DV+  GV+L
Sbjct: 191 GG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 71.3 bits (175), Expect = 5e-15
 Identities = 27/94 (28%), Positives = 40/94 (42%), Gaps = 19/94 (20%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 73
           +   + YL       IIHRD+K  NI++ +D   K+ DFG  A +  G      T    G
Sbjct: 139 LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTF--CG 191

Query: 74  TYGYMSPEYAIQGIFSIKS------DVFSFGVLL 101
           T  Y +PE     +           +++S GV L
Sbjct: 192 TIEYCAPE-----VLMGNPYRGPELEMWSLGVTL 220

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 71.1 bits (175), Expect = 5e-15
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 9/96 (9%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQ 65
           +R+I+ I +G+ YLHQ     I+H DLK  NILL       + KI DFGM+R  G     
Sbjct: 134 IRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-- 188

Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                I+GT  Y++PE       +  +D+++ G++ 
Sbjct: 189 -ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 70.8 bits (174), Expect = 6e-15
 Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 12/98 (12%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
                +   + YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L  
Sbjct: 118 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 172

Query: 67  NTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLL 101
               + GT  Y++PE         ++   D +S GV+L
Sbjct: 173 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 71.3 bits (175), Expect = 7e-15
 Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 12/98 (12%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
                +   + YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L  
Sbjct: 243 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 297

Query: 67  NTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLL 101
               + GT  Y++PE         ++   D +S GV+L
Sbjct: 298 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 70.4 bits (173), Expect = 8e-15
 Identities = 24/90 (26%), Positives = 40/90 (44%), Gaps = 11/90 (12%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGGNELQANTSRIVG 73
           + + + + H      ++HRD+K  NIL+D +    K+ DFG   +              G
Sbjct: 158 VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DF--DG 210

Query: 74  TYGYMSPEYAIQGI--FSIKSDVFSFGVLL 101
           T  Y  PE+ I+        + V+S G+LL
Sbjct: 211 TRVYSPPEW-IRYHRYHGRSAAVWSLGILL 239

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 70.4 bits (173), Expect = 1e-14
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 9/95 (9%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
             I+ I + + Y H      I+HR+LK  N+LL    K    K++DFG+A     +E   
Sbjct: 132 HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 186

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                 GT GY+SPE   +  +S   D+++ GV+L
Sbjct: 187 -WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 69.9 bits (172), Expect = 1e-14
 Identities = 25/65 (38%), Positives = 40/65 (61%), Gaps = 5/65 (7%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLW 168

Query: 77  YMSPE 81
           Y +PE
Sbjct: 169 YRAPE 173

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 70.5 bits (173), Expect = 1e-14
 Identities = 24/95 (25%), Positives = 45/95 (47%), Gaps = 8/95 (8%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-DKDMNP-KISDFGMARICGGNELQA 66
           +  +    +GL ++H++    I+H D+K  NI+   K  +  KI DFG+A     +E+  
Sbjct: 152 INYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                  T  + +PE   +      +D+++ GVL 
Sbjct: 209 V---TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 69.6 bits (171), Expect = 1e-14
 Identities = 34/115 (29%), Positives = 49/115 (42%), Gaps = 23/115 (20%)

Query: 2   LLDWVTRVRIIEGIAQ--------GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDF 53
           +LD V   R     A         GL YLH      I+H+D+K  N+LL      KIS  
Sbjct: 97  MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISAL 153

Query: 54  GMARI----CGGNELQANTSRIVGTYGYMSPEYAIQGIFS---IKSDVFSFGVLL 101
           G+A         +  +  TS+  G+  +  PE    G+ +    K D++S GV L
Sbjct: 154 GVAEALHPFAADDTCR--TSQ--GSPAFQPPE-IANGLDTFSGFKVDIWSAGVTL 203

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 69.6 bits (171), Expect = 2e-14
 Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 8/95 (8%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
            I+  +   + ++H    V ++HRDLK  N+L    + ++  KI DFG AR+   +    
Sbjct: 110 YIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
            T     T  Y +PE   Q  +    D++S GV+L
Sbjct: 167 KT--PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 69.6 bits (171), Expect = 2e-14
 Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 11/90 (12%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVG 73
           +   + + H      ++HRD+K  NIL+D      K+ DFG   +              G
Sbjct: 148 VVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT--DF--DG 200

Query: 74  TYGYMSPEYAIQGI--FSIKSDVFSFGVLL 101
           T  Y  PE+ I      ++ + V+S G+LL
Sbjct: 201 TRVYSPPEW-ISRHQYHALPATVWSLGILL 229

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 69.7 bits (171), Expect = 2e-14
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 9/95 (9%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
             ++ I + + YLH+     I+HRDLK  N+L      D   KI+DFG+++I     L  
Sbjct: 152 DAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-- 206

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
               + GT GY +PE      +  + D++S G++ 
Sbjct: 207 -MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 69.1 bits (170), Expect = 2e-14
 Identities = 20/65 (30%), Positives = 39/65 (60%), Gaps = 5/65 (7%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL + H      ++HRDLK  N+L++++   K+++FG+AR   G  ++  ++ +V T  
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLW 166

Query: 77  YMSPE 81
           Y  P+
Sbjct: 167 YRPPD 171

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 69.1 bits (170), Expect = 2e-14
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 9/95 (9%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
             I+ I + + Y H      I+HR+LK  N+LL    K    K++DFG+A     +E   
Sbjct: 109 HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 163

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                 GT GY+SPE   +  +S   D+++ GV+L
Sbjct: 164 -WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 69.5 bits (171), Expect = 2e-14
 Identities = 25/65 (38%), Positives = 42/65 (64%), Gaps = 5/65 (7%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +G+ + HQ+   RI+HRDLK  N+L++ D   K++DFG+AR   G  +++ T  +V T  
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLW 184

Query: 77  YMSPE 81
           Y +P+
Sbjct: 185 YRAPD 189

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 69.3 bits (170), Expect = 2e-14
 Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 22/99 (22%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI--CGGNELQANT 68
           ++ G+     YLH      I HRD+K  N+LLD+  N KISDFG+A +      E   N 
Sbjct: 114 LMAGVV----YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 69  SRIVGTYGYMSPEYAIQGIFSIK------SDVFSFGVLL 101
               GT  Y++PE     +   +       DV+S G++L
Sbjct: 167 M--CGTLPYVAPE-----LLKRREFHAEPVDVWSCGIVL 198

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 68.8 bits (169), Expect = 2e-14
 Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 12/94 (12%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI--CGGNELQANT 68
           ++ G+     YLH      I HRD+K  N+LLD+  N KISDFG+A +      E   N 
Sbjct: 114 LMAGVV----YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 69  SRIVGTYGYMSPE-YAIQGIFSIKSDVFSFGVLL 101
               GT  Y++PE    +   +   DV+S G++L
Sbjct: 167 M--CGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 69.2 bits (170), Expect = 2e-14
 Identities = 28/97 (28%), Positives = 42/97 (43%), Gaps = 10/97 (10%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGMARICGGNEL 64
              ++ I  G+ YLH      I H DLK  NI+L          KI DFG+A        
Sbjct: 117 TEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                 I GT  +++PE        +++D++S GV+ 
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 69.3 bits (170), Expect = 3e-14
 Identities = 28/97 (28%), Positives = 43/97 (44%), Gaps = 10/97 (10%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGMARICGGNEL 64
              I+ I  G+ YLH      I H DLK  NI+L        + K+ DFG+A        
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                 I GT  +++PE        +++D++S GV+ 
Sbjct: 175 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 69.2 bits (170), Expect = 3e-14
 Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 9/96 (9%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-DKDMNP---KISDFGMARICGGNELQ 65
            ++  I + + YLH      ++HRDLK SNIL  D+  NP   +I DFG A+        
Sbjct: 120 AVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176

Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
             T     T  +++PE   +  +    D++S GVLL
Sbjct: 177 LMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 68.8 bits (169), Expect = 4e-14
 Identities = 23/95 (24%), Positives = 42/95 (44%), Gaps = 8/95 (8%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL--DKDMNPKISDFGMARICGGNELQA 66
           V  +  + + L +LH ++   I H D++  NI+    +    KI +FG AR     +   
Sbjct: 105 VSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
               +     Y +PE     + S  +D++S G L+
Sbjct: 162 L---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 68.9 bits (169), Expect = 4e-14
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 8/95 (8%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
             I+ I + +L+ HQ     ++HR+LK  N+LL    K    K++DFG+A    G +   
Sbjct: 114 HCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                 GT GY+SPE   +  +    D+++ GV+L
Sbjct: 171 FG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 68.8 bits (169), Expect = 4e-14
 Identities = 30/65 (46%), Positives = 45/65 (69%), Gaps = 5/65 (7%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL YLHQ+    I+HRDLK +N+LLD++   K++DFG+A+   G+  +A T ++V T  
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRW 177

Query: 77  YMSPE 81
           Y +PE
Sbjct: 178 YRAPE 182

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 68.0 bits (167), Expect = 5e-14
 Identities = 28/96 (29%), Positives = 45/96 (46%), Gaps = 10/96 (10%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGMARICGGNELQ 65
           + ++ I  G+ YLH     RI H DLK  NI+L      +   K+ DFG+A         
Sbjct: 112 QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-- 166

Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                I GT  +++PE        +++D++S GV+ 
Sbjct: 167 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 68.4 bits (168), Expect = 5e-14
 Identities = 25/65 (38%), Positives = 39/65 (60%), Gaps = 5/65 (7%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           QGL + H+    +I+HRDLK  N+L++K    K+ DFG+AR   G  +   +S +V T  
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLW 173

Query: 77  YMSPE 81
           Y +P+
Sbjct: 174 YRAPD 178

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 68.0 bits (167), Expect = 5e-14
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 13/93 (13%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I+  +     Y H++    ++HRDLK  N+LLD  MN KI+DFG++ +    E    TS 
Sbjct: 120 ILSAVD----YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS- 170

Query: 71  IVGTYGYMSPEYAIQGIF--SIKSDVFSFGVLL 101
             G+  Y +PE  I G      + D++S GV+L
Sbjct: 171 -CGSPNYAAPE-VISGRLYAGPEVDIWSCGVIL 201

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 68.1 bits (167), Expect = 5e-14
 Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 10/97 (10%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-DKDMNP---KISDFGMARICGGNEL 64
              I+ I  G+ YLH      I H DLK  NI+L DK++     K+ DFG+A        
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                 I GT  +++PE        +++D++S GV+ 
Sbjct: 175 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 68.0 bits (167), Expect = 7e-14
 Identities = 25/68 (36%), Positives = 41/68 (60%), Gaps = 7/68 (10%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG---GNELQANTSRIVG 73
            GL Y+H+    +I+HRD+K +N+L+ +D   K++DFG+AR       ++    T+R+V 
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV- 190

Query: 74  TYGYMSPE 81
           T  Y  PE
Sbjct: 191 TLWYRPPE 198

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 68.1 bits (167), Expect = 7e-14
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 13/93 (13%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           II  I     Y H++   +I+HRDLK  N+LLD ++N KI+DFG++ I         TS 
Sbjct: 117 IICAIE----YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS- 167

Query: 71  IVGTYGYMSPEYAIQGIF--SIKSDVFSFGVLL 101
             G+  Y +PE  I G      + DV+S G++L
Sbjct: 168 -CGSPNYAAPE-VINGKLYAGPEVDVWSCGIVL 198

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 67.5 bits (166), Expect = 7e-14
 Identities = 25/65 (38%), Positives = 39/65 (60%), Gaps = 5/65 (7%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
            G+ Y H     R++HRDLK  N+L++++   KI+DFG+AR   G  ++  T  IV T  
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLW 165

Query: 77  YMSPE 81
           Y +P+
Sbjct: 166 YRAPD 170

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 68.2 bits (167), Expect = 8e-14
 Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 13/96 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           +   +  +HQ      +HRD+K  NIL+D + + +++DFG   ++     +Q++    VG
Sbjct: 184 MVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVG 238

Query: 74  TYGYMSPEYAIQGIFSIKS------DVFSFGVLLLE 103
           T  Y+SPE  +Q +   K       D +S GV + E
Sbjct: 239 TPDYISPE-ILQAMEGGKGRYGPECDWWSLGVCMYE 273

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 67.9 bits (166), Expect = 1e-13
 Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 8/95 (8%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-DKDMNP-KISDFGMARICGGNELQA 66
           V  +  + +GL ++H+ +    +H DLK  NI+   K  N  K+ DFG+       +   
Sbjct: 258 VEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 311

Query: 67  NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
           +     GT  + +PE A        +D++S GVL 
Sbjct: 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 67.8 bits (166), Expect = 1e-13
 Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 4/89 (4%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH  S   +++RDLK+ N++LDKD + KI+DFG+ +    +     T    GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 312

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
             Y++PE      +    D +  GV++ E
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 67.4 bits (165), Expect = 1e-13
 Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 11/96 (11%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARIC-GGNELQ 65
            I++ I + + YLH  +   I HRD+K  N+L      +   K++DFG A+     N L 
Sbjct: 165 EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221

Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 101
                   T  Y++PE      +    D++S GV++
Sbjct: 222 ----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 67.2 bits (165), Expect = 1e-13
 Identities = 35/90 (38%), Positives = 54/90 (60%), Gaps = 7/90 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +A  L +LH      II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189

Query: 75  YGYMSPEYAIQGIFSIKS-DVFSFGVLLLE 103
             YM+PE  +      +S D +SFGVL+ E
Sbjct: 190 VEYMAPE-VVNRRGHTQSADWWSFGVLMFE 218

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 67.4 bits (165), Expect = 1e-13
 Identities = 26/97 (26%), Positives = 46/97 (47%), Gaps = 13/97 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           I   +  +H+      +HRD+K  NILLD+  + +++DFG   ++     +++     VG
Sbjct: 171 IVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVG 225

Query: 74  TYGYMSPE-------YAIQGIFSIKSDVFSFGVLLLE 103
           T  Y+SPE           G +  + D ++ GV   E
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 66.9 bits (164), Expect = 1e-13
 Identities = 30/105 (28%), Positives = 46/105 (43%), Gaps = 16/105 (15%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA 66
            +++ +A  L +LH      I HRDLK  NIL    ++    KI DF +      N   +
Sbjct: 115 VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 67  NTSR-----IVGTYGYMSPE-----YAIQGIFSIKSDVFSFGVLL 101
             S        G+  YM+PE          I+  + D++S GV+L
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 66.9 bits (164), Expect = 2e-13
 Identities = 21/65 (32%), Positives = 37/65 (56%), Gaps = 5/65 (7%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL Y H+    +++HRDLK  N+L+++    K++DFG+AR       +   + +V T  
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLW 165

Query: 77  YMSPE 81
           Y  P+
Sbjct: 166 YRPPD 170

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 67.1 bits (164), Expect = 2e-13
 Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 13/93 (13%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSR 70
           I+ G+     Y H++    ++HRDLK  N+LLD  MN KI+DFG++ +    E    TS 
Sbjct: 125 ILSGVD----YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS- 175

Query: 71  IVGTYGYMSPEYAIQGIF--SIKSDVFSFGVLL 101
             G+  Y +PE  I G      + D++S GV+L
Sbjct: 176 -CGSPNYAAPE-VISGRLYAGPEVDIWSSGVIL 206

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 66.4 bits (163), Expect = 2e-13
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I+  L +LHQ     II+RDLK  NI+L+   + K++DFG+ +    +    +T    GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
             YM+PE  ++   +   D +S G L+ +
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYD 213

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 67.0 bits (163), Expect = 3e-13
 Identities = 38/92 (41%), Positives = 51/92 (55%), Gaps = 11/92 (11%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           IA GL +L       II+RDLK+ N++LD + + KI+DFGM +  I  G      T    
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFC 503

Query: 73  GTYGYMSPEYAIQGIFSIKS-DVFSFGVLLLE 103
           GT  Y++PE  I      KS D ++FGVLL E
Sbjct: 504 GTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYE 534

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 66.1 bits (162), Expect = 3e-13
 Identities = 20/44 (45%), Positives = 29/44 (65%), Gaps = 3/44 (6%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
           +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI  
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 66.1 bits (162), Expect = 3e-13
 Identities = 27/65 (41%), Positives = 36/65 (55%), Gaps = 6/65 (9%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 76
           +GL +LH      I+HRDLK  NIL+      K++DFG+ARI       A T  +V T  
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVV-TLW 184

Query: 77  YMSPE 81
           Y +PE
Sbjct: 185 YRAPE 189

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 66.4 bits (162), Expect = 3e-13
 Identities = 24/71 (33%), Positives = 35/71 (49%), Gaps = 10/71 (14%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP----KISDFGMARICG--GNELQANTSR 70
            G+ YLH      ++HRDLK +NIL+  +       KI+D G AR+       L      
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 71  IVGTYGYMSPE 81
           +V T+ Y +PE
Sbjct: 196 VV-TFWYRAPE 205

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 65.8 bits (161), Expect = 4e-13
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 12/94 (12%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           I   L +LH+     II+RD+K+ NILLD + +  ++DFG+++  +    E         
Sbjct: 168 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER---AYDFC 221

Query: 73  GTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLE 103
           GT  YM+P+       G      D +S GVL+ E
Sbjct: 222 GTIEYMAPDIVRGGDSG-HDKAVDWWSLGVLMYE 254

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 65.7 bits (161), Expect = 4e-13
 Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 5/89 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I   L YLH      +++RD+K+ N++LDKD + KI+DFG+ +    +     T    GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 168

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
             Y++PE      +    D +  GV++ E
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 65.7 bits (161), Expect = 4e-13
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 9/91 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA--RICGGNELQANTSRIV 72
           I   L++LH      II+RDLK+ N+LLD + + K++DFGM    IC G      T+   
Sbjct: 133 IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFC 185

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           GT  Y++PE   + ++    D ++ GVLL E
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYE 216

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 65.7 bits (161), Expect = 5e-13
 Identities = 35/91 (38%), Positives = 49/91 (53%), Gaps = 9/91 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           IA GL +L       II+RDLK+ N++LD + + KI+DFGM +  I  G      T    
Sbjct: 130 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFC 182

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           GT  Y++PE      +    D ++FGVLL E
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 65.7 bits (161), Expect = 5e-13
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 9/91 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           I+  L YLH+     II+RDLK+ N+LLD + + K++D+GM +  +  G+     TS   
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFC 171

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           GT  Y++PE      +    D ++ GVL+ E
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 65.1 bits (159), Expect = 8e-13
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 9/91 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           I+  L YLH+     II+RDLK+ N+LLD + + K++D+GM +  +  G+     TS   
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFC 214

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           GT  Y++PE      +    D ++ GVL+ E
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 64.9 bits (159), Expect = 8e-13
 Identities = 38/91 (41%), Positives = 53/91 (58%), Gaps = 9/91 (9%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 72
           I  GL +LH      I++RDLK+ NILLDKD + KI+DFGM +  + G       T+   
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFC 179

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           GT  Y++PE  +   ++   D +SFGVLL E
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 65.0 bits (159), Expect = 1e-12
 Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 5/89 (5%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           IA  L YLH  +   I++RDLK  NILLD   +  ++DFG+ +    +    +T    GT
Sbjct: 148 IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGT 202

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
             Y++PE   +  +    D +  G +L E
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYE 231

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 64.6 bits (158), Expect = 1e-12
 Identities = 21/68 (30%), Positives = 35/68 (51%), Gaps = 5/68 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVG 73
           + + +  LH  S   + HRD+K  N+L+++     K+ DFG A+    +E   N + I  
Sbjct: 138 LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAYICS 194

Query: 74  TYGYMSPE 81
            Y Y +PE
Sbjct: 195 RY-YRAPE 201

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 10/94 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 73
           +   L  +H       IHRD+K  N+LLDK  + K++DFG   ++     ++ +T+  VG
Sbjct: 177 VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VG 231

Query: 74  TYGYMSPE----YAIQGIFSIKSDVFSFGVLLLE 103
           T  Y+SPE        G +  + D +S GV L E
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 63.8 bits (156), Expect = 2e-12
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 10/90 (11%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I     YLH      +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGT 201

Query: 75  YGYMSPEYAIQGIFSIKS-DVFSFGVLLLE 103
              ++PE  I      K+ D ++ GVL+ E
Sbjct: 202 PEALAPE-IILSKGYNKAVDWWALGVLIYE 230

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 63.8 bits (156), Expect = 2e-12
 Identities = 25/72 (34%), Positives = 34/72 (47%), Gaps = 10/72 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-----KISDFGMARICGGNELQANTS 69
           +  G+ + H     R +HRDLK  N+LL           KI DFG+AR   G  ++  T 
Sbjct: 141 LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTH 196

Query: 70  RIVGTYGYMSPE 81
            I+ T  Y  PE
Sbjct: 197 EII-TLWYRPPE 207

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 62.9 bits (154), Expect = 4e-12
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 10/90 (11%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +   L YLH      II+RDLK  NILLDK+ + KI+DFG A+      +   T  + GT
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 166

Query: 75  YGYMSPEYAIQGIFSIKS-DVFSFGVLLLE 103
             Y++PE  +      KS D +SFG+L+ E
Sbjct: 167 PDYIAPE-VVSTKPYNKSIDWWSFGILIYE 195

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 62.6 bits (153), Expect = 4e-12
 Identities = 23/67 (34%), Positives = 32/67 (47%), Gaps = 5/67 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
             Q + + H++     IHRD+K  NIL+ K    K+ DFG AR+  G         +  T
Sbjct: 111 TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-T 165

Query: 75  YGYMSPE 81
             Y SPE
Sbjct: 166 RWYRSPE 172

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 62.8 bits (153), Expect = 5e-12
 Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 23/99 (23%)

Query: 11  IIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD--MNPKISDFGMARICGGNELQANT 68
           ++ G++    Y H    ++I HRDLK+ N LLD       KI DFG ++    +     +
Sbjct: 125 LLSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 176

Query: 69  SRIVGTYGYMSPEYAIQGIFSIK------SDVFSFGVLL 101
           +  VGT  Y++PE     +   +      +DV+S GV L
Sbjct: 177 T--VGTPAYIAPE-----VLLRQEYDGKIADVWSCGVTL 208

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 62.2 bits (152), Expect = 7e-12
 Identities = 22/67 (32%), Positives = 32/67 (47%), Gaps = 5/67 (7%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I  G+ + H +    IIHRD+K  NIL+ +    K+ DFG AR       +     +  T
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-T 187

Query: 75  YGYMSPE 81
             Y +PE
Sbjct: 188 RWYRAPE 194

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 62.4 bits (152), Expect = 8e-12
 Identities = 26/68 (38%), Positives = 34/68 (50%), Gaps = 7/68 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVG 73
           + + L Y+H      I HRD+K  N+LLD D    K+ DFG A+     E   N S I  
Sbjct: 165 LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICS 219

Query: 74  TYGYMSPE 81
            Y Y +PE
Sbjct: 220 RY-YRAPE 226

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 61.2 bits (149), Expect = 2e-11
 Identities = 25/68 (36%), Positives = 35/68 (51%), Gaps = 7/68 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-KISDFGMARICGGNELQANTSRIVG 73
           + + L Y+H    + I HRD+K  N+LLD      K+ DFG A+I      + N S I  
Sbjct: 150 LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICS 204

Query: 74  TYGYMSPE 81
            Y Y +PE
Sbjct: 205 RY-YRAPE 211

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 60.8 bits (147), Expect = 3e-11
 Identities = 16/101 (15%), Positives = 30/101 (29%), Gaps = 14/101 (13%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILL-----------DKDMNPKISDFGMARICGGNE 63
           +   +  +H      IIH D+K  N +L           D      + D G +       
Sbjct: 181 MLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 64  LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
                +    T G+   E      ++ + D F     +  +
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCM 278

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 60.5 bits (147), Expect = 3e-11
 Identities = 19/68 (27%), Positives = 36/68 (52%), Gaps = 7/68 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGGNELQANTSRIVG 73
           + + + ++H    + I HRD+K  N+L++ KD   K+ DFG A+       + + + I  
Sbjct: 150 LFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICS 204

Query: 74  TYGYMSPE 81
            + Y +PE
Sbjct: 205 RF-YRAPE 211

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 59.8 bits (145), Expect = 6e-11
 Identities = 21/69 (30%), Positives = 34/69 (49%), Gaps = 3/69 (4%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           +  G+ Y+H      I+HRDLK +N L+++D + K+ DFG+AR     E   +   I   
Sbjct: 165 LLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221

Query: 75  YGYMSPEYA 83
              M+    
Sbjct: 222 EDDMNLVTF 230

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 6/87 (6%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +       V T  Y
Sbjct: 139 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYY 192

Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEM 219

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 57.4 bits (139), Expect = 4e-10
 Identities = 19/69 (27%), Positives = 33/69 (47%), Gaps = 3/69 (4%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G  ++H+     IIHRDLK +N LL++D + K+ DFG+AR     +     + +      
Sbjct: 141 GENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 78  MSPEYAIQG 86
                 ++ 
Sbjct: 198 GPHNKNLKK 206

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 56.9 bits (138), Expect = 5e-10
 Identities = 24/65 (36%), Positives = 36/65 (55%), Gaps = 6/65 (9%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
            +  LH      +IHRDLK SN+L++ + + K+ DFG+ARI   +E  A+ S   G    
Sbjct: 124 AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSG 178

Query: 78  MSPEY 82
           M  E+
Sbjct: 179 MV-EF 182

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 56.9 bits (138), Expect = 6e-10
 Identities = 25/65 (38%), Positives = 36/65 (55%), Gaps = 4/65 (6%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYG 76
           GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T  
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196

Query: 77  YMSPE 81
           Y +PE
Sbjct: 197 YRAPE 201

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 56.8 bits (137), Expect = 7e-10
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 6/87 (6%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +    +  V T  Y
Sbjct: 176 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 229

Query: 78  MSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +PE  +   +    D++S G ++ E+
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEM 256

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 56.2 bits (136), Expect = 1e-09
 Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 3/64 (4%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 77
            + YLH      ++HRD+K SNILL+ + + K++DFG++R         N   +      
Sbjct: 121 VIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 78  MSPE 81
            + +
Sbjct: 178 ENFD 181

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 55.7 bits (135), Expect = 1e-09
 Identities = 24/98 (24%), Positives = 44/98 (44%), Gaps = 24/98 (24%)

Query: 17  QGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTY 75
           + L Y H  S   I+HRD+K  N+++D +    ++ D+G+A     +  Q    R+   Y
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY 195

Query: 76  GYMSPE---------YAIQGIFSIKSDVFSFGVLLLEI 104
            +  PE         Y++        D++S G +L  +
Sbjct: 196 -FKGPELLVDYQMYDYSL--------DMWSLGCMLASM 224

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 55.4 bits (134), Expect = 2e-09
 Identities = 23/67 (34%), Positives = 32/67 (47%), Gaps = 6/67 (8%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
           I  GL  LH+     ++HRDL   NILL  + +  I DF +AR    +    N +  V  
Sbjct: 143 ILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTH 196

Query: 75  YGYMSPE 81
             Y +PE
Sbjct: 197 RWYRAPE 203

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 55.0 bits (133), Expect = 3e-09
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 54.7 bits (132), Expect = 3e-09
 Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 13/101 (12%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP------KISDFGMARICGGNE 63
           +I + +  GL Y+H   R  IIH D+K  N+L++   +P      KI+D G A  C  +E
Sbjct: 135 QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190

Query: 64  LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
              + +  + T  Y SPE  +   +   +D++S   L+ E+
Sbjct: 191 ---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 228

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 54.3 bits (131), Expect = 5e-09
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           + +GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR
Sbjct: 137 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 53.8 bits (130), Expect = 5e-09
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           + +GL Y+H      ++HRDLK  N+ +++D   KI DFG+AR
Sbjct: 135 MLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 52.7 bits (127), Expect = 1e-08
 Identities = 24/66 (36%), Positives = 36/66 (54%), Gaps = 5/66 (7%)

Query: 18  GLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGGNELQANT-SRIVGTY 75
           GL Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARI   +       S  + T 
Sbjct: 132 GLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 76  GYMSPE 81
            Y SP 
Sbjct: 189 WYRSPR 194

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 49.6 bits (119), Expect = 1e-07
 Identities = 17/50 (34%), Positives = 27/50 (54%), Gaps = 6/50 (12%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMA 56
            I++ I + + YLH    + I HRD+K  N+L      +   K++DFG A
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 49.0 bits (117), Expect = 2e-07
 Identities = 10/95 (10%), Positives = 23/95 (24%), Gaps = 32/95 (33%)

Query: 9   VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANT 68
           +R ++ +A      H   R  +       S + +  D +  ++                 
Sbjct: 132 IRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174

Query: 69  SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
                    M          + + D+   G  L  
Sbjct: 175 --------TMPDA-------NPQDDIRGIGASLYA 194

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 48.9 bits (117), Expect = 2e-07
 Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 10/92 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--KISDFGMARICGGNELQANTSRIV 72
           +   LL+L     + IIH DLK  NILL        KI DFG +  C   +      + +
Sbjct: 166 MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQ---RIYQYI 219

Query: 73  GTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLE 103
            +  Y SPE  + G+ + +  D++S G +L+E
Sbjct: 220 QSRFYRSPE-VLLGMPYDLAIDMWSLGCILVE 250

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 47.4 bits (113), Expect = 9e-07
 Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 10/92 (10%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--KISDFGMARICGGNELQANTSRIV 72
           I Q L  LH+    RIIH DLK  NILL +      K+ DFG +  C  ++        +
Sbjct: 209 ILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQ---RVYTYI 260

Query: 73  GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
            +  Y +PE  +   + +  D++S G +L E+
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 46.4 bits (109), Expect = 2e-06
 Identities = 14/56 (25%), Positives = 20/56 (35%), Gaps = 2/56 (3%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           L    T   I+  +   L        +R  HRDL   N+LL K    K+      +
Sbjct: 157 LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 45.7 bits (108), Expect = 4e-06
 Identities = 32/145 (22%), Positives = 52/145 (35%), Gaps = 56/145 (38%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL--------------------------- 42
           +II+ + QGL YLH  ++ RIIH D+K  NILL                           
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207

Query: 43  ----------------------DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 80
                                  + +  KI+D G A       +  + +  + T  Y S 
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW-----VHKHFTEDIQTRQYRSL 262

Query: 81  EYAIQGIFSIKSDVFSFGVLLLEIA 105
           E  I   ++  +D++S   +  E+A
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELA 287

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.4 bits (96), Expect = 1e-04
 Identities = 33/252 (13%), Positives = 66/252 (26%), Gaps = 95/252 (37%)

Query: 6   VTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ 65
           V+R++    + Q LL L     V +I                      G+    G   + 
Sbjct: 131 VSRLQPYLKLRQALLELRPAKNV-LID---------------------GVLG-SGKTWVA 167

Query: 66  ANTSRIVGTYGYMSPEYAIQGIFSIKSDVF--SFG-----VLLLEIAWDL---------- 108
            +              Y +Q     K  +F  +         +LE+   L          
Sbjct: 168 LDVCL----------SYKVQCKMDFK--IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTS 215

Query: 109 -------------WTSNRTLELIDDP-------VLEDEYSSK---------QMLL--RYV 137
                                L+          VL +  ++K         ++LL  R+ 
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFK 275

Query: 138 NIALLCVQESADDRPTMNDVVCMLT-NEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCS 196
            +    +  +     +++     LT +E  +LL        Y+             E  +
Sbjct: 276 QVTDF-LSAATTTHISLDHHSMTLTPDEVKSLLL------KYLDCRPQDLPR----EVLT 324

Query: 197 INQVTISLLEAR 208
            N   +S++   
Sbjct: 325 TNPRRLSIIAES 336

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 40.8 bits (96), Expect = 2e-04
 Identities = 28/109 (25%), Positives = 43/109 (39%), Gaps = 29/109 (26%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-------------------KISDFGM 55
           +   L +LH     ++ H DLK  NIL                          +++DFG 
Sbjct: 132 LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188

Query: 56  ARICGGNELQANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLE 103
           A     +E   + + IV T  Y  PE  I  + ++   DV+S G +L E
Sbjct: 189 A--TFDHE---HHTTIVATRHYRPPE-VILELGWAQPCDVWSIGCILFE 231

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 39.2 bits (92), Expect = 5e-04
 Identities = 30/109 (27%), Positives = 46/109 (42%), Gaps = 29/109 (26%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-------------------KISDFGM 55
           I + + +LH     ++ H DLK  NIL  +                       K+ DFG 
Sbjct: 127 ICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183

Query: 56  ARICGGNELQANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLE 103
           A     +E   + S +V T  Y +PE  I  + +S   DV+S G +L+E
Sbjct: 184 A--TYDDE---HHSTLVSTRHYRAPE-VILALGWSQPCDVWSIGCILIE 226

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	208
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.97
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.97
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.96
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.96
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.96
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.96
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.96
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.96
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.96
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.96
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.96
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.96
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.96
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.96
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.96
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.96
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.96
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.96
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.96
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.96
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.96
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.96
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.96
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.96
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.96
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.96
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.96
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.96
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.96
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.96
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.96
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.96
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.96
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.95
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.95
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.95
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.95
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.95
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.95
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.95
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.95
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.95
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.95
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.95
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.95
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.95
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.95
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.95
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.95
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.95
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.95
3niz_A	311	Rhodanese family protein; structural genomics, str	99.95
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.95
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.95
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.95
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.95
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.95
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.95
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.95
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.95
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.95
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.95
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.95
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.95
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.95
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.95
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.95
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.95
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.95
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.95
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.95
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.95
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.95
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.95
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.95
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.95
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.95
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.95
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.95
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.95
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.95
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.95
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.95
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.95
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.95
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.95
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.95
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.95
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.95
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.95
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.95
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.95
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.95
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.95
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.95
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.95
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.95
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.95
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.95
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.95
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.95
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.95
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.95
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.95
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.95
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.95
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.95
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.95
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.95
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.95
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.95
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.95
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.95
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.95
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.95
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.95
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.95
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.95
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.95
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.95
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.95
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.95
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.95
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.94
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.94
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.94
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.94
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.94
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.94
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.94
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.94
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.94
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.94
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.94
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.94
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.94
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.94
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.94
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.94
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.94
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.94
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.94
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.94
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.94
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.94
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.94
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.94
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.94
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.94
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.94
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.94
3bhy_A	283	Death-associated protein kinase 3; death associate	99.94
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.94
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.94
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.94
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.94
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.94
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.94
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.94
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.94
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.94
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.94
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.94
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.94
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.94
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.94
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.94
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.94
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.94
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.94
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.94
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.94
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.94
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.94
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.94
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.94
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.93
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.93
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.93
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.93
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.93
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.93
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.93
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.93
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.93
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.93
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.93
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.93
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.93
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.93
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.91
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.91
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.91
3uqc_A	286	Probable conserved transmembrane protein; structur	99.89
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.87
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.7
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.4
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.2
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	98.97
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.39
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.14
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	97.08
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.02
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.65
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	96.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	95.59
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.32
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	94.2
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.19
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	92.67
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	91.87
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	91.5
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.34
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	91.33
3ats_A	357	Putative uncharacterized protein; hypothetical pro	90.72
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	90.5
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	90.35
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.05
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	89.03
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	88.95
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	88.02
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	87.8
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	86.48
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.78
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	84.37
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	84.15
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	81.16

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=245.65  Aligned_cols=165  Identities=25%  Similarity=0.361  Sum_probs=127.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++|.+++.|+.||+.||.|||+++   |+||||||.|||++.++.+||+|||++................||+.|+|||
T Consensus       128 ~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE  204 (307)
T 3omv_A          128 KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE  204 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHH
Confidence            4789999999999999999999998   9999999999999999999999999997654433333334457899999999


Q ss_pred             hhcc---CCCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCccc--hhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           82 YAIQ---GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVLE--DEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        82 ~~~~---~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      ++.+   +.|+.++|||||||++|||++|..|+......      +......  ....+.+++..+.+|+.+||+.||++
T Consensus       205 ~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~  284 (307)
T 3omv_A          205 VIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEE  284 (307)
T ss_dssp             HHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTT
T ss_pred             HhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhH
Confidence            9964   35899999999999999999999888543211      1111111  01223456678899999999999999


Q ss_pred             CCCHHHHHHHHhhhhhccC
Q 028458          151 RPTMNDVVCMLTNEAATLL  169 (208)
Q Consensus       151 Rps~~~i~~~l~~~~~~~~  169 (208)
                      |||+.||++.|+.+...++
T Consensus       285 RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          285 RPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             SCCHHHHHHHHHHHHTTCC
T ss_pred             CcCHHHHHHHHHHHhccCC
Confidence            9999999999998875543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.2e-37  Score=247.80  Aligned_cols=161  Identities=27%  Similarity=0.335  Sum_probs=123.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+|.+++.|+.||+.||.|||+++   |+||||||.|||++.++.+||+|||++................|++.|+|||
T Consensus       154 ~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE  230 (329)
T 4aoj_A          154 PLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE  230 (329)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChh
Confidence            4889999999999999999999999   9999999999999999999999999998765444333334457899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--ccc---CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--LID---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..|+.++|||||||++|||++ |..|+.....  .+.   ...  ....+..++.++.+|+.+||+.||++||+++
T Consensus       231 ~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~--~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~  308 (329)
T 4aoj_A          231 SILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR--ELERPRACPPEVYAIMRGCWQREPQQRHSIK  308 (329)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHH
T ss_pred             hhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--CCCCcccccHHHHHHHHHHcCcChhHCcCHH
Confidence            9999999999999999999999998 7777643211  111   000  0123445667899999999999999999999


Q ss_pred             HHHHHHhhhhhc
Q 028458          156 DVVCMLTNEAAT  167 (208)
Q Consensus       156 ~i~~~l~~~~~~  167 (208)
                      ||++.|+.+...
T Consensus       309 ei~~~L~~l~~~  320 (329)
T 4aoj_A          309 DVHARLQALAQA  320 (329)
T ss_dssp             HHHHHHHHHHHS
T ss_pred             HHHHHHHHHhhC
Confidence            999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-37  Score=247.10  Aligned_cols=161  Identities=25%  Similarity=0.335  Sum_probs=131.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+|.+++.|+.||+.||.|||+++   |+||||||.||+++.++.+||+|||++................|++.|+|||
T Consensus       124 ~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE  200 (299)
T 4asz_A          124 ELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE  200 (299)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHH
Confidence            4899999999999999999999999   9999999999999999999999999998664443333333346789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--cc---cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--LI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..|+.++|||||||++|||++ |..|+.....  ..   .....  ...+..++.++.+|+.+||+.||++||+++
T Consensus       201 ~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~  278 (299)
T 4asz_A          201 SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV--LQRPRTCPQEVYELMLGCWQREPHMRKNIK  278 (299)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCcCHH
Confidence            9999999999999999999999998 7777653221  11   10110  122445667899999999999999999999


Q ss_pred             HHHHHHhhhhhc
Q 028458          156 DVVCMLTNEAAT  167 (208)
Q Consensus       156 ~i~~~l~~~~~~  167 (208)
                      +|++.|+.+...
T Consensus       279 ~i~~~L~~~~~~  290 (299)
T 4asz_A          279 GIHTLLQNLAKA  290 (299)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhc
Confidence            999999988754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.9e-36  Score=240.75  Aligned_cols=166  Identities=19%  Similarity=0.160  Sum_probs=130.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC-CeEEeccccceecCCCcccc---cccccccCCCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGMARICGGNELQA---NTSRIVGTYGY   77 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~~   77 (208)
                      .|++..+..|+.||+.||.|||+++   |+||||||.|||++.++ .+||+|||++..........   ......||+.|
T Consensus       146 ~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y  222 (336)
T 4g3f_A          146 CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH  222 (336)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccc
Confidence            4788999999999999999999999   99999999999999887 69999999998765433221   12235799999


Q ss_pred             cCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           78 MSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        78 ~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      +|||++.+..|+.++|+|||||++|+|++|..||......     +..........+...+..+.++|.+||+.||++||
T Consensus       223 mAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  302 (336)
T 4g3f_A          223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA  302 (336)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             cCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCc
Confidence            9999999999999999999999999999999988543211     11111111123455677899999999999999999


Q ss_pred             CHHHHHHHHhhhhhccCC
Q 028458          153 TMNDVVCMLTNEAATLLP  170 (208)
Q Consensus       153 s~~~i~~~l~~~~~~~~~  170 (208)
                      |+.|+++.|.........
T Consensus       303 sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          303 SAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             CHHHHHHHHHHHHHHTTS
T ss_pred             CHHHHHHHHHHHHhhhhh
Confidence            999999998776654433

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.4e-37  Score=244.39  Aligned_cols=158  Identities=26%  Similarity=0.364  Sum_probs=129.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+|.++++|+.||+.||.|||+++   |+||||||.|||++.++.+||+|||++................|++.|+|||
T Consensus       141 ~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE  217 (308)
T 4gt4_A          141 ALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE  217 (308)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHH
Confidence            4789999999999999999999999   9999999999999999999999999997664433333334457889999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.++.|+.++||||||+++|||++ |..|+.....     .+......  ..+..++..+.+++.+||+.||++||++.
T Consensus       218 ~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~--~~p~~~~~~~~~li~~C~~~dP~~RPs~~  295 (308)
T 4gt4_A          218 AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL--PCPDDCPAWVYALMIECWNEFPSRRPRFK  295 (308)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCcccchHHHHHHHHHHcCCChhHCcCHH
Confidence            9999999999999999999999998 6666643211     11111111  23445677899999999999999999999


Q ss_pred             HHHHHHhhh
Q 028458          156 DVVCMLTNE  164 (208)
Q Consensus       156 ~i~~~l~~~  164 (208)
                      ||++.|+..
T Consensus       296 ei~~~L~a~  304 (308)
T 4gt4_A          296 DIHSRLRAW  304 (308)
T ss_dssp             HHHHHHHTS
T ss_pred             HHHHHHHhc
Confidence            999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.5e-36  Score=243.72  Aligned_cols=162  Identities=28%  Similarity=0.319  Sum_probs=130.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|++.+++.|+.||+.||.|||+++   |+||||||.||+++.++.+||+|||++................||+.|+|||
T Consensus       181 ~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE  257 (353)
T 4ase_A          181 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  257 (353)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHH
Confidence            3789999999999999999999999   9999999999999999999999999998765444333334456889999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc--ccccCCccc--hhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL--ELIDDPVLE--DEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~--~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..|+.++|||||||++|||++ |..|+....  +.+......  ....+...+.++.++|.+||+.||++|||+.|
T Consensus       258 ~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~e  337 (353)
T 4ase_A          258 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE  337 (353)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHH
Confidence            9999999999999999999999997 777764321  111100000  01223445678899999999999999999999


Q ss_pred             HHHHHhhhhh
Q 028458          157 VVCMLTNEAA  166 (208)
Q Consensus       157 i~~~l~~~~~  166 (208)
                      |++.|+.+.+
T Consensus       338 il~~L~~llq  347 (353)
T 4ase_A          338 LVEHLGNLLQ  347 (353)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999987653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6e-35  Score=232.39  Aligned_cols=163  Identities=24%  Similarity=0.281  Sum_probs=124.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC--------CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc--ccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY--------SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRI   71 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~--------~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~   71 (208)
                      .++|..+++++.|++.||.|||++        +   |+||||||.|||++.++.+||+|||++..........  .....
T Consensus        96 ~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~  172 (303)
T 3hmm_A           96 TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR  172 (303)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC----
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---EeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccc
Confidence            478999999999999999999987        6   9999999999999999999999999998764433221  22335


Q ss_pred             ccCCCccCcchhccC------CCCCcchhHHHHHHHHHHHHhhhcCCccccc--------------------c----cCC
Q 028458           72 VGTYGYMSPEYAIQG------IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--------------------I----DDP  121 (208)
Q Consensus        72 ~~~~~~~ape~~~~~------~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------------------~----~~~  121 (208)
                      .||+.|+|||++.+.      .++.++|||||||++|||++|..+++.....                    +    ..+
T Consensus       173 ~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp  252 (303)
T 3hmm_A          173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP  252 (303)
T ss_dssp             -CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC
T ss_pred             cccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCC
Confidence            789999999998654      3677899999999999999986554321110                    0    011


Q ss_pred             ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhhhhhc
Q 028458          122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAAT  167 (208)
Q Consensus       122 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~  167 (208)
                      .++......+.+..+.+|+.+||+.||++|||+.||++.|+++...
T Consensus       253 ~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          253 NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            2222222334567789999999999999999999999999987643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.5e-35  Score=236.53  Aligned_cols=154  Identities=21%  Similarity=0.255  Sum_probs=125.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||++........  ......||+.|+|||
T Consensus       166 ~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPE  240 (346)
T 4fih_A          166 RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPE  240 (346)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCCHH
Confidence            4788899999999999999999999   99999999999999999999999999987643322  223467999999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      ++.+..|+.++|||||||++|+|++|..||.....     .+..............+.++.+||.+||+.||++||+++|
T Consensus       241 vl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e  320 (346)
T 4fih_A          241 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE  320 (346)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            99999999999999999999999999998854321     1111111111223445678899999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       321 ~l~H  324 (346)
T 4fih_A          321 LLKH  324 (346)
T ss_dssp             HTTC
T ss_pred             HhcC
Confidence            9873

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-35  Score=236.20  Aligned_cols=154  Identities=26%  Similarity=0.338  Sum_probs=125.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+...+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++................||+.|+|||
T Consensus       128 ~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPE  204 (311)
T 4aw0_A          128 SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE  204 (311)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHH
Confidence            4788899999999999999999999   9999999999999999999999999998875444333344568999999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      .+.+..|+.++|+|||||++|+|++|..||.....  ............+...+.++.+||.+||+.||++||+++|++
T Consensus       205 vl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             HHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            99999999999999999999999999999854321  111000001122334567789999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.2e-35  Score=227.71  Aligned_cols=152  Identities=22%  Similarity=0.294  Sum_probs=114.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++..++..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++........   .....||+.|+|||
T Consensus       108 ~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~---~~~~~GT~~Y~APE  181 (275)
T 3hyh_A          108 KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPE  181 (275)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCc---cCCeeECcccCChh
Confidence            4788899999999999999999999   99999999999999999999999999976543322   22357899999999


Q ss_pred             hhccCCC-CCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           82 YAIQGIF-SIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        82 ~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      .+.+..+ +.++|+|||||++|+|++|..|+......  ...........+...+.++.++|.+||+.||++|||++|++
T Consensus       182 ~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil  261 (275)
T 3hyh_A          182 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIM  261 (275)
T ss_dssp             HHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             hhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence            9988876 57899999999999999999988543211  11000000012334567788999999999999999999998


Q ss_pred             H
Q 028458          159 C  159 (208)
Q Consensus       159 ~  159 (208)
                      +
T Consensus       262 ~  262 (275)
T 3hyh_A          262 Q  262 (275)
T ss_dssp             H
T ss_pred             c
Confidence            7

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.1e-34  Score=237.34  Aligned_cols=154  Identities=21%  Similarity=0.258  Sum_probs=124.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|++..+..|+.||+.||.|||+++   |+||||||+|||++.+|.+||+|||++........  ......||+.|+|||
T Consensus       243 ~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPE  317 (423)
T 4fie_A          243 RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPE  317 (423)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHH
Confidence            3678899999999999999999999   99999999999999999999999999987643322  223467999999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      ++.+..|+.++|||||||++|+|++|..||......     +.............++.++.+||.+||+.||++||+++|
T Consensus       318 vl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e  397 (423)
T 4fie_A          318 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE  397 (423)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            999999999999999999999999999888543211     110110111123345677899999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       398 ll~H  401 (423)
T 4fie_A          398 LLKH  401 (423)
T ss_dssp             HTTC
T ss_pred             HhcC
Confidence            9873

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.4e-34  Score=225.52  Aligned_cols=151  Identities=25%  Similarity=0.397  Sum_probs=119.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-CCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..|+.||+.||.|||+++. .|+||||||.|||++. ++.+||+|||++......    ......||+.|+||
T Consensus       125 ~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAP  199 (290)
T 3fpq_A          125 VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP  199 (290)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCH
Confidence            57889999999999999999999863 3999999999999974 789999999999754322    22345799999999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc------cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE------LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+. ++|+.++|||||||++|+|++|..|+.....      .+..... ....+...+.++.+||.+||+.||++|||+
T Consensus       200 E~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~s~  277 (290)
T 3fpq_A          200 EMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKVAIPEVKEIIEGCIRQNKDERYSI  277 (290)
T ss_dssp             GGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             HHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC-CCCCCccCCHHHHHHHHHHccCChhHCcCH
Confidence            9886 4699999999999999999999998853221      1111111 112233344578899999999999999999


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      +|+++
T Consensus       278 ~e~l~  282 (290)
T 3fpq_A          278 KDLLN  282 (290)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.1e-35  Score=238.15  Aligned_cols=151  Identities=25%  Similarity=0.332  Sum_probs=123.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..|+.||+.||.|||+++   |+||||||.|||++.++.+||+|||++.......  .......||+.|+|||
T Consensus       121 ~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE  195 (350)
T 4b9d_A          121 LFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPE  195 (350)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc--ccccccCCCccccCHH
Confidence            3577889999999999999999999   9999999999999999999999999997653221  1123357999999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--ccc---CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LID---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..|+.++|+|||||++|+|++|..||.....  .+.   ....+  ..+...+.++.+||.+||+.||++||+++|
T Consensus       196 ~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  273 (350)
T 4b9d_A          196 ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP--PVSLHYSYDLRSLVSQLFKRNPRDRPSVNS  273 (350)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            99999999999999999999999999998854321  111   01111  123345677899999999999999999999


Q ss_pred             HHH
Q 028458          157 VVC  159 (208)
Q Consensus       157 i~~  159 (208)
                      +++
T Consensus       274 ~l~  276 (350)
T 4b9d_A          274 ILE  276 (350)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.5e-34  Score=228.16  Aligned_cols=153  Identities=22%  Similarity=0.258  Sum_probs=120.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++..++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++........  ......||+.|+|||
T Consensus       122 ~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE  196 (304)
T 3ubd_A          122 MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPE  196 (304)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCCc--cccccccCcccCCHH
Confidence            5788899999999999999999999   99999999999999999999999999976533221  223357899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH-----
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM-----  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----  154 (208)
                      .+.+..|+.++|+|||||++|+|++|..|+.....  ............+...+.++.+||.+||+.||++||++     
T Consensus       197 ~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~  276 (304)
T 3ubd_A          197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGV  276 (304)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTH
T ss_pred             HhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCH
Confidence            99999999999999999999999999998854321  11100000112234456778999999999999999984     


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      +|+++
T Consensus       277 ~eil~  281 (304)
T 3ubd_A          277 EEIKR  281 (304)
T ss_dssp             HHHHT
T ss_pred             HHHHc
Confidence            66665

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.6e-33  Score=222.44  Aligned_cols=148  Identities=27%  Similarity=0.375  Sum_probs=109.6

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc----------ccccccc
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA----------NTSRIVG   73 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~----------~~~~~~~   73 (208)
                      ++..++.|+.||++||.|||+++   |+||||||.||+++.++.+||+|||++..........          ......|
T Consensus       116 ~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~G  192 (299)
T 4g31_A          116 ERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVG  192 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------C
T ss_pred             HHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCccc
Confidence            45668899999999999999999   9999999999999999999999999998764332111          1123469


Q ss_pred             CCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCccchhhhhHHHHHHHHHHHhhccccC
Q 028458           74 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVLEDEYSSKQMLLRYVNIALLCVQES  147 (208)
Q Consensus        74 ~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  147 (208)
                      |+.|+|||.+.+..|+.++|+|||||++|+|++   |+....+.      +.....+  .........+.+||.+||+.|
T Consensus       193 T~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p--~~~~~~~~~~~~li~~~L~~d  267 (299)
T 4g31_A          193 TKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFP--PLFTQKYPCEYVMVQDMLSPS  267 (299)
T ss_dssp             CCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCC--HHHHHHCHHHHHHHHHHTCSS
T ss_pred             CccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCC--CCCcccCHHHHHHHHHHcCCC
Confidence            999999999999999999999999999999985   44322211      1111111  123334455678999999999


Q ss_pred             CCCCCCHHHHHH
Q 028458          148 ADDRPTMNDVVC  159 (208)
Q Consensus       148 p~~Rps~~~i~~  159 (208)
                      |++||++.|+++
T Consensus       268 P~~Rps~~eil~  279 (299)
T 4g31_A          268 PMERPEAINIIE  279 (299)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhHCcCHHHHhc
Confidence            999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.97  E-value=1e-31  Score=220.75  Aligned_cols=160  Identities=23%  Similarity=0.229  Sum_probs=121.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc--cccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL--QANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~~a   79 (208)
                      .|++..+..++.||+.||.|||+++   |+||||||.||+++.++.+|++|||++........  ........||+.|+|
T Consensus       154 ~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~A  230 (398)
T 4b99_A          154 PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA  230 (398)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcC
Confidence            4788999999999999999999999   99999999999999999999999999976543221  122334689999999


Q ss_pred             cchhccCC-CCCcchhHHHHHHHHHHHHhhhcCCccccc--c-------cCCc------------------------cch
Q 028458           80 PEYAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I-------DDPV------------------------LED  125 (208)
Q Consensus        80 pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~-------~~~~------------------------~~~  125 (208)
                      ||++.+.. ++.++|+||+||++|+|++|..||......  .       ..+.                        ...
T Consensus       231 PEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (398)
T 4b99_A          231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPW  310 (398)
T ss_dssp             HHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCH
T ss_pred             HHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCH
Confidence            99987754 689999999999999999999887432110  0       0000                        000


Q ss_pred             hhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhh
Q 028458          126 EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNE  164 (208)
Q Consensus       126 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~  164 (208)
                      ....+..+.++.+||.+||..||++|||++|+++.  |++.
T Consensus       311 ~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          311 ETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             HHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             HHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            00111234678899999999999999999999873  5554

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.97  E-value=1.1e-31  Score=218.15  Aligned_cols=155  Identities=18%  Similarity=0.267  Sum_probs=116.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC-CCeEEeccccceecCCCccc---------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGGNELQ---------------   65 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~---------------   65 (208)
                      .+++.++..++.||+.||.|||++|   |+||||||+||+++.+ +.+||+|||++.........               
T Consensus       113 ~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~  189 (361)
T 4f9c_A          113 SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCS  189 (361)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC----------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccc
Confidence            4788899999999999999999999   9999999999999876 78999999999765432211               


Q ss_pred             -----------ccccccccCCCccCcchhccCC-CCCcchhHHHHHHHHHHHHhhhcCCccccccc--------------
Q 028458           66 -----------ANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELID--------------  119 (208)
Q Consensus        66 -----------~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~--------------  119 (208)
                                 .......||+.|+|||.+.+.. |+.++|+||+||++|+|++|..|+........              
T Consensus       190 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~  269 (361)
T 4f9c_A          190 QNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRET  269 (361)
T ss_dssp             ----------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred             cccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccc
Confidence                       0112346899999999997754 88999999999999999999988743221100              


Q ss_pred             -------------CCccchh------------------------------hhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458          120 -------------DPVLEDE------------------------------YSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus       120 -------------~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                                   ....+..                              ......+.++.+||.+||+.||++|+|++|
T Consensus       270 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~e  349 (361)
T 4f9c_A          270 IQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEE  349 (361)
T ss_dssp             HHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             hhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence                         0000000                              000112456789999999999999999999


Q ss_pred             HHH
Q 028458          157 VVC  159 (208)
Q Consensus       157 i~~  159 (208)
                      +++
T Consensus       350 aL~  352 (361)
T 4f9c_A          350 ALL  352 (361)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=2.5e-31  Score=209.99  Aligned_cols=175  Identities=14%  Similarity=0.152  Sum_probs=138.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC-----eEEeccccceecCCCcccc-----ccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN-----PKISDFGMARICGGNELQA-----NTSRI   71 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~-----~~l~dfg~~~~~~~~~~~~-----~~~~~   71 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.     ++|+|||++..........     .....
T Consensus       102 ~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  178 (298)
T 1csn_A          102 KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL  178 (298)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCC
Confidence            4788999999999999999999999   999999999999987665     9999999998765433211     12334


Q ss_pred             ccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCc----------cchhhhhHHHHHHHHHHHh
Q 028458           72 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPV----------LEDEYSSKQMLLRYVNIAL  141 (208)
Q Consensus        72 ~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~li~  141 (208)
                      .|+..|.|||.+.+..++.++|+||||+++|+|++|..|+...........          ..........+..+.+++.
T Consensus       179 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  258 (298)
T 1csn_A          179 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMH  258 (298)
T ss_dssp             CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHH
T ss_pred             CCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHH
Confidence            688999999999988899999999999999999999988765321110000          0000112234668999999


Q ss_pred             hccccCCCCCCCHHHHHHHHhhhhhccCCCCCCCcccc
Q 028458          142 LCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYV  179 (208)
Q Consensus       142 ~~l~~~p~~Rps~~~i~~~l~~~~~~~~~p~~~~~~~~  179 (208)
                      +||+.||++||+++++++.|+++..........++.|.
T Consensus       259 ~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  296 (298)
T 1csn_A          259 YARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  296 (298)
T ss_dssp             HHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             HHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence            99999999999999999999999888777766666664

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.97  E-value=1.4e-30  Score=205.61  Aligned_cols=176  Identities=19%  Similarity=0.209  Sum_probs=139.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe---CCCCCeEEeccccceecCCCcccc-----ccccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA-----NTSRIVG   73 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~   73 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||++   +.++.++|+|||++..........     ......+
T Consensus       101 ~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~g  177 (296)
T 3uzp_A          101 KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG  177 (296)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccccc
Confidence            4788899999999999999999999   9999999999999   478899999999998765433211     1223467


Q ss_pred             CCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccch----------hhhhHHHHHHHHHHHhhc
Q 028458           74 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLED----------EYSSKQMLLRYVNIALLC  143 (208)
Q Consensus        74 ~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~  143 (208)
                      +..|.|||.+.+..++.++|+||||+++|+|++|..|+..............          .......+..+.+++.+|
T Consensus       178 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  257 (296)
T 3uzp_A          178 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFC  257 (296)
T ss_dssp             CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHH
T ss_pred             ccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHH
Confidence            8999999999998899999999999999999999988764322111011000          011133457789999999


Q ss_pred             cccCCCCCCCHHHHHHHHhhhhhccCCCCCCCccccc
Q 028458          144 VQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVR  180 (208)
Q Consensus       144 l~~~p~~Rps~~~i~~~l~~~~~~~~~p~~~~~~~~~  180 (208)
                      |+.||++||++.++++.|+.+......+...++.|..
T Consensus       258 l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~  294 (296)
T 3uzp_A          258 RSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  294 (296)
T ss_dssp             HTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred             HhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence            9999999999999999999998888777776676653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.97  E-value=1.1e-30  Score=206.03  Aligned_cols=175  Identities=19%  Similarity=0.213  Sum_probs=138.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe---CCCCCeEEeccccceecCCCcccc-----ccccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA-----NTSRIVG   73 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~   73 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||++   +.++.++|+|||++..........     ......+
T Consensus       101 ~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~g  177 (296)
T 4hgt_A          101 KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG  177 (296)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCC
Confidence            4788999999999999999999999   9999999999999   788899999999998765433211     1223567


Q ss_pred             CCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccch----------hhhhHHHHHHHHHHHhhc
Q 028458           74 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLED----------EYSSKQMLLRYVNIALLC  143 (208)
Q Consensus        74 ~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~  143 (208)
                      +..|.|||.+.+..++.++|+||||+++|+|++|..|+..............          .......+..+.+++.+|
T Consensus       178 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  257 (296)
T 4hgt_A          178 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFC  257 (296)
T ss_dssp             CGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHH
T ss_pred             CccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHH
Confidence            8999999999998999999999999999999999988864322211111110          001122356899999999


Q ss_pred             cccCCCCCCCHHHHHHHHhhhhhccCCCCCCCcccc
Q 028458          144 VQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYV  179 (208)
Q Consensus       144 l~~~p~~Rps~~~i~~~l~~~~~~~~~p~~~~~~~~  179 (208)
                      |+.||++||++.++++.|+.+.........-++.|.
T Consensus       258 l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 4hgt_A          258 RSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             HTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred             HhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence            999999999999999999999887776665555554

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=7.8e-31  Score=210.08  Aligned_cols=163  Identities=27%  Similarity=0.406  Sum_probs=128.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC----------CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccccccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY----------SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRI   71 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~----------~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~   71 (208)
                      .+++..+..++.|++.||.|||+.          +   ++|+||||.||+++.++.++|+|||++...............
T Consensus       117 ~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~  193 (322)
T 3soc_A          117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ  193 (322)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccC
Confidence            478899999999999999999999          8   999999999999999999999999999876554433333335


Q ss_pred             ccCCCccCcchhccC-----CCCCcchhHHHHHHHHHHHHhhhcCCccccccc-------------------------CC
Q 028458           72 VGTYGYMSPEYAIQG-----IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-------------------------DP  121 (208)
Q Consensus        72 ~~~~~~~ape~~~~~-----~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-------------------------~~  121 (208)
                      .|+..|+|||.+.+.     .++.++|+||||+++|+|++|..|+........                         .+
T Consensus       194 ~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (322)
T 3soc_A          194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRP  273 (322)
T ss_dssp             CCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCC
T ss_pred             ccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCC
Confidence            688999999998763     456778999999999999999877653221110                         01


Q ss_pred             ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhhhhhc
Q 028458          122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAAT  167 (208)
Q Consensus       122 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~  167 (208)
                      .+.........+..+.++|.+||+.||++||++.++++.|+++...
T Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          274 VLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1111112233456689999999999999999999999999988653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=7.8e-31  Score=213.39  Aligned_cols=177  Identities=14%  Similarity=0.086  Sum_probs=136.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC--CCCCeEEeccccceecCCCccccc-----ccccccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD--KDMNPKISDFGMARICGGNELQAN-----TSRIVGT   74 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~--~~~~~~l~dfg~~~~~~~~~~~~~-----~~~~~~~   74 (208)
                      .+++.+++.++.||+.||.|||+++   |+||||||.||+++  .++.++|+|||++...........     .....|+
T Consensus       148 ~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt  224 (364)
T 3op5_A          148 RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT  224 (364)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCC
Confidence            4789999999999999999999999   99999999999998  889999999999977643322111     1224589


Q ss_pred             CCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccC---Cc--cch--hhhh------HHHHHHHHHHHh
Q 028458           75 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD---PV--LED--EYSS------KQMLLRYVNIAL  141 (208)
Q Consensus        75 ~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~---~~--~~~--~~~~------~~~~~~~~~li~  141 (208)
                      ..|+|||.+.+..++.++|+||||+++|+|++|..|+.........   ..  ...  ....      ...+..+.+++.
T Consensus       225 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  304 (364)
T 3op5_A          225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYME  304 (364)
T ss_dssp             TTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHH
T ss_pred             CCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHH
Confidence            9999999999888999999999999999999999888642211000   00  000  0001      123567899999


Q ss_pred             hccccCCCCCCCHHHHHHHHhhhhhccCCCCCCCcccccc
Q 028458          142 LCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVRN  181 (208)
Q Consensus       142 ~~l~~~p~~Rps~~~i~~~l~~~~~~~~~p~~~~~~~~~~  181 (208)
                      .||+.||++||++.++++.|+.+...........+.+...
T Consensus       305 ~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~  344 (364)
T 3op5_A          305 TVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVV  344 (364)
T ss_dssp             HHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC---
T ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEec
Confidence            9999999999999999999999888777776666666433

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=3.7e-30  Score=205.80  Aligned_cols=162  Identities=39%  Similarity=0.633  Sum_probs=131.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++................|+..|+|||
T Consensus       135 ~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  211 (321)
T 2qkw_B          135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPE  211 (321)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHH
Confidence            3788999999999999999999999   9999999999999999999999999998754333222223345788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--------------------ccCCccchhhhhHHHHHHHHHHHh
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--------------------IDDPVLEDEYSSKQMLLRYVNIAL  141 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~li~  141 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......                    ..+..... ......+..+.+++.
T Consensus       212 ~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~  290 (321)
T 2qkw_B          212 YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD-KIRPESLRKFGDTAV  290 (321)
T ss_dssp             HHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT-CSCHHHHHHHHHHHH
T ss_pred             HhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc-ccCHHHHHHHHHHHH
Confidence            999889999999999999999999998776432110                    00011111 235677888999999


Q ss_pred             hccccCCCCCCCHHHHHHHHhhhhhc
Q 028458          142 LCVQESADDRPTMNDVVCMLTNEAAT  167 (208)
Q Consensus       142 ~~l~~~p~~Rps~~~i~~~l~~~~~~  167 (208)
                      +||+.||++||++.|+++.|+.....
T Consensus       291 ~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          291 KCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            99999999999999999999887643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.97  E-value=9.7e-31  Score=213.47  Aligned_cols=159  Identities=25%  Similarity=0.310  Sum_probs=127.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.+++.++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++................++..|+|||.
T Consensus       200 ~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~  276 (370)
T 2psq_A          200 MTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEA  276 (370)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhH
Confidence            688899999999999999999999   99999999999999999999999999987654433333333456778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+.....  .   +....  ....+...+..+.++|.+||+.||++||++.|
T Consensus       277 ~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e  354 (370)
T 2psq_A          277 LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH--RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQ  354 (370)
T ss_dssp             HHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            999899999999999999999998 7766643211  1   11000  00123345667899999999999999999999


Q ss_pred             HHHHHhhhhh
Q 028458          157 VVCMLTNEAA  166 (208)
Q Consensus       157 i~~~l~~~~~  166 (208)
                      +++.|+++..
T Consensus       355 ll~~L~~il~  364 (370)
T 2psq_A          355 LVEDLDRILT  364 (370)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=2.6e-30  Score=207.51  Aligned_cols=174  Identities=16%  Similarity=0.133  Sum_probs=135.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC-----eEEeccccceecCCCcccc-----ccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN-----PKISDFGMARICGGNELQA-----NTSRI   71 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~-----~~l~dfg~~~~~~~~~~~~-----~~~~~   71 (208)
                      .+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.     ++|+|||++..........     .....
T Consensus       101 ~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~  177 (330)
T 2izr_A          101 TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL  177 (330)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCc
Confidence            4788999999999999999999999   999999999999998876     9999999998764433211     12335


Q ss_pred             ccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCC-----ccchhhhhHHHHHHHHHHHh
Q 028458           72 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDP-----VLEDEYSSKQMLLRYVNIAL  141 (208)
Q Consensus        72 ~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~~~~li~  141 (208)
                      .|+..|+|||.+.+..++.++|+||||+++|+|++|..|+......     ....     ...........+ .+.+++.
T Consensus       178 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~  256 (330)
T 2izr_A          178 TGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLR  256 (330)
T ss_dssp             CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHH
T ss_pred             CCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHH
Confidence            6899999999999989999999999999999999999888543211     0000     000000011133 8899999


Q ss_pred             hccccCCCCCCCHHHHHHHHhhhhhccCCCCCCCcccc
Q 028458          142 LCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYV  179 (208)
Q Consensus       142 ~~l~~~p~~Rps~~~i~~~l~~~~~~~~~p~~~~~~~~  179 (208)
                      .||+.||.+||+++++.+.|+.+...........+.|.
T Consensus       257 ~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  294 (330)
T 2izr_A          257 YVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI  294 (330)
T ss_dssp             HHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred             HHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence            99999999999999999999988877666555555554

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=5.4e-30  Score=205.11  Aligned_cols=159  Identities=39%  Similarity=0.637  Sum_probs=129.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC---CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY---SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~---~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+.   +   ++|+||||.||+++.++.++|+|||++.......... .....|+..|+
T Consensus       127 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~  202 (326)
T 3uim_A          127 PLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHI  202 (326)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCE-ECCCCSCGGGC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccCccccccCcccccc-cccccCCcCcc
Confidence            378999999999999999999999   8   9999999999999999999999999998764333221 22245789999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccc----------------------ccccCCccchhhhhHHHHHHH
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL----------------------ELIDDPVLEDEYSSKQMLLRY  136 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~  136 (208)
                      |||.+.+..++.++|+||||+++|+|++|..|+....                      .......... ......+..+
T Consensus       203 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l  281 (326)
T 3uim_A          203 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG-NYKDEEVEQL  281 (326)
T ss_dssp             CHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTT-SCCHHHHHHH
T ss_pred             CHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhcc-ccCHHHHHHH
Confidence            9999988889999999999999999999988774110                      0111111111 3356677889


Q ss_pred             HHHHhhccccCCCCCCCHHHHHHHHhhhh
Q 028458          137 VNIALLCVQESADDRPTMNDVVCMLTNEA  165 (208)
Q Consensus       137 ~~li~~~l~~~p~~Rps~~~i~~~l~~~~  165 (208)
                      .+++.+||+.||++||++.++++.|++..
T Consensus       282 ~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          282 IQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             HHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            99999999999999999999999998754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=4.9e-31  Score=210.90  Aligned_cols=178  Identities=21%  Similarity=0.267  Sum_probs=121.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++................++..|.|||
T Consensus       133 ~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  209 (323)
T 3qup_A          133 NLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE  209 (323)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence            3788999999999999999999999   9999999999999999999999999997764433322222234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccccc-cCCcc--chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLELI-DDPVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+....... .....  .....+...+..+.+++.+||+.||++||++.++
T Consensus       210 ~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  289 (323)
T 3qup_A          210 SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCL  289 (323)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             hhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9999999999999999999999999 676664322110 00000  0001233455678999999999999999999999


Q ss_pred             HHHHhhhhhccCCCCCCCccccccc
Q 028458          158 VCMLTNEAATLLPPKQPAFSYVRNT  182 (208)
Q Consensus       158 ~~~l~~~~~~~~~p~~~~~~~~~~~  182 (208)
                      ++.|+++.........+..+...++
T Consensus       290 ~~~l~~~l~~~~~~~~~~~pl~~~~  314 (323)
T 3qup_A          290 RMELENILGHLSVLSTSQDPLYINI  314 (323)
T ss_dssp             HHHHHHHHHC---------------
T ss_pred             HHHHHHHHHHhhhcCCCCCCCCCCC
Confidence            9999998765544444444443333

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.97  E-value=2.6e-30  Score=205.72  Aligned_cols=164  Identities=30%  Similarity=0.457  Sum_probs=127.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccccc------------cc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN------------TS   69 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------------~~   69 (208)
                      .+++.++..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++...........            ..
T Consensus       104 ~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (310)
T 3s95_A          104 QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY  180 (310)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------C
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccccccccccccc
Confidence            4788999999999999999999999   99999999999999999999999999987643322111            11


Q ss_pred             ccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccch-----hhhhHHHHHHHHHHHhhcc
Q 028458           70 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLED-----EYSSKQMLLRYVNIALLCV  144 (208)
Q Consensus        70 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l  144 (208)
                      ...|+..|+|||.+.+..++.++|+||||+++|+|+++..++..............     ...+...+..+.+++.+||
T Consensus       181 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  260 (310)
T 3s95_A          181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCC  260 (310)
T ss_dssp             CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHT
T ss_pred             ccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHc
Confidence            34678899999999998999999999999999999998876654322221111111     0112334567889999999


Q ss_pred             ccCCCCCCCHHHHHHHHhhhhhcc
Q 028458          145 QESADDRPTMNDVVCMLTNEAATL  168 (208)
Q Consensus       145 ~~~p~~Rps~~~i~~~l~~~~~~~  168 (208)
                      +.||++||++.++++.|+.+....
T Consensus       261 ~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          261 DLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCChhhCcCHHHHHHHHHHHHHhc
Confidence            999999999999999998877543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=3e-30  Score=204.12  Aligned_cols=160  Identities=29%  Similarity=0.355  Sum_probs=124.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhc--------cCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc--ccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLH--------QYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRI   71 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh--------~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~   71 (208)
                      .+++..++.++.|++.||.|||        +.+   ++||||||+||+++.++.++|+|||++..........  .....
T Consensus       101 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  177 (301)
T 3q4u_A          101 TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR  177 (301)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCC
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccc
Confidence            4788899999999999999999        888   9999999999999999999999999987654333221  12234


Q ss_pred             ccCCCccCcchhccC------CCCCcchhHHHHHHHHHHHHh----------hhcCCccccc--------------ccCC
Q 028458           72 VGTYGYMSPEYAIQG------IFSIKSDVFSFGVLLLEIAWD----------LWTSNRTLEL--------------IDDP  121 (208)
Q Consensus        72 ~~~~~~~ape~~~~~------~~~~~~Dv~slG~~~~~l~~~----------~~~~~~~~~~--------------~~~~  121 (208)
                      .|+..|+|||.+.+.      .++.++|+||||+++|+|++|          ..|+......              ....
T Consensus       178 ~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~  257 (301)
T 3q4u_A          178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP  257 (301)
T ss_dssp             CCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC
T ss_pred             ccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCC
Confidence            688999999999776      345789999999999999998          4444321110              0111


Q ss_pred             ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhhh
Q 028458          122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNE  164 (208)
Q Consensus       122 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l~~~  164 (208)
                      ...........+..+.+++.+||+.||++||++.++++.|+++
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          258 NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            2222223445678899999999999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.96  E-value=7.1e-31  Score=226.02  Aligned_cols=151  Identities=23%  Similarity=0.243  Sum_probs=121.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+...+..|+.||+.||.|||+++   |+||||||.|||++.+|.+||+|||++.......    .....||+.|+|||
T Consensus       288 ~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPE  360 (689)
T 3v5w_A          288 VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPE  360 (689)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHH
Confidence            4788899999999999999999999   9999999999999999999999999998765432    23357999999999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC--
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT--  153 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps--  153 (208)
                      ++.. ..|+.++|+|||||++|+|++|..||.....     ............+...+.++.+||.+||+.||++|++  
T Consensus       361 vl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~  440 (689)
T 3v5w_A          361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCL  440 (689)
T ss_dssp             HHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCS
T ss_pred             HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCC
Confidence            9964 5789999999999999999999999853211     1110000111224456678899999999999999997  


Q ss_pred             ---HHHHHH
Q 028458          154 ---MNDVVC  159 (208)
Q Consensus       154 ---~~~i~~  159 (208)
                         ++||.+
T Consensus       441 ~~ga~ei~~  449 (689)
T 3v5w_A          441 GRGAQEVKE  449 (689)
T ss_dssp             SSTHHHHTT
T ss_pred             CCCHHHHhc
Confidence               678776

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.96  E-value=4.1e-30  Score=207.72  Aligned_cols=162  Identities=17%  Similarity=0.173  Sum_probs=127.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC--CeEEeccccceecCCCcccc-----cccccccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM--NPKISDFGMARICGGNELQA-----NTSRIVGT   74 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~   74 (208)
                      .+++.+++.++.||+.||.|||+++   ++||||||.||+++.++  .++|+|||++..........     ......|+
T Consensus       147 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt  223 (345)
T 2v62_A          147 TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT  223 (345)
T ss_dssp             BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCC
Confidence            4788999999999999999999999   99999999999998777  99999999997764322111     11234688


Q ss_pred             CCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc---cC--CccchhhhhH---------HHHHHHHHHH
Q 028458           75 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---DD--PVLEDEYSSK---------QMLLRYVNIA  140 (208)
Q Consensus        75 ~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~--~~~~~~~~~~---------~~~~~~~~li  140 (208)
                      ..|+|||.+.+..++.++|+||||+++|+|++|..|+.......   ..  ..... ..+.         ..+..+.+++
T Consensus       224 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li  302 (345)
T 2v62_A          224 IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLD-ELPQSVLKWAPSGSSCCEIAQFL  302 (345)
T ss_dssp             TTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHH-TTTHHHHHHSCTTSCCHHHHHHH
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcc-cccHHHHhhccccccHHHHHHHH
Confidence            99999999998889999999999999999999998884321110   00  00000 0111         3445899999


Q ss_pred             hhccccCCCCCCCHHHHHHHHhhhhhc
Q 028458          141 LLCVQESADDRPTMNDVVCMLTNEAAT  167 (208)
Q Consensus       141 ~~~l~~~p~~Rps~~~i~~~l~~~~~~  167 (208)
                      ..||+.||++||+++++++.|+.....
T Consensus       303 ~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          303 VCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             HHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             HHHhhcCcccCCCHHHHHHHHhccCCc
Confidence            999999999999999999999987643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.96  E-value=3.8e-31  Score=212.40  Aligned_cols=160  Identities=23%  Similarity=0.318  Sum_probs=120.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++................++..|+|||
T Consensus       113 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE  189 (327)
T 3lzb_A          113 NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE  189 (327)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHH
Confidence            3678889999999999999999999   9999999999999999999999999998764433322222334567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......     +....  ....+...+..+.+++.+||+.||.+||++.
T Consensus       190 ~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  267 (327)
T 3lzb_A          190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--RLPQPPICTIDVYMIMRKCWMIDADSRPKFR  267 (327)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            9999999999999999999999998 77776533221     11000  0012333456788999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|+++..
T Consensus       268 ell~~L~~~~~  278 (327)
T 3lzb_A          268 ELIIEFSKMAR  278 (327)
T ss_dssp             HHHHHHHHHHT
T ss_pred             HHHHHHHHHHh
Confidence            99999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.96  E-value=2e-30  Score=206.71  Aligned_cols=166  Identities=28%  Similarity=0.380  Sum_probs=120.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+.+. +++||||||+||+++.++.++|+|||++........  ......|+..|+|||.
T Consensus       134 ~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~  210 (309)
T 3p86_A          134 LDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEV  210 (309)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCcccccccc--ccccCCCCccccChhh
Confidence            7788999999999999999999863 399999999999999999999999999875433221  1222467899999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--cC--CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--DD--PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      +.+..++.++|+||||+++|+|++|..|+.......  ..  ........+...+..+.++|.+||+.||++||++.+++
T Consensus       211 ~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll  290 (309)
T 3p86_A          211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIM  290 (309)
T ss_dssp             HTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999889999999999999999999988875432210  00  00011122344566789999999999999999999999


Q ss_pred             HHHhhhhhccCCC
Q 028458          159 CMLTNEAATLLPP  171 (208)
Q Consensus       159 ~~l~~~~~~~~~p  171 (208)
                      +.|+.+.....+|
T Consensus       291 ~~L~~~~~~~~p~  303 (309)
T 3p86_A          291 DLLRPLIKSAVPP  303 (309)
T ss_dssp             HHHHHHHC-----
T ss_pred             HHHHHHHHhCCCC
Confidence            9999887654444

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.96  E-value=2.8e-30  Score=209.10  Aligned_cols=176  Identities=14%  Similarity=0.114  Sum_probs=136.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC--CeEEeccccceecCCCcccc-----cccccccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM--NPKISDFGMARICGGNELQA-----NTSRIVGT   74 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~   74 (208)
                      .+++.+++.++.||+.||.|||+++   ++||||||.||+++.++  .++|+|||++..........     ......++
T Consensus       155 ~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt  231 (352)
T 2jii_A          155 VLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD  231 (352)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCC
Confidence            4789999999999999999999999   99999999999999988  89999999997654322111     11224678


Q ss_pred             CCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc---ccC---------Ccc-chhhhhHHHHHHHHHHHh
Q 028458           75 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---IDD---------PVL-EDEYSSKQMLLRYVNIAL  141 (208)
Q Consensus        75 ~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~---------~~~-~~~~~~~~~~~~~~~li~  141 (208)
                      ..|+|||.+.+..++.++|+||||+++|+|++|..|+......   +..         ..+ .........+..+.+++.
T Consensus       232 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  311 (352)
T 2jii_A          232 LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLK  311 (352)
T ss_dssp             TTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHH
T ss_pred             ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHH
Confidence            9999999999888999999999999999999998887643210   000         000 000000123567899999


Q ss_pred             hccccCCCCCCCHHHHHHHHhhhhhccCCCCCCCccccc
Q 028458          142 LCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVR  180 (208)
Q Consensus       142 ~~l~~~p~~Rps~~~i~~~l~~~~~~~~~p~~~~~~~~~  180 (208)
                      +||+.||++||++.++++.|+++..........++.|..
T Consensus       312 ~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~  350 (352)
T 2jii_A          312 VVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPM  350 (352)
T ss_dssp             HHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC
T ss_pred             HHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcC
Confidence            999999999999999999999998887776666665543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.96  E-value=8.6e-31  Score=210.23  Aligned_cols=160  Identities=23%  Similarity=0.327  Sum_probs=125.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++................++..|+|||
T Consensus       113 ~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE  189 (327)
T 3poz_A          113 NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE  189 (327)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChH
Confidence            4678899999999999999999999   9999999999999999999999999998765443333333345577899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......     +....  ....+...+..+.+++.+||+.||++||++.
T Consensus       190 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  267 (327)
T 3poz_A          190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--RLPQPPICTIDVYMIMVKCWMIDADSRPKFR  267 (327)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHH
T ss_pred             HhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcCCChhhCCCHH
Confidence            9999999999999999999999998 77776432211     11000  0012333456788999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|+.+..
T Consensus       268 ell~~l~~~~~  278 (327)
T 3poz_A          268 ELIIEFSKMAR  278 (327)
T ss_dssp             HHHHHHHHHHT
T ss_pred             HHHHHHHHHHh
Confidence            99999988764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.96  E-value=2.1e-30  Score=212.23  Aligned_cols=165  Identities=27%  Similarity=0.289  Sum_probs=131.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++................++..|+|||.
T Consensus       188 l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~  264 (382)
T 3tt0_A          188 LSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA  264 (382)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHH
Confidence            789999999999999999999999   99999999999999999999999999987654433333333456778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+.....     .+....  ....+...+..+.+++.+||+.||++||++++
T Consensus       265 ~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  342 (382)
T 3tt0_A          265 LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ  342 (382)
T ss_dssp             HHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC--CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            999889999999999999999998 7766643211     011000  00112334567889999999999999999999


Q ss_pred             HHHHHhhhhhccCCCC
Q 028458          157 VVCMLTNEAATLLPPK  172 (208)
Q Consensus       157 i~~~l~~~~~~~~~p~  172 (208)
                      +++.|+++........
T Consensus       343 ll~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          343 LVEDLDRIVALTSNQE  358 (382)
T ss_dssp             HHHHHHHHHHHSCSCC
T ss_pred             HHHHHHHHHHHHhcCC
Confidence            9999999886654443

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.96  E-value=5.9e-30  Score=215.33  Aligned_cols=163  Identities=18%  Similarity=0.220  Sum_probs=129.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe---CCCCCeEEeccccceecCCCcccc-----ccccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQA-----NTSRIVG   73 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~   73 (208)
                      .+++.+++.|+.||+.||.|||+++   |+||||||.||++   +.++.++|+|||++..........     ......|
T Consensus        99 ~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~g  175 (483)
T 3sv0_A           99 KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG  175 (483)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCC
Confidence            4789999999999999999999999   9999999999999   578899999999998765433211     1224568


Q ss_pred             CCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccc----------hhhhhHHHHHHHHHHHhhc
Q 028458           74 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLE----------DEYSSKQMLLRYVNIALLC  143 (208)
Q Consensus        74 ~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~  143 (208)
                      +..|+|||.+.+..++.++||||||+++|+|++|..|+.............          .......++.++.++|..|
T Consensus       176 t~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~c  255 (483)
T 3sv0_A          176 TARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYC  255 (483)
T ss_dssp             CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHH
T ss_pred             CccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHH
Confidence            899999999999999999999999999999999998875432211000000          0011233456889999999


Q ss_pred             cccCCCCCCCHHHHHHHHhhhhhc
Q 028458          144 VQESADDRPTMNDVVCMLTNEAAT  167 (208)
Q Consensus       144 l~~~p~~Rps~~~i~~~l~~~~~~  167 (208)
                      |+.+|++||++.+|++.|+.+...
T Consensus       256 l~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          256 RSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hcCChhhCcCHHHHHHHHHHHHHH
Confidence            999999999999999999887543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.96  E-value=4.6e-30  Score=220.00  Aligned_cols=151  Identities=19%  Similarity=0.212  Sum_probs=123.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC--CCeEEeccccceecCCCcccccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD--MNPKISDFGMARICGGNELQANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~a   79 (208)
                      .|++.++..++.||+.||.|||+++   |+||||||.||+++.+  +.+||+|||++........   .....||+.|+|
T Consensus       251 ~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~---~~~~~GT~~y~A  324 (573)
T 3uto_A          251 KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAA  324 (573)
T ss_dssp             CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE---EEEECSSGGGCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc---eeeeEECccccC
Confidence            3678899999999999999999999   9999999999999854  7899999999988754332   223578999999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccC--CccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDD--PVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      ||.+.+..|+.++|+|||||++|+|++|..||......     +..  ..... ......+..+.+||.+||+.||++||
T Consensus       325 PEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~dli~~~L~~dp~~R~  403 (573)
T 3uto_A          325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD-SAFSGISEDGKDFIRKLLLADPNTRM  403 (573)
T ss_dssp             HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS-GGGTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred             HHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc-ccccCCCHHHHHHHHHHccCChhHCc
Confidence            99999999999999999999999999999888533221     111  11111 22344567788999999999999999


Q ss_pred             CHHHHHH
Q 028458          153 TMNDVVC  159 (208)
Q Consensus       153 s~~~i~~  159 (208)
                      ++.|+++
T Consensus       404 t~~e~l~  410 (573)
T 3uto_A          404 TIHQALE  410 (573)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHhc
Confidence            9999987

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.96  E-value=9.3e-31  Score=209.82  Aligned_cols=160  Identities=21%  Similarity=0.262  Sum_probs=125.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++................++..|+|||
T Consensus       111 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  187 (325)
T 3kex_A          111 ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE  187 (325)
T ss_dssp             GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChH
Confidence            3677889999999999999999999   9999999999999999999999999998765443333333345678899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......     +....  ....+...+..+.+++.+||+.||++||++.
T Consensus       188 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  265 (325)
T 3kex_A          188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE--RLAQPQICTIDVYMVMVKCWMIDENIRPTFK  265 (325)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC--BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHH
T ss_pred             HhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC--CCCCCCcCcHHHHHHHHHHcCCChhhCcCHH
Confidence            9998999999999999999999998 88777532211     11000  0011222445678899999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|++...
T Consensus       266 el~~~l~~~~~  276 (325)
T 3kex_A          266 ELANEFTRMAR  276 (325)
T ss_dssp             HHHHHHHHHTT
T ss_pred             HHHHHHHHHHh
Confidence            99999988764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=4.7e-29  Score=200.14  Aligned_cols=164  Identities=26%  Similarity=0.339  Sum_probs=124.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC--------CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccccc--cccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY--------SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN--TSRI   71 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~--------~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~   71 (208)
                      .+++..++.++.|++.||.|||+.        +   ++||||||+||+++.++.++|+|||++...........  ....
T Consensus       130 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  206 (337)
T 3mdy_A          130 TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR  206 (337)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCC
Confidence            467889999999999999999998        8   99999999999999999999999999976543322211  1234


Q ss_pred             ccCCCccCcchhccCCCCCc------chhHHHHHHHHHHHHhhh----------cCCccccc----------c----cCC
Q 028458           72 VGTYGYMSPEYAIQGIFSIK------SDVFSFGVLLLEIAWDLW----------TSNRTLEL----------I----DDP  121 (208)
Q Consensus        72 ~~~~~~~ape~~~~~~~~~~------~Dv~slG~~~~~l~~~~~----------~~~~~~~~----------~----~~~  121 (208)
                      .|+..|+|||.+.+..+...      +|+||||+++|+|++|..          |+......          .    ...
T Consensus       207 ~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  286 (337)
T 3mdy_A          207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRP  286 (337)
T ss_dssp             CSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC
T ss_pred             ccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCc
Confidence            67899999999987766554      899999999999999843          33221100          0    011


Q ss_pred             ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhhhhhcc
Q 028458          122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATL  168 (208)
Q Consensus       122 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~  168 (208)
                      ...........+..+.+++.+||+.||++||++.++++.|+++....
T Consensus       287 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          287 SFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            11221223467788999999999999999999999999999887543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.96  E-value=4.3e-29  Score=198.17  Aligned_cols=160  Identities=37%  Similarity=0.547  Sum_probs=127.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++................|+..|+|||
T Consensus       129 ~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE  205 (307)
T 2nru_A          129 PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE  205 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChH
Confidence            4788999999999999999999999   9999999999999999999999999988765433222223346788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc-----------CCccc------hhhhhHHHHHHHHHHHhhcc
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-----------DPVLE------DEYSSKQMLLRYVNIALLCV  144 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----------~~~~~------~~~~~~~~~~~~~~li~~~l  144 (208)
                      .+.+ .++.++|+||||+++|+|++|..|+........           ...+.      ........+..+.+++.+||
T Consensus       206 ~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  284 (307)
T 2nru_A          206 ALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCL  284 (307)
T ss_dssp             HHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHT
T ss_pred             HhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHc
Confidence            8864 578999999999999999999877653221100           00000      00124556778999999999


Q ss_pred             ccCCCCCCCHHHHHHHHhhhh
Q 028458          145 QESADDRPTMNDVVCMLTNEA  165 (208)
Q Consensus       145 ~~~p~~Rps~~~i~~~l~~~~  165 (208)
                      +.||++||+++++++.|+++.
T Consensus       285 ~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          285 HEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             CSSTTTSCCHHHHHHHHHHHC
T ss_pred             CCCcccCcCHHHHHHHHHHHh
Confidence            999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.96  E-value=4.6e-30  Score=204.40  Aligned_cols=163  Identities=23%  Similarity=0.300  Sum_probs=122.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++................++..|.|||
T Consensus       143 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  219 (313)
T 3brb_A          143 HIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE  219 (313)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCch
Confidence            4788999999999999999999999   9999999999999999999999999987664433222222334577899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......     .....  ....+...+..+.+++.+||+.||++||++.
T Consensus       220 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  297 (313)
T 3brb_A          220 SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH--RLKQPEDCLDELYEIMYSCWRTDPLDRPTFS  297 (313)
T ss_dssp             HHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             hhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC--CCCCCccccHHHHHHHHHHcCCChhhCcCHH
Confidence            9998889999999999999999999 66665432211     00000  0012334556789999999999999999999


Q ss_pred             HHHHHHhhhhhccC
Q 028458          156 DVVCMLTNEAATLL  169 (208)
Q Consensus       156 ~i~~~l~~~~~~~~  169 (208)
                      ++++.|+++...++
T Consensus       298 ~l~~~L~~l~~~lp  311 (313)
T 3brb_A          298 VLRLQLEKLLESLP  311 (313)
T ss_dssp             HHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHHhcC
Confidence            99999999876543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.96  E-value=6.6e-30  Score=201.53  Aligned_cols=162  Identities=27%  Similarity=0.403  Sum_probs=118.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++................|+..|+|||
T Consensus       116 ~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  192 (289)
T 3og7_A          116 KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE  192 (289)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCch
Confidence            3678899999999999999999999   9999999999999999999999999987654322222223346789999999


Q ss_pred             hhc---cCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCcc--chhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           82 YAI---QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVL--EDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        82 ~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      .+.   +..++.++|+||||+++|+|++|..|+......      ......  ........++..+.+++.+||+.||++
T Consensus       193 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  272 (289)
T 3og7_A          193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDE  272 (289)
T ss_dssp             HHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             hhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhh
Confidence            986   556788999999999999999998887543211      000000  000122345677899999999999999


Q ss_pred             CCCHHHHHHHHhhhhh
Q 028458          151 RPTMNDVVCMLTNEAA  166 (208)
Q Consensus       151 Rps~~~i~~~l~~~~~  166 (208)
                      ||+++++++.|+++..
T Consensus       273 Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          273 RPSFPRILAEIEELAR  288 (289)
T ss_dssp             SCCHHHHHHHHHHTTC
T ss_pred             CCCHHHHHHHHHHHhh
Confidence            9999999999998753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.96  E-value=2.3e-30  Score=211.67  Aligned_cols=158  Identities=25%  Similarity=0.286  Sum_probs=125.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................++..|+|||.
T Consensus       210 ~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~  286 (377)
T 3cbl_A          210 LRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA  286 (377)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhH
Confidence            678899999999999999999999   99999999999999999999999999876544332222222234667999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccC-CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDD-PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      +.+..++.++|+||||+++|+|++ |..|+......     +.. ...   ..+...+..+.++|.+||+.||++||+++
T Consensus       287 ~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~  363 (377)
T 3cbl_A          287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL---PCPELCPDAVFRLMEQCWAYEPGQRPSFS  363 (377)
T ss_dssp             HHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence            998889999999999999999997 76666432211     110 011   12333456788999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|+.+..
T Consensus       364 ~i~~~L~~i~~  374 (377)
T 3cbl_A          364 TIYQELQSIRK  374 (377)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHh
Confidence            99999988764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.96  E-value=3.9e-30  Score=204.54  Aligned_cols=159  Identities=26%  Similarity=0.323  Sum_probs=127.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++.++..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++................++..|.|||.
T Consensus       147 ~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  223 (314)
T 2ivs_A          147 LTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES  223 (314)
T ss_dssp             ECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence            788899999999999999999999   99999999999999999999999999987654433322333455778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+......     +....  ....+...+..+.+++.+||+.||++||++.+
T Consensus       224 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  301 (314)
T 2ivs_A          224 LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH--RMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD  301 (314)
T ss_dssp             HHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC--cCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            998889999999999999999998 77766432211     11000  00123345677899999999999999999999


Q ss_pred             HHHHHhhhhh
Q 028458          157 VVCMLTNEAA  166 (208)
Q Consensus       157 i~~~l~~~~~  166 (208)
                      +++.|+++..
T Consensus       302 l~~~l~~~~~  311 (314)
T 2ivs_A          302 ISKDLEKMMV  311 (314)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHh
Confidence            9999988754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.96  E-value=1e-29  Score=202.62  Aligned_cols=150  Identities=21%  Similarity=0.269  Sum_probs=118.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++........   .....|+..|+|||
T Consensus       153 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE  226 (311)
T 3p1a_A          153 SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPE  226 (311)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCccccCHh
Confidence            4789999999999999999999999   99999999999999999999999999877643322   22245789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccc--ccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL--ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .+.+ .++.++|+||||+++|+|++|..++....  ..+....... ......+..+.++|.+||+.||++||+++|+++
T Consensus       227 ~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          227 LLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP-EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             GGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCc-ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            8865 78999999999999999999865443221  1122122211 233445678999999999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.96  E-value=1.8e-30  Score=210.33  Aligned_cols=162  Identities=27%  Similarity=0.296  Sum_probs=127.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++................++..|+|||.
T Consensus       190 l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~  266 (359)
T 3vhe_A          190 LTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET  266 (359)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhh
Confidence            889999999999999999999999   99999999999999999999999999986644333333333467788999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--cccCCcc--chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--LIDDPVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +.+..++.++|+||||+++|+|++ |..|+.....  .......  .....+...+..+.+++.+||+.||++||++.++
T Consensus       267 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  346 (359)
T 3vhe_A          267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  346 (359)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            999999999999999999999997 8777643221  0000000  0001223345678899999999999999999999


Q ss_pred             HHHHhhhhhc
Q 028458          158 VCMLTNEAAT  167 (208)
Q Consensus       158 ~~~l~~~~~~  167 (208)
                      ++.|+.+...
T Consensus       347 l~~L~~~~~~  356 (359)
T 3vhe_A          347 VEHLGNLLQA  356 (359)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999887643

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.5e-29  Score=199.87  Aligned_cols=165  Identities=24%  Similarity=0.262  Sum_probs=128.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc--cccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~a   79 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++..........  ......++..|.|
T Consensus       120 ~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~a  196 (298)
T 3pls_A          120 NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA  196 (298)
T ss_dssp             CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccC
Confidence            4678899999999999999999999   9999999999999999999999999997654332211  1122356778999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc------cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      ||.+.+..++.++|+||||+++|+|++|..++.......      ....  ....+...+..+.+++.+||+.||.+||+
T Consensus       197 PE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps  274 (298)
T 3pls_A          197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR--RLPQPEYCPDSLYQVMQQCWEADPAVRPT  274 (298)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             hhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC--CCCCCccchHHHHHHHHHHccCChhhCcC
Confidence            999998899999999999999999999665543221111      0000  00123334567889999999999999999


Q ss_pred             HHHHHHHHhhhhhccCCC
Q 028458          154 MNDVVCMLTNEAATLLPP  171 (208)
Q Consensus       154 ~~~i~~~l~~~~~~~~~p  171 (208)
                      ++++++.|+++...+...
T Consensus       275 ~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          275 FRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             HHHHHHHHHHHHHHCCSC
T ss_pred             HHHHHHHHHHHHHHHhcc
Confidence            999999999987665543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.96  E-value=7.7e-30  Score=204.47  Aligned_cols=172  Identities=21%  Similarity=0.217  Sum_probs=115.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc----------ccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA----------NTSRI   71 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~----------~~~~~   71 (208)
                      .+++.++..++.||+.||.|||+++. .++|+||||+||+++.++.++|+|||++..........          .....
T Consensus       132 ~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (337)
T 3ll6_A          132 PLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR  210 (337)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC------------------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccc
Confidence            47889999999999999999999852 39999999999999999999999999997664322211          11123


Q ss_pred             ccCCCccCcchh---ccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-cCCccchhhhhHHHHHHHHHHHhhccccC
Q 028458           72 VGTYGYMSPEYA---IQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-DDPVLEDEYSSKQMLLRYVNIALLCVQES  147 (208)
Q Consensus        72 ~~~~~~~ape~~---~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~  147 (208)
                      .++..|+|||.+   .+..++.++|+||||+++|+|++|..|+....... ....... ......+..+.+++.+||+.|
T Consensus       211 ~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~  289 (337)
T 3ll6_A          211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSI-PPHDTQYTVFHSLIRAMLQVN  289 (337)
T ss_dssp             -------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------CCC-CTTCCSSGGGHHHHHHHSCSS
T ss_pred             cCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCcccC-CcccccchHHHHHHHHHccCC
Confidence            578899999998   45668899999999999999999988875332211 0000000 111222345778999999999


Q ss_pred             CCCCCCHHHHHHHHhhhhhccCCCCCCC
Q 028458          148 ADDRPTMNDVVCMLTNEAATLLPPKQPA  175 (208)
Q Consensus       148 p~~Rps~~~i~~~l~~~~~~~~~p~~~~  175 (208)
                      |++||++.|+++.|+.+..........+
T Consensus       290 p~~Rps~~e~l~~l~~~~~~~~~~~~~~  317 (337)
T 3ll6_A          290 PEERLSIAEVVHQLQEIAAARNVNPKSP  317 (337)
T ss_dssp             GGGSCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred             hhhCcCHHHHHHHHHHHHhccCCCCCcc
Confidence            9999999999999999887655544433

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.96  E-value=2.7e-29  Score=201.75  Aligned_cols=165  Identities=25%  Similarity=0.338  Sum_probs=124.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccC---------CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc------cc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQY---------SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ------AN   67 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~---------~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~------~~   67 (208)
                      +++..+..++.||+.||.|||+.         +   ++||||||+||+++.++.++|+|||++.........      ..
T Consensus       108 ~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~  184 (336)
T 3g2f_A          108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA  184 (336)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC--------
T ss_pred             cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccc
Confidence            46788999999999999999999         8   999999999999999999999999999876533211      11


Q ss_pred             ccccccCCCccCcchhcc-------CCCCCcchhHHHHHHHHHHHHhhhcCCccccccc---------------------
Q 028458           68 TSRIVGTYGYMSPEYAIQ-------GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID---------------------  119 (208)
Q Consensus        68 ~~~~~~~~~~~ape~~~~-------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---------------------  119 (208)
                      .....|+..|+|||.+.+       ..++.++|+||||+++|+|++|..++........                     
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (336)
T 3g2f_A          185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVL  264 (336)
T ss_dssp             -CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHH
T ss_pred             cccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhh
Confidence            123468899999999876       3456789999999999999998655422111000                     


Q ss_pred             ------CCccchh-hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhhhhhccCC
Q 028458          120 ------DPVLEDE-YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLP  170 (208)
Q Consensus       120 ------~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~  170 (208)
                            .+.++.. ......+..+.++|.+||+.||++||++.|+++.|+++......
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~  322 (336)
T 3g2f_A          265 VSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER  322 (336)
T ss_dssp             HTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred             hcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence                  0000000 01223556799999999999999999999999999998755443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.96  E-value=3e-30  Score=207.74  Aligned_cols=161  Identities=25%  Similarity=0.371  Sum_probs=126.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.+++.++.||++||.|||+++   ++|+||||.||+++.++.++|+|||++................++..|.|||
T Consensus       170 ~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  246 (343)
T 1luf_A          170 PLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE  246 (343)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChh
Confidence            4788899999999999999999999   9999999999999999999999999987664433222223345678899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......     +......  ..+...+..+.+++.+||+.||++||++.
T Consensus       247 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~  324 (343)
T 1luf_A          247 SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL--ACPENCPLELYNLMRLCWSKLPADRPSFC  324 (343)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC--CCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence            9998899999999999999999998 77666432111     1111110  12334556789999999999999999999


Q ss_pred             HHHHHHhhhhhc
Q 028458          156 DVVCMLTNEAAT  167 (208)
Q Consensus       156 ~i~~~l~~~~~~  167 (208)
                      ++++.|+++...
T Consensus       325 ~~~~~L~~~~~~  336 (343)
T 1luf_A          325 SIHRILQRMCER  336 (343)
T ss_dssp             HHHHHHHHTTC-
T ss_pred             HHHHHHHHHHhh
Confidence            999999988643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.96  E-value=1.7e-29  Score=200.18  Aligned_cols=154  Identities=22%  Similarity=0.319  Sum_probs=123.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++.........  .....|+..|+|||
T Consensus       112 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE  186 (297)
T 3fxz_A          112 CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPE  186 (297)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc--cCCccCCcCccChh
Confidence            3678889999999999999999999   999999999999999999999999998776433321  22346789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc-----CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-----DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+||||+++|+|++|..|+........     .........+...+..+.++|.+||+.||++||+++|
T Consensus       187 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  266 (297)
T 3fxz_A          187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE  266 (297)
T ss_dssp             HHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHH
Confidence            99999999999999999999999999988754322100     0000011123445667889999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       267 ll~h  270 (297)
T 3fxz_A          267 LLQH  270 (297)
T ss_dssp             HTTC
T ss_pred             HhhC
Confidence            9873

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.96  E-value=2.7e-30  Score=210.59  Aligned_cols=161  Identities=27%  Similarity=0.323  Sum_probs=125.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC---CeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++.+++.++.||+.||.|||+++   |+||||||.||+++.++   .++|+|||++................++..|+
T Consensus       177 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~  253 (367)
T 3l9p_A          177 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM  253 (367)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGC
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEE
Confidence            3788899999999999999999999   99999999999998554   59999999987543222222223345678899


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+.+..++.++|+||||+++|+|++ |..|+......     +....  ....+...+..+.+++.+||+.||++||
T Consensus       254 aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rp  331 (367)
T 3l9p_A          254 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG--RMDPPKNCPGPVYRIMTQCWQHQPEDRP  331 (367)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcCCCHhHCc
Confidence            9999999999999999999999999997 77766433211     11000  0012334456788999999999999999


Q ss_pred             CHHHHHHHHhhhhhc
Q 028458          153 TMNDVVCMLTNEAAT  167 (208)
Q Consensus       153 s~~~i~~~l~~~~~~  167 (208)
                      ++.++++.|+.....
T Consensus       332 s~~eil~~l~~~~~~  346 (367)
T 3l9p_A          332 NFAIILERIEYCTQD  346 (367)
T ss_dssp             CHHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHHHhhC
Confidence            999999999887643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=5.2e-30  Score=206.63  Aligned_cols=160  Identities=26%  Similarity=0.322  Sum_probs=126.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.||+.||.|||+++   ++|+||||.||+++.++.++|+|||++................++..|.|||.
T Consensus       169 l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  245 (344)
T 1rjb_A          169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES  245 (344)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHH
Confidence            788999999999999999999999   99999999999999999999999999976643332222233456778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc------ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL------IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      +.+..++.++|+||||+++|+|++ |..|+......      +... ... ..+...+..+.+++.+||+.||.+||++.
T Consensus       246 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~  323 (344)
T 1rjb_A          246 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG-FKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFP  323 (344)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT-CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcC-CCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence            998899999999999999999997 77776433211      1100 000 12333466789999999999999999999


Q ss_pred             HHHHHHhhhhhc
Q 028458          156 DVVCMLTNEAAT  167 (208)
Q Consensus       156 ~i~~~l~~~~~~  167 (208)
                      ++++.|+.....
T Consensus       324 ~l~~~l~~~~~~  335 (344)
T 1rjb_A          324 NLTSFLGCQLAD  335 (344)
T ss_dssp             HHHHHHHHHC--
T ss_pred             HHHHHHHHHHHH
Confidence            999999987654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=1e-29  Score=203.98  Aligned_cols=161  Identities=24%  Similarity=0.361  Sum_probs=125.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++..++.++.|++.||.|||+.+   |+||||||.||+++.++.++|+|||++.......... ......++..|+||
T Consensus       147 ~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aP  223 (325)
T 3kul_A          147 QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP  223 (325)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCH
Confidence            4788899999999999999999999   9999999999999999999999999998765432211 11122346679999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++|+||||+++|+|++ |..|+......     +....  ....+...+..+.++|.+||+.||++||++
T Consensus       224 E~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  301 (325)
T 3kul_A          224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY--RLPAPMGCPHALHQLMLDCWHKDRAQRPRF  301 (325)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--CCCCCCCcCHHHHHHHHHHccCChhhCcCH
Confidence            99998889999999999999999998 77776432211     11000  001233456678999999999999999999


Q ss_pred             HHHHHHHhhhhhc
Q 028458          155 NDVVCMLTNEAAT  167 (208)
Q Consensus       155 ~~i~~~l~~~~~~  167 (208)
                      .++++.|+.+...
T Consensus       302 ~eil~~L~~l~~~  314 (325)
T 3kul_A          302 SQIVSVLDALIRS  314 (325)
T ss_dssp             HHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHhC
Confidence            9999999998754

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=1.9e-29  Score=208.60  Aligned_cols=145  Identities=17%  Similarity=0.219  Sum_probs=115.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||++......     .....| ..|+|||.
T Consensus       208 l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~  278 (413)
T 3dzo_A          208 LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPET  278 (413)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchh
Confidence            567788999999999999999999   999999999999999999999999998765433     223456 89999999


Q ss_pred             h----------ccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc-CCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           83 A----------IQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-DPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        83 ~----------~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      +          ....++.++|+|||||++|+|++|..|+........ ...+.   .....+..+.++|.+||+.||++|
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dP~~R  355 (413)
T 3dzo_A          279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR---SCKNIPQPVRALLEGFLRYPKEDR  355 (413)
T ss_dssp             HHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS---SCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred             hhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh---hcccCCHHHHHHHHHHccCChhhC
Confidence            9          444578899999999999999999988754322111 11111   112345678999999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      |++.++++
T Consensus       356 pt~~~~l~  363 (413)
T 3dzo_A          356 LLPLQAME  363 (413)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHHh
Confidence            99776644

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.96  E-value=9.6e-30  Score=207.90  Aligned_cols=146  Identities=17%  Similarity=0.198  Sum_probs=116.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.|+.||+.||.|||+++   |+||||||.||+++.++.+||+|||++......     .....| ..|+|||.
T Consensus       203 l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~  273 (377)
T 3byv_A          203 LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPEL  273 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHH
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhh
Confidence            456888899999999999999999   999999999999999999999999999864321     223456 89999999


Q ss_pred             hccC-----------CCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           83 AIQG-----------IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        83 ~~~~-----------~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      +.+.           .++.++|+||||+++|+|++|..|+.............  ......+..+.++|.+||+.||++|
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R  351 (377)
T 3byv_A          274 EARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF--RSCKNIPQPVRALLEGFLRYPKEDR  351 (377)
T ss_dssp             HHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG--SSCCCCCHHHHHHHHHHTCSSGGGC
T ss_pred             hcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh--hhccCCCHHHHHHHHHHcCCCchhC
Confidence            9887           79999999999999999999988875432211101110  1123345678899999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      |++.++++
T Consensus       352 pt~~e~l~  359 (377)
T 3byv_A          352 LLPLQAME  359 (377)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhh
Confidence            99999987

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=5.8e-29  Score=197.93  Aligned_cols=163  Identities=25%  Similarity=0.326  Sum_probs=124.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhcc---CCCCceEeeCCCCCeeEeCCCCC-eEEeccccceecCCCcccccccccccCCCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQ---YSRVRIIHRDLKVSNILLDKDMN-PKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~---~~~~~i~h~~l~~~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      +++..++.++.|+++||.|||+   ++   ++|+||||+||+++.++. ++|+|||++.......     ....|+..|+
T Consensus        99 ~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~  170 (307)
T 2eva_A           99 YTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----TNNKGSAAWM  170 (307)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSS
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccccccc-----ccCCCCCceE
Confidence            5678899999999999999999   77   999999999999988876 7999999987553221     1235788999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-------ccCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-------IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      |||.+.+..++.++|+||||+++|+|++|..|+......       .....  ........+..+.+++.+||+.||++|
T Consensus       171 aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~R  248 (307)
T 2eva_A          171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT--RPPLIKNLPKPIESLMTRCWSKDPSQR  248 (307)
T ss_dssp             CHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC--CCCCBTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             ChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC--CCCcccccCHHHHHHHHHHhcCChhhC
Confidence            999999888999999999999999999998887532111       00000  001223445678899999999999999


Q ss_pred             CCHHHHHHHHhhhhhccCCCCCCC
Q 028458          152 PTMNDVVCMLTNEAATLLPPKQPA  175 (208)
Q Consensus       152 ps~~~i~~~l~~~~~~~~~p~~~~  175 (208)
                      |+++++++.|+.+....+....|.
T Consensus       249 ps~~ell~~L~~~~~~~~~~~~~~  272 (307)
T 2eva_A          249 PSMEEIVKIMTHLMRYFPGADEPL  272 (307)
T ss_dssp             CCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred             cCHHHHHHHHHHHHHhccCCCCcc
Confidence            999999999999887665554444

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.96  E-value=4.3e-29  Score=198.87  Aligned_cols=162  Identities=23%  Similarity=0.324  Sum_probs=118.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-ccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~ap   80 (208)
                      .+++.++..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++......... .......|+..|+||
T Consensus       112 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  188 (311)
T 3ork_A          112 PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP  188 (311)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCH
Confidence            4788899999999999999999999   999999999999999999999999998765433221 112234578999999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++|+||||+++|+|++|..|+......      ...............+..+.++|.+||+.||++||++
T Consensus       189 E~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~  268 (311)
T 3ork_A          189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT  268 (311)
T ss_dssp             HHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred             HHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhh
Confidence            9999889999999999999999999998887543221      1111111112223356778999999999999999966


Q ss_pred             HHHH-HHHhhhhh
Q 028458          155 NDVV-CMLTNEAA  166 (208)
Q Consensus       155 ~~i~-~~l~~~~~  166 (208)
                      .+++ ..|.+...
T Consensus       269 ~~~l~~~l~~~~~  281 (311)
T 3ork_A          269 AAEMRADLVRVHN  281 (311)
T ss_dssp             HHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhc
Confidence            6555 45666543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.96  E-value=1.3e-29  Score=201.44  Aligned_cols=161  Identities=24%  Similarity=0.329  Sum_probs=127.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++................++..|.|||.
T Consensus       142 ~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  218 (313)
T 1t46_A          142 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES  218 (313)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHH
Confidence            789999999999999999999999   99999999999999999999999999987654433222233456778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc--cc---CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL--ID---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+......  ..   ..... ...+...+..+.+++.+||+.||++||++.+
T Consensus       219 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  297 (313)
T 1t46_A          219 IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ  297 (313)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCC-CCCcccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            998899999999999999999998 77776432211  00   00000 0112334567899999999999999999999


Q ss_pred             HHHHHhhhhhc
Q 028458          157 VVCMLTNEAAT  167 (208)
Q Consensus       157 i~~~l~~~~~~  167 (208)
                      +++.|++....
T Consensus       298 ll~~L~~~~~~  308 (313)
T 1t46_A          298 IVQLIEKQISE  308 (313)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999887644

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.96  E-value=1.4e-29  Score=203.64  Aligned_cols=163  Identities=25%  Similarity=0.293  Sum_probs=128.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++................++..|.|||.
T Consensus       154 ~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  230 (334)
T 2pvf_A          154 MTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEA  230 (334)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHH
Confidence            788999999999999999999999   99999999999999999999999999987655433322333345678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+.....  .   +....  ....+...+..+.+++.+||+.||.+||++.+
T Consensus       231 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  308 (334)
T 2pvf_A          231 LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH--RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQ  308 (334)
T ss_dssp             HHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC--CCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            988889999999999999999998 7766643211  0   00000  00122344567889999999999999999999


Q ss_pred             HHHHHhhhhhccCC
Q 028458          157 VVCMLTNEAATLLP  170 (208)
Q Consensus       157 i~~~l~~~~~~~~~  170 (208)
                      +++.|+++......
T Consensus       309 ll~~L~~l~~~~~~  322 (334)
T 2pvf_A          309 LVEDLDRILTLTTN  322 (334)
T ss_dssp             HHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHhcccc
Confidence            99999988755433

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.96  E-value=2.1e-29  Score=196.30  Aligned_cols=159  Identities=23%  Similarity=0.326  Sum_probs=125.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++........... ....++..|.|||
T Consensus       100 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE  175 (268)
T 3sxs_A          100 GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS-VGTKFPVKWSAPE  175 (268)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC-CSCCCCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcc-cCCCcCcccCCHH
Confidence            3788899999999999999999999   99999999999999999999999999987654432221 1234466799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......     .....  ....+...+..+.+++.+||+.||++||+++
T Consensus       176 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  253 (268)
T 3sxs_A          176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH--RLYRPHLASDTIYQIMYSCWHELPEKRPTFQ  253 (268)
T ss_dssp             HHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             HHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC--CCCCCCcChHHHHHHHHHHcCCChhhCcCHH
Confidence            9998889999999999999999998 77776432211     00000  0011222356788999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|+.+..
T Consensus       254 ~ll~~L~~l~~  264 (268)
T 3sxs_A          254 QLLSSIEPLRE  264 (268)
T ss_dssp             HHHHHHGGGCC
T ss_pred             HHHHHHHHhhh
Confidence            99999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=8.1e-30  Score=201.41  Aligned_cols=162  Identities=23%  Similarity=0.316  Sum_probs=122.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-ccccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~ape   81 (208)
                      +++..++.++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++......... .......++..|.|||
T Consensus       111 ~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  187 (295)
T 3ugc_A          111 IDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE  187 (295)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcH
Confidence            678899999999999999999999   999999999999999999999999999776433221 1112234566799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc----cCCcc---------------chhhhhHHHHHHHHHHHhh
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI----DDPVL---------------EDEYSSKQMLLRYVNIALL  142 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~----~~~~~---------------~~~~~~~~~~~~~~~li~~  142 (208)
                      .+.+..++.++|+||||+++|+|++|..++.......    .....               .....+...+..+.+++.+
T Consensus       188 ~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  267 (295)
T 3ugc_A          188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE  267 (295)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             HhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHH
Confidence            9999999999999999999999999876654322110    00000               0001123445678999999


Q ss_pred             ccccCCCCCCCHHHHHHHHhhhhhc
Q 028458          143 CVQESADDRPTMNDVVCMLTNEAAT  167 (208)
Q Consensus       143 ~l~~~p~~Rps~~~i~~~l~~~~~~  167 (208)
                      ||+.||++||++.|+++.|+.+...
T Consensus       268 ~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          268 CWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HcCCChhhCCCHHHHHHHHHHHHHh
Confidence            9999999999999999999988654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=3.4e-29  Score=201.90  Aligned_cols=153  Identities=22%  Similarity=0.282  Sum_probs=122.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........   .....|++.|.|||
T Consensus       104 ~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE  177 (336)
T 3h4j_B          104 RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPE  177 (336)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSCGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCcCCHH
Confidence            4788899999999999999999999   99999999999999999999999999876544322   22346789999999


Q ss_pred             hhccCCC-CCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           82 YAIQGIF-SIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        82 ~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      .+.+..+ +.++|+||||+++|+|++|..|+.....  ............+...+..+.++|.+||+.||.+||+++|++
T Consensus       178 ~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil  257 (336)
T 3h4j_B          178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIR  257 (336)
T ss_dssp             GSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHT
T ss_pred             HHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            9987776 6899999999999999999988754321  111111111122334566788999999999999999999998


Q ss_pred             HH
Q 028458          159 CM  160 (208)
Q Consensus       159 ~~  160 (208)
                      +.
T Consensus       258 ~h  259 (336)
T 3h4j_B          258 RD  259 (336)
T ss_dssp             TC
T ss_pred             hC
Confidence            74

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.96  E-value=7.7e-29  Score=204.21  Aligned_cols=152  Identities=19%  Similarity=0.246  Sum_probs=117.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC---CCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.||+.||.|||+.+   |+||||||.||+++.   ++.++|+|||++........   .....|+..|+
T Consensus       157 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~  230 (400)
T 1nxk_A          157 AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYV  230 (400)
T ss_dssp             CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCCc---cccCCCCCCcc
Confidence            4789999999999999999999999   999999999999987   78899999999986543221   12346788999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCC-----------ccchhhhhHHHHHHHHHHHhhccccC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDP-----------VLEDEYSSKQMLLRYVNIALLCVQES  147 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~~  147 (208)
                      |||++.+..++.++|+|||||++|+|++|..|+..........           .... ......+..+.+||.+||+.|
T Consensus       231 aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~d  309 (400)
T 1nxk_A          231 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVSEEVKMLIRNLLKTE  309 (400)
T ss_dssp             CGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT-TTTTTSCHHHHHHHHTTSCSS
T ss_pred             CHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC-cccccCCHHHHHHHHHHCCCC
Confidence            9999988899999999999999999999998875432211100           0000 111345667899999999999


Q ss_pred             CCCCCCHHHHHHH
Q 028458          148 ADDRPTMNDVVCM  160 (208)
Q Consensus       148 p~~Rps~~~i~~~  160 (208)
                      |++||++.|+++.
T Consensus       310 P~~Rpt~~eil~h  322 (400)
T 1nxk_A          310 PTQRMTITEFMNH  322 (400)
T ss_dssp             GGGSCCHHHHHHS
T ss_pred             hhHCcCHHHHhcC
Confidence            9999999999984

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.96  E-value=1.6e-29  Score=198.16  Aligned_cols=161  Identities=27%  Similarity=0.362  Sum_probs=125.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........   .....++..|.|||
T Consensus       118 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE  191 (284)
T 2a19_B          118 KLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPE  191 (284)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChh
Confidence            4678899999999999999999999   99999999999999999999999999887654322   12235788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML  161 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l  161 (208)
                      .+.+..++.++|+||||+++|+|+++..++........  .+.........+..+.++|.+||+.||++||++.++++.|
T Consensus       192 ~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l  269 (284)
T 2a19_B          192 QISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT--DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL  269 (284)
T ss_dssp             HHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH--HHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH--HhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            99988899999999999999999987655432211111  0000011222345678999999999999999999999999


Q ss_pred             hhhhhccCC
Q 028458          162 TNEAATLLP  170 (208)
Q Consensus       162 ~~~~~~~~~  170 (208)
                      .........
T Consensus       270 ~~~~~~~~~  278 (284)
T 2a19_B          270 TVWKKSPEK  278 (284)
T ss_dssp             HHHTC----
T ss_pred             HHHhhCCCc
Confidence            988755433

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.96  E-value=9.5e-29  Score=199.14  Aligned_cols=149  Identities=23%  Similarity=0.318  Sum_probs=124.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++........   .....|+..|+|||
T Consensus       126 ~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE  199 (335)
T 3dls_A          126 RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPE  199 (335)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChh
Confidence            4788899999999999999999999   99999999999999999999999999987654332   12246789999999


Q ss_pred             hhccCCC-CCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458           82 YAIQGIF-SIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus        82 ~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      .+.+..+ +.++|+||||+++|+|++|..|+....+.......    .+...+..+.++|.+||+.||++||+++++++.
T Consensus       200 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIH----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccC----CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            9988776 78899999999999999999988765544432221    122245678899999999999999999999884

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.96  E-value=1.6e-29  Score=201.94  Aligned_cols=158  Identities=26%  Similarity=0.370  Sum_probs=125.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++................++..|.|||.
T Consensus       135 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (322)
T 1p4o_A          135 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  211 (322)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhh
Confidence            578899999999999999999999   99999999999999999999999999876543332222223355778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+......     +......  ..+...+..+.+++.+||+.||++||++.+
T Consensus       212 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  289 (322)
T 1p4o_A          212 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPSFLE  289 (322)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            998889999999999999999998 66665432111     1001110  123345567889999999999999999999


Q ss_pred             HHHHHhhhh
Q 028458          157 VVCMLTNEA  165 (208)
Q Consensus       157 i~~~l~~~~  165 (208)
                      +++.|++..
T Consensus       290 ~l~~L~~~~  298 (322)
T 1p4o_A          290 IISSIKEEM  298 (322)
T ss_dssp             HHHHHGGGS
T ss_pred             HHHHHHHhh
Confidence            999998864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.96  E-value=1.5e-29  Score=211.49  Aligned_cols=166  Identities=27%  Similarity=0.433  Sum_probs=125.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......... .....++..|+|||
T Consensus       276 ~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~~~~y~aPE  351 (452)
T 1fmk_A          276 YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPE  351 (452)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceec-ccCCcccccccCHh
Confidence            4788899999999999999999999   9999999999999999999999999997654332211 11234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+.....  .   +....  ....+...+..+.++|.+||+.||++||+++
T Consensus       352 ~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~  429 (452)
T 1fmk_A          352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCPPECPESLHDLMCQCWRKEPEERPTFE  429 (452)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence            9999999999999999999999999 7766643211  1   11000  0012334567789999999999999999999


Q ss_pred             HHHHHHhhhhhccCCCCC
Q 028458          156 DVVCMLTNEAATLLPPKQ  173 (208)
Q Consensus       156 ~i~~~l~~~~~~~~~p~~  173 (208)
                      ++++.|+.+.....+...
T Consensus       430 ~l~~~L~~~~~~~~~~~~  447 (452)
T 1fmk_A          430 YLQAFLEDYFTSTEPQYQ  447 (452)
T ss_dssp             HHHHHHHTTTSCSCCCCC
T ss_pred             HHHHHHHHHhccCCcccc
Confidence            999999998766554433

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.96  E-value=5.4e-29  Score=196.81  Aligned_cols=165  Identities=25%  Similarity=0.300  Sum_probs=125.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc--cccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~a   79 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++..........  ......++..|.|
T Consensus       124 ~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~a  200 (298)
T 3f66_A          124 NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA  200 (298)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccC
Confidence            3678899999999999999999999   9999999999999999999999999997664433221  1122345678999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccC--C--ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD--P--VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      ||.+.+..++.++|+||||+++|+|++|..++.........  .  .......+...+..+.+++.+||+.||++||++.
T Consensus       201 PE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  280 (298)
T 3f66_A          201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS  280 (298)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHH
Confidence            99999989999999999999999999955433221111000  0  0000011233456788999999999999999999


Q ss_pred             HHHHHHhhhhhccC
Q 028458          156 DVVCMLTNEAATLL  169 (208)
Q Consensus       156 ~i~~~l~~~~~~~~  169 (208)
                      ++++.|+++.....
T Consensus       281 ell~~L~~~~~~~~  294 (298)
T 3f66_A          281 ELVSRISAIFSTFI  294 (298)
T ss_dssp             HHHHHHHHHHHTSC
T ss_pred             HHHHHHHHHHHhhc
Confidence            99999999876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.96  E-value=4.1e-29  Score=200.31  Aligned_cols=155  Identities=25%  Similarity=0.315  Sum_probs=122.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++................|+..|+|||
T Consensus       101 ~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  177 (323)
T 3tki_A          101 GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE  177 (323)
T ss_dssp             BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcH
Confidence            4788899999999999999999999   9999999999999999999999999997654333222233456889999999


Q ss_pred             hhccCCC-CCcchhHHHHHHHHHHHHhhhcCCccccccc------CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIF-SIKSDVFSFGVLLLEIAWDLWTSNRTLELID------DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..+ +.++|+||||+++|+|++|..|+........      .... ........+..+.++|.+||+.||++||++
T Consensus       178 ~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  256 (323)
T 3tki_A          178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKKIDSAPLALLHKILVENPSARITI  256 (323)
T ss_dssp             HHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT-TSTTGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             HhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc-cCCccccCCHHHHHHHHHHccCChhhCcCH
Confidence            9987775 7789999999999999999988754322110      0000 001123455678899999999999999999


Q ss_pred             HHHHHH
Q 028458          155 NDVVCM  160 (208)
Q Consensus       155 ~~i~~~  160 (208)
                      +|+++.
T Consensus       257 ~eil~h  262 (323)
T 3tki_A          257 PDIKKD  262 (323)
T ss_dssp             HHHTTC
T ss_pred             HHHhhC
Confidence            999874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=9.1e-29  Score=195.69  Aligned_cols=162  Identities=27%  Similarity=0.364  Sum_probs=124.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++......... ......|+..|+|||
T Consensus       107 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE  182 (294)
T 4eqm_A          107 PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPE  182 (294)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccccc-ccCccccCccccCHh
Confidence            4788899999999999999999999   999999999999999999999999998765433221 122246789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCC-C
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRP-T  153 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s  153 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......      ...... .........+..+.++|.+||+.||.+|| +
T Consensus       183 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~  262 (294)
T 4eqm_A          183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKT  262 (294)
T ss_dssp             HHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSS
T ss_pred             HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHcccc
Confidence            999988999999999999999999999887543221      111110 01122334567889999999999999999 9


Q ss_pred             HHHHHHHHhhhhhc
Q 028458          154 MNDVVCMLTNEAAT  167 (208)
Q Consensus       154 ~~~i~~~l~~~~~~  167 (208)
                      ++++.+.|+.....
T Consensus       263 ~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          263 IQEMKDDLSSVLHE  276 (294)
T ss_dssp             HHHHHHHHHTSSSS
T ss_pred             HHHHHHHHHHHHhh
Confidence            99999999887543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.96  E-value=3.5e-29  Score=200.64  Aligned_cols=163  Identities=25%  Similarity=0.265  Sum_probs=125.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ape   81 (208)
                      +++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......... ......++..|.|||
T Consensus       124 ~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  200 (327)
T 3lxl_A          124 LDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE  200 (327)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHH
Confidence            688899999999999999999999   9999999999999999999999999998765433221 222245677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc-----CCccc-------------hhhhhHHHHHHHHHHHhhc
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-----DPVLE-------------DEYSSKQMLLRYVNIALLC  143 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----~~~~~-------------~~~~~~~~~~~~~~li~~~  143 (208)
                      .+.+..++.++|+||||+++|+|++|..|+........     .....             ....+...+..+.+++.+|
T Consensus       201 ~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  280 (327)
T 3lxl_A          201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLC  280 (327)
T ss_dssp             HHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             HhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHH
Confidence            99988899999999999999999998776643322100     00000             0011223456789999999


Q ss_pred             cccCCCCCCCHHHHHHHHhhhhhcc
Q 028458          144 VQESADDRPTMNDVVCMLTNEAATL  168 (208)
Q Consensus       144 l~~~p~~Rps~~~i~~~l~~~~~~~  168 (208)
                      |+.||++||++.++++.|+.+....
T Consensus       281 l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          281 WAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHC----
T ss_pred             cCCChhhCcCHHHHHHHHHHHHhhh
Confidence            9999999999999999999886543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.95  E-value=1.2e-28  Score=198.33  Aligned_cols=163  Identities=25%  Similarity=0.306  Sum_probs=125.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhc--------cCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc--ccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLH--------QYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRI   71 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh--------~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~   71 (208)
                      .+++..++.++.|++.||.|||        +.+   ++|+||||+||+++.++.++|+|||++..........  .....
T Consensus       135 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~  211 (342)
T 1b6c_B          135 TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR  211 (342)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSC
T ss_pred             CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccC
Confidence            3678899999999999999999        787   9999999999999999999999999997764433211  12334


Q ss_pred             ccCCCccCcchhccCC------CCCcchhHHHHHHHHHHHHh----------hhcCCcccc----------cc----cCC
Q 028458           72 VGTYGYMSPEYAIQGI------FSIKSDVFSFGVLLLEIAWD----------LWTSNRTLE----------LI----DDP  121 (208)
Q Consensus        72 ~~~~~~~ape~~~~~~------~~~~~Dv~slG~~~~~l~~~----------~~~~~~~~~----------~~----~~~  121 (208)
                      .++..|.|||.+.+..      ++.++|+||||+++|+|++|          ..|+.....          .+    ..+
T Consensus       212 ~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  291 (342)
T 1b6c_B          212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP  291 (342)
T ss_dssp             CCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC
T ss_pred             CcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCC
Confidence            6788999999987652      33689999999999999998          444432210          00    011


Q ss_pred             ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhhhhhc
Q 028458          122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAAT  167 (208)
Q Consensus       122 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~  167 (208)
                      ..............+.+++.+||+.||++||++.++++.|+.+...
T Consensus       292 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          292 NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            1222122345667899999999999999999999999999988654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=1.3e-28  Score=200.34  Aligned_cols=159  Identities=11%  Similarity=0.085  Sum_probs=125.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-----------CCCeEEeccccceecCCCcccccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-----------DMNPKISDFGMARICGGNELQANTSR   70 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-----------~~~~~l~dfg~~~~~~~~~~~~~~~~   70 (208)
                      .+++..++.++.||+.||.|||+++   |+||||||+||+++.           ++.++|+|||++..............
T Consensus       168 ~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~  244 (365)
T 3e7e_A          168 VMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA  244 (365)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeee
Confidence            4789999999999999999999999   999999999999988           89999999999976543222223334


Q ss_pred             cccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc--CCccchhhhhHHHHHHHHHHHhhccccCC
Q 028458           71 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID--DPVLEDEYSSKQMLLRYVNIALLCVQESA  148 (208)
Q Consensus        71 ~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p  148 (208)
                      ..|+..|+|||.+.+..++.++|+||||+++|+|++|..|+........  ...... .   .....+.+++..|++.+|
T Consensus       245 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~l~~~p  320 (365)
T 3e7e_A          245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR-L---PHLDMWNEFFHVMLNIPD  320 (365)
T ss_dssp             SSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECSCCTT-C---SSHHHHHHHHHHHHCCCC
T ss_pred             ecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeechhccc-c---CcHHHHHHHHHHHcCCCC
Confidence            5689999999999998899999999999999999999987743322110  111111 1   124467789999999999


Q ss_pred             CCC-CCHHHHHHHHhhhhhc
Q 028458          149 DDR-PTMNDVVCMLTNEAAT  167 (208)
Q Consensus       149 ~~R-ps~~~i~~~l~~~~~~  167 (208)
                      .+| |+++++.+.|+.....
T Consensus       321 ~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          321 CHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             TTCCCCHHHHHHHHHHHHHH
T ss_pred             CCcchHHHHHHHHHHHHHHH
Confidence            998 5888888888776544

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.95  E-value=1.4e-29  Score=198.87  Aligned_cols=159  Identities=21%  Similarity=0.276  Sum_probs=116.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......... .....++..|.|||
T Consensus       112 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE  187 (281)
T 1mp8_A          112 SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPE  187 (281)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcccccc-cccCCCcccccChh
Confidence            4788899999999999999999999   9999999999999999999999999987764332211 11234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......     +....  ....+...+..+.+++.+||+.||++||++.
T Consensus       188 ~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  265 (281)
T 1mp8_A          188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT  265 (281)
T ss_dssp             HHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence            9998899999999999999999996 76666432211     11000  0012334567788999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|+.+..
T Consensus       266 ~l~~~l~~~~~  276 (281)
T 1mp8_A          266 ELKAQLSTILE  276 (281)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999988653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.2e-29  Score=198.30  Aligned_cols=167  Identities=22%  Similarity=0.256  Sum_probs=131.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++.......... ......++..|.||
T Consensus       106 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  182 (287)
T 1u59_A          106 EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP  182 (287)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCH
Confidence            3788999999999999999999999   9999999999999999999999999998765333221 12223457789999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++|+||||+++|+|++ |..|+......     +....  ....+...+..+.++|.+||+.||++||++
T Consensus       183 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  260 (287)
T 1u59_A          183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--RMECPPECPPELYALMSDCWIYKWEDRPDF  260 (287)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC--cCCCCCCcCHHHHHHHHHHcCCChhhCcCH
Confidence            99988889999999999999999998 88777533211     11000  012234556788999999999999999999


Q ss_pred             HHHHHHHhhhhhccCCCCC
Q 028458          155 NDVVCMLTNEAATLLPPKQ  173 (208)
Q Consensus       155 ~~i~~~l~~~~~~~~~p~~  173 (208)
                      .++++.|+.+......+..
T Consensus       261 ~~l~~~l~~~~~~~~~~~~  279 (287)
T 1u59_A          261 LTVEQRMRACYYSLASKVE  279 (287)
T ss_dssp             HHHHHHHHHHHHHHHTTCS
T ss_pred             HHHHHHHHHHHHhcCCccc
Confidence            9999999988765554443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.95  E-value=3.5e-29  Score=196.14  Aligned_cols=162  Identities=28%  Similarity=0.419  Sum_probs=127.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+++   ++|+||+|.||+++.++.++|+|||++.......... .....++..|.|||
T Consensus       105 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE  180 (279)
T 1qpc_A          105 KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPE  180 (279)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC-CTTCCCCTTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccccc-ccCCCCccCccChh
Confidence            4788899999999999999999999   9999999999999999999999999998765433221 12234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+.....  .   +....  ....+...+..+.+++.+||+.||++||+++
T Consensus       181 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  258 (279)
T 1qpc_A          181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--RMVRPDNCPEELYQLMRLCWKERPEDRPTFD  258 (279)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc--CCCCcccccHHHHHHHHHHhccChhhCCCHH
Confidence            9988889999999999999999998 7766643211  1   00000  0012234456788999999999999999999


Q ss_pred             HHHHHHhhhhhccC
Q 028458          156 DVVCMLTNEAATLL  169 (208)
Q Consensus       156 ~i~~~l~~~~~~~~  169 (208)
                      ++++.|+.+.....
T Consensus       259 ~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          259 YLRSVLEDFFTATE  272 (279)
T ss_dssp             HHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHHhcc
Confidence            99999998775543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.95  E-value=1.3e-29  Score=203.50  Aligned_cols=161  Identities=24%  Similarity=0.316  Sum_probs=125.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++................++..|.|||
T Consensus       160 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  236 (333)
T 2i1m_A          160 TASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE  236 (333)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHH
Confidence            3678899999999999999999999   9999999999999999999999999997654333222222334567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc--cc---CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL--ID---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......  ..   ..... ...+...+..+.+++.+||+.||.+||++.
T Consensus       237 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  315 (333)
T 2i1m_A          237 SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ-MAQPAFAPKNIYSIMQACWALEPTHRPTFQ  315 (333)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCcCHH
Confidence            9998899999999999999999998 66665432111  00   00000 011222356788999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|+....
T Consensus       316 ~l~~~L~~~~~  326 (333)
T 2i1m_A          316 QICSFLQEQAQ  326 (333)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999987653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.95  E-value=5.9e-29  Score=197.66  Aligned_cols=152  Identities=24%  Similarity=0.269  Sum_probs=120.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++........   .....++..|+|||.
T Consensus       117 ~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~  190 (308)
T 3g33_A          117 LPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEV  190 (308)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchH
Confidence            788999999999999999999999   99999999999999999999999999876543222   223467899999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc------------CC------cc-----------chhhhhHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID------------DP------VL-----------EDEYSSKQML  133 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------------~~------~~-----------~~~~~~~~~~  133 (208)
                      +.+..++.++|+||||+++|+|++|..|+........            ..      ..           .........+
T Consensus       191 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (308)
T 3g33_A          191 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEME  270 (308)
T ss_dssp             HHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCC
T ss_pred             HcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCcccc
Confidence            9999999999999999999999998877743221100            00      00           0001112345


Q ss_pred             HHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          134 LRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       134 ~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ..+.++|.+||+.||++||++.|+++.
T Consensus       271 ~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          271 ESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            678899999999999999999999863

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.95  E-value=3.1e-29  Score=202.37  Aligned_cols=154  Identities=25%  Similarity=0.327  Sum_probs=114.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.||.|||+.+   |+||||||.||+++ ++.++|+|||++................|++.|+|||
T Consensus       104 ~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE  179 (343)
T 3dbq_A          104 SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE  179 (343)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHH
Confidence            4788899999999999999999999   99999999999997 5789999999997765443322233456899999999


Q ss_pred             hhcc-----------CCCCCcchhHHHHHHHHHHHHhhhcCCccccccc------CCccchhhhhHHHHHHHHHHHhhcc
Q 028458           82 YAIQ-----------GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID------DPVLEDEYSSKQMLLRYVNIALLCV  144 (208)
Q Consensus        82 ~~~~-----------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l  144 (208)
                      .+.+           ..++.++|+||||+++|+|++|..|+........      ...... ..+...+..+.+++.+||
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L  258 (343)
T 3dbq_A          180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-EFPDIPEKDLQDVLKCCL  258 (343)
T ss_dssp             HHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC-CCCCCSCHHHHHHHHHHT
T ss_pred             HHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc-CCcccCCHHHHHHHHHHc
Confidence            9865           5688999999999999999999988864322110      000000 112223456889999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 028458          145 QESADDRPTMNDVVCM  160 (208)
Q Consensus       145 ~~~p~~Rps~~~i~~~  160 (208)
                      +.||++||++.|+++.
T Consensus       259 ~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          259 KRDPKQRISIPELLAH  274 (343)
T ss_dssp             CSSTTTSCCHHHHHTS
T ss_pred             CCChhHCCCHHHHHhC
Confidence            9999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.95  E-value=1.6e-29  Score=201.17  Aligned_cols=162  Identities=27%  Similarity=0.293  Sum_probs=127.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++................++..|+|||.
T Consensus       145 ~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  221 (316)
T 2xir_A          145 LTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET  221 (316)
T ss_dssp             EEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchh
Confidence            788999999999999999999999   99999999999999999999999999976644332222233456778999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc--ccCCcc--chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL--IDDPVL--EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +.+..++.++|+||||+++|+|++ |..|+......  ......  .....+...+..+.+++.+||+.||.+||++.++
T Consensus       222 ~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  301 (316)
T 2xir_A          222 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  301 (316)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            999899999999999999999997 77776432110  000000  0001123345678899999999999999999999


Q ss_pred             HHHHhhhhhc
Q 028458          158 VCMLTNEAAT  167 (208)
Q Consensus       158 ~~~l~~~~~~  167 (208)
                      ++.|+.+...
T Consensus       302 l~~L~~~~~~  311 (316)
T 2xir_A          302 VEHLGNLLQA  311 (316)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHhh
Confidence            9999887643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.95  E-value=1.5e-28  Score=196.89  Aligned_cols=154  Identities=23%  Similarity=0.328  Sum_probs=122.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++.........  .....|+..|+|||
T Consensus       137 ~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE  211 (321)
T 2c30_A          137 RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPE  211 (321)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHh
Confidence            4788999999999999999999999   999999999999999999999999998776433221  22346789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......     +..............+..+.+++.+||+.||++||++.+
T Consensus       212 ~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  291 (321)
T 2c30_A          212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQE  291 (321)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            999888999999999999999999998877533211     000000000112334567889999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       292 ll~h  295 (321)
T 2c30_A          292 LLDH  295 (321)
T ss_dssp             HHTS
T ss_pred             HhcC
Confidence            9874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.95  E-value=3.8e-29  Score=203.87  Aligned_cols=142  Identities=10%  Similarity=0.022  Sum_probs=113.8

Q ss_pred             HHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchhcc--C
Q 028458            9 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ--G   86 (208)
Q Consensus         9 ~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~--~   86 (208)
                      ..++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++........     ...++..|+|||.+.+  .
T Consensus       197 ~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~  268 (371)
T 3q60_A          197 HILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTA  268 (371)
T ss_dssp             HHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEE
T ss_pred             HHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCC
Confidence            677799999999999999   99999999999999999999999999987643221     2345689999999987  6


Q ss_pred             CCCCcchhHHHHHHHHHHHHhhhcCCccccccc----C--------CccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           87 IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID----D--------PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        87 ~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~----~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .++.++|+||||+++|+|++|..|+........    .        ..... ......+..+.++|.+||+.||++||++
T Consensus       269 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~  347 (371)
T 3q60_A          269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAF-GSCTPLPDFVKTLIGRFLNFDRRRRLLP  347 (371)
T ss_dssp             ECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCC-TTSSCCCHHHHHHHHHHTCSSTTTCCCH
T ss_pred             CcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccch-hhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence            789999999999999999999988765422110    0        00000 1123456788999999999999999999


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      .++++
T Consensus       348 ~e~l~  352 (371)
T 3q60_A          348 LEAME  352 (371)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99976

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=1.7e-29  Score=197.01  Aligned_cols=159  Identities=27%  Similarity=0.381  Sum_probs=125.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......... .....++..|.|||
T Consensus       102 ~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE  177 (269)
T 4hcu_A          102 LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPE  177 (269)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS-TTSTTCCGGGCCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccc-ccCcccccccCCHH
Confidence            3688899999999999999999999   9999999999999999999999999987654332211 12234566899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......     +....  ....+...+..+.+++.+||+.||++||++.
T Consensus       178 ~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  255 (269)
T 4hcu_A          178 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF--RLYKPRLASTHVYQIMNHCWRERPEDRPAFS  255 (269)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc--cCCCCCcCCHHHHHHHHHHccCCcccCcCHH
Confidence            9998999999999999999999998 77776433211     00000  0012233456788999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|+++..
T Consensus       256 ~ll~~l~~l~~  266 (269)
T 4hcu_A          256 RLLRQLAEIAE  266 (269)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.95  E-value=3.1e-29  Score=201.56  Aligned_cols=153  Identities=25%  Similarity=0.277  Sum_probs=120.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++........   .....|++.|+|||
T Consensus       110 ~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE  183 (328)
T 3fe3_A          110 RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPE  183 (328)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---cccccCCcceeCcc
Confidence            4678889999999999999999999   99999999999999999999999999876543321   23356889999999


Q ss_pred             hhccCCCC-CcchhHHHHHHHHHHHHhhhcCCccccc-ccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           82 YAIQGIFS-IKSDVFSFGVLLLEIAWDLWTSNRTLEL-IDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        82 ~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      .+.+..+. .++|+||||+++|+|++|..|+...... ...... .....+...+..+.+++.+||+.||.+||+++|++
T Consensus       184 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil  263 (328)
T 3fe3_A          184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM  263 (328)
T ss_dssp             HHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHT
T ss_pred             cccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            99888764 7899999999999999999887543211 000000 00011223456788999999999999999999998


Q ss_pred             HH
Q 028458          159 CM  160 (208)
Q Consensus       159 ~~  160 (208)
                      +.
T Consensus       264 ~h  265 (328)
T 3fe3_A          264 KD  265 (328)
T ss_dssp             TC
T ss_pred             cC
Confidence            74

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.95  E-value=6.3e-29  Score=200.42  Aligned_cols=154  Identities=20%  Similarity=0.267  Sum_probs=121.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++.......  .......|++.|+|||
T Consensus       101 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE  175 (337)
T 1o6l_A          101 VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPE  175 (337)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC--CcccccccChhhCChh
Confidence            4678889999999999999999999   9999999999999999999999999987532221  1123356889999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----CH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----TM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......  ...........+...+..+.++|.+||+.||++||     ++
T Consensus       176 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~  255 (337)
T 1o6l_A          176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA  255 (337)
T ss_dssp             GGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTH
T ss_pred             hhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCH
Confidence            999888999999999999999999999887543211  11000001112334566788999999999999999     89


Q ss_pred             HHHHHH
Q 028458          155 NDVVCM  160 (208)
Q Consensus       155 ~~i~~~  160 (208)
                      +|+++.
T Consensus       256 ~ei~~h  261 (337)
T 1o6l_A          256 KEVMEH  261 (337)
T ss_dssp             HHHHTS
T ss_pred             HHHHcC
Confidence            999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.95  E-value=2.6e-29  Score=210.08  Aligned_cols=159  Identities=29%  Similarity=0.425  Sum_probs=126.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++.......... .....++..|+|||
T Consensus       280 ~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE  355 (454)
T 1qcf_A          280 KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPE  355 (454)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT-TCSSSSCGGGSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec-cCCCcccccccCHH
Confidence            3677889999999999999999999   9999999999999999999999999997654322111 11223467899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--cc---c-CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--LI---D-DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~~---~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+....++.++|+||||+++|+|++ |..|+.....  ..   . ...+   ..+...+..+.++|.+||+.||++||++
T Consensus       356 ~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~  432 (454)
T 1qcf_A          356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENCPEELYNIMMRCWKNRPEERPTF  432 (454)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHccCChhHCcCH
Confidence            9998999999999999999999998 7777643211  11   0 0011   1233456778999999999999999999


Q ss_pred             HHHHHHHhhhhhc
Q 028458          155 NDVVCMLTNEAAT  167 (208)
Q Consensus       155 ~~i~~~l~~~~~~  167 (208)
                      ++|++.|+.+...
T Consensus       433 ~~i~~~L~~~~~~  445 (454)
T 1qcf_A          433 EYIQSVLDDFYTA  445 (454)
T ss_dssp             HHHHHHHHTSSSS
T ss_pred             HHHHHHHHHHHhc
Confidence            9999999988644

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=7.1e-29  Score=202.71  Aligned_cols=163  Identities=24%  Similarity=0.311  Sum_probs=118.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc--cccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~a   79 (208)
                      .+++..++.++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++..........  ......++..|+|
T Consensus       188 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~a  264 (373)
T 3c1x_A          188 NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA  264 (373)
T ss_dssp             CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccC
Confidence            3678899999999999999999999   9999999999999999999999999997654332211  1122345678999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHh-hhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWD-LWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~-~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      ||.+.+..++.++|+||||+++|+|+++ ..|+.....  .   +....  ....+...+..+.+++.+||+.||++||+
T Consensus       265 PE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~--~~~~p~~~~~~l~~li~~cl~~dp~~RPs  342 (373)
T 3c1x_A          265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDPLYEVMLKCWHPKAEMRPS  342 (373)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             hHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence            9999999999999999999999999995 444432211  0   00000  00123334567899999999999999999


Q ss_pred             HHHHHHHHhhhhhccC
Q 028458          154 MNDVVCMLTNEAATLL  169 (208)
Q Consensus       154 ~~~i~~~l~~~~~~~~  169 (208)
                      +.++++.|+.+.....
T Consensus       343 ~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          343 FSELVSRISAIFSTFI  358 (373)
T ss_dssp             HHHHHHHHHHHHHTCC
T ss_pred             HHHHHHHHHHHHHhcc
Confidence            9999999999876544

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.95  E-value=7.5e-29  Score=198.33  Aligned_cols=153  Identities=29%  Similarity=0.409  Sum_probs=117.7

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc----------cccccccc
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ----------ANTSRIVG   73 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~   73 (208)
                      ++..++.++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++.........          .......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            45568899999999999999999   999999999999999999999999999876543211          11122467


Q ss_pred             CCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccC-CccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           74 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD-PVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        74 ~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      +..|+|||.+.+..++.++|+||||+++|+|+++..++......... ...............+.++|.+||+.||++||
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  318 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP  318 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence            89999999999989999999999999999999876554332222110 00111123344556778999999999999999


Q ss_pred             CHHHHHH
Q 028458          153 TMNDVVC  159 (208)
Q Consensus       153 s~~~i~~  159 (208)
                      +++|+++
T Consensus       319 s~~~~l~  325 (332)
T 3qd2_B          319 EATDIIE  325 (332)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHhh
Confidence            9999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.95  E-value=4.8e-28  Score=193.37  Aligned_cols=158  Identities=18%  Similarity=0.199  Sum_probs=125.7

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe----CCCCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      +++.++..++.|++.||.|||+++   ++|+||||.||++    +.++.++|+|||++.........   ....++..|+
T Consensus       109 ~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~  182 (319)
T 4euu_A          109 LPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYL  182 (319)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCB---CCCCSCGGGC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCce---eecccCCCcc
Confidence            788999999999999999999999   9999999999999    77788999999999876543321   2245788999


Q ss_pred             Ccchhc--------cCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc-----------C-------------------
Q 028458           79 SPEYAI--------QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-----------D-------------------  120 (208)
Q Consensus        79 ape~~~--------~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----------~-------------------  120 (208)
                      |||.+.        +..++.++|+||||+++|+|++|..|+........           .                   
T Consensus       183 aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  262 (319)
T 4euu_A          183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS  262 (319)
T ss_dssp             CHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEE
T ss_pred             CHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccC
Confidence            999986        46789999999999999999999877642111000           0                   


Q ss_pred             -CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhhhhh
Q 028458          121 -PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAA  166 (208)
Q Consensus       121 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l~~~~~  166 (208)
                       ...............+.+++.+||+.||++||+++|+++.......
T Consensus       263 ~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          263 GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             ccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence             0000112346677889999999999999999999999999887653

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=1.2e-28  Score=196.27  Aligned_cols=166  Identities=22%  Similarity=0.234  Sum_probs=118.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||+|.||+++.++.++|+|||++.......... .....++..|.|||
T Consensus       130 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE  205 (309)
T 2h34_A          130 PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPE  205 (309)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccccc-ccccCCCcCccCHH
Confidence            4788899999999999999999999   9999999999999999999999999987654332211 12245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-CHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-TMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~  155 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......     +..............+..+.++|.+||+.||++|| +++
T Consensus       206 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~  285 (309)
T 2h34_A          206 RFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCG  285 (309)
T ss_dssp             GTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHH
T ss_pred             HHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHH
Confidence            998888999999999999999999998887543221     11111111123344566788999999999999999 999


Q ss_pred             HHHHHHhhhhhccCCC
Q 028458          156 DVVCMLTNEAATLLPP  171 (208)
Q Consensus       156 ~i~~~l~~~~~~~~~p  171 (208)
                      ++++.|+.........
T Consensus       286 ~l~~~l~~~l~~~~~~  301 (309)
T 2h34_A          286 DLSAAAHAALATADQD  301 (309)
T ss_dssp             HHHHHHHHTCC-----
T ss_pred             HHHHHHHHHHHhhccc
Confidence            9999999876554433

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.95  E-value=3.6e-29  Score=200.00  Aligned_cols=161  Identities=25%  Similarity=0.308  Sum_probs=127.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-ccccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~ape   81 (208)
                      +++..++.++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++......... .......++..|+|||
T Consensus       131 ~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE  207 (318)
T 3lxp_A          131 IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE  207 (318)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChH
Confidence            678899999999999999999999   999999999999999999999999999876543322 1122245677899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc--------------------cCCccchhhhhHHHHHHHHHHHh
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--------------------DDPVLEDEYSSKQMLLRYVNIAL  141 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~li~  141 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.......                    ....  ....+...+..+.++|.
T Consensus       208 ~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~  285 (318)
T 3lxp_A          208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE--RLPRPDKCPAEVYHLMK  285 (318)
T ss_dssp             HHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHH
T ss_pred             HhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc--CCCCCccccHHHHHHHH
Confidence            9998889999999999999999999877764332110                    0000  00112334567899999


Q ss_pred             hccccCCCCCCCHHHHHHHHhhhhhcc
Q 028458          142 LCVQESADDRPTMNDVVCMLTNEAATL  168 (208)
Q Consensus       142 ~~l~~~p~~Rps~~~i~~~l~~~~~~~  168 (208)
                      +||+.||++||++.++++.|+.+....
T Consensus       286 ~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          286 NCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            999999999999999999998876543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.95  E-value=8.7e-29  Score=196.77  Aligned_cols=165  Identities=22%  Similarity=0.296  Sum_probs=119.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++.........  .....++..|.|||
T Consensus       132 ~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  206 (310)
T 2wqm_A          132 LIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPE  206 (310)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc--ccccCCCeeEeChH
Confidence            3678899999999999999999999   999999999999999999999999998765432211  12245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-------ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-------IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......       +....... ......+..+.+++.+||+.||++||++
T Consensus       207 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~  285 (310)
T 2wqm_A          207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP-LPSDHYSEELRQLVNMCINPDPEKRPDV  285 (310)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC-CCTTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC-CcccccCHHHHHHHHHHcCCChhhCCCH
Confidence            999888999999999999999999998776432110       11011110 1123345678899999999999999999


Q ss_pred             HHHHHHHhhhhhccCCCC
Q 028458          155 NDVVCMLTNEAATLLPPK  172 (208)
Q Consensus       155 ~~i~~~l~~~~~~~~~p~  172 (208)
                      .++++.|+++.+....|.
T Consensus       286 ~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          286 TYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             HHHHHHHHHHHHHHC---
T ss_pred             HHHHHHHHHHHHhhhhhh
Confidence            999999999987665553

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.95  E-value=3.5e-28  Score=193.85  Aligned_cols=153  Identities=21%  Similarity=0.195  Sum_probs=117.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.........  .....++..|+|||
T Consensus       115 ~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE  189 (311)
T 3niz_A          115 GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPD  189 (311)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCccc--ccCCcccCCcCCHH
Confidence            3778899999999999999999999   999999999999999999999999999876433221  12245788999999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccccc---------cCC---c--------------------cchhhh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------DDP---V--------------------LEDEYS  128 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~~~---~--------------------~~~~~~  128 (208)
                      .+.+ ..++.++|+||||+++|+|++|..|+.......         ..+   .                    ......
T Consensus       190 ~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (311)
T 3niz_A          190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSI  269 (311)
T ss_dssp             HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHH
T ss_pred             HhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHh
Confidence            9876 458999999999999999999987764321110         000   0                    000011


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ....+.++.++|.+||+.||++||+++|+++
T Consensus       270 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          270 IPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             STTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1223457889999999999999999999987

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.95  E-value=3.9e-29  Score=204.22  Aligned_cols=161  Identities=25%  Similarity=0.389  Sum_probs=116.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++.+++.++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++.......... ......++..|+||
T Consensus       143 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aP  219 (373)
T 2qol_A          143 QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP  219 (373)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccCh
Confidence            4788899999999999999999999   9999999999999999999999999987664332111 11112346689999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++|+||||+++|++++ |..|+......     +.... . ...+...+..+.+++.+||+.||++||++
T Consensus       220 E~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~  297 (373)
T 2qol_A          220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-R-LPPPMDCPAALYQLMLDCWQKDRNNRPKF  297 (373)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-E-CCCCTTCBHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-CCCCccccHHHHHHHHHHhCcChhhCcCH
Confidence            99999999999999999999999987 77776432111     11000 0 01123445678899999999999999999


Q ss_pred             HHHHHHHhhhhhc
Q 028458          155 NDVVCMLTNEAAT  167 (208)
Q Consensus       155 ~~i~~~l~~~~~~  167 (208)
                      .++++.|+++...
T Consensus       298 ~~i~~~L~~~~~~  310 (373)
T 2qol_A          298 EQIVSILDKLIRN  310 (373)
T ss_dssp             HHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHhC
Confidence            9999999887643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.95  E-value=7.4e-29  Score=203.66  Aligned_cols=154  Identities=24%  Similarity=0.314  Sum_probs=115.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.||+.||.|||+.+   |+||||||.||+++ ++.++|+|||++................|++.|+|||
T Consensus       151 ~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE  226 (390)
T 2zmd_A          151 SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE  226 (390)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChH
Confidence            3677889999999999999999999   99999999999996 5789999999998764433222223456899999999


Q ss_pred             hhcc-----------CCCCCcchhHHHHHHHHHHHHhhhcCCcccccc------cCCccchhhhhHHHHHHHHHHHhhcc
Q 028458           82 YAIQ-----------GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------DDPVLEDEYSSKQMLLRYVNIALLCV  144 (208)
Q Consensus        82 ~~~~-----------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l  144 (208)
                      .+.+           ..++.++|+||||+++|+|++|..|+.......      ....... ..+...+..+.++|.+||
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L  305 (390)
T 2zmd_A          227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-EFPDIPEKDLQDVLKCCL  305 (390)
T ss_dssp             HHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC-CCCCCSCHHHHHHHHHHT
T ss_pred             HhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC-CCCccchHHHHHHHHHHc
Confidence            9865           358889999999999999999998885432211      0000000 111122456889999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 028458          145 QESADDRPTMNDVVCM  160 (208)
Q Consensus       145 ~~~p~~Rps~~~i~~~  160 (208)
                      +.||++||++.|+++.
T Consensus       306 ~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          306 KRDPKQRISIPELLAH  321 (390)
T ss_dssp             CSSTTTSCCHHHHHTS
T ss_pred             ccChhhCCCHHHHhhC
Confidence            9999999999999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.95  E-value=3.7e-29  Score=196.39  Aligned_cols=159  Identities=25%  Similarity=0.359  Sum_probs=125.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++.......... .....++..|.|||
T Consensus       116 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE  191 (283)
T 3gen_A          116 RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPE  191 (283)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS-TTSTTSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccccc-ccCCccCcccCCHH
Confidence            3678899999999999999999999   9999999999999999999999999987654332211 11234567799999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......     +....  ....+...+..+.+++.+||+.||++||+++
T Consensus       192 ~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  269 (283)
T 3gen_A          192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL--RLYRPHLASEKVYTIMYSCWHEKADERPTFK  269 (283)
T ss_dssp             HHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc--CCCCCCcCCHHHHHHHHHHccCChhHCcCHH
Confidence            9998899999999999999999997 87776532211     11000  0011223356788999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|+.+..
T Consensus       270 ~ll~~L~~~~~  280 (283)
T 3gen_A          270 ILLSNILDVMD  280 (283)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHhh
Confidence            99999988753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.95  E-value=9e-29  Score=206.67  Aligned_cols=154  Identities=24%  Similarity=0.307  Sum_probs=123.3

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.......     ....++..|+|||.
T Consensus       286 ~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~  357 (450)
T 1k9a_A          286 LGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEA  357 (450)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHH
Confidence            688899999999999999999999   9999999999999999999999999987543221     11245678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+.....  .   +....  ....+..++..+.++|.+||+.||++||++.+
T Consensus       358 ~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~  435 (450)
T 1k9a_A          358 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQ  435 (450)
T ss_dssp             HHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            999999999999999999999997 7766643211  1   11000  01223445678899999999999999999999


Q ss_pred             HHHHHhhhhh
Q 028458          157 VVCMLTNEAA  166 (208)
Q Consensus       157 i~~~l~~~~~  166 (208)
                      +++.|+.+..
T Consensus       436 l~~~L~~i~~  445 (450)
T 1k9a_A          436 LREQLEHIRT  445 (450)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999988764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=6.2e-29  Score=199.95  Aligned_cols=161  Identities=25%  Similarity=0.375  Sum_probs=120.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++..++.++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++.......... ......++..|.||
T Consensus       143 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  219 (333)
T 1mqb_A          143 EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP  219 (333)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCc
Confidence            4788899999999999999999999   9999999999999999999999999987664332111 11122346789999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++|+||||+++|+|++ |..|+.....     .+.....  ...+...+..+.+++.+||+.||++||++
T Consensus       220 E~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~  297 (333)
T 1mqb_A          220 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR--LPTPMDCPSAIYQLMMQCWQQERARRPKF  297 (333)
T ss_dssp             HHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--CCCCTTCBHHHHHHHHHHTCSSTTTSCCH
T ss_pred             hhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc--CCCcccCCHHHHHHHHHHcCCChhhCcCH
Confidence            99998889999999999999999998 7777643211     1110000  01123445678899999999999999999


Q ss_pred             HHHHHHHhhhhhc
Q 028458          155 NDVVCMLTNEAAT  167 (208)
Q Consensus       155 ~~i~~~l~~~~~~  167 (208)
                      .++++.|+++...
T Consensus       298 ~~l~~~L~~~~~~  310 (333)
T 1mqb_A          298 ADIVSILDKLIRA  310 (333)
T ss_dssp             HHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHhc
Confidence            9999999887644

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.95  E-value=5.9e-29  Score=196.85  Aligned_cols=161  Identities=20%  Similarity=0.291  Sum_probs=125.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-ccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++......... .......++..|.||
T Consensus       122 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  198 (302)
T 4e5w_A          122 KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP  198 (302)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCH
T ss_pred             cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCC
Confidence            4678899999999999999999999   999999999999999999999999999876544321 122234567789999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc---CCcc---c------------hhhhhHHHHHHHHHHHhh
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID---DPVL---E------------DEYSSKQMLLRYVNIALL  142 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---~~~~---~------------~~~~~~~~~~~~~~li~~  142 (208)
                      |.+.+..++.++|+||||+++|+|++|..++........   ....   .            ....+...+..+.+++.+
T Consensus       199 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  278 (302)
T 4e5w_A          199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRK  278 (302)
T ss_dssp             HHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             eeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence            999988899999999999999999998765432211100   0000   0            001123345678999999


Q ss_pred             ccccCCCCCCCHHHHHHHHhhhh
Q 028458          143 CVQESADDRPTMNDVVCMLTNEA  165 (208)
Q Consensus       143 ~l~~~p~~Rps~~~i~~~l~~~~  165 (208)
                      ||+.||++||++.++++.|+.+.
T Consensus       279 ~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          279 CWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             TTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HcCCCCCCCCCHHHHHHHHHHHh
Confidence            99999999999999999998753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=5.1e-29  Score=204.27  Aligned_cols=156  Identities=24%  Similarity=0.302  Sum_probs=117.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc-----------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL-----------------   64 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~-----------------   64 (208)
                      .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........                 
T Consensus       105 ~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~  181 (388)
T 3oz6_A          105 ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD  181 (388)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccc
Confidence            4677888999999999999999999   99999999999999999999999999976532110                 


Q ss_pred             --cccccccccCCCccCcchhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c-------cCCccc--------
Q 028458           65 --QANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I-------DDPVLE--------  124 (208)
Q Consensus        65 --~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~-------~~~~~~--------  124 (208)
                        ........|+..|+|||.+.+ ..++.++|+|||||++|+|++|..++......  .       ..+...        
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~  261 (388)
T 3oz6_A          182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSP  261 (388)
T ss_dssp             --------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCS
T ss_pred             cccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCH
Confidence              111223468899999999976 56899999999999999999998777432110  0       000000        


Q ss_pred             -------------------hhhh-------------hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          125 -------------------DEYS-------------SKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       125 -------------------~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                                         ....             ....+..+.+|+.+||+.||++||+++|+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          262 FAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             SHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence                               0000             00224578899999999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.95  E-value=2.6e-28  Score=192.62  Aligned_cols=154  Identities=20%  Similarity=0.206  Sum_probs=118.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.........  .....++..|+|||
T Consensus        97 ~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE  171 (292)
T 3o0g_A           97 DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPD  171 (292)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccc--ccCCccccCCcChH
Confidence            4678899999999999999999999   999999999999999999999999999876433221  22246688999999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcCCcccccc----------cCC----------------------ccchhhh
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI----------DDP----------------------VLEDEYS  128 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~----------~~~----------------------~~~~~~~  128 (208)
                      .+.+.. ++.++|+||||+++|+|+++..|+.......          ..+                      .......
T Consensus       172 ~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (292)
T 3o0g_A          172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV  251 (292)
T ss_dssp             HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTT
T ss_pred             HHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhc
Confidence            997766 7999999999999999998776642211100          000                      0000011


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ....+..+.++|.+||+.||++||+++|+++.
T Consensus       252 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            22345678899999999999999999999873

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.95  E-value=3.3e-28  Score=197.92  Aligned_cols=152  Identities=22%  Similarity=0.233  Sum_probs=121.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC----CeEEeccccceecCCCcccccccccccCCCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM----NPKISDFGMARICGGNELQANTSRIVGTYGY   77 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~   77 (208)
                      .+++..+..++.||+.||.|||+.+   |+|+||||.||+++.++    .++|+|||++........   .....|++.|
T Consensus       111 ~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y  184 (361)
T 2yab_A          111 SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEF  184 (361)
T ss_dssp             CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSCGGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc---cccCCCCccE
Confidence            4788999999999999999999999   99999999999998776    799999999987654321   2234688999


Q ss_pred             cCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---cCCccc-hhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           78 MSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---DDPVLE-DEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        78 ~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      +|||.+.+..++.++|+||||+++|+|++|..|+......  .   ...... ........+..+.+||.+||..||++|
T Consensus       185 ~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  264 (361)
T 2yab_A          185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKR  264 (361)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTS
T ss_pred             ECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHC
Confidence            9999999888999999999999999999999887543211  1   101100 001223345678899999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      |++.|+++
T Consensus       265 ~t~~e~l~  272 (361)
T 2yab_A          265 LTIQEALR  272 (361)
T ss_dssp             CCHHHHHT
T ss_pred             cCHHHHhc
Confidence            99999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.95  E-value=1.6e-28  Score=193.15  Aligned_cols=156  Identities=25%  Similarity=0.416  Sum_probs=121.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC-----eEEeccccceecCCCcccccccccccCCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN-----PKISDFGMARICGGNELQANTSRIVGTYG   76 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~-----~~l~dfg~~~~~~~~~~~~~~~~~~~~~~   76 (208)
                      .+++..+..++.|++.||.|||+++. +++|+||||+||+++.++.     ++|+|||++......     .....++..
T Consensus       118 ~~~~~~~~~~~~~l~~~l~~lH~~~~-~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~  191 (287)
T 4f0f_A          118 PIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQ  191 (287)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCT
T ss_pred             CccHHHHHHHHHHHHHHHHHHHhCCC-CeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-----ccccCCCcc
Confidence            47889999999999999999999862 2999999999999987776     999999998754322     223467899


Q ss_pred             ccCcchhc--cCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-------ccCCccchhhhhHHHHHHHHHHHhhccccC
Q 028458           77 YMSPEYAI--QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-------IDDPVLEDEYSSKQMLLRYVNIALLCVQES  147 (208)
Q Consensus        77 ~~ape~~~--~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  147 (208)
                      |.|||.+.  ...++.++|+||||+++|+|++|..|+......       ........ ..+...+..+.+++.+||+.|
T Consensus       192 y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~d  270 (287)
T 4f0f_A          192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP-TIPEDCPPRLRNVIELCWSGD  270 (287)
T ss_dssp             TSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC-CCCTTSCHHHHHHHHHHTCSS
T ss_pred             ccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC-CCCcccCHHHHHHHHHHhcCC
Confidence            99999984  445788999999999999999998887532210       00000010 223445677899999999999


Q ss_pred             CCCCCCHHHHHHHHhhh
Q 028458          148 ADDRPTMNDVVCMLTNE  164 (208)
Q Consensus       148 p~~Rps~~~i~~~l~~~  164 (208)
                      |++||+++++++.|+++
T Consensus       271 p~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          271 PKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             GGGSCCHHHHHHHHHTC
T ss_pred             hhhCcCHHHHHHHHHhC
Confidence            99999999999999763

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.95  E-value=5.4e-29  Score=195.39  Aligned_cols=161  Identities=24%  Similarity=0.265  Sum_probs=122.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++.......... .....++..|.|||
T Consensus       109 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE  184 (281)
T 3cc6_A          109 SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPE  184 (281)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccccccc-cccCCCCcceeCch
Confidence            3788899999999999999999999   9999999999999999999999999987654332211 12234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc--ccCC-ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL--IDDP-VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......  .... .......+...+..+.+++.+||+.||++||++.++
T Consensus       185 ~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el  264 (281)
T 3cc6_A          185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTEL  264 (281)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence            9988889999999999999999997 88776432111  0000 000001122345678899999999999999999999


Q ss_pred             HHHHhhhhh
Q 028458          158 VCMLTNEAA  166 (208)
Q Consensus       158 ~~~l~~~~~  166 (208)
                      ++.|+.+..
T Consensus       265 l~~L~~~~~  273 (281)
T 3cc6_A          265 VCSLSDVYQ  273 (281)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999987653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.8e-28  Score=196.49  Aligned_cols=153  Identities=20%  Similarity=0.238  Sum_probs=122.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC--CCCeEEeccccceecCCCcccccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK--DMNPKISDFGMARICGGNELQANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~a   79 (208)
                      .+++..+..++.|++.||.|||+.+   ++||||||.||+++.  ++.++|+|||++........   .....+++.|.|
T Consensus        98 ~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~a  171 (321)
T 1tki_A           98 ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYA  171 (321)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---cccccCChhhcC
Confidence            4788899999999999999999999   999999999999987  78999999999987654332   223467889999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c----cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I----DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      ||.+.+..++.++|+||||+++|+|++|..|+......  .    ..............+..+.++|.+||+.||++||+
T Consensus       172 PE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt  251 (321)
T 1tki_A          172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT  251 (321)
T ss_dssp             HHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             cHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcC
Confidence            99998888899999999999999999998887543221  1    00000011122345677899999999999999999


Q ss_pred             HHHHHHH
Q 028458          154 MNDVVCM  160 (208)
Q Consensus       154 ~~~i~~~  160 (208)
                      +.|+++.
T Consensus       252 ~~e~l~h  258 (321)
T 1tki_A          252 ASEALQH  258 (321)
T ss_dssp             HHHHHHS
T ss_pred             HHHHhcC
Confidence            9999984

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.95  E-value=4.5e-28  Score=198.35  Aligned_cols=150  Identities=25%  Similarity=0.253  Sum_probs=119.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC-CCCceEeeCCCCCeeEeCCCC----------------------------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDM----------------------------------   46 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~h~~l~~~nil~~~~~----------------------------------   46 (208)
                      .+++..+..++.||+.||.|||++ +   |+||||||.||+++.++                                  
T Consensus       142 ~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (397)
T 1wak_A          142 GLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG  218 (397)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccc
Confidence            378889999999999999999998 8   99999999999998775                                  


Q ss_pred             ---------------CeEEeccccceecCCCcccccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcC
Q 028458           47 ---------------NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTS  111 (208)
Q Consensus        47 ---------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~  111 (208)
                                     .++|+|||++.......     ....++..|+|||.+.+..++.++|+|||||++|+|++|..|+
T Consensus       219 ~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf  293 (397)
T 1wak_A          219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF  293 (397)
T ss_dssp             TTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCC
Confidence                           79999999998764322     2246788999999999988999999999999999999998877


Q ss_pred             Ccccccc---------------cCCc-----------------------------------cchhhhhHHHHHHHHHHHh
Q 028458          112 NRTLELI---------------DDPV-----------------------------------LEDEYSSKQMLLRYVNIAL  141 (208)
Q Consensus       112 ~~~~~~~---------------~~~~-----------------------------------~~~~~~~~~~~~~~~~li~  141 (208)
                      .......               ....                                   ..........+..+.+||.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  373 (397)
T 1wak_A          294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLL  373 (397)
T ss_dssp             CCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHG
T ss_pred             CCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHH
Confidence            4321100               0000                                   0000123456678899999


Q ss_pred             hccccCCCCCCCHHHHHH
Q 028458          142 LCVQESADDRPTMNDVVC  159 (208)
Q Consensus       142 ~~l~~~p~~Rps~~~i~~  159 (208)
                      +||+.||++||+++|+++
T Consensus       374 ~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          374 PMLELIPEKRATAAECLR  391 (397)
T ss_dssp             GGGCSSGGGSCCHHHHHT
T ss_pred             HHhccChhhcCCHHHHhh
Confidence            999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.95  E-value=1.3e-28  Score=192.10  Aligned_cols=158  Identities=31%  Similarity=0.369  Sum_probs=118.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC--------CCCeEEeccccceecCCCccccccccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK--------DMNPKISDFGMARICGGNELQANTSRIVG   73 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~--------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~   73 (208)
                      .+++..+..++.|++.||.|||+++..+++|+||||+||+++.        ++.++|+|||++........    ....+
T Consensus       101 ~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~  176 (271)
T 3dtc_A          101 RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAG  176 (271)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------C
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc----cCCCC
Confidence            4678899999999999999999997333789999999999985        67899999999876543322    12357


Q ss_pred             CCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----cCCccchhhhhHHHHHHHHHHHhhccccCC
Q 028458           74 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----DDPVLEDEYSSKQMLLRYVNIALLCVQESA  148 (208)
Q Consensus        74 ~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  148 (208)
                      +..|.|||.+.+..++.++|+||||+++|+|++|..|+.......     ...... ...+...+..+.+++.+||+.||
T Consensus       177 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p  255 (271)
T 3dtc_A          177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA-LPIPSTCPEPFAKLMEDCWNPDP  255 (271)
T ss_dssp             CGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC-CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             ccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC-CCCCcccCHHHHHHHHHHhcCCc
Confidence            889999999998889999999999999999999988875432211     000000 01233445678999999999999


Q ss_pred             CCCCCHHHHHHHHhhh
Q 028458          149 DDRPTMNDVVCMLTNE  164 (208)
Q Consensus       149 ~~Rps~~~i~~~l~~~  164 (208)
                      ++||++.|+++.|+.+
T Consensus       256 ~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          256 HSRPSFTNILDQLTTI  271 (271)
T ss_dssp             GGSCCHHHHHHHHHC-
T ss_pred             ccCcCHHHHHHHHhcC
Confidence            9999999999999753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.95  E-value=6.2e-29  Score=196.08  Aligned_cols=161  Identities=24%  Similarity=0.272  Sum_probs=126.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++.......... ......++..|.||
T Consensus       113 ~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  189 (291)
T 1xbb_A          113 HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP  189 (291)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeCh
Confidence            3678899999999999999999999   9999999999999999999999999998764433221 11223356789999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++|+||||+++|+|++ |..|+......     +.....  ...+...+..+.+++.+||+.||++||++
T Consensus       190 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~  267 (291)
T 1xbb_A          190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGF  267 (291)
T ss_dssp             HHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            99988888999999999999999998 88777543211     110000  01233456778999999999999999999


Q ss_pred             HHHHHHHhhhhhc
Q 028458          155 NDVVCMLTNEAAT  167 (208)
Q Consensus       155 ~~i~~~l~~~~~~  167 (208)
                      .++++.|+.+...
T Consensus       268 ~~l~~~L~~~~~~  280 (291)
T 1xbb_A          268 AAVELRLRNYYYD  280 (291)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHH
Confidence            9999999887643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.95  E-value=5.6e-28  Score=202.60  Aligned_cols=152  Identities=24%  Similarity=0.275  Sum_probs=115.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.||+.||.|||+.+   |+||||||.||+++.++.++|+|||++........   .....|+..|+|||.
T Consensus       161 l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~  234 (464)
T 3ttj_A          161 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEV  234 (464)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CCC---C----CCCTTCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcc---cCCCcccccccCHHH
Confidence            678889999999999999999999   99999999999999999999999999976543321   223567899999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c-------cC--------------------Cccch--------
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I-------DD--------------------PVLED--------  125 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~-------~~--------------------~~~~~--------  125 (208)
                      +.+..++.++|+|||||++|+|++|..++......  .       ..                    +....        
T Consensus       235 ~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (464)
T 3ttj_A          235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP  314 (464)
T ss_dssp             HTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSC
T ss_pred             HcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCc
Confidence            99999999999999999999999998877432110  0       00                    00000        


Q ss_pred             -------hhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          126 -------EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       126 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                             .......+..+.+||.+||+.||++||+++|+++.
T Consensus       315 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          315 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             GGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                   00111225678999999999999999999999984

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.95  E-value=1.1e-28  Score=195.22  Aligned_cols=152  Identities=24%  Similarity=0.319  Sum_probs=119.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++.........  .....|+..|+|||
T Consensus       133 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE  207 (298)
T 2zv2_A          133 PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPE  207 (298)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChh
Confidence            4788999999999999999999999   999999999999999999999999999876533221  12346789999999


Q ss_pred             hhccCC---CCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           82 YAIQGI---FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        82 ~~~~~~---~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      .+.+..   ++.++|+||||+++|+|++|..|+......     +....... ......+..+.++|.+||+.||++||+
T Consensus       208 ~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~R~s  286 (298)
T 2zv2_A          208 SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF-PDQPDIAEDLKDLITRMLDKNPESRIV  286 (298)
T ss_dssp             GCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-CSSSCCCHHHHHHHHHHTCSCTTTSCC
T ss_pred             hhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCC-CCccccCHHHHHHHHHHhhcChhhCCC
Confidence            987655   367899999999999999999887543211     00000000 111234567889999999999999999


Q ss_pred             HHHHHH
Q 028458          154 MNDVVC  159 (208)
Q Consensus       154 ~~~i~~  159 (208)
                      +.|+++
T Consensus       287 ~~e~l~  292 (298)
T 2zv2_A          287 VPEIKL  292 (298)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999875

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.95  E-value=2.5e-28  Score=195.97  Aligned_cols=152  Identities=22%  Similarity=0.238  Sum_probs=121.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC----CeEEeccccceecCCCcccccccccccCCCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM----NPKISDFGMARICGGNELQANTSRIVGTYGY   77 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~   77 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||.||+++.++    .++|+|||++........   .....|+..|
T Consensus       110 ~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y  183 (326)
T 2y0a_A          110 SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF  183 (326)
T ss_dssp             CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTT
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCc
Confidence            4788999999999999999999999   99999999999998877    799999999987643321   1234678999


Q ss_pred             cCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc-----CCccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           78 MSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID-----DPVLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        78 ~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      +|||.+.+..++.++|+||||+++|+|++|..|+......  ..     ...... ......+..+.++|.+||+.||++
T Consensus       184 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~  262 (326)
T 2y0a_A          184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED-EYFSNTSALAKDFIRRLLVKDPKK  262 (326)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH-HHHTTSCHHHHHHHHHHSCSSGGG
T ss_pred             CCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc-cccccCCHHHHHHHHHHccCChhh
Confidence            9999998888999999999999999999999887432211  00     011111 122334567889999999999999


Q ss_pred             CCCHHHHHHH
Q 028458          151 RPTMNDVVCM  160 (208)
Q Consensus       151 Rps~~~i~~~  160 (208)
                      ||++.++++.
T Consensus       263 Rpt~~e~l~h  272 (326)
T 2y0a_A          263 RMTIQDSLQH  272 (326)
T ss_dssp             SCCHHHHHHS
T ss_pred             CCCHHHHhcC
Confidence            9999999873

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.95  E-value=2.2e-28  Score=198.19  Aligned_cols=153  Identities=22%  Similarity=0.265  Sum_probs=121.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC---eEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN---PKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||.||+++.++.   ++|+|||++.........  .....|++.|+
T Consensus       126 ~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~  200 (351)
T 3c0i_A          126 VYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFM  200 (351)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCB--CCCCCSCGGGC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCee--ecCCcCCcCcc
Confidence            3678899999999999999999999   999999999999976554   999999999876543321  22346889999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccC----Ccc-chhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD----PVL-EDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      |||.+.+..++.++|+||||+++|+|++|..|+.........    ... .........+..+.++|.+||+.||++||+
T Consensus       201 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s  280 (351)
T 3c0i_A          201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERIT  280 (351)
T ss_dssp             CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred             CHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcC
Confidence            999999888999999999999999999999887543321110    000 000112234677899999999999999999


Q ss_pred             HHHHHH
Q 028458          154 MNDVVC  159 (208)
Q Consensus       154 ~~~i~~  159 (208)
                      +.++++
T Consensus       281 ~~e~l~  286 (351)
T 3c0i_A          281 VYEALN  286 (351)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.95  E-value=6.8e-29  Score=209.68  Aligned_cols=158  Identities=25%  Similarity=0.347  Sum_probs=125.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.||+.||.|||+++   |+||||||.||+++.++.+||+|||++.......... .....++..|+|||
T Consensus       314 ~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE  389 (495)
T 1opk_A          314 EVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPE  389 (495)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC-CTTCCCCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceee-cCCCcCCcceeCHh
Confidence            3678899999999999999999999   9999999999999999999999999998764332211 11234467899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+.....  .   +... .. ...+..++..+.+||.+||+.||++||++.
T Consensus       390 ~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  467 (495)
T 1opk_A          390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR-MERPEGCPEKVYELMRACWQWNPSDRPSFA  467 (495)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC-CCCCCCCCHHHHHHHHHHcCcChhHCcCHH
Confidence            9998889999999999999999998 6666532211  1   1100 00 012344567789999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      ++++.|+.+.
T Consensus       468 el~~~L~~~~  477 (495)
T 1opk_A          468 EIHQAFETMF  477 (495)
T ss_dssp             HHHHHHHTSC
T ss_pred             HHHHHHHHHH
Confidence            9999998875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.95  E-value=1e-28  Score=193.57  Aligned_cols=155  Identities=23%  Similarity=0.275  Sum_probs=119.5

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........     ...++..|.|||.
T Consensus       114 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~y~aPE~  185 (278)
T 1byg_A          114 LGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEA  185 (278)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccccc-----CCCccccccCHHH
Confidence            677889999999999999999999   99999999999999999999999999875433221     1245678999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      +.+..++.++|+||||+++|+|++ |..|+......     +....  ....+...+..+.+++.+||+.||++||++.+
T Consensus       186 ~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  263 (278)
T 1byg_A          186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQ  263 (278)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CCCCcccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence            998889999999999999999997 77766432111     11000  00123345667899999999999999999999


Q ss_pred             HHHHHhhhhhc
Q 028458          157 VVCMLTNEAAT  167 (208)
Q Consensus       157 i~~~l~~~~~~  167 (208)
                      +++.|+.+...
T Consensus       264 l~~~L~~i~~~  274 (278)
T 1byg_A          264 LREQLEHIKTH  274 (278)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHhh
Confidence            99999987643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.95  E-value=1.2e-28  Score=202.74  Aligned_cols=153  Identities=22%  Similarity=0.274  Sum_probs=119.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++.......  .......|++.|+|||
T Consensus       149 ~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE  223 (396)
T 4dc2_A          149 KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPE  223 (396)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCch
Confidence            4788899999999999999999999   9999999999999999999999999987532211  1223357899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc----------c-cCCccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL----------I-DDPVLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----------~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......          . ..........+...+..+.++|.+||+.||++
T Consensus       224 ~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~  303 (396)
T 4dc2_A          224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKE  303 (396)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTT
T ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhH
Confidence            999999999999999999999999999888422110          0 00000000123345667889999999999999


Q ss_pred             CCCH------HHHHH
Q 028458          151 RPTM------NDVVC  159 (208)
Q Consensus       151 Rps~------~~i~~  159 (208)
                      ||++      +|+++
T Consensus       304 R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          304 RLGCHPQTGFADIQG  318 (396)
T ss_dssp             STTCSTTTHHHHHHH
T ss_pred             cCCCCCCCCHHHHhc
Confidence            9985      56665

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.95  E-value=9.9e-29  Score=196.91  Aligned_cols=161  Identities=20%  Similarity=0.238  Sum_probs=123.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-------cccccccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-------NTSRIVGT   74 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~   74 (208)
                      .+++.++..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++..........       ......++
T Consensus       130 ~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt  206 (317)
T 2buj_A          130 FLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT  206 (317)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCC
Confidence            4788999999999999999999999   9999999999999999999999999887643211110       01123468


Q ss_pred             CCccCcchhccCC---CCCcchhHHHHHHHHHHHHhhhcCCccccc-------ccCCccchhhhhHHHHHHHHHHHhhcc
Q 028458           75 YGYMSPEYAIQGI---FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-------IDDPVLEDEYSSKQMLLRYVNIALLCV  144 (208)
Q Consensus        75 ~~~~ape~~~~~~---~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~li~~~l  144 (208)
                      ..|.|||.+.+..   ++.++|+||||+++|+|++|..|+......       ... ... .......+..+.++|.+||
T Consensus       207 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~l~~li~~~l  284 (317)
T 2buj_A          207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QLS-IPQSPRHSSALWQLLNSMM  284 (317)
T ss_dssp             GGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C---CCCCTTSCHHHHHHHHHHT
T ss_pred             cccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-cCC-CCccccCCHHHHHHHHHHh
Confidence            8899999987544   688999999999999999998876431110       110 000 0112334567899999999


Q ss_pred             ccCCCCCCCHHHHHHHHhhhhhc
Q 028458          145 QESADDRPTMNDVVCMLTNEAAT  167 (208)
Q Consensus       145 ~~~p~~Rps~~~i~~~l~~~~~~  167 (208)
                      +.||.+||+++++++.|+.+...
T Consensus       285 ~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          285 TVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             CSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hcChhhCCCHHHHHHHhhhcCCC
Confidence            99999999999999999988643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.95  E-value=2.9e-28  Score=200.90  Aligned_cols=155  Identities=23%  Similarity=0.254  Sum_probs=112.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe----CCCCCeEEeccccceecCCCccc-ccccccccCCCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGY   77 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~----~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~   77 (208)
                      +++..+..++.||+.||.|||+.+   |+||||||.||++    +.++.++|+|||++......... .......|+..|
T Consensus       125 l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  201 (405)
T 3rgf_A          125 LPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY  201 (405)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcc
Confidence            788899999999999999999999   9999999999999    67789999999999876432211 122335678999


Q ss_pred             cCcchhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccccC---------------------Cccchh---------
Q 028458           78 MSPEYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD---------------------PVLEDE---------  126 (208)
Q Consensus        78 ~ape~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~---------------------~~~~~~---------  126 (208)
                      +|||.+.+. .++.++|+|||||++|+|++|..|+.........                     ......         
T Consensus       202 ~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~  281 (405)
T 3rgf_A          202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTL  281 (405)
T ss_dssp             CCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHH
T ss_pred             cCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhh
Confidence            999999874 4899999999999999999998877432221000                     000000         


Q ss_pred             ------------hhhH-------HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          127 ------------YSSK-------QMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       127 ------------~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                                  ....       ..+..+.+||.+||+.||.+|||++|+++.
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          282 MKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                        0000       014567899999999999999999999984

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.95  E-value=3.7e-29  Score=203.00  Aligned_cols=153  Identities=24%  Similarity=0.288  Sum_probs=117.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++.......  .......|++.|+|||
T Consensus       120 ~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE  194 (353)
T 3txo_A          120 RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPE  194 (353)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChh
Confidence            4678899999999999999999999   9999999999999999999999999987532221  1223356899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH-----
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM-----  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......  ...........+...+..+.++|.+||+.||++||++     
T Consensus       195 ~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~  274 (353)
T 3txo_A          195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGG  274 (353)
T ss_dssp             HHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTC
T ss_pred             hcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCC
Confidence            999888999999999999999999999887543221  1100000001233355678899999999999999998     


Q ss_pred             -HHHHH
Q 028458          155 -NDVVC  159 (208)
Q Consensus       155 -~~i~~  159 (208)
                       +++++
T Consensus       275 ~~~il~  280 (353)
T 3txo_A          275 EHAILR  280 (353)
T ss_dssp             THHHHT
T ss_pred             HHHHhh
Confidence             77776

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=2e-28  Score=191.76  Aligned_cols=153  Identities=27%  Similarity=0.402  Sum_probs=101.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|.|||
T Consensus       108 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  182 (278)
T 3cok_A          108 PFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPE  182 (278)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---------------------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceeccCCCCcCCcc
Confidence            4788899999999999999999999   999999999999999999999999998775432211  12245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.....  ............+...+..+.++|.+||+.||++||+++++++
T Consensus       183 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ---------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            99888889999999999999999999887753221  1111111111223345567889999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.95  E-value=2.2e-28  Score=196.24  Aligned_cols=153  Identities=25%  Similarity=0.311  Sum_probs=119.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC---CCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||.||+++.   ++.++|+|||++........   .....++..|+
T Consensus       127 ~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~  200 (327)
T 3lm5_A          127 MVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYL  200 (327)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCcc
Confidence            4788899999999999999999999   999999999999987   78999999999987643322   12246788999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----c-cCCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----I-DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+.+..++.++|+||||+++|+|++|..|+......     + ..............+..+.++|.+||+.||++||
T Consensus       201 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  280 (327)
T 3lm5_A          201 APEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP  280 (327)
T ss_dssp             CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred             CCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCc
Confidence            999999889999999999999999999998887433211     0 0000001122234556788999999999999999


Q ss_pred             CHHHHHHH
Q 028458          153 TMNDVVCM  160 (208)
Q Consensus       153 s~~~i~~~  160 (208)
                      +++++++.
T Consensus       281 t~~~ll~h  288 (327)
T 3lm5_A          281 TAEICLSH  288 (327)
T ss_dssp             CHHHHTTC
T ss_pred             CHHHHhCC
Confidence            99999874

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.95  E-value=2.7e-28  Score=192.21  Aligned_cols=153  Identities=24%  Similarity=0.290  Sum_probs=115.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++........  ......++..|+|||
T Consensus        96 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE  170 (288)
T 1ob3_A           96 GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPD  170 (288)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCch
Confidence            3678889999999999999999999   99999999999999999999999999876543221  112235688999999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccc---------cCC----------------------ccchhhhh
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------DDP----------------------VLEDEYSS  129 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~~~----------------------~~~~~~~~  129 (208)
                      .+.+. .++.++|+||||+++|+|++|..|+.......         ...                      ........
T Consensus       171 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (288)
T 1ob3_A          171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL  250 (288)
T ss_dssp             HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTC
T ss_pred             heeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHh
Confidence            98764 48999999999999999999987764321100         000                      00000111


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ...+..+.++|.+||+.||++||++.|+++
T Consensus       251 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          251 KGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            234567889999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.95  E-value=4.7e-28  Score=201.34  Aligned_cols=161  Identities=23%  Similarity=0.273  Sum_probs=117.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc----------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ----------------   65 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~----------------   65 (208)
                      .+++..+..++.||+.||.|||+.+   |+||||||.||+++.++.++|+|||++.........                
T Consensus       125 ~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~  201 (432)
T 3n9x_A          125 FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN  201 (432)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC----------------------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccc
Confidence            4788999999999999999999999   999999999999999999999999999876433211                


Q ss_pred             ----ccccccccCCCccCcchh-ccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc---------------------
Q 028458           66 ----ANTSRIVGTYGYMSPEYA-IQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID---------------------  119 (208)
Q Consensus        66 ----~~~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---------------------  119 (208)
                          .......|+..|+|||.+ ....++.++|+|||||++|+|++|..++........                     
T Consensus       202 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~  281 (432)
T 3n9x_A          202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVH  281 (432)
T ss_dssp             ---------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------C
T ss_pred             cchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCccccccccc
Confidence                112345789999999986 456689999999999999999975433321100000                     


Q ss_pred             ----------------CC------------------------ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          120 ----------------DP------------------------VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       120 ----------------~~------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                                      .+                        ........+..+..+.+||.+||+.||++||+++|+++
T Consensus       282 ~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          282 EKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                            00                        00000001234567889999999999999999999998


Q ss_pred             H--Hhhhh
Q 028458          160 M--LTNEA  165 (208)
Q Consensus       160 ~--l~~~~  165 (208)
                      .  ++...
T Consensus       362 Hp~f~~~~  369 (432)
T 3n9x_A          362 HPYLKDVR  369 (432)
T ss_dssp             CGGGTTTC
T ss_pred             Chhhhhcc
Confidence            4  55543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.95  E-value=6.7e-28  Score=201.64  Aligned_cols=103  Identities=30%  Similarity=0.428  Sum_probs=84.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc----------------
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ----------------   65 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~----------------   65 (208)
                      .+++..+..++.||+.||.|||+.+   |+||||||.||+++.++.+||+|||++.........                
T Consensus       152 ~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~  228 (458)
T 3rp9_A          152 YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV  228 (458)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-----------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccc
Confidence            4788899999999999999999999   999999999999999999999999999765422110                


Q ss_pred             ---------ccccccccCCCccCcchh-ccCCCCCcchhHHHHHHHHHHHHh
Q 028458           66 ---------ANTSRIVGTYGYMSPEYA-IQGIFSIKSDVFSFGVLLLEIAWD  107 (208)
Q Consensus        66 ---------~~~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~~~~~l~~~  107 (208)
                               .......|+..|+|||++ .+..++.++|+|||||++|+|+++
T Consensus       229 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             ----------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence                     112234678999999986 456689999999999999999974

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.1e-28  Score=213.28  Aligned_cols=164  Identities=21%  Similarity=0.265  Sum_probs=125.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.......... ......++..|+||
T Consensus       432 ~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~AP  508 (613)
T 2ozo_A          432 EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP  508 (613)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCH
Confidence            4788999999999999999999999   9999999999999999999999999997654322111 11122345789999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++|+||||+++|+|++ |..|+.....  .   +....  ....+..++..+.++|..||+.||++||++
T Consensus       509 E~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPs~  586 (613)
T 2ozo_A          509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--RMECPPECPPELYALMSDCWIYKWEDRPDF  586 (613)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHTTCSSTTTSCCH
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--CCCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence            99999999999999999999999997 8777643221  1   11110  012234566789999999999999999999


Q ss_pred             HHHHHHHhhhhhccCC
Q 028458          155 NDVVCMLTNEAATLLP  170 (208)
Q Consensus       155 ~~i~~~l~~~~~~~~~  170 (208)
                      .++++.|+........
T Consensus       587 ~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          587 LTVEQRMRACYYSLAS  602 (613)
T ss_dssp             HHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHHHHhcc
Confidence            9999999987655433

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.95  E-value=5.4e-29  Score=212.12  Aligned_cols=163  Identities=26%  Similarity=0.436  Sum_probs=127.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.+++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++......... ......++..|+|||
T Consensus       359 ~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE  434 (535)
T 2h8h_A          359 YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE  434 (535)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-TTCSTTSCGGGSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-cccCCcCcccccCHH
Confidence            4788899999999999999999999   999999999999999999999999998765432211 111234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++||||||+++|+|++ |..|+.....  .   +.... . ...+..++..+.+||.+||+.||++||+++
T Consensus       435 ~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  512 (535)
T 2h8h_A          435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-R-MPCPPECPESLHDLMCQCWRKEPEERPTFE  512 (535)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-CCCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence            9998999999999999999999998 7766643211  1   11000 0 012334566789999999999999999999


Q ss_pred             HHHHHHhhhhhccCC
Q 028458          156 DVVCMLTNEAATLLP  170 (208)
Q Consensus       156 ~i~~~l~~~~~~~~~  170 (208)
                      ++++.|+.+.....+
T Consensus       513 ~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          513 YLQAFLEDYFTSTEP  527 (535)
T ss_dssp             HHHHHHHTSSCCCSC
T ss_pred             HHHHHHHHHhhccCc
Confidence            999999988754433

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.95  E-value=6.6e-28  Score=193.19  Aligned_cols=159  Identities=18%  Similarity=0.227  Sum_probs=117.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++........  ......++..|+|||
T Consensus        96 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE  170 (324)
T 3mtl_A           96 IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPD  170 (324)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--ccccccCcccccChh
Confidence            4778899999999999999999999   99999999999999999999999999876532221  112235688999999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccccc---------c---CCccch--------------------hhh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------D---DPVLED--------------------EYS  128 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~---~~~~~~--------------------~~~  128 (208)
                      .+.+ ..++.++|+||||+++|+|++|..|+.......         .   ....+.                    ...
T Consensus       171 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (324)
T 3mtl_A          171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH  250 (324)
T ss_dssp             HHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHH
T ss_pred             hhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhh
Confidence            9876 557999999999999999999987774322100         0   000000                    001


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HHhhhh
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVC--MLTNEA  165 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~--~l~~~~  165 (208)
                      ....+..+.+||.+||+.||++||+++|+++  .+....
T Consensus       251 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          251 APRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             cCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence            1223467889999999999999999999988  355544

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.95  E-value=6e-28  Score=201.30  Aligned_cols=154  Identities=21%  Similarity=0.247  Sum_probs=121.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC---CCCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||+||+++   .++.++|+|||++.........  .....|++.|+
T Consensus       106 ~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~--~~~~~gt~~Y~  180 (444)
T 3soa_A          106 YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYL  180 (444)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB--CCCSCSCGGGC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce--eecccCCcccC
Confidence            4678899999999999999999999   99999999999998   4678999999999766433221  12346889999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---cCCccc-hhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---DDPVLE-DEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+.+..++.++|+||||+++|+|++|..|+......  .   ...... ........+..+.++|.+||+.||++||
T Consensus       181 APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp  260 (444)
T 3soa_A          181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI  260 (444)
T ss_dssp             CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             CHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCC
Confidence            999999888999999999999999999999887543221  1   000000 0011224456788999999999999999


Q ss_pred             CHHHHHHH
Q 028458          153 TMNDVVCM  160 (208)
Q Consensus       153 s~~~i~~~  160 (208)
                      ++.|+++.
T Consensus       261 ta~e~L~h  268 (444)
T 3soa_A          261 TAAEALKH  268 (444)
T ss_dssp             CHHHHHHS
T ss_pred             CHHHHhcC
Confidence            99999984

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.95  E-value=3e-28  Score=197.56  Aligned_cols=149  Identities=23%  Similarity=0.266  Sum_probs=116.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-------------------------CCCeEEeccccce
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-------------------------DMNPKISDFGMAR   57 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-------------------------~~~~~l~dfg~~~   57 (208)
                      +++..+..++.||+.||.|||+++   |+||||||+||+++.                         ++.++|+|||++.
T Consensus       134 ~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~  210 (360)
T 3llt_A          134 FHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT  210 (360)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCE
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCce
Confidence            788899999999999999999999   999999999999975                         7889999999997


Q ss_pred             ecCCCcccccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc-------CCccchh----
Q 028458           58 ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-------DPVLEDE----  126 (208)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-------~~~~~~~----  126 (208)
                      ......     ....|+..|+|||.+.+..++.++|+|||||++|+|++|..|+........       ....+..    
T Consensus       211 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~  285 (360)
T 3llt_A          211 FKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYE  285 (360)
T ss_dssp             ETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHH
T ss_pred             ecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhh
Confidence            644322     234678899999999999999999999999999999999887743221000       0000000    


Q ss_pred             -------------------------------------hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          127 -------------------------------------YSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       127 -------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                                                           .........+.+||.+||+.||++||+++|+++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          286 ATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                                                 000001156779999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.95  E-value=1.6e-28  Score=196.87  Aligned_cols=158  Identities=23%  Similarity=0.269  Sum_probs=123.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++.......   ......++..|.|||
T Consensus       138 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE  211 (327)
T 1fvr_A          138 TLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIE  211 (327)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChh
Confidence            4788899999999999999999999   9999999999999999999999999986432111   111234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+.....     .+....  ....+...+..+.++|.+||+.||++||++.
T Consensus       212 ~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  289 (327)
T 1fvr_A          212 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVYDLMRQCWREKPYERPSFA  289 (327)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC--CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence            9988889999999999999999997 8777643221     111000  0012334456789999999999999999999


Q ss_pred             HHHHHHhhhhhc
Q 028458          156 DVVCMLTNEAAT  167 (208)
Q Consensus       156 ~i~~~l~~~~~~  167 (208)
                      ++++.|+.+...
T Consensus       290 ell~~L~~~~~~  301 (327)
T 1fvr_A          290 QILVSLNRMLEE  301 (327)
T ss_dssp             HHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHh
Confidence            999999887754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.95  E-value=9.1e-29  Score=194.52  Aligned_cols=159  Identities=25%  Similarity=0.342  Sum_probs=125.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......... .....++..|.|||
T Consensus       107 ~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE  182 (288)
T 3kfa_A          107 EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPE  182 (288)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE-ETTEEECGGGCCHH
T ss_pred             CccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc-ccCCccccCcCChh
Confidence            3788899999999999999999999   9999999999999999999999999987664333211 12234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......     +... .. ...+...+..+.+++.+||+.||++||+++
T Consensus       183 ~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  260 (288)
T 3kfa_A          183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR-MERPEGCPEKVYELMRACWQWNPSDRPSFA  260 (288)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-CC-CCCCCCCCHHHHHHHHHHhCCChhhCcCHH
Confidence            9998999999999999999999998 76665432111     1100 00 012334556789999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|+....
T Consensus       261 ~~~~~l~~~~~  271 (288)
T 3kfa_A          261 EIHQAFETMFQ  271 (288)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999987654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.95  E-value=1.5e-28  Score=198.88  Aligned_cols=153  Identities=22%  Similarity=0.274  Sum_probs=119.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||.||+++.++.++|+|||++.......  .......|+..|+|||
T Consensus       106 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE  180 (345)
T 3a8x_A          106 KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPE  180 (345)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCcc
Confidence            4678899999999999999999999   9999999999999999999999999987532221  1123356889999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc----------c-cCCccchhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL----------I-DDPVLEDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----------~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      .+.+..++.++|+|||||++|+|++|..|+......          + ..........+...+..+.++|.+||+.||++
T Consensus       181 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~  260 (345)
T 3a8x_A          181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKE  260 (345)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTT
T ss_pred             ccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhH
Confidence            999888999999999999999999999888531100          0 00000000123345567889999999999999


Q ss_pred             CCCH------HHHHH
Q 028458          151 RPTM------NDVVC  159 (208)
Q Consensus       151 Rps~------~~i~~  159 (208)
                      ||++      .++++
T Consensus       261 R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          261 RLGCHPQTGFADIQG  275 (345)
T ss_dssp             STTCCTTTHHHHHHT
T ss_pred             CCCCCCcCCHHHHhc
Confidence            9985      56665

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.95  E-value=3e-28  Score=194.98  Aligned_cols=150  Identities=24%  Similarity=0.269  Sum_probs=120.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.......     ....|++.|+|||
T Consensus       102 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~-----~~~~gt~~y~aPE  173 (318)
T 1fot_A          102 RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPE  173 (318)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----CCCCSCTTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCcc-----ccccCCccccCHh
Confidence            3678889999999999999999999   9999999999999999999999999998754322     2346789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----CH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----TM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......  ...........+...+..+.++|.+||+.||++||     ++
T Consensus       174 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~  253 (318)
T 1fot_A          174 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGT  253 (318)
T ss_dssp             HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTT
T ss_pred             HhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCH
Confidence            999888999999999999999999999887543211  10000000012334556788999999999999999     88


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      +++++
T Consensus       254 ~~i~~  258 (318)
T 1fot_A          254 EDVKN  258 (318)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99886

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.95  E-value=4.3e-28  Score=189.47  Aligned_cols=154  Identities=25%  Similarity=0.325  Sum_probs=120.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||+|.||+++.++.++|+|||++................++..|.|||
T Consensus       101 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  177 (276)
T 2yex_A          101 GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE  177 (276)
T ss_dssp             BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChH
Confidence            4678899999999999999999999   9999999999999999999999999987654332222223346788999999


Q ss_pred             hhccCCC-CCcchhHHHHHHHHHHHHhhhcCCcccccc------cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIF-SIKSDVFSFGVLLLEIAWDLWTSNRTLELI------DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..+ +.++|+||||+++|+|++|..|+.......      .... .........+..+.++|.+||+.||++||++
T Consensus       178 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  256 (276)
T 2yex_A          178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLNPWKKIDSAPLALLHKILVENPSARITI  256 (276)
T ss_dssp             GGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             HHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-cccCchhhcCHHHHHHHHHHCCCCchhCCCH
Confidence            9987665 778999999999999999988875432210      0000 0001123456678899999999999999999


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      +|+++
T Consensus       257 ~~il~  261 (276)
T 2yex_A          257 PDIKK  261 (276)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.95  E-value=1.4e-28  Score=205.30  Aligned_cols=153  Identities=20%  Similarity=0.254  Sum_probs=120.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.||+.||.|||+ .+   |+||||||.||+++.++.++|+|||++........  ......|+..|+||
T Consensus       244 ~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aP  318 (446)
T 4ejn_A          244 VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAP  318 (446)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCCc--ccccccCCccccCH
Confidence            46888999999999999999998 88   99999999999999999999999999875322211  12235689999999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----C
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----T  153 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s  153 (208)
                      |.+.+..++.++|+||||+++|+|++|..|+......  ...........+...+..+.++|.+||+.||++||     +
T Consensus       319 E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t  398 (446)
T 4ejn_A          319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSED  398 (446)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTT
T ss_pred             hhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCC
Confidence            9999999999999999999999999999887543211  11000011112334556788999999999999999     9


Q ss_pred             HHHHHH
Q 028458          154 MNDVVC  159 (208)
Q Consensus       154 ~~~i~~  159 (208)
                      ++|+++
T Consensus       399 ~~ell~  404 (446)
T 4ejn_A          399 AKEIMQ  404 (446)
T ss_dssp             HHHHHT
T ss_pred             HHHHHh
Confidence            999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.95  E-value=8.3e-28  Score=195.49  Aligned_cols=160  Identities=22%  Similarity=0.273  Sum_probs=122.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++.......... ......|+..|+||
T Consensus       124 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  200 (364)
T 3qyz_A          124 HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP  200 (364)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCC
Confidence            3678899999999999999999999   9999999999999999999999999998764332221 12334678999999


Q ss_pred             chhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc-------C------------------------Cccchh
Q 028458           81 EYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID-------D------------------------PVLEDE  126 (208)
Q Consensus        81 e~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~-------~------------------------~~~~~~  126 (208)
                      |.+.+. .++.++|+||||+++|+|++|..|+......  ..       .                        ......
T Consensus       201 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (364)
T 3qyz_A          201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN  280 (364)
T ss_dssp             HHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH
T ss_pred             HHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHH
Confidence            987554 4899999999999999999998777432211  00       0                        000000


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhh
Q 028458          127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNE  164 (208)
Q Consensus       127 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~  164 (208)
                      ......+..+.++|.+||+.||++||++.|+++.  ++..
T Consensus       281 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          281 RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            1112335678899999999999999999999984  4443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.95  E-value=3.7e-28  Score=201.82  Aligned_cols=102  Identities=26%  Similarity=0.301  Sum_probs=90.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC--eEEeccccceecCCCcccccccccccCCCccCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN--PKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      +++..+..++.||+.||.|||+.+   |+||||||.||+++.++.  ++|+|||++.......     ....++..|+||
T Consensus       197 ~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aP  268 (429)
T 3kvw_A          197 FSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAP  268 (429)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCcc-----cccCCCCCccCh
Confidence            788899999999999999999999   999999999999998887  9999999997654322     224678899999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCC
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSN  112 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~  112 (208)
                      |.+.+..++.++|+|||||++|+|++|..++.
T Consensus       269 E~~~~~~~~~~~DiwSlG~il~elltG~~pf~  300 (429)
T 3kvw_A          269 EVILGARYGMPIDMWSLGCILAELLTGYPLLP  300 (429)
T ss_dssp             HHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             HHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999999987664

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=8.9e-29  Score=192.47  Aligned_cols=159  Identities=27%  Similarity=0.380  Sum_probs=124.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......... ......++..|.|||
T Consensus       100 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE  175 (267)
T 3t9t_A          100 LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPE  175 (267)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc-ccccccccccccChh
Confidence            3678899999999999999999999   999999999999999999999999998765432211 111234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......     +....  ....+...+..+.+++.+||+.||++||++.
T Consensus       176 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  253 (267)
T 3t9t_A          176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF--RLYKPRLASTHVYQIMNHCWRERPEDRPAFS  253 (267)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC--cCCCCccCcHHHHHHHHHHccCChhhCcCHH
Confidence            9998889999999999999999999 67666432111     00000  0011233456788999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|+++..
T Consensus       254 ~ll~~L~~l~~  264 (267)
T 3t9t_A          254 RLLRQLAEIAE  264 (267)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHh
Confidence            99999998764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.95  E-value=2.6e-28  Score=191.30  Aligned_cols=152  Identities=22%  Similarity=0.272  Sum_probs=117.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++.......    .....++..|.|||
T Consensus       105 ~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE  177 (279)
T 3fdn_A          105 KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE  177 (279)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHh
Confidence            3678889999999999999999999   9999999999999999999999999875543222    12245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......  ...........+...+..+.++|.+||+.||++||+++|+++
T Consensus       178 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             HHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            999888999999999999999999998877532211  000000000112334567889999999999999999999998


Q ss_pred             H
Q 028458          160 M  160 (208)
Q Consensus       160 ~  160 (208)
                      .
T Consensus       258 h  258 (279)
T 3fdn_A          258 H  258 (279)
T ss_dssp             C
T ss_pred             C
Confidence            5

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.95  E-value=2.3e-28  Score=198.14  Aligned_cols=150  Identities=21%  Similarity=0.241  Sum_probs=121.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++.......     ....|++.|+|||
T Consensus       137 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE  208 (350)
T 1rdq_E          137 RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPE  208 (350)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCCc-----ccccCCccccCHH
Confidence            4678889999999999999999999   9999999999999999999999999998764332     2346789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC-----H
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT-----M  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......  ...........+...+..+.++|.+||+.||++||+     +
T Consensus       209 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~  288 (350)
T 1rdq_E          209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGV  288 (350)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTT
T ss_pred             HhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCH
Confidence            999888999999999999999999999887543211  100000000123345677899999999999999998     8


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      +++++
T Consensus       289 ~ei~~  293 (350)
T 1rdq_E          289 NDIKN  293 (350)
T ss_dssp             HHHHT
T ss_pred             HHHHh
Confidence            88876

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.95  E-value=2.2e-28  Score=194.93  Aligned_cols=172  Identities=26%  Similarity=0.366  Sum_probs=117.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc---cccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL---QANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++ ++.++|+|||++........   ........|+..|.
T Consensus       126 ~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~  201 (319)
T 2y4i_B          126 VLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL  201 (319)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCccccc
Confidence            4788899999999999999999999   99999999999998 67999999999765432111   11122235788999


Q ss_pred             Ccchhcc---------CCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhcc
Q 028458           79 SPEYAIQ---------GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCV  144 (208)
Q Consensus        79 ape~~~~---------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l  144 (208)
                      |||.+.+         ..++.++|+||||+++|+|++|..|+......     +....... ......+..+.+++.+||
T Consensus       202 aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l  280 (319)
T 2y4i_B          202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN-LSQIGMGKEISDILLFCW  280 (319)
T ss_dssp             CHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC-CCCSSCCTTHHHHHHHHH
T ss_pred             ChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC-CCcCCCCHHHHHHHHHHh
Confidence            9999864         34788999999999999999998887543211     00000000 111124456889999999


Q ss_pred             ccCCCCCCCHHHHHHHHhhhhhccCCCCCCCccc
Q 028458          145 QESADDRPTMNDVVCMLTNEAATLLPPKQPAFSY  178 (208)
Q Consensus       145 ~~~p~~Rps~~~i~~~l~~~~~~~~~p~~~~~~~  178 (208)
                      +.||++||++.++++.|+.+.........|...+
T Consensus       281 ~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~  314 (319)
T 2y4i_B          281 AFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW  314 (319)
T ss_dssp             CSSTTTSCCHHHHHHHHTTC--------------
T ss_pred             cCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence            9999999999999999999886655544444433

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.95  E-value=2.7e-28  Score=194.93  Aligned_cols=154  Identities=24%  Similarity=0.256  Sum_probs=118.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++........  ......++..|+|||
T Consensus       104 ~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE  178 (317)
T 2pmi_A          104 GLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPD  178 (317)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCch
Confidence            3678889999999999999999999   99999999999999999999999999987643221  112245788999999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccc---------cC----------------Ccc--------c---
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------DD----------------PVL--------E---  124 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~~----------------~~~--------~---  124 (208)
                      .+.+. .++.++|+||||+++|+|++|..|+.......         ..                ...        .   
T Consensus       179 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (317)
T 2pmi_A          179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVL  258 (317)
T ss_dssp             HHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHH
T ss_pred             HhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhh
Confidence            98764 58999999999999999999987764321100         00                000        0   


Q ss_pred             hhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       125 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ........+..+.++|.+||+.||++||+++|+++.
T Consensus       259 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          259 QPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            000011234578899999999999999999999873

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.95  E-value=2e-28  Score=198.61  Aligned_cols=153  Identities=27%  Similarity=0.306  Sum_probs=120.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++.......  .......|++.|+|||
T Consensus       117 ~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE  191 (353)
T 2i0e_A          117 RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPE  191 (353)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccChh
Confidence            4678899999999999999999999   9999999999999999999999999987532221  1223356899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC-----H
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT-----M  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.....  ............+...+..+.++|.+||+.||++||+     +
T Consensus       192 ~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~  271 (353)
T 2i0e_A          192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGE  271 (353)
T ss_dssp             HHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHH
T ss_pred             hhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCH
Confidence            99988999999999999999999999988754321  1110000001123345678899999999999999995     5


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      +++++
T Consensus       272 ~~i~~  276 (353)
T 2i0e_A          272 RDIKE  276 (353)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            77765

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.95  E-value=1.9e-28  Score=192.89  Aligned_cols=160  Identities=26%  Similarity=0.266  Sum_probs=123.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ape   81 (208)
                      +++..+..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++.......... ......++..|.|||
T Consensus       118 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  194 (291)
T 1u46_A          118 FLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE  194 (291)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCch
Confidence            678899999999999999999999   9999999999999999999999999998765433221 122234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+......     +..... ....+...+..+.+++.+||+.||++||++.
T Consensus       195 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  273 (291)
T 1u46_A          195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV  273 (291)
T ss_dssp             HHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC-CCCCCcCcCHHHHHHHHHHccCCcccCcCHH
Confidence            9988888999999999999999998 77776432211     100000 0012334567789999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|++...
T Consensus       274 ~l~~~l~~~~~  284 (291)
T 1u46_A          274 ALRDFLLEAQP  284 (291)
T ss_dssp             HHHHHHHHHC-
T ss_pred             HHHHHHHHhCc
Confidence            99999988764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.95  E-value=6.6e-28  Score=189.46  Aligned_cols=160  Identities=23%  Similarity=0.286  Sum_probs=126.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........    ....++..|.|||
T Consensus       110 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE  182 (284)
T 2vgo_A          110 RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RTMCGTLDYLPPE  182 (284)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB----CCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccccc----ccccCCCCcCCHH
Confidence            3678889999999999999999999   99999999999999999999999999876543221    2245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......     +.....   ..+...+..+.++|.+||+.||.+||++++
T Consensus       183 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  259 (284)
T 2vgo_A          183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL---KFPPFLSDGSKDLISKLLRYHPPQRLPLKG  259 (284)
T ss_dssp             HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHH
Confidence            999888999999999999999999998877543211     000000   122334567889999999999999999999


Q ss_pred             HHH--HHhhhhhccCCC
Q 028458          157 VVC--MLTNEAATLLPP  171 (208)
Q Consensus       157 i~~--~l~~~~~~~~~p  171 (208)
                      +++  .++.......||
T Consensus       260 ll~h~~~~~~~~~~~p~  276 (284)
T 2vgo_A          260 VMEHPWVKANSRRVLPP  276 (284)
T ss_dssp             HHTCHHHHHHCCCCCCC
T ss_pred             HhhCHHHHhhccccCCC
Confidence            997  466554443333

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=2.8e-29  Score=197.55  Aligned_cols=156  Identities=18%  Similarity=0.262  Sum_probs=119.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC--------eEEeccccceecCCCcccccccccccC
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN--------PKISDFGMARICGGNELQANTSRIVGT   74 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~   74 (208)
                      +++..+..++.|++.||.|||+++   ++||||||+||+++.++.        ++++|||++......      ....++
T Consensus       110 ~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~  180 (289)
T 4fvq_A          110 INILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQER  180 (289)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCcccccccCc------cccCCc
Confidence            778899999999999999999999   999999999999988876        999999987554322      123467


Q ss_pred             CCccCcchhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccccc--CCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           75 YGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID--DPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        75 ~~~~ape~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      ..|+|||.+.+ ..++.++|+||||+++|+|++|..++........  .........+...+..+.+++.+||+.||++|
T Consensus       181 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  260 (289)
T 4fvq_A          181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHR  260 (289)
T ss_dssp             TTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGS
T ss_pred             CcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHC
Confidence            88999999987 6689999999999999999996544432211100  00000001112224568899999999999999


Q ss_pred             CCHHHHHHHHhhhhhc
Q 028458          152 PTMNDVVCMLTNEAAT  167 (208)
Q Consensus       152 ps~~~i~~~l~~~~~~  167 (208)
                      |++.++++.|+.+...
T Consensus       261 ps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          261 PSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             CCHHHHHHHHHTCC--
T ss_pred             cCHHHHHHHHHHhcCC
Confidence            9999999999988743

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.95  E-value=1e-28  Score=197.97  Aligned_cols=159  Identities=28%  Similarity=0.335  Sum_probs=122.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC---CCCeEEeccccceecCCCcccccccccccCCCccC
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGYMS   79 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~a   79 (208)
                      +++..++.++.|++.||.|||+.+   ++|+||||.||+++.   +..++|+|||++................++..|+|
T Consensus       137 ~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  213 (327)
T 2yfx_A          137 LAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP  213 (327)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCC
T ss_pred             ccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeC
Confidence            788899999999999999999999   999999999999984   44699999999875533332222233456788999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      ||.+.+..++.++|+||||+++|+|++ |..|+......     +.....  ...+...+..+.++|.+||+.||.+||+
T Consensus       214 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps  291 (327)
T 2yfx_A          214 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--MDPPKNCPGPVYRIMTQCWQHQPEDRPN  291 (327)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHhcCChhhCcC
Confidence            999998899999999999999999997 76666432211     110000  0122344567889999999999999999


Q ss_pred             HHHHHHHHhhhhh
Q 028458          154 MNDVVCMLTNEAA  166 (208)
Q Consensus       154 ~~~i~~~l~~~~~  166 (208)
                      +.++++.|.....
T Consensus       292 ~~~ll~~l~~~~~  304 (327)
T 2yfx_A          292 FAIILERIEYCTQ  304 (327)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhc
Confidence            9999999987764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.95  E-value=5.9e-28  Score=196.49  Aligned_cols=153  Identities=21%  Similarity=0.265  Sum_probs=120.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC---CCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD---MNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||+||+++.+   +.++|+|||++........   .....|++.|+
T Consensus       124 ~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~  197 (362)
T 2bdw_A          124 FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYL  197 (362)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCcccc
Confidence            3678899999999999999999999   9999999999999765   4599999999976653322   12346789999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---cCCccc-hhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---DDPVLE-DEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+.+..++.++|+||||+++|+|++|..|+......  .   ...... ........+..+.++|.+||+.||++||
T Consensus       198 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  277 (362)
T 2bdw_A          198 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI  277 (362)
T ss_dssp             CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSC
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCc
Confidence            999999888999999999999999999999887543211  0   000000 0011233456788999999999999999


Q ss_pred             CHHHHHHH
Q 028458          153 TMNDVVCM  160 (208)
Q Consensus       153 s~~~i~~~  160 (208)
                      ++.++++.
T Consensus       278 t~~e~l~h  285 (362)
T 2bdw_A          278 TADQALKV  285 (362)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99998864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.95  E-value=6e-28  Score=191.30  Aligned_cols=156  Identities=19%  Similarity=0.175  Sum_probs=120.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++++|||++................++..|.|||
T Consensus       105 ~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  181 (305)
T 2wtk_C          105 RFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE  181 (305)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChh
Confidence            4678899999999999999999999   9999999999999999999999999998764332222223346788999999


Q ss_pred             hhccCC--CCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           82 YAIQGI--FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        82 ~~~~~~--~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      .+.+..  ++.++|+||||+++|+|++|..|+......  ...........+...+..+.++|.+||+.||++||++.++
T Consensus       182 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  261 (305)
T 2wtk_C          182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI  261 (305)
T ss_dssp             HHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHH
Confidence            987644  377899999999999999998877542211  0000000001122345678899999999999999999999


Q ss_pred             HHH
Q 028458          158 VCM  160 (208)
Q Consensus       158 ~~~  160 (208)
                      ++.
T Consensus       262 l~~  264 (305)
T 2wtk_C          262 RQH  264 (305)
T ss_dssp             HHS
T ss_pred             hcC
Confidence            974

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.95  E-value=1.5e-27  Score=194.57  Aligned_cols=153  Identities=26%  Similarity=0.296  Sum_probs=113.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++||||||.||+++.++.++|+|||++........   .....++..|+|||
T Consensus       123 ~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE  196 (371)
T 2xrw_A          123 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPE  196 (371)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccccc---cCCceecCCccCHH
Confidence            3678889999999999999999999   99999999999999999999999999876543221   12246788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------cc-----------------------CCccc--------
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------ID-----------------------DPVLE--------  124 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~-----------------------~~~~~--------  124 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......      ..                       .+...        
T Consensus       197 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (371)
T 2xrw_A          197 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLF  276 (371)
T ss_dssp             HHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHS
T ss_pred             HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhc
Confidence            999888999999999999999999998877432210      00                       00000        


Q ss_pred             -------hhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          125 -------DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       125 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                             ........+..+.+||.+||+.||++|||++|+++.
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          277 PDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                   000122336678999999999999999999999884

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.95  E-value=1.8e-27  Score=191.88  Aligned_cols=150  Identities=19%  Similarity=0.259  Sum_probs=118.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe-------------------CCCCCeEEeccccceecCCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-------------------DKDMNPKISDFGMARICGGN   62 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~-------------------~~~~~~~l~dfg~~~~~~~~   62 (208)
                      .+++..+..++.||+.||.|||+++   |+|+||||.||++                   +.++.++|+|||++......
T Consensus       119 ~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~  195 (355)
T 2eu9_A          119 PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH  195 (355)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc
Confidence            4788999999999999999999999   9999999999999                   56788999999999764332


Q ss_pred             cccccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----cC--Cccch----------
Q 028458           63 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----DD--PVLED----------  125 (208)
Q Consensus        63 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~--~~~~~----------  125 (208)
                      .     ....|+..|+|||.+.+..++.++|+||||+++|+|++|..|+.......     ..  ...+.          
T Consensus       196 ~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  270 (355)
T 2eu9_A          196 H-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQK  270 (355)
T ss_dssp             C-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGG
T ss_pred             c-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchh
Confidence            2     22467889999999998899999999999999999999988775432110     00  00000          


Q ss_pred             -----------------------------hhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          126 -----------------------------EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       126 -----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                                                   .......+..+.+||.+||+.||++||++.|+++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          271 YFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             GEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                                         0001123457889999999999999999999985

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.95  E-value=8.1e-29  Score=200.40  Aligned_cols=153  Identities=27%  Similarity=0.374  Sum_probs=120.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++........  ......|++.|+|||
T Consensus       114 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE  188 (345)
T 1xjd_A          114 KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPE  188 (345)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChh
Confidence            4678899999999999999999999   99999999999999999999999999875422211  123356889999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN-DVV  158 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~i~  158 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.....  ............+...+..+.++|.+||+.||++||++. ++.
T Consensus       189 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             hhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            99998899999999999999999999988754321  111000001112233556788999999999999999997 665


Q ss_pred             H
Q 028458          159 C  159 (208)
Q Consensus       159 ~  159 (208)
                      +
T Consensus       269 ~  269 (345)
T 1xjd_A          269 Q  269 (345)
T ss_dssp             G
T ss_pred             c
Confidence            3

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.95  E-value=2.4e-28  Score=195.48  Aligned_cols=148  Identities=22%  Similarity=0.337  Sum_probs=120.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC-CCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++ .++.++|+|||++........    ....++..|+||
T Consensus       145 ~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aP  217 (320)
T 3a99_A          145 ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPP  217 (320)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccccccccccc----cCCCCCccCCCh
Confidence            4678889999999999999999999   99999999999998 778999999999987654322    224578899999


Q ss_pred             chhccCCC-CCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           81 EYAIQGIF-SIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        81 e~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      |.+.+..+ +.++|+||||+++|+|++|..|+...........    ......+..+.++|.+||+.||++||+++++++
T Consensus       218 E~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccc----cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            99987775 6789999999999999999988765443332111    112234567889999999999999999999987


Q ss_pred             H
Q 028458          160 M  160 (208)
Q Consensus       160 ~  160 (208)
                      .
T Consensus       294 h  294 (320)
T 3a99_A          294 H  294 (320)
T ss_dssp             S
T ss_pred             C
Confidence            3

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.95  E-value=4.7e-28  Score=198.43  Aligned_cols=152  Identities=24%  Similarity=0.254  Sum_probs=119.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||.||+++.++.++|+|||++........   .....|++.|+|||
T Consensus       111 ~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE  184 (384)
T 4fr4_A          111 HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPE  184 (384)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCCCCSCGGGCCGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCCc---eeccCCCccccCCe
Confidence            4678899999999999999999999   99999999999999999999999999987643321   23356899999999


Q ss_pred             hhcc---CCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           82 YAIQ---GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        82 ~~~~---~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      .+..   ..++.++|+|||||++|+|++|..|+.......     ..........+...+..+.++|.+||+.||++||+
T Consensus       185 ~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s  264 (384)
T 4fr4_A          185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFS  264 (384)
T ss_dssp             GTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred             eeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcc
Confidence            9864   348899999999999999999998885321110     00000001123345677899999999999999998


Q ss_pred             -HHHHHH
Q 028458          154 -MNDVVC  159 (208)
Q Consensus       154 -~~~i~~  159 (208)
                       ++++.+
T Consensus       265 ~~~~l~~  271 (384)
T 4fr4_A          265 QLSDVQN  271 (384)
T ss_dssp             SHHHHHT
T ss_pred             cHHHHHc
Confidence             777665

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.95  E-value=1.1e-28  Score=213.84  Aligned_cols=161  Identities=24%  Similarity=0.280  Sum_probs=124.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-ccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..|+.||+.||.|||+++   |+||||||+||+++.++.+||+|||++......... .......++..|+||
T Consensus       465 ~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~AP  541 (635)
T 4fl3_A          465 HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP  541 (635)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeCh
Confidence            4788899999999999999999999   999999999999999999999999999766433221 112223456789999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++|+||||+++|+|++ |..|+......     +....  ....+..++..+.++|..||+.||++||++
T Consensus       542 E~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPs~  619 (635)
T 4fl3_A          542 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--RMGCPAGCPREMYDLMNLCWTYDVENRPGF  619 (635)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCCHhHCcCH
Confidence            99999999999999999999999997 88777433211     11111  012234456788999999999999999999


Q ss_pred             HHHHHHHhhhhhc
Q 028458          155 NDVVCMLTNEAAT  167 (208)
Q Consensus       155 ~~i~~~l~~~~~~  167 (208)
                      .++++.|+.....
T Consensus       620 ~~l~~~L~~~~~~  632 (635)
T 4fl3_A          620 AAVELRLRNYYYD  632 (635)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHH
Confidence            9999999887543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.95  E-value=7.1e-28  Score=197.47  Aligned_cols=161  Identities=19%  Similarity=0.258  Sum_probs=119.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc-----cccccccccCCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL-----QANTSRIVGTYG   76 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~   76 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||.||+++.++.++|+|||.+........     ........|+..
T Consensus       124 ~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~  200 (389)
T 3gni_B          124 GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP  200 (389)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecccccccccccccccccccccc
Confidence            3678899999999999999999999   99999999999999999999999998765422111     111122357788


Q ss_pred             ccCcchhcc--CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc---CCcc--------------------------
Q 028458           77 YMSPEYAIQ--GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID---DPVL--------------------------  123 (208)
Q Consensus        77 ~~ape~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~---~~~~--------------------------  123 (208)
                      |+|||.+.+  ..++.++|+|||||++|+|++|..|+......  ..   ....                          
T Consensus       201 y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (389)
T 3gni_B          201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSG  280 (389)
T ss_dssp             GSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------------------------
T ss_pred             ccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccc
Confidence            999999987  56899999999999999999998877432110  00   0000                          


Q ss_pred             -----------------chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhhh
Q 028458          124 -----------------EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       124 -----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~  165 (208)
                                       .........+..+.+||.+||+.||++||++.|+++.  ++...
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          281 LSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             -------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             cccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence                             0001122344668899999999999999999999874  55443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.95  E-value=7e-28  Score=195.11  Aligned_cols=153  Identities=22%  Similarity=0.255  Sum_probs=112.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC---CCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++.++..++.|++.||.|||+.+   ++||||||.||+++.   ++.++|+|||++........   .....|+..|+
T Consensus       144 ~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~  217 (349)
T 2w4o_A          144 YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYC  217 (349)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcccc---cccccCCCCcc
Confidence            3688899999999999999999999   999999999999975   78999999999876543221   12246788999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      |||.+.+..++.++|+||||+++|+|++|..|+......      +..... .........+..+.++|.+||+.||++|
T Consensus       218 aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  297 (349)
T 2w4o_A          218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKR  297 (349)
T ss_dssp             CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGS
T ss_pred             CHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhC
Confidence            999999888999999999999999999998877432211      000000 0001123456678899999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      |++.++++.
T Consensus       298 pt~~e~l~h  306 (349)
T 2w4o_A          298 LTTFQALQH  306 (349)
T ss_dssp             CCHHHHHHS
T ss_pred             cCHHHHhcC
Confidence            999999873

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.95  E-value=1.8e-27  Score=192.37  Aligned_cols=156  Identities=21%  Similarity=0.257  Sum_probs=118.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc--ccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~a   79 (208)
                      .+++.++..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.........  .......++..|+|
T Consensus       120 ~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a  196 (351)
T 3mi9_A          120 KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP  196 (351)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccC
Confidence            3688899999999999999999999   999999999999999999999999999876432221  11223467889999


Q ss_pred             cchhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccccc------------cCCc----------------------cc
Q 028458           80 PEYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------------DDPV----------------------LE  124 (208)
Q Consensus        80 pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------------~~~~----------------------~~  124 (208)
                      ||.+.+ ..++.++|+||||+++|+|++|..++.......            ....                      ..
T Consensus       197 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (351)
T 3mi9_A          197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK  276 (351)
T ss_dssp             HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHH
T ss_pred             chhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHH
Confidence            999876 457999999999999999999887764321100            0000                      00


Q ss_pred             hhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       125 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ........+..+.+||.+||+.||++||+++|+++.
T Consensus       277 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          277 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            000000113558899999999999999999999884

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=1.2e-27  Score=192.81  Aligned_cols=158  Identities=19%  Similarity=0.195  Sum_probs=118.2

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC--CeEEeccccceecCCCccc--ccccccccCCCccC
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM--NPKISDFGMARICGGNELQ--ANTSRIVGTYGYMS   79 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~a   79 (208)
                      ++..+..++.|++.||.|||+.+   ++|+||||.||+++.++  .++|+|||++.........  .......++..|+|
T Consensus       166 ~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a  242 (345)
T 3hko_A          166 REKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA  242 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCC
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccC
Confidence            56678899999999999999999   99999999999998766  8999999999865322111  11223467889999


Q ss_pred             cchhcc--CCCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           80 PEYAIQ--GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        80 pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      ||.+.+  ..++.++|+||||+++|+|++|..|+......      ...............+..+.++|.+||+.||++|
T Consensus       243 PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             chhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence            999875  56889999999999999999999887533221      1111111111222356678899999999999999


Q ss_pred             CCHHHHHHH--Hhhh
Q 028458          152 PTMNDVVCM--LTNE  164 (208)
Q Consensus       152 ps~~~i~~~--l~~~  164 (208)
                      |++.++++.  ++..
T Consensus       323 ps~~~~l~hp~~~~~  337 (345)
T 3hko_A          323 FDAMRALQHPWISQF  337 (345)
T ss_dssp             CCHHHHHHSHHHHTT
T ss_pred             CCHHHHhcChhhccC
Confidence            999999873  4443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.95  E-value=1e-27  Score=201.33  Aligned_cols=153  Identities=26%  Similarity=0.419  Sum_probs=122.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   ++||||||.||+++.++.++|+|||++........   .....|++.|+|||
T Consensus       112 ~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE  185 (476)
T 2y94_A          112 RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPE  185 (476)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccc---ccccCCCcCeEChh
Confidence            4788899999999999999999999   99999999999999999999999999987654322   22346789999999


Q ss_pred             hhccCCC-CCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIF-SIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..+ +.++|+||||+++|+|++|..|+......     +.....   ..+...+..+.++|.+||+.||++||+++
T Consensus       186 ~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~  262 (476)
T 2y94_A          186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF---YTPQYLNPSVISLLKHMLQVDPMKRATIK  262 (476)
T ss_dssp             HHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc---CCCccCCHHHHHHHHHHcCCCchhCcCHH
Confidence            9988765 68999999999999999999887543211     111111   11223456788999999999999999999


Q ss_pred             HHHH--HHhh
Q 028458          156 DVVC--MLTN  163 (208)
Q Consensus       156 ~i~~--~l~~  163 (208)
                      ++++  .++.
T Consensus       263 eil~hp~~~~  272 (476)
T 2y94_A          263 DIREHEWFKQ  272 (476)
T ss_dssp             HHHTCHHHHT
T ss_pred             HHHhCHHhhh
Confidence            9997  3554

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.95  E-value=9.4e-28  Score=196.06  Aligned_cols=155  Identities=21%  Similarity=0.229  Sum_probs=122.2

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe--CCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL--DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      +++..+..++.||+.||.|||+.+   |+||||||.||++  +.++.++|+|||++........   .....|+..|+||
T Consensus       184 l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aP  257 (373)
T 2x4f_A          184 LTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAP  257 (373)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeCh
Confidence            678889999999999999999999   9999999999999  5677899999999987654332   1224578999999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++|+||||+++|+|++|..|+......      ...............+..+.+||.+||+.||.+||++
T Consensus       258 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~  337 (373)
T 2x4f_A          258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISA  337 (373)
T ss_dssp             HHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             hhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCH
Confidence            9998888999999999999999999998887533211      0000000011223456778999999999999999999


Q ss_pred             HHHHH--HHhh
Q 028458          155 NDVVC--MLTN  163 (208)
Q Consensus       155 ~~i~~--~l~~  163 (208)
                      .|+++  .+..
T Consensus       338 ~e~l~hp~~~~  348 (373)
T 2x4f_A          338 SEALKHPWLSD  348 (373)
T ss_dssp             HHHHHSHHHHC
T ss_pred             HHHhcCcCcCC
Confidence            99998  4443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.95  E-value=3.2e-28  Score=195.01  Aligned_cols=162  Identities=23%  Similarity=0.308  Sum_probs=125.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++..++.++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++.......... ......++..|.||
T Consensus       141 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  217 (326)
T 2w1i_A          141 RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP  217 (326)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECc
Confidence            3788899999999999999999999   9999999999999999999999999998765433211 11223456679999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc----cCCcc---------------chhhhhHHHHHHHHHHHh
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI----DDPVL---------------EDEYSSKQMLLRYVNIAL  141 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~----~~~~~---------------~~~~~~~~~~~~~~~li~  141 (208)
                      |.+.+..++.++|+||||+++|+|++|..++.......    .....               .....+...+..+.++|.
T Consensus       218 E~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  297 (326)
T 2w1i_A          218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMT  297 (326)
T ss_dssp             HHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Confidence            99988889999999999999999999876654321100    00000               000112334567899999


Q ss_pred             hccccCCCCCCCHHHHHHHHhhhhh
Q 028458          142 LCVQESADDRPTMNDVVCMLTNEAA  166 (208)
Q Consensus       142 ~~l~~~p~~Rps~~~i~~~l~~~~~  166 (208)
                      +||+.||++||++.++++.|+.+..
T Consensus       298 ~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          298 ECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHHHHHHHHH
Confidence            9999999999999999999988764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.95  E-value=1.2e-27  Score=191.79  Aligned_cols=151  Identities=23%  Similarity=0.260  Sum_probs=118.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-------------------CCCeEEeccccceecCCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-------------------DMNPKISDFGMARICGGN   62 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-------------------~~~~~l~dfg~~~~~~~~   62 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++.                   ++.++|+|||++......
T Consensus       114 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~  190 (339)
T 1z57_A          114 PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH  190 (339)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc
Confidence            4678899999999999999999999   999999999999987                   667999999998765432


Q ss_pred             cccccccccccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----c---CC-------------
Q 028458           63 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----D---DP-------------  121 (208)
Q Consensus        63 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~---~~-------------  121 (208)
                      .     ....++..|+|||.+.+..++.++|+||||+++|+|++|..|+.......     .   ..             
T Consensus       191 ~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  265 (339)
T 1z57_A          191 H-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRK  265 (339)
T ss_dssp             C-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGG
T ss_pred             c-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchh
Confidence            2     22467889999999998899999999999999999999987764321100     0   00             


Q ss_pred             -------------------------ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          122 -------------------------VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       122 -------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                                               ...........+..+.++|.+||+.||++||++.|+++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          266 YFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             GEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence                                     000000122345678899999999999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.95  E-value=1.3e-27  Score=193.01  Aligned_cols=161  Identities=23%  Similarity=0.235  Sum_probs=120.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc--------ccccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--------NTSRIVG   73 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~   73 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++..........        ......|
T Consensus       108 ~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~g  184 (353)
T 2b9h_A          108 MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA  184 (353)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccc
Confidence            4788899999999999999999999   9999999999999999999999999998764322111        1122457


Q ss_pred             CCCccCcchhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccccc---------cC-----------------------
Q 028458           74 TYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------DD-----------------------  120 (208)
Q Consensus        74 ~~~~~ape~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~~-----------------------  120 (208)
                      +..|+|||.+.+ ..++.++|+||||+++|+|++|..|+.......         ..                       
T Consensus       185 t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (353)
T 2b9h_A          185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLP  264 (353)
T ss_dssp             CGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSC
T ss_pred             cccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhccc
Confidence            889999998765 668999999999999999999987764322100         00                       


Q ss_pred             --CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhhh
Q 028458          121 --PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       121 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~  165 (208)
                        ............+..+.++|.+||+.||++||+++++++.  ++...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          265 MYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence              0000001112345678899999999999999999999873  55443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.95  E-value=2e-27  Score=189.97  Aligned_cols=153  Identities=22%  Similarity=0.215  Sum_probs=121.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC----CeEEeccccceecCCCcccccccccccCCCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM----NPKISDFGMARICGGNELQANTSRIVGTYGY   77 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~   77 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++    .++|+|||++........   .....|+..|
T Consensus       111 ~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y  184 (321)
T 2a2a_A          111 SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEF  184 (321)
T ss_dssp             CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCc
Confidence            3678899999999999999999999   99999999999999887    799999999987654322   1224578899


Q ss_pred             cCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           78 MSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        78 ~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .|||.+.+..++.++|+||||+++|+|++|..|+......     +..... .........+..+.++|.+||+.||++|
T Consensus       185 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  264 (321)
T 2a2a_A          185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKR  264 (321)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTS
T ss_pred             cCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhC
Confidence            9999999888999999999999999999998887533211     000000 0001223345678899999999999999


Q ss_pred             CCHHHHHHH
Q 028458          152 PTMNDVVCM  160 (208)
Q Consensus       152 ps~~~i~~~  160 (208)
                      |++.|+++.
T Consensus       265 ps~~e~l~h  273 (321)
T 2a2a_A          265 LTIQEALRH  273 (321)
T ss_dssp             CCHHHHHHS
T ss_pred             cCHHHHhcC
Confidence            999999873

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.95  E-value=2.5e-28  Score=195.89  Aligned_cols=154  Identities=19%  Similarity=0.233  Sum_probs=103.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC---CeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++.++..++.|++.||.|||+++   ++||||||.||+++.++   .++|+|||++.........  .....++..|+
T Consensus       102 ~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~  176 (325)
T 3kn6_A          102 HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYA  176 (325)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--ccccCCCcCcc
Confidence            4788899999999999999999999   99999999999997665   7999999999765433221  12245688999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------------ccCCccc-hhhhhHHHHHHHHHHHhhccc
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------------IDDPVLE-DEYSSKQMLLRYVNIALLCVQ  145 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------------~~~~~~~-~~~~~~~~~~~~~~li~~~l~  145 (208)
                      |||.+.+..++.++|+||||+++|+|++|..|+......            +...... ........+..+.++|.+||+
T Consensus       177 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  256 (325)
T 3kn6_A          177 APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLT  256 (325)
T ss_dssp             -------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHC
T ss_pred             CHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCC
Confidence            999999889999999999999999999998887543211            1111110 111223456788999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 028458          146 ESADDRPTMNDVVCM  160 (208)
Q Consensus       146 ~~p~~Rps~~~i~~~  160 (208)
                      .||++||++.++++.
T Consensus       257 ~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          257 VDPNKRLKMSGLRYN  271 (325)
T ss_dssp             CCTTTCCCTTTSTTC
T ss_pred             CChhHCCCHHHHhcC
Confidence            999999999998753

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.95  E-value=1.8e-27  Score=193.47  Aligned_cols=150  Identities=21%  Similarity=0.243  Sum_probs=117.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccC-CCCceEeeCCCCCeeEeC------CCCCeEEeccccceecCCCcccccccccccCC
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLD------KDMNPKISDFGMARICGGNELQANTSRIVGTY   75 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~h~~l~~~nil~~------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~   75 (208)
                      +++..+..++.||+.||.|||++ +   ++|+||||.||+++      ..+.++|+|||++.......     ....++.
T Consensus       128 ~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~  199 (373)
T 1q8y_A          128 IPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTR  199 (373)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCG
T ss_pred             CcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCc
Confidence            77889999999999999999998 8   99999999999994      44479999999997764322     2235788


Q ss_pred             CccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc---------------c---------------------
Q 028458           76 GYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------------D---------------------  119 (208)
Q Consensus        76 ~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------------~---------------------  119 (208)
                      .|+|||.+.+..++.++|+||||+++|+|++|..|+.......               .                     
T Consensus       200 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  279 (373)
T 1q8y_A          200 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG  279 (373)
T ss_dssp             GGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--
T ss_pred             cccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcc
Confidence            9999999999889999999999999999999988775321100               0                     


Q ss_pred             ------CCc--------cchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          120 ------DPV--------LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       120 ------~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                            ...        ......+...+..+.+||.+||+.||++||+++|+++.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          280 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             hhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence                  000        00001235667889999999999999999999999883

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.95  E-value=1e-27  Score=195.49  Aligned_cols=155  Identities=25%  Similarity=0.280  Sum_probs=111.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+.+   ++||||||.||+++.++.++|+|||++......     .....++..|+|||
T Consensus       128 ~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE  199 (367)
T 2fst_X          128 KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPE  199 (367)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChH
Confidence            4678899999999999999999999   999999999999999999999999998765432     12246788999999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c-------cCC------------------------ccchhh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I-------DDP------------------------VLEDEY  127 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~-------~~~------------------------~~~~~~  127 (208)
                      .+.+ ..++.++|+|||||++|+|++|..++......  .       ..+                        ......
T Consensus       200 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (367)
T 2fst_X          200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN  279 (367)
T ss_dssp             HHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHH
T ss_pred             HHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHH
Confidence            9876 56899999999999999999998776432210  0       000                        000000


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhh
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNE  164 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~  164 (208)
                      .....+..+.+||.+||+.||++||++.++++.  ++..
T Consensus       280 ~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          280 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             HTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence            011224568899999999999999999999874  4444

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.95  E-value=2.1e-28  Score=199.94  Aligned_cols=152  Identities=23%  Similarity=0.240  Sum_probs=118.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++........  ......|++.|+|||
T Consensus       135 ~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE  209 (373)
T 2r5t_A          135 CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPE  209 (373)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCCC--ccccccCCccccCHH
Confidence            3677888999999999999999999   99999999999999999999999999875322211  223356899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      .+.+..++.++|+||||+++|+|++|..|+.....  ............+...+..+.++|.+||+.||++||++.+..
T Consensus       210 ~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             HhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            99998899999999999999999999988753321  111000000012234556788999999999999999985433

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.95  E-value=5.6e-28  Score=192.06  Aligned_cols=154  Identities=21%  Similarity=0.226  Sum_probs=114.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++.........  .....++..|.|||
T Consensus        98 ~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  172 (311)
T 4agu_A           98 GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDDEVATRWYRSPE  172 (311)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--cCCCcCCccccChH
Confidence            4678899999999999999999999   999999999999999999999999999876433221  12245788899999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccccc--------------------------CCcc-------chhh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID--------------------------DPVL-------EDEY  127 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~--------------------------~~~~-------~~~~  127 (208)
                      .+.+ ..++.++|+||||+++|+|++|..|+......-.                          ....       ....
T Consensus       173 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (311)
T 4agu_A          173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLEL  252 (311)
T ss_dssp             HHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHH
T ss_pred             HHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhh
Confidence            9876 5679999999999999999999877643221000                          0000       0000


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      .....+..+.+++.+||+.||++||+++|+++.
T Consensus       253 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          253 KFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             hcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            112345568899999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3e-27  Score=192.60  Aligned_cols=156  Identities=24%  Similarity=0.274  Sum_probs=121.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++||||||.||+++.++.++|+|||++.......     ....++..|+|||
T Consensus       124 ~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE  195 (367)
T 1cm8_A          124 KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPE  195 (367)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccccccc-----CcCcCCCCcCCHH
Confidence            3678889999999999999999999   9999999999999999999999999998754321     2246788999999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c-------cCCc------------------------cchhh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I-------DDPV------------------------LEDEY  127 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~-------~~~~------------------------~~~~~  127 (208)
                      .+.+ ..++.++|+|||||++|+|++|..++......  .       ..+.                        .....
T Consensus       196 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (367)
T 1cm8_A          196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS  275 (367)
T ss_dssp             HHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGG
T ss_pred             HHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHH
Confidence            9877 67899999999999999999998877432110  0       0000                        00000


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhhh
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~  165 (208)
                      .....+..+.+++.+||+.||++||+++++++.  ++...
T Consensus       276 ~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          276 ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            112335678899999999999999999999984  55543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.94  E-value=3e-28  Score=190.98  Aligned_cols=148  Identities=18%  Similarity=0.264  Sum_probs=115.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-------------------CCCeEEeccccceecCCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-------------------DMNPKISDFGMARICGGN   62 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-------------------~~~~~l~dfg~~~~~~~~   62 (208)
                      .+++..+..++.||+.||.|||+++   ++|+||||+||+++.                   ...++++|||++......
T Consensus       111 ~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~  187 (289)
T 1x8b_A          111 YFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP  187 (289)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc
Confidence            3788899999999999999999999   999999999999984                   447899999998876543


Q ss_pred             cccccccccccCCCccCcchhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHH
Q 028458           63 ELQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNI  139 (208)
Q Consensus        63 ~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l  139 (208)
                      ..      ..++..|.|||.+.+. .++.++|+||||+++|+|+++..++.....  .+......  ..+...+..+.++
T Consensus       188 ~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l  259 (289)
T 1x8b_A          188 QV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLP--RIPQVLSQEFTEL  259 (289)
T ss_dssp             CC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTTCCC--CCSSCCCHHHHHH
T ss_pred             cc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcCCCC--CCCcccCHHHHHH
Confidence            22      3468899999999765 456899999999999999987755432211  11111111  1233345678899


Q ss_pred             HhhccccCCCCCCCHHHHHHH
Q 028458          140 ALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       140 i~~~l~~~p~~Rps~~~i~~~  160 (208)
                      +.+||+.||++||++.++++.
T Consensus       260 i~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          260 LKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHHhCCCcccCCCHHHHhhC
Confidence            999999999999999999863

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.94  E-value=1.7e-27  Score=186.88  Aligned_cols=153  Identities=21%  Similarity=0.254  Sum_probs=120.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC---eEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN---PKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.   ++|+|||++.........   ....++..|+
T Consensus       101 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~  174 (284)
T 3kk8_A          101 FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYL  174 (284)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC---CCSCSCGGGC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc---cCCCCCcCCc
Confidence            4678899999999999999999999   999999999999976554   999999999776543321   2246788999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----cCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----DDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+.+..++.++|+||||+++|+|++|..|+.......     ..... .........+..+.+++.+||+.||++||
T Consensus       175 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  254 (284)
T 3kk8_A          175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI  254 (284)
T ss_dssp             CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             CchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCC
Confidence            9999998889999999999999999999988874432210     00000 00011223456788999999999999999


Q ss_pred             CHHHHHHH
Q 028458          153 TMNDVVCM  160 (208)
Q Consensus       153 s~~~i~~~  160 (208)
                      ++.|+++.
T Consensus       255 s~~~~l~h  262 (284)
T 3kk8_A          255 TADQALKV  262 (284)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999883

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.94  E-value=1e-27  Score=196.65  Aligned_cols=152  Identities=20%  Similarity=0.257  Sum_probs=121.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC--CCCeEEeccccceecCCCcccccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK--DMNPKISDFGMARICGGNELQANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~a   79 (208)
                      .+++..+..++.||+.||.|||+++   ++||||||+||+++.  .+.++|+|||++........   .....++..|+|
T Consensus       145 ~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~a  218 (387)
T 1kob_A          145 KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAA  218 (387)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccC
Confidence            4788999999999999999999999   999999999999974  46799999999987654322   122367899999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc-----CCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID-----DPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      ||.+.+..++.++|+||||+++|+|++|..|+......  ..     ...... ......+..+.++|.+||+.||++||
T Consensus       219 PE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rp  297 (387)
T 1kob_A          219 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-DAFSSVSPEAKDFIKNLLQKEPRKRL  297 (387)
T ss_dssp             HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-STTTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred             chhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-cccccCCHHHHHHHHHHcCCChhHCc
Confidence            99999888999999999999999999999887543211  00     000010 12234566788999999999999999


Q ss_pred             CHHHHHHH
Q 028458          153 TMNDVVCM  160 (208)
Q Consensus       153 s~~~i~~~  160 (208)
                      ++.++++.
T Consensus       298 t~~ell~h  305 (387)
T 1kob_A          298 TVHDALEH  305 (387)
T ss_dssp             CHHHHHTS
T ss_pred             CHHHHhhC
Confidence            99999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.94  E-value=5.7e-28  Score=194.42  Aligned_cols=154  Identities=24%  Similarity=0.310  Sum_probs=121.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||
T Consensus       137 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE  211 (335)
T 2owb_A          137 ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE  211 (335)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCccc--ccccCCCccccCHH
Confidence            4788899999999999999999999   999999999999999999999999999876432211  22346788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .+.+..++.++|+||||+++|+|++|..++......  ...........+...+..+.++|.+||+.||++||+++|+++
T Consensus       212 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            999888999999999999999999998877542210  000000000112234457889999999999999999999987


Q ss_pred             H
Q 028458          160 M  160 (208)
Q Consensus       160 ~  160 (208)
                      .
T Consensus       292 ~  292 (335)
T 2owb_A          292 D  292 (335)
T ss_dssp             S
T ss_pred             C
Confidence            3

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.94  E-value=1.4e-27  Score=195.36  Aligned_cols=104  Identities=29%  Similarity=0.341  Sum_probs=90.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc--CCCCceEeeCCCCCeeEeC--CCCCeEEeccccceecCCCcccccccccccCCCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ--YSRVRIIHRDLKVSNILLD--KDMNPKISDFGMARICGGNELQANTSRIVGTYGY   77 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~--~~~~~i~h~~l~~~nil~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~   77 (208)
                      .+++..+..++.|++.||.|||.  .+   |+||||||.||+++  .++.++|+|||++.......     ....++..|
T Consensus       153 ~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y  224 (382)
T 2vx3_A          153 GVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFY  224 (382)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceeccccc-----ccccCCccc
Confidence            37889999999999999999994  56   99999999999994  47789999999998764332     224678889


Q ss_pred             cCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCc
Q 028458           78 MSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNR  113 (208)
Q Consensus        78 ~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~  113 (208)
                      +|||.+.+..++.++|+|||||++|+|++|..|+..
T Consensus       225 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999998999999999999999999999887753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.94  E-value=1.3e-27  Score=196.43  Aligned_cols=157  Identities=19%  Similarity=0.268  Sum_probs=120.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC-CCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||.||+++ .++.++|+|||++........   .....++..|+||
T Consensus       137 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aP  210 (394)
T 4e7w_A          137 TMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAP  210 (394)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCH
Confidence            4677889999999999999999999   99999999999998 789999999999987643322   1224568889999


Q ss_pred             chhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccc--c----c---C------------------Cccch----hhh
Q 028458           81 EYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I----D---D------------------PVLED----EYS  128 (208)
Q Consensus        81 e~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~----~---~------------------~~~~~----~~~  128 (208)
                      |.+.+. .++.++|+|||||++|+|++|..|+......  .    .   .                  +....    ...
T Consensus       211 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (394)
T 4e7w_A          211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVF  290 (394)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHS
T ss_pred             HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhc
Confidence            998765 4899999999999999999998877533210  0    0   0                  00000    011


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhh
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNE  164 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~  164 (208)
                      ....+..+.++|.+||+.||++||++.|+++.  ++.+
T Consensus       291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          291 RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             cccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence            12245678999999999999999999999984  5544

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.94  E-value=7.7e-28  Score=199.40  Aligned_cols=153  Identities=21%  Similarity=0.260  Sum_probs=117.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC-CCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||.||+++.+ +.+||+|||++........   .....++..|+||
T Consensus       152 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aP  225 (420)
T 1j1b_A          152 TLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAP  225 (420)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCH
Confidence            4678889999999999999999999   9999999999999955 5689999999987543321   1224678899999


Q ss_pred             chhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccc--c----c---C------------------Cccch----hhh
Q 028458           81 EYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I----D---D------------------PVLED----EYS  128 (208)
Q Consensus        81 e~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~----~---~------------------~~~~~----~~~  128 (208)
                      |.+.+. .++.++|+|||||++|+|++|..++......  +    .   .                  +.+..    ...
T Consensus       226 E~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  305 (420)
T 1j1b_A          226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF  305 (420)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHS
T ss_pred             HHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhc
Confidence            998765 6899999999999999999998877432210  0    0   0                  00000    001


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ....+..+.+||.+||+.||++||++.|+++.
T Consensus       306 ~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          306 RPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            12335678999999999999999999999873

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.94  E-value=1.9e-27  Score=193.97  Aligned_cols=151  Identities=21%  Similarity=0.261  Sum_probs=116.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++.......     ....++..|+|||
T Consensus       140 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~~~~~t~~y~aPE  211 (371)
T 4exu_A          140 EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPE  211 (371)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccCc-----CCcccCccccCHH
Confidence            3688899999999999999999999   9999999999999999999999999987653322     2245688999999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc-------------------------------CCccchhh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID-------------------------------DPVLEDEY  127 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~-------------------------------~~~~~~~~  127 (208)
                      .+.+ ..++.++|+||||+++|+|++|..|+......  ..                               ........
T Consensus       212 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (371)
T 4exu_A          212 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ  291 (371)
T ss_dssp             HHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHH
T ss_pred             HhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHH
Confidence            9877 67899999999999999999998887542210  00                               00000000


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      .....+..+.+||.+||+.||++||+++|+++.
T Consensus       292 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          292 LFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            112235678999999999999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.94  E-value=7.3e-28  Score=210.02  Aligned_cols=153  Identities=27%  Similarity=0.313  Sum_probs=122.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..|+.||+.||.|||+++   |+||||||+||+++.++.++|+|||++........  ......|++.|+|||
T Consensus       438 ~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE  512 (674)
T 3pfq_A          438 RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPE  512 (674)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHh
Confidence            4678899999999999999999999   99999999999999999999999999976432221  223457899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH-----
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM-----  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----  154 (208)
                      ++.+..++.++|+||||+++|+|++|..|+.....  ............+..++.++.+||.+||+.||++|+++     
T Consensus       513 ~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~  592 (674)
T 3pfq_A          513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGE  592 (674)
T ss_dssp             HHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHH
T ss_pred             hhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcH
Confidence            99999999999999999999999999988854322  11100011112334566788999999999999999987     


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      +||++
T Consensus       593 ~ei~~  597 (674)
T 3pfq_A          593 RDIKE  597 (674)
T ss_dssp             HHHHS
T ss_pred             HHHhc
Confidence            67765

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.94  E-value=1.2e-27  Score=191.56  Aligned_cols=152  Identities=17%  Similarity=0.224  Sum_probs=117.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC-CeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      ++..++..++.|++.||.|||+++   ++|+||||.||+++.++ .++|+|||++........   .....++..|.|||
T Consensus       127 ~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE  200 (330)
T 3nsz_A          127 LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE  200 (330)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChh
Confidence            577889999999999999999999   99999999999999776 799999999987643322   12245678899999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccccccC---------------------Ccc----------------
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD---------------------PVL----------------  123 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~---------------------~~~----------------  123 (208)
                      .+.+ ..++.++|+||||+++|+|++|..|+.........                     ...                
T Consensus       201 ~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (330)
T 3nsz_A          201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW  280 (330)
T ss_dssp             HHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCG
T ss_pred             hhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccch
Confidence            9877 56899999999999999999998877332111000                     000                


Q ss_pred             ---chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          124 ---EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       124 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                         .........+..+.+||.+||+.||++||+++|+++.
T Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          281 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             GGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               0000111245678899999999999999999999873

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.94  E-value=6.7e-28  Score=193.50  Aligned_cols=154  Identities=23%  Similarity=0.232  Sum_probs=116.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.||+.||.|||+++   ++||||||.||+++.++.++|+|||++........  ......|+..|+|||
T Consensus       117 ~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE  191 (327)
T 3a62_A          117 IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPE  191 (327)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccCCc--cccccCCCcCccCHh
Confidence            3677889999999999999999999   99999999999999999999999999865432211  122346789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----CH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----TM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~  154 (208)
                      .+.+..++.++|+||||+++|+|++|..|+......  ...........+...+..+.++|.+||+.||++||     ++
T Consensus       192 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~  271 (327)
T 3a62_A          192 ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDA  271 (327)
T ss_dssp             HHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTH
T ss_pred             hCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCH
Confidence            998888999999999999999999999887543211  10000000012234456788999999999999999     77


Q ss_pred             HHHHHH
Q 028458          155 NDVVCM  160 (208)
Q Consensus       155 ~~i~~~  160 (208)
                      .++++.
T Consensus       272 ~e~l~h  277 (327)
T 3a62_A          272 GEVQAH  277 (327)
T ss_dssp             HHHHHS
T ss_pred             HHHHcC
Confidence            888763

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.94  E-value=3.3e-28  Score=196.97  Aligned_cols=149  Identities=32%  Similarity=0.408  Sum_probs=118.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++......      ....|+..|+|||
T Consensus       150 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE  220 (348)
T 1u5q_A          150 PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPE  220 (348)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHh
Confidence            4788899999999999999999999   999999999999999999999999998765322      2246788999999


Q ss_pred             hhc---cCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           82 YAI---QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        82 ~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      .+.   .+.++.++|+||||+++|+|++|..|+......     +...... .......+..+.++|.+||+.||++||+
T Consensus       221 ~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps  299 (348)
T 1u5q_A          221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRPT  299 (348)
T ss_dssp             HHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             hhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcC
Confidence            985   466899999999999999999998876432211     0000000 0112234567889999999999999999


Q ss_pred             HHHHHHH
Q 028458          154 MNDVVCM  160 (208)
Q Consensus       154 ~~~i~~~  160 (208)
                      ++++++.
T Consensus       300 ~~~ll~h  306 (348)
T 1u5q_A          300 SEVLLKH  306 (348)
T ss_dssp             HHHHTTC
T ss_pred             HHHHhhC
Confidence            9999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.94  E-value=8.7e-28  Score=191.37  Aligned_cols=156  Identities=22%  Similarity=0.253  Sum_probs=113.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC---eEEeccccceecCCCccc-----cccccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN---PKISDFGMARICGGNELQ-----ANTSRIVG   73 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~---~~l~dfg~~~~~~~~~~~-----~~~~~~~~   73 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.   ++|+|||++.........     .......|
T Consensus       107 ~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~g  183 (316)
T 2ac3_A          107 HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG  183 (316)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccC
Confidence            4678899999999999999999999   999999999999987765   999999998765322111     11122357


Q ss_pred             CCCccCcchhcc-----CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--------------------ccCCccc-hhh
Q 028458           74 TYGYMSPEYAIQ-----GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--------------------IDDPVLE-DEY  127 (208)
Q Consensus        74 ~~~~~ape~~~~-----~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------------------~~~~~~~-~~~  127 (208)
                      +..|+|||.+.+     ..++.++|+||||+++|+|++|..|+......                    +...... ...
T Consensus       184 t~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  263 (316)
T 2ac3_A          184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK  263 (316)
T ss_dssp             SGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHH
T ss_pred             CcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCch
Confidence            889999999875     45789999999999999999998887543211                    0000000 000


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      .....+..+.++|.+||+.||++||++.|+++.
T Consensus       264 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          264 DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            112245678899999999999999999999883

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.94  E-value=1.6e-27  Score=196.05  Aligned_cols=157  Identities=17%  Similarity=0.211  Sum_probs=124.0

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe----CCCCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      +++..+..++.|++.||.|||+++   |+||||||+||++    +.++.++|+|||++........   .....|+..|+
T Consensus       109 l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~  182 (396)
T 4eut_A          109 LPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL  182 (396)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCcccc
Confidence            788999999999999999999999   9999999999999    7777899999999987644322   12246789999


Q ss_pred             Ccchhcc--------CCCCCcchhHHHHHHHHHHHHhhhcCCccccc------c----c-C-------------------
Q 028458           79 SPEYAIQ--------GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------I----D-D-------------------  120 (208)
Q Consensus        79 ape~~~~--------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~----~-~-------------------  120 (208)
                      |||.+.+        ..++.++|+||||+++|+|++|..|+......      +    . .                   
T Consensus       183 aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  262 (396)
T 4eut_A          183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS  262 (396)
T ss_dssp             CHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEE
T ss_pred             CHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccC
Confidence            9999865        45778999999999999999998776421110      0    0 0                   


Q ss_pred             -CccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhhhh
Q 028458          121 -PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEA  165 (208)
Q Consensus       121 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l~~~~  165 (208)
                       ...............+.+++.+||+.||++||+++++++.+..+.
T Consensus       263 ~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          263 GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             ccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence             000011223667788999999999999999999999999887754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.94  E-value=1.4e-27  Score=190.00  Aligned_cols=153  Identities=23%  Similarity=0.315  Sum_probs=121.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++.........  .....++..|.|||
T Consensus       121 ~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  195 (314)
T 3com_A          121 TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPE  195 (314)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC--BCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc--cCccCCCCCccChh
Confidence            4788899999999999999999999   999999999999999999999999999776433221  12245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc-----CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-----DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+||||+++|+|++|..|+........     .........+...+..+.++|.+||+.||.+||++.+
T Consensus       196 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~  275 (314)
T 3com_A          196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ  275 (314)
T ss_dssp             HHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             hcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            99888899999999999999999999887754322100     0000000113334567889999999999999999999


Q ss_pred             HHH
Q 028458          157 VVC  159 (208)
Q Consensus       157 i~~  159 (208)
                      +++
T Consensus       276 ll~  278 (314)
T 3com_A          276 LLQ  278 (314)
T ss_dssp             HTT
T ss_pred             HHh
Confidence            987

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.94  E-value=3.9e-27  Score=184.34  Aligned_cols=151  Identities=21%  Similarity=0.267  Sum_probs=118.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe---CCCCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||+|+||++   +.++.++|+|||++........   .....++..|+
T Consensus       102 ~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~  175 (277)
T 3f3z_A          102 VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYV  175 (277)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---hhccCCCCCcc
Confidence            4688899999999999999999999   9999999999999   7888999999999987653332   22246788999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c----cCCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I----DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+.+ .++.++|+||||+++|+|++|..|+......  .    ..............+..+.++|.+||+.||++||
T Consensus       176 aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  254 (277)
T 3f3z_A          176 SPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI  254 (277)
T ss_dssp             CHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             ChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCc
Confidence            9998865 4899999999999999999998887543221  0    0000000011123467789999999999999999


Q ss_pred             CHHHHHH
Q 028458          153 TMNDVVC  159 (208)
Q Consensus       153 s~~~i~~  159 (208)
                      ++.++++
T Consensus       255 s~~~~l~  261 (277)
T 3f3z_A          255 TSLQALE  261 (277)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.94  E-value=2.4e-27  Score=192.99  Aligned_cols=152  Identities=22%  Similarity=0.299  Sum_probs=119.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+.|   ++|+||+|.||+++.++.++++|||++........   .....|+..|+|||
T Consensus       196 ~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE  269 (365)
T 2y7j_A          196 ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPE  269 (365)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChh
Confidence            4788899999999999999999999   99999999999999999999999999887653322   22346788999999


Q ss_pred             hhccC------CCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----cCCccch-hhhhHHHHHHHHHHHhhccccCCC
Q 028458           82 YAIQG------IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----DDPVLED-EYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        82 ~~~~~------~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      .+.+.      .++.++|+||||+++|+|++|..|+.......     ....... .......+..+.++|.+||+.||+
T Consensus       270 ~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  349 (365)
T 2y7j_A          270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPE  349 (365)
T ss_dssp             HHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTT
T ss_pred             hccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChh
Confidence            98643      47889999999999999999998875432110     0000000 011122355688999999999999


Q ss_pred             CCCCHHHHHH
Q 028458          150 DRPTMNDVVC  159 (208)
Q Consensus       150 ~Rps~~~i~~  159 (208)
                      +||++.++++
T Consensus       350 ~Rps~~ell~  359 (365)
T 2y7j_A          350 ARLTAEQALQ  359 (365)
T ss_dssp             TSCCHHHHHH
T ss_pred             HCcCHHHHhc
Confidence            9999999987

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.94  E-value=9.3e-28  Score=186.83  Aligned_cols=155  Identities=19%  Similarity=0.247  Sum_probs=121.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+. .++|+||||+||+++.++.+++.|||+......       ....++..|+|||
T Consensus       107 ~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE  178 (271)
T 3kmu_A          107 VVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPE  178 (271)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChh
Confidence            47899999999999999999999753 399999999999999999999998887644221       1235678999999


Q ss_pred             hhccCCCCC---cchhHHHHHHHHHHHHhhhcCCccccccc-----CCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           82 YAIQGIFSI---KSDVFSFGVLLLEIAWDLWTSNRTLELID-----DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        82 ~~~~~~~~~---~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      .+.+..++.   ++|+||||+++|+|++|..|+........     ..... ...+...+..+.+++.+||+.||++||+
T Consensus       179 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps  257 (271)
T 3kmu_A          179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-PTIPPGISPHVSKLMKICMNEDPAKRPK  257 (271)
T ss_dssp             HHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             hhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence            998765544   79999999999999999888754322100     00000 0123345667899999999999999999


Q ss_pred             HHHHHHHHhhhh
Q 028458          154 MNDVVCMLTNEA  165 (208)
Q Consensus       154 ~~~i~~~l~~~~  165 (208)
                      ++++++.|+.+.
T Consensus       258 ~~~il~~L~~l~  269 (271)
T 3kmu_A          258 FDMIVPILEKMQ  269 (271)
T ss_dssp             HHHHHHHHHHHC
T ss_pred             HHHHHHHHHHhh
Confidence            999999998875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.94  E-value=2.7e-27  Score=189.21  Aligned_cols=151  Identities=23%  Similarity=0.290  Sum_probs=119.9

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++.......   ......++..|.|||.
T Consensus       117 ~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~  190 (326)
T 1blx_A          117 VPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEV  190 (326)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHH
Confidence            788899999999999999999999   9999999999999999999999999987654222   1223467889999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc------------------C-----------CccchhhhhHHHH
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID------------------D-----------PVLEDEYSSKQML  133 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------------------~-----------~~~~~~~~~~~~~  133 (208)
                      +.+..++.++|+||||+++|+|++|..++........                  .           ............+
T Consensus       191 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (326)
T 1blx_A          191 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID  270 (326)
T ss_dssp             HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC
T ss_pred             HhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCC
Confidence            9988899999999999999999999877643221000                  0           0000001123345


Q ss_pred             HHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          134 LRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       134 ~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ..+.++|.+||+.||++||++.++++
T Consensus       271 ~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          271 ELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            67889999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=5.5e-28  Score=196.09  Aligned_cols=155  Identities=21%  Similarity=0.249  Sum_probs=119.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||.||+++.++.++|+|||++......... ......|+..|+|||
T Consensus       155 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE  230 (355)
T 1vzo_A          155 RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPD  230 (355)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC-cccCcccCcCccChh
Confidence            3678889999999999999999999   999999999999999999999999999765432221 122346899999999


Q ss_pred             hhccC--CCCCcchhHHHHHHHHHHHHhhhcCCcccccccC-----Cc-cchhhhhHHHHHHHHHHHhhccccCCCCCC-
Q 028458           82 YAIQG--IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD-----PV-LEDEYSSKQMLLRYVNIALLCVQESADDRP-  152 (208)
Q Consensus        82 ~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~-----~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-  152 (208)
                      .+.+.  .++.++|+||||+++|+|++|..|+.........     .. ......+...+..+.++|.+||+.||++|| 
T Consensus       231 ~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~  310 (355)
T 1vzo_A          231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLG  310 (355)
T ss_dssp             HHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred             hhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcC
Confidence            99753  4688999999999999999998887532211000     00 000012334456788999999999999999 


Q ss_pred             ----CHHHHHHH
Q 028458          153 ----TMNDVVCM  160 (208)
Q Consensus       153 ----s~~~i~~~  160 (208)
                          +++++++.
T Consensus       311 ~~~~s~~ell~h  322 (355)
T 1vzo_A          311 CGPRDADEIKEH  322 (355)
T ss_dssp             SSTTTHHHHHTS
T ss_pred             CCCCCHHHHHcC
Confidence                99999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.94  E-value=4.6e-28  Score=190.53  Aligned_cols=155  Identities=25%  Similarity=0.399  Sum_probs=112.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC-CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||++ +   ++|+||||+||+++.++.++|+|||++.........   ....++..|.||
T Consensus       105 ~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aP  178 (290)
T 3fme_A          105 TIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCKPYMAP  178 (290)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccccccc---cccCCCccccCh
Confidence            478889999999999999999998 8   999999999999999999999999998765433221   223578899999


Q ss_pred             chh----ccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-------ccCCccchhhhhHHHHHHHHHHHhhccccCCC
Q 028458           81 EYA----IQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-------IDDPVLEDEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        81 e~~----~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      |.+    .+..++.++|+||||+++|+|++|..|+......       ..... .. ......+..+.+++.+||+.||+
T Consensus       179 E~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~p~  256 (290)
T 3fme_A          179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQ-LPADKFSAEFVDFTSQCLKKNSK  256 (290)
T ss_dssp             HHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-CC-CCTTTSCHHHHHHHHHHTCSSGG
T ss_pred             hhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-CC-cccccCCHHHHHHHHHHhhcChh
Confidence            996    4556889999999999999999999887532111       01000 00 11223456788999999999999


Q ss_pred             CCCCHHHHHH--HHhhh
Q 028458          150 DRPTMNDVVC--MLTNE  164 (208)
Q Consensus       150 ~Rps~~~i~~--~l~~~  164 (208)
                      +||++.|+++  .++..
T Consensus       257 ~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          257 ERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             GSCCHHHHTTSHHHHHH
T ss_pred             hCcCHHHHHhCcccccC
Confidence            9999999988  45443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=2.1e-27  Score=191.85  Aligned_cols=154  Identities=25%  Similarity=0.274  Sum_probs=118.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++........  ......++..|.|||
T Consensus       108 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE  182 (346)
T 1ua2_A          108 VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPE  182 (346)
T ss_dssp             SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCch
Confidence            3677889999999999999999999   99999999999999999999999999876543221  122346788999999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccc--c-------cCC---------------------ccchhhhhH
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I-------DDP---------------------VLEDEYSSK  130 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~-------~~~---------------------~~~~~~~~~  130 (208)
                      .+.+. .++.++|+||||+++|+|++|..++......  .       ..+                     .........
T Consensus       183 ~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (346)
T 1ua2_A          183 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS  262 (346)
T ss_dssp             HHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCT
T ss_pred             HhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhc
Confidence            98764 4789999999999999999987665332110  0       000                     000001112


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          131 QMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       131 ~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ..+..+.++|.+||+.||++||++.|+++.
T Consensus       263 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          263 AAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            345678999999999999999999999885

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.94  E-value=8.2e-28  Score=189.79  Aligned_cols=151  Identities=25%  Similarity=0.342  Sum_probs=121.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........  ......++..|.|||
T Consensus       111 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE  185 (294)
T 2rku_A          111 ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPE  185 (294)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcc
Confidence            4788899999999999999999999   99999999999999999999999999887643221  122245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+|+||+++|+|++|..|+......     +.....   ..+...+..+.+++.+||+.||++||++++
T Consensus       186 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  262 (294)
T 2rku_A          186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---SIPKHINPVAASLIQKMLQTDPTARPTINE  262 (294)
T ss_dssp             HHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC---CCccccCHHHHHHHHHHcccChhhCcCHHH
Confidence            998888999999999999999999998877543211     000110   112334567889999999999999999999


Q ss_pred             HHHH
Q 028458          157 VVCM  160 (208)
Q Consensus       157 i~~~  160 (208)
                      +++.
T Consensus       263 ll~~  266 (294)
T 2rku_A          263 LLND  266 (294)
T ss_dssp             GGGS
T ss_pred             HhhC
Confidence            9874

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=3.5e-27  Score=193.09  Aligned_cols=153  Identities=18%  Similarity=0.218  Sum_probs=118.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC-CCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.||+.||.|||+.+   |+||||||.||+++ .++.++|+|||++.........   ....++..|+||
T Consensus       137 ~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aP  210 (383)
T 3eb0_A          137 SIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAP  210 (383)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCH
Confidence            4778899999999999999999999   99999999999997 6789999999999876433221   224568889999


Q ss_pred             chhccCC-CCCcchhHHHHHHHHHHHHhhhcCCcccccc---------cC------------------Cccc----hhhh
Q 028458           81 EYAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------DD------------------PVLE----DEYS  128 (208)
Q Consensus        81 e~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~~------------------~~~~----~~~~  128 (208)
                      |.+.+.. ++.++|+|||||++|+|++|..++......-         ..                  +...    ....
T Consensus       211 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (383)
T 3eb0_A          211 ELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL  290 (383)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHS
T ss_pred             HHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhC
Confidence            9987654 8999999999999999999988775332110         00                  0000    0011


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      +...+..+.++|.+||+.||++||++.|+++.
T Consensus       291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            22345668899999999999999999999863

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.94  E-value=9.7e-28  Score=190.14  Aligned_cols=154  Identities=25%  Similarity=0.359  Sum_probs=122.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........  .....++..|.|||
T Consensus       115 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE  189 (303)
T 3a7i_A          115 PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPE  189 (303)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC--BCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccccc--cCccCCCcCccCHH
Confidence            4678899999999999999999999   999999999999999999999999999776543321  12346788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCcc---chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVL---EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      .+.+..++.++|+||||+++|+|++|..|+............   .........+..+.+++.+||+.||++||++.+++
T Consensus       190 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  269 (303)
T 3a7i_A          190 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL  269 (303)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred             HHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            999888999999999999999999998877543211000000   00011223456788999999999999999999998


Q ss_pred             HH
Q 028458          159 CM  160 (208)
Q Consensus       159 ~~  160 (208)
                      +.
T Consensus       270 ~~  271 (303)
T 3a7i_A          270 KH  271 (303)
T ss_dssp             TC
T ss_pred             hC
Confidence            74

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.94  E-value=9.8e-28  Score=191.02  Aligned_cols=154  Identities=24%  Similarity=0.318  Sum_probs=113.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||+++. +.++|+|||++................++..|+|||
T Consensus       123 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  198 (313)
T 3cek_A          123 SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE  198 (313)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHH
Confidence            4678899999999999999999999   999999999999964 789999999987664433222223346788999999


Q ss_pred             hhcc-----------CCCCCcchhHHHHHHHHHHHHhhhcCCccccccc------CCccchhhhhHHHHHHHHHHHhhcc
Q 028458           82 YAIQ-----------GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID------DPVLEDEYSSKQMLLRYVNIALLCV  144 (208)
Q Consensus        82 ~~~~-----------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l  144 (208)
                      .+.+           ..++.++|+||||+++|+|++|..|+........      ...... ..+...+..+.+++.+||
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l  277 (313)
T 3cek_A          199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-EFPDIPEKDLQDVLKCCL  277 (313)
T ss_dssp             HHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC-CCCCCSCHHHHHHHHHHT
T ss_pred             HHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc-CCcccchHHHHHHHHHHc
Confidence            9865           4678899999999999999999988754322110      000000 111222457889999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 028458          145 QESADDRPTMNDVVCM  160 (208)
Q Consensus       145 ~~~p~~Rps~~~i~~~  160 (208)
                      +.||++||++.|+++.
T Consensus       278 ~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          278 KRDPKQRISIPELLAH  293 (313)
T ss_dssp             CSSTTTSCCHHHHHTS
T ss_pred             cCCcccCcCHHHHhcC
Confidence            9999999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.94  E-value=1.1e-27  Score=193.55  Aligned_cols=153  Identities=20%  Similarity=0.221  Sum_probs=118.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC----CCeEEeccccceecCCCcccccccccccCCCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD----MNPKISDFGMARICGGNELQANTSRIVGTYGY   77 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~   77 (208)
                      .+++..+..++.||+.||.|||+++   ++||||||+||++...    +.++|+|||++........  ......++..|
T Consensus       112 ~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y  186 (342)
T 2qr7_A          112 FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANF  186 (342)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccc
Confidence            4688899999999999999999999   9999999999998433    3499999999987643321  12234678999


Q ss_pred             cCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc-----ccc-----CCccchhhhhHHHHHHHHHHHhhccccC
Q 028458           78 MSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE-----LID-----DPVLEDEYSSKQMLLRYVNIALLCVQES  147 (208)
Q Consensus        78 ~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~  147 (208)
                      +|||.+.+..++.++|+||||+++|+|++|..|+.....     ...     ...... ......+..+.++|.+||+.|
T Consensus       187 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~d  265 (342)
T 2qr7_A          187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG-GYWNSVSDTAKDLVSKMLHVD  265 (342)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS-TTTTTSCHHHHHHHHHHTCSS
T ss_pred             cCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc-cccccCCHHHHHHHHHHCCCC
Confidence            999999887889999999999999999999988753211     000     000000 112345677889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 028458          148 ADDRPTMNDVVCM  160 (208)
Q Consensus       148 p~~Rps~~~i~~~  160 (208)
                      |++||++.++++.
T Consensus       266 P~~R~t~~~il~h  278 (342)
T 2qr7_A          266 PHQRLTAALVLRH  278 (342)
T ss_dssp             TTTSCCHHHHTTS
T ss_pred             hhHCcCHHHHhcC
Confidence            9999999999873

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.94  E-value=2.4e-27  Score=188.65  Aligned_cols=148  Identities=20%  Similarity=0.352  Sum_probs=121.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC-CCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++ .++.++|+|||++........    ....++..|.||
T Consensus       135 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aP  207 (312)
T 2iwi_A          135 PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPP  207 (312)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcc----cccCCcccccCc
Confidence            4788899999999999999999999   99999999999998 788999999999887654322    224578899999


Q ss_pred             chhccCCC-CCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           81 EYAIQGIF-SIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        81 e~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      |.+.+..+ +.++|+||||+++|+|++|..++....+......    ..+...+..+.++|.+||+.||++||+++|+++
T Consensus       208 E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCC----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             eeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhcc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            99887766 4589999999999999999988865444332111    122334567889999999999999999999997


Q ss_pred             H
Q 028458          160 M  160 (208)
Q Consensus       160 ~  160 (208)
                      .
T Consensus       284 ~  284 (312)
T 2iwi_A          284 D  284 (312)
T ss_dssp             S
T ss_pred             C
Confidence            4

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.94  E-value=5.2e-27  Score=184.04  Aligned_cols=158  Identities=20%  Similarity=0.198  Sum_probs=121.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC----CeEEeccccceecCCCcccccccccccCCCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM----NPKISDFGMARICGGNELQANTSRIVGTYGY   77 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~   77 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++    .++|+|||++........   .....++..|
T Consensus       104 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y  177 (283)
T 3bhy_A          104 SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEF  177 (283)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCc
Confidence            4788899999999999999999999   99999999999998776    799999999887643321   1223578899


Q ss_pred             cCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---cCCcc-chhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           78 MSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---DDPVL-EDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        78 ~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .|||.+.+..++.++|+||||+++|+|++|..|+......  .   ..... .........+..+.+++.+||+.||++|
T Consensus       178 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  257 (283)
T 3bhy_A          178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR  257 (283)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGS
T ss_pred             cCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHC
Confidence            9999998888999999999999999999998877543211  0   00000 0111223345678899999999999999


Q ss_pred             CCHHHHHH--HHhhhh
Q 028458          152 PTMNDVVC--MLTNEA  165 (208)
Q Consensus       152 ps~~~i~~--~l~~~~  165 (208)
                      |++.++++  .++...
T Consensus       258 ps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          258 MTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             CCHHHHHHCHHHHHHH
T ss_pred             cCHHHHHhCHHHHHHH
Confidence            99999998  455554

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.94  E-value=1.8e-27  Score=191.04  Aligned_cols=153  Identities=20%  Similarity=0.225  Sum_probs=111.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC-----CCCCeEEeccccceecCCCcccccccccccCCC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-----KDMNPKISDFGMARICGGNELQANTSRIVGTYG   76 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~-----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~   76 (208)
                      .+++..+..++.||+.||.|||+++   |+|+||||+||+++     ..+.++|+|||++.........  .....++..
T Consensus       128 ~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~  202 (329)
T 3gbz_A          128 DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEIITLW  202 (329)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccc--cCCCcCCcc
Confidence            4678899999999999999999999   99999999999994     4556999999998765432211  122356889


Q ss_pred             ccCcchhccCC-CCCcchhHHHHHHHHHHHHhhhcCCcccccc------------cCCc----------------cc---
Q 028458           77 YMSPEYAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------------DDPV----------------LE---  124 (208)
Q Consensus        77 ~~ape~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------------~~~~----------------~~---  124 (208)
                      |+|||.+.+.. ++.++|+||||+++|+|++|..++.......            ....                ..   
T Consensus       203 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (329)
T 3gbz_A          203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKT  282 (329)
T ss_dssp             TCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCC
T ss_pred             ccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhcccc
Confidence            99999997744 7999999999999999999887764322100            0000                00   


Q ss_pred             -hhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          125 -DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       125 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                       ........+..+.+||.+||+.||++||+++|+++
T Consensus       283 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          283 LKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             00111124467889999999999999999999987

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.94  E-value=1.4e-27  Score=203.05  Aligned_cols=153  Identities=27%  Similarity=0.324  Sum_probs=121.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||.||+++.++.++|+|||++.........  .....|++.|+|||
T Consensus       285 ~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE  359 (543)
T 3c4z_A          285 GFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE  359 (543)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC--BCCCCSCTTTSCHH
T ss_pred             cccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc--cccccCCccccChh
Confidence            4788899999999999999999999   999999999999999999999999999876443221  22347899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc-----CCcc-chhhhhHHHHHHHHHHHhhccccCCCCCCCH-
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-----DPVL-EDEYSSKQMLLRYVNIALLCVQESADDRPTM-  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-  154 (208)
                      .+.+..++.++|+|||||++|+|++|..|+........     .... .....+...+..+.++|.+||+.||++||++ 
T Consensus       360 ~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred             hhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence            99998999999999999999999999988864321110     0000 0001234456778899999999999999965 


Q ss_pred             ----HHHHH
Q 028458          155 ----NDVVC  159 (208)
Q Consensus       155 ----~~i~~  159 (208)
                          +++++
T Consensus       440 ~~~a~ei~~  448 (543)
T 3c4z_A          440 DGSCDGLRT  448 (543)
T ss_dssp             TTBSHHHHT
T ss_pred             ccCHHHHHc
Confidence                66664

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.94  E-value=1.8e-27  Score=190.99  Aligned_cols=154  Identities=24%  Similarity=0.302  Sum_probs=115.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||.||+++.++.++|+|||++........  ......++..|+|||
T Consensus       120 ~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE  194 (331)
T 4aaa_A          120 GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPE  194 (331)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcc
Confidence            4678899999999999999999999   99999999999999999999999999876543221  112245788999999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccccc-----------------------------CCc----cchhh
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-----------------------------DPV----LEDEY  127 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----------------------------~~~----~~~~~  127 (208)
                      .+.+. .++.++|+||||+++|+|++|..|+........                             .+.    .....
T Consensus       195 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (331)
T 4aaa_A          195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLER  274 (331)
T ss_dssp             HHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHH
T ss_pred             cccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhh
Confidence            99775 678999999999999999999877643321100                             000    00001


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      .....+..+.++|.+||+.||++||++.|+++.
T Consensus       275 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          275 RYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            112346778999999999999999999998873

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.94  E-value=1.2e-27  Score=189.26  Aligned_cols=155  Identities=30%  Similarity=0.484  Sum_probs=115.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc---cccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL---QANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++........   ........++..|+
T Consensus       117 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~  193 (303)
T 2vwi_A          117 VLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM  193 (303)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCcccc
Confidence            3788999999999999999999999   99999999999999999999999999866543221   11112346788999


Q ss_pred             Ccchhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccC--Cccch----hhhhHHHHHHHHHHHhhccc
Q 028458           79 SPEYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDD--PVLED----EYSSKQMLLRYVNIALLCVQ  145 (208)
Q Consensus        79 ape~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~--~~~~~----~~~~~~~~~~~~~li~~~l~  145 (208)
                      |||.+.+ ..++.++|+||||+++|+|++|..|+......      ...  .....    .......+..+.+++.+||+
T Consensus       194 aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  273 (303)
T 2vwi_A          194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQ  273 (303)
T ss_dssp             CHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCC
T ss_pred             CHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHcc
Confidence            9999875 56889999999999999999998877542211      000  00000    01112234678899999999


Q ss_pred             cCCCCCCCHHHHHH
Q 028458          146 ESADDRPTMNDVVC  159 (208)
Q Consensus       146 ~~p~~Rps~~~i~~  159 (208)
                      .||++||++.++++
T Consensus       274 ~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          274 KDPEKRPTAAELLR  287 (303)
T ss_dssp             SSGGGSCCHHHHHT
T ss_pred             CChhhCcCHHHHhh
Confidence            99999999999987

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.94  E-value=3e-27  Score=191.73  Aligned_cols=157  Identities=19%  Similarity=0.189  Sum_probs=114.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   ++|+||||.||+++.++.++|+|||++........   .....++..|.|||
T Consensus       130 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE  203 (362)
T 3pg1_A          130 VISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPE  203 (362)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcH
Confidence            4788999999999999999999999   99999999999999999999999999875432221   12245678899999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c-------cCC-------------------------ccchh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I-------DDP-------------------------VLEDE  126 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~-------~~~-------------------------~~~~~  126 (208)
                      .+.+ ..++.++|+||||+++|+|++|..|+......  .       ..+                         .....
T Consensus       204 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (362)
T 3pg1_A          204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT  283 (362)
T ss_dssp             HHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHH
T ss_pred             HhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHH
Confidence            9876 66899999999999999999998877542210  0       000                         00000


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhh
Q 028458          127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNE  164 (208)
Q Consensus       127 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~  164 (208)
                      ......+..+.++|.+||+.||++||++.|+++.  ++..
T Consensus       284 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          284 AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence            1122234568899999999999999999999874  4444

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.94  E-value=6.7e-27  Score=184.22  Aligned_cols=151  Identities=25%  Similarity=0.398  Sum_probs=117.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC-CCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+.+. .++|+||||+||+++ .++.++|+|||++........    ....++..|+||
T Consensus       125 ~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aP  199 (290)
T 1t4h_A          125 VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAP  199 (290)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCccccccccc----ccccCCcCcCCH
Confidence            46788999999999999999999853 299999999999997 788999999999865433221    224578899999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+. +.++.++|+||||+++|+|++|..|+......      .... ..........+..+.++|.+||+.||++||++
T Consensus       200 E~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  277 (290)
T 1t4h_A          200 EMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPASFDKVAIPEVKEIIEGCIRQNKDERYSI  277 (290)
T ss_dssp             GGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc-CCccccCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            9876 56899999999999999999998887542221      1111 11112223334578899999999999999999


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      .++++
T Consensus       278 ~ell~  282 (290)
T 1t4h_A          278 KDLLN  282 (290)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            99986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.94  E-value=1e-27  Score=204.83  Aligned_cols=152  Identities=26%  Similarity=0.289  Sum_probs=122.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      +++..+..++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++........   .....|++.|+|||.
T Consensus       283 l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEv  356 (576)
T 2acx_A          283 FPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEV  356 (576)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccccCHHH
Confidence            788999999999999999999999   99999999999999999999999999987643322   122468999999999


Q ss_pred             hccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCcc------chhhhhHHHHHHHHHHHhhccccCCCCCC----
Q 028458           83 AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVL------EDEYSSKQMLLRYVNIALLCVQESADDRP----  152 (208)
Q Consensus        83 ~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----  152 (208)
                      +.+..++.++|+||||+++|+|++|..|+...........+      .....+...+..+.++|.+||+.||++||    
T Consensus       357 l~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~  436 (576)
T 2acx_A          357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRG  436 (576)
T ss_dssp             HTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSS
T ss_pred             HcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCC
Confidence            99888999999999999999999999888653221100000      00012334567789999999999999999    


Q ss_pred             -CHHHHHHH
Q 028458          153 -TMNDVVCM  160 (208)
Q Consensus       153 -s~~~i~~~  160 (208)
                       +++|+++.
T Consensus       437 ~sa~eil~H  445 (576)
T 2acx_A          437 GSAREVKEH  445 (576)
T ss_dssp             SHHHHHHTS
T ss_pred             CCHHHHHhC
Confidence             78888763

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.94  E-value=5.3e-27  Score=189.87  Aligned_cols=151  Identities=21%  Similarity=0.266  Sum_probs=116.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||+++.++.++|+|||++......     .....++..|+|||
T Consensus       122 ~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE  193 (353)
T 3coi_A          122 KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPE  193 (353)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHH
Confidence            3678899999999999999999999   999999999999999999999999998764322     12245688999999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc-------------------------------CCccchhh
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID-------------------------------DPVLEDEY  127 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~-------------------------------~~~~~~~~  127 (208)
                      .+.+ ..++.++|+||||+++|+|++|..|+......  ..                               ........
T Consensus       194 ~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (353)
T 3coi_A          194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ  273 (353)
T ss_dssp             HHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTT
T ss_pred             HHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHH
Confidence            9876 56899999999999999999998877532210  00                               00000001


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      .....+..+.++|.+||+.||++||+++++++.
T Consensus       274 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          274 LFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            122345678999999999999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.94  E-value=2.6e-27  Score=190.71  Aligned_cols=157  Identities=19%  Similarity=0.222  Sum_probs=105.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC---CCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++.++..++.|++.||.|||+++   ++|+||||.||+++.   ++.++|+|||++........    ....++..|+
T Consensus       124 ~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~  196 (336)
T 3fhr_A          124 AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYV  196 (336)
T ss_dssp             CCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceecccccc----ccCCCCcCcc
Confidence            4789999999999999999999999   999999999999976   45599999999976543322    2235688999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc---------CCcc-chhhhhHHHHHHHHHHHhhccccCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID---------DPVL-EDEYSSKQMLLRYVNIALLCVQESA  148 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p  148 (208)
                      |||.+.+..++.++|+||||+++|+|++|..|+........         .... .........+..+.++|.+||+.||
T Consensus       197 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  276 (336)
T 3fhr_A          197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDP  276 (336)
T ss_dssp             -------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred             ChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCCh
Confidence            99999888889999999999999999999888743322110         0000 0001112456678899999999999


Q ss_pred             CCCCCHHHHHH--HHhhhh
Q 028458          149 DDRPTMNDVVC--MLTNEA  165 (208)
Q Consensus       149 ~~Rps~~~i~~--~l~~~~  165 (208)
                      ++||++.|+++  .++...
T Consensus       277 ~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          277 TERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             GGSCCHHHHHHSHHHHTGG
T ss_pred             hHCcCHHHHhcCccccccc
Confidence            99999999998  455543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.94  E-value=1.9e-27  Score=193.44  Aligned_cols=152  Identities=22%  Similarity=0.272  Sum_probs=109.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC--eEEeccccceecCCCcccccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN--PKISDFGMARICGGNELQANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~a   79 (208)
                      .+++..+..++.|++.||.|||+++   ++||||||.||+++.++.  ++|+|||++.......   ......|+..|+|
T Consensus       112 ~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~a  185 (361)
T 3uc3_A          112 RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIA  185 (361)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcCC
Confidence            4678899999999999999999999   999999999999987665  9999999986432221   1122467899999


Q ss_pred             cchhccCCCCCc-chhHHHHHHHHHHHHhhhcCCccccccc---------CCccchhhhhHHHHHHHHHHHhhccccCCC
Q 028458           80 PEYAIQGIFSIK-SDVFSFGVLLLEIAWDLWTSNRTLELID---------DPVLEDEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        80 pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      ||.+.+..+..+ +|+||||+++|+|++|..|+........         ...... ......+..+.+||.+||+.||+
T Consensus       186 PE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~  264 (361)
T 3uc3_A          186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI-PDDIRISPECCHLISRIFVADPA  264 (361)
T ss_dssp             HHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC-CTTSCCCHHHHHHHHHHSCSCTT
T ss_pred             hhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC-CCcCCCCHHHHHHHHHHccCChh
Confidence            999988887655 8999999999999999988754322100         000000 01112356788999999999999


Q ss_pred             CCCCHHHHHHH
Q 028458          150 DRPTMNDVVCM  160 (208)
Q Consensus       150 ~Rps~~~i~~~  160 (208)
                      +||++.|+++.
T Consensus       265 ~Rps~~ell~h  275 (361)
T 3uc3_A          265 TRISIPEIKTH  275 (361)
T ss_dssp             TSCCHHHHHTS
T ss_pred             HCcCHHHHHhC
Confidence            99999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.94  E-value=4.6e-27  Score=194.67  Aligned_cols=153  Identities=24%  Similarity=0.277  Sum_probs=113.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC---CeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+++   ++||||||+||+++.++   .++|+|||++........   .....|+..|+
T Consensus       235 ~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~  308 (419)
T 3i6u_A          235 RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYL  308 (419)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccceecCCCcc---ccccCCCCCcc
Confidence            4688899999999999999999999   99999999999997544   599999999977643321   22346789999


Q ss_pred             Ccchhcc---CCCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCccc-hhhhhHHHHHHHHHHHhhccccCC
Q 028458           79 SPEYAIQ---GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVLE-DEYSSKQMLLRYVNIALLCVQESA  148 (208)
Q Consensus        79 ape~~~~---~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p  148 (208)
                      |||.+.+   ..++.++|+||||+++|+|++|..|+......      +...... ........+..+.++|.+||+.||
T Consensus       309 aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  388 (419)
T 3i6u_A          309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP  388 (419)
T ss_dssp             CTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSST
T ss_pred             CceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCCh
Confidence            9999853   56788999999999999999999887543221      1111110 001122346778999999999999


Q ss_pred             CCCCCHHHHHHH
Q 028458          149 DDRPTMNDVVCM  160 (208)
Q Consensus       149 ~~Rps~~~i~~~  160 (208)
                      ++||+++|+++.
T Consensus       389 ~~Rps~~e~l~h  400 (419)
T 3i6u_A          389 KARFTTEEALRH  400 (419)
T ss_dssp             TTSCCHHHHHHS
T ss_pred             hHCcCHHHHhCC
Confidence            999999999873

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.94  E-value=2.2e-27  Score=192.26  Aligned_cols=158  Identities=17%  Similarity=0.191  Sum_probs=120.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhc--cCCCCceEeeCCCCCeeEeCC-CCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLH--QYSRVRIIHRDLKVSNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh--~~~~~~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||  +.+   |+|+||||.||+++. ++.++|+|||++.........   ....++..|+
T Consensus       125 ~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~  198 (360)
T 3e3p_A          125 APPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYR  198 (360)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCc---ccccCCccee
Confidence            3567788999999999999999  888   999999999999986 889999999999876433321   2245788999


Q ss_pred             CcchhccCC-CCCcchhHHHHHHHHHHHHhhhcCCccccccc---------CC---------------------ccchh-
Q 028458           79 SPEYAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELID---------DP---------------------VLEDE-  126 (208)
Q Consensus        79 ape~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---------~~---------------------~~~~~-  126 (208)
                      |||.+.+.. ++.++|+||||+++|+|++|..|+........         .+                     ..... 
T Consensus       199 aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (360)
T 3e3p_A          199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSN  278 (360)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHH
T ss_pred             CHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCccc
Confidence            999986654 79999999999999999999887754321100         00                     00000 


Q ss_pred             ---hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhhh
Q 028458          127 ---YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       127 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~  165 (208)
                         ......+..+.+||.+||+.||++||++.|+++.  ++...
T Consensus       279 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          279 VFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             ccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence               0001135678999999999999999999999984  55543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.94  E-value=2.4e-27  Score=197.22  Aligned_cols=155  Identities=19%  Similarity=0.193  Sum_probs=120.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++......... ......|++.|+|||
T Consensus       171 ~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE  246 (437)
T 4aw2_A          171 RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPE  246 (437)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChH
Confidence            4788899999999999999999999   999999999999999999999999999765433221 122346899999999


Q ss_pred             hhc-----cCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCC-----ccchhhhhHHHHHHHHHHHhhccccCCC
Q 028458           82 YAI-----QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDP-----VLEDEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        82 ~~~-----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      .+.     ...++.++|+||||+++|+|++|..|+.....  .....     ...-.......+..+.+||++||..+|+
T Consensus       247 ~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~  326 (437)
T 4aw2_A          247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREH  326 (437)
T ss_dssp             HHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGG
T ss_pred             HHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhccccc
Confidence            987     45689999999999999999999988754321  11100     0000001122566788999999999888


Q ss_pred             C--CCCHHHHHHH
Q 028458          150 D--RPTMNDVVCM  160 (208)
Q Consensus       150 ~--Rps~~~i~~~  160 (208)
                      +  |++++|+++.
T Consensus       327 r~~r~~~~eil~H  339 (437)
T 4aw2_A          327 RLGQNGIEDFKKH  339 (437)
T ss_dssp             CTTTTTTHHHHTS
T ss_pred             ccCCCCHHHHhCC
Confidence            8  9999999884

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.94  E-value=2.6e-27  Score=191.02  Aligned_cols=151  Identities=25%  Similarity=0.386  Sum_probs=118.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+ .+   ++|+||+|.||+++.++.++|+|||++.......    .....++..|.||
T Consensus       147 ~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aP  219 (348)
T 2pml_X          147 FIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPP  219 (348)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEEecccccccccccc----ccCCCCCcCccCc
Confidence            47888999999999999999999 88   9999999999999999999999999998764331    2234678899999


Q ss_pred             chhccC-CCCC-cchhHHHHHHHHHHHHhhhcCCcccc------cccCCccchh----------------hhhHHHHHHH
Q 028458           81 EYAIQG-IFSI-KSDVFSFGVLLLEIAWDLWTSNRTLE------LIDDPVLEDE----------------YSSKQMLLRY  136 (208)
Q Consensus        81 e~~~~~-~~~~-~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~~----------------~~~~~~~~~~  136 (208)
                      |.+.+. .++. ++|+||||+++|+|++|..|+.....      .+........                ......+..+
T Consensus       220 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  299 (348)
T 2pml_X          220 EFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNED  299 (348)
T ss_dssp             GGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHH
T ss_pred             hhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHH
Confidence            999877 5555 89999999999999999887754322      0110100000                0013456778


Q ss_pred             HHHHhhccccCCCCCCCHHHHHH
Q 028458          137 VNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       137 ~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .+++.+||+.||++||++.|+++
T Consensus       300 ~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          300 IDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHccCChhhCCCHHHHhc
Confidence            99999999999999999999987

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.94  E-value=2.5e-27  Score=186.44  Aligned_cols=149  Identities=23%  Similarity=0.358  Sum_probs=112.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe---CCCCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||||+||++   +.++.++|+|||++........   .....++..|.
T Consensus       120 ~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~  193 (285)
T 3is5_A          120 ALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYM  193 (285)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc---CcCcccccCcC
Confidence            4788899999999999999999999   9999999999999   4567899999999876543321   12345788999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-c------cCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-I------DDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      |||.+. +.++.++|+||||+++|+|++|..|+...... .      ......  ......+..+.+++.+||+.||++|
T Consensus       194 aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R  270 (285)
T 3is5_A          194 APEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA--VECRPLTPQAVDLLKQMLTKDPERR  270 (285)
T ss_dssp             CHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--C--CCCCHHHHHHHHHHTCSCTTTS
T ss_pred             ChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc--cccCcCCHHHHHHHHHHccCChhhC
Confidence            999875 56889999999999999999998887532210 0      000000  0111134678899999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      |++.|+++
T Consensus       271 ps~~e~l~  278 (285)
T 3is5_A          271 PSAAQVLH  278 (285)
T ss_dssp             CCHHHHHT
T ss_pred             cCHHHHhc
Confidence            99999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.94  E-value=4e-27  Score=194.58  Aligned_cols=154  Identities=19%  Similarity=0.216  Sum_probs=118.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++......... ......|++.|+|||
T Consensus       158 ~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE  233 (412)
T 2vd5_A          158 RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPE  233 (412)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCcc-ccceeccccCcCCHH
Confidence            4778889999999999999999999   999999999999999999999999999876443221 112346899999999


Q ss_pred             hhc-------cCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCc-----cchhhhhHHHHHHHHHHHhhccccC
Q 028458           82 YAI-------QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPV-----LEDEYSSKQMLLRYVNIALLCVQES  147 (208)
Q Consensus        82 ~~~-------~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~  147 (208)
                      .+.       ...++.++|+||||+++|+|++|..|+......  .....     ..........+..+.++|.+||. +
T Consensus       234 ~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~  312 (412)
T 2vd5_A          234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-P  312 (412)
T ss_dssp             HHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-C
T ss_pred             HHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-C
Confidence            987       356899999999999999999999887543211  11000     00001123456788999999999 9


Q ss_pred             CCCC---CCHHHHHHH
Q 028458          148 ADDR---PTMNDVVCM  160 (208)
Q Consensus       148 p~~R---ps~~~i~~~  160 (208)
                      |.+|   |+++|+++.
T Consensus       313 p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          313 PETRLGRGGAGDFRTH  328 (412)
T ss_dssp             GGGCTTTTTHHHHHTS
T ss_pred             hhhcCCCCCHHHHhcC
Confidence            9998   589999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.94  E-value=4.3e-27  Score=195.64  Aligned_cols=150  Identities=24%  Similarity=0.339  Sum_probs=111.0

Q ss_pred             HHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC-------------CCeEEeccccceecCCCcccc--ccccc
Q 028458            7 TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-------------MNPKISDFGMARICGGNELQA--NTSRI   71 (208)
Q Consensus         7 ~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~-------------~~~~l~dfg~~~~~~~~~~~~--~~~~~   71 (208)
                      .++.++.||+.||.|||+++   |+||||||.||+++..             +.++|+|||++..........  .....
T Consensus       116 ~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~  192 (434)
T 2rio_A          116 NPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP  192 (434)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC------------
T ss_pred             hHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCC
Confidence            45789999999999999999   9999999999999654             479999999998765432211  12234


Q ss_pred             ccCCCccCcchhcc-------CCCCCcchhHHHHHHHHHHHH-hhhcCCcccccc----cC-Ccc--chhhhhHHHHHHH
Q 028458           72 VGTYGYMSPEYAIQ-------GIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLELI----DD-PVL--EDEYSSKQMLLRY  136 (208)
Q Consensus        72 ~~~~~~~ape~~~~-------~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~~----~~-~~~--~~~~~~~~~~~~~  136 (208)
                      .|+..|+|||.+.+       ..++.++|+|||||++|+|++ |..|+.......    .. ...  .........+..+
T Consensus       193 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  272 (434)
T 2rio_A          193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEA  272 (434)
T ss_dssp             --CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHH
T ss_pred             CCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHhcCCCCcccccccccccchHHH
Confidence            68899999999965       568899999999999999998 777775432110    00 000  0112244567789


Q ss_pred             HHHHhhccccCCCCCCCHHHHHH
Q 028458          137 VNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       137 ~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .++|.+||+.||++||++.++++
T Consensus       273 ~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          273 TDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhhCChhhCCCHHHHHh
Confidence            99999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.94  E-value=3.9e-27  Score=186.84  Aligned_cols=152  Identities=22%  Similarity=0.302  Sum_probs=120.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe---CCCCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||++   +.++.++|+|||++.......    .....++..|.
T Consensus       102 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~  174 (304)
T 2jam_A          102 VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYV  174 (304)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT----THHHHSCCCBC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc----cccccCCCCcc
Confidence            4678899999999999999999999   9999999999999   778899999999986543321    12235788999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+.+..++.++|+||||+++|+|++|..|+......     +..... .........+..+.++|.+||+.||++||
T Consensus       175 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  254 (304)
T 2jam_A          175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY  254 (304)
T ss_dssp             CTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSC
T ss_pred             ChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCc
Confidence            999999888999999999999999999998877543211     000000 00012234567789999999999999999


Q ss_pred             CHHHHHHH
Q 028458          153 TMNDVVCM  160 (208)
Q Consensus       153 s~~~i~~~  160 (208)
                      ++.++++.
T Consensus       255 s~~~~l~h  262 (304)
T 2jam_A          255 TCEKALSH  262 (304)
T ss_dssp             CHHHHHTS
T ss_pred             CHHHHhcC
Confidence            99999873

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.94  E-value=1.3e-27  Score=207.92  Aligned_cols=158  Identities=21%  Similarity=0.288  Sum_probs=122.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......... .....++..|+|||
T Consensus       487 ~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE  562 (656)
T 2j0j_A          487 SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPE  562 (656)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCccee-ccCCCCCcceeCHH
Confidence            3688899999999999999999999   9999999999999999999999999997764332211 12234567899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+.....  .   +....  ....+...+..+.++|.+||+.||++||++.
T Consensus       563 ~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~  640 (656)
T 2j0j_A          563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT  640 (656)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCCccccHHHHHHHHHHcCCChhHCcCHH
Confidence            9998899999999999999999997 7666643211  1   00000  0012334556788999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      ++++.|+.+.
T Consensus       641 el~~~L~~il  650 (656)
T 2j0j_A          641 ELKAQLSTIL  650 (656)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999998764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.94  E-value=8.7e-27  Score=186.31  Aligned_cols=152  Identities=23%  Similarity=0.288  Sum_probs=117.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC---eEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN---PKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||.||+++.++.   ++|+|||++........   .....++..|.
T Consensus       110 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~  183 (322)
T 2ycf_A          110 RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYL  183 (322)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH---HHHHHSCCTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceecccccc---cccccCCcCcc
Confidence            4678899999999999999999999   999999999999987654   99999999987643321   12245788999


Q ss_pred             Ccchhc---cCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc------cCCccc-hhhhhHHHHHHHHHHHhhccccCC
Q 028458           79 SPEYAI---QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------DDPVLE-DEYSSKQMLLRYVNIALLCVQESA  148 (208)
Q Consensus        79 ape~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p  148 (208)
                      |||.+.   ...++.++|+||||+++|+|++|..|+.......      ...... ........+..+.++|.+||+.||
T Consensus       184 aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  263 (322)
T 2ycf_A          184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP  263 (322)
T ss_dssp             CHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSST
T ss_pred             CchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCH
Confidence            999874   4567899999999999999999988875432211      000000 001123346778999999999999


Q ss_pred             CCCCCHHHHHH
Q 028458          149 DDRPTMNDVVC  159 (208)
Q Consensus       149 ~~Rps~~~i~~  159 (208)
                      ++||++.++++
T Consensus       264 ~~Rps~~~~l~  274 (322)
T 2ycf_A          264 KARFTTEEALR  274 (322)
T ss_dssp             TTSCCHHHHHT
T ss_pred             hhCCCHHHHhh
Confidence            99999999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.94  E-value=2.6e-27  Score=195.61  Aligned_cols=154  Identities=20%  Similarity=0.211  Sum_probs=121.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.||+.||.|||+.+   |+||||||.||+++.++.++|+|||++......... ......|++.|+|||
T Consensus       164 ~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE  239 (410)
T 3v8s_A          164 DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPE  239 (410)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE-ECCSCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc-cccCCcCCccccCHH
Confidence            3677889999999999999999999   999999999999999999999999999876543321 122357899999999


Q ss_pred             hhccCC----CCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccch-----hhhhHHHHHHHHHHHhhccccCCCC
Q 028458           82 YAIQGI----FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLED-----EYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        82 ~~~~~~----~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      .+.+..    ++.++|+||||+++|+|++|..|+......  .. ..+..     .......+..+.++|.+||+.+|.+
T Consensus       240 ~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~r  318 (410)
T 3v8s_A          240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS-KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVR  318 (410)
T ss_dssp             HHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-HHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGC
T ss_pred             HhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH-HHHhccccccCCCcccccHHHHHHHHHHccChhhh
Confidence            997655    789999999999999999999888543211  11 00000     0011234567889999999999988


Q ss_pred             --CCCHHHHHHH
Q 028458          151 --RPTMNDVVCM  160 (208)
Q Consensus       151 --Rps~~~i~~~  160 (208)
                        ||+++||++.
T Consensus       319 lgR~~~~ei~~H  330 (410)
T 3v8s_A          319 LGRNGVEEIKRH  330 (410)
T ss_dssp             TTSSCHHHHHTS
T ss_pred             CCCCCHHHHhcC
Confidence              9999999984

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.94  E-value=6.7e-27  Score=186.06  Aligned_cols=159  Identities=23%  Similarity=0.253  Sum_probs=117.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC-CCCCeEEeccccceecCCCcccc-cccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~a   79 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++ .++.++|+|||++.......... ......++..|.|
T Consensus       116 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  192 (320)
T 2i6l_A          116 PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS  192 (320)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCC
T ss_pred             CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccC
Confidence            3678889999999999999999999   99999999999997 56789999999987654322111 1222356788999


Q ss_pred             cchhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccccc------C-C-------------------------ccchh
Q 028458           80 PEYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID------D-P-------------------------VLEDE  126 (208)
Q Consensus        80 pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------~-~-------------------------~~~~~  126 (208)
                      ||.+.+ ..++.++|+||||+++|+|++|..|+........      . +                         .....
T Consensus       193 PE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (320)
T 2i6l_A          193 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLT  272 (320)
T ss_dssp             HHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHH
T ss_pred             cHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChh
Confidence            998865 6689999999999999999999887754322100      0 0                         00000


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HHhh
Q 028458          127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVC--MLTN  163 (208)
Q Consensus       127 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~--~l~~  163 (208)
                      ......+..+.++|.+||+.||++||++.++++  .++.
T Consensus       273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (320)
T 2i6l_A          273 QLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI  311 (320)
T ss_dssp             HHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence            111234567899999999999999999999987  3543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.94  E-value=8.4e-28  Score=188.19  Aligned_cols=159  Identities=26%  Similarity=0.306  Sum_probs=120.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCC--CCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYS--RVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~--~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~a   79 (208)
                      .+++..++.++.|++.||.|||+.+  ...++|+||+|.||+++.++.++|+|||++.........  .....++..|.|
T Consensus       107 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a  184 (279)
T 2w5a_A          107 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMS  184 (279)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHH--HHHHHSCCTTCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccccc--ccccCCCccccC
Confidence            3788999999999999999999975  112999999999999999999999999998765432211  112357889999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      ||.+.+..++.++|+||||+++|+|++|..|+......     +......  ..+...+..+.++|.+||+.||++||++
T Consensus       185 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~  262 (279)
T 2w5a_A          185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPSV  262 (279)
T ss_dssp             HHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc--cCCcccCHHHHHHHHHHcCCCcccCCCH
Confidence            99999888999999999999999999998877543211     0000000  1223455678999999999999999999


Q ss_pred             HHHHHHHhhh
Q 028458          155 NDVVCMLTNE  164 (208)
Q Consensus       155 ~~i~~~l~~~  164 (208)
                      .++++.+...
T Consensus       263 ~~ll~~~~~~  272 (279)
T 2w5a_A          263 EEILENPLIL  272 (279)
T ss_dssp             HHHHTSTTCC
T ss_pred             HHHHhChhhh
Confidence            9999876443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.94  E-value=4.1e-27  Score=185.53  Aligned_cols=152  Identities=28%  Similarity=0.352  Sum_probs=116.4

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-CCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      +++..+..++.|++.||.|||+.+   ++|+||+|.||+++. ++.++|+|||++........  ......++..|.|||
T Consensus       119 ~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE  193 (295)
T 2clq_A          119 DNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPE  193 (295)
T ss_dssp             TCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHH
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccChh
Confidence            457788899999999999999999   999999999999987 88999999999877643221  112345788999999


Q ss_pred             hhccCC--CCCcchhHHHHHHHHHHHHhhhcCCccccccc---CC-c-cchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGI--FSIKSDVFSFGVLLLEIAWDLWTSNRTLELID---DP-V-LEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~--~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---~~-~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..  ++.++|+||||+++|+|++|..|+........   .. . ......+...+..+.++|.+||+.||++||++
T Consensus       194 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  273 (295)
T 2clq_A          194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACA  273 (295)
T ss_dssp             HHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCH
T ss_pred             hhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCH
Confidence            987654  78999999999999999999887753211100   00 0 00001233456678899999999999999999


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      .++++
T Consensus       274 ~~ll~  278 (295)
T 2clq_A          274 NDLLV  278 (295)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.93  E-value=1.6e-26  Score=194.68  Aligned_cols=156  Identities=26%  Similarity=0.291  Sum_probs=119.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC---CCCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||.||+++   .++.++|+|||++........   .....|++.|+
T Consensus       117 ~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~  190 (486)
T 3mwu_A          117 RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYI  190 (486)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc---cCCCcCCCCCC
Confidence            4678899999999999999999999   99999999999995   456799999999876543321   22346789999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+.+ .++.++|+||||+++|+|++|..|+......     +..... .........+..+.++|.+||+.||++||
T Consensus       191 aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~  269 (486)
T 3mwu_A          191 APEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI  269 (486)
T ss_dssp             CGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSC
T ss_pred             CHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCc
Confidence            9999865 5899999999999999999999887543221     100000 00012234566788999999999999999


Q ss_pred             CHHHHHHH--Hhhh
Q 028458          153 TMNDVVCM--LTNE  164 (208)
Q Consensus       153 s~~~i~~~--l~~~  164 (208)
                      ++.++++.  ++..
T Consensus       270 t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          270 TATQCLEHPWIQKY  283 (486)
T ss_dssp             CHHHHHHCHHHHHT
T ss_pred             CHHHHhcCHhhccC
Confidence            99999984  5443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.93  E-value=2.7e-27  Score=189.31  Aligned_cols=152  Identities=24%  Similarity=0.336  Sum_probs=112.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.||+.||.|||+.+   ++|+||+|.||+++.++.++|+|||++........  ......++..|+|||
T Consensus       125 ~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE  199 (326)
T 2x7f_A          125 TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPE  199 (326)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChh
Confidence            3677889999999999999999999   99999999999999999999999999876543221  112245788999999


Q ss_pred             hhc-----cCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----cCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           82 YAI-----QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----DDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        82 ~~~-----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+.     +..++.++|+||||+++|+|++|..|+.......     ...... .......+..+.++|.+||+.||++|
T Consensus       200 ~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~R  278 (326)
T 2x7f_A          200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQR  278 (326)
T ss_dssp             HHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSCSCSCHHHHHHHHHHCCSSGGGS
T ss_pred             hhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc-cCCccccCHHHHHHHHHHhccChhhC
Confidence            986     4568899999999999999999988774432110     000000 01122345678899999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      |++.++++
T Consensus       279 ps~~~ll~  286 (326)
T 2x7f_A          279 PATEQLMK  286 (326)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhh
Confidence            99999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.93  E-value=2.9e-27  Score=191.82  Aligned_cols=157  Identities=24%  Similarity=0.379  Sum_probs=119.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC-CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+. +   ++|+||||.||+++.++.++|+|||++......    ......++..|+||
T Consensus       127 ~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aP  199 (360)
T 3eqc_A          127 RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP  199 (360)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECH
Confidence            467888999999999999999996 7   999999999999999999999999988654211    11224678899999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc----C-----------------------------Ccc----
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID----D-----------------------------PVL----  123 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~----~-----------------------------~~~----  123 (208)
                      |.+.+..++.++|+||||+++|+|++|..|+........    .                             ...    
T Consensus       200 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (360)
T 3eqc_A          200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFE  279 (360)
T ss_dssp             HHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHH
T ss_pred             HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchh
Confidence            999988899999999999999999999887743211000    0                             000    


Q ss_pred             ---------chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhhh
Q 028458          124 ---------EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       124 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~  165 (208)
                               .........+..+.+||.+||+.||++||+++|+++.  ++...
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          280 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             HHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             hhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                     0000011134578899999999999999999999984  44443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.93  E-value=2.6e-27  Score=189.63  Aligned_cols=151  Identities=26%  Similarity=0.409  Sum_probs=102.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC-CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+. +   ++|+||||.||+++.++.++|+|||++........   .....|+..|.||
T Consensus       121 ~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aP  194 (327)
T 3aln_A          121 VIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAP  194 (327)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC----------------------
T ss_pred             cCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCc
Confidence            467888999999999999999998 8   99999999999999999999999999876543221   1223578899999


Q ss_pred             chh----ccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc---cccC---C---ccchhhhhHHHHHHHHHHHhhccccC
Q 028458           81 EYA----IQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE---LIDD---P---VLEDEYSSKQMLLRYVNIALLCVQES  147 (208)
Q Consensus        81 e~~----~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~---~---~~~~~~~~~~~~~~~~~li~~~l~~~  147 (208)
                      |.+    .+..++.++|+||||+++|+|++|..|+.....   ....   .   .+.. ......+..+.+++.+||+.|
T Consensus       195 E~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~d  273 (327)
T 3aln_A          195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN-SEEREFSPSFINFVNLCLTKD  273 (327)
T ss_dssp             -----------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC-CSSCCCCHHHHHHHHHHTCSS
T ss_pred             eeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC-cccccCCHHHHHHHHHHhhCC
Confidence            998    455688999999999999999999887754221   1110   0   0000 111234567889999999999


Q ss_pred             CCCCCCHHHHHH
Q 028458          148 ADDRPTMNDVVC  159 (208)
Q Consensus       148 p~~Rps~~~i~~  159 (208)
                      |++||++.++++
T Consensus       274 p~~Rps~~ell~  285 (327)
T 3aln_A          274 ESKRPKYKELLK  285 (327)
T ss_dssp             GGGSCCHHHHTT
T ss_pred             hhhCcCHHHHHh
Confidence            999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.93  E-value=3.4e-27  Score=187.90  Aligned_cols=153  Identities=24%  Similarity=0.339  Sum_probs=110.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccC-CCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQY-SRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||++ +   ++|+||+|.||+++.++.++|+|||++........   .....++..|.||
T Consensus       120 ~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aP  193 (318)
T 2dyl_A          120 PIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAP  193 (318)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccCh
Confidence            467888999999999999999995 8   99999999999999999999999999876543221   1223578899999


Q ss_pred             chhc-----cCCCCCcchhHHHHHHHHHHHHhhhcCCccccc---cc---CCccchhhhhHHHHHHHHHHHhhccccCCC
Q 028458           81 EYAI-----QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---ID---DPVLEDEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        81 e~~~-----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      |.+.     ...++.++|+||||+++|+|++|..|+......   ..   .............+..+.++|.+||+.||.
T Consensus       194 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  273 (318)
T 2dyl_A          194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHR  273 (318)
T ss_dssp             HHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTT
T ss_pred             hhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChh
Confidence            9984     455788999999999999999998877542111   00   000000001122456788999999999999


Q ss_pred             CCCCHHHHHHH
Q 028458          150 DRPTMNDVVCM  160 (208)
Q Consensus       150 ~Rps~~~i~~~  160 (208)
                      +||+++++++.
T Consensus       274 ~Rps~~~ll~h  284 (318)
T 2dyl_A          274 KRPKYNKLLEH  284 (318)
T ss_dssp             TSCCHHHHTTS
T ss_pred             HCcCHHHHhhC
Confidence            99999999873

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.93  E-value=3.2e-27  Score=184.58  Aligned_cols=153  Identities=23%  Similarity=0.342  Sum_probs=112.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........   .....++..|.|||
T Consensus       107 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE  180 (276)
T 2h6d_A          107 RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPE  180 (276)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcc---eecccCCccccCHH
Confidence            3678899999999999999999999   99999999999999999999999999876543321   12235678999999


Q ss_pred             hhccCCC-CCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458           82 YAIQGIF-SIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus        82 ~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      .+.+..+ +.++|+||||+++|+|++|..|+......  ...........+...+..+.+++.+||+.||++||++++++
T Consensus       181 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l  260 (276)
T 2h6d_A          181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIR  260 (276)
T ss_dssp             GGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            9987765 68999999999999999998877542211  00000000011223456788999999999999999999999


Q ss_pred             HH
Q 028458          159 CM  160 (208)
Q Consensus       159 ~~  160 (208)
                      +.
T Consensus       261 ~h  262 (276)
T 2h6d_A          261 EH  262 (276)
T ss_dssp             HS
T ss_pred             hC
Confidence            84

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.93  E-value=1.8e-26  Score=182.23  Aligned_cols=152  Identities=22%  Similarity=0.286  Sum_probs=119.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++........   .....++..|.|||
T Consensus       120 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE  193 (298)
T 1phk_A          120 TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPE  193 (298)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHH
Confidence            4678899999999999999999999   99999999999999999999999999887643322   12245788999999


Q ss_pred             hhc------cCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc------cCCccchhhhhHHHHHHHHHHHhhccccCCC
Q 028458           82 YAI------QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------DDPVLEDEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        82 ~~~------~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      .+.      ...++.++|+||||+++|+|++|..|+.......      ..............+..+.+++.+||+.||+
T Consensus       194 ~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  273 (298)
T 1phk_A          194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQ  273 (298)
T ss_dssp             HHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGG
T ss_pred             HhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcc
Confidence            885      3457889999999999999999988774332110      0000000011234566789999999999999


Q ss_pred             CCCCHHHHHH
Q 028458          150 DRPTMNDVVC  159 (208)
Q Consensus       150 ~Rps~~~i~~  159 (208)
                      +||++.++++
T Consensus       274 ~Rps~~~ll~  283 (298)
T 1phk_A          274 KRYTAEEALA  283 (298)
T ss_dssp             GSCCHHHHTT
T ss_pred             cCCCHHHHHh
Confidence            9999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.93  E-value=1.3e-26  Score=192.77  Aligned_cols=152  Identities=22%  Similarity=0.321  Sum_probs=109.0

Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-----CCCeEEeccccceecCCCccc-ccccccccCCCcc
Q 028458            5 WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-----DMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYM   78 (208)
Q Consensus         5 ~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-----~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~   78 (208)
                      ...+..++.||+.||.|||+.+   |+||||||.||+++.     ...++|+|||++......... .......|+..|+
T Consensus       117 ~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~  193 (432)
T 3p23_A          117 GLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI  193 (432)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSC
T ss_pred             chhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCcc
Confidence            3456789999999999999999   999999999999943     335789999999776433211 1223356899999


Q ss_pred             Ccchhc---cCCCCCcchhHHHHHHHHHHHH-hhhcCCcccccc-----cCCccchhhhhHHHHHHHHHHHhhccccCCC
Q 028458           79 SPEYAI---QGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLELI-----DDPVLEDEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        79 ape~~~---~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      |||.+.   ...++.++|+|||||++|+|++ |..|++......     .................+.++|.+||+.||+
T Consensus       194 APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  273 (432)
T 3p23_A          194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQ  273 (432)
T ss_dssp             CGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGG
T ss_pred             ChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHh
Confidence            999987   3556789999999999999999 777765432211     1111111112233455678999999999999


Q ss_pred             CCCCHHHHHH
Q 028458          150 DRPTMNDVVC  159 (208)
Q Consensus       150 ~Rps~~~i~~  159 (208)
                      +||++.++++
T Consensus       274 ~Rps~~evl~  283 (432)
T 3p23_A          274 KRPSAKHVLK  283 (432)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHHh
Confidence            9999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.93  E-value=6.5e-27  Score=196.89  Aligned_cols=157  Identities=25%  Similarity=0.319  Sum_probs=122.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEe---CCCCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||.||++   +.++.++|+|||++........   .....|++.|+
T Consensus       122 ~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~  195 (484)
T 3nyv_A          122 RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYI  195 (484)
T ss_dssp             CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCCcccc
Confidence            4688899999999999999999999   9999999999999   4678899999999876543321   12246789999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+.+ .++.++|+||||+++|+|++|..|+......     +..... .........+..+.++|.+||+.||++||
T Consensus       196 aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~  274 (484)
T 3nyv_A          196 APEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI  274 (484)
T ss_dssp             CHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSC
T ss_pred             CceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCc
Confidence            9999865 6899999999999999999999887543221     110000 00012234567788999999999999999


Q ss_pred             CHHHHHHH--Hhhhh
Q 028458          153 TMNDVVCM--LTNEA  165 (208)
Q Consensus       153 s~~~i~~~--l~~~~  165 (208)
                      ++.++++.  ++...
T Consensus       275 s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          275 SARDALDHEWIQTYT  289 (484)
T ss_dssp             CHHHHHTSHHHHHHT
T ss_pred             CHHHHhhChhhcccc
Confidence            99999973  55443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.93  E-value=3.5e-27  Score=186.65  Aligned_cols=153  Identities=20%  Similarity=0.326  Sum_probs=115.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .......++..|.|||
T Consensus       113 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE  187 (302)
T 2j7t_A          113 GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPE  187 (302)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcCCe
Confidence            4788899999999999999999999   9999999999999999999999999875321111  0112235788999999


Q ss_pred             hhc-----cCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---cCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           82 YAI-----QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        82 ~~~-----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+.     +..++.++|+||||+++|+|++|..|+......  .   ..........+...+..+.++|.+||+.||++|
T Consensus       188 ~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  267 (302)
T 2j7t_A          188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETR  267 (302)
T ss_dssp             HHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             eeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhC
Confidence            983     566889999999999999999998877543211  0   000000111233445678899999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      |++.++++
T Consensus       268 ps~~~ll~  275 (302)
T 2j7t_A          268 PSAAQLLE  275 (302)
T ss_dssp             CCHHHHTT
T ss_pred             CCHHHHhc
Confidence            99999876

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.93  E-value=2.8e-26  Score=193.62  Aligned_cols=156  Identities=24%  Similarity=0.315  Sum_probs=120.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC---CCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD---MNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||.||+++..   +.++|+|||++........   .....|++.|+
T Consensus       132 ~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~  205 (494)
T 3lij_A          132 KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYI  205 (494)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC---BCCCCSCTTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc---ccccCCCcCee
Confidence            4678889999999999999999999   9999999999999764   4599999999987654322   22346889999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+. +.++.++|+||||+++|+|++|..|+......     +..... .........+..+.++|.+||+.||++||
T Consensus       206 aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~  284 (494)
T 3lij_A          206 APEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI  284 (494)
T ss_dssp             CHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             CHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCc
Confidence            999885 56899999999999999999999887543221     000000 00011234556788999999999999999


Q ss_pred             CHHHHHHH--Hhhh
Q 028458          153 TMNDVVCM--LTNE  164 (208)
Q Consensus       153 s~~~i~~~--l~~~  164 (208)
                      ++.++++.  ++..
T Consensus       285 s~~e~l~hp~~~~~  298 (494)
T 3lij_A          285 SAQQALEHPWIKEM  298 (494)
T ss_dssp             CHHHHHTCHHHHHH
T ss_pred             cHHHHhcCcccccC
Confidence            99999873  5443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.93  E-value=3.1e-26  Score=193.79  Aligned_cols=152  Identities=26%  Similarity=0.329  Sum_probs=119.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC---CeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM---NPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||.||+++.++   .++|+|||++........   .....|++.|+
T Consensus       142 ~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~  215 (504)
T 3q5i_A          142 KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYI  215 (504)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCC
Confidence            4788899999999999999999999   99999999999998775   699999999987654322   22346889999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---cCCccc-hhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---DDPVLE-DEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+. +.++.++|+||||+++|+|++|..|+......  .   ...... ........+..+.++|.+||+.||.+||
T Consensus       216 aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~  294 (504)
T 3q5i_A          216 APEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC  294 (504)
T ss_dssp             CHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             CHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCC
Confidence            999886 56899999999999999999999887543221  1   101100 0011233467789999999999999999


Q ss_pred             CHHHHHHH
Q 028458          153 TMNDVVCM  160 (208)
Q Consensus       153 s~~~i~~~  160 (208)
                      +++|+++.
T Consensus       295 t~~e~l~h  302 (504)
T 3q5i_A          295 TAEEALNS  302 (504)
T ss_dssp             CHHHHHTS
T ss_pred             CHHHHhcC
Confidence            99999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.93  E-value=1.3e-26  Score=183.04  Aligned_cols=153  Identities=24%  Similarity=0.354  Sum_probs=109.6

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc------------cccccc
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL------------QANTSR   70 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~   70 (208)
                      +++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........            ......
T Consensus       113 ~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (303)
T 1zy4_A          113 QQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS  189 (303)
T ss_dssp             GCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC---------------------
T ss_pred             cchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccccccccccccc
Confidence            466788999999999999999999   99999999999999999999999999876542210            011123


Q ss_pred             cccCCCccCcchhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccc---cccC--CccchhhhhHHHHHHHHHHHhhcc
Q 028458           71 IVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLE---LIDD--PVLEDEYSSKQMLLRYVNIALLCV  144 (208)
Q Consensus        71 ~~~~~~~~ape~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~~~~li~~~l  144 (208)
                      ..++..|.|||.+.+. .++.++|+||||+++|+|+++.........   .+..  ...+. ......+..+.+++.+||
T Consensus       190 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l  268 (303)
T 1zy4_A          190 AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPP-DFDDNKMKVEKKIIRLLI  268 (303)
T ss_dssp             ----CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHSTTCCCCT-TCCTTTSHHHHHHHHHHT
T ss_pred             CCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCCchhHHHHHHhccccccccCc-cccccchHHHHHHHHHHH
Confidence            4578899999998764 689999999999999999872211111110   0000  11111 223334556789999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 028458          145 QESADDRPTMNDVVC  159 (208)
Q Consensus       145 ~~~p~~Rps~~~i~~  159 (208)
                      +.||++||++.++++
T Consensus       269 ~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          269 DHDPNKRPGARTLLN  283 (303)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             hcCcccCcCHHHHhC
Confidence            999999999999987

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.93  E-value=5.2e-26  Score=178.93  Aligned_cols=151  Identities=25%  Similarity=0.294  Sum_probs=116.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC---CCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD---MNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.+   +.++|+|||++.........   ....++..|.
T Consensus       117 ~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~y~  190 (287)
T 2wei_A          117 RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYI  190 (287)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC---SCHHHHHTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc---ccccCccccc
Confidence            4678899999999999999999999   9999999999999754   46999999998765433211   1234678899


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccc-hhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLE-DEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+.+ .++.++|+||||+++|+|++|..|+......     +...... ........+..+.++|.+||+.||++||
T Consensus       191 aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  269 (287)
T 2wei_A          191 APEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI  269 (287)
T ss_dssp             CHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             ChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCc
Confidence            9998865 5889999999999999999998877533211     0000000 0011234456788999999999999999


Q ss_pred             CHHHHHH
Q 028458          153 TMNDVVC  159 (208)
Q Consensus       153 s~~~i~~  159 (208)
                      ++.++++
T Consensus       270 s~~ell~  276 (287)
T 2wei_A          270 TATQCLE  276 (287)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHhc
Confidence            9999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.91  E-value=9.3e-25  Score=190.83  Aligned_cols=148  Identities=23%  Similarity=0.320  Sum_probs=117.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.+++.++.||+.||.|||+++   |+||||||.||+++.+ .++|+|||++......      ....|++.|+|||
T Consensus       178 ~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE  247 (681)
T 2pzi_A          178 KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPE  247 (681)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHH
Confidence            4788999999999999999999999   9999999999999875 8999999999876433      2346789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-CHHHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-TMNDVVCM  160 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~i~~~  160 (208)
                      .+.+.. +.++|+||||+++|+|++|..++......    .+.........+..+.++|.+||+.||++|| +++++...
T Consensus       248 ~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~  322 (681)
T 2pzi_A          248 IVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ  322 (681)
T ss_dssp             HHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS----SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred             HHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc----cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHH
Confidence            987654 88999999999999999887665432211    1111122334456788999999999999999 56666666


Q ss_pred             Hhhh
Q 028458          161 LTNE  164 (208)
Q Consensus       161 l~~~  164 (208)
                      |...
T Consensus       323 l~~~  326 (681)
T 2pzi_A          323 LTGV  326 (681)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.91  E-value=1.4e-24  Score=171.83  Aligned_cols=137  Identities=18%  Similarity=0.244  Sum_probs=105.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC---CCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+++   ++|+||||+||+++.   ++.++|+|||++....                  
T Consensus       113 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------  171 (299)
T 3m2w_A          113 AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------  171 (299)
T ss_dssp             CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------
Confidence            4788999999999999999999999   999999999999998   7889999999876532                  


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc------cCCccchh----hhhHHHHHHHHHHHhhccccCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------DDPVLEDE----YSSKQMLLRYVNIALLCVQESA  148 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p  148 (208)
                            +..++.++|+||||+++|+|++|..|+.......      ........    ......+..+.+++.+||+.||
T Consensus       172 ------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  245 (299)
T 3m2w_A          172 ------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP  245 (299)
T ss_dssp             ------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSST
T ss_pred             ------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccCh
Confidence                  2345678999999999999999988874332110      00000000    1113356789999999999999


Q ss_pred             CCCCCHHHHHHH--Hhhhh
Q 028458          149 DDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       149 ~~Rps~~~i~~~--l~~~~  165 (208)
                      ++||++.|+++.  +....
T Consensus       246 ~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          246 TQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             TTSCCHHHHHTSHHHHTGG
T ss_pred             hhCCCHHHHhcChhhcccc
Confidence            999999999983  55544

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.91  E-value=6.4e-25  Score=189.84  Aligned_cols=150  Identities=27%  Similarity=0.292  Sum_probs=114.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCC---eEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMN---PKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.   ++|+|||++.........   ....++..|+
T Consensus       117 ~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~  190 (676)
T 3qa8_A          117 GLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYL  190 (676)
T ss_dssp             CCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCC---CCCCSCCTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccccccccccc---ccccCCcccC
Confidence            4678889999999999999999999   999999999999987654   899999999876443321   2346789999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--------------------cccC-----Cc-cchhhhhHHH
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--------------------LIDD-----PV-LEDEYSSKQM  132 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------------------~~~~-----~~-~~~~~~~~~~  132 (208)
                      |||.+.+..++.++|+||||+++|+|++|..|+.....                    ....     .. ..........
T Consensus       191 APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~l  270 (676)
T 3qa8_A          191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGIL  270 (676)
T ss_dssp             SSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGG
T ss_pred             ChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhh
Confidence            99999988999999999999999999999877642100                    0000     00 0011223446


Q ss_pred             HHHHHHHHhhccccCCCCCCCHHHH
Q 028458          133 LLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus       133 ~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      +..+.++|.+||+.||++||++.++
T Consensus       271 s~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          271 AGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             HHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hHHHHHHHHHHccCCHhhCcCHHHH
Confidence            7789999999999999999999773

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.89  E-value=3.2e-23  Score=163.40  Aligned_cols=131  Identities=13%  Similarity=0.119  Sum_probs=102.3

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchh
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA   83 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~   83 (208)
                      ...++.+++.|++.||.|||+++   |+||||||.||+++.++.+++++++.                      .+    
T Consensus       127 ~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~----------------------~~----  177 (286)
T 3uqc_A          127 SPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT----------------------MP----  177 (286)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC----------------------CT----
T ss_pred             ChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc----------------------cC----
Confidence            34568899999999999999999   99999999999999999999974432                      22    


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           84 IQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        84 ~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                         .++.++|+||||+++|+|++|..|+......         ...............+..+.++|.+||+.||++| ++
T Consensus       178 ---~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~  253 (286)
T 3uqc_A          178 ---DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SA  253 (286)
T ss_dssp             ---TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CH
T ss_pred             ---CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CH
Confidence               2578899999999999999999887543221         1111111112234456789999999999999999 99


Q ss_pred             HHHHHHHhhhhhc
Q 028458          155 NDVVCMLTNEAAT  167 (208)
Q Consensus       155 ~~i~~~l~~~~~~  167 (208)
                      .++++.|++....
T Consensus       254 ~el~~~L~~~~~~  266 (286)
T 3uqc_A          254 STLLNLMQQATAV  266 (286)
T ss_dssp             HHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHhcc
Confidence            9999999987754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.87  E-value=5.7e-23  Score=165.12  Aligned_cols=141  Identities=16%  Similarity=0.134  Sum_probs=107.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhc-cCCCCceEeeCCCCCeeEeCCCC--------------------CeEEeccccceecC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLH-QYSRVRIIHRDLKVSNILLDKDM--------------------NPKISDFGMARICG   60 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh-~~~~~~i~h~~l~~~nil~~~~~--------------------~~~l~dfg~~~~~~   60 (208)
                      .+++..+..++.||+.||.||| +.+   |+||||||.||+++.++                    .+||+|||++....
T Consensus       157 ~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~  233 (336)
T 2vuw_A          157 LSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER  233 (336)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC
Confidence            4688899999999999999999 898   99999999999999887                    89999999998764


Q ss_pred             CCcccccccccccCCCccCcchhccCCCCCcchhHHHHHH-HHHHHHhhhcCCccc-------ccc---cCCccchhhhh
Q 028458           61 GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVL-LLEIAWDLWTSNRTL-------ELI---DDPVLEDEYSS  129 (208)
Q Consensus        61 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~~-~~~l~~~~~~~~~~~-------~~~---~~~~~~~~~~~  129 (208)
                      ..       ...|+..|+|||.+.+.. +.++|+|||+++ .++++.|..|+....       ...   ...........
T Consensus       234 ~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (336)
T 2vuw_A          234 DG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAM  305 (336)
T ss_dssp             TT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHH
T ss_pred             CC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhh
Confidence            32       236789999999998666 889999998777 444544555543210       001   11111122345


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVV  158 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~  158 (208)
                      ...+.++.+||.+||+.|     |++|++
T Consensus       306 ~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          306 KQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            667889999999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.70  E-value=8.2e-19  Score=150.25  Aligned_cols=91  Identities=16%  Similarity=0.172  Sum_probs=61.2

Q ss_pred             HHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchhccCCC
Q 028458            9 VRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIF   88 (208)
Q Consensus         9 ~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~   88 (208)
                      .+|+.||+.||.|+|++|   |+||||||.|||++.+|.+||+|||++........  ......||+.|+|||.+.+ .+
T Consensus       342 ~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~  415 (569)
T 4azs_A          342 EKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NK  415 (569)
T ss_dssp             HHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC-----
T ss_pred             HHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHHHhCC-CC
Confidence            368999999999999999   99999999999999999999999999976543322  1223568999999999865 45


Q ss_pred             CCcchhHHHHHHHHHHH
Q 028458           89 SIKSDVFSFGVLLLEIA  105 (208)
Q Consensus        89 ~~~~Dv~slG~~~~~l~  105 (208)
                      ...+|+|++|++.+++.
T Consensus       416 ~~~~d~~s~g~~~~~l~  432 (569)
T 4azs_A          416 SWNGFWRSAPVHPFNLP  432 (569)
T ss_dssp             -------------CCCC
T ss_pred             CCcccccccccchhhhc
Confidence            67899999999877764

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.40  E-value=2.7e-14  Score=121.60  Aligned_cols=92  Identities=25%  Similarity=0.265  Sum_probs=73.6

Q ss_pred             HHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-----cccccccCCCccCcch
Q 028458            8 RVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-----NTSRIVGTYGYMSPEY   82 (208)
Q Consensus         8 ~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~ape~   82 (208)
                      +..++.|++++|.|||+++   |+||||||.||+++.  .++|+|||++..........     ......|+..|+|||.
T Consensus       433 ~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv  507 (540)
T 3en9_A          433 NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEI  507 (540)
T ss_dssp             CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHH
T ss_pred             HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHH
Confidence            3578999999999999999   999999999999998  99999999998875433211     1123568899999999


Q ss_pred             hcc--CCCCCcchhHHHHHHHHHH
Q 028458           83 AIQ--GIFSIKSDVFSFGVLLLEI  104 (208)
Q Consensus        83 ~~~--~~~~~~~Dv~slG~~~~~l  104 (208)
                      +..  ..|+...|+|+..+-..+-
T Consensus       508 ~~~~~~~Y~~~~d~ws~vl~~l~~  531 (540)
T 3en9_A          508 WERFLEGYKSVYDRWEIILELMKD  531 (540)
T ss_dssp             HHHHHHHHHHHCTTHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhHHHHHHHHHHH
Confidence            976  5577778999876554443

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.20  E-value=6.8e-12  Score=98.39  Aligned_cols=48  Identities=21%  Similarity=0.261  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458            7 TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus         7 ~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      ....++.|++.||.|||+.+   ++||||||.||+++ ++.++|+|||++..
T Consensus       194 ~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          194 NPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence            35679999999999999999   99999999999999 99999999999864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=98.97  E-value=5.2e-10  Score=86.43  Aligned_cols=49  Identities=20%  Similarity=0.257  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHhhc-cCCCCceEeeCCCCCeeEeCCCCCeEEeccccceec
Q 028458            6 VTRVRIIEGIAQGLLYLH-QYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARIC   59 (208)
Q Consensus         6 ~~~~~i~~qi~~~l~~Lh-~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~   59 (208)
                      ..+..++.|++.+|.||| +.+   ++||||||.||+++.  .++|+|||++...
T Consensus       170 ~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          170 LDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            367889999999999999 998   999999999999988  8999999998754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.39  E-value=1.1e-07  Score=77.51  Aligned_cols=50  Identities=22%  Similarity=0.305  Sum_probs=43.3

Q ss_pred             HHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC----------CeEEeccccceec
Q 028458            7 TRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM----------NPKISDFGMARIC   59 (208)
Q Consensus         7 ~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~----------~~~l~dfg~~~~~   59 (208)
                      ....++.|++.+|.+||+.|   ++||||||.|||++.++          .+.++||+.+...
T Consensus       206 ~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          206 DPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            45678899999999999999   99999999999998765          3789999877654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.14  E-value=0.00053  Score=54.88  Aligned_cols=56  Identities=14%  Similarity=0.332  Sum_probs=44.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCC-------------------------------------------------------C
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYS-------------------------------------------------------R   27 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~-------------------------------------------------------~   27 (208)
                      ++..++..++.+++..|..||+..                                                       .
T Consensus       136 l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  215 (359)
T 3dxp_A          136 MSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADL  215 (359)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCC
Confidence            456677888899999999999721                                                       1


Q ss_pred             CceEeeCCCCCeeEeCCCCC--eEEecccccee
Q 028458           28 VRIIHRDLKVSNILLDKDMN--PKISDFGMARI   58 (208)
Q Consensus        28 ~~i~h~~l~~~nil~~~~~~--~~l~dfg~~~~   58 (208)
                      ..++|+|+++.||+++.++.  +.++||+.+..
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            24999999999999987653  68999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=97.08  E-value=0.00035  Score=53.23  Aligned_cols=29  Identities=28%  Similarity=0.328  Sum_probs=24.3

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEeccccce
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMAR   57 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~   57 (208)
                      .++|+|+++.||+++.+..+.++||+.+.
T Consensus       184 ~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             eEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence            38999999999999876566799998653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.02  E-value=0.00049  Score=52.07  Aligned_cols=29  Identities=21%  Similarity=0.344  Sum_probs=24.9

Q ss_pred             eEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           30 IIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        30 i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      ++|+|+++.||+++.++.+.++||+.+..
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhccc
Confidence            99999999999998776677999997643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.65  E-value=0.025  Score=42.18  Aligned_cols=128  Identities=9%  Similarity=-0.005  Sum_probs=73.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .|+..+++.++.|.+.+|.-+-. ..   -..+=+.+..|++..+|.+.+.+ +.+.              .....+.||
T Consensus        45 PlsEEqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~~p  106 (229)
T 2yle_A           45 PINEEQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPPVAG  106 (229)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECC-C--------------------------
T ss_pred             CcCHHHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccc-cccc--------------ccccCCCCh
Confidence            57788999999999999877621 11   11233456788888888877753 1110              011245677


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchhhhhHHHHHHHHHHHhhcccc--------------
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQE--------------  146 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--------------  146 (208)
                      |... ...+.+.-||+||+++|.-+--..+...               ...+++++-+||..|...              
T Consensus       107 e~~~-~~~te~~~IysLG~tLY~ALDygL~e~e---------------E~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~  170 (229)
T 2yle_A          107 KLGY-SQCMETEVIESLGIIIYKALDYGLKENE---------------ERELSPPLEQLIDHMANTVEADGSNDEGYEAA  170 (229)
T ss_dssp             CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE---------------EECCCHHHHHHHHHHTTCCC------------
T ss_pred             hhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc---------------chhhCHHHHHHHHHHHhccccccccccccccc
Confidence            7652 3345667799999999976421111111               112233455677777654              


Q ss_pred             -----------CCCCCCCHHHHHHHHhh
Q 028458          147 -----------SADDRPTMNDVVCMLTN  163 (208)
Q Consensus       147 -----------~p~~Rps~~~i~~~l~~  163 (208)
                                 .+..|.+.++|++.=+.
T Consensus       171 ~eg~~d~~~~~~~~~~~sl~~Vi~~C~~  198 (229)
T 2yle_A          171 EEGLGDEDEKRKISAIRSYRDVMKLCAA  198 (229)
T ss_dssp             --------CCSCCCCCCSHHHHHHHHHT
T ss_pred             ccccccccccccccCcCCHHHHHHHHHh
Confidence                       34688899998865443

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=96.09  E-value=0.0052  Score=47.89  Aligned_cols=31  Identities=39%  Similarity=0.551  Sum_probs=26.3

Q ss_pred             ceEeeCCCCCeeEeCC--CCCeEEeccccceec
Q 028458           29 RIIHRDLKVSNILLDK--DMNPKISDFGMARIC   59 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~--~~~~~l~dfg~~~~~   59 (208)
                      .++|+|+++.||+++.  ...+.++||+.+...
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence            4899999999999987  556789999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.32  E-value=0.022  Score=44.72  Aligned_cols=29  Identities=21%  Similarity=0.334  Sum_probs=25.9

Q ss_pred             eEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           30 IIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        30 i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      ++|+|+.+.||+++.++.+.++||+.+..
T Consensus       224 l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          224 LCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             EECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             eecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            99999999999998778899999987643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=94.20  E-value=0.065  Score=41.75  Aligned_cols=30  Identities=40%  Similarity=0.564  Sum_probs=24.6

Q ss_pred             ceEeeCCCCCeeEeCC---CCC-eEEecccccee
Q 028458           29 RIIHRDLKVSNILLDK---DMN-PKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~---~~~-~~l~dfg~~~~   58 (208)
                      .++|+|+.+.|++++.   ++. +.++||+.+..
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            3899999999999987   345 48999987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.19  E-value=0.069  Score=43.55  Aligned_cols=29  Identities=21%  Similarity=0.400  Sum_probs=25.6

Q ss_pred             eEeeCCCCCeeEeCCCCCeEEeccccceec
Q 028458           30 IIHRDLKVSNILLDKDMNPKISDFGMARIC   59 (208)
Q Consensus        30 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~   59 (208)
                      ++|+|+.+.||+++.++ +.++||+.+...
T Consensus       234 liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             EECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             EEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            99999999999998776 999999887653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=92.67  E-value=0.052  Score=41.14  Aligned_cols=30  Identities=23%  Similarity=0.377  Sum_probs=25.6

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.||+++..+.+.|+||+.+..
T Consensus       194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            489999999999999877778999987643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=91.87  E-value=0.27  Score=38.48  Aligned_cols=31  Identities=26%  Similarity=0.431  Sum_probs=26.3

Q ss_pred             ceEeeCCCCCeeEeCCC----CCeEEeccccceec
Q 028458           29 RIIHRDLKVSNILLDKD----MNPKISDFGMARIC   59 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~----~~~~l~dfg~~~~~   59 (208)
                      .++|+|+.+.||+++.+    +.+.++||+.+...
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            39999999999999874    67899999987653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=91.50  E-value=0.073  Score=41.49  Aligned_cols=30  Identities=30%  Similarity=0.317  Sum_probs=25.3

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.||+++.++.+.++||+.+..
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            399999999999998776668999987643

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.34  E-value=0.22  Score=36.93  Aligned_cols=49  Identities=10%  Similarity=0.167  Sum_probs=40.5

Q ss_pred             CccHHHHHHHHHHHHHHHH-hhccCCCCceEeeCCCCCeeEeCCCCCeEEecccc
Q 028458            2 LLDWVTRVRIIEGIAQGLL-YLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM   55 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~-~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~   55 (208)
                      .++...+++++.+|+.... +++.     -+|--+.|+|++++.++.+++.-.|+
T Consensus        81 ~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f~~~~~p~i~hRGi  130 (219)
T 4ano_A           81 KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMFNRALEPFFLHVGV  130 (219)
T ss_dssp             TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEECTTCCEEESCCEE
T ss_pred             hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEEeCCCcEEEEEcCC
Confidence            3567789999999988766 4544     57899999999999999999987775

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=90.72  E-value=0.094  Score=41.51  Aligned_cols=30  Identities=20%  Similarity=0.328  Sum_probs=24.9

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.||+++....+.++||+.+..
T Consensus       223 ~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          223 VLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             EEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             eEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            499999999999998644578999987653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=90.50  E-value=0.27  Score=38.23  Aligned_cols=28  Identities=36%  Similarity=0.450  Sum_probs=23.9

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.||+++ + .+.++||+.+..
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            389999999999998 4 789999987644

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=90.35  E-value=0.45  Score=39.38  Aligned_cols=15  Identities=40%  Similarity=0.421  Sum_probs=14.1

Q ss_pred             ceEeeCCCCCeeEeC
Q 028458           29 RIIHRDLKVSNILLD   43 (208)
Q Consensus        29 ~i~h~~l~~~nil~~   43 (208)
                      .++|+|+.+.||+++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            499999999999998

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.05  E-value=0.36  Score=35.70  Aligned_cols=49  Identities=12%  Similarity=0.045  Sum_probs=40.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEecccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGM   55 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~   55 (208)
                      .++...+++++.+|+....+++.     -+|--+.|+|++++.++.++++-.|+
T Consensus        77 ~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f~~~~~p~i~~RGi  125 (215)
T 4ann_A           77 SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFFTRDGLPIAKTRGL  125 (215)
T ss_dssp             GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEECTTSCEEESCCEE
T ss_pred             hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEEcCCCCEEEEEccC
Confidence            35667899999999987755544     47899999999999999999987664

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=89.03  E-value=0.63  Score=35.84  Aligned_cols=29  Identities=24%  Similarity=0.241  Sum_probs=24.4

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.|++ ..++.+.++||+.+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4999999999999 4556789999987754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=88.95  E-value=0.47  Score=37.45  Aligned_cols=30  Identities=20%  Similarity=0.386  Sum_probs=26.4

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.|++++.++.+.++||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            499999999999998777899999987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=88.02  E-value=0.51  Score=38.64  Aligned_cols=30  Identities=37%  Similarity=0.443  Sum_probs=24.0

Q ss_pred             ceEeeCCCCCeeEeCCC----------------------------CCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKD----------------------------MNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~----------------------------~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.||+++.+                            +.+.++||+.+..
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            49999999999999875                            6788999977643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=87.80  E-value=0.3  Score=38.85  Aligned_cols=29  Identities=24%  Similarity=0.399  Sum_probs=23.8

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.||+++.++ +.++||+.+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            499999999999998654 89999987643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=86.48  E-value=1  Score=36.08  Aligned_cols=28  Identities=29%  Similarity=0.418  Sum_probs=24.1

Q ss_pred             eEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           30 IIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        30 i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      ++|+|+.+.||+++.+ .+.++||..+..
T Consensus       229 L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          229 LIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             EECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            9999999999999865 488999987654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=84.15  E-value=0.58  Score=37.72  Aligned_cols=30  Identities=27%  Similarity=0.370  Sum_probs=25.9

Q ss_pred             ceEeeCCCCCeeEeCCC----CCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKD----MNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~----~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            49999999999999876    6889999987653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=81.16  E-value=0.96  Score=36.55  Aligned_cols=30  Identities=27%  Similarity=0.372  Sum_probs=24.7

Q ss_pred             ceEeeCCCCCeeEe------CCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILL------DKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~------~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.||++      +....+.++||.++..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4456799999987754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	208
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-40
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-38
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-35
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-35
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-35
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-35
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-34
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-34
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-34
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-33
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-33
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-33
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-33
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-33
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-33
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-33
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-33
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-32
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-32
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-32
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-32
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-32
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-30
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-29
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-29
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-29
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-28
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-26
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-23
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-22
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-22
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-22
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-22
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-22
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-22
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-21
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-21
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-20
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-19
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-19
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-19
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-19
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-19
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-19
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-18
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-18
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-17
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-17
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-17
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-17
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-16
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-16
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-14
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-14
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-14
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-13
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-13
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-10
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-09

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-41
 Identities = 47/181 (25%), Positives = 86/181 (47%), Gaps = 16/181 (8%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
            + +  + I    AQG+ YLH  S   IIHRDLK +NI L +D+  KI DFG+A +    
Sbjct: 101 FEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157

Query: 63  ELQANTSRIVGTYGYMSPEYA---IQGIFSIKSDVFSFGVLLLEIA------WDLWTSNR 113
                  ++ G+  +M+PE      +  +S +SDV++FG++L E+        ++   ++
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217

Query: 114 TLELIDDPVLEDEYSS--KQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPP 171
            + ++    L  + S            +   C+++  D+RP    ++  +   A +L  P
Sbjct: 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL--P 275

Query: 172 K 172
           K
Sbjct: 276 K 276

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 6e-40
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 12/177 (6%)

Query: 5   WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL 64
               V +   IA G+ Y+ +      +HRDL+ +NIL+ +++  K++DFG+AR+   NE 
Sbjct: 112 LPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168

Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLELI 118
            A          + +PE A+ G F+IKSDV+SFG+LL E+       +    +   L+ +
Sbjct: 169 TARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 227

Query: 119 DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPKQPA 175
           +           +      ++   C ++  ++RPT   +   L +   +  P  QP 
Sbjct: 228 ERGYRMP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  130 bits (328), Expect = 8e-38
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 11/165 (6%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L    ++ I   +A G+ YL +    + +HRDL   N L+ ++M  KI+DFG++R     
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLE 116
           +             +M PE      ++ +SDV+++GV+L EI       +        + 
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY 253

Query: 117 LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
            + D  +      +   L   N+  LC  +   DRP+   +  +L
Sbjct: 254 YVRDGNILA--CPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 5e-37
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 18/168 (10%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L     + +   IA+G+ ++ + +    IHRDL+ +NIL+   ++ KI+DFG+AR+   N
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLE 116
           E  A          + +PE    G F+IKSDV+SFG+LL EI       +   T+   ++
Sbjct: 163 EYTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221

Query: 117 LIDD---PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
            ++     V  D             +  LC +E  +DRPT + +  +L
Sbjct: 222 NLERGYRMVRPDNCPE-----ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-35
 Identities = 41/166 (24%), Positives = 77/166 (46%), Gaps = 12/166 (7%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
              +  V ++ GIA G+ YL     +  +HRDL   NIL++ ++  K+SDFG++R+   +
Sbjct: 107 FSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163

Query: 63  ELQANT-SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTL 115
                T S       + +PE      F+  SDV+SFG+++ E+       +   +++  +
Sbjct: 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223

Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           + I+D       +          + + C Q+    RP   D+V +L
Sbjct: 224 KAINDGFRLP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-35
 Identities = 38/168 (22%), Positives = 67/168 (39%), Gaps = 10/168 (5%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L +   +     +A+G+ +L        +HRDL   N+L+      KI DFG+AR    +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLE 116
                         +M+PE   +GI++IKSDV+S+G+LL EI       +     +    
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277

Query: 117 LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNE 164
            +     + +            I   C    +  RP+  ++   L  +
Sbjct: 278 KLIQNGFKMDQPFY-ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-35
 Identities = 37/164 (22%), Positives = 73/164 (44%), Gaps = 11/164 (6%)

Query: 4   DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE 63
                +     IA+G+ YL      R++HRDL   N+L+    + KI+DFG+A++ G  E
Sbjct: 109 GSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165

Query: 64  LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLEL 117
            + +         +M+ E  +  I++ +SDV+S+GV + E+       +D   ++    +
Sbjct: 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 225

Query: 118 IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           ++      +       +    I + C    AD RP   +++   
Sbjct: 226 LEKGERLPQ--PPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 4e-35
 Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 37/198 (18%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQ-----YSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR 57
           +     +++    A GL +LH        +  I HRDLK  NIL+ K+    I+D G+A 
Sbjct: 97  VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156

Query: 58  IC--GGNELQANTSRIVGTYGYMSPEYAIQGI------FSIKSDVFSFGVLLLEIA---- 105
                 + +    +  VGT  YM+PE     I         ++D+++ G++  EIA    
Sbjct: 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216

Query: 106 ------------WDLWTSNRTLELID--------DPVLEDEYSSKQMLLRYVNIALLCVQ 145
                       +DL  S+ ++E +          P + + + S + L     I   C  
Sbjct: 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276

Query: 146 ESADDRPTMNDVVCMLTN 163
            +   R T   +   L+ 
Sbjct: 277 ANGAARLTALRIKKTLSQ 294

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-34
 Identities = 38/163 (23%), Positives = 73/163 (44%), Gaps = 14/163 (8%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILL-DKDMNPKISDFGMARICGG 61
           +           I +GL +LH  +   IIHRDLK  NI +     + KI D G+A +   
Sbjct: 109 MKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTL 115
           +        ++GT  +M+PE   +  +    DV++FG+ +LE+A       +   + +  
Sbjct: 168 S----FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222

Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
             +   V    +  K  +     I   C++++ D+R ++ D++
Sbjct: 223 RRVTSGVKPASF-DKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 4e-34
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 8/165 (4%)

Query: 1   MLLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
            L    T + +   + +G+ YL +     +IHRDL   N L+ ++   K+SDFGM R   
Sbjct: 96  GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152

Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWD--LWTSNRTLELI 118
            ++   +++       + SPE      +S KSDV+SFGVL+ E+  +  +   NR+   +
Sbjct: 153 DDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 211

Query: 119 DDPVLEDEYSSKQMLL--RYVNIALLCVQESADDRPTMNDVVCML 161
            + +       K  L       I   C +E  +DRP  + ++  L
Sbjct: 212 VEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (303), Expect = 4e-34
 Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 16/168 (9%)

Query: 4   DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE 63
             +  V ++ GIA G+ YL        +HRDL   NIL++ ++  K+SDFG++R    + 
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 64  LQANTSRIVG---TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRT 114
                +  +G      + +PE      F+  SDV+S+G+++ E+       +   T+   
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242

Query: 115 LELID-DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           +  I+ D  L         L     + L C Q+  + RP    +V  L
Sbjct: 243 INAIEQDYRLPPPMDCPSAL---HQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 1e-33
 Identities = 38/171 (22%), Positives = 65/171 (38%), Gaps = 18/171 (10%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +     + ++  ++ G+ YL +      +HRDL   N+LL      KISDFG+++    +
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160

Query: 63  ELQANTS-RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           E              + +PE      FS KSDV+SFGVL+ E        +     +   
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220

Query: 116 ELIDD---PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            +++                     ++  LC     ++RP    V   L N
Sbjct: 221 AMLEKGERMGCPAGCPR-----EMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 1e-33
 Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 17/166 (10%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRV--RIIHRDLKVSNILLDKDMNPKISDFGMARICG 60
           LD    +R++  +   L   H+ S     ++HRDLK +N+ LD   N K+ DFG+ARI  
Sbjct: 106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165

Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWD--LWTSNRTLELI 118
            +   A     VGT  YMSPE   +  ++ KSD++S G LL E+      +T+    EL 
Sbjct: 166 HDTSFAKA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA 223

Query: 119 ------DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
                     +   YS +        I    +      RP++ +++
Sbjct: 224 GKIREGKFRRIPYRYSDE-----LNEIITRMLNLKDYHRPSVEEIL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 2e-33
 Identities = 40/177 (22%), Positives = 76/177 (42%), Gaps = 17/177 (9%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
                 +     +A+G+      +  + +HRDL   N +LD+    K++DFG+AR     
Sbjct: 127 PTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183

Query: 63  ELQANTSR--IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRT 114
           E  +  ++        +M+ E      F+ KSDV+SFGVLL E+       +    +   
Sbjct: 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243

Query: 115 LELI--DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLL 169
              +     +L+ EY    +      + L C    A+ RP+ +++V  ++   +T +
Sbjct: 244 TVYLLQGRRLLQPEYCPDPL----YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 3e-33
 Identities = 37/184 (20%), Positives = 67/184 (36%), Gaps = 18/184 (9%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +       ++  ++ G+ YL + +    +HRDL   N+LL      KISDFG+++  G +
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162

Query: 63  ELQAN-TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI------AWDLWTSNRTL 115
           +      S       + +PE      FS +SDV+S+GV + E        +        +
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222

Query: 116 ELIDD---PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLPPK 172
             I+         E   +        +   C     +DRP    V   +     +L    
Sbjct: 223 AFIEQGKRMECPPECPPE-----LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277

Query: 173 QPAF 176
           +   
Sbjct: 278 EGHH 281

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  118 bits (296), Expect = 4e-33
 Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 12/165 (7%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +  V  + +   I+  + YL +      IHRDL   N L+ ++   K++DFG++R+  G+
Sbjct: 112 VSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLE 116
              A+         + +PE      FSIKSDV++FGVLL EIA      +     ++  E
Sbjct: 169 TYTAHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227

Query: 117 LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           L++     +    +    +   +   C Q +  DRP+  ++    
Sbjct: 228 LLEKDYRME--RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 5e-33
 Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 16/171 (9%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD    +     +A+G+ +L        IHRDL   NILL      KI DFG+AR    +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-------WDLWTSNRTL 115
                         +M+PE     +++ +SDV+S+G+ L E+          +   ++  
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258

Query: 116 ELIDD--PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNE 164
           ++I +   +L  E++  +M     +I   C       RPT   +V ++  +
Sbjct: 259 KMIKEGFRMLSPEHAPAEM----YDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 5e-33
 Identities = 39/165 (23%), Positives = 69/165 (41%), Gaps = 14/165 (8%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L     +     +A+G+ YL Q    + IHRDL   NIL+ ++   KI+DFG++R     
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLE 116
                 +       +M+ E     +++  SDV+S+GVLL EI       +   T     E
Sbjct: 181 V---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237

Query: 117 LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
            +      ++           ++   C +E   +RP+   ++  L
Sbjct: 238 KLPQGYRLEK--PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 5e-33
 Identities = 41/167 (24%), Positives = 74/167 (44%), Gaps = 12/167 (7%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
                 + + + + + + YL      + +HRDL   N L++     K+SDFG++R    +
Sbjct: 97  FQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLE 116
           E  ++         +  PE  +   FS KSD+++FGVL+ EI       ++ +T++ T E
Sbjct: 154 EYTSSVG-SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 212

Query: 117 LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            I        Y       +   I   C  E AD+RPT   ++  + +
Sbjct: 213 HIAQG--LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 8e-33
 Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 16/170 (9%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L     +     +A+G+ +L      + IHRDL   NILL +    KI DFG+AR    +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI---AWDLWTSNRTLELID 119
                         +M+PE     +++I+SDV+SFGVLL EI       +   +  E   
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 120 DPVLED------EYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
             + E       +Y++ +M        L C       RPT +++V  L N
Sbjct: 248 RRLKEGTRMRAPDYTTPEMY----QTMLDCWHGEPSQRPTFSELVEHLGN 293

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 2e-32
 Identities = 39/163 (23%), Positives = 65/163 (39%), Gaps = 19/163 (11%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
            D       I  +A  L Y H     R+IHRD+K  N+LL      KI+DFG +     +
Sbjct: 103 FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRTLEL 117
                 + + GT  Y+ PE     +   K D++S GVL  E       ++  T   T + 
Sbjct: 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 215

Query: 118 I--DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
           I   +    D  +         ++    ++ +   RP + +V+
Sbjct: 216 ISRVEFTFPDFVTE-----GARDLISRLLKHNPSQRPMLREVL 253

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-32
 Identities = 46/183 (25%), Positives = 83/183 (45%), Gaps = 15/183 (8%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
                 +++   IA G+ YL+     + +HRDL   N ++ +D   KI DFGM R     
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLE 116
           +      + +    +MSPE    G+F+  SDV+SFGV+L EIA      +   ++ + L 
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246

Query: 117 LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAATLLP-PKQPA 175
            + +  L D+            +  +C Q +   RP+  +++  +  E   + P  ++ +
Sbjct: 247 FVMEGGLLDK--PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE---MEPGFREVS 301

Query: 176 FSY 178
           F Y
Sbjct: 302 FYY 304

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (291), Expect = 3e-32
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 24/167 (14%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L  V    +  G  QGL YLH +    +IHRD+K  NILL +    K+ DFG A I    
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM--- 165

Query: 63  ELQANTSRIVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRT 114
              A  +  VGT  +M+PE  +   +G +  K DV+S G+  +E+A          +   
Sbjct: 166 ---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222

Query: 115 LELI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVV 158
           L  I   + P L+  + S+       N    C+Q+   DRPT   ++
Sbjct: 223 LYHIAQNESPALQSGHWSEYF----RNFVDSCLQKIPQDRPTSEVLL 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 4e-32
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 6/103 (5%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +      ++   + +GL YL    + +I+HRD+K SNIL++     K+ DFG++     +
Sbjct: 101 IPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
                 +  VGT  YMSPE      +S++SD++S G+ L+E+A
Sbjct: 159 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 4e-32
 Identities = 37/165 (22%), Positives = 63/165 (38%), Gaps = 16/165 (9%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L     ++    + + + YL        +HRDL   N+L+ +D   K+SDFG+ +     
Sbjct: 100 LGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK----- 151

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLE 116
           E  +          + +PE   +  FS KSDV+SFG+LL EI       +        + 
Sbjct: 152 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 211

Query: 117 LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
            ++     D  +          +   C    A  RP+   +   L
Sbjct: 212 RVEKGYKMD--APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 4e-32
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 9/161 (5%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +      R    +  G++YLH      I HRD+K  N+LLD+  N KISDFG+A +   N
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIA---WDLWTSNRTLELI 118
             +   +++ GT  Y++PE   +  F +   DV+S G++L  +          + + +  
Sbjct: 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216

Query: 119 DDPVLEDEYSSKQMLLRYVNIALL--CVQESADDRPTMNDV 157
            D   +  Y +    +    +ALL   + E+   R T+ D+
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 8e-30
 Identities = 43/167 (25%), Positives = 62/167 (37%), Gaps = 11/167 (6%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGG 61
               T  R    +A+G+ YL      R IHRDL   N+LL      KI DFG+ R +   
Sbjct: 108 FLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTL 115
           ++           + + +PE      FS  SD + FGV L E+       W     ++ L
Sbjct: 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224

Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLT 162
             ID                  N+ + C     +DRPT   +   L 
Sbjct: 225 HKIDKEGERLPRPED-CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 1e-29
 Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 11/165 (6%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L     V     +A+G+ YL      + IHRDL   N+L+ +D   KI+DFG+AR     
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLE 116
           +    T+       +M+PE     I++ +SDV+SFGVLL EI       +         +
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248

Query: 117 LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCML 161
           L+ +    D+            +   C       RPT   +V  L
Sbjct: 249 LLKEGHRMDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 2e-29
 Identities = 35/170 (20%), Positives = 64/170 (37%), Gaps = 18/170 (10%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           LD  + +     ++  L YL      R +HRD+   N+L+  +   K+ DFG++R    +
Sbjct: 105 LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA------WDLWTSNRTLE 116
                 S+      +M+PE      F+  SDV+ FGV + EI       +    +N  + 
Sbjct: 162 TYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220

Query: 117 LI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTN 163
            I   +   +              ++   C       RP   ++   L+ 
Sbjct: 221 RIENGERLPMPPNCPPT-----LYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 3e-29
 Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 15/165 (9%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L       + +     L YLH     +IIHRDLK  NIL   D + K++DFG++      
Sbjct: 107 LTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163

Query: 63  ELQANTSRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIA-----WDLWTSN 112
             + ++   +GT  +M+PE  +        +  K+DV+S G+ L+E+A            
Sbjct: 164 IQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221

Query: 113 RTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
           R L  I            +    + +    C++++ D R T + +
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 7e-28
 Identities = 38/159 (23%), Positives = 71/159 (44%), Gaps = 10/159 (6%)

Query: 4   DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE 63
           D      +     Q L +LH     ++IHRD+K  NILL  D + K++DFG         
Sbjct: 114 DEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 169

Query: 64  LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRTLELI 118
            Q+  S +VGT  +M+PE   +  +  K D++S G++ +E+      +      R L LI
Sbjct: 170 -QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228

Query: 119 DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
                 +  + +++   + +    C+    + R +  ++
Sbjct: 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 3e-26
 Identities = 35/157 (22%), Positives = 67/157 (42%), Gaps = 16/157 (10%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
                 A+ +  L       IIHRDLK  NILL++DM+ +I+DFG A++      QA  +
Sbjct: 109 CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168

Query: 70  RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRTLELI--DDPV 122
             VGT  Y+SPE   +      SD+++ G ++ ++      +         + I   +  
Sbjct: 169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 228

Query: 123 LEDEYSS--KQMLLRYVNIALLCVQESADDRPTMNDV 157
             +++    + ++ +        +   A  R    ++
Sbjct: 229 FPEKFFPKARDLVEK-------LLVLDATKRLGCEEM 258

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 90.5 bits (224), Expect = 9e-23
 Identities = 36/167 (21%), Positives = 63/167 (37%), Gaps = 18/167 (10%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L      +I+  + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG +      
Sbjct: 107 LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 163

Query: 63  ELQANTSRIVGTYGYMSPEYA------IQGIFSIKSDVFSFGVLLLEIA-----WDLWTS 111
           E       + GT  Y++PE            +  + D++S GV++  +      +     
Sbjct: 164 E---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220

Query: 112 NRTLELI-DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
              L +I                    ++    +      R T  + 
Sbjct: 221 MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 90.5 bits (224), Expect = 2e-22
 Identities = 34/165 (20%), Positives = 65/165 (39%), Gaps = 18/165 (10%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--KISDFGMARICG 60
           +     +  +    +GL ++H      I+H D+K  NI+ +       KI DFG+A    
Sbjct: 124 MSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180

Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRTL 115
            +E+         T  + +PE   +      +D+++ GVL   +      +       TL
Sbjct: 181 PDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 237

Query: 116 ELI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
           + +   D    ED +SS     +  +     +Q+    R T++D 
Sbjct: 238 QNVKRCDWEFDEDAFSSVSPEAK--DFIKNLLQKEPRKRLTVHDA 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.9 bits (222), Expect = 3e-22
 Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 6/102 (5%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +   T   ++  + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI    
Sbjct: 113 VPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 169

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
                 + +V T  Y +PE  +Q  ++   D++S G +  E+
Sbjct: 170 M---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 208

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 90.1 bits (223), Expect = 3e-22
 Identities = 29/163 (17%), Positives = 59/163 (36%), Gaps = 14/163 (8%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--KISDFGMARICG 60
           +     V  +  + +GL ++H       +H DLK  NI+     +   K+ DFG+     
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177

Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRTL 115
             +   +     GT  + +PE A        +D++S GVL   +      +     + TL
Sbjct: 178 PKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234

Query: 116 ELI-DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
             +       D+ +   +     +     +    + R T++  
Sbjct: 235 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 89.4 bits (221), Expect = 5e-22
 Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 18/149 (12%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 74
            A+  L L       II+RDLK  NILLDK+ + KI+DFG A+      +   T  + GT
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 164

Query: 75  YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRTLELI--DDPVLEDEY 127
             Y++PE      ++   D +SFG+L+ E+      +    + +T E I   +      +
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF 224

Query: 128 SS------KQMLLRYVNIALLCVQESADD 150
           +        +++ R ++  L  +Q   +D
Sbjct: 225 NEDVKDLLSRLITRDLSQRLGNLQNGTED 253

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.4 bits (221), Expect = 5e-22
 Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 7/156 (4%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
            D          I  GL +LH      I++RDLK+ NILLDKD + KI+DFGM +     
Sbjct: 100 FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA--WDLWTSNRTLELIDD 120
           + + NT    GT  Y++PE  +   ++   D +SFGVLL E+      +      EL   
Sbjct: 157 DAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS 214

Query: 121 PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND 156
             +++ +  + +     ++ +       + R  +  
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG 250

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 88.3 bits (218), Expect = 8e-22
 Identities = 25/182 (13%), Positives = 59/182 (32%), Gaps = 23/182 (12%)

Query: 2   LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP-----KISDFGMA 56
                T     + +   +  +H+     +++RD+K  N L+ +  +       + DFGM 
Sbjct: 97  KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153

Query: 57  RICGGNELQAN-----TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA----WD 107
           +       + +        + GT  YMS    +    S + D+ + G + +         
Sbjct: 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 213

Query: 108 LWTSNRTLELIDDPVLEDEYSSKQMLLR------YVNIALLCVQESADDRPTMNDVVCML 161
                 T +   + + E + S+    L       +          + D  P  + +  + 
Sbjct: 214 QGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

Query: 162 TN 163
           + 
Sbjct: 274 SK 275

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 88.0 bits (217), Expect = 1e-21
 Identities = 32/179 (17%), Positives = 60/179 (33%), Gaps = 21/179 (11%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNIL---LDKDMNPKISDFGMARIC 59
               T + + + +   + Y+H       IHRD+K  N L     K     I DFG+A+  
Sbjct: 100 FSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156

Query: 60  GGNELQAN-----TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-----WDLW 109
                  +        + GT  Y S    +    S + D+ S G +L+        W   
Sbjct: 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216

Query: 110 TSNRTLELIDDPVLEDEYSSKQMLLRYV-----NIALLCVQESADDRPTMNDVVCMLTN 163
            +    +  +    +   +  ++L +            C     DD+P  + +  +  N
Sbjct: 217 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.8 bits (217), Expect = 2e-21
 Identities = 33/167 (19%), Positives = 68/167 (40%), Gaps = 22/167 (13%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP--KISDFGMARICG 60
           L+    V  +  + + L +LH +    I H D++  NI+     +   KI +FG AR   
Sbjct: 99  LNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155

Query: 61  GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRTL 115
             +   N   +     Y +PE     + S  +D++S G L+  +      +   T+ + +
Sbjct: 156 PGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212

Query: 116 ELIDDPVLEDEYSSKQMLLRYVNIALL-----CVQESADDRPTMNDV 157
           E I    +  EY+  +   + ++I  +      + +    R T ++ 
Sbjct: 213 ENI----MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.0 bits (207), Expect = 3e-20
 Identities = 33/157 (21%), Positives = 59/157 (37%), Gaps = 13/157 (8%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGG 61
           L           + + + + H      ++HRD+K  NIL+D +    K+ DFG   +   
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163

Query: 62  NELQANTSRIVGTYGYMSPEY-AIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD 120
                  +   GT  Y  PE+          + V+S G+LL ++           E+I  
Sbjct: 164 T----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 219

Query: 121 PVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV 157
            V   +  S +      ++   C+     DRPT  ++
Sbjct: 220 QVFFRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 252

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.0 bits (204), Expect = 1e-19
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 5/104 (4%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L        +  I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +
Sbjct: 106 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162

Query: 63  ELQANT-SRIVGTYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEI 104
                  +  V T  Y +PE  +      KS D++S G +L E+
Sbjct: 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 206

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.8 bits (204), Expect = 2e-19
 Identities = 29/168 (17%), Positives = 58/168 (34%), Gaps = 19/168 (11%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP---KISDFGMARIC 59
                   I++ I + + YLH    + I HRD+K  N+L          K++DFG A+  
Sbjct: 108 FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164

Query: 60  GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRT 114
             +           T  Y++PE      +    D++S GV++  +      +        
Sbjct: 165 TSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221

Query: 115 LELIDDPVLEDEYSSKQMLLRYVNIALL-----CVQESADDRPTMNDV 157
              +   +   +Y         V+  +       ++     R T+ + 
Sbjct: 222 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.1 bits (202), Expect = 2e-19
 Identities = 35/160 (21%), Positives = 63/160 (39%), Gaps = 18/160 (11%)

Query: 5   WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL 64
             T  R     A+ +  L       +++RD+K+ N++LDKD + KI+DFG+ +    +  
Sbjct: 101 VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-- 158

Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRTLELI- 118
            A      GT  Y++PE      +    D +  GV++ E+      +      R  ELI 
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218

Query: 119 -DDPVLEDEYSS--KQMLLRYVNIALLCVQESADDRPTMN 155
            ++       S   K +L          +++    R    
Sbjct: 219 MEEIRFPRTLSPEAKSLLAG-------LLKKDPKQRLGGG 251

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 81.2 bits (200), Expect = 4e-19
 Identities = 33/162 (20%), Positives = 62/162 (38%), Gaps = 11/162 (6%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
                  R+I  +   + YLH    V    +   +    LD+D    ISDFG++++    
Sbjct: 104 YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA--WDLWTSNRTLELIDD 120
            +    S   GT GY++PE   Q  +S   D +S GV+   +   +  +      +L + 
Sbjct: 164 SV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220

Query: 121 PVLEDEYSSKQMLLRYV-----NIALLCVQESADDRPTMNDV 157
            +L+ EY         +     +     +++  + R T    
Sbjct: 221 -ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 80.6 bits (198), Expect = 5e-19
 Identities = 37/158 (23%), Positives = 67/158 (42%), Gaps = 10/158 (6%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMAR-ICGG 61
           +     + +I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR I   
Sbjct: 108 MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA-----WDLWTSNRTLE 116
                 T+ ++GT  Y+SPE A       +SDV+S G +L E+      +   +      
Sbjct: 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 224

Query: 117 LI-DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT 153
               +  +      + +      + L  + ++ ++R  
Sbjct: 225 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 80.9 bits (199), Expect = 9e-19
 Identities = 35/156 (22%), Positives = 63/156 (40%), Gaps = 13/156 (8%)

Query: 5   WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL 64
                     I  GL ++H      +++RDLK +NILLD+  + +ISD G+A      + 
Sbjct: 106 EADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161

Query: 65  QANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA-----WDLWTSNRTLELI 118
                  VGT+GYM+PE   +G+ +   +D FS G +L ++      +    +    E+ 
Sbjct: 162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218

Query: 119 DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM 154
              +               ++    +Q   + R   
Sbjct: 219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.7 bits (193), Expect = 3e-18
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 6/104 (5%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L        +    QGL YLHQ+    I+HRDLK +N+LLD++   K++DFG+A+  G  
Sbjct: 97  LTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153

Query: 63  ELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIA 105
                 +  V T  Y +PE      ++ +  D+++ G +L E+ 
Sbjct: 154 --NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 195

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.0 bits (191), Expect = 7e-18
 Identities = 26/94 (27%), Positives = 46/94 (48%), Gaps = 3/94 (3%)

Query: 15  IAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARI--CGGNELQANTSRIV 72
           +   L  L+   R +I+HRD+K +N+L+ +D   K++DFG+AR      N      +  V
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 73  GTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
            T  Y  PE  +    +    D++  G ++ E+ 
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 216

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.5 bits (187), Expect = 2e-17
 Identities = 23/101 (22%), Positives = 49/101 (48%), Gaps = 1/101 (0%)

Query: 5   WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL 64
            +    +   + Q L  L       ++HRDLK  N+L++++   K+++FG+AR   G  +
Sbjct: 97  DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPV 155

Query: 65  QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
           +  ++ +V  +           ++S   D++S G +  E+A
Sbjct: 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 76.8 bits (188), Expect = 2e-17
 Identities = 28/103 (27%), Positives = 47/103 (45%), Gaps = 8/103 (7%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
                       I     YLH      +I+RDLK  N+L+D+    +++DFG A+   G 
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
                T  + GT   ++PE  +   ++   D ++ GVL+ E+A
Sbjct: 194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.7 bits (185), Expect = 4e-17
 Identities = 26/103 (25%), Positives = 49/103 (47%), Gaps = 4/103 (3%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           +        +  + QGL + H +   R++HRDLK  N+L++ +   K++DFG+AR   G 
Sbjct: 99  IPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GV 154

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
            ++  T  +V  +            +S   D++S G +  E+ 
Sbjct: 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.8 bits (183), Expect = 7e-17
 Identities = 36/166 (21%), Positives = 61/166 (36%), Gaps = 18/166 (10%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNP----KISDFGMARI 58
           L        ++ I  G+ YLH     +I H DLK  NI+L     P    KI DFG+A  
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166

Query: 59  CGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW--DLWTSNRTLE 116
                       I GT  +++PE        +++D++S GV+   +      +  +   E
Sbjct: 167 IDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223

Query: 117 LIDDPVLEDEYSSKQMLLRYVNIALL-----CVQESADDRPTMNDV 157
            + + V    Y  +       +          + +    R T+ D 
Sbjct: 224 TLAN-VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.1 bits (181), Expect = 2e-16
 Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 8/105 (7%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD-MNPKISDFGMARICGG 61
           L  +     +  + + L Y+H +    I HRD+K  N+LLD D    K+ DFG A+    
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175

Query: 62  NELQANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIA 105
            E   +    + +  Y +PE       ++   DV+S G +L E+ 
Sbjct: 176 GEPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 72.6 bits (177), Expect = 4e-16
 Identities = 30/103 (29%), Positives = 53/103 (51%), Gaps = 6/103 (5%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L+ VT    +  +  G+ Y H     R++HRDLK  N+L++++   KI+DFG+AR  G  
Sbjct: 97  LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153

Query: 63  ELQANTSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
             +      + T  Y +P+  +    +S   D++S G +  E+
Sbjct: 154 VRKYTH--EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 67.8 bits (164), Expect = 3e-14
 Identities = 24/104 (23%), Positives = 47/104 (45%), Gaps = 3/104 (2%)

Query: 4   DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGMARICGGN 62
             +   +I + +  GL Y+H+  R  IIH D+K  N+L++  D    +    +A +    
Sbjct: 123 PLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAW 106
               + +  + T  Y SPE  +   +   +D++S   L+ E+  
Sbjct: 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.8 bits (162), Expect = 7e-14
 Identities = 33/154 (21%), Positives = 67/154 (43%), Gaps = 9/154 (5%)

Query: 10  RIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTS 69
            +   + + +L L    ++ II+RD+K+ NILLD + +  ++DFG+++    +E +    
Sbjct: 130 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAY 188

Query: 70  RIVGTYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEIA-----WDLWTSNRTLELIDDPV 122
              GT  YM+P+    G        D +S GVL+ E+      + +     +   I   +
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 248

Query: 123 LEDEYS-SKQMLLRYVNIALLCVQESADDRPTMN 155
           L+ E    ++M     ++    + +    R    
Sbjct: 249 LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.8 bits (162), Expect = 7e-14
 Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 9/103 (8%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L       ++  + +GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR     
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR----- 169

Query: 63  ELQANTSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEI 104
           +  +  +  V T  Y +PE  +    ++   D++S G ++ E+
Sbjct: 170 QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 212

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.1 bits (160), Expect = 1e-13
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 6/102 (5%)

Query: 4   DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNE 63
           D      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + 
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173

Query: 64  LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIA 105
           +    +  V T  Y +PE  +   +    D++S G ++ E+ 
Sbjct: 174 M---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 64.9 bits (157), Expect = 3e-13
 Identities = 22/105 (20%), Positives = 46/105 (43%), Gaps = 8/105 (7%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGG 61
           L        +  I + L Y H    + I+HRD+K  N+++D +    ++ D+G+A     
Sbjct: 126 LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182

Query: 62  NELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIA 105
            +     +  V +  +  PE  +   ++    D++S G +L  + 
Sbjct: 183 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.8 bits (136), Expect = 2e-10
 Identities = 29/102 (28%), Positives = 46/102 (45%), Gaps = 7/102 (6%)

Query: 3   LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGN 62
           L       +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR     
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174

Query: 63  ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 104
                T  +   +            ++   D++S G ++ E+
Sbjct: 175 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 52.9 bits (126), Expect = 2e-09
 Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 11/100 (11%)

Query: 5   WVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL 64
                 +++ I + +   +      I+H DL   N+L+  +    I DF  +   G    
Sbjct: 102 VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGW 157

Query: 65  QANTSR-IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 103
           +    R +     Y S  Y        + D+ S    +L+
Sbjct: 158 REILERDVRNIITYFSRTY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	208
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.98
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.98
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.98
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.98
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.97
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.97
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.97
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.97
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.97
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.97
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.97
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.97
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.97
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.97
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.97
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.96
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.96
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.95
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.95
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.95
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.95
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.95
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.93
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.26
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.17
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	92.99
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	92.27
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	87.51
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	87.2

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-36  Score=235.92  Aligned_cols=165  Identities=27%  Similarity=0.415  Sum_probs=126.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.||++||.|||+++   |+||||||+||+++.++.+||+|||++................|++.|+|||
T Consensus       100 ~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE  176 (276)
T d1uwha_         100 KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE  176 (276)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHH
Confidence            3789999999999999999999999   9999999999999999999999999997765433333334457899999999


Q ss_pred             hhcc---CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c----cCCcc--chhhhhHHHHHHHHHHHhhccccCCCC
Q 028458           82 YAIQ---GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I----DDPVL--EDEYSSKQMLLRYVNIALLCVQESADD  150 (208)
Q Consensus        82 ~~~~---~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~----~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~  150 (208)
                      .+.+   +.|+.++||||||+++|||++|..|+......  +    .....  .......+.+..+.++|.+||+.||++
T Consensus       177 ~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~  256 (276)
T d1uwha_         177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE  256 (276)
T ss_dssp             HHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             HHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhH
Confidence            9864   34789999999999999999999887543211  1    10110  011223445678999999999999999


Q ss_pred             CCCHHHHHHHHhhhhhccC
Q 028458          151 RPTMNDVVCMLTNEAATLL  169 (208)
Q Consensus       151 Rps~~~i~~~l~~~~~~~~  169 (208)
                      |||++||++.|+.+...+|
T Consensus       257 RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         257 RPLFPQILASIELLARSLP  275 (276)
T ss_dssp             SCCHHHHHHHHHHHHHTCC
T ss_pred             CcCHHHHHHHHHHHHHcCC
Confidence            9999999999998876543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-35  Score=233.25  Aligned_cols=159  Identities=28%  Similarity=0.315  Sum_probs=122.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|++..++.++.||++||.|||+++   |+||||||+||+++.++.+||+|||++................||+.|+|||
T Consensus       130 ~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE  206 (299)
T d1ywna1         130 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  206 (299)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchh
Confidence            3788999999999999999999999   9999999999999999999999999998765444333334457889999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhh-cCCccc--cc----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLW-TSNRTL--EL----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~-~~~~~~--~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..++.++|||||||++|+|+++.. |+....  +.    +.....  ...+...+.++.++|.+||+.||++|||+
T Consensus       207 ~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  284 (299)
T d1ywna1         207 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--MRAPDYTTPEMYQTMLDCWHGEPSQRPTF  284 (299)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--CCCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence            9999999999999999999999998653 443211  11    110000  02233456678999999999999999999


Q ss_pred             HHHHHHHhhhh
Q 028458          155 NDVVCMLTNEA  165 (208)
Q Consensus       155 ~~i~~~l~~~~  165 (208)
                      +|+++.|+.+.
T Consensus       285 ~eil~~L~~il  295 (299)
T d1ywna1         285 SELVEHLGNLL  295 (299)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999998764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-35  Score=234.72  Aligned_cols=157  Identities=26%  Similarity=0.345  Sum_probs=126.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|++..++.++.||++||.|||+++   |+||||||.||+++.++.+||+|||++................|++.|+|||
T Consensus       160 ~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE  236 (325)
T d1rjba_         160 VLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE  236 (325)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChH
Confidence            4788999999999999999999999   9999999999999999999999999997664433333333456789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc------cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE------LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.++.++.++|||||||++|+|++ |..|+.....      .+... .. ...+...+..+.+||.+||+.||++|||+
T Consensus       237 ~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~-~~-~~~p~~~~~~l~~li~~cl~~dP~~RPt~  314 (325)
T d1rjba_         237 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG-FK-MDQPFYATEEIYIIMQSCWAFDSRKRPSF  314 (325)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT-CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CC-CCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence            9999999999999999999999997 7777643211      11111 01 12234456789999999999999999999


Q ss_pred             HHHHHHHhh
Q 028458          155 NDVVCMLTN  163 (208)
Q Consensus       155 ~~i~~~l~~  163 (208)
                      +||++.|..
T Consensus       315 ~ei~~~L~~  323 (325)
T d1rjba_         315 PNLTSFLGC  323 (325)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHhC
Confidence            999999853

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-35  Score=228.33  Aligned_cols=161  Identities=26%  Similarity=0.380  Sum_probs=121.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++.++++++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.......... ......|+..|+||
T Consensus       106 ~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~AP  182 (283)
T d1mqba_         106 EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP  182 (283)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCH
T ss_pred             cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCH
Confidence            5789999999999999999999999   9999999999999999999999999997764332211 12224578899999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccc------ccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTL------ELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.++.++.++||||||+++|||+++..++....      ..+......  ..+...+..+.++|.+||+.||++||++
T Consensus       183 E~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~  260 (283)
T d1mqba_         183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL--PTPMDCPSAIYQLMMQCWQQERARRPKF  260 (283)
T ss_dssp             HHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--CCCTTCBHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC--CCchhhHHHHHHHHHHHCcCCHhHCcCH
Confidence            99999999999999999999999998654432211      111111110  2233456778999999999999999999


Q ss_pred             HHHHHHHhhhhhc
Q 028458          155 NDVVCMLTNEAAT  167 (208)
Q Consensus       155 ~~i~~~l~~~~~~  167 (208)
                      .||++.|+++...
T Consensus       261 ~eil~~L~~l~~~  273 (283)
T d1mqba_         261 ADIVSILDKLIRA  273 (283)
T ss_dssp             HHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHhhC
Confidence            9999999887643

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-35  Score=226.44  Aligned_cols=154  Identities=25%  Similarity=0.324  Sum_probs=123.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.||++||.|||+++   |+||||||+||+++.++.+||+|||++................||+.|+|||
T Consensus        99 ~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE  175 (271)
T d1nvra_          99 GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE  175 (271)
T ss_dssp             BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHh
Confidence            4788999999999999999999999   9999999999999999999999999998764433333334467899999999


Q ss_pred             hhccCCC-CCcchhHHHHHHHHHHHHhhhcCCccccccc------CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           82 YAIQGIF-SIKSDVFSFGVLLLEIAWDLWTSNRTLELID------DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        82 ~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      .+.+..+ +.++|+|||||++|+|++|..|+........      .... ........+..+.++|.+||+.||++|||+
T Consensus       176 ~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~  254 (271)
T d1nvra_         176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKKIDSAPLALLHKILVENPSARITI  254 (271)
T ss_dssp             HHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             HhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCccccCCHHHHHHHHHHcCCChhHCcCH
Confidence            9988776 5779999999999999999988854322110      0000 001123456678899999999999999999


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      +|+++
T Consensus       255 ~eil~  259 (271)
T d1nvra_         255 PDIKK  259 (271)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.2e-35  Score=230.47  Aligned_cols=159  Identities=25%  Similarity=0.372  Sum_probs=118.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccccc---ccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQAN---TSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~~~~~   78 (208)
                      .+++.+++.++.||++||.|||+++   ++||||||+||+++.++.+||+|||++...........   .....+++.|+
T Consensus       124 ~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~  200 (299)
T d1jpaa_         124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT  200 (299)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCcccc
Confidence            4789999999999999999999999   99999999999999999999999999987644332211   11234678999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--c---cc-CCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--L---ID-DPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~---~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      |||.+.++.++.++|||||||++|||++ |..|+.....  .   +. ....   ..+...+..+.+++.+||+.||++|
T Consensus       201 aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~R  277 (299)
T d1jpaa_         201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL---PPPMDCPSALHQLMLDCWQKDRNHR  277 (299)
T ss_dssp             CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTS
T ss_pred             CHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCCHhHC
Confidence            9999999999999999999999999997 6777643221  1   11 1111   2234456778999999999999999


Q ss_pred             CCHHHHHHHHhhhhh
Q 028458          152 PTMNDVVCMLTNEAA  166 (208)
Q Consensus       152 ps~~~i~~~l~~~~~  166 (208)
                      |+++||++.|+++.+
T Consensus       278 Ps~~ei~~~L~~~l~  292 (299)
T d1jpaa_         278 PKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHhc
Confidence            999999999988754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=225.85  Aligned_cols=158  Identities=29%  Similarity=0.430  Sum_probs=126.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+++++.||++||.|||+++   |+||||||.||+++.++.+||+|||++.......... .....+++.|+|||
T Consensus       105 ~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE  180 (272)
T d1qpca_         105 KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPE  180 (272)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC-CTTCCCCTTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccc-ccccCCcccccChH
Confidence            3789999999999999999999999   9999999999999999999999999998775443222 22346788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc------cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE------LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.++.++.++||||||+++|||+++..++.....      .+....  ....+...+..+.+|+.+||+.||++|||++
T Consensus       181 ~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~--~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~  258 (272)
T d1qpca_         181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--RMVRPDNCPEELYQLMRLCWKERPEDRPTFD  258 (272)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--CCCCcccChHHHHHHHHHHcCCCHhHCcCHH
Confidence            99988999999999999999999996554432211      111110  0022344566789999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      +|++.|+..-
T Consensus       259 ei~~~L~~~f  268 (272)
T d1qpca_         259 YLRSVLEDFF  268 (272)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHhhhhh
Confidence            9999998653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-35  Score=231.81  Aligned_cols=159  Identities=25%  Similarity=0.373  Sum_probs=127.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++................++..|+|||
T Consensus       136 ~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE  212 (301)
T d1lufa_         136 PLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE  212 (301)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHH
Confidence            4788999999999999999999999   9999999999999999999999999997664443333333456778999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhh-cCCccc--cc---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLW-TSNRTL--EL---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~-~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++||||||+++|||+++.. |+....  +.   +......  ..+..++.++.+|+.+||+.||++|||+.
T Consensus       213 ~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~--~~p~~~~~~~~~li~~cl~~~P~~RPt~~  290 (301)
T d1lufa_         213 SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL--ACPENCPLELYNLMRLCWSKLPADRPSFC  290 (301)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--CCCccchHHHHHHHHHHcCCChhHCcCHH
Confidence            9999999999999999999999998854 343221  11   1111111  22445567889999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      ||++.|++++
T Consensus       291 ev~~~L~~i~  300 (301)
T d1lufa_         291 SIHRILQRMC  300 (301)
T ss_dssp             HHHHHHHHTT
T ss_pred             HHHHHHHHhc
Confidence            9999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-35  Score=226.36  Aligned_cols=160  Identities=27%  Similarity=0.379  Sum_probs=117.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.......... .....|+..|+|||
T Consensus        97 ~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE  172 (263)
T d1sm2a_          97 LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPE  172 (263)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee-ecceecCcccCChH
Confidence            4788999999999999999999999   9999999999999999999999999997664333222 22246788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc---cccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE---LIDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      .+.+..++.++||||||+++|||+++..++.....   ....... .....+...+.++.+++.+||+.||++||+++||
T Consensus       173 ~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~i  252 (263)
T d1sm2a_         173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRL  252 (263)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            99999999999999999999999986443322111   1110000 0001233445678999999999999999999999


Q ss_pred             HHHHhhhh
Q 028458          158 VCMLTNEA  165 (208)
Q Consensus       158 ~~~l~~~~  165 (208)
                      ++.|+++.
T Consensus       253 l~~L~~i~  260 (263)
T d1sm2a_         253 LRQLAEIA  260 (263)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-35  Score=225.46  Aligned_cols=151  Identities=23%  Similarity=0.278  Sum_probs=123.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||++||.|||+++   |+||||||+||+++.++.+||+|||++.......    .....||+.|+|||
T Consensus       102 ~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE  174 (263)
T d2j4za1         102 KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPE  174 (263)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHH
Confidence            4788899999999999999999999   9999999999999999999999999997654332    22356899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .+.+..++.++|+|||||++|+|++|..|+.....  ......-.....+...+.++.++|.+||+.||++|||++|+++
T Consensus       175 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            99998999999999999999999999988753321  1110000001123345677899999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-35  Score=231.20  Aligned_cols=162  Identities=23%  Similarity=0.323  Sum_probs=125.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+++++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++................|+..|+|||
T Consensus       107 ~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE  183 (317)
T d1xkka_         107 NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE  183 (317)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChH
Confidence            5788999999999999999999999   9999999999999999999999999998765444333333346789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccc-ccccCCccch--hhhhHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTL-ELIDDPVLED--EYSSKQMLLRYVNIALLCVQESADDRPTMNDV  157 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  157 (208)
                      .+.++.++.++||||||+++|||++ |..|+.... ..+......+  ...+...+..+.+++.+||+.||++||++.||
T Consensus       184 ~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei  263 (317)
T d1xkka_         184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL  263 (317)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHH
Confidence            9999999999999999999999998 555554321 1110000000  02234456778999999999999999999999


Q ss_pred             HHHHhhhhh
Q 028458          158 VCMLTNEAA  166 (208)
Q Consensus       158 ~~~l~~~~~  166 (208)
                      ++.|..+..
T Consensus       264 l~~l~~~~~  272 (317)
T d1xkka_         264 IIEFSKMAR  272 (317)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHh
Confidence            999887653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-34  Score=224.60  Aligned_cols=153  Identities=22%  Similarity=0.327  Sum_probs=124.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++..++..++.||+.||.|||++|   |+||||||+||+++.++.+||+|||++........  ......|++.|+|||
T Consensus       112 ~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE  186 (293)
T d1yhwa1         112 CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPE  186 (293)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccChh
Confidence            4788899999999999999999999   99999999999999999999999999987643322  123356899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc---CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMND  156 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  156 (208)
                      .+.+..++.++|+|||||++|+|++|..|+......  ..   .........+...+..+.+||.+||+.||++|||++|
T Consensus       187 ~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  266 (293)
T d1yhwa1         187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKE  266 (293)
T ss_dssp             HHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            999999999999999999999999999887543211  10   0000111223455678899999999999999999999


Q ss_pred             HHH
Q 028458          157 VVC  159 (208)
Q Consensus       157 i~~  159 (208)
                      +++
T Consensus       267 il~  269 (293)
T d1yhwa1         267 LLQ  269 (293)
T ss_dssp             HTT
T ss_pred             Hhc
Confidence            976

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-34  Score=226.18  Aligned_cols=158  Identities=26%  Similarity=0.370  Sum_probs=126.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.......... .....++..|+|||
T Consensus       111 ~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~-~~~~~g~~~y~aPE  186 (287)
T d1opja_         111 EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPE  186 (287)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE-ETTEEECGGGCCHH
T ss_pred             chHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCcee-eccccccccccChH
Confidence            4788899999999999999999999   9999999999999999999999999997664433222 12235678899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc------cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE------LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.++.++.++||||||+++|+|+++..|+.....      .+.... . ...+...+..+.+||.+||+.||++|||++
T Consensus       187 ~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  264 (287)
T d1opja_         187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-R-MERPEGCPEKVYELMRACWQWNPSDRPSFA  264 (287)
T ss_dssp             HHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC-C-CCCCccchHHHHHHHHHHcCCCHhHCcCHH
Confidence            99999999999999999999999997655432211      111111 1 122345567899999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      |+++.|+.+.
T Consensus       265 ei~~~L~~~~  274 (287)
T d1opja_         265 EIHQAFETMF  274 (287)
T ss_dssp             HHHHHHHHTT
T ss_pred             HHHHHHHHHH
Confidence            9999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-34  Score=226.29  Aligned_cols=160  Identities=22%  Similarity=0.270  Sum_probs=129.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-ccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~ap   80 (208)
                      .+++.++..++.||+.||.|||+++   ++||||||.||+++.++.+||+|||++......... .......+++.|+||
T Consensus       105 ~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aP  181 (285)
T d1u59a_         105 EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP  181 (285)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccCh
Confidence            4789999999999999999999999   999999999999999999999999999877543322 222334578899999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.++.++.++||||||+++|||++ |..|+.....     .+.....  ...+...+.++.+||.+||+.||++||++
T Consensus       182 E~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~RPs~  259 (285)
T d1u59a_         182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDF  259 (285)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             HHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCCHhHCcCH
Confidence            99999999999999999999999987 7777643221     1111111  12344566789999999999999999999


Q ss_pred             HHHHHHHhhhhh
Q 028458          155 NDVVCMLTNEAA  166 (208)
Q Consensus       155 ~~i~~~l~~~~~  166 (208)
                      .+|.+.|+....
T Consensus       260 ~~i~~~L~~~~~  271 (285)
T d1u59a_         260 LTVEQRMRACYY  271 (285)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHH
Confidence            999999987653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-34  Score=225.12  Aligned_cols=159  Identities=24%  Similarity=0.298  Sum_probs=126.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCccc-ccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQ-ANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~ap   80 (208)
                      .+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++++|||++......... .......|++.|+||
T Consensus       103 ~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~AP  179 (277)
T d1xbba_         103 HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP  179 (277)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCc
Confidence            4789999999999999999999999   999999999999999999999999999876443322 222334678899999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++||||||+++|||++ |..|+.....     .+....  ....+..++..+.+||.+||+.||++||++
T Consensus       180 E~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~--~~~~p~~~~~~~~~li~~cl~~dp~~RPs~  257 (277)
T d1xbba_         180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--RMGCPAGCPREMYDLMNLCWTYDVENRPGF  257 (277)
T ss_dssp             HHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             hhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC--CCCCCcccCHHHHHHHHHHcCCCHhHCcCH
Confidence            99999999999999999999999997 7777653221     111111  112234556788999999999999999999


Q ss_pred             HHHHHHHhhhh
Q 028458          155 NDVVCMLTNEA  165 (208)
Q Consensus       155 ~~i~~~l~~~~  165 (208)
                      ++|.+.|+...
T Consensus       258 ~~i~~~L~~~~  268 (277)
T d1xbba_         258 AAVELRLRNYY  268 (277)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHhhCHH
Confidence            99998887643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-34  Score=224.01  Aligned_cols=166  Identities=27%  Similarity=0.427  Sum_probs=126.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++|..++.++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++.......... .....+++.|.|||
T Consensus       109 ~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE  184 (285)
T d1fmka3         109 YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPE  184 (285)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHH
T ss_pred             cchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCcee-eccccccccccChH
Confidence            4799999999999999999999999   9999999999999999999999999997664333222 22245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc------cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE------LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      ++..+.++.++||||||+++|+|+++..++.....      .+... .. ...+...+..+.++|.+||+.||++||+++
T Consensus       185 ~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  262 (285)
T d1fmka3         185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YR-MPCPPECPESLHDLMCQCWRKEPEERPTFE  262 (285)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CC-CCCCcccCHHHHHHHHHHcccCHhHCcCHH
Confidence            99999999999999999999999987654422211      11111 01 123445567889999999999999999999


Q ss_pred             HHHHHHhhhhhccCCCCC
Q 028458          156 DVVCMLTNEAATLLPPKQ  173 (208)
Q Consensus       156 ~i~~~l~~~~~~~~~p~~  173 (208)
                      +|++.|+..-....|+..
T Consensus       263 ~i~~~L~~~~~~~~p~~~  280 (285)
T d1fmka3         263 YLQAFLEDYFTSTEPQYQ  280 (285)
T ss_dssp             HHHHHHHTTTSCSCCCCC
T ss_pred             HHHHHHhhhhcCCCCCCC
Confidence            999999987755544333

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-34  Score=227.47  Aligned_cols=155  Identities=26%  Similarity=0.334  Sum_probs=121.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++................||+.|+|||
T Consensus       104 ~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE  180 (288)
T d1uu3a_         104 SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE  180 (288)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCce
Confidence            5788899999999999999999999   9999999999999999999999999998775443333333457899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      .+.+..++.++|+|||||++|+|++|..|+.....  ............+...+.++.+||.+||+.||++|||++|+++
T Consensus       181 ~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             eeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            99999999999999999999999999988854321  1110000001123445677899999999999999999998744

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-34  Score=223.99  Aligned_cols=160  Identities=28%  Similarity=0.301  Sum_probs=129.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++................+++.|.|||
T Consensus       131 ~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  207 (299)
T d1fgka_         131 QLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE  207 (299)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhh
Confidence            4789999999999999999999999   9999999999999999999999999998765444333334456788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.++.|+.++|+||||+++|+|++ |..|+.....     .+.....  ...+...+..+.+||.+||+.||++|||+.
T Consensus       208 ~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~Rps~~  285 (299)
T d1fgka_         208 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFK  285 (299)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHccCCHhHCcCHH
Confidence            9999999999999999999999997 5655532211     1111110  022334566789999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ||++.|+++.+
T Consensus       286 eil~~L~~i~a  296 (299)
T d1fgka_         286 QLVEDLDRIVA  296 (299)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHhh
Confidence            99999998864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=8.7e-34  Score=219.00  Aligned_cols=156  Identities=25%  Similarity=0.372  Sum_probs=125.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+++++.|+++||.|||+++   |+||||||+||+++.++.+||+|||++.......... .....++..|+|||
T Consensus        96 ~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~t~~y~aPE  171 (258)
T d1k2pa_          96 RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPE  171 (258)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC-CCCSCCCGGGCCHH
T ss_pred             CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee-ecccCCCCCcCCcH
Confidence            4678899999999999999999999   9999999999999999999999999997665433222 22245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++||||||+++|||++ |..|+......     +....  ....+...+..+.++|.+||+.||++|||++
T Consensus       172 ~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~  249 (258)
T d1k2pa_         172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL--RLYRPHLASEKVYTIMYSCWHEKADERPTFK  249 (258)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             HhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC--CCCCcccccHHHHHHHHHHccCCHhHCcCHH
Confidence            9999999999999999999999997 67666432111     11110  0122334556789999999999999999999


Q ss_pred             HHHHHHhh
Q 028458          156 DVVCMLTN  163 (208)
Q Consensus       156 ~i~~~l~~  163 (208)
                      +|++.|..
T Consensus       250 eil~~L~d  257 (258)
T d1k2pa_         250 ILLSNILD  257 (258)
T ss_dssp             HHHHHHHC
T ss_pred             HHHHHhhC
Confidence            99999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.5e-33  Score=220.95  Aligned_cols=153  Identities=24%  Similarity=0.329  Sum_probs=121.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.......  .......|++.|+|||
T Consensus       106 ~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE  180 (288)
T d2jfla1         106 PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPE  180 (288)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHH
Confidence            4788999999999999999999999   9999999999999999999999999987543211  1122357899999999


Q ss_pred             hhc-----cCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---cCCccchhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           82 YAI-----QGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        82 ~~~-----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      .+.     ...|+.++|+|||||++|+|++|..|+......  .   ..........+...+.++.+||.+||+.||++|
T Consensus       181 ~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R  260 (288)
T d2jfla1         181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDAR  260 (288)
T ss_dssp             HHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred             HHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHC
Confidence            984     455789999999999999999999887543211  1   001111112234566788999999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      ||++|+++
T Consensus       261 ~t~~ell~  268 (288)
T d2jfla1         261 WTTSQLLQ  268 (288)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999976

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.2e-33  Score=219.99  Aligned_cols=159  Identities=26%  Similarity=0.262  Sum_probs=125.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .|++..++.++.|++.||.|||+++   |+||||||.||+++.++.+|++|||++.......... ......++..|.||
T Consensus       107 ~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aP  183 (273)
T d1u46a_         107 HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP  183 (273)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCH
Confidence            4789999999999999999999999   9999999999999999999999999998765443322 22234567889999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHH-hhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+..++.++|+||||+++|||++ |..|+......     +....... ..+...+..+.++|.+||+.||++|||+
T Consensus       184 E~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~  262 (273)
T d1u46a_         184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-PRPEDCPQDIYNVMVQCWAHKPEDRPTF  262 (273)
T ss_dssp             HHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-CCcccccHHHHHHHHHHcCCChhHCcCH
Confidence            99999999999999999999999997 77776432111     11111111 2234556788999999999999999999


Q ss_pred             HHHHHHHhhh
Q 028458          155 NDVVCMLTNE  164 (208)
Q Consensus       155 ~~i~~~l~~~  164 (208)
                      .+|++.|++.
T Consensus       263 ~ei~~~L~~~  272 (273)
T d1u46a_         263 VALRDFLLEA  272 (273)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHhc
Confidence            9999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=7.1e-33  Score=215.14  Aligned_cols=151  Identities=25%  Similarity=0.409  Sum_probs=118.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC-CCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++.++..++.||++||.|||+++. .|+||||||.||+++ .++.+||+|||++.......    .....||+.|+||
T Consensus       108 ~~~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aP  182 (270)
T d1t4ha_         108 VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAP  182 (270)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCG
T ss_pred             cccHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc----cCCcccCccccCH
Confidence            57888999999999999999999863 399999999999996 47899999999997543222    2235789999999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc------cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE------LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      |.+.+ +++.++|||||||++|+|++|..|+.....      .+.... .........+.++.++|.+||+.||++|||+
T Consensus       183 E~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~  260 (270)
T d1t4ha_         183 EMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KPASFDKVAIPEVKEIIEGCIRQNKDERYSI  260 (270)
T ss_dssp             GGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             HHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC-CCcccCccCCHHHHHHHHHHccCCHhHCcCH
Confidence            98865 699999999999999999999988753321      111111 1112233345678899999999999999999


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      +|+++
T Consensus       261 ~ell~  265 (270)
T d1t4ha_         261 KDLLN  265 (270)
T ss_dssp             HHHHT
T ss_pred             HHHhC
Confidence            99976

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-33  Score=219.69  Aligned_cols=158  Identities=21%  Similarity=0.286  Sum_probs=117.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..++.++.||++||.|||+++   ++||||||+||+++.++.+|++|||++......... ......+++.|.|||
T Consensus       104 ~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE  179 (273)
T d1mp8a_         104 SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE  179 (273)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcce-eccceecCcccchhh
Confidence            4788999999999999999999999   999999999999999999999999999765433221 122345788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc--cc---cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE--LI---DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.+..++.++|+||||+++|+|++ |..|+.....  ..   .....  ...+...+..+.+||.+||+.||++|||+.
T Consensus       180 ~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~  257 (273)
T d1mp8a_         180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFT  257 (273)
T ss_dssp             HHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCHhHCcCHH
Confidence            9999999999999999999999987 6666543211  11   11110  123445667899999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      ||++.|+.+.
T Consensus       258 ei~~~L~~i~  267 (273)
T d1mp8a_         258 ELKAQLSTIL  267 (273)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-33  Score=218.76  Aligned_cols=154  Identities=27%  Similarity=0.339  Sum_probs=113.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCC--CCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYS--RVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~--~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~a   79 (208)
                      .+++..+..++.||+.||.|||+++  ...|+||||||+||+++.++.+||+|||++.........  .....|++.|+|
T Consensus       105 ~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~A  182 (269)
T d2java1         105 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMS  182 (269)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCc--cccCCCCcccCC
Confidence            4788999999999999999999854  113999999999999999999999999999876433221  223568899999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCH
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTM  154 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  154 (208)
                      ||.+.+..++.++|+|||||++|+|++|..|+......     +......  ..+...+.++.+||.+||+.||++|||+
T Consensus       183 PE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~li~~~L~~dp~~Rps~  260 (269)
T d2java1         183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPSV  260 (269)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC--CCCcccCHHHHHHHHHHcCCChhHCcCH
Confidence            99999989999999999999999999999887532211     1111111  1234456788999999999999999999


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      +|+++
T Consensus       261 ~ell~  265 (269)
T d2java1         261 EEILE  265 (269)
T ss_dssp             HHHHT
T ss_pred             HHHHh
Confidence            99875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=4.3e-33  Score=220.28  Aligned_cols=148  Identities=31%  Similarity=0.400  Sum_probs=119.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++......      ....||+.|+|||
T Consensus       111 ~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------~~~~GT~~Y~APE  181 (309)
T d1u5ra_         111 PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPE  181 (309)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC------CccccCccccCHH
Confidence            5789999999999999999999999   999999999999999999999999999765332      2346899999999


Q ss_pred             hhcc---CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc---CCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           82 YAIQ---GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        82 ~~~~---~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      .+.+   +.|+.++|||||||++|+|++|..|+......  +.   ...... ......+..+.+||.+||+.||++|||
T Consensus       182 ~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rpt  260 (309)
T d1u5ra_         182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-LQSGHWSEYFRNFVDSCLQKIPQDRPT  260 (309)
T ss_dssp             HHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-CCCCCCCHHHHHHHHHHCcCChhHCcC
Confidence            9864   45889999999999999999999887533211  10   000000 122334567899999999999999999


Q ss_pred             HHHHHH
Q 028458          154 MNDVVC  159 (208)
Q Consensus       154 ~~~i~~  159 (208)
                      ++|+++
T Consensus       261 ~~ell~  266 (309)
T d1u5ra_         261 SEVLLK  266 (309)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-32  Score=218.01  Aligned_cols=161  Identities=25%  Similarity=0.321  Sum_probs=127.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc--cccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~a   79 (208)
                      .+++..+++++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..........  ......|+..|.|
T Consensus       126 ~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~a  202 (311)
T d1r0pa_         126 NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA  202 (311)
T ss_dssp             CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSC
T ss_pred             cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccC
Confidence            3567889999999999999999999   9999999999999999999999999998765433222  1222457889999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccccc------CCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID------DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      ||.+..+.++.++||||||+++|||+++..|+.......+      ...  ....+...+..+.++|.+||+.||++||+
T Consensus       203 PE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~--~~~~p~~~~~~l~~li~~cl~~dP~~RPs  280 (311)
T d1r0pa_         203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDPLYEVMLKCWHPKAEMRPS  280 (311)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             hHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--CCCCcccCcHHHHHHHHHHcCCCHhHCcC
Confidence            9999999999999999999999999997776643322110      000  00123345567899999999999999999


Q ss_pred             HHHHHHHHhhhhhc
Q 028458          154 MNDVVCMLTNEAAT  167 (208)
Q Consensus       154 ~~~i~~~l~~~~~~  167 (208)
                      +.||++.|+++...
T Consensus       281 ~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         281 FSELVSRISAIFST  294 (311)
T ss_dssp             HHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHh
Confidence            99999999998754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1e-32  Score=217.92  Aligned_cols=153  Identities=23%  Similarity=0.281  Sum_probs=113.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC---CCCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .+++..+..++.||+.||.|||+++   |+||||||.||++.   .++.+||+|||++........   .....||+.|+
T Consensus       103 ~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~GT~~y~  176 (307)
T d1a06a_         103 FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYV  176 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTS
T ss_pred             CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCCe---eeeeeeCcccc
Confidence            4788999999999999999999999   99999999999994   578899999999976543322   22356899999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      |||.+.+..++.++|+|||||++|+|++|..|+......      ...............+.++.+||.+||+.||++||
T Consensus       177 APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  256 (307)
T d1a06a_         177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF  256 (307)
T ss_dssp             CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred             CcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCc
Confidence            999999999999999999999999999999988543211      11111111122345567889999999999999999


Q ss_pred             CHHHHHHH
Q 028458          153 TMNDVVCM  160 (208)
Q Consensus       153 s~~~i~~~  160 (208)
                      |++|+++.
T Consensus       257 s~~eil~h  264 (307)
T d1a06a_         257 TCEQALQH  264 (307)
T ss_dssp             CHHHHHHS
T ss_pred             CHHHHhcC
Confidence            99999873

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.6e-33  Score=216.17  Aligned_cols=147  Identities=22%  Similarity=0.331  Sum_probs=121.1

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-CCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++.++..++.||+.||.|||+++   |+||||||+||+++. ++.++|+|||++.......    .....||..|+||
T Consensus       106 ~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aP  178 (273)
T d1xwsa_         106 ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPP  178 (273)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCcCCH
Confidence            4788899999999999999999999   999999999999985 4789999999997754332    2235689999999


Q ss_pred             chhccCCC-CCcchhHHHHHHHHHHHHhhhcCCcccccccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458           81 EYAIQGIF-SIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus        81 e~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      |.+.+..+ +.++|+|||||++|+|++|..|+....+......    ..+...+.++.+||.+||+.||++|||++|+++
T Consensus       179 E~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhccc----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            99987775 5678999999999999999998876544332111    122334567889999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=5e-32  Score=213.25  Aligned_cols=176  Identities=18%  Similarity=0.184  Sum_probs=133.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC---CCCeEEeccccceecCCCcccc-----ccccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGMARICGGNELQA-----NTSRIVG   73 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~   73 (208)
                      .+++..+..++.|++.||+|||+++   |+||||||+||+++.   +..++++|||++..........     ......|
T Consensus        99 ~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~g  175 (299)
T d1ckia_          99 KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG  175 (299)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCC
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCC
Confidence            5788999999999999999999999   999999999999753   4579999999998765433211     2233578


Q ss_pred             CCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccCCcc----------chhhhhHHHHHHHHHHHhhc
Q 028458           74 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDDPVL----------EDEYSSKQMLLRYVNIALLC  143 (208)
Q Consensus        74 ~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~  143 (208)
                      ++.|+|||.+.+..++.++|+|||||++|+|++|..|+............          .........+.++.+++..|
T Consensus       176 t~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~c  255 (299)
T d1ckia_         176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFC  255 (299)
T ss_dssp             CSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHH
T ss_pred             CccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHH
Confidence            99999999999989999999999999999999999887543222110111          00011223457789999999


Q ss_pred             cccCCCCCCCHHHHHHHHhhhhhccCCCCCCCccccc
Q 028458          144 VQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYVR  180 (208)
Q Consensus       144 l~~~p~~Rps~~~i~~~l~~~~~~~~~p~~~~~~~~~  180 (208)
                      |+.+|++||++.++.+.|+............+++|..
T Consensus       256 l~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~  292 (299)
T d1ckia_         256 RSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  292 (299)
T ss_dssp             HHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHH
T ss_pred             ccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchh
Confidence            9999999999999999988776554444444455543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-32  Score=219.09  Aligned_cols=157  Identities=24%  Similarity=0.351  Sum_probs=120.6

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+ ++   |+||||||+||+++.++.+||+|||++......    ......||+.|+||
T Consensus       100 ~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~AP  172 (322)
T d1s9ja_         100 RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP  172 (322)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCc
Confidence            47888999999999999999997 47   999999999999999999999999998765321    12335789999999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc----ccCCc-----------------------------cchhh
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL----IDDPV-----------------------------LEDEY  127 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----~~~~~-----------------------------~~~~~  127 (208)
                      |++.+..|+.++|+||+||++|+|++|..|+......    .....                             .....
T Consensus       173 Evl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (322)
T d1s9ja_         173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFE  252 (322)
T ss_dssp             HHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHH
T ss_pred             hHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHH
Confidence            9999999999999999999999999998887432110    00000                             00000


Q ss_pred             -------------hhHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HHhhhh
Q 028458          128 -------------SSKQMLLRYVNIALLCVQESADDRPTMNDVVC--MLTNEA  165 (208)
Q Consensus       128 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~--~l~~~~  165 (208)
                                   .....+.++.+||.+||+.||++|||++|+++  .+++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         253 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             HHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             HHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                         00012356889999999999999999999988  466543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=3.6e-32  Score=218.40  Aligned_cols=150  Identities=21%  Similarity=0.241  Sum_probs=122.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.......     ....|++.|+|||
T Consensus       137 ~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE  208 (350)
T d1rdqe_         137 RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPE  208 (350)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccccc-----ccccCccccCCHH
Confidence            4788899999999999999999999   9999999999999999999999999998764332     2356899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----CH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----TM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~  154 (208)
                      ++.+..++.++|+|||||++|+|++|..|+......  ...........+...+.++.++|.+||+.||.+|+     ++
T Consensus       209 ~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~  288 (350)
T d1rdqe_         209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGV  288 (350)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTT
T ss_pred             HHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccH
Confidence            999999999999999999999999999887543211  11000001122344567789999999999999994     89


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      +++++
T Consensus       289 ~ell~  293 (350)
T d1rdqe_         289 NDIKN  293 (350)
T ss_dssp             HHHHT
T ss_pred             HHHHc
Confidence            99986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.97  E-value=2.1e-32  Score=213.23  Aligned_cols=161  Identities=24%  Similarity=0.334  Sum_probs=122.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcc-cccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~ap   80 (208)
                      .+++.++..++.||++||.|||+++   |+||||||+||+++.++..+++|||.+........ ........|++.|+||
T Consensus       107 ~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP  183 (277)
T d1o6ya_         107 PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP  183 (277)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCH
Confidence            5789999999999999999999999   99999999999999999999999998865533222 1122335689999999


Q ss_pred             chhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--c----ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-C
Q 028458           81 EYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--L----IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-T  153 (208)
Q Consensus        81 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s  153 (208)
                      |.+.+..++.++|+||||+++|+|++|..|+.....  .    +..............+..+.++|.+||+.||++|| +
T Consensus       184 E~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~s  263 (277)
T d1o6ya_         184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT  263 (277)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred             HHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhH
Confidence            999998999999999999999999999988754321  1    11111111122344567889999999999999999 8


Q ss_pred             HHHHHHHHhhhh
Q 028458          154 MNDVVCMLTNEA  165 (208)
Q Consensus       154 ~~~i~~~l~~~~  165 (208)
                      ++++.+.|.++.
T Consensus       264 a~~l~~~l~r~~  275 (277)
T d1o6ya_         264 AAEMRADLVRVH  275 (277)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHh
Confidence            999999987753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8e-32  Score=212.50  Aligned_cols=163  Identities=25%  Similarity=0.294  Sum_probs=124.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc--------CCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc--ccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ--------YSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRI   71 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~--------~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~   71 (208)
                      .++|..+++++.|++.||.|||+        ++   |+||||||+||+++.++.+||+|||++..........  .....
T Consensus        96 ~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~  172 (303)
T d1vjya_          96 TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR  172 (303)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----C
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccce
Confidence            47899999999999999999997        46   9999999999999999999999999998764433221  22345


Q ss_pred             ccCCCccCcchhccCC------CCCcchhHHHHHHHHHHHHhhhcCCccccc--------------------c----cCC
Q 028458           72 VGTYGYMSPEYAIQGI------FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--------------------I----DDP  121 (208)
Q Consensus        72 ~~~~~~~ape~~~~~~------~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------------------~----~~~  121 (208)
                      .|++.|+|||.+.+..      ++.++|+|||||++|||++|..+++.....                    .    ..+
T Consensus       173 ~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p  252 (303)
T d1vjya_         173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP  252 (303)
T ss_dssp             CSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC
T ss_pred             ecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCC
Confidence            7899999999987543      567899999999999999987654321100                    0    001


Q ss_pred             ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhhhhhc
Q 028458          122 VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCMLTNEAAT  167 (208)
Q Consensus       122 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~  167 (208)
                      .++...........+.+++.+||+.||++|||+.||++.|+++...
T Consensus       253 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         253 NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            1222223344556789999999999999999999999999988754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.8e-32  Score=215.61  Aligned_cols=153  Identities=19%  Similarity=0.220  Sum_probs=123.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC---CCCeEEeccccceecCCCcccccccccccCCCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGYM   78 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~   78 (208)
                      .|++.++..|+.||+.||.|||+++   |+||||||+||+++.   .+.+||+|||++........   .....|++.|+
T Consensus       107 ~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~  180 (335)
T d2ozaa1         107 AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYV  180 (335)
T ss_dssp             CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSC
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCCc---cccccCCcccC
Confidence            5789999999999999999999999   999999999999975   46799999999987654332   22356899999


Q ss_pred             CcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccCCcc-chhhhhHHHHHHHHHHHhhccccCC
Q 028458           79 SPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDDPVL-EDEYSSKQMLLRYVNIALLCVQESA  148 (208)
Q Consensus        79 ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p  148 (208)
                      |||.+.+..|+.++|+|||||++|+|++|..|+......         +..... .+.......+.++.+||.+||+.||
T Consensus       181 aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  260 (335)
T d2ozaa1         181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP  260 (335)
T ss_dssp             CCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSST
T ss_pred             CcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCCh
Confidence            999999989999999999999999999999887433211         110111 0112234567789999999999999


Q ss_pred             CCCCCHHHHHHH
Q 028458          149 DDRPTMNDVVCM  160 (208)
Q Consensus       149 ~~Rps~~~i~~~  160 (208)
                      ++||++.|+++.
T Consensus       261 ~~R~s~~eil~h  272 (335)
T d2ozaa1         261 TQRMTITEFMNH  272 (335)
T ss_dssp             TTSCCHHHHHHS
T ss_pred             hHCcCHHHHHcC
Confidence            999999999873

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-32  Score=213.01  Aligned_cols=155  Identities=23%  Similarity=0.284  Sum_probs=119.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++|..+++++.||+.||.|||+.+   ++||||||+||+++.++.++++|||++.......     ....++..|+|||
T Consensus        99 ~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE  170 (262)
T d1byga_          99 VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPE  170 (262)
T ss_dssp             HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHH
T ss_pred             CCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC-----ccccccccCCChH
Confidence            3789999999999999999999998   9999999999999999999999999987653322     1234578899999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHH-hhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAW-DLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.++.++.++||||||+++|||++ |..|+.....     .+.....  ...+...+..+.++|.+||+.||++|||+.
T Consensus       171 ~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~Rps~~  248 (262)
T d1byga_         171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFL  248 (262)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcccCHhHCcCHH
Confidence            9999999999999999999999997 5555432211     1111111  123444567889999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      ++++.|+++..
T Consensus       249 ~l~~~L~~i~~  259 (262)
T d1byga_         249 QLREQLEHIKT  259 (262)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHh
Confidence            99999988753

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-32  Score=217.81  Aligned_cols=161  Identities=24%  Similarity=0.322  Sum_probs=128.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||++|+.|||+++   ++||||||+||+++.++.++++|||.+................+++.|+|||
T Consensus       141 ~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE  217 (311)
T d1t46a_         141 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE  217 (311)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHH
Confidence            4788999999999999999999999   9999999999999999999999999998776544333334457789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCC-cc--ccccc---CCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSN-RT--LELID---DPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~-~~--~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.++.++.++||||||+++|+|+++..++. ..  .+.+.   ...... ..+...+..+.+||.+||+.||++||+++
T Consensus       218 ~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~  296 (311)
T d1t46a_         218 SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFK  296 (311)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccccHHHHHHHHHHcCCChhHCcCHH
Confidence            9999999999999999999999998544332 21  11111   001111 12334567889999999999999999999


Q ss_pred             HHHHHHhhhhh
Q 028458          156 DVVCMLTNEAA  166 (208)
Q Consensus       156 ~i~~~l~~~~~  166 (208)
                      +|++.|++.-.
T Consensus       297 ~il~~L~~~i~  307 (311)
T d1t46a_         297 QIVQLIEKQIS  307 (311)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHhhc
Confidence            99999987543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-32  Score=217.74  Aligned_cols=159  Identities=26%  Similarity=0.370  Sum_probs=127.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+.+++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++................+++.|.|||
T Consensus       129 ~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe  205 (308)
T d1p4oa_         129 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE  205 (308)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHH
Confidence            3578899999999999999999998   9999999999999999999999999997765444433344456789999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhh-hcCCccc--c---cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDL-WTSNRTL--E---LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~-~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.++.++.++|+||||+++|||+++. .|+....  +   .+.+...  ...+...+..+.++|.+||+.||++|||+.
T Consensus       206 ~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~RPs~~  283 (308)
T d1p4oa_         206 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFL  283 (308)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC--CCCcccchHHHHHHHHHHcCCChhHCcCHH
Confidence            999999999999999999999999875 3432211  1   1111111  122344567899999999999999999999


Q ss_pred             HHHHHHhhhh
Q 028458          156 DVVCMLTNEA  165 (208)
Q Consensus       156 ~i~~~l~~~~  165 (208)
                      +|++.|++..
T Consensus       284 ~il~~L~~~~  293 (308)
T d1p4oa_         284 EIISSIKEEM  293 (308)
T ss_dssp             HHHHHHGGGS
T ss_pred             HHHHHHHHhc
Confidence            9999998764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.1e-32  Score=213.20  Aligned_cols=153  Identities=22%  Similarity=0.278  Sum_probs=121.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   |+||||||+||+++..+.++++|||++.......   ......||+.|+|||
T Consensus       112 ~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE  185 (305)
T d1blxa_         112 GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPE  185 (305)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhcccc---cCCCcccChhhcCcc
Confidence            4678889999999999999999999   9999999999999999999999999987543222   223457899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---------------------------cCCccchhhhhHHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---------------------------DDPVLEDEYSSKQM  132 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---------------------------~~~~~~~~~~~~~~  132 (208)
                      .+.+..|+.++|+||+||++|+|++|..|+......  .                           ..............
T Consensus       186 ~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (305)
T d1blxa_         186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI  265 (305)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSC
T ss_pred             hhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccC
Confidence            999999999999999999999999998887432110  0                           00000000112234


Q ss_pred             HHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          133 LLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       133 ~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      +..+.+||.+||+.||++|||++|+++.
T Consensus       266 s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         266 DELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            5678899999999999999999999873

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.97  E-value=5.1e-32  Score=217.43  Aligned_cols=156  Identities=19%  Similarity=0.227  Sum_probs=124.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC--CCCCeEEeccccceecCCCcccccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD--KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~a   79 (208)
                      .+++..+..++.||+.||.|||+++   ++||||||+||+++  .++.+||+|||++........   .....||+.|+|
T Consensus       120 ~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~a  193 (350)
T d1koaa2         120 KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAA  193 (350)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC---EEEECSCTTTCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccccc---cceecCcccccC
Confidence            4789999999999999999999999   99999999999995  457899999999987654332   223567999999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--ccc-----CCccchhhhhHHHHHHHHHHHhhccccCCCCCC
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LID-----DPVLEDEYSSKQMLLRYVNIALLCVQESADDRP  152 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  152 (208)
                      ||++.+..++.++|+|||||++|+|++|..|+.....  ...     ..... .......+..+.+||.+||+.||++||
T Consensus       194 PEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~  272 (350)
T d1koaa2         194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-DSAFSGISEDGKDFIRKLLLADPNTRM  272 (350)
T ss_dssp             HHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-CGGGGGCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-cccccCCCHHHHHHHHHHccCChhHCc
Confidence            9999999999999999999999999999988753211  111     01111 122344567789999999999999999


Q ss_pred             CHHHHHHH--Hhhh
Q 028458          153 TMNDVVCM--LTNE  164 (208)
Q Consensus       153 s~~~i~~~--l~~~  164 (208)
                      |++|+++.  |...
T Consensus       273 t~~eil~hp~~~~~  286 (350)
T d1koaa2         273 TIHQALEHPWLTPG  286 (350)
T ss_dssp             CHHHHHHSTTTSCT
T ss_pred             CHHHHhcCcccCCC
Confidence            99999984  5443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.3e-32  Score=217.48  Aligned_cols=153  Identities=20%  Similarity=0.276  Sum_probs=122.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.||+.||.|||+++   |+||||||+||+++.+|.+||+|||++........  ......||+.|+|||
T Consensus       101 ~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE  175 (337)
T d1o6la_         101 VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPE  175 (337)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGG
T ss_pred             CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhh
Confidence            4677889999999999999999999   99999999999999999999999999976533221  223357899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC-----H
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT-----M  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~  154 (208)
                      ++.+..|+.++|+|||||++|+|++|..|+.....  ............+...+.++.+||.+||+.||++|++     +
T Consensus       176 ~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~  255 (337)
T d1o6la_         176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA  255 (337)
T ss_dssp             GGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTH
T ss_pred             hccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccH
Confidence            99999999999999999999999999887743321  1110000111223445677889999999999999995     7


Q ss_pred             HHHHH
Q 028458          155 NDVVC  159 (208)
Q Consensus       155 ~~i~~  159 (208)
                      .|+++
T Consensus       256 ~eil~  260 (337)
T d1o6la_         256 KEVME  260 (337)
T ss_dssp             HHHHT
T ss_pred             HHHHc
Confidence            88876

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.2e-32  Score=212.72  Aligned_cols=153  Identities=24%  Similarity=0.255  Sum_probs=118.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.||+.||+|||+++   ++||||||+||+++.++.+||+|||++.........  .....|+..|+|||
T Consensus        96 ~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE  170 (299)
T d1ua2a_          96 VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPE  170 (299)
T ss_dssp             SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc--ccceecChhhccHH
Confidence            4677889999999999999999999   999999999999999999999999999765433221  12246789999999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccc--c---------------c-------------CCccchhhhhH
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I---------------D-------------DPVLEDEYSSK  130 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~---------------~-------------~~~~~~~~~~~  130 (208)
                      .+.+. .++.++|+|||||++|+|++|..++......  .               .             .+.........
T Consensus       171 ~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (299)
T d1ua2a_         171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS  250 (299)
T ss_dssp             HHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCT
T ss_pred             HHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcc
Confidence            98755 4789999999999999999998766322110  0               0             00000001112


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          131 QMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       131 ~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ..+.++.+||.+||+.||++|||++|+++
T Consensus       251 ~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         251 AAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            34567899999999999999999999987

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.97  E-value=5.7e-32  Score=217.30  Aligned_cols=156  Identities=22%  Similarity=0.250  Sum_probs=125.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeC--CCCCeEEeccccceecCCCcccccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLD--KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~a   79 (208)
                      .|++.++..++.||+.||.|||++|   |+||||||.||+++  .++.+||+|||++........   .....|++.|+|
T Consensus       123 ~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~a  196 (352)
T d1koba_         123 KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAA  196 (352)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCc---eeeccCcccccC
Confidence            4788999999999999999999999   99999999999997  568899999999988754332   223467889999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc-----ccCCcc-chhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL-----IDDPVL-EDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      ||++.+..++.++|+|||||++|+|++|..|+......     +..... .........+..+.+||.+||+.||++|||
T Consensus       197 PE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s  276 (352)
T d1koba_         197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT  276 (352)
T ss_dssp             HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             HHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC
Confidence            99999999999999999999999999999888543211     110111 111223456678899999999999999999


Q ss_pred             HHHHHHH--Hhh
Q 028458          154 MNDVVCM--LTN  163 (208)
Q Consensus       154 ~~~i~~~--l~~  163 (208)
                      ++|+++.  |+.
T Consensus       277 ~~eil~Hp~~~~  288 (352)
T d1koba_         277 VHDALEHPWLKG  288 (352)
T ss_dssp             HHHHHTSTTTSS
T ss_pred             HHHHhcCHhhCC
Confidence            9999873  544

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6e-32  Score=213.78  Aligned_cols=158  Identities=25%  Similarity=0.280  Sum_probs=124.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|++..+.+++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++........   .....++..|.|||
T Consensus       123 ~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE  196 (309)
T d1fvra_         123 TLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIE  196 (309)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEcccccccccccccc---ccceecCCcccchH
Confidence            4788999999999999999999999   99999999999999999999999999875432221   12245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhh-cCCcc--ccc---ccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLW-TSNRT--LEL---IDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN  155 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~-~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  155 (208)
                      .+.++.++.++||||||+++|+|+++.. |+...  .+.   +....  ....+...+..+.+||.+||+.||++||+++
T Consensus       197 ~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~  274 (309)
T d1fvra_         197 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVYDLMRQCWREKPYERPSFA  274 (309)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC--CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC--CCCCCccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            9999999999999999999999998764 34221  111   11110  1122345567899999999999999999999


Q ss_pred             HHHHHHhhhhhc
Q 028458          156 DVVCMLTNEAAT  167 (208)
Q Consensus       156 ~i~~~l~~~~~~  167 (208)
                      ||++.|+++...
T Consensus       275 eil~~L~~i~~~  286 (309)
T d1fvra_         275 QILVSLNRMLEE  286 (309)
T ss_dssp             HHHHHHHHHHHS
T ss_pred             HHHHHHHHHHhc
Confidence            999999887643

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=6.5e-32  Score=217.93  Aligned_cols=151  Identities=23%  Similarity=0.237  Sum_probs=121.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++........    ....||+.|+|||
T Consensus       103 ~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~----~~~~GT~~y~APE  175 (364)
T d1omwa3         103 VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPE  175 (364)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC----CSCCSCGGGCCHH
T ss_pred             cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCcc----cccccccccchhH
Confidence            4677889999999999999999999   99999999999999999999999999987654332    2346899999999


Q ss_pred             hhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCcccc-----cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC--
Q 028458           82 YAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE-----LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT--  153 (208)
Q Consensus        82 ~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps--  153 (208)
                      .+.. ..++.++|+|||||++|+|++|..|+.....     ............+...+.++.+||.+||+.||++||+  
T Consensus       176 ~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  255 (364)
T d1omwa3         176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCL  255 (364)
T ss_dssp             HHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTS
T ss_pred             HhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCc
Confidence            9865 4589999999999999999999988854221     1110111111223345677899999999999999999  


Q ss_pred             ---HHHHHH
Q 028458          154 ---MNDVVC  159 (208)
Q Consensus       154 ---~~~i~~  159 (208)
                         ++|+++
T Consensus       256 ~~~a~eil~  264 (364)
T d1omwa3         256 GRGAQEVKE  264 (364)
T ss_dssp             SSTHHHHHT
T ss_pred             ccCHHHHHc
Confidence               688876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=6.9e-32  Score=213.94  Aligned_cols=151  Identities=24%  Similarity=0.256  Sum_probs=121.8

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.......     ....|++.|+|||
T Consensus       100 ~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE  171 (316)
T d1fota_         100 RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPE  171 (316)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----CCCCSCTTTCCHH
T ss_pred             cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecccc-----ccccCcccccCHH
Confidence            3567788899999999999999999   9999999999999999999999999998765432     2357899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCC-----CH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRP-----TM  154 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~  154 (208)
                      .+.+..++.++|+|||||++|+|++|..|+.....  ............+...+.++.+++.+||+.||.+|+     ++
T Consensus       172 ~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~  251 (316)
T d1fota_         172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGT  251 (316)
T ss_dssp             HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTT
T ss_pred             HHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhH
Confidence            99998999999999999999999999988854321  111000001122344566788999999999999996     89


Q ss_pred             HHHHHH
Q 028458          155 NDVVCM  160 (208)
Q Consensus       155 ~~i~~~  160 (208)
                      +++++.
T Consensus       252 ~~il~H  257 (316)
T d1fota_         252 EDVKNH  257 (316)
T ss_dssp             HHHHTS
T ss_pred             HHHHcC
Confidence            999873

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.1e-31  Score=209.22  Aligned_cols=152  Identities=22%  Similarity=0.237  Sum_probs=122.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC----CeEEeccccceecCCCcccccccccccCCCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM----NPKISDFGMARICGGNELQANTSRIVGTYGY   77 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~   77 (208)
                      .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++    .+|++|||++.........   ....+++.|
T Consensus       109 ~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y  182 (293)
T d1jksa_         109 SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF  182 (293)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBC---SCCCCCGGG
T ss_pred             ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCCCccc---cccCCCCcc
Confidence            4788999999999999999999999   99999999999998766    4899999999876543321   224678899


Q ss_pred             cCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--c---ccCCccc-hhhhhHHHHHHHHHHHhhccccCCCCC
Q 028458           78 MSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--L---IDDPVLE-DEYSSKQMLLRYVNIALLCVQESADDR  151 (208)
Q Consensus        78 ~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~---~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R  151 (208)
                      +|||.+.+..++.++|+|||||++|+|++|..|+.....  .   +...... ........+..+.+||.+||+.||++|
T Consensus       183 ~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  262 (293)
T d1jksa_         183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR  262 (293)
T ss_dssp             CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGS
T ss_pred             cCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHC
Confidence            999999988899999999999999999999988754321  1   1111111 112233456778999999999999999


Q ss_pred             CCHHHHHH
Q 028458          152 PTMNDVVC  159 (208)
Q Consensus       152 ps~~~i~~  159 (208)
                      ||++|+++
T Consensus       263 ~s~~eil~  270 (293)
T d1jksa_         263 MTIQDSLQ  270 (293)
T ss_dssp             CCHHHHHH
T ss_pred             cCHHHHhc
Confidence            99999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.97  E-value=7.1e-31  Score=206.13  Aligned_cols=175  Identities=14%  Similarity=0.148  Sum_probs=135.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCC-----CCCeEEeccccceecCCCcccc-----ccccc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDK-----DMNPKISDFGMARICGGNELQA-----NTSRI   71 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~-----~~~~~l~dfg~~~~~~~~~~~~-----~~~~~   71 (208)
                      .++..++..++.|++.||.|||++|   |+||||||.||+++.     .+.++++|||++..........     .....
T Consensus        97 ~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~  173 (293)
T d1csna_          97 KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL  173 (293)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCC
T ss_pred             chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCce
Confidence            4788899999999999999999999   999999999999964     5679999999998764332211     12235


Q ss_pred             ccCCCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccccC----------CccchhhhhHHHHHHHHHHHh
Q 028458           72 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELIDD----------PVLEDEYSSKQMLLRYVNIAL  141 (208)
Q Consensus        72 ~~~~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~li~  141 (208)
                      .||+.|+|||.+.+..++.++|+||||+++|+|++|..|+.........          ...........++.++.+++.
T Consensus       174 ~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~  253 (293)
T d1csna_         174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMH  253 (293)
T ss_dssp             CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHH
T ss_pred             EEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHH
Confidence            7899999999999989999999999999999999999888532211100          000111122335567999999


Q ss_pred             hccccCCCCCCCHHHHHHHHhhhhhccCCCCCCCcccc
Q 028458          142 LCVQESADDRPTMNDVVCMLTNEAATLLPPKQPAFSYV  179 (208)
Q Consensus       142 ~~l~~~p~~Rps~~~i~~~l~~~~~~~~~p~~~~~~~~  179 (208)
                      .|++.+|++||+++.+.+.|+............+++|.
T Consensus       254 ~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~  291 (293)
T d1csna_         254 YARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  291 (293)
T ss_dssp             HHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             HHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence            99999999999999999998887766666555556553

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=4.7e-31  Score=205.51  Aligned_cols=152  Identities=22%  Similarity=0.277  Sum_probs=122.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++.++..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++........   .....|+..|.|||
T Consensus       106 ~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE  179 (277)
T d1phka_         106 TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPE  179 (277)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccCCCc---eeeeeccCCCCCHH
Confidence            4789999999999999999999999   99999999999999999999999999987754332   22356889999999


Q ss_pred             hhcc------CCCCCcchhHHHHHHHHHHHHhhhcCCccccc------ccCCccchhhhhHHHHHHHHHHHhhccccCCC
Q 028458           82 YAIQ------GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL------IDDPVLEDEYSSKQMLLRYVNIALLCVQESAD  149 (208)
Q Consensus        82 ~~~~------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  149 (208)
                      .+.+      ..++.++|+||+||++|+|++|..|+......      ...............+.++.+++.+||+.||+
T Consensus       180 ~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~  259 (277)
T d1phka_         180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQ  259 (277)
T ss_dssp             HHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGG
T ss_pred             HhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChh
Confidence            9863      23678999999999999999999888544321      11111111123345677899999999999999


Q ss_pred             CCCCHHHHHH
Q 028458          150 DRPTMNDVVC  159 (208)
Q Consensus       150 ~Rps~~~i~~  159 (208)
                      +||+++|+++
T Consensus       260 ~R~s~~eil~  269 (277)
T d1phka_         260 KRYTAEEALA  269 (277)
T ss_dssp             GSCCHHHHTT
T ss_pred             HCcCHHHHHc
Confidence            9999999876

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.6e-31  Score=206.74  Aligned_cols=159  Identities=19%  Similarity=0.230  Sum_probs=122.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||.|||+++   |+||||||.||+++.++.+|++|||++.........  .....|+..|.|||
T Consensus        98 ~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~apE  172 (298)
T d1gz8a_          98 GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPE  172 (298)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC--TTCCBCCCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCccc--ceeecccceeeehh
Confidence            4789999999999999999999999   999999999999999999999999999766433221  22246789999999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcCCccccc----------------cc-----C-------Cccch---hhhh
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLEL----------------ID-----D-------PVLED---EYSS  129 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----------------~~-----~-------~~~~~---~~~~  129 (208)
                      .+.... ++.++|+||||+++|+|++|..|+......                ..     .       .....   ....
T Consensus       173 ~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (298)
T d1gz8a_         173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV  252 (298)
T ss_dssp             HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHS
T ss_pred             hhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhc
Confidence            887666 478999999999999999998887422100                00     0       00000   0011


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhhh
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~  165 (208)
                      ...+.++.+|+.+||+.||++|||++|+++.  |+.+.
T Consensus       253 ~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         253 PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence            2234678899999999999999999999985  66553

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1e-31  Score=213.36  Aligned_cols=153  Identities=27%  Similarity=0.374  Sum_probs=121.9

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .++...+..++.||+.||.|||+++   ++||||||.||+++.++.++++|||++........  ......|++.|+|||
T Consensus        99 ~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE  173 (320)
T d1xjda_          99 KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPE  173 (320)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccccc--cccccCCCCCcCCHH
Confidence            3677889999999999999999999   99999999999999999999999999976543322  223357899999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccc--cccCCccchhhhhHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLE--LIDDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPTMN-DVV  158 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~i~  158 (208)
                      .+.+..++.++|+|||||++|+|++|..|+.....  ............+...+..+.+||.+||+.||++||++. +++
T Consensus       174 ~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            99999999999999999999999999988853221  111001111122334567789999999999999999995 675


Q ss_pred             H
Q 028458          159 C  159 (208)
Q Consensus       159 ~  159 (208)
                      +
T Consensus       254 ~  254 (320)
T d1xjda_         254 Q  254 (320)
T ss_dssp             G
T ss_pred             h
Confidence            4

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.4e-30  Score=206.80  Aligned_cols=152  Identities=20%  Similarity=0.241  Sum_probs=121.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCC--CCeEEeccccceecCCCcccccccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKD--MNPKISDFGMARICGGNELQANTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~a   79 (208)
                      .++..++..++.||+.||.|||+++   |+||||||.||+++.+  ..++++|||++........   .....+++.|.|
T Consensus        98 ~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~---~~~~~~t~~y~a  171 (321)
T d1tkia_          98 ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYA  171 (321)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCc---cccccccccccc
Confidence            4788999999999999999999999   9999999999999744  5799999999987644332   222457889999


Q ss_pred             cchhccCCCCCcchhHHHHHHHHHHHHhhhcCCccccc--c----cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC
Q 028458           80 PEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--I----DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT  153 (208)
Q Consensus        80 pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  153 (208)
                      ||.+.+..++.++|+|||||++|+|++|..|+......  .    ..............+.++.+||.+||..||++||+
T Consensus       172 pe~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s  251 (321)
T d1tkia_         172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT  251 (321)
T ss_dssp             HHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             chhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcC
Confidence            99999889999999999999999999999887543221  1    10000111222345677899999999999999999


Q ss_pred             HHHHHH
Q 028458          154 MNDVVC  159 (208)
Q Consensus       154 ~~~i~~  159 (208)
                      ++|+++
T Consensus       252 ~~eil~  257 (321)
T d1tkia_         252 ASEALQ  257 (321)
T ss_dssp             HHHHHH
T ss_pred             HHHHhc
Confidence            999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.3e-30  Score=205.95  Aligned_cols=160  Identities=23%  Similarity=0.283  Sum_probs=121.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc-cccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA-NTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~ap   80 (208)
                      .+++..+..++.|++.||.|||+++   |+||||||.||+++.++.+||+|||++.......... ......|+..|.||
T Consensus       105 ~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aP  181 (345)
T d1pmea_         105 HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP  181 (345)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechH
Confidence            4788999999999999999999999   9999999999999999999999999997654332221 22335678899999


Q ss_pred             chhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc---------ccCC------------------------ccchh
Q 028458           81 EYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL---------IDDP------------------------VLEDE  126 (208)
Q Consensus        81 e~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~~------------------------~~~~~  126 (208)
                      |.+.. ..++.++|+||+||++|+|++|..|+......         ...+                        .....
T Consensus       182 E~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (345)
T d1pmea_         182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN  261 (345)
T ss_dssp             GGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH
T ss_pred             HHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHH
Confidence            99854 45789999999999999999998887432210         0000                        00000


Q ss_pred             hhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhh
Q 028458          127 YSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNE  164 (208)
Q Consensus       127 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~  164 (208)
                      ......+.++.+|+.+||+.||++||++.|+++.  |+..
T Consensus       262 ~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         262 RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            1111233568899999999999999999999974  5443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.5e-30  Score=204.30  Aligned_cols=157  Identities=20%  Similarity=0.220  Sum_probs=120.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC-CeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .+++.++..++.||+.||+|||++|   |+||||||+||+++.++ .+||+|||++.........   ....|+..|.||
T Consensus       118 ~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aP  191 (350)
T d1q5ka_         118 TLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAP  191 (350)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCC---CSCCSCTTSCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCccc---ccccccccccCh
Confidence            4788899999999999999999999   99999999999999775 7999999999876443322   224678899999


Q ss_pred             chhcc-CCCCCcchhHHHHHHHHHHHHhhhcCCccccc--cc----------------------CCccc-------hhhh
Q 028458           81 EYAIQ-GIFSIKSDVFSFGVLLLEIAWDLWTSNRTLEL--ID----------------------DPVLE-------DEYS  128 (208)
Q Consensus        81 e~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~----------------------~~~~~-------~~~~  128 (208)
                      |.+.+ ..++.++|+||+||++|+|++|..|+......  ..                      .....       ....
T Consensus       192 E~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (350)
T d1q5ka_         192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF  271 (350)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTS
T ss_pred             HHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhc
Confidence            98865 46899999999999999999998877432110  00                      00000       0011


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhh
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNE  164 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~  164 (208)
                      ....+.++.+||.+||+.||++|||+.|+++.  |+.+
T Consensus       272 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         272 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            22345678899999999999999999999973  5554

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.6e-29  Score=200.37  Aligned_cols=156  Identities=20%  Similarity=0.243  Sum_probs=116.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccc--cccccccCCCccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMS   79 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~a   79 (208)
                      .++...+..++.|++.||.|||+++   |+||||||+||+++.++.++++|||++..........  ......||+.|+|
T Consensus       113 ~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~a  189 (318)
T d3blha1         113 KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP  189 (318)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCC
T ss_pred             ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhh
Confidence            3566788999999999999999999   9999999999999999999999999997765433222  1223468899999


Q ss_pred             cchhccC-CCCCcchhHHHHHHHHHHHHhhhcCCcccccc-----------------------------cCCc-----cc
Q 028458           80 PEYAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI-----------------------------DDPV-----LE  124 (208)
Q Consensus        80 pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----------------------------~~~~-----~~  124 (208)
                      ||.+.+. .++.++|+|||||++|+|++|..|+.......                             ....     ..
T Consensus       190 PE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (318)
T d3blha1         190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK  269 (318)
T ss_dssp             HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHH
T ss_pred             HHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccch
Confidence            9998765 58899999999999999999987764211100                             0000     00


Q ss_pred             hhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          125 DEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       125 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                      ...........+.+||.+||+.||++|||++|+++.
T Consensus       270 ~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         270 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            000011123457789999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.96  E-value=3.9e-30  Score=201.11  Aligned_cols=153  Identities=23%  Similarity=0.273  Sum_probs=116.4

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+...+..++.||+.||.|||+.+   |+||||||+||+++.++.+|++|||.+.........  .....++..|.|||
T Consensus        96 ~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~y~~pE  170 (286)
T d1ob3a_          96 GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPD  170 (286)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHH
T ss_pred             CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCccc--cceecccchhhhHH
Confidence            4788899999999999999999999   999999999999999999999999999776443321  12235678999999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcCCcccccc---------------------c----------CCccchhhhh
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------------------D----------DPVLEDEYSS  129 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------------------~----------~~~~~~~~~~  129 (208)
                      .+.+.. ++.++|+||||+++|+|++|..|+......-                     .          ..........
T Consensus       171 ~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (286)
T d1ob3a_         171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL  250 (286)
T ss_dssp             HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTC
T ss_pred             HHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhc
Confidence            987654 6899999999999999999988874321100                     0          0000011122


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          130 KQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       130 ~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ...+..+.+||.+||+.||++|||++|+++
T Consensus       251 ~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         251 KGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            334567889999999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.6e-29  Score=202.60  Aligned_cols=156  Identities=23%  Similarity=0.235  Sum_probs=122.3

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|++..+..++.||+.||.|||++|   |+||||||.||+++.++.++++|||++.......     ....++..|+|||
T Consensus       117 ~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE  188 (346)
T d1cm8a_         117 KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPE  188 (346)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTH
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCcc-----ccccccccccCHH
Confidence            4788999999999999999999999   9999999999999999999999999998764432     2346788999999


Q ss_pred             hhccC-CCCCcchhHHHHHHHHHHHHhhhcCCccccccc---------------------------------CCccchhh
Q 028458           82 YAIQG-IFSIKSDVFSFGVLLLEIAWDLWTSNRTLELID---------------------------------DPVLEDEY  127 (208)
Q Consensus        82 ~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---------------------------------~~~~~~~~  127 (208)
                      .+.+. .++.++|+||+||++|+|++|..|+........                                 ........
T Consensus       189 ~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (346)
T d1cm8a_         189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS  268 (346)
T ss_dssp             HHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGG
T ss_pred             HHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHH
Confidence            98764 468999999999999999999887743211000                                 00000001


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhhhh
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVCM--LTNEA  165 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~--l~~~~  165 (208)
                      .....+..+.+||.+||..||++|||++|+++.  |+.+.
T Consensus       269 ~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            122334567899999999999999999999984  66554

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.95  E-value=8.9e-29  Score=196.85  Aligned_cols=152  Identities=16%  Similarity=0.205  Sum_probs=117.2

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCC-CeEEeccccceecCCCcccccccccccCCCccCc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDM-NPKISDFGMARICGGNELQANTSRIVGTYGYMSP   80 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap   80 (208)
                      .|+...+..++.||+.||.|||++|   |+||||||+||+++.++ .++++|||++........   .....++..|.||
T Consensus       125 ~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aP  198 (328)
T d3bqca1         125 TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGP  198 (328)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCc
Confidence            5788899999999999999999999   99999999999998655 589999999987654322   2234678899999


Q ss_pred             chhccCC-CCCcchhHHHHHHHHHHHHhhhcCCccccccc-------------------------------------CC-
Q 028458           81 EYAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELID-------------------------------------DP-  121 (208)
Q Consensus        81 e~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-------------------------------------~~-  121 (208)
                      |.+.+.. ++.++|+||+||+++++++|..|+........                                     .. 
T Consensus       199 E~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (328)
T d3bqca1         199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR  278 (328)
T ss_dssp             HHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCC
T ss_pred             ccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccc
Confidence            9987654 79999999999999999998877643211000                                     00 


Q ss_pred             --ccchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          122 --VLEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       122 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                        ...........+.++.+||.+||+.||++|||++|+++
T Consensus       279 ~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         279 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00000112223467889999999999999999999987

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=8.7e-29  Score=193.66  Aligned_cols=153  Identities=20%  Similarity=0.186  Sum_probs=117.0

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.++++|||.+..........  ....++..|.|||
T Consensus        97 ~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~~~~~~pe  171 (292)
T d1unla_          97 DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPD  171 (292)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC--CSCCSCGGGCCHH
T ss_pred             ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCccc--eeeccccchhhhh
Confidence            4678899999999999999999999   9999999999999999999999999998765433222  1234567899999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcCCcccccc--------------------------------cCCccchhhh
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI--------------------------------DDPVLEDEYS  128 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~  128 (208)
                      .+.... ++.++|+|||||++|+|++|..|+.......                                ..........
T Consensus       172 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (292)
T d1unla_         172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV  251 (292)
T ss_dssp             HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTT
T ss_pred             HhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhc
Confidence            887665 5899999999999999999887652211100                                0000001012


Q ss_pred             hHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 028458          129 SKQMLLRYVNIALLCVQESADDRPTMNDVVC  159 (208)
Q Consensus       129 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~  159 (208)
                      ....+..+.+|+.+||+.||++|||++|+++
T Consensus       252 ~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2334567889999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.5e-29  Score=197.23  Aligned_cols=153  Identities=22%  Similarity=0.247  Sum_probs=118.1

Q ss_pred             ccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcch
Q 028458            3 LDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY   82 (208)
Q Consensus         3 l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~   82 (208)
                      ++...+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.......... .....|++.|.+||.
T Consensus       126 ~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~  201 (322)
T d1vzoa_         126 FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDI  201 (322)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHH
T ss_pred             ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhccccccc-ccccccccccchhHH
Confidence            456778889999999999999999   9999999999999999999999999998764433322 223567899999999


Q ss_pred             hccCC--CCCcchhHHHHHHHHHHHHhhhcCCcccccc------cCCccchhhhhHHHHHHHHHHHhhccccCCCCCCC-
Q 028458           83 AIQGI--FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------DDPVLEDEYSSKQMLLRYVNIALLCVQESADDRPT-  153 (208)
Q Consensus        83 ~~~~~--~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-  153 (208)
                      +.+..  ++.++|||||||++|+|++|..|+.......      ..........+...+..+.++|.+||+.||++||+ 
T Consensus       202 ~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~  281 (322)
T d1vzoa_         202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC  281 (322)
T ss_dssp             HTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             hhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence            97654  6789999999999999999998874332111      00000000123356778999999999999999994 


Q ss_pred             ----HHHHHH
Q 028458          154 ----MNDVVC  159 (208)
Q Consensus       154 ----~~~i~~  159 (208)
                          ++|+++
T Consensus       282 ~~~t~~eil~  291 (322)
T d1vzoa_         282 GPRDADEIKE  291 (322)
T ss_dssp             STTTHHHHHT
T ss_pred             CcccHHHHHc
Confidence                788886

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=8.5e-28  Score=193.18  Aligned_cols=153  Identities=24%  Similarity=0.270  Sum_probs=114.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      -+++..+..++.||+.||.|||++|   |+||||||.||+++.++.++++|||++........   .....++..|+|||
T Consensus       115 ~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE  188 (355)
T d2b1pa1         115 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPE  188 (355)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccccc---cccccccccccChh
Confidence            4678899999999999999999999   99999999999999999999999998776543322   12245788999999


Q ss_pred             hhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc----------------------------cC-------------
Q 028458           82 YAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI----------------------------DD-------------  120 (208)
Q Consensus        82 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~----------------------------~~-------------  120 (208)
                      .+.+..++.++|+||+||++++|++|..|+.......                            ..             
T Consensus       189 ~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (355)
T d2b1pa1         189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLF  268 (355)
T ss_dssp             HHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHS
T ss_pred             hhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccc
Confidence            9999999999999999999999999988763221000                            00             


Q ss_pred             --Cc-cchhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          121 --PV-LEDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       121 --~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                        .. ..........+.++.+||.+||+.||++|||++|+++.
T Consensus       269 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         269 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              00 00001233456778999999999999999999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.5e-28  Score=195.69  Aligned_cols=156  Identities=25%  Similarity=0.268  Sum_probs=116.5

Q ss_pred             CccHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcc
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE   81 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape   81 (208)
                      .|+..++..++.||+.||.|||++|   |+||||||+||+++.++.++++|||++......     .....|+..|.|||
T Consensus       117 ~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE  188 (348)
T d2gfsa1         117 KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE  188 (348)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHH
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCcc-----cccccccccccCch
Confidence            4788899999999999999999999   999999999999999999999999998654322     22245678899999


Q ss_pred             hhccCC-CCCcchhHHHHHHHHHHHHhhhcCCcccccc---------------------------------cCCccchhh
Q 028458           82 YAIQGI-FSIKSDVFSFGVLLLEIAWDLWTSNRTLELI---------------------------------DDPVLEDEY  127 (208)
Q Consensus        82 ~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------------------------------~~~~~~~~~  127 (208)
                      ...+.. ++.++|+|||||++|+|++|..|+.......                                 .........
T Consensus       189 ~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (348)
T d2gfsa1         189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN  268 (348)
T ss_dssp             HHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHH
T ss_pred             hhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhh
Confidence            876654 5889999999999999999988764221100                                 000000000


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HHhhhh
Q 028458          128 SSKQMLLRYVNIALLCVQESADDRPTMNDVVC--MLTNEA  165 (208)
Q Consensus       128 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~--~l~~~~  165 (208)
                      .....+..+.+||.+||+.||++|||++|+++  .|.+..
T Consensus       269 ~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         269 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence            11223456789999999999999999999998  466554

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.93  E-value=1.3e-26  Score=186.41  Aligned_cols=151  Identities=22%  Similarity=0.232  Sum_probs=115.7

Q ss_pred             CccHHHHHHHHHHHHHHHHhhcc-CCCCceEeeCCCCCeeEeCCCCC------eEEeccccceecCCCcccccccccccC
Q 028458            2 LLDWVTRVRIIEGIAQGLLYLHQ-YSRVRIIHRDLKVSNILLDKDMN------PKISDFGMARICGGNELQANTSRIVGT   74 (208)
Q Consensus         2 ~l~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~h~~l~~~nil~~~~~~------~~l~dfg~~~~~~~~~~~~~~~~~~~~   74 (208)
                      .++...+..++.||+.|+.|||+ .|   |+||||||.||+++.++.      ++++|||.+.......     ....|+
T Consensus       121 ~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt  192 (362)
T d1q8ya_         121 GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQT  192 (362)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSC
T ss_pred             CCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeeccccccccccc-----cccccc
Confidence            35677889999999999999997 77   999999999999976543      8999999987653222     234678


Q ss_pred             CCccCcchhccCCCCCcchhHHHHHHHHHHHHhhhcCCcccccc------------------------------------
Q 028458           75 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIAWDLWTSNRTLELI------------------------------------  118 (208)
Q Consensus        75 ~~~~ape~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------------------------------------  118 (208)
                      ..|+|||.+.+..++.++|+||+||++++|++|..|+.......                                    
T Consensus       193 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~  272 (362)
T d1q8ya_         193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR  272 (362)
T ss_dssp             GGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC-
T ss_pred             ccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccc
Confidence            89999999999999999999999999999999887753211100                                    


Q ss_pred             ------cCCc---c-----chhhhhHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 028458          119 ------DDPV---L-----EDEYSSKQMLLRYVNIALLCVQESADDRPTMNDVVCM  160 (208)
Q Consensus       119 ------~~~~---~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i~~~  160 (208)
                            ....   .     .........+..+.+||.+||..||++|||++|+++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         273 GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             -CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             hhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  0000   0     0001134556788999999999999999999999874

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.26  E-value=2.5e-13  Score=98.73  Aligned_cols=86  Identities=19%  Similarity=0.172  Sum_probs=59.4

Q ss_pred             cHHHHHHHHHHHHHHHHhhccCCCCceEeeCCCCCeeEeCCCCCeEEeccccceecCCCcccccccccccCCCccCcchh
Q 028458            4 DWVTRVRIIEGIAQGLLYLHQYSRVRIIHRDLKVSNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA   83 (208)
Q Consensus         4 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ape~~   83 (208)
                      +......++.|++.++.|||+.+   ++||||||.||+++.++ ++++|||.+..............-...    -.+.+
T Consensus       101 ~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~~f  172 (191)
T d1zara2         101 RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRN----IITYF  172 (191)
T ss_dssp             CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHHHHHHHHHHH----HHHHH
T ss_pred             hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECCCcccCCCCCcHHHHHHHHHH----HHHHH
Confidence            44556789999999999999999   99999999999998664 889999998765433211100000000    00111


Q ss_pred             ccCCCCCcchhHHHH
Q 028458           84 IQGIFSIKSDVFSFG   98 (208)
Q Consensus        84 ~~~~~~~~~Dv~slG   98 (208)
                       .++|+..+|+|++.
T Consensus       173 -~r~y~~~~d~~s~~  186 (191)
T d1zara2         173 -SRTYRTEKDINSAI  186 (191)
T ss_dssp             -HHHHCCCCCHHHHH
T ss_pred             -cCCCCCcccHHHHH
Confidence             35678889999964

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.17  E-value=0.021  Score=42.69  Aligned_cols=29  Identities=31%  Similarity=0.339  Sum_probs=26.0

Q ss_pred             eEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           30 IIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        30 i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      ++|+|+.++|++++.+....+.||+.++.
T Consensus       185 iIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         185 VIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCcchhhhhcccccceeEeccccccc
Confidence            99999999999999887778999997753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=92.99  E-value=0.041  Score=39.62  Aligned_cols=29  Identities=28%  Similarity=0.328  Sum_probs=24.8

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEeccccce
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMAR   57 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~   57 (208)
                      .++|+|+.+.||+++.++.+.++||+.+.
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhcc
Confidence            38999999999999987667799998654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=92.27  E-value=0.026  Score=40.54  Aligned_cols=30  Identities=20%  Similarity=0.310  Sum_probs=25.1

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.||+++.+..+.++||+.+..
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            389999999999998876678999986543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=87.51  E-value=0.45  Score=35.35  Aligned_cols=28  Identities=32%  Similarity=0.396  Sum_probs=22.9

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.||+++++  ..++||+.++.
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            48999999999999754  45789987764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=87.20  E-value=0.16  Score=39.09  Aligned_cols=29  Identities=28%  Similarity=0.368  Sum_probs=24.8

Q ss_pred             ceEeeCCCCCeeEeCCCCCeEEecccccee
Q 028458           29 RIIHRDLKVSNILLDKDMNPKISDFGMARI   58 (208)
Q Consensus        29 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   58 (208)
                      .++|+|+.+.||+++.++ ++++||.++..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            399999999999998764 89999987654